Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.7674234567361152,-2.7791779961433396,0.0,0.0,0.0,72/91,15.71%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;SRPRA;RPL30;RPS3;RPL19;RPS21;RPL4;RPL32;RPL21;RPS16;RPL18;SSR1;RPL5;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;ARL6IP1;RPL17;RPL23;SEC62;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;RPL36A;RPL6;SRP14;RPL31;RPSA;RPS26;RPL36
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7682093190082728,-2.759301107202183,0.0,0.0,0.0,69/87,15.71%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPS3;RPL19;RPS21;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;RPL17;RPL23;SEC61B;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;RPL36A;RPL6;SRP14;RPL31;RPSA;RPS26;RPL36
prerank,protein targeting to ER (GO:0045047),-0.7491365036545644,-2.7571617495129828,0.0,0.0,0.0,78/99,18.40%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;SRPRA;RPL30;RPS3;RPL19;RPS21;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;RPL17;RPL23;SEC62;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;RPL36A;RPL6;SGTB;SRP14;RPL31;RPSA;SPCS1;RPS26;RPL36;SRPRB;RPL13A;ZFAND2B;CHMP4B;CHMP4A;RPL35
prerank,cytoplasmic translation (GO:0002181),-0.7316450342213529,-2.6396579191101197,0.0,0.0,0.0,68/91,15.71%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPS3;RPL19;RPS21;EIF3M;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPS4X;EIF2B3;RPS5;RPL36A;RPL6;RPL31;RPSA;RPS26;RPL36
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6632823018602048,-2.491717407681056,0.0,0.0,0.0,80/110,20.81%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPS3;RPL19;RPS21;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;PPP2R1A;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;RPL36A;RPL6;SMG5;RPL31;RPSA;RPS26;RPL36;RNPS1;PABPC1;RPL13A;PNRC2;RPL35;RPL24;RPS13;HELZ2;RPL11;DHX34;EIF4A3
prerank,peptide biosynthetic process (GO:0043043),-0.5864108550617522,-2.274487664759237,0.0,0.0,0.0,70/153,15.07%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPS3;RPL19;RPS21;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;PCSK5;RPS7;RPL39;ABCF1;RPL14;RPS17;RPL28;RPL34;EEF1A1;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;RPL36A;RPL6;RPL31;HBS1L;RPSA;RPS26
prerank,translation (GO:0006412),-0.5294213442116754,-2.1664272330886485,0.0,0.0,0.0,106/208,25.37%,RPS24;RPS12;LARS2;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPS3;WARS2;EEF2K;RPL19;RPS21;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;ABCF1;RPL14;RPS17;RPL28;RPL34;EEF1A1;RPL12;RPL9;RPS25;GARS1;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;DARS2;RPL36A;RPL6;RPL31;HBS1L;RPSA;RPS26;ABCE1;RPL36;APEH;EEFSEC;RPL13A;RPL35;MRPL16;EEF2;COPS5;RPL24;RPS13;MRPL34;RPL11;CARS1;EEF1D;RSL24D1;IARS1;MRPS2;MRPS16;RPL22L1;MRPS21;MRPL10;MRPL13;TUFM;EEF1G;RPS27A;MRPS33;NDUFA7;EIF4EBP2;MRPL35;EEF1A2;GTPBP2
prerank,glutamate receptor signaling pathway (GO:0007215),-0.6902285309357982,-2.1254099431196405,0.0,0.0005280326291367749,0.004,22/37,15.42%,GRID2;GRIK2;GRIA4;GRM7;GRM5;GRM3;GRIK1;GRIN2B;GRIA2;GRM8;PTK2B;GRIA3;GRIK4;GRIN3A;APP;GRIN2A;GRM1;KCNB1;HOMER1;CDK5R1;GRIN1;GRIK3
prerank,positive regulation of cell junction assembly (GO:1901890),-0.6362567180124532,-2.124103723942759,0.0,0.0004693623370104666,0.004,18/56,8.32%,NRP1;NLGN1;CNTNAP2;NRXN1;GRID2;PTPRD;IL1RAPL1;PTPRJ;TEK;CAV1;CLSTN2;CLDN5;EPHB1;IL1RAP;SYNDIG1;KDR;EPHB2;MYOC
prerank,action potential (GO:0001508),-0.6626211973187648,-2.1047590669779823,0.0,0.0011616717841009048,0.009,18/44,15.36%,KCND2;ANK3;AKAP6;KCNJ2;SCN1A;SCN2A;KCNMB2;CACNA1G;SCN7A;KCNQ1;SCN3A;SCN9A;KCNB1;GPER1;GNA14;SCN8A;KCNE4;CACNA1H
prerank,regulation of synapse assembly (GO:0051963),-0.6365747181761352,-2.0487642511598962,0.0,0.003264201707390972,0.027,18/46,10.87%,NLGN1;NRXN1;GRID2;MEF2C;PTPRD;ROBO2;IL1RAPL1;CLSTN2;GPC6;EPHB1;LRFN5;IL1RAP;IL1RAPL2;SYNDIG1;APP;EPHB2;SLITRK1;GPC4
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5033961044532549,-2.036709039013115,0.0,0.003696228403957424,0.034,90/168,21.58%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPS3;RPL19;RPS21;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;PPP2R1A;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;RPL12;RPL9;RPS25;CNOT2;RPL7A;RPS2;RPS9;RPS11;DCP1B;RPS10;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;TNKS1BP1;RPL36A;RPL6;SMG5;RPL31;RPSA;RPS26;NBAS;RPL36;RNPS1;PABPC1;RPL13A;PNRC2;XRN2;RPL35;ERI1;RPL24;RPS13;HELZ2;RPL11;DHX34;LSM1;EIF4A3;DCP2;CNOT7;CNOT6L
prerank,regulation of fatty acid oxidation (GO:0046320),0.8549621900376402,1.9581285497785086,0.0,0.2385219942293066,0.176,4/16,1.76%,PRKAG2;APPL2;PPARGC1A;PPARA
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.5355560358691396,-1.9442684533910328,0.0,0.019415353594413723,0.188,30/88,13.77%,NRP1;PTPRM;TEK;CDH13;CAV1;BMPR2;VEGFC;THBS1;NRP2;SEMA5A;TIE1;PPP1R16B;CAV2;F3;ACVRL1;AKT3;KDR;APOE;ECM1;BMP2;PROX1;ATOH8;XDH;FGF2;FLT4;ITGB3;BMP4;HIF1A;PRKD1;VEGFA
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.6969175900305052,-1.9385109352908432,0.0,0.020216106372665094,0.206,9/25,7.01%,PDE4D;SPTBN1;PDE4B;RUNX1;ANXA1;PTPRC;RPS3;PLCG2;MAP3K7
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.4672466662048071,-1.9329634695966948,0.0,0.021121305165470994,0.232,72/224,13.31%,NLGN1;DLG2;NRXN1;GRIK2;KCND2;SYT1;GRIA4;CACNB2;GRM7;GRM5;SLC12A7;CACNA1E;GRM3;SNAP25;CHRM3;GABRG3;GRIK1;HTR2C;GABRB3;GRIN2B;GRIA1;GRIA2;GABRB1;RIT2;GABRA3;PLP1;KCNQ3;GLRB;GRIA3;SLC1A2;DLGAP1;GABRA2;UNC13B;GRIK4;SLC1A1;APBA2;SYN2;PDE7B;GABRB2;MBP;GLRA3;MINK1;CALM1;PTCHD1;HTR2A;GRIN2A;CACNA1B;AMPH;SYPL1;CHRM2;GRM1;CAMK4;GLRA1;GABRG2;HTR1F;GABBR2;HTR7;CAMKK2;RPS6KA3;RPS6KA2;GABRA4;SLC12A4;GABRG1;NRXN2;HCRTR2;PRKAR1B;PRKAR2B;HOMER1;HTR4;SLC12A6;SNCA;GLRA2
prerank,neuron development (GO:0048666),-0.4967789807922921,-1.9323290117976595,0.0,0.020131243985839542,0.235,41/141,9.93%,FRY;NLGN1;CNTNAP2;TENM2;MEF2C;PTPRM;CNTN4;EPHA5;TENM3;TGFB2;PLP1;TENM4;PBX3;RUNX1;ATP8A2;SH3GL2;UGCG;NTRK2;MYT1L;TMEM108;GPM6B;LYN;GSK3B;STX3;APOE;APP;STMN2;VSX1;B4GALT5;DCX;SRRM4;ULK1;LGI1;MYOC;GPRIN3;RASGRF1;ETV1;PPT1;RP1;PBX1;UHMK1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.8135152712085343,-1.928387761099728,0.0,0.0209970621939094,0.261,8/13,10.44%,PDE4D;SLC8A1;CAV1;ANK3;CAMK2D;CALM1;CALM2;CALM3
prerank,angiogenesis involved in wound healing (GO:0060055),-0.8338927093367091,-1.92365299661647,0.0,0.021414656626102535,0.275,8/11,13.77%,ADIPOR2;CD34;NDNF;KDR;GATA2;MCAM;ITGB3;VEGFA
prerank,dendrite self-avoidance (GO:0070593),-0.7675719932582196,-1.91842579283067,0.0022522522522522522,0.021955040895686954,0.296,7/16,8.05%,BSG;CNTN4;NPTN;DSCAML1;CNTN6;ROBO4;EMB
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.8235706374391162,-1.9135497169972222,0.0,0.022388583475399258,0.318,7/12,10.44%,PDE4D;CAV1;CAMK2D;GJD3;CALM1;CALM2;CALM3
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.6804977006096147,-1.9127781443996499,0.0,0.021624193383696498,0.323,10/25,13.16%,NRP1;ITGA6;THBS1;AR;APP;PSEN1;BTBD10;PTH1R;ILK;SNCA
prerank,positive regulation of nervous system development (GO:0051962),-0.5992645754154035,-1.9113940078304743,0.0,0.021121305165470998,0.327,14/42,11.23%,NLGN1;NRXN1;GRID2;PTPRD;IL1RAPL1;CLSTN2;EPHB1;IL1RAP;SYNDIG1;SERPINF1;EPHB2;MME;NAP1L1;GPER1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.5968840817494712,-1.885953229509175,0.00273224043715847,0.03218703243694602,0.465,17/39,8.46%,ACTN4;GCNT2;THBS1;EFNA5;CASK;ACER2;NEXMIF;JAG1;NOTCH1;SEMA3E;AJAP1;FZD4;CORO2B;ADAM15;CORO1C;MYOC;SPOCK1
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.7427893661721002,-1.881671080034935,0.0,0.034014101860227255,0.493,11/17,10.04%,SERPINE2;TENM4;NOTCH1;HES1;TNFRSF1B;PTPRZ1;BIN1;BMP2;TGFB1;PTN;ID2
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.4681942267032578,-1.8790762748856962,0.0,0.03404754392673924,0.504,46/159,8.05%,NLGN1;ADGRL3;CDH11;GRID2;TENM2;LRRC4C;CADM1;PTPRM;PTPRD;ROBO2;HMCN1;IL1RAPL1;CDH8;CDH2;CDH13;PECAM1;KIRREL3;BSG;CLDN5;GPC6;CNTN4;UNC5D;LRFN5;NPTN;TENM3;PTPRT;TGFB2;ATP2C1;VCAM1;CDH10;TENM4;CDH12;CLDN11;NTNG1;DSCAML1;IGSF11;CNTN6;ICAM1;CDH6;PTPRF;ITGB1;CDH19;CDH20;CDH7;ROBO4;EMB
prerank,positive regulation of synapse assembly (GO:0051965),-0.6659542351030274,-1.8764678943729012,0.00234192037470726,0.03375347037020461,0.512,11/27,7.96%,NLGN1;NRXN1;GRID2;PTPRD;IL1RAPL1;CLSTN2;EPHB1;IL1RAP;SYNDIG1;SEMA4D;EPHB2
prerank,chemical synaptic transmission (GO:0007268),-0.4469175639181117,-1.8709937669142698,0.0,0.03531951586003761,0.532,99/284,17.14%,NLGN1;DLG2;NRXN1;GRID2;GRIK2;KCND2;SYT1;GRIA4;CACNB2;GRM7;GRM5;SLC12A7;CDH8;CACNA1E;GRM3;SNAP25;CHRM3;RIMS1;GABRG3;GRIK1;HTR2C;GABRB3;GRIN2B;GRIA1;GRIA2;LIN7A;GABRB1;RIT2;GABRA3;PLP1;KCNQ3;GLRB;GRIA3;SLC1A2;DLGAP1;PTPRN2;GABRA2;UNC13B;GRIK4;SLC1A1;APBA2;SYN2;PDE7B;SHISA6;GABRB2;MBP;GLRA3;DLGAP2;MINK1;CALM1;APOE;HSPA8;PTCHD1;HTR2A;GRIN2A;CACNA1B;AMPH;SYPL1;SLC1A4;CHRM2;GRM1;CAMK4;GLRA1;GABRG2;HTR1F;GABBR2;GRID1;HTR7;CAMKK2;RPS6KA3;RPS6KA2;GABRA4;SLC17A6;SLC12A4;ERC1;GABRG1;NRXN2;HCRTR2;PRKAR1B;PRKAR2B;HOMER1;HTR4;SLC12A6;SNCA;GLRA2;RPS6KA1;HTR1B;GRIN1;HRH1;SLC1A6;GRIK3;SLC12A5;SCN2B;NAPB;CHRNA7;CHRFAM7A;GABRA5;GABRE;STXBP3
prerank,regulation of smoothened signaling pathway (GO:0008589),0.6517507319766055,1.862599929453204,0.0,0.8612759912594519,0.751,16/50,9.30%,RORA;TULP3;FGFR2;DCDC2;FBXL17;TTC23;GLI3;SUFU;GAS1;SMO;RAB34;MGRN1;BTRC;IFT122;ZIC1;GLI1
prerank,regulation of interleukin-2 production (GO:0032663),-0.5916775952630458,-1.862251094292538,0.0,0.03903669793975443,0.588,12/43,7.01%,PDE4D;SPTBN1;PDE4B;NAV3;CD34;RUNX1;HDAC7;ANXA1;PTPRC;RPS3;PLCG2;MAP3K7
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.7458077503012601,-1.8455687700787622,0.0,0.048870330227693236,0.671,7/14,9.20%,GHR;PIK3R1;STAT3;LYN;SOCS2;PTK2;STAT5B
prerank,neuronal action potential (GO:0019228),-0.679101438306493,-1.8451226653187967,0.0,0.0473821279212066,0.672,11/22,15.36%,ANK3;SCN1A;SCN2A;KCNMB2;CACNA1G;SCN7A;SCN3A;SCN9A;GPER1;SCN8A;CACNA1H
prerank,axon development (GO:0061564),-0.5208810715643654,-1.838028609396017,0.0,0.05065706577589576,0.704,28/78,14.09%,CTNNA2;GRM7;MAP1B;ANK3;KLF7;ACTB;CNTN4;RTN4;DCC;SEMA5A;PAK3;PLP1;NTNG1;S100A6;DSCAML1;SHTN1;APP;NRCAM;EPHB2;GAP43;S100B;SLITRK1;PLPPR4;MARK2;MAPT;RTN4RL1;ADGRB1;CDK5R1
prerank,positive regulation of developmental growth (GO:0048639),-0.5622870482365971,-1.8318280342988247,0.0,0.05372732001466684,0.734,20/49,21.68%,GHR;SYT1;RIMS2;RIMS1;SEMA7A;CDKL5;NGF;NEDD4L;NTN1;SHTN1;SEMA4D;PPIB;AGRN;MAPT;SMURF1;BDNF;CPNE9;SYT2;L1CAM;TWF2
prerank,negative regulation of vascular permeability (GO:0043116),-0.8025313759738087,-1.8317983950664818,0.0,0.05216322336320867,0.736,8/12,9.51%,SLIT2;PTPRJ;PDE3A;CLDN5;SH3GL2;RAMP2;CEACAM1;PDE2A
prerank,regulation of T cell migration (GO:2000404),-0.7022047716947584,-1.8286381204612134,0.0,0.05267901994211589,0.756,6/18,9.22%,LRCH1;CD200;CXCL12;APP;APOD;DOCK8
prerank,basement membrane organization (GO:0071711),-0.7395052328213315,-1.8251743519996533,0.0045871559633027525,0.05388950146504457,0.77,6/14,11.63%,FLRT2;COL4A1;NTNG1;RAMP2;NTN4;CTSS
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.6049150218699709,-1.8243386220136706,0.0,0.05309661437430903,0.773,17/33,16.47%,NLGN1;NRG3;GRID2;GRIK2;LRRC4C;GRIK1;ABR;NGF;GRIK4;CACNA1B;RELN;GRID1;LRP8;FABP5;GRIK3;BDNF;CX3CR1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.7653479026690367,1.82375388643923,0.003484320557491289,1.0,0.931,9/19,13.24%,DDO;ALDH7A1;ASPA;PIPOX;GOT2;OGDH;DLD;AASS;GCDH
prerank,smooth muscle cell differentiation (GO:0051145),-0.793893090651091,-1.8205445583581379,0.0,0.054572885778892626,0.799,11/12,19.50%,MEF2C;MRTFB;TBX18;MRTFA;TMEM204;HEY2;BMP4;MYOCD;EDNRB;APLNR;GATA6
prerank,limb development (GO:0060173),0.7289477047657719,1.8158310771327375,0.0,0.9524048580063341,0.947,7/28,8.24%,SMOC1;RSPO2;LRP4;GLI3;COMP;CHD7;IFT122
prerank,chloride transmembrane transport (GO:1902476),-0.5568748770065515,-1.8157180612103294,0.0,0.056582864890656503,0.818,29/48,17.12%,SLC12A7;ANO4;GABRG3;GABRB3;ANO1;GABRB1;GABRA3;GLRB;SLC12A2;GABRA2;SLC1A1;ANO3;GABRB2;GLRA3;GLRA1;GABRG2;SLC12A8;GABRA4;SLC12A4;GABRG1;SLC12A6;GLRA2;CLCN1;ANO5;ANO2;CLCN3;SLC12A5;GABRA5;GABRE
prerank,neural crest cell migration (GO:0001755),-0.596065117487892,-1.815714771387807,0.0,0.05513202220115249,0.818,12/36,7.53%,NRP1;SEMA3C;ERBB4;SEMA6A;SEMA6D;FN1;SEMA5A;SEMA7A;SEMA3E;TBX1;SEMA4D;CORO1C
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.6616888858352568,-1.8156785198263192,0.0,0.05378012327758053,0.819,12/24,14.99%,NRP1;SEMA3C;SEMA6A;SEMA6D;SEMA5A;SEMA7A;SEMA3E;SEMA4D;SEMA3D;SEMA3G;VEGFA;SEMA4C
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.6077988001306605,-1.8151076843232767,0.005208333333333333,0.052932051359808406,0.823,19/34,21.60%,GRID2;MEF2C;GABRG3;GRIN2B;GABRA3;GABRA2;GSK3B;GRIN2A;GLRA1;GABRG2;GABRA4;GABRG1;GRIN1;INSYN2A;GABRA5;GABRE;ARRB2;GABRA1;DRD2
prerank,rRNA metabolic process (GO:0016072),-0.4589264952964326,-1.8132604669826475,0.0,0.053381584364636823,0.833,66/160,18.85%,RPS24;RPL8;RPL41;RPL13;RPLP2;RPS6;RPL18A;RPL37;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPL19;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;WDR3;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPL36A;RPL6;MAPT;EMG1;MDN1;RPL31;NOP53;TRIR;DDX10;NOL11;RPL36;TEX10;RPL13A;FBL;XRN2;RPL35;UTP15
prerank,carnitine shuttle (GO:0006853),0.850244047052431,1.8114579794450119,0.0,0.8171301866823342,0.956,5/11,8.41%,PRKAG2;PRKAA2;CPT1A;SLC25A20;CPT2
prerank,regulation of dendrite development (GO:0050773),-0.5774008205205953,-1.8109776500503405,0.002617801047120419,0.05385932817195104,0.844,18/37,13.06%,CSMD3;ADGRB3;HECW2;BMP5;MARK1;HECW1;DCC;CDKL5;NEDD4L;GSK3B;DAB2IP;SEMA4D;LZTS1;PTN;RAP2A;MFSD2A;VLDLR;LRP8
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.7069661876395976,1.8072551528560266,0.0017064846416382253,0.7272676665445995,0.96,8/26,8.44%,EYA1;EYA2;EYA4;FGFR1;MAP2K5;TERT;PPP2R1B;GDNF
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.8389425468165921,1.8060440099559028,0.0,0.6360128521241131,0.962,4/14,1.93%,ACTN2;ATP1B3;ANK2;LRRC38
prerank,regulation of mononuclear cell migration (GO:0071675),-0.6431516350268994,-1.8004233045158844,0.0024813895781637717,0.061083774597867825,0.877,9/23,15.16%,SLIT2;BMP5;THBS1;LYN;STK10;PTK2;MSN;CMKLR1;RARRES2
prerank,regulation of osteoblast differentiation (GO:0045667),0.5813610867727531,1.7997668952527621,0.0015015015015015015,0.6142181796963344,0.97,13/82,4.77%,RANBP3L;SMOC1;TMEM64;BMP6;BMP7;WNT4;DDX5;IGF1;FGFR2;NPNT;BMPR1A;SUFU;SMAD6
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.7393899263896331,1.7993876972954401,0.0017889087656529517,0.4935866428970973,0.97,6/21,8.44%,EYA1;EYA2;EYA4;MAP2K5;TERT;GDNF
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.7393899263896331,1.7993876972954401,0.0017889087656529517,0.4935866428970973,0.97,6/21,8.44%,EYA1;EYA2;EYA4;MAP2K5;TERT;GDNF
prerank,positive regulation of chemotaxis (GO:0050921),-0.5634504370536048,-1.7929972563416807,0.0026109660574412533,0.06599234458367159,0.909,19/43,15.16%,NRP1;NTRK3;CDH13;TMSB4X;THBS1;SEMA5A;F3;KDR;STX3;MET;TGFB1;PTN;FGF2;P2RY12;EDN3;PRKD1;VEGFA;PPM1F;RARRES2
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.6247240861026848,-1.7920011916683647,0.002336448598130841,0.06549900395335734,0.91,11/29,12.57%,GRIK2;SLC4A10;MCTP1;SHISA6;SHISA9;APOE;APP;EPHB2;NETO1;ZDHHC2;NCDN
prerank,mesenchymal cell differentiation (GO:0048762),0.6243218237572574,1.7894003723468923,0.0015698587127158557,0.5220728839967704,0.978,12/51,4.57%,RANBP3L;TGFBR3;BMP7;ROCK2;WNT4;DDX5;FGFR2;FBXL17;FGFR1;TGFBR1;FOXC1;LOXL3
prerank,cellular response to copper ion (GO:0071280),-0.69830907604628,-1.7880987673006075,0.0021413276231263384,0.06790274915963121,0.92,10/16,14.18%,MT1E;MT1F;MT1M;MT1G;MT1X;MT1H;MT1A;MT1B;SNCA;MT3
prerank,endoderm formation (GO:0001706),-0.5850121229881633,-1.784146964534558,0.002380952380952381,0.06963430296741219,0.927,20/35,22.93%,COL8A1;COL12A1;FN1;COL6A1;COL4A2;SOX17;LAMA3;ITGA4;DUSP1;SOX7;SETD2;MMP15;ITGA5;COL11A1;ITGB2;INHBA;VTN;ITGA7;COL7A1;LHX1
prerank,synaptic membrane adhesion (GO:0099560),-0.7329674588346197,-1.7831014682526876,0.00423728813559322,0.069204602945232,0.93,8/14,10.87%,LRRC4C;PTPRD;GPC6;LRFN5;NTNG1;PTPRF;SLITRK1;GPC4
prerank,epithelial tube morphogenesis (GO:0060562),-0.6110902006131794,-1.7829415796820551,0.004975124378109453,0.06809508785347848,0.932,17/32,13.46%,SLIT2;MEF2C;COL4A1;PODXL;RYR2;ACVRL1;RASIP1;PAK1;SOX17;HES1;MET;RHOB;PKD1;BMP4;CTNNB1;MTSS1;ACVR1
prerank,histone H3-K4 methylation (GO:0051568),0.7043946811835886,1.781305159187599,0.008460236886632826,0.5311442391658652,0.986,14/26,20.71%,KMT2A;CXXC1;CTR9;TET2;ASH2L;KMT2C;WDR82;KMT2D;BEND3;OGT;SETD1B;TET3;SETD1A;KDM6A
prerank,chloride transport (GO:0006821),-0.4967317705461996,-1.7779076478790863,0.0,0.07129475851442807,0.943,34/74,17.12%,SLC4A10;SLC12A7;SLC26A7;CLIC4;ANO4;GABRG3;GABRB3;ANO1;GABRB1;GABRA3;GLRB;SLC12A2;GABRA2;SLC1A1;ANO3;GABRB2;GLRA3;GLRA1;GABRG2;SLC12A8;GABRA4;SLC12A4;CLIC5;GABRG1;SLC12A6;GLRA2;CLCN1;TTYH1;ANO5;ANO2;CLCN3;SLC12A5;GABRA5;GABRE
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.7538308165369951,-1.7774406982337914,0.0020964360587002098,0.07053297388430843,0.944,7/13,13.39%,NOS3;CALM1;GCH1;HSP90AA1;PRKG2;MTHFD1L;QDPR
prerank,axonogenesis (GO:0007409),-0.4329085653821642,-1.7768643071431638,0.0,0.06972023280564435,0.947,71/237,10.34%,NRP1;NRXN1;NRXN3;SPTBN1;SLIT2;CTNNA2;ROBO2;RPS6KA5;SEMA3C;UNC5C;LAMA1;SEMA6A;PIK3R1;SEMA6D;MAP1B;BSG;ANK3;SHANK3;KLF7;ACTB;ENAH;SH3KBP1;EPHB1;CNTN4;UNC5D;NOTCH3;DCC;NPTN;EPHA5;DAB1;EFNA5;NRP2;CXCL12;EPHA6;SEMA5A;PAK3;SEMA7A;LAMA2;EVL;GAB1;NTNG1;S100A6;DSCAML1;NOTCH1;HSP90AB1;SEMA3E;SHTN1;NTN4;CNTN6;APP;NRCAM;B4GALT5;EPHA7;SEMA4D;KIF5C;LAMA3;ULK1;LGI1;ROBO4;FEZ1;RELN;EPHB2;EMB;ULK2;PTK2;SLC9A6;TNR;S100B;SLITRK1;PLPPR4;HSP90AA1
prerank,cellular response to zinc ion (GO:0071294),-0.7160473154550673,-1.7752053709521358,0.00631578947368421,0.07020878291114896,0.95,13/15,22.95%,GLRA1;MT1E;MT1F;MT1M;MT1G;MT1X;MT1H;MT1A;MT1B;GLRA2;MT3;MT2A;HVCN1
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.5878894982613438,-1.7667182552573002,0.002544529262086514,0.07726557453259571,0.965,18/35,18.06%,NRP1;SEMA3C;SEMA6A;SEMA6D;NRP2;SEMA5A;SEMA7A;SEMA3E;FLNA;MET;SEMA4D;PLXNA4;SEMA3D;SEMA3G;SEMA4C;PLXND1;ARHGDIA;SEMA4A
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5744284519262385,-1.764599323729299,0.0026595744680851063,0.07762079648310591,0.968,11/37,6.02%,NLGN1;GRID2;TENM2;CADM1;PTPRD;HMCN1;IL1RAPL1;TENM3;VCAM1;TENM4;ICAM1
prerank,mesonephros development (GO:0001823),0.8109244330731122,1.759340001176541,0.011131725417439703,0.6680687369387838,0.998,3/11,1.09%,FGF1;BMP7;OSR1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.782982062302085,-1.758691040567114,0.0,0.08200254093190758,0.975,6/11,13.39%,NOS3;CALM1;GCH1;HSP90AA1;PRKG2;QDPR
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.6209481914396362,-1.7581005163081276,0.0,0.08149910510400706,0.975,9/27,7.16%,CTNNA2;IL1RAPL1;MARK1;NTNG1;CCDC88A;MBOAT1;GSK3B;DISC1;PSEN1
prerank,vasoconstriction (GO:0042310),-0.7614085764051159,-1.7511821200184723,0.0,0.08725962939124668,0.981,7/11,16.55%,SLC8A1;EDNRA;ACTA2;EDN1;EDN3;EDNRB;PIK3C2A
prerank,platelet aggregation (GO:0070527),-0.5861569362349011,-1.750193076044542,0.0,0.08696697401882682,0.983,17/33,17.82%,ACTB;GNAS;ACTN1;UBASH3B;FN1;ACTG1;MYH9;PPIA;FLNA;MYL12A;P2RY12;ITGB3;ILK;MYL9;TYRO3;STXBP3;HSPB1
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.47126017059925274,-1.7492132428156177,0.0,0.08682241426625988,0.983,32/107,8.65%,NLGN1;NRG3;GRID2;GRIK2;MEF2C;LRRC4C;SYT1;GRM7;GRM5;RIMS2;CDH2;CLSTN2;GRM3;MCTP1;RIMS1;DGKI;GRIK1;ABR;GRM8;SLC12A2;DLGAP1;NGF;GRIK4;TMEM108;DLGAP2;APP;CACNA1B;ITGB1;CNTNAP4;LGI1;RELN;GRM1
prerank,adherens junction organization (GO:0034332),-0.540142409409618,-1.7485828304020399,0.0027472527472527475,0.08623965165546746,0.984,18/48,12.06%,CDH11;CADM2;CADM1;CDH8;CDH2;CDH13;ACTB;CDH10;CDH12;RAMP2;CDH6;CDH19;CDH20;CDH7;SMAD7;PVR;CDH1;CTNNB1
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.7884132563394426,-1.7476879932693798,0.002008032128514056,0.08579273002927028,0.984,10/10,21.21%,GABRG3;GABRA3;GABRA2;GABRB2;GABRG2;GABRA4;GABRG1;GABRA5;GABRE;GABRA1
prerank,regulation of dendritic spine development (GO:0060998),-0.6535264756615824,-1.7474541148014424,0.004555808656036446,0.08463372983882869,0.984,8/19,7.16%,NLGN1;MEF2C;PPFIA2;SHANK3;TANC2;GRIN3A;APOE;PSEN1
prerank,maturation of 5.8S rRNA (GO:0000460),0.7539813336404191,1.741324936752962,0.007561436672967864,0.7834403289720658,1.0,2/17,0.31%,NSA2;MPHOSPH6
prerank,cation transmembrane transport (GO:0098655),0.6332807446399633,1.740034010815194,0.003194888178913738,0.7434576674969919,1.0,10/44,7.03%,TRPM3;ATP1A2;TRPM6;SLC7A2;SFXN2;SLC25A20;SLC6A9;P2RX3;SLC22A5;TRPM5
prerank,regulation of membrane repolarization (GO:0060306),-0.727254623427159,-1.739153140439994,0.0,0.0924463279934846,0.989,7/13,8.00%,CAV1;AKAP6;CACNA2D1;KCNJ2;NEDD4L;YWHAE;KCNQ1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.6667532296785048,1.7352510494854196,0.008620689655172414,0.7415942144170755,1.0,6/32,2.21%,PRKAG2;SORBS1;PRKAA2;PPARA;AVIL;ZBTB20
prerank,endothelial cell migration (GO:0043542),-0.5646413967060447,-1.7339038041283144,0.0025974025974025974,0.09691798892974078,0.992,18/37,15.97%,NRP1;CDH13;NOS3;FAP;ID1;CCN3;CYP1B1;MYH9;PLEKHG5;STARD13;SOX18;EMP2;LPXN;VEGFA;SCG2;PTP4A3;PLXND1;NR4A1
prerank,cellular glucan metabolic process (GO:0006073),0.8186498894143397,1.7325826747549584,0.003968253968253968,0.719130234499221,1.0,3/11,3.00%,PRKAG2;PYGM;PHKB
prerank,regulation of cation channel activity (GO:2001257),-0.4812814386724102,-1.7323494943492712,0.0,0.09736291194560773,0.992,40/89,15.27%,PDE4D;NLGN1;DLG2;FGF14;MEF2C;GRIA4;CACNB2;AHNAK;FGF12;ANK3;CAMK2D;LRRC7;GRIN2B;GRIA1;GRIA2;PTK2B;GRIA3;KCNAB1;SHISA6;SHISA9;MINK1;CALM1;APP;CALM2;GRIN2A;ITGB1;RELN;NETO1;FGF13;FKBP1A;JPH2;CTSS;DAPK1;HOMER1;NOS1;SHANK1;SELENON;CACNG8;STAC;GRIN1
prerank,heme catabolic process (GO:0042167),-0.7058495111651781,-1.7278289559052307,0.002145922746781116,0.1000966201320147,0.993,3/14,4.06%,ABCG2;SLCO2B1;HMOX2
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.7058495111651781,-1.7278289559052307,0.002145922746781116,0.1000966201320147,0.993,3/14,4.06%,ABCG2;SLCO2B1;HMOX2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.6056998650256017,-1.7274773945927475,0.012195121951219513,0.09901366128641867,0.993,12/24,16.20%,NRP1;PTPRJ;TEK;PIK3R1;KDR;IQSEC1;MYOC;DUSP3;VEGFA;PPM1F;LIMS1;ARF6
prerank,regulation of gluconeogenesis (GO:0006111),0.6759594647503212,1.7235515924855924,0.012110726643598616,0.7586858862145888,1.0,15/27,24.29%,C1QTNF3;PPARGC1A;SIK1;GCK;SIRT1;USP7;OGT;CLK2;CRY1;GNMT;EP300;PDK2;SELENOS;ARPP19;DGKQ
prerank,positive regulation of vasoconstriction (GO:0045907),-0.7131139110658528,-1.7219402468123606,0.012875536480686695,0.1042232290806023,0.993,2/13,2.36%,CAV1;ADRA1B
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.6970043716851405,-1.7188742669635673,0.006928406466512702,0.107131953422639,0.994,6/15,5.30%,NTRK3;CDH13;VEGFC;CXCL12;F3;KDR
prerank,neuron cell-cell adhesion (GO:0007158),-0.7031112232434676,-1.718123968174765,0.010638297872340425,0.10647452466977159,0.994,7/14,3.27%,NLGN1;NRXN1;NRXN3;ASTN2;NCAM2;CNTN4;ASTN1
prerank,regulation of glucose import (GO:0046324),0.6591670949242444,1.7178852381044247,0.01155115511551155,0.7697295085421978,1.0,8/30,6.42%,PRKAG2;APPL2;OSBPL8;SORBS1;IGF1;RHOQ;ITLN1;CREBL2
prerank,ganglion development (GO:0061548),-0.749743928310975,-1.7144196588912528,0.006423982869379015,0.10961671957836669,0.995,3/11,2.99%,NRP1;UNC5C;NRP2
prerank,glycerolipid catabolic process (GO:0046503),-0.667448692782699,-1.7141865981799975,0.008948545861297539,0.10847902332985904,0.995,6/19,7.94%,ABHD2;PLA2G4A;GPCPD1;MGLL;ENPP6;GDPD1
prerank,positive regulation of behavior (GO:0048520),-0.7588493305677486,-1.7070760494095731,0.006423982869379015,0.11633392555613366,0.998,4/10,7.68%,NLGN1;MEF2C;SGIP1;STRA6
prerank,cellular response to glucose starvation (GO:0042149),0.6182153022157361,1.7067356541970615,0.006482982171799027,0.8351636035847515,1.0,14/41,11.45%,PRKAG2;PRKAA2;MTMR3;CPEB4;PRKAG3;SESN1;SESN2;NUAK2;TP53;SIK1;PICK1;BRSK1;BECN1;IMPACT
prerank,positive regulation of tissue remodeling (GO:0034105),0.827193706978258,1.7050246640157205,0.013461538461538462,0.8101870349301907,1.0,4/10,8.46%,ROCK2;IL18;IL12B;HRG
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.6215308761069187,-1.7030025876542825,0.004618937644341801,0.11997998544645472,1.0,9/23,16.01%,SLC12A7;SLC12A2;ATP6V0A4;SLC9A7;SLC12A8;SLC12A4;SLC12A6;CLCN3;SLC12A5
prerank,cellular response to sterol (GO:0036315),0.7662261895179745,1.7021028800478615,0.013232514177693762,0.8010334494618007,1.0,5/13,7.03%,RORA;GRAMD1B;INSIG2;SMO;RORC
prerank,long-chain fatty acid transport (GO:0015909),0.6657267353854327,1.7014350025032974,0.008576329331046312,0.7721020514463388,1.0,8/30,9.67%,PRKAG2;ACSL1;PRKAA2;CPT1A;SLC25A20;SLC27A1;CPT2;SPX
prerank,positive regulation of protein secretion (GO:0050714),0.565706794793784,1.7010648327739781,0.003129890453834116,0.7428164793404616,1.0,17/69,9.99%,NNAT;BMP6;C1QTNF3;FRMD4A;WLS;IGF1;NLGN2;MCU;MYO18A;EZR;TLR4;PTPN23;GCK;RBP4;DNM1L;GOLPH3L;TCF7L2
prerank,alpha-amino acid catabolic process (GO:1901606),0.6697823729868658,1.6976012196130557,0.008726003490401396,0.7421111723682781,1.0,7/29,12.38%,DDO;PRODH;ACADSB;ALDH4A1;GOT2;FAH;MTRR
prerank,regulation of presynapse organization (GO:0099174),-0.6518175514090226,-1.6959852468641186,0.01327433628318584,0.12686151013944288,1.0,9/18,13.16%,PTPRD;IL1RAPL1;GPC6;LRFN5;IL1RAPL2;APP;SLITRK1;GPC4;SNCA
prerank,regulation of presynapse assembly (GO:1905606),-0.6518175514090226,-1.6959852468641186,0.01327433628318584,0.12686151013944288,1.0,9/18,13.16%,PTPRD;IL1RAPL1;GPC6;LRFN5;IL1RAPL2;APP;SLITRK1;GPC4;SNCA
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.6361564300513503,-1.6935082950448592,0.013043478260869565,0.12874755579927416,1.0,10/20,14.99%,SEMA3C;SEMA6A;SEMA6D;SEMA5A;SEMA7A;SEMA3E;SEMA4D;SEMA3D;SEMA3G;SEMA4C
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.6246472129961973,-1.6846904416377706,0.0045045045045045045,0.13997427917067692,1.0,11/22,16.33%,NTRK3;SH3GL2;NGF;NTRK2;TMEM108;RAP1A;STMN2;MAPT;BDNF;ACAP2;WASF1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.7008445747965458,-1.6806413147424673,0.008264462809917356,0.14416578659895266,1.0,4/13,5.75%,GRIK2;SLC4A10;SHISA6;SHISA9
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.644924729940206,-1.6791766353790283,0.018604651162790697,0.14497358497311838,1.0,6/18,11.72%,SLIT2;MTUS1;PTK2B;LYN;PTN;EDN3
prerank,axon guidance (GO:0007411),-0.41312730717359003,-1.6750964730805744,0.0,0.14992355005847716,1.0,60/201,9.70%,NRP1;NRXN1;NRXN3;SPTBN1;SLIT2;PTPRM;ROBO2;RPS6KA5;SEMA3C;UNC5C;LAMA1;SEMA6A;PIK3R1;SEMA6D;BSG;SHANK3;KLF7;ENAH;SH3KBP1;EPHB1;CNTN4;UNC5D;NOTCH3;DCC;NPTN;EPHA5;DAB1;EFNA5;NRP2;CXCL12;EPHA6;SEMA5A;SEMA7A;TMEFF1;LAMA2;EVL;CHN1;GAB1;DSCAML1;NOTCH1;NTN1;SEMA3E;NTN4;CNTN6;EPHA7;SEMA4D;KIF5C;LAMA3;LGI1;ROBO4;FEZ1;PLXNC1;RELN;EPHB2;EMB;PTK2;PLXNA4;TNR;GAP43;RHOH
prerank,2-oxoglutarate metabolic process (GO:0006103),0.7670226223572039,1.6735916681143217,0.012915129151291513,0.9261223088593239,1.0,9/13,18.13%,ADHFE1;GPT2;GOT2;OGDH;IDH1;D2HGDH;GOT1;IDH2;PHYH
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.7181062436092529,1.6701531813206363,0.0125,0.9255194823873722,1.0,4/20,7.27%,C1QTNF3;WNT4;SIK1;GCK
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.6018778829685006,-1.6665208472486568,0.020930232558139535,0.162037683510631,1.0,11/24,15.93%,PDE4D;PDE3A;PDE3B;PDE11A;PEX5L;GNAI1;PDE2A;PRKAR1B;PRKAR2B;UBE2B;APLNR
prerank,thyroid hormone generation (GO:0006590),0.7975136859305596,1.6663944565909563,0.013861386138613862,0.9280511578466886,1.0,2/10,1.23%,SLC5A5;CPQ
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.732268975472301,-1.6659437467505114,0.011061946902654867,0.16114819051539295,1.0,6/11,14.65%,CACNB2;CAMK2D;CACNA2D1;BIN1;NOS1;SESTD1
prerank,regulation of macrophage migration (GO:1905521),-0.7265591409810951,-1.665927050577435,0.019148936170212766,0.15934446718801018,1.0,5/10,16.47%,MTUS1;CD200;PTK2B;P2RY12;CX3CR1
prerank,metal ion homeostasis (GO:0055065),-0.5311625018735792,-1.6653227480273618,0.0026041666666666665,0.15830178206689086,1.0,15/40,16.01%,SLC8A1;TMTC2;SLC12A7;CAV1;ANK3;SLC12A2;SLC12A8;SLC12A4;JPH2;SLC12A6;SNCA;MT3;SELENON;GRIN1;SLC12A5
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.6391579673395689,-1.664905588166272,0.011037527593818985,0.15725879626853206,1.0,9/18,12.00%,DAAM2;TENM4;NOTCH1;HES1;TNFRSF1B;PTPRZ1;TNFRSF21;PTN;OPALIN
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.48516076789887763,-1.6639958605457605,0.0,0.1568726270873232,1.0,21/64,8.55%,UTRN;LIMCH1;CDH13;THBS1;EFNA5;PEAK1;CASK;ACER2;NEXMIF;PTK2B;ACTG1;JAG1;SEMA3E;GPM6B;GSK3B;AJAP1;MINK1;ADAM15;CORO1C;MYOC;PTK2
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.6308768368121173,1.6629218933209091,0.011824324324324325,0.9284183407195786,1.0,4/31,4.77%,RANBP3L;TMEM64;SUFU;SMAD6
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.7642464696560002,1.6626360630220296,0.0225140712945591,0.8998755182825815,1.0,2/11,0.35%,DAB2;WNT5B
prerank,substantia nigra development (GO:0021762),-0.557083502006372,-1.6600638985071594,0.007425742574257425,0.16167082541767935,1.0,18/37,20.13%,ACTB;PLP1;GNB4;YWHAE;MBP;CALM1;CALM2;BASP1;DYNLL1;HSPA5;GLUD1;CALM3;FGF9;SUDS3;NDRG2;SIRT2;YWHAQ;PADI2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.5602568386359723,-1.6592009464318878,0.009876543209876543,0.16137136305227787,1.0,16/32,13.12%,THBS1;CLASP2;CASK;ACER2;NEXMIF;ACVRL1;JAG1;SEMA3E;AJAP1;ADAM15;CORO1C;MYOC;APOD;FAM107A;RASA1;DMTN
prerank,ribosome biogenesis (GO:0042254),-0.41613582578465164,-1.6585792615299437,0.0,0.16054463033840266,1.0,70/187,19.06%,RPS24;RPL8;RPL41;RPL13;RPLP2;RPS6;RPL18A;RPL37;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPL19;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;RPL14;XPO1;RPS17;RPL28;RPL34;WDR3;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPL36A;RPL6;EMG1;MDN1;MALSU1;RPL31;NOP53;DDX10;LTV1;ABCE1;NOL11;RPL36;TEX10;RPL13A;FBL;XRN2;RBIS;RPL35;UTP15;RAN
prerank,regulation of sequestering of triglyceride (GO:0010889),0.7404168206610704,1.656871728152979,0.02376599634369287,0.9249242575395535,1.0,3/15,5.39%,OSBPL8;PPARA;OSBPL11
prerank,bicarbonate transport (GO:0015701),-0.5843611112125321,-1.654661427500682,0.011682242990654205,0.16556631607635428,1.0,4/25,6.93%,SLC4A10;SLC26A7;CA4;CA2
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.6652335861745258,-1.6534582291395632,0.007042253521126761,0.16552433363887534,1.0,6/16,6.28%,KCNC2;NOS3;NDNF;GUCY1B1;APOE;GUCY1A1
prerank,negative regulation of cell adhesion (GO:0007162),-0.4753737940824568,-1.653056040306558,0.0,0.16457016941429484,1.0,30/72,13.12%,SEMA6A;CDH13;GCNT2;PODXL;PDE3B;SEMA5A;ACER2;NEXMIF;ACVRL1;CYP1B1;JAG1;NOTCH1;PTPRC;FZD4;CORO2B;SEMA4D;TGFBI;PLXNC1;EPHB2;ARHGDIB;TGFB1;SPOCK1;PTK2;PLXNA4;ADAM22;DUSP1;CDH1;RASA1;LPXN;DMTN
prerank,synaptic vesicle cycle (GO:0099504),-0.5412566889064714,-1.6530193870206678,0.020833333333333332,0.1628953442710191,1.0,8/30,14.55%,NLGN1;SNAP25;RIMS1;PCLO;SYNDIG1;SLC17A6;SNCA;SYT7
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.6913343934853533,-1.651665920527385,0.017057569296375266,0.16326984416431176,1.0,7/13,13.77%,NRP1;COL4A1;ENG;SEMA3E;KDR;CTNNB1;VEGFA
prerank,dendritic spine morphogenesis (GO:0060997),-0.6653813276299714,-1.6491301959470417,0.0087527352297593,0.16570623961637698,1.0,8/15,13.89%,CTNND2;DOCK10;SHANK3;EPHB1;PAK3;EPHB2;DIP2A;SHANK1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.4689691960349665,-1.6485616477246965,0.003115264797507788,0.16506299986815584,1.0,28/75,15.97%,NRP1;TEK;CDH13;BMPR2;VEGFC;NRP2;SEMA5A;PPP1R16B;F3;AKT3;KDR;ECM1;ITGA4;BMP2;GATA2;AGTR1;PROX1;FGF2;FLT4;JCAD;ITGB3;BMP4;HIF1A;PRKD1;VEGFA;SCG2;APLNR;NR4A1
prerank,negative regulation of viral life cycle (GO:1903901),-0.6649085259194893,-1.6481761289101748,0.01263157894736842,0.1640560782407128,1.0,5/15,11.73%,GSN;LY6E;MID2;PPIA;IFITM3
prerank,negative regulation of axon extension (GO:0030517),-0.568379333754157,-1.6461591492765106,0.009732360097323601,0.16582295271087424,1.0,13/30,14.99%,SEMA3C;SEMA6A;SEMA6D;RTN4;SEMA5A;SEMA7A;SEMA3E;DIP2B;SEMA4D;SEMA3D;SEMA3G;MT3;SEMA4C
prerank,neurotransmitter secretion (GO:0007269),-0.5068210642157749,-1.6444296645531589,0.0026666666666666666,0.16690957611102056,1.0,10/44,6.77%,NRXN1;SYT1;RIMS2;SNAP25;RIMS1;LIN7A;PCLO;PTPRN2;SYN2;HSPA8
prerank,nuclear migration (GO:0007097),0.7368979650145535,1.6333260907407576,0.04291044776119403,1.0,1.0,5/13,9.80%,SYNE2;SYNE3;CLMN;FBXW11;DOCK7
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.6758438769945732,1.632235551895324,0.02555366269165247,1.0,1.0,4/21,1.91%,CACNA1D;ANK2;KCNA5;SNTA1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.49586474239039685,-1.631990044349733,0.006134969325153374,0.18751251018537857,1.0,19/54,9.40%,KCNIP4;DPP10;CAV1;AKAP6;KCNJ3;KCNMA1;DPP6;KCNJ2;KCNN2;KCNIP1;KCNAB1;KCNMB2;GNG2;NEDD4L;YWHAE;FLNA;KCNQ1;BIN1;GABBR2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.6559129215115459,1.6310718738905086,0.022569444444444444,1.0,1.0,7/26,5.22%,CACNA1D;ACTN2;ATP1B3;ANK2;DLG1;NEDD4;KCNS1
prerank,cellular response to purine-containing compound (GO:0071415),-0.736442567046438,-1.6304452512709011,0.02702702702702703,0.18844227313345932,1.0,7/10,21.42%,SLC8A1;RYR2;RYR3;P2RY1;TRPM2;CASQ2;GSTM2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.5283349901847605,-1.6299687232324533,0.010638297872340425,0.1874515833435551,1.0,11/35,7.33%,NLGN1;CDH11;CDH8;CDH13;ATP2C1;CDH10;CDH12;CDH6;CDH19;CDH20;CDH7
prerank,sodium ion export across plasma membrane (GO:0036376),0.7512726657619222,1.6287625661382992,0.032196969696969696,1.0,1.0,3/13,6.17%,ATP1A2;ATP1B3;ATP4A
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.6489920960525963,-1.6261000701717685,0.03164556962025317,0.1924703607625467,1.0,7/14,19.76%,DAB2IP;HSPA5;DDRGK1;BFAR;PTPN1;BCL2L11;COPS5
prerank,lipid phosphorylation (GO:0046834),-0.7469036745926668,-1.6252063723791608,0.01016260162601626,0.1924385581742913,1.0,6/10,13.00%,DGKH;DGKB;DGKI;DGKK;DGKG;DGKZ
prerank,fatty acid transmembrane transport (GO:1902001),0.703294361269302,1.6249276965206265,0.014678899082568808,1.0,1.0,6/19,8.41%,PRKAG2;PRKAA2;CPT1A;SLC25A20;SLC27A1;CPT2
prerank,membrane repolarization (GO:0086009),0.7171845943444354,1.6244064942658094,0.024029574861367836,1.0,1.0,3/15,1.34%,ATP1A2;ATP1B3;KCND3
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.5972756298764017,-1.6234396645630236,0.02252252252252252,0.19390908329437453,1.0,12/19,23.88%,NRP1;PTPRJ;TEK;KDR;MYOC;VEGFA;PPM1F;LIMS1;S100A10;SFRP1;THY1;MAP4K4
prerank,carboxylic acid transport (GO:0046942),0.5673807597090751,1.6225698092035903,0.012048192771084338,1.0,1.0,7/55,1.78%,SLC16A6;SLC13A3;SLC6A13;SLC6A12;SLC16A12;SLC16A11;SLC38A3
prerank,histone H3-K4 trimethylation (GO:0080182),0.762313959258891,1.621547020882197,0.022222222222222223,1.0,1.0,10/11,19.69%,KMT2A;CTR9;TET2;WDR82;KMT2D;BEND3;OGT;SETD1B;TET3;SETD1A
prerank,endocardial cushion development (GO:0003197),-0.6138220574055017,-1.6196509775805226,0.014084507042253521,0.19933711779576102,1.0,10/21,13.46%,BMPR2;ENG;NOS3;TGFB2;ACVRL1;NOTCH1;HEYL;BMP2;BMP4;ACVR1
prerank,regulation of small molecule metabolic process (GO:0062012),0.6278085814242925,1.618243996288367,0.022336769759450172,1.0,1.0,9/28,11.94%,RORA;PPARA;PRKN;NCOR2;RORC;SIRT1;MLYCD;ARV1;TTC39B
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.5245265800203373,-1.6174136551559755,0.00963855421686747,0.2018511758516363,1.0,12/36,10.43%,SLIT2;MEF2C;PTPRM;DCN;THBS1;ACVRL1;NOTCH1;DAB2IP;APOE;TGFB1;FGF2;ATP2B4
prerank,positive regulation of locomotion (GO:0040017),-0.5649485359286537,-1.616883570315814,0.013513513513513514,0.20082212384562556,1.0,10/27,15.16%,SPOCK2;THBS1;CAVIN1;NTN1;STX3;TGFB1;P2RY12;TWIST1;PPM1F;RARRES2
prerank,protein ADP-ribosylation (GO:0006471),0.6329277088336351,1.6144996539441863,0.029616724738675958,1.0,1.0,16/28,13.20%,ART5;PARP10;PARP14;TIPARP;SIRT5;PARP4;PARP12;TNKS2;SIRT3;PARP9;SIRT1;ZC3HAV1;PARP11;PARP6;SIRT4;ART4
prerank,detection of calcium ion (GO:0005513),-0.6809364809239175,-1.6140730462192432,0.017467248908296942,0.20438133746180762,1.0,6/13,10.44%,SYT1;RYR2;KCNMB2;CALM1;CALM2;CALM3
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.535748371431164,-1.6140410024735357,0.007692307692307693,0.20262557363348557,1.0,16/32,14.16%,RHOJ;THBS1;MEOX2;HDAC7;HDAC9;NOTCH1;AKT3;KDR;ANXA1;GATA2;PTGS2;FGF2;JCAD;STARD13;VEGFA;SRPX2
prerank,extracellular matrix assembly (GO:0085029),-0.5845806012507101,-1.6132772140049056,0.01643192488262911,0.20247066795143676,1.0,9/23,11.27%,GAS6;NTNG1;GPM6B;RAMP2;NTN4;TGFB1;MYH11;TNXB;MFAP4
prerank,lipid modification (GO:0030258),-0.5282082264005348,-1.612082385242288,0.008064516129032258,0.20288288172953498,1.0,11/37,13.00%,DGKH;DGKB;DGKI;PLPP1;MBOAT1;PLPPR1;PLPPR5;PLPPR4;DGKK;DGKG;DGKZ
prerank,myelination (GO:0042552),-0.5024670997196574,-1.6114140998340398,0.015789473684210527,0.20249374362486167,1.0,25/46,23.24%,ADGRG6;ACER3;MAL;PLP1;EPB41L3;NFASC;SCN2A;MBP;B4GALT5;PLLP;MYOC;MARVELD1;TNFRSF21;ABCD2;SCN8A;GAL3ST1;MAL2;CMTM8;MALL;TPPP;SIRT2;LGI4;MPZ;CXCR4;SOX10
prerank,regulation of NMDA receptor activity (GO:2000310),-0.5530566080011627,-1.6097650239448078,0.009925558312655087,0.20384744396353086,1.0,14/32,7.96%,NLGN1;DLG2;MEF2C;GRIA4;LRRC7;GRIN2B;GRIA1;GRIA2;PTK2B;GRIA3;APP;GRIN2A;RELN;EPHB2
prerank,energy reserve metabolic process (GO:0006112),0.6830116660035344,1.6092188459245849,0.03963963963963964,1.0,1.0,4/19,3.00%,PRKAG2;LEPR;PYGM;PHKB
prerank,intracellular lipid transport (GO:0032365),0.6726535913068529,1.608001935938713,0.02640845070422535,1.0,1.0,7/21,11.10%,PRKAG2;PRKAA2;CPT1A;SLC25A20;CPT2;PLEKHA8;ARV1
prerank,modified amino acid transport (GO:0072337),0.7154961632719915,1.6073204629432847,0.034482758620689655,1.0,1.0,5/15,8.49%,SLC6A13;SLC16A12;PDPN;SLC19A1;CTNS
prerank,regulation of exocytosis (GO:0017157),-0.5008333377658926,-1.6057033327905332,0.0056657223796034,0.21044984482940302,1.0,10/46,6.67%,STXBP6;SYT1;IL1RAPL1;RIMS2;CADPS;CLASP2;STXBP5L;RAB3C;ANXA1;RAB27A
prerank,negative regulation of TOR signaling (GO:0032007),0.5983908204031132,1.6050613816311747,0.018121911037891267,1.0,1.0,20/36,19.83%,RNF152;PRKAA2;FNIP1;NPRL3;SESN1;DEPTOR;SESN2;ATM;NPRL2;UBR2;SIRT1;DEPDC5;FLCN;KPTN;TSC1;TMEM127;UBR1;TBC1D7;ITFG2;TSC2
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.740062531586472,1.6034361920879296,0.02443609022556391,1.0,1.0,4/13,3.46%,DAB2;BMP6;BMPR1A;TGFBR1
prerank,acylglycerol metabolic process (GO:0006639),-0.5274061579142592,-1.6011646712372753,0.007874015748031496,0.2178838638694712,1.0,11/37,13.92%,DGKH;DGKB;ABHD2;CAV1;DGKI;MGLL;APOE;DGKK;DGKG;DGKZ;PNPLA3
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.5105524551901417,-1.5999270258898421,0.010309278350515464,0.21850950253005447,1.0,16/39,15.49%,RPS24;RPS6;RPS19;RPS28;RPS15;RPS16;RPS7;RPS17;WDR3;RPS25;RPS27;RPS5;EMG1;RPSA;LTV1;NOL11
prerank,response to copper ion (GO:0046688),-0.600339274375689,-1.5997406228481414,0.009280742459396751,0.2171079733013025,1.0,10/20,14.18%,MT1E;MT1F;MT1M;MT1G;MT1X;MT1H;MT1A;MT1B;SNCA;MT3
prerank,regulation of neuron projection development (GO:0010975),-0.40620617108125223,-1.5991399116328562,0.004405286343612335,0.2166135804957999,1.0,56/163,14.41%,CSMD3;CTNNA2;LRRC4C;IL1RAPL1;PPFIA2;MARK1;NTRK3;CDH2;ITGA6;SHANK3;ROR1;DCC;LRRC7;NPTN;TANC2;TENM3;RIT2;PAK3;CHN1;PTK2B;TOX;FUT9;NDNF;SERPINI1;CDKL5;NTNG1;CCDC88A;NTRK2;MBOAT1;LYN;GSK3B;ROR2;DAB2IP;PAK1;RAP1A;APOE;STMN2;DISC1;PRAG1;PSEN1;RELN;SPOCK1;PTN;SCARF1;TRPV4;PLPPR5;MFSD2A;MARK2;ABI3;PRKD1;CFL1;RET;RTN4RL1;CDK5R1;MT3;FES
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.6962262043110148,1.598822331470829,0.03710575139146568,1.0,1.0,3/17,1.15%,ATP1A2;BMP7;TFPI
prerank,endothelial cell proliferation (GO:0001935),-0.6067644483087923,-1.5986914539755965,0.01948051948051948,0.2158120455213851,1.0,6/17,4.30%,TEK;BMPER;BMPR2;SEMA5A;CD34;ACVRL1
prerank,bone development (GO:0060348),0.5875147738651301,1.5980448938367398,0.01335559265442404,1.0,1.0,8/39,6.69%,RANBP3L;DYM;FGFR2;AKAP13;SULF2;CYP26B1;TP53;SH3PXD2B
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.7130362659449695,1.5971464650658203,0.030852994555353903,1.0,1.0,5/15,12.92%,MOXD1;SMOX;SAT1;PAOX;ASMT
prerank,anion transport (GO:0006820),0.6062384668316207,1.5969283009785886,0.018425460636515914,1.0,1.0,6/33,5.94%,SLC22A6;SLC13A4;SLC13A3;VDAC2;SLC26A3;SLC19A1
prerank,cyclooxygenase pathway (GO:0019371),0.7748694775942101,1.5968587417938478,0.03815261044176707,0.9905791264138827,1.0,2/10,1.04%,PTGDS;PTGS1
prerank,endothelial cell differentiation (GO:0045446),-0.6867163658576781,-1.595788994183832,0.0125,0.21987278677255306,1.0,7/12,12.21%,BMPR2;TIE1;ACVRL1;JAG1;KDR;PROX1;SOX18
prerank,response to ethanol (GO:0045471),-0.6503659018699481,-1.5951982755322744,0.03125,0.21930117049783673,1.0,8/14,15.27%,GRIN2B;ADCY7;GRIN3A;GRIN2A;GLRA1;GLRA2;SDF4;GRIN1
prerank,triglyceride homeostasis (GO:0070328),0.6340092186404453,1.5921369582138087,0.039383561643835614,1.0,1.0,7/26,12.36%,RORA;C1QTNF3;IL18;ANGPTL8;SIRT1;PLA2G12B;MLXIPL
prerank,phosphate ion homeostasis (GO:0055062),-0.7039467400097807,-1.5910386878820217,0.032454361054766734,0.22562376891918287,1.0,3/10,7.03%,SFRP4;XPR1;ENPP1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.7373136247368395,1.5906577830521027,0.03231939163498099,1.0,1.0,6/13,12.28%,SORBS1;PRKCZ;ECHDC3;GKAP1;SIRT1;PTPN11
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.6202209391192278,-1.5900027470783875,0.033936651583710405,0.2261134724081633,1.0,10/18,10.63%,GRID2;GRIK2;CDH8;GRIK1;GRIA2;UNC13B;GRIK4;SLC1A4;GRID1;SLC17A6
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.701804944088855,-1.589909522258317,0.027253668763102725,0.2246226244690671,1.0,3/11,3.67%,MECOM;CD34;RUNX1
prerank,vascular transport (GO:0010232),0.5191172757992132,1.5890966413960455,0.007385524372230428,0.9985436891033337,1.0,20/81,9.62%,ATP1A2;SLC22A8;SLC13A3;SLC6A13;SLC6A1;SLC24A3;LEPR;SLC16A12;SLC5A5;SLC38A3;SLC7A2;SLC5A3;SLC6A9;SLC19A1;SLC22A5;SLC27A1;SLC38A1;SLC1A3;LRP1;LRP3
prerank,detection of visible light (GO:0009584),0.6985097201419631,1.5889028649406878,0.029574861367837338,0.9821020703743634,1.0,5/16,11.75%,ABCA4;CEP250;GNAT2;RHO;CACNA2D4
prerank,inorganic anion transmembrane transport (GO:0098661),-0.467534210447942,-1.5887009505494276,0.011267605633802818,0.22551867411486168,1.0,32/63,17.12%,SLC12A7;ANO4;GABRG3;GABRB3;ANO1;SLC26A2;GABRB1;GABRA3;GLRB;SLC12A2;GABRA2;SLC1A1;ANO3;GABRB2;SLC5A6;GLRA3;XPR1;GLRA1;GABRG2;SLC12A8;GABRA4;SLC12A4;GABRG1;SLC12A6;GLRA2;CLCN1;ANO5;ANO2;CLCN3;SLC12A5;GABRA5;GABRE
prerank,cellular response to drug (GO:0035690),-0.5646624086491588,-1.5883336960854537,0.018140589569160998,0.2244743291345572,1.0,10/25,14.49%,MEF2C;PDE4B;ACER2;GAS6;TFRC;KCNQ1;RAP2A;AIM2;HTR1B;PPM1F
prerank,positive regulation of axon extension (GO:0045773),-0.5747553606982065,-1.5865835995047004,0.013574660633484163,0.22630198405701232,1.0,6/22,5.18%,NRP1;SEMA5A;SEMA7A;CDKL5;NTN1;SHTN1
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.578749644650584,-1.586571360197173,0.009195402298850575,0.22461634606046751,1.0,14/24,25.60%,PECAM1;VCAM1;F11R;ICAM1;SEMA4D;ITGB1;ITGA4;MSN;NT5E;SYK;ITGB2;CERCAM;FERMT3;SELP
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.6145932515074753,1.5860763249584025,0.029209621993127148,0.9875614336246658,1.0,3/26,1.62%,PRKAG2;LPGAT1;PRKAA2
prerank,dendritic spine organization (GO:0097061),-0.555959056040409,-1.5856743108192721,0.01650943396226415,0.2246581809876553,1.0,9/26,13.89%,CTNND2;DOCK10;SHANK3;EPHB1;PAK3;EPHB2;MTMR2;DIP2A;SHANK1
prerank,transport across blood-brain barrier (GO:0150104),0.5141773329893392,1.5850607482240868,0.01023391812865497,0.9785206203555425,1.0,20/83,9.62%,ATP1A2;SLC22A8;SLC13A3;SLC6A13;SLC6A1;SLC24A3;LEPR;SLC16A12;SLC5A5;SLC38A3;SLC7A2;SLC5A3;SLC6A9;SLC19A1;SLC22A5;SLC27A1;SLC38A1;SLC1A3;LRP1;LRP3
prerank,positive regulation of dendrite extension (GO:1903861),-0.6256191967693069,-1.5849165239197534,0.028953229398663696,0.22457423284827457,1.0,4/17,4.88%,SYT1;RIMS2;RIMS1;NEDD4L
prerank,maintenance of blood-brain barrier (GO:0035633),-0.5471012161236816,-1.5846773937190803,0.010443864229765013,0.22338109768202355,1.0,14/30,7.16%,PECAM1;ACTB;CLDN5;ESAM;LAMA2;F11R;SLC12A2;ACTG1;SLC1A1;LSR;MBP;OCLN;JAM2;ITGB1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5933616760062025,-1.5843558348957603,0.04100227790432802,0.22229788261381478,1.0,9/18,26.09%,VCAM1;JAM2;ITGB1;ITGA4;ADD2;CX3CR1;GCNT1;SELP;ITGB7
prerank,response to sterol (GO:0036314),0.7347342891554328,1.5842263906691538,0.03621730382293763,0.9690287664612063,1.0,4/11,7.34%,RORA;TGFBR1;RORC;TGFBR2
prerank,glycogen metabolic process (GO:0005977),0.6182038372560377,1.5828551482927649,0.03436426116838488,0.9636568950837519,1.0,5/27,8.86%,PRKAG2;PYGM;PHKB;GYS1;PHKG1
prerank,regulation of dendrite extension (GO:1903859),-0.6191316141654066,-1.5827357889263711,0.03218390804597701,0.2237633924052072,1.0,4/18,4.88%,SYT1;RIMS2;RIMS1;NEDD4L
prerank,positive chemotaxis (GO:0050918),-0.6242604660925375,-1.582653494971376,0.026726057906458798,0.22225995011175845,1.0,8/17,17.17%,NRP1;PTPRJ;SEMA5A;MET;FGF7;VEGFA;SCG2;SCRIB
prerank,cGMP-mediated signaling (GO:0019934),-0.6571903923110612,-1.5820091603484003,0.019867549668874173,0.22181142085381236,1.0,6/13,9.51%,PDE3A;KCNC2;HTR2C;GUCY1B1;APOE;PDE2A
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.5810193053891922,-1.580733372872958,0.022988505747126436,0.22253017651464851,1.0,10/21,15.00%,PDE4D;CAV1;RASSF2;NCK2;SMAD7;CNKSR3;DDIT4;DMTN;PPM1F;NCK1
prerank,regulation of cardiac conduction (GO:1903779),0.5556643172526291,1.5804966035022412,0.012403100775193798,0.9664308489304364,1.0,11/54,6.24%,ATP1A2;ATP1B3;ANK2;CORIN;ITPR2;ITPR1;NPR1;SLC8A3;DMPK;NPR2;AHCYL1
prerank,regulation of MAP kinase activity (GO:0043405),0.5083855882557092,1.5794859063871667,0.005633802816901409,0.958660384262976,1.0,14/92,6.37%,FGF1;ROBO1;BMP7;TPD52L1;KSR1;KIT;CD300A;PPEF2;FGFR1;ADRA2A;LRRK2;FLT1;TRIB2;PDGFRB
prerank,regulation of glycolytic process (GO:0006110),0.5266228944856176,1.5790345821728922,0.0196078431372549,0.9470452489398521,1.0,14/68,13.91%,PRKAG2;IGF1;PRKAA2;PPARA;ZBTB20;NUPR1;GCK;HDAC4;NUP42;NUP98;MLXIPL;NUP43;NCOR1;OGT
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.63590568175248,1.5784504011260958,0.03826955074875208,0.9365163681513576,1.0,3/23,0.48%,UACA;BMP7;C1QTNF3
prerank,leukocyte tethering or rolling (GO:0050901),-0.5982213303553574,-1.5783834800446015,0.04484304932735426,0.22555917759280628,1.0,9/17,26.09%,VCAM1;JAM2;ITGB1;ITGA4;ADD2;CX3CR1;GCNT1;SELP;ITGB7
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.7012744489296536,-1.576726457140217,0.01948051948051948,0.2271574215331197,1.0,3/10,4.11%,CAV1;ANK3;KCNAB1
prerank,epithelial cell development (GO:0002064),0.6619429793499857,1.573556367619549,0.041237113402061855,0.9594228627508582,1.0,5/20,8.51%,WNT5B;PKHD1;RILPL1;DACT2;LRTOMT
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.5973641205428959,-1.5725756570862197,0.029723991507430998,0.2337571114042439,1.0,7/18,7.73%,NLGN1;RIMS2;RIMS1;GSK3B;RAP1B;RAP1A;PREPL
prerank,neural crest cell development (GO:0014032),-0.4959151171054513,-1.5719894409737618,0.007692307692307693,0.23342683812184323,1.0,17/44,18.48%,SEMA3C;ERBB4;SEMA6A;SEMA6D;CDH2;SEMA5A;SEMA7A;SEMA3E;TBX1;SEMA4D;CORO1C;SEMA3D;SEMA3G;SEMA4C;KLHL12;SEMA4A;SOX8
prerank,endothelial tube morphogenesis (GO:0061154),-0.7009036576488799,-1.5714327381634585,0.027450980392156862,0.23294918933355938,1.0,5/10,12.06%,ACVRL1;RHOB;STARD13;BMP4;CTNNB1
prerank,linoleic acid metabolic process (GO:0043651),0.6791784243397654,1.5708573995259163,0.047706422018348627,0.966265619674715,1.0,2/17,2.35%,ACSL1;ALOX12
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.7315187823419829,1.5689902535163327,0.04961832061068702,0.9657167984833912,1.0,2/11,1.47%,NECAB1;BACE2
prerank,cellular response to arsenic-containing substance (GO:0071243),0.6995532668626099,1.5686381905344637,0.046296296296296294,0.9538582975775738,1.0,2/15,5.49%,CPEB2;DDX3X
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.7205129666888916,1.5685775386297267,0.041666666666666664,0.940326004645813,1.0,3/14,3.17%,AUTS2;KMT2A;CTR9
prerank,gliogenesis (GO:0042063),-0.6193960463568347,-1.5672808812382144,0.027139874739039668,0.23941071246235404,1.0,7/15,15.42%,CDH2;CD9;TGFB2;ANXA1;RELN;PAX2;METTL3
prerank,positive regulation of dephosphorylation (GO:0035306),-0.5465310116674099,-1.56685947542079,0.022388059701492536,0.23864934164161403,1.0,11/27,14.43%,PPP1R16B;PPP2R5A;PPIA;CALM1;CALM2;CAMTA1;BMP2;TGFB1;CALM3;MTMR9;SPPL3
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.7048273601145584,1.5668375708170197,0.030965391621129327,0.940344248170727,1.0,4/16,7.63%,AUTS2;KMT2A;CTR9;BCOR
prerank,negative regulation of gluconeogenesis (GO:0045721),0.755866377822962,1.5665851000680648,0.03903345724907063,0.928738145157257,1.0,3/11,7.27%,C1QTNF3;SIK1;GCK
prerank,positive regulation of cell projection organization (GO:0031346),-0.41860679817732055,-1.5664069356237635,0.0,0.2380257689167827,1.0,37/115,9.95%,SLIT2;PTPRD;ROBO2;IL1RAPL1;NTRK3;ITGA6;ROR1;LRRC7;NPTN;TENM3;GRIP1;RIT2;CARMIL1;PTK2B;TOX;FUT9;NDNF;SERPINI1;CDKL5;NGF;NTRK2;LYN;ROR2;DAB2IP;TIAM1;FZD4;RAP1A;APOE;STMN2;PLXNC1;RELN;PTN;PLXNA4;SCARF1;MAP6;PLPPR5;SLITRK1
prerank,mesenchyme morphogenesis (GO:0072132),-0.6125766770266817,-1.5663908811655183,0.03090507726269316,0.23646709219755813,1.0,7/17,8.22%,ENG;NOS3;TGFB2;ACVRL1;NOTCH1;HEYL;BMP2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.434874369468202,-1.5662532136249911,0.0,0.23509691163487004,1.0,32/86,16.20%,NAV3;SEMA5A;NCK2;EVL;CARMIL1;PTK2B;CDC42EP3;PAK1;APOE;APP;RPS3;MET;STMN2;OCLN;PSEN1;BIN1;PROX1;TRPV4;CDK5RAP2;WDR1;EDN1;SYNPO2;MAPT;PFN2;CLIP1;CDK5R1;FES;CDC42EP2;CLU;NCK1;GPX1;ARF6
prerank,positive regulation of B cell proliferation (GO:0030890),-0.5334091172562222,-1.566008923586555,0.0234192037470726,0.23401572387611644,1.0,10/29,22.40%,MEF2C;TFRC;CD38;PTPRC;EPHB2;TIRAP;CD74;IRS2;CD320;CD81
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.6508653769987779,-1.5655192911425513,0.029850746268656716,0.23350776266270712,1.0,10/13,28.30%,CDH13;CD9;LDLR;ITGB1;SREBF2;SYK;ITGB2;CD81;ABCA1;CD36
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.6665908588408469,-1.565023036504682,0.04329004329004329,0.2329652529485002,1.0,6/12,10.34%,EPHB1;HSP90AB1;B4GALT5;MYCBP2;EPHB2;HSP90AA1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.6266152773973812,1.564848393613704,0.034071550255536626,0.9290003614405865,1.0,9/26,16.01%,LGR4;APPL2;TLR3;GPS2;FLOT2;IRF1;LRRC14;TLR5;BIRC3
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.6412857691380467,-1.5645854416818237,0.01948051948051948,0.232327543495934,1.0,5/15,9.15%,TGFB2;TGFB3;TGFB1;IRAK3;SMAD7
prerank,regulation of receptor binding (GO:1900120),-0.7004872688019986,-1.563891025494383,0.02012072434607646,0.23240882296018742,1.0,7/10,21.32%,GREM2;B2M;PTPRF;ADAM15;ATP2A3;BDNF;ATP2A2
prerank,B cell receptor signaling pathway (GO:0050853),-0.5249759089841621,-1.5634220515421315,0.02925531914893617,0.23182986704712036,1.0,13/32,18.36%,MEF2C;RFTN1;CD38;PTPRC;BMX;PLCG2;PLEKHA1;TEC;BCAR1;SH2B2;BLNK;SYK;BTK
prerank,cellular response to decreased oxygen levels (GO:0036294),0.5245215980815663,1.5630993083700908,0.015432098765432098,0.9286541800415209,1.0,13/65,9.72%,EPAS1;CPEB2;RORA;BMP7;SLC8A3;CPEB4;FAM162A;TP53;TERT;SIRT1;AK4;PICK1;NPEPPS
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.7014997331086643,1.562729990348254,0.044573643410852716,0.9187391860137116,1.0,2/12,0.43%,NOTCH2;DOCK11
prerank,endodermal cell differentiation (GO:0035987),-0.5357594733853812,-1.5591804224386032,0.026252983293556086,0.23843680986324267,1.0,16/31,20.10%,COL8A1;COL12A1;FN1;COL6A1;COL4A2;LAMA3;ITGA4;SETD2;MMP15;CDC73;ITGA5;COL11A1;ITGB2;INHBA;VTN;ITGA7
prerank,positive regulation of glucose import (GO:0046326),0.6397363808021164,1.5590420928679114,0.03747870528109029,0.93264283249273,1.0,6/21,6.42%,OSBPL8;SORBS1;IGF1;RHOQ;ITLN1;CREBL2
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.5046997640405393,-1.5589125725966688,0.032663316582914576,0.23734900631701447,1.0,11/34,12.66%,PDE4D;SLC8A1;PDE4B;RYR2;ATP1B1;CALM1;CALM2;KCNQ1;SMAD7;CALM3;NOS1
prerank,positive regulation of heart rate (GO:0010460),-0.6106693369986061,-1.5567262066381284,0.03805496828752643,0.24030104911228206,1.0,6/17,11.72%,PDE4D;RYR2;ADRA1B;KCNQ1;EDN1;EDN3
prerank,regulation of DNA repair (GO:0006282),0.5643861244772747,1.5564361626461798,0.0352760736196319,0.9387251086867582,1.0,14/44,14.03%,EYA1;EYA2;EYA4;BABAM2;RNF8;TRIP12;SIRT1;UBR5;AXIN2;UIMC1;KAT7;BABAM1;PML;SMCHD1
prerank,cardiac ventricle development (GO:0003231),-0.5799204860394522,-1.55635097940699,0.023965141612200435,0.23964154127804885,1.0,7/20,9.51%,ENG;NOTCH1;HES1;STRA6;HEYL;HEY2;PDE2A
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.5870443618576641,-1.5558281911422343,0.03117505995203837,0.23909447825740116,1.0,6/21,15.16%,MTUS1;THBS1;PTK2B;PTK2;CMKLR1;RARRES2
prerank,regulation of ruffle assembly (GO:1900027),-0.5617939049581474,-1.5550171351204918,0.028169014084507043,0.2390918786875387,1.0,8/23,12.78%,NLGN1;CAV1;EVL;RDX;P2RY12;EPS8;ABI3;PFN2
prerank,inhibitory synapse assembly (GO:1904862),-0.6895103849946542,-1.5537807592647597,0.01768172888015717,0.24009386069956892,1.0,6/11,10.88%,GABRB3;GABRA2;GABRB2;GABRG2;FGF13;LGI2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.4972361328074216,-1.5524916881022,0.027989821882951654,0.24110929905710843,1.0,18/39,15.30%,NRP1;SLIT2;COL4A1;ENG;TIE1;RASIP1;SEMA3E;KDR;PAK1;MET;BMP2;SIX1;FGF2;PKD1;BMP4;CTNNB1;VEGFA;PAX2
prerank,cellular response to starvation (GO:0009267),0.4688320967055967,1.550416521874219,0.00516795865633075,0.969109496821205,1.0,32/147,11.45%,PRKAG2;RNF152;PRKAA2;PPARA;FNIP1;MTMR3;CPEB4;PRKAG3;NPRL3;SESN1;ATP6V0E1;LRRK2;LAMP2;SESN2;ATG5;NPRL2;NUAK2;ATP6V0B;TP53;SIK1;EIF2AK2;WIPI1;NUPR2;SIRT1;PICK1;BRSK1;BECN1;ATG7;ATP6V1D;ATP6V1E1;ATF2;IMPACT
prerank,substrate-dependent cell migration (GO:0006929),-0.6287358074212849,-1.5502939757048573,0.03305785123966942,0.24425008108973734,1.0,7/14,10.22%,NRP1;VEGFC;NTN1;SHTN1;PTPRC;CD2AP;P2RY12
prerank,photoreceptor cell development (GO:0042461),-0.6326769268875285,-1.5502865637813419,0.02531645569620253,0.2428001532419937,1.0,6/14,13.77%,RORB;DCX;RP1;MFSD2A;AHI1;VEGFA
prerank,peptidyl-lysine trimethylation (GO:0018023),0.6136817090541772,1.550215354109584,0.033628318584070796,0.9579975592482787,1.0,13/26,19.69%,KMT2A;CTR9;KMT5C;TET2;KMT5B;WDR82;KMT2D;BEND3;OGT;SETD1B;TET3;SETD3;SETD1A
prerank,odontogenesis (GO:0042476),0.5748838407685124,1.5492931817157298,0.03908794788273615,0.952645303565033,1.0,11/35,11.87%,OSR1;FGFR2;WNT6;GLI2;TUFT1;FOXC1;EDA;BCOR;COL1A2;HDAC1;AXIN2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.5549564528420876,-1.5486696640707074,0.018018018018018018,0.24463625985852225,1.0,14/24,24.01%,PDE4D;AKAP6;CAMK2D;CALM1;CALM2;CALM3;FKBP1A;JPH2;NOS1;SELENON;CASQ2;GSTM2;JPH3;DMD
prerank,regulation of focal adhesion assembly (GO:0051893),-0.45881195544757675,-1.5471967807883837,0.011661807580174927,0.2461631876873961,1.0,22/54,14.56%,NRP1;LIMCH1;PTPRJ;TEK;THBS1;CLASP2;EFNA5;PEAK1;ACTG1;ACVRL1;GPM6B;KDR;CORO1C;MYOC;APOD;PTK2;DUSP3;FAM107A;DMTN;VEGFA;PPM1F;LIMS1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.6648577245177126,-1.5471794058159338,0.03512396694214876,0.2447462296791842,1.0,6/11,22.96%,NRP1;PAK1;BCAR1;STMN1;SIRT2;HGF
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.5484279658774709,-1.546959526004016,0.027707808564231738,0.24382138243648974,1.0,12/26,14.41%,NAV3;PAK1;RPS3;MET;STMN2;OCLN;TRPV4;CDK5RAP2;MAPT;CLIP1;CDK5R1;FES
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.3662034195088015,-1.546901937321429,0.0,0.2425081948025023,1.0,133/306,25.77%,ST3GAL4;POLA1;RPS24;RPS12;RPL8;FUT9;EXT1;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;PTMA;APOE;RPL35A;RPLP0;RPS15;RPL30;RPS3;EEF2K;RPL19;RPS21;RPL4;B4GALT5;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;ABCF1;RPL14;RPS17;RPL28;RPL34;EEF1A1;POLD3;RPL12;RPL9;RPS25;EXT2;RPL7A;RPS2;RPS9;RPS11;NAP1L1;RPS10;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;RPL36A;RPL6;TAF1B;DUT;POLR2J;RPL31;HBS1L;RNASEH2A;RPSA;RPS26;TIPIN;RPL36;BCL3;RPA1;ORC5;GCNT1;RNPS1;ORC2;EEFSEC;BARD1;RPL13A;CDC45;BRIP1;RPL35;DNA2;PAX8;INHBA;EEF2;RFC4;COPS5;RPL24;RPS13;MRPL34;RPL11;POLD1;EEF1D;RSL24D1;MRPS16;RFC2;POLR2C;POLR2L;BLM;MRPS21;RECQL5;MLF1;MRPL10;MRPL13;TUFM;EEF1G;RPS27A;MRPS33;HOXD3;EIF4EBP2;MRPL35;EEF1A2;SET;GTPBP2;MCM6;RFC5
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.6915079297636575,1.546611440812844,0.046153846153846156,0.9596760534459754,1.0,3/13,7.27%,SORBS1;IGF1;GCK
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.6818443897458676,-1.5462224967373965,0.04048582995951417,0.24260199707692148,1.0,7/10,24.83%,GHR;STAT3;LYN;STAT5B;PTPN1;PRLR;JAK2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.679649505474277,1.545939248355925,0.051233396584440226,0.952609236731228,1.0,5/16,10.66%,RORA;PRKN;RORC;SIRT1;MLYCD
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.5890069947809194,-1.5459034532729279,0.026128266033254157,0.241893568209726,1.0,13/18,16.55%,RHOJ;HDAC7;HDAC9;AKT3;KDR;ANXA1;GATA2;PTGS2;FGF2;JCAD;VEGFA;SRPX2;PIK3C2A
prerank,sphingolipid metabolic process (GO:0006665),-0.4206468806625246,-1.5458850705155247,0.01107011070110701,0.2405535618588585,1.0,30/108,13.22%,ST6GALNAC3;ELOVL7;CERT1;SGMS1;ESYT2;SGMS2;ELOVL5;ACER3;PRKD3;ACER2;PPM1L;PLPP1;UGCG;SPTLC2;DEGS2;SPNS2;PSAP;PPP2R1A;GLTP;HEXB;B3GALNT1;PPT1;ELOVL6;ESYT3;CERS4;ENPP2;SERINC1;ASAH2;GAL3ST1;PRKD1
prerank,dicarboxylic acid transport (GO:0006835),0.5977198703008091,1.5451691633666726,0.049403747870528106,0.946548079150619,1.0,7/28,9.88%,SLC22A6;SLC13A3;PDPN;SLC19A1;SLC26A1;SLC1A3;SLC25A12
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.6996647242386784,-1.5450517670564965,0.03543307086614173,0.24084888296501147,1.0,7/10,15.93%,PDE4D;PDE3A;PDE3B;PDE11A;PDE2A;UBE2B;APLNR
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.7045777488867049,1.5448815630296742,0.0603290676416819,0.9367641676392618,1.0,5/13,9.48%,RHOQ;LRRK2;OPA1;AK3;AK4
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.4185598838046178,-1.5433877393061808,0.0,0.24276971352481622,1.0,33/93,15.00%,PDE4D;NTRK3;CAV1;RASSF2;NCK2;BCAR3;GAS6;NGF;TFRC;HSP90AB1;PAK1;APP;TGFB1;SMAD7;CNKSR3;FNIP2;CD44;DDIT4;HSP90AA1;ATP2B4;TNKS1BP1;NOS1;PFN2;AXIN1;DMTN;SNCA;PRKD1;VEGFA;TXN;PINK1;TERF2IP;PPM1F;NCK1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.7058625682169838,1.5433738440664917,0.038834951456310676,0.9355823597007377,1.0,3/12,7.27%,SORBS1;IGF1;GCK
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.6447980044380957,1.5428355055888747,0.051056338028169015,0.9285434987525959,1.0,5/21,6.91%,DAB2;BMP6;BMPR1A;TGFBR1;WWTR1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.4672371048977771,-1.5423133467217465,0.011049723756906077,0.24364256121495276,1.0,19/57,14.61%,RPS24;RPS6;RPL26;RPL38;RPL7;RPS19;RPS28;RPL35A;RPS15;RPS16;RPL5;RPS7;RPL14;XPO1;RPS17;RPS25;EMG1;MALSU1;LTV1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.6734214621269221,1.542272420654969,0.06628787878787878,0.9214892167002136,1.0,7/16,9.60%,BMP7;NAPEPLD;METRNL;RREB1;FNDC5;SIRT1;SOX13
prerank,sprouting angiogenesis (GO:0002040),-0.4698555994241103,-1.5414402828724172,0.014534883720930232,0.2440041729143993,1.0,16/51,5.33%,NRP1;SLIT2;TEK;BMPER;CDH13;RSPO3;ENG;CCBE1;VEGFC;THBS1;SEMA5A;PTK2B;ACVRL1;SEMA3E;KDR;RAMP2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.6770932807267699,1.5410385927139099,0.05859375,0.9195085505220174,1.0,8/14,20.04%,AMACR;ACOXL;CRAT;ACOT8;ACOX3;EHHADH;ECI2;CROT
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.461123780429874,-1.5403960708476694,0.00847457627118644,0.24450257540717726,1.0,19/57,8.44%,NLGN1;DLG2;MEF2C;GRIA4;LRRC7;GRIN2B;GRIA1;GRIA2;PTK2B;GRIA3;DLGAP1;SHISA6;SHISA9;DLGAP2;MINK1;APP;GRIN2A;RELN;NETO1
prerank,carbohydrate derivative transport (GO:1901264),-0.5939838593970885,-1.5397008232704532,0.00881057268722467,0.24459288227671536,1.0,9/18,15.36%,SCARB1;PLTP;ABCG1;SLC10A7;NPC2;MFSD2A;VLDLR;LBP;SLC29A1
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.4833991093081713,-1.536679204175607,0.02368421052631579,0.24926041373437846,1.0,12/43,13.46%,MEF2C;ENG;RYR2;MICAL2;TBX3;NOTCH1;SOX17;HES1;VANGL2;SOX18;AHI1;ACVR1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.7314861282891398,1.5365258013600673,0.060665362035225046,0.9412310488819704,1.0,3/11,1.42%,ACTN2;LEPROT;PICALM
prerank,sodium ion transport (GO:0006814),0.5082419771854494,1.5356493266232651,0.011834319526627219,0.936590097850093,1.0,8/85,1.99%,ATP1A2;SLC6A13;SLC6A1;SLC24A3;SLC6A12;ATP1B3;SLC5A5;SLC8A3
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.5501339085713743,-1.5354820954854678,0.02981651376146789,0.25036825808851343,1.0,8/24,8.32%,TEK;SEMA5A;NDNF;GAS6;KDR;RAMP2;ICAM1;GATA2
prerank,regulation of actomyosin structure organization (GO:0110020),0.7125763712424575,1.535031324295754,0.060109289617486336,0.9299893883375165,1.0,7/13,14.57%,ROCK2;FHOD1;AKAP13;ASAP3;CDC42;TSC1;ALMS1
prerank,eye development (GO:0001654),0.5423662142723346,1.53437796915745,0.03840245775729647,0.9242513547000121,1.0,10/54,7.54%,SMOC1;COL5A1;SHROOM2;FOXC1;CACNA1C;MEIS1;SH3PXD2B;FBN1;NIPBL;RBP4
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.5274931038467373,1.5338740858519293,0.029542097488921712,0.9174662687461635,1.0,7/61,3.04%,NOTCH2;ROBO1;AUTS2;LPAR1;IGF1;ALS2;AKAP13
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.5736714270330274,-1.5336454846239336,0.013043478260869565,0.25254308385486124,1.0,11/22,21.68%,SLIT2;GSN;TMSB4X;KANK3;KANK4;PFN2;KANK1;HIP1R;MYADM;SSH2;TWF2
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.6238081259476354,1.533368159914383,0.04144144144144144,0.9109018637439591,1.0,3/23,2.32%,PRKAG2;BMP7;SPHK1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.6156731164769429,1.532927324465918,0.036458333333333336,0.9041683764079971,1.0,5/25,4.88%,WNK4;ACTN2;ATP1B3;ANK2;SLC6A9
prerank,regulation of cellular biosynthetic process (GO:0031326),0.6057014176078668,1.5320787817281611,0.03541315345699832,0.9003509524794981,1.0,7/28,9.35%,PRKAG2;PRKAA2;AVIL;MITF;SIRT5;CTNS;SIRT1
prerank,positive regulation of interferon-beta production (GO:0032728),0.5816710197031096,1.5307150218256307,0.03782894736842105,0.8997624666865617,1.0,14/33,13.35%,OAS2;TLR3;TLR4;RNF135;DDX3X;TRIM56;RIPK2;MAVS;TOMM70;DHX58;PTPN11;IRF1;POLR3A;OAS3
prerank,positive regulation of histone methylation (GO:0031062),0.6303887034903792,1.5298634047876045,0.041811846689895474,0.8962107272254125,1.0,9/24,16.98%,AUTS2;KMT2A;JARID2;CTR9;SIRT1;PHF1;OGT;TET1;SMAD4
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.6170368046727966,-1.5296285625694874,0.03655913978494624,0.2592383328323066,1.0,5/15,10.00%,CDH13;PTPN12;CEACAM1;ERBB2;MVB12B
prerank,regulation of fatty acid metabolic process (GO:0019217),0.6525027896044481,1.527976173733119,0.07749077490774908,0.8991969825684801,1.0,3/17,1.76%,PRKAG2;PRKAA2;PPARA
prerank,signal release from synapse (GO:0099643),-0.47403507156697355,-1.5276901463246915,0.010610079575596816,0.26187011743060573,1.0,9/43,6.77%,NRXN1;SYT1;SNAP25;RIMS1;LIN7A;PCLO;PTPRN2;SYN2;HSPA8
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.4797570560539631,-1.5259023451777223,0.021505376344086023,0.2641800893945368,1.0,15/46,12.85%,NRP1;TMEFF2;TEK;PIK3R1;PARVB;PEAK1;FN1;LAMC3;NTNG1;NTN4;ITGA4;ITGA8;ITGB3;ILK;LPXN
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.6439841828603432,-1.5254916317612488,0.04564315352697095,0.26356692509678165,1.0,4/12,11.73%,GSN;LY6E;MID2;IFITM3
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.6109792417716668,1.52525796958466,0.04819277108433735,0.9076181924095006,1.0,7/26,6.42%,OSBPL8;SORBS1;IGF1;RHOQ;ITLN1;BRAF;CREBL2
prerank,secretion (GO:0046903),0.6771880326272326,1.5247905671425743,0.056530214424951264,0.9012385288638121,1.0,2/14,1.93%,SLC22A6;NPR1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.5437665516983861,1.5222394990726125,0.018376722817764167,0.9089130653488774,1.0,13/53,14.03%,EYA1;EYA2;DDX5;EYA4;BABAM2;NACC2;ATM;RNF8;FBH1;SIRT1;UIMC1;BABAM1;SMCHD1
prerank,regulation of stem cell proliferation (GO:0072091),0.6611267639251056,1.520740785020915,0.06088560885608856,0.9096936325744833,1.0,4/17,8.39%,ACE;FBLN1;EIF2AK2;TERT
prerank,response to zinc ion (GO:0010043),-0.5356129482713082,-1.520528410568275,0.030501089324618737,0.27293978661845547,1.0,13/25,14.18%,PAM;GLRA1;MT1E;MT1F;MT1M;MT1G;MT1X;MT1H;MT1A;MT1B;CRIP1;GLRA2;MT3
prerank,negative regulation of calcium ion transport (GO:0051926),0.6891416170983189,1.520151864792089,0.04990403071017274,0.9040092960446834,1.0,2/15,3.65%,ATP1A2;ADRA2A
prerank,skeletal system morphogenesis (GO:0048705),0.5417859893061466,1.5198306939942818,0.050156739811912224,0.8975575919710855,1.0,11/42,9.74%,WWOX;FGFR2;HOXB4;FGFR1;TGFBR1;HOXB3;CYP26B1;HOXB9;HOXA3;HOXC4;DYNC2I1
prerank,blood vessel morphogenesis (GO:0048514),-0.45410330539749544,-1.519373219399962,0.02556818181818182,0.27393221151975594,1.0,26/54,12.50%,NRP1;LAMA1;CDH2;CAV1;COL4A1;ENG;CCBE1;ID1;CYP1B1;RASIP1;SLC1A1;KDR;RAMP2;TBX1;ITGB8;SOX17;HES1;STRA6;TGFB1;PROX1;SMAD7;HEY2;FLT4;RASA1;SOX18;LOX
prerank,lysine catabolic process (GO:0006554),0.7007013565103417,1.5188475022178942,0.06859205776173286,0.8866075033578061,1.0,6/12,13.24%,ALDH7A1;PIPOX;OGDH;DLD;AASS;GCDH
prerank,lysine metabolic process (GO:0006553),0.7007013565103417,1.5188475022178942,0.06859205776173286,0.8866075033578061,1.0,6/12,13.24%,ALDH7A1;PIPOX;OGDH;DLD;AASS;GCDH
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.7099700912554708,1.518570658853979,0.05860113421550094,0.8800307448379658,1.0,5/12,12.28%,SORBS1;PRKCZ;GKAP1;SIRT1;PTPN11
prerank,dicarboxylic acid catabolic process (GO:0043649),0.6948837981883594,1.5182376673758322,0.06469500924214418,0.8736937684311351,1.0,7/13,16.22%,DDO;ASPA;GOT2;GLUL;ACOT8;QPRT;GOT1
prerank,diacylglycerol metabolic process (GO:0046339),-0.5565894619663094,-1.5180627945683525,0.02262443438914027,0.27513541003638803,1.0,8/23,13.46%,DGKH;DGKB;PLCE1;DGKI;DGKK;DGKG;DGKZ;LIPE
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.6269902209016825,1.518002649134665,0.044326241134751775,0.8671090224056658,1.0,4/22,10.48%,ALDH1A2;RBP1;CYP2R1;GC
prerank,kidney development (GO:0001822),0.514595884999268,1.5161406710340688,0.021398002853067047,0.8704217461802375,1.0,12/65,4.95%,BMP7;ACE;LRP4;WNT4;OSR1;GREB1L;GLI2;KANK2;TGFBR1;FOXC1;SULF2;CTSH
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.5649326533354219,-1.5160681399636116,0.052980132450331126,0.2777726646253778,1.0,9/19,15.66%,PTPRJ;GRM5;RYR2;VCAM1;KDR;PTPRC;DMTN;TRPM2;STIMATE
prerank,phospholipid transport (GO:0015914),-0.45655213422058305,-1.5157171037372297,0.014450867052023121,0.27707212651782104,1.0,21/52,14.29%,ATP10A;ATP8A1;ATP8B1;PITPNC1;ATP11A;ATP8A2;SCARB1;PLTP;APOE;ABCG1;LDLR;NPC2;ATP11C;PITPNB;TNFAIP8L3;MTTP;MFSD2A;PITPNA;TMEM30A;ATP8B2;ABCB4
prerank,positive regulation of neuron migration (GO:2001224),-0.6488301042414084,-1.5155428515642693,0.04357298474945534,0.2759868687072717,1.0,4/11,5.82%,SEMA6A;SHTN1;ARHGEF2;DAB2IP
prerank,response to interleukin-6 (GO:0070741),-0.6809965710088466,-1.515107107706334,0.04056795131845842,0.2755680437781181,1.0,5/10,11.87%,PID1;PTPRT;PTGIS;ST3GAL6;SBNO2
prerank,excitatory postsynaptic potential (GO:0060079),-0.5809025247484982,-1.5146670871922698,0.041189931350114416,0.275018790371421,1.0,5/19,7.11%,GRID2;MEF2C;GRIN2B;GSK3B;GRIN2A
prerank,ameboidal-type cell migration (GO:0001667),-0.4670684126876673,-1.5145313959548008,0.024930747922437674,0.2739336786689258,1.0,22/51,18.48%,SEMA3C;ERBB4;SEMA6A;SEMA6D;SEMA5A;SEMA7A;CCN3;SEMA3E;TBX1;SEMA4D;CORO1C;ITGA4;PDLIM1;AMOT;SEMA3D;SEMA3G;PKN3;FAT2;SEMA4C;AMOTL1;SEMA4A;SOX8
prerank,positive regulation of fat cell differentiation (GO:0045600),0.5363110060042113,1.513309212125089,0.047619047619047616,0.879549853720568,1.0,9/47,6.42%,TMEM64;BMP7;MEDAG;NAPEPLD;ADIG;METRNL;RREB1;FNDC5;CREBL2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.434705026170833,-1.513212177250032,0.005988023952095809,0.27551569182514385,1.0,29/71,22.70%,PIK3R1;MYO10;ACTB;ACTG1;HSP90AB1;DOCK1;LYN;ACTR2;PAK1;WIPF3;PLCG2;CRK;PTK2;ABI1;HSP90AA1;ACTR3;ELMO1;ARPC1B;ARPC5;ARPC4;NCK1;VAV1;WASF2;SYK;NCKAP1;WIPF1;YES1;ARPC3;FYN
prerank,regulation of amyloid fibril formation (GO:1905906),-0.6037340576103007,-1.5131477802346123,0.04670912951167728,0.2742373280730852,1.0,7/15,16.77%,APOE;APP;LDLR;PSEN1;CLU;IAPP;CHRNA7
prerank,protein mono-ADP-ribosylation (GO:0140289),0.7225807409244206,1.5125057778061581,0.05639097744360902,0.8769201158083116,1.0,8/11,10.70%,PARP10;PARP14;TIPARP;PARP4;PARP12;PARP9;PARP11;PARP6
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.6179984229498294,-1.5124247786740932,0.045454545454545456,0.27433407214172,1.0,7/15,15.42%,GRM7;GRM5;GRM3;GRM8;GRM1;HOMER1;GRIK3
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.4377413581416978,-1.5122837461919654,0.006042296072507553,0.2732214207002046,1.0,29/70,22.70%,PIK3R1;MYO10;ACTB;ACTG1;HSP90AB1;DOCK1;LYN;ACTR2;PAK1;WIPF3;PLCG2;CRK;PTK2;ABI1;HSP90AA1;ACTR3;ELMO1;ARPC1B;ARPC5;ARPC4;NCK1;VAV1;WASF2;SYK;NCKAP1;WIPF1;YES1;ARPC3;FYN
prerank,rRNA processing (GO:0006364),-0.3796724376100544,-1.510870657187269,0.0,0.2747651768011123,1.0,79/172,24.14%,RPS24;RPL8;RPL41;RPL13;RPLP2;RPS6;RPL18A;RPL37;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPL19;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;WDR3;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;SART1;RPL36A;RPL6;EMG1;MDN1;RPL31;NOP53;DDX10;NOL11;RPL36;TEX10;RPL13A;FBL;XRN2;RPL35;ERI1;UTP15;NHP2;RPL24;NOP56;RPL11;TFB1M;MTREX;EXOSC10;RRP15;NOP58;IMP4;EXOSC4;EXOSC1;POP4
prerank,regulation of cytoplasmic translation (GO:2000765),0.6979005755572611,1.5108525482053048,0.061930783242258654,0.8792836461377229,1.0,4/14,8.32%,CPEB2;CPEB4;ZCCHC13;CPEB3
prerank,cell-cell junction assembly (GO:0007043),-0.44350949002923845,-1.5107208481961971,0.015337423312883436,0.27366136377449174,1.0,22/63,10.63%,CDH11;CTNND2;CDH8;CDH2;ACTB;CLDN5;CD9;CDH10;EPB41L3;CDH12;ACTG1;CLDN11;GJC1;GJD3;RAMP2;CDH6;CDH19;CDH20;CDH7;SMAD7;TRPV4;WDR1
prerank,membrane lipid biosynthetic process (GO:0046467),-0.452452368528245,-1.5104563117191272,0.020289855072463767,0.2728996870350414,1.0,17/58,10.64%,ST3GAL4;ELOVL7;CERT1;SGMS1;SGMS2;ELOVL5;ACER3;PRKD3;ACER2;PPM1L;PLPP1;SPTLC2;DEGS2;SPNS2;ST8SIA6;ELOVL6;CERS4
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.6715029328968257,-1.5100318752623196,0.0536779324055666,0.272336048188445,1.0,5/10,19.59%,FN1;HSP90AB1;LAPTM4B;GATA6;TYROBP
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.586131980423114,-1.5087149984330441,0.04838709677419355,0.2736285590308287,1.0,8/18,17.63%,HEG1;RASIP1;MET;KCTD10;MYOC;CUL3;STMN1;KANK1
prerank,cAMP-mediated signaling (GO:0019933),-0.5466740438892667,-1.5084887910147156,0.043478260869565216,0.27270972133214655,1.0,9/24,5.44%,PDE4D;PDE3A;RIMS2;ADGRG6;AKAP6;ADCY2;EPHA5;PDE7B;CAP2
prerank,negative regulation of ion transport (GO:0043271),0.6234660049432484,1.5084354684313743,0.05235602094240838,0.8870440949394841,1.0,5/24,3.86%,WNK4;ACTN2;SYT11;ADRA2A;NEDD4
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.6937367337100058,1.5080681501757216,0.08445297504798464,0.8818530690723154,1.0,6/13,9.60%,BMP7;NAPEPLD;METRNL;RREB1;FNDC5;SOX13
prerank,transepithelial transport (GO:0070633),-0.5984526840917648,-1.5079244860461163,0.059734513274336286,0.2725714586077669,1.0,4/15,4.70%,ABCG2;SLC12A2;SLC1A2;SLC1A1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.5693539210770362,-1.5072576374242561,0.045951859956236324,0.2727680132637453,1.0,11/21,22.70%,GRIN2B;NGF;EPHA7;AIM2;MT3;USP50;GRIN1;PSMB9;SOX2;PYCARD;FYN
prerank,ganglioside biosynthetic process (GO:0001574),-0.6138763236087973,-1.5069166786644215,0.038202247191011236,0.27218321923236954,1.0,6/15,8.77%,ST6GALNAC3;ST8SIA4;ST3GAL1;ST6GALNAC5;B4GALT5;ST8SIA6
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.661322557956446,-1.5068173221611463,0.04051172707889126,0.2711485088481969,1.0,5/11,11.29%,SEMA6A;THBS1;EPN2;KLF2;CREB3L1
prerank,positive regulation of interleukin-13 production (GO:0032736),0.7116963929452776,1.5062950639770278,0.058365758754863814,0.8849651058686563,1.0,2/10,2.00%,PRKCZ;IL18
prerank,lamellipodium organization (GO:0097581),-0.5119039606725111,-1.5062264743957634,0.03588516746411483,0.27112981074204134,1.0,14/29,13.12%,CDH13;ABLIM1;PARVB;CARMIL1;SPATA13;CCDC88A;ARHGEF7;ABLIM3;ITGB1;S1PR1;P2RY12;ABLIM2;SPEF1;DMTN
prerank,positive regulation of protein processing (GO:0010954),-0.5642393744073235,-1.5060279155285656,0.05194805194805195,0.2702386709023466,1.0,6/19,16.71%,GSN;CCBE1;MYH9;NKD2;RHBDD1;CLEC3B
prerank,positive regulation of cell communication (GO:0010647),-0.5180528888401181,-1.5060088650218741,0.02336448598130841,0.26901041756545674,1.0,11/28,12.24%,GRIK2;SYT1;RIMS2;CLSTN2;ANK3;RIMS1;LGI1;EDN1;EDN3;HOMER1;ILK
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.671989089691337,-1.5054881744336366,0.043824701195219126,0.2688643908935781,1.0,4/10,8.44%,SHANK3;NPTN;APP;NETO1
prerank,sodium ion transmembrane transport (GO:0035725),0.49025024050960836,1.5053136038711838,0.02263083451202263,0.8833140703981301,1.0,7/84,1.99%,ATP1A2;SLC6A13;SLC6A1;SLC24A3;SLC6A12;ATP1B3;SLC8A3
prerank,cardiac cell development (GO:0055006),-0.6613401885992954,-1.505129127071679,0.03956043956043956,0.2683823621407869,1.0,5/11,13.77%,SLC8A1;JAG1;NOTCH1;MYH11;VEGFA
prerank,base conversion or substitution editing (GO:0016553),-0.6492999345160128,-1.5048173689738087,0.05485232067510549,0.2677831095449023,1.0,4/11,15.42%,ADARB1;ADARB2;APOBEC1;METTL3
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.49393851440673514,-1.5039007695306614,0.04156479217603912,0.26848763673988507,1.0,11/32,9.64%,ADGRB3;HECW2;PTPRD;IL1RAPL1;HECW1;CDKL5;NEDD4L;GSK3B;SEMA4D;LZTS1;RAP2A
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.5710647098100875,1.5035709578159546,0.05442176870748299,0.8863357617105146,1.0,10/31,9.74%,OSR1;FGFR2;HOXB4;TGFBR1;HOXB3;HOXB9;HOXA3;TGFBR2;HOXC4;DYNC2I1
prerank,metal ion export (GO:0070839),0.5854201208771737,1.502747527827688,0.04674457429048414,0.8839756821400088,1.0,4/31,1.81%,ATP1A2;ATP1B3;KCND3;KCNA5
prerank,positive regulation of DNA metabolic process (GO:0051054),0.5210210068229255,1.5021336238925427,0.029185867895545316,0.8798691007648909,1.0,16/61,14.03%,EYA1;EYA2;SMOC2;EYA4;BABAM2;USP9X;ATRX;PDGFRB;RNF8;SIRT1;UIMC1;RAD50;USP7;BABAM1;PML;SMCHD1
prerank,regulation of histone methylation (GO:0031060),0.6949157680988558,1.5015474394611512,0.05762081784386617,0.8760714079713907,1.0,6/13,15.19%,JARID2;CTR9;NSD1;MTHFR;AASS;TET1
prerank,peptide hormone secretion (GO:0030072),-0.5296285856904853,-1.500494597192503,0.03233256351039261,0.2741236788667498,1.0,5/26,11.72%,RIMS2;LTBP4;ANXA1;EDN1;EDN3
prerank,carboxylic acid catabolic process (GO:0046395),0.6929088449936878,1.5004891751804204,0.0817490494296578,0.8750072210991988,1.0,5/12,12.41%,RENBP;NPL;PON3;GNPDA1;ACOT8
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.5695379284914541,1.4993980991743145,0.03648424543946932,0.8740944987494325,1.0,12/38,13.78%,BMP6;SASH1;IFNK;ANKRD17;PLSCR1;DDX60;LY96;DHX58;NMI;PRKCA;IFI35;ACOD1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.5183677883962438,1.49888696700579,0.023952095808383235,0.8697873730690048,1.0,10/66,6.37%,FGF1;ROBO1;TPD52L1;KIT;SASH1;FGFR1;ADRA2A;LRRK2;FLT1;PDGFRB
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.6508912125380959,-1.4984644150978854,0.05485232067510549,0.27715472644063605,1.0,7/11,24.07%,GSN;ST18;FAS;HTRA2;LGALS9;PRR7;PLAUR
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.6862608682767122,1.4982276894126363,0.05595667870036101,0.8666976507926947,1.0,12/15,25.06%,SPHK1;SIRT3;SAMD8;PLA2G6;SPHK2;NSMAF;SMPD3;SMPD2;TNFRSF1A;ORMDL3;ORMDL1;PRKCD
prerank,histone modification (GO:0016570),0.47042185098864553,1.4981886114176555,0.012129380053908356,0.8599718145490689,1.0,29/109,17.45%,EYA1;EYA2;BRD8;CCNA2;EYA4;PADI6;USP3;CPA4;NSD1;BAZ1B;TBL1X;HUWE1;TBL1XR1;KAT6B;HDAC4;SIRT1;NSD3;HDAC1;AURKB;PRDM5;HLCS;SIN3A;MIER3;MTA2;EHMT2;CREBBP;EHMT1;SGF29;PADI4
prerank,negative regulation of chemotaxis (GO:0050922),-0.496976091164265,-1.4976728171891092,0.037383177570093455,0.27758746992357697,1.0,14/31,12.46%,SLIT2;ROBO2;SEMA3C;SEMA6A;SEMA6D;THBS1;SEMA5A;SEMA7A;NOTCH1;SEMA3E;SEMA4D;DUSP3;SEMA3D;SEMA3G
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.7300602200941344,1.497325359854242,0.06719367588932806,0.8516771016326533,1.0,3/10,11.75%,CEP250;GNAT2;CACNA2D4
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.7300602200941344,1.497325359854242,0.06719367588932806,0.8516771016326533,1.0,3/10,11.75%,CEP250;GNAT2;CACNA2D4
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.61670458140314,1.4971675020302782,0.06375227686703097,0.8457822805707916,1.0,10/21,21.38%,DCDC2;TTC23;SMO;RAB34;GLI1;EVC;STK36;IHH;GAS8;DLG5
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.6388538181416337,-1.4970942177684397,0.06172839506172839,0.27770234946952704,1.0,6/12,18.31%,PTPRJ;F3;APOD;SNCA;CBL;NDRG4
prerank,fat cell differentiation (GO:0045444),0.5272708889996185,1.4967901233653564,0.029595015576323987,0.8413208738065031,1.0,19/57,17.33%,WNT5B;C1QTNF3;OSBPL8;PPARGC1A;ADIG;METRNL;SMAD6;OSBPL11;SIRT1;CBY1;TCF7L2;MKKS;FAM120B;ERAP1;PER2;BBS2;CLIP3;CTBP2;MED1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.6177167130607,1.4965794541726776,0.05317324185248713,0.8360551017331582,1.0,12/23,22.24%,C1QTNF3;PPARA;NUPR1;SIK1;GCK;HDAC4;NCOR1;CLK2;CRY1;PLEK;GSK3A;EP300
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.7116824057721116,1.4957341148550038,0.08155339805825243,0.8343864688553384,1.0,3/10,7.30%,APPL2;CD300A;ANO6
prerank,peripheral nervous system development (GO:0007422),-0.5410531449636617,-1.4949238897923836,0.04195804195804196,0.2809228301380582,1.0,14/23,30.20%,ADGRG6;SERPINI1;NGF;NFASC;SCN8A;ADGRB1;BDNF;SOX8;SOX10;ERBB3;NF1;ADGRB2;NTF3;GPC1
prerank,arachidonic acid metabolic process (GO:0019369),0.5599612360619609,1.4948823958768669,0.04950495049504951,0.8330928572883204,1.0,5/35,6.61%,PTGDS;PTGS1;ALOX12;EPHX1;DAGLA
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5829011617455239,-1.4948704810592106,0.03811659192825112,0.27974414359338995,1.0,6/17,9.92%,MAML2;NOTCH3;NOTCH1;HEYL;WWC1;PBX1
prerank,negative regulation of cellular protein localization (GO:1903828),0.5649581587958146,1.4943740364999096,0.06230529595015576,0.8295914133515053,1.0,4/34,1.42%,ROCK2;ACTN2;LEPROT;PICALM
prerank,positive regulation of synaptic transmission (GO:0050806),-0.4315348514116809,-1.4941686209210863,0.006191950464396285,0.27996994040337325,1.0,21/72,11.23%,NLGN1;NRXN1;GRIK2;SYT1;RIMS2;CLSTN2;SHANK3;SLC24A2;RIMS1;NPTN;GRIN2B;PTK2B;PLK2;APP;GRIN2A;LGI1;RELN;EPHB2;ZDHHC2;SHANK2;GPER1
prerank,organic acid transport (GO:0015849),0.47552112079788544,1.4939842800070746,0.025174825174825177,0.8255895638609169,1.0,18/94,8.70%,SLC22A6;SLC13A3;SLC6A13;ACSL1;SLC6A12;SLC38A4;SLC38A3;SLC7A11;SLC7A2;PDPN;SLC25A48;SLC10A4;SLC19A1;SLC27A1;GOT2;SLC26A1;SLC38A1;SLC51A
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.6220695956449062,-1.493785111537151,0.07126948775055679,0.27959561355548485,1.0,4/12,9.22%,CXCL12;APP;JAM2;DOCK8
prerank,negative regulation of platelet activation (GO:0010544),-0.5842751368136206,-1.4930681777054953,0.05043859649122807,0.27989916387123276,1.0,7/16,10.25%,PRKG1;CD9;SERPINE2;NOS3;APOE;CEACAM1;PDGFA
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.5404971920983953,1.492958826075779,0.048154093097913325,0.8253160221473723,1.0,7/41,13.91%,PRKAG2;LACC1;GCK;NUP42;NUP98;NUP43;OGT
prerank,positive regulation of signaling (GO:0023056),-0.4820239625302315,-1.4910526441197782,0.020460358056265986,0.2827985278240859,1.0,16/37,17.66%,GRIK2;SYT1;RIMS2;CLSTN2;RIMS1;ECE1;LGI1;NSF;EDN1;EDN3;HOMER1;ILK;SNCA;NMU;SCRIB;CDKN2AIP
prerank,negative regulation of TORC1 signaling (GO:1904262),0.6679378453761269,1.489794512415593,0.07344632768361582,0.8368000477695434,1.0,4/13,5.45%,RNF152;SESN1;SESN2;ATM
prerank,response to muscle stretch (GO:0035994),-0.589908737642943,-1.4897499443569022,0.05510204081632653,0.28418301052659806,1.0,6/15,12.06%,SLC8A1;CDH2;GSN;RYR2;PTK2;CTNNB1
prerank,neuron projection development (GO:0031175),-0.37854845557505884,-1.4893625100545926,0.0,0.2837831012504206,1.0,54/168,16.18%,FRY;NLGN1;CNTNAP2;CTNND2;PTPRM;DCLK1;GRM7;DOCK10;SHANK3;EPHB1;CNTN4;NYAP2;PAK3;PLP1;EPB41L3;SH3GL2;NGF;TRIO;NRK;TMEM108;GPM6B;SHTN1;LYN;GSK3B;DAB2IP;STX3;MINK1;PAK1;APOE;APP;STMN2;ULK1;LGI1;EPHB2;MYOC;GPRIN3;SLC9A6;RASGRF1;UHMK1;MARK2;DIP2A;NCDN;MAP4;MAPT;ERCC6;GPM6A;SHANK1;CDK5R1;UBB;MYO16;STMN1;BDNF;BICDL1;PACSIN1
prerank,cellular protein metabolic process (GO:0044267),-0.3435568161069705,-1.4885728833430778,0.0,0.28410898474203355,1.0,119/396,15.79%,LTBP1;CDH2;MSRB3;ST8SIA4;CHRM3;CST3;FN1;RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;GAS6;RPL18A;RPS20;MGAT4A;ST3GAL1;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;IGFBP4;DAB2IP;RPL7;RPS19;RPL22;RPS28;APOE;RPL35A;RPLP0;APP;RPS15;MSLN;RPL30;RPS3;SFTPA1;SFTPA2;RPL19;RPS21;RPL4;PSEN1;IGFBP6;RPL32;UBE2G1;VCAN;RPL21;RPS16;RPL18;RPL5;PCSK5;RPS7;RPL39;ABCF1;RPL14;CKAP4;RPS17;CCN1;SIAH2;ST3GAL6;RPL28;RPL34;EEF1A1;SHISA5;RPL12;RPL9;FBXL2;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;PAPPA;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;SPARCL1;ZDHHC2;BMP4;RPS4X;RPS5;LCMT1;LOX;RPL36A;RPL6;LMCD1;UBE2D3;TMEM208;MMP15;CSNK1G3;RPL31;MFGE8;HBS1L;QPCT;SPPL3;RPSA;DUSP12;SPCS1;RPN1;SCG2;RPS26;MSRB2;PHEX;RPL36;GOLM1
prerank,protein export from nucleus (GO:0006611),0.5800205959819581,1.4883761541788805,0.04975124378109453,0.8385477431926582,1.0,1/27,0.01%,RANBP3L
prerank,retinoic acid metabolic process (GO:0042573),0.6870471888801726,1.4883152629498875,0.07777777777777778,0.8327988737857215,1.0,3/14,7.48%,ALDH1A2;CYP26B1;SCPEP1
prerank,carbohydrate derivative catabolic process (GO:1901136),0.648509621570066,1.4881731534502696,0.056140350877192984,0.8275478797234006,1.0,6/18,8.43%,NGLY1;NEU2;ADAMTS9;DERA;SAMHD1;MANBA
prerank,cellular amino acid catabolic process (GO:0009063),0.4822353416512992,1.4871311454718255,0.025245441795231416,0.8272907290056392,1.0,22/87,13.24%,DDO;ALDH7A1;IVD;ASPA;PRODH;ACADSB;ALDH4A1;HNMT;PIPOX;BCAT2;GOT2;OGDH;DLD;GLUL;MCCC1;AASS;UROC1;FAH;ABAT;MTRR;ALDH6A1;GCDH
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4843879960028795,1.4861596099334347,0.019005847953216373,0.8268803393519569,1.0,11/85,4.42%,FGF1;TGFBR3;BMP6;OSR1;IGF1;FGFR2;MCC;LAMC1;PKHD1;NUPR1;FUT1
prerank,cellular response to cadmium ion (GO:0071276),-0.5241870148745957,-1.4858518806442838,0.03529411764705882,0.28857438382867107,1.0,16/24,32.29%,MT1E;MT1F;MT1M;MT1G;MT1X;MT1H;MT1A;MT1B;MT3;MT2A;MAPK8;HSF1;FOS;MAPK3;JUN;NCF1
prerank,activation of protein kinase B activity (GO:0032148),0.5753294872323295,1.484776728456336,0.05660377358490566,0.8282773782459018,1.0,8/29,8.75%,FGF1;OSBPL8;IGF1;IL18;ADRA2A;RICTOR;NRG1;PDPK1
prerank,endocardial cushion morphogenesis (GO:0003203),-0.5764795586004215,-1.4844127369009126,0.053452115812917596,0.29010067320085214,1.0,9/18,13.46%,ENG;NOS3;TGFB2;ACVRL1;NOTCH1;HEYL;BMP2;BMP4;ACVR1
prerank,histone H3-K36 demethylation (GO:0070544),0.7428336005077122,1.4829821102735496,0.05845511482254697,0.8322308403436143,1.0,4/10,11.82%,KDM7A;KDM2B;KDM2A;RIOX2
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.38746199341550075,-1.482713805079699,0.0076045627376425855,0.29242627525570364,1.0,36/118,12.71%,ADGRB3;MEF2C;LRRC4C;HECW2;PID1;FMNL2;BMPER;PPFIA2;CDH2;SHANK3;HECW1;CLASP2;EFNA5;TANC2;PAK3;PHLDB1;CHN1;NEDD4L;GSK3B;TBX1;PAK1;SEMA4D;TSPAN12;LZTS1;TGFB1;CEACAM1;FGF2;FLT4;RAP2A;ERBB2;LFNG;MARK2;ABI3;CTNNB1;EMP2;MAPT
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.6128313489632523,-1.4827112233450013,0.05128205128205128,0.29119089591638814,1.0,8/13,32.04%,TBX3;NOTCH1;TGFB1;BMP4;SOX8;EID2B;SOSTDC1;ANKRD2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.5310944611080588,-1.4824888501265854,0.047961630695443645,0.29043584543638334,1.0,6/25,8.94%,GRID2;MEF2C;GRIN2B;GSK3B;GRIN2A;GLRA1
prerank,regulation of TORC1 signaling (GO:1903432),0.5538671493780065,1.4824277507779495,0.05351170568561873,0.8299112039358402,1.0,10/33,17.13%,RNF152;SESN1;GPR137;SESN2;ATM;DEPDC5;FLCN;KPTN;TELO2;RRAGD
prerank,polyol biosynthetic process (GO:0046173),0.6607002240465385,1.48239582819293,0.08614232209737828,0.8243402369528363,1.0,5/16,9.75%,ISYNA1;CYP27A1;CYP2R1;ITPKB;PPIP5K2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.43968506398058166,1.4819122221418162,0.006345177664974619,0.8213949662632017,1.0,32/186,9.99%,DAB2;TMEM64;WWOX;RNF43;LRP4;BICC1;NXN;MCC;PRKN;TRABD2B;DKK3;RNF213;GLI3;APCDD1;CXXC4;VGLL4;LZTS2;APC2;WWTR1;UBAC2;PTPRU;INVS;TMEM170B;CSNK1A1;GLI1;LRP1;TLE1;HDAC1;SOX13;CBY1;GRB10;TCF7L2
prerank,hematopoietic stem cell differentiation (GO:0060218),0.7259747225887755,1.4818690964397783,0.08224299065420561,0.816042783910749,1.0,4/10,12.63%,ACE;HOXB4;TP53;LMBR1L
prerank,positive regulation of lipid metabolic process (GO:0045834),0.6117826076218456,1.4815685902352003,0.050816696914700546,0.8121601119987418,1.0,7/22,12.56%,SORBS1;PPARA;ZBTB20;F2;CREBL2;MLXIPL;SIRT4
prerank,cardiac myofibril assembly (GO:0055003),0.6639648063041405,1.4815487028602428,0.0843806104129264,0.8067803770496412,1.0,6/15,10.73%,NEBL;CSRP3;OBSL1;PDGFRB;MEF2A;MYLK3
prerank,stem cell differentiation (GO:0048863),0.55868395907126,1.4804906267221687,0.048286604361370715,0.8071084157957641,1.0,7/39,2.45%,ACE;OSR1;KIT;FGFR2;HOXB4;JARID2;FBXL17
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.425674864720811,-1.4803139331502324,0.012269938650306749,0.29379557246307997,1.0,29/73,22.70%,PIK3R1;MYO10;ACTB;ACTG1;HSP90AB1;DOCK1;LYN;ACTR2;PAK1;WIPF3;PLCG2;CRK;PTK2;ABI1;HSP90AA1;ACTR3;ELMO1;ARPC1B;ARPC5;ARPC4;NCK1;VAV1;WASF2;SYK;NCKAP1;WIPF1;YES1;ARPC3;FYN
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.4310547580285523,-1.4799365018013129,0.02572347266881029,0.29335984210184535,1.0,21/70,12.85%,NRP1;TMEFF2;MEF2C;TEK;PIK3R1;PARVB;ACTN1;PEAK1;FN1;LAMC3;NTNG1;NTN4;ITGA4;RELN;PROX1;ARL13B;ITGA8;ITGB3;ATF4;ILK;LPXN
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.6018844279846973,-1.4792887594721047,0.05739514348785872,0.2936966088772721,1.0,6/15,13.79%,ACTR2;ACTR3;TRIM27;ARPC1B;ARPC5;ARPC4
prerank,mitochondrion distribution (GO:0048311),0.671068575599291,1.4792102801855977,0.09430604982206406,0.8087824264378104,1.0,5/12,8.88%,TRAK1;LRRK2;CLUH;MEF2A;DNM1L
prerank,regulation of dopamine secretion (GO:0014059),0.5984930103780214,1.4785912940826864,0.06060606060606061,0.8066062642289656,1.0,5/25,4.05%,SYT9;SYT11;SYT12;PRKN;DTNBP1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.4602341379965251,-1.4782096544218526,0.022443890274314215,0.29494142554816455,1.0,13/46,3.62%,NLGN1;NRXN1;MEF2C;SYT1;GRM7;GRM5;CDH2;SHANK3;GRM3;DGKI;GRIK1;GRM8;PTK2B
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.4752538064691612,-1.47800074651363,0.022099447513812154,0.29412074744946337,1.0,15/42,16.19%,UTRN;NRP1;PTPRJ;TEK;CDH13;PTK2B;KDR;GSK3B;MYOC;EMP2;VEGFA;PPM1F;LIMS1;RRAS;SKAP1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.6506139845053902,1.4776655916443615,0.0847457627118644,0.8063381099457521,1.0,6/15,15.96%,DAB2;AAK1;WASL;NEU3;BMP2K;SMAP1
prerank,neuron migration (GO:0001764),-0.45888919707454323,-1.477458713233304,0.030303030303030304,0.2941839969255984,1.0,24/48,15.00%,NRP1;ADGRL3;MEF2C;MARK1;ASTN2;MAP1B;ASTN1;NDNF;DNER;CDKL5;NTRK2;DISC1;NRCAM;DCX;RELN;SPOCK1;TUBGCP2;FGF13;DDIT4;MARK2;VEGFA;GPM6A;CDK5R1;TUBB2B
prerank,cell junction assembly (GO:0034329),-0.39679262344896593,-1.4773673210886757,0.011583011583011582,0.2931602389386854,1.0,28/100,7.82%,NLGN1;ADGRL3;CDH11;CTNND2;NRXN1;DNM3;CDH8;CDH2;KIRREL3;ITGA6;SHANK3;SPOCK2;ACTB;CLDN5;FN1;CDH10;DNER;CDH12;ACTG1;GJC1;VMP1;CDH6;FLNA;NRCAM;CDH19;CDH20;CDH7;LIMS2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.5676485197076896,1.4769156579334903,0.06229508196721312,0.8053864508751288,1.0,7/30,9.56%,DAB2;DDX5;KLK2;NCOR2;SMARCA4;SIRT1;HDAC1
prerank,central nervous system development (GO:0007417),-0.35376427782324743,-1.4767273203144515,0.0,0.29327884412243443,1.0,61/250,10.91%,CNTNAP2;ADGRL3;ROBO2;ADGRL2;DCLK1;ZFHX3;CDH2;SLC2A1;GSN;COL4A1;WWP1;CNTN4;GRIK1;GRIN2B;ADAM23;TBX3;MAL;VIT;IL1RAPL2;SHROOM4;STAT3;PBX3;DNER;SERPINI1;SH3GL2;DSCAML1;ZBTB16;LSR;MBP;SNTG2;CNTN6;PDGFC;MARCKS;NRCAM;PTCH1;EPHA7;DCX;GRIN2A;MOG;HSPG2;VCAN;MEIS2;RELN;PTPRZ1;PCDH18;APOD;SPOCK1;PROX1;TUBGCP2;ADAM22;PPT1;S100B;ECRG4;RAB18;PBX1;DDIT4;UFM1;CDK5RAP2;RPS6KA3;PKD1;MFSD2A
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.6606430233520291,-1.4758557159203551,0.05708245243128964,0.2938361490856789,1.0,5/10,20.71%,PTPRC;CEACAM1;CX3CR1;ARRB2;LGALS9
prerank,mononuclear cell differentiation (GO:1903131),-0.534355571769264,-1.4757954413454066,0.04176904176904177,0.29275760279660457,1.0,11/24,15.37%,GAS6;MYH9;LYN;IKZF1;MT1G;BMP4;THOC5;VEGFA;TRPM2;RELB;IL31RA
prerank,ncRNA processing (GO:0034470),-0.36317620738709633,-1.4726545427407547,0.0,0.2981096925824493,1.0,69/200,19.20%,RPS24;RPL8;RPL41;RPL13;RPLP2;RPS6;RPL18A;RPL37;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPL19;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;RPL14;RPS17;SMAD1;RPL28;RPL34;WDR3;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;DROSHA;RPL36A;RPL6;EMG1;MDN1;RPL31;NOP53;DDX10;METTL3;NOL11;RPL36;LIN28B;TEX10;RPL13A;FBL;XRN2;RPL35;UTP15;ADAT1
prerank,ceramide transport (GO:0035627),-0.6378521149918271,-1.4726369531401766,0.0728476821192053,0.2969587373022753,1.0,6/12,14.29%,CERT1;PLTP;PSAP;GLTP;PLEKHA3;ABCB4
prerank,sensory perception of sound (GO:0007605),0.47931770164641607,1.4724958600637168,0.021865889212827987,0.8235275898053939,1.0,15/88,8.94%,EYA1;CACNA1D;KIT;GSDME;WHRN;ALDH7A1;DCDC2;EML2;HOXA1;COL4A3;TBL1X;CDC14A;NIPBL;LRTOMT;EPS8L2
prerank,bile acid and bile salt transport (GO:0015721),-0.5165830422168705,-1.472152760131968,0.05995203836930456,0.2968306796417306,1.0,6/24,9.00%,ABCC4;ATP8B1;SLCO1C1;SLCO2B1;CEACAM1;STARD5
prerank,regulation of cell junction assembly (GO:1901888),-0.5147631270889308,-1.4711322965921676,0.03926096997690531,0.2977132448293799,1.0,8/27,6.59%,MEF2C;PRKCH;CLDN5;RUNX1;F11R;RAP1B;RAP1A;OCLN
prerank,response to cadmium ion (GO:0046686),-0.5101515505238688,-1.4708643848579646,0.03579952267303103,0.2971708732743459,1.0,16/26,32.29%,MT1E;MT1F;MT1M;MT1G;MT1X;MT1H;MT1A;MT1B;MT3;MT2A;MAPK8;HSF1;FOS;MAPK3;JUN;NCF1
prerank,negative regulation of leukocyte migration (GO:0002686),-0.6461970856370701,-1.470838143519964,0.0625,0.2960502940693518,1.0,3/10,1.98%,SLIT2;BMP5;CD200
prerank,peptidyl-lysine modification (GO:0018205),0.4697982696118067,1.4706511788454342,0.028050490883590462,0.8283657760713823,1.0,33/99,23.22%,NNAT;EYA1;SENP3;LOXL1;LOXL3;PIAS1;SIRT5;NDUFAB1;SIRT3;HDAC4;SIRT1;CTH;NUP42;NUP98;SIRT4;NSMCE2;NUP43;VIPAS39;KAT2B;PIAS3;NUP155;SUMO1;PIAS4;NUP188;P3H4;ATP7A;UBE2I;NUP153;EP300;VPS33B;EEF1AKMT1;ESCO1;USPL1
prerank,ERBB signaling pathway (GO:0038127),-0.4334403192870464,-1.469517151096859,0.01557632398753894,0.297731093584496,1.0,17/64,10.35%,RPS6KA5;ERBB4;PIK3R1;REPS2;PLCE1;PTPN12;IQGAP1;NCK2;GAB1;PTK2B;NRG2;TGFB1;PTK2;ERBIN;ERBB2;HSP90AA1;BCAR1
prerank,apoptotic cell clearance (GO:0043277),-0.4910345740238417,-1.4694021509044242,0.046511627906976744,0.2968000726844777,1.0,9/30,10.38%,RHOBTB1;XKR4;THBS1;SCARB1;GAS6;XKR6;ANXA1;RHOH;ITGB3
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.44961724690679444,-1.4694013566103665,0.02127659574468085,0.2956361508308131,1.0,21/48,17.82%,RHOJ;TMSB4X;NOS3;THBS1;HDAC7;HDAC9;AKT3;KDR;ANXA1;GATA2;TGFB1;PTGS2;FGF2;JCAD;HIF1A;PRKD1;VEGFA;SRPX2;NUS1;PIK3C2A;HSPB1
prerank,mesoderm formation (GO:0001707),-0.5648331709667461,-1.4694011821659998,0.05813953488372093,0.29448132211663025,1.0,6/17,14.63%,BMPR2;ITGB4;ITGB1;ITGA8;ITGB3;ITGA2
prerank,lung development (GO:0030324),0.5659634244715607,1.4683376433868096,0.08176100628930817,0.8354212019476379,1.0,7/33,7.54%,FGF1;ERRFI1;FGFR2;GLI2;PDPN;LOXL3;RBP4
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.4248128135961984,-1.4675478519183704,0.021021021021021023,0.29714882109546775,1.0,22/67,14.56%,UTRN;NRP1;CDH13;FN1;VIT;CARMIL1;PTK2B;NDNF;ARHGEF7;DOCK1;GSK3B;FBLN2;FLNA;CRK;LIMS2;MYOC;CALR;ILK;EMP2;DMTN;PPM1F;LIMS1
prerank,regulation of protein neddylation (GO:2000434),0.7057404192969022,1.466996886134005,0.08617234468937876,0.8376697159016206,1.0,1/10,0.14%,EPAS1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.4849221343890086,-1.4669856794080423,0.03485254691689008,0.29707361311806646,1.0,12/35,6.19%,PDE4D;PDE3A;RIMS2;ADGRG6;AKAP6;ADCY2;EPHA5;HTR2C;PDE7B;GUCY1B1;CAP2;APOE
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.4876862146327427,1.4668720205598487,0.03299856527977044,0.8330727857894239,1.0,15/76,7.35%,UACA;BMP7;C1QTNF3;SASH1;DLG1;SPHK1;NFAT5;TLR3;EZR;TLR4;DDX3X;CD27;IL12B;EIF2AK2;PTPN22
prerank,prostanoid biosynthetic process (GO:0046457),0.6568468458467713,1.4650611743893587,0.08235294117647059,0.8374177806975537,1.0,2/15,1.04%,PTGDS;PTGS1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.38035327995392737,-1.4644169110575145,0.0,0.30133741614745235,1.0,33/138,10.35%,PTPRD;TEK;ERBB4;NTRK3;BMPR2;PTPRG;ROR1;EPHB1;MPZL1;LIFR;EPHA5;MERTK;PTPRT;EPHA6;TIE1;PTK2B;NGF;TRIO;NTRK2;IL6ST;KDR;LYN;ROR2;MET;PTPRF;EPHA7;EPHB2;PTK2;PTN;ABI1;FLT4;ERBB2;BCAR1
prerank,negative regulation of nuclear division (GO:0051784),0.6848984626251517,1.4640712000540927,0.08812260536398467,0.837562981439445,1.0,2/11,2.84%,BMP7;TOM1L2
prerank,positive regulation of myoblast differentiation (GO:0045663),0.6384846258972827,1.4636994204389895,0.09403254972875226,0.8343460886851752,1.0,1/16,0.01%,RANBP3L
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.5542854127907634,1.4635179333260109,0.07958477508650519,0.8302894918359609,1.0,9/29,12.56%,LPGAT1;SORBS1;PPARA;ZBTB20;CREBL2;SLC27A1;SLC45A3;MLXIPL;SIRT4
prerank,response to metal ion (GO:0010038),-0.42541830530367797,-1.462504263994458,0.022435897435897436,0.3039883845940413,1.0,21/67,14.18%,CAV1;KCNMA1;THBS1;GPHN;NEDD4L;TRPC3;SLC25A13;CALM1;CALM2;TRPC1;PAM;PPP3CA;CALM3;MT1X;MT1A;HOMER1;CRIP1;MAPT;HIF1A;SNCA;MT3
prerank,positive regulation of cell division (GO:0051781),0.5351273193865336,1.4620383423081047,0.0672,0.8329972477461327,1.0,7/38,11.35%,FGF1;PKP4;FGFR2;CDC14A;AURKB;CDC14B;CDC42
prerank,anion transmembrane transport (GO:0098656),0.497150929426719,1.461969357731781,0.03676470588235294,0.8283626373880983,1.0,10/67,8.27%,SLC13A4;SLC13A3;SLC6A13;SLC16A12;SLC7A2;SFXN2;SLC6A9;SLC19A1;SLC27A1;SLC1A3
prerank,regulation of viral entry into host cell (GO:0046596),-0.486436545805248,-1.4619662938479279,0.04597701149425287,0.303952575484709,1.0,12/30,24.80%,GSN;HS3ST5;LY6E;MID2;TRIM14;TRIM27;IFITM3;CD74;TRIM68;LGALS9;IFITM1;IFITM2
prerank,prostaglandin biosynthetic process (GO:0001516),0.6423291231861704,1.4618639476923414,0.0851063829787234,0.8239866511200276,1.0,2/18,1.04%,PTGDS;PTGS1
prerank,histone lysine demethylation (GO:0070076),0.6032958182907384,1.461805755541119,0.06770833333333333,0.819380872295257,1.0,11/25,21.00%,KDM7A;KDM2B;KDM2A;HR;RIOX2;KDM3B;PHF2;KDM6B;KDM1A;KDM6A;RIOX1
prerank,prostaglandin metabolic process (GO:0006693),0.5922868170123642,1.4614221648811092,0.07832422586520947,0.816530217764438,1.0,2/26,1.04%,PTGDS;PTGS1
prerank,quinone biosynthetic process (GO:1901663),0.6510506736992364,1.4607779506341028,0.10271317829457365,0.8149311768863282,1.0,7/14,14.81%,FDXR;PDSS2;COQ8B;COQ10A;COQ5;COQ8A;COQ7
prerank,regulation of mitotic nuclear division (GO:0007088),0.50289067391359,1.460219214295176,0.05271084337349398,0.8128078241683118,1.0,8/55,6.37%,BMP7;IGF1;ANAPC15;OBSL1;TOM1L2;PHIP;CD28;PDGFRB
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.6057679810084641,-1.460113045166413,0.06567796610169492,0.3069884966998925,1.0,4/13,8.56%,PTPRT;PTPRC;HES1;MGAT5
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5690620660597909,-1.4593719996614933,0.06073752711496746,0.30755591759295053,1.0,5/17,9.06%,SLIT2;CASK;SFRP4;TMEM204;PCSK6
prerank,GTP metabolic process (GO:0046039),0.6412790165303907,1.4592763804389082,0.09430604982206406,0.812925342245298,1.0,5/15,9.48%,RHOQ;LRRK2;OPA1;AK3;AK4
prerank,ubiquinone biosynthetic process (GO:0006744),0.6355199749688272,1.45756107899091,0.10857142857142857,0.8169333568296319,1.0,10/15,23.85%,FDXR;PDSS2;COQ8B;COQ10A;COQ5;COQ8A;COQ7;NDUFA9;COQ9;COQ6
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.6331860570972557,1.4573351616602148,0.07889908256880734,0.8135287847649898,1.0,3/16,2.62%,FGF1;NPNT;FOXD1
prerank,myoblast differentiation (GO:0045445),0.6510388524854347,1.4572378949910314,0.11195445920303605,0.809406080389786,1.0,3/14,1.44%,EPAS1;DDX5;IGF1
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.5631874212134528,-1.4570207184097512,0.05856832971800434,0.31135123957274696,1.0,10/17,31.48%,NLGN1;CACNA1G;RAB27A;KCNB1;CACNA1H;SYT10;DOC2B;STX1A;RAB3A;SCAMP5
prerank,regulation of glucose transmembrane transport (GO:0010827),0.6297357921491484,1.4564963187958493,0.09908256880733946,0.8084521629752358,1.0,3/18,6.00%,PRKAG2;PRKCB;BRAF
prerank,organic hydroxy compound transport (GO:0015850),-0.46514298526445397,-1.4548382330859886,0.04292929292929293,0.31516573943608933,1.0,9/36,9.00%,ABCC4;ATP8B1;SLCO1C1;SLC16A1;SLCO2B1;NPC2;STRA6;CEACAM1;STARD5
prerank,ubiquinone metabolic process (GO:0006743),0.6449469159740226,1.4547762746790316,0.09393346379647749,0.8127660997919491,1.0,7/15,14.81%,FDXR;PDSS2;COQ8B;COQ10A;COQ5;COQ8A;COQ7
prerank,microvillus organization (GO:0032528),-0.612151998660575,-1.45474985263722,0.07158351409978309,0.3141794143363811,1.0,6/13,9.64%,FXYD5;RAP1B;MINK1;RAP1A;RAPGEF6;RAP2A
prerank,carnitine metabolic process (GO:0009437),0.6815231900329853,1.4545195177827939,0.0888030888030888,0.809418540650572,1.0,6/12,12.41%,CPT1A;BBOX1;TMLHE;CPT2;ACADM;CRAT
prerank,histone lysine methylation (GO:0034968),0.5710801843394393,1.454433724348525,0.0658578856152513,0.8052764908020276,1.0,14/33,21.16%,KMT2A;CXXC1;SMYD3;ASH2L;PRDM5;WDR82;KMT2D;DOT1L;SETD1B;SETDB2;EHMT2;SETD3;KDM6A;N6AMT1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.6525574641062767,-1.4536081407273684,0.07407407407407407,0.31556574719415215,1.0,5/10,8.90%,PRKG1;CD9;SERPINE2;RDX;CEACAM1
prerank,myofibril assembly (GO:0030239),0.5339175495800168,1.4532563334007538,0.0594679186228482,0.8065376866953173,1.0,9/42,6.37%,ACTN2;CSRP3;OBSL1;CFLAR;TMOD2;TMOD3;TPM1;KLHL41;PDGFRB
prerank,cardiac conduction system development (GO:0003161),0.5894922658689278,1.4532044673345599,0.06932409012131716,0.8023294267357577,1.0,3/24,3.18%,NOTCH2;GJB6;BMPR1A
prerank,epithelial to mesenchymal transition (GO:0001837),0.5166579271919821,1.4531564767197453,0.0464,0.7981039023181955,1.0,8/47,4.57%,TGFBR3;BMP7;ROCK2;WNT4;DDX5;FGFR1;TGFBR1;LOXL3
prerank,response to progesterone (GO:0032570),-0.5525520416807581,-1.4526048070439508,0.05592841163310962,0.31649645303736934,1.0,6/18,8.45%,ABHD2;CAV1;THBS1;TGFB2;TGFB3;TGFB1
prerank,glycerolipid metabolic process (GO:0046486),-0.6441275043787587,-1.4521656076337341,0.0709812108559499,0.3162463970816637,1.0,6/11,19.38%,DGKB;DGKG;GAL3ST1;DGKZ;PNPLA3;PLA2G15
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.47127184113062287,-1.4521004539514344,0.04938271604938271,0.31519636606657037,1.0,16/39,19.77%,TEK;THBS1;SEMA5A;NDNF;GAS6;KDR;RAMP2;ICAM1;ITGA4;GATA2;GPER1;ECSCR;SCG2;PDCD4;RGCC;PAK4
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6906549813852624,1.450420893818764,0.09108159392789374,0.8066499310337265,1.0,5/11,8.77%,DAB2;PRKN;EZR;PTPN23;EIPR1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.5151746795853704,1.4493652947315305,0.05172413793103448,0.8073294680405483,1.0,11/44,14.09%,PRKAG2;CYP27A1;ALOX12;INSIG2;AMACR;OSBPL9;TM7SF2;ACOT8;SRD5A2;LBR;PER2
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.5448638802171336,1.4483098456528318,0.0634648370497427,0.8080904790907283,1.0,4/37,2.95%,PRKAG2;BMP7;SPHK1;PPEF2
prerank,regulation of ossification (GO:0030278),-0.4777753610346679,-1.4482885852627563,0.03674540682414698,0.32242334811452755,1.0,15/36,13.90%,MEF2C;BMPR2;SGMS2;TGFB2;NOTCH1;ZBTB16;ENPP1;ECM1;BMP2;PTN;S1PR1;BMP4;TWIST1;ACVR1;TXLNG
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.6055390281537019,-1.447937455333628,0.06,0.3219795433947324,1.0,5/12,6.58%,PODXL;IQGAP1;PROM1;JAG1;BASP1
prerank,regulation of glucose metabolic process (GO:0010906),0.5404071625461455,1.4474788996013381,0.07557117750439367,0.8078918784054058,1.0,8/34,13.91%,RORA;PRKN;RORC;SIRT1;SLC45A3;MLYCD;USP7;OGT
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.42240444196085,-1.4473647128395721,0.019662921348314606,0.32210764051525154,1.0,23/59,11.40%,CADM1;PTPRM;ROBO2;HMCN1;CDH2;CDH13;PECAM1;KIRREL3;BSG;CNTN4;NPTN;TENM3;PTPRT;DSCAML1;IGSF11;CNTN6;ITGB1;ROBO4;EMB;CEACAM1;PKD1;PVR;CDH1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.6611284130308906,1.447040463934313,0.08639705882352941,0.8056374060637499,1.0,5/14,13.89%,TLR3;ANKRD17;DDX60;DHX58;TLR5
prerank,regulation of smooth muscle contraction (GO:0006940),-0.5378341741745226,-1.4465284272226595,0.06695464362850972,0.3228476288103125,1.0,8/20,15.41%,KCNB2;CAV1;PLCE1;CHRM3;CHRM2;ATP2B1;MYOCD;NMU
prerank,regulation of striated muscle contraction (GO:0006942),0.5824680183546438,1.445782366200381,0.08421052631578947,0.8074290441621661,1.0,3/27,1.99%,ATP1A2;ANK2;SLC8A3
prerank,"phagocytosis, engulfment (GO:0006911)",-0.4642817118501353,-1.443905157525112,0.034210526315789476,0.32726118270841326,1.0,10/36,10.69%,RHOBTB1;XKR4;GSN;THBS1;XKR6;MYH9;DOCK1;ARHGAP25;RHOH;ELMO1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.48572731645321515,1.443812509748898,0.03765060240963856,0.8130999098495045,1.0,15/72,12.28%,FGF1;FGFBP1;FGFR2;KL;POLR2A;FRS2;FGFR1;HNRNPH1;FLRT1;TIA1;POLR2D;FIBP;GTF2F1;KLB;PTPN11
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.4345699066184102,-1.4436897388811316,0.014044943820224719,0.3265269599467026,1.0,16/55,10.87%,GPC5;GPC6;DCN;CEMIP;BGN;LUM;CSPG4;HSPG2;VCAN;SDC3;TGFB1;HEXB;FGF2;CD44;AGRN;GPC4
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.6990496992748441,1.4434030448073163,0.1266294227188082,0.8110063309079797,1.0,5/10,16.98%,KMT2A;RAPGEF3;CAMK1;SPHK2;SMAD4
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.6636813825619333,1.4417787865918814,0.09925093632958802,0.8149990797304977,1.0,7/12,16.16%,DAB2;NCOR2;SMARCA4;SIRT1;HDAC1;NCOR1;NODAL
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.4704335608047342,1.4417356219938742,0.026170798898071626,0.8109737732778257,1.0,7/90,2.00%,EPAS1;ACSL1;PPARGC1B;APPL2;LEPR;PPARGC1A;IL18
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5799634868635816,-1.441679286986542,0.06637168141592921,0.3297211111788075,1.0,3/16,11.51%,CLDN5;CLDN11;CLDN14
prerank,atrial septum development (GO:0003283),0.660825082017885,1.439464050102432,0.11423220973782772,0.8176150852257104,1.0,2/13,0.80%,NOTCH2;ANK2
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.5468817252513916,-1.439455793139207,0.07289293849658314,0.3336292493089011,1.0,7/18,14.08%,NAV3;CD34;HDAC7;PTPRC;TRIM27;HAVCR2;LAPTM5
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.4652518512933538,-1.4393883046648057,0.021108179419525065,0.33260377865411045,1.0,12/39,9.38%,UTRN;FGF14;HECW2;FGF12;ANK3;HECW1;CAMK2D;FXYD5;NEDD4L;WNK2;NETO1;FGF13
prerank,regulation of catecholamine secretion (GO:0050433),0.5724127662878213,1.4381018718444447,0.07807308970099668,0.8200862966392293,1.0,5/29,4.05%,SYT9;SYT11;SYT12;PRKN;DTNBP1
prerank,protein localization to cilium (GO:0061512),0.5493397295453987,1.4364752357347221,0.0730050933786078,0.8239449591563034,1.0,10/32,15.70%,TULP3;ZNF423;IFT122;WDR19;INVS;ATP6V1D;ROPN1;WDR35;RAB29;ARL6
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.6332334536662871,-1.4350669136326897,0.08768267223382047,0.3411128500839933,1.0,5/10,8.45%,CST3;FAP;NOTCH1;TNFRSF1B;TGFB1
prerank,monosaccharide transmembrane transport (GO:0015749),0.6366039648033578,1.434603828731134,0.09584086799276673,0.8286271835505831,1.0,3/16,9.53%,SLC2A12;SLC5A3;SLC45A3
prerank,monocarboxylic acid metabolic process (GO:0032787),0.44605002206484723,1.4345253223110315,0.03195739014647137,0.8247724298071843,1.0,29/117,15.29%,ALDH1A2;ME2;IGF1;PCCA;PPARA;ECHDC3;ALOX12;LDHB;ACADSB;CPT1A;GPAT2;ACSBG2;ALDH4A1;CYP26B1;AMACR;NAAA;GOT2;SCPEP1;DLD;ACOT11;MCCC1;MECR;AASDH;ABAT;HLCS;PER2;THEM4;DLAT;GPAM
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.640562377962433,-1.432542511543902,0.08559498956158663,0.34581063585331817,1.0,5/10,10.44%,PDE4B;CACNB2;CACNA2D1;CALM1;CALM3
prerank,cellular response to organonitrogen compound (GO:0071417),-0.38785788526193005,-1.4319110527640881,0.025089605734767026,0.3459400152421186,1.0,29/99,15.27%,SLIT2;MEF2C;PDE3A;ACTB;AKAP6;HCN1;GABRB3;GABRB1;RYR3;GABRB2;RAP1B;RAP1A;KCNQ1;SH3BP4;GLRA1;EGR1;GABRG2;PDE2A;CAPN2;P2RY12;CDH1;CTNNB1;SPAAR;DMTN;GLRA2;HTR1B;P2RY1;TRPM2;HRH1
prerank,regulation of lipid metabolic process (GO:0019216),0.45975950344801786,1.4316291760663222,0.03409090909090909,0.8346121654963243,1.0,15/88,8.30%,PRKAG2;RORA;NFYC;PPARA;CHD9;NCOR2;NFYB;GPS2;C1QTNF2;TBL1X;RORC;SMARCD3;ANGPTL8;NR1D2;TBL1XR1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.48529060236633886,-1.4315231828179353,0.046228710462287104,0.3455647035756379,1.0,10/33,10.43%,MEF2C;THBS1;ACVRL1;MEOX2;NOTCH1;APOE;TGFB1;FGF2;STARD13;ATP2B4
prerank,cellular modified amino acid catabolic process (GO:0042219),0.6253419082255304,1.4313650900764885,0.11977186311787072,0.8316404689640583,1.0,6/15,15.81%,PRODH;ALDH4A1;GGACT;GOT2;ABHD12;SARDH
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.47208692551411524,-1.4306482336843427,0.06666666666666667,0.3462704114451865,1.0,13/35,18.37%,HEG1;TGFB2;RASIP1;DAB2IP;MET;KCTD10;EPHB2;MYOC;CUL3;SPRY1;STMN1;KANK1;SPRY4
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.6026302880289433,1.4305554146843715,0.08823529411764706,0.8311296762366503,1.0,3/20,3.46%,EPAS1;PRKN;TGFBR1
prerank,negative chemotaxis (GO:0050919),-0.47630428679518944,-1.4299706492453677,0.05048076923076923,0.3465635628440361,1.0,14/33,12.46%,SLIT2;SEMA3C;UNC5C;SEMA6A;SEMA6D;SEMA7A;NTN1;SEMA3E;EPHA7;SEMA4D;PDGFA;ITGB3;SEMA3D;SEMA3G
prerank,protein localization to synapse (GO:0035418),-0.6124313786165912,-1.4295709559015601,0.08368200836820083,0.3463820196419881,1.0,5/12,13.89%,NLGN1;NRXN1;PCLO;NRXN2;SHANK1
prerank,regulation of insulin secretion (GO:0050796),0.45648108345370075,1.4290913034948443,0.03851444291609354,0.8339613757912571,1.0,20/101,9.99%,NNAT;ADCY5;CACNA1D;ITPR2;ITPR1;STXBP4;KCNA5;PRKN;NLGN2;MCU;ADRA2A;RAPGEF3;DPP4;CACNA1C;GCK;RBP4;EIPR1;MIDN;PICK1;TCF7L2
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.6434068494745787,1.4269939029634207,0.10909090909090909,0.8399851949722729,1.0,4/13,5.77%,RENBP;LARGE1;MGAT3;PGM3
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.4556901988556162,-1.426272745103937,0.03926701570680628,0.3529502561266224,1.0,14/41,10.43%,SLC8A1;SLC24A2;RYR2;CACNA2D1;HTR2C;GRIN2B;RYR3;PTPRC;PLCG2;HTR2A;GRIN2A;FGF2;TRPV4;ATP2B4
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.4232876814389466,-1.4259096294712554,0.041884816753926704,0.3525094495611499,1.0,19/54,18.09%,MEF2C;TMSB4X;NOS3;THBS1;ACVRL1;AKT3;KDR;APOE;GATA2;TGFB1;FGF2;ATP2B4;HIF1A;PRKD1;VEGFA;NUS1;ANGPT2;HSPB1;RGCC
prerank,activin receptor signaling pathway (GO:0032924),0.6264843769999133,1.4257178735649998,0.11397058823529412,0.8423545922442158,1.0,2/15,3.46%,SMAD3;TGFBR1
prerank,regulation of endothelial cell migration (GO:0010594),-0.3923181210836357,-1.4253336957945155,0.023411371237458192,0.35268560000786037,1.0,35/85,13.86%,NRP1;SLIT2;PTPRM;TEK;BMPER;RHOJ;BMPR2;DCN;THBS1;NRP2;PTK2B;SCARB1;ACVRL1;KDR;GPI;DAB2IP;FOXP1;APOE;RHOB;PTK2;PROX1;CALR;ATOH8;PTN;CEACAM1;FGF2;FLT4;BCAR1;ITGB3;EDN1;BMP4;EMP2;PRKD1;VEGFA;ADGRB1
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6979233711975388,1.4232958360838686,0.1075050709939148,0.8498222545470462,1.0,5/10,17.97%,OXSR1;ADAM17;WNK1;CCR2;WNT5A
prerank,aminoglycan catabolic process (GO:0006026),-0.4809620083192816,-1.422885420754166,0.05121951219512195,0.35732878414770275,1.0,6/28,10.87%,GPC5;GPC6;HSPG2;SDC3;AGRN;GPC4
prerank,negative regulation of receptor binding (GO:1900121),-0.6408409292355983,-1.4226847919016445,0.07157057654075547,0.3565653737315904,1.0,4/10,9.26%,B2M;PTPRF;ADAM15;ATP2A3
prerank,mitotic sister chromatid cohesion (GO:0007064),0.6225919326366511,1.4223322425762503,0.12264150943396226,0.8502862148412729,1.0,7/16,19.19%,DSCC1;NIPBL;PDS5A;MAU2;REC8;RB1;PDS5B
prerank,cellular biogenic amine catabolic process (GO:0042402),0.6842252647996051,1.4222171860675281,0.10192307692307692,0.8466170225149697,1.0,4/10,8.51%,ALDH7A1;HNMT;SMOX;LRTOMT
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.6123143806289056,-1.421842499665624,0.09127789046653144,0.357257473553149,1.0,6/12,20.19%,JAG1;NOTCH1;HES1;N4BP2L2;NELFB;YTHDF2
prerank,tRNA wobble uridine modification (GO:0002098),0.6384432746297554,1.421816816023046,0.10037878787878787,0.8445615232955285,1.0,1/14,0.80%,TRMT9B
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.595007831153229,-1.4214221147717387,0.08651911468812877,0.3569572659330351,1.0,4/12,10.81%,SLIT2;BMP5;CCN3;DUSP1
prerank,triglyceride biosynthetic process (GO:0019432),0.6134024545129709,1.421077188925401,0.07553956834532374,0.8438593694858708,1.0,4/18,7.28%,LPGAT1;MOGAT3;GPAT2;GK
prerank,regulation of protein localization to membrane (GO:1905475),-0.4893757143396552,-1.4207076837390946,0.08333333333333333,0.3573846963993547,1.0,8/28,11.20%,SPTBN1;GPC5;GSN;ACTB;GPC6;AR;GPC4;ZDHHC2
prerank,regulation of TOR signaling (GO:0032006),0.4791015498479141,1.4204335778598953,0.047058823529411764,0.8429512653147647,1.0,31/67,24.29%,PRKAA2;FNIP1;PKHD1;NPRL3;DEPTOR;NPRL2;UBR2;RICTOR;PIK3CA;SIRT1;ARAF;ROS1;DEPDC5;FLCN;TSC1;WDR24;RPTOR;TMEM127;UBR1;TELO2;RRAGD;TBC1D7;LAMTOR1;ITFG2;TSC2;GSK3A;DYRK3;TBCK;RRAGB;SLC38A9;DGKQ
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.40185514688878543,-1.4203312258615244,0.029605263157894735,0.35697869635431134,1.0,22/75,10.91%,CTNNA2;MEF2C;MAP1B;ANK3;KLF7;ACTB;CNTN4;DCC;PAK3;NTNG1;S100A6;DSCAML1;SHTN1;MINK1;APP;NRCAM;BTBD3;MAP6;S100B;SLITRK1;PLPPR4;MFSD2A
prerank,lipid translocation (GO:0034204),-0.5351015791729882,-1.420285728107249,0.08088235294117647,0.35585474636980446,1.0,9/21,14.29%,ATP10A;ATP8A1;ATP8B1;ATP11A;ATP8A2;ATP11C;TMEM30A;ATP8B2;ABCB4
prerank,nitric oxide biosynthetic process (GO:0006809),-0.5923851468074685,-1.4201293376461128,0.06823027718550106,0.35502993864505333,1.0,5/13,17.93%,NOS3;CYP1B1;GCH1;NOS1;CYB5R3
prerank,phospholipid catabolic process (GO:0009395),-0.5150864907095059,-1.4196246620928135,0.07488986784140969,0.3549867681921526,1.0,6/24,11.86%,PLA2G4A;GPCPD1;ENPP6;GDPD1;ENPP2;SMPDL3A
prerank,response to histamine (GO:0034776),-0.6280860687313458,-1.4192839909484023,0.07142857142857142,0.3545518355226547,1.0,5/10,15.27%,GABRB3;GABRB1;GABRB2;GABRG2;HRH1
prerank,negative regulation of histone methylation (GO:0031061),0.6771661066588833,1.4190134533436338,0.09689922480620156,0.8457977398396672,1.0,5/10,17.74%,JARID2;BCOR;AASS;PHF1;KDM1A
prerank,endothelial cell development (GO:0001885),-0.495303959276695,-1.4173793113057893,0.05787037037037037,0.3578829149412681,1.0,13/25,12.21%,PDE4D;PECAM1;COL15A1;PPP1R16B;RAP1B;ICAM1;RAP1A;MET;ROBO4;RDX;PDE2A;MSN;SOX18
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5325174583428716,1.4172834012074949,0.08292682926829269,0.8502017558130911,1.0,6/32,2.92%,PPARGC1A;IGF1;PRKAA2;PPARA;ZBTB20;NUPR1
prerank,vascular process in circulatory system (GO:0003018),0.6481871607557219,1.4165725489399479,0.10112359550561797,0.8456651767786423,1.0,3/13,1.93%,ROCK2;ACE;NPR1
prerank,regulation of tube diameter (GO:0035296),0.6481871607557219,1.4165725489399479,0.10112359550561797,0.8456651767786423,1.0,3/13,1.93%,ROCK2;ACE;NPR1
prerank,BMP signaling pathway (GO:0030509),0.4872069281025923,1.4157143042991396,0.05663189269746647,0.8458716715692869,1.0,9/62,5.76%,TGFBR3;BMP6;BMP7;SMAD3;DDX5;BMPR1A;SMAD6;RGMB;USP9X
prerank,ribosomal large subunit assembly (GO:0000027),-0.5087497163782575,-1.415454455311578,0.07692307692307693,0.36110414788049927,1.0,16/24,28.66%,RPL3;RPLP0;RPL5;RPL23A;RPL6;MDN1;NOP53;BRIX1;MRPL20;RPL24;RPL11;RSL24D1;RRS1;DDX28;FASTKD2;RPL10
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.6789605937700509,1.4154169087094242,0.108348134991119,0.8432493158212971,1.0,5/10,18.91%,ADRA2A;HBEGF;ADAM17;TGFA;BTC
prerank,regulation of urine volume (GO:0035809),0.67610688461607,1.4142766965778568,0.10231660231660232,0.8447355735238393,1.0,4/10,13.48%,NPR1;NPR3;ADM;ADCY6
prerank,T cell migration (GO:0072678),-0.5827866421258431,-1.4135138029884795,0.10121457489878542,0.364339017199546,1.0,7/13,29.86%,SLC12A2;S1PR1;CXCL16;MSN;CXCL10;PIK3CD;MYO1G
prerank,epithelial cell morphogenesis (GO:0003382),0.6221953428560152,1.4134352017310576,0.10707803992740472,0.844849997443892,1.0,5/17,5.02%,COL22A1;PKHD1;COL18A1;RILPL1;DACT2
prerank,protein autoubiquitination (GO:0051865),0.4874950888188383,1.4129481301123288,0.06811145510835913,0.8432259536962949,1.0,16/61,16.33%,RNF220;SH3RF2;PRKN;RNF213;RNF181;RNF8;RNF141;SH3RF1;RNF41;RNF13;WWP2;DDB2;RNF115;AMFR;RNF146;RNF19B
prerank,T cell differentiation (GO:0030217),0.5177466933420442,1.4127644718500958,0.0762987012987013,0.840337374349636,1.0,11/40,12.63%,LEPR;KIT;GLI3;NHEJ1;CD28;PTPN22;CHD7;TCF7;SOX13;ADAM17;LMBR1L
prerank,regulation of macrophage cytokine production (GO:0010935),-0.5893324046998516,-1.4126254588921514,0.0859538784067086,0.3650570137015564,1.0,9/13,20.17%,TGFB2;SEMA7A;PLCG2;TGFB3;TGFB1;IRAK3;LAPTM5;CD74;CUEDC2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.40599473974275174,-1.412376285366879,0.041666666666666664,0.3644502049695275,1.0,31/70,34.29%,B2M;PSMB2;MFSD6;CALR;PSMD14;PDIA3;NCF2;PSMC6;CYBA;IKBKB;PSMA4;PSMB9;TAP1;PSMD11;PSMB10;PSMD2;CYBB;PSMA2;PSMB3;SNAP23;PSMB5;PSMA7;CD36;FCGR1A;PSMF1;PSMD7;SEC22B;NCF1;PSMA5;PSMD4;PSME4
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.5149847365769868,-1.412051940572831,0.07042253521126761,0.36413130105271996,1.0,3/22,0.98%,PDE4B;CACNB2;AHNAK
prerank,Rac protein signal transduction (GO:0016601),-0.5369530343974733,-1.4117440957197755,0.08035714285714286,0.36371784805291224,1.0,8/18,19.46%,CDH13;TIAM1;RHOH;EPS8;ELMO1;HACE1;WASF1;NCKAP1
prerank,early endosome to late endosome transport (GO:0045022),0.5982705807703741,1.411185326299504,0.11444652908067542,0.8442647424627362,1.0,14/20,25.11%,HOOK2;PTPN23;BECN1;ANKRD27;SNF8;HOOK3;EEA1;WDR91;WDR81;RAB7A;HOOK1;RILP;PIK3C3;KIF16B
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.40524758582419534,-1.4107402553480748,0.046875,0.3649066662293156,1.0,30/67,34.29%,B2M;PSMB2;CALR;PSMD14;PDIA3;NCF2;PSMC6;CYBA;IKBKB;PSMA4;PSMB9;TAP1;PSMD11;PSMB10;PSMD2;CYBB;PSMA2;PSMB3;SNAP23;PSMB5;PSMA7;CD36;FCGR1A;PSMF1;PSMD7;SEC22B;NCF1;PSMA5;PSMD4;PSME4
prerank,protein K63-linked ubiquitination (GO:0070534),0.5145517226094258,1.4101124030473582,0.08737864077669903,0.8457300929552104,1.0,7/41,7.45%,RNF152;UBE2E2;PRKN;NEDD4;RNF135;TRIM56;RNF8
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6568216244468814,1.4095732273515729,0.11654135338345864,0.84420109262497,1.0,3/12,6.47%,IL18;IL17D;IL12B
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6300761930755587,-1.409352791790933,0.10395010395010396,0.3669278167171612,1.0,5/10,18.31%,PTPRJ;PTPN12;APOD;SNCA;NDRG4
prerank,steroid biosynthetic process (GO:0006694),0.48858942656193954,1.409128244961095,0.058823529411764705,0.8425905553194817,1.0,8/56,6.67%,PRKAG2;CYP27A1;INSIG2;CYP21A2;AMACR;FDXR;OSBPL9;DHRS11
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.5950267709648227,1.4089889150139392,0.10498220640569395,0.839471999833402,1.0,4/20,3.91%,DAB2;PICALM;RHOQ;PPFIA1
prerank,regulation of neuron differentiation (GO:0045664),-0.3917757836939518,-1.4075698626405504,0.020066889632107024,0.37003638051305987,1.0,22/76,10.06%,NLGN1;MEF2C;ZFHX3;BRINP3;CNTN4;BRINP1;NGF;VWC2;ARHGEF2;TIAM1;BEND6;HES1;NRCAM;YWHAG;HEYL;BIN1;BMP2;SIX1;CALR;BRINP2;ID2;CDK5RAP2
prerank,negative regulation of interleukin-6 production (GO:0032715),0.5606999147123626,1.4073264428802592,0.06654991243432574,0.8436461794019933,1.0,5/27,7.35%,C1QTNF3;SYT11;TLR4;ARRB1;PTPN22
prerank,cellular zinc ion homeostasis (GO:0006882),-0.49502669668786664,-1.4072851707360516,0.08591885441527446,0.36962624705786584,1.0,12/26,14.18%,SLC39A10;MT1E;MT1F;MT1M;MT1G;MT1X;MT1H;MT1A;MT1B;SLC30A1;SLC39A12;MT3
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.6404852218320353,-1.40724529369286,0.10144927536231885,0.36852942234698327,1.0,5/10,14.58%,HSP90AB1;SORL1;EGR1;HSP90AA1;CLU
prerank,hepaticobiliary system development (GO:0061008),0.583930362617148,1.406797024627613,0.10452961672473868,0.8423459795848195,1.0,6/20,13.89%,TGFBR3;WNT4;NIPBL;CDK5RAP3;PHF2;PRKCSH
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.625207937236544,-1.4066340457796214,0.0875,0.368752940487485,1.0,6/11,21.85%,MERTK;CXCL12;GAS6;NOD2;CCL19;HCLS1
prerank,xenobiotic transport (GO:0042908),-0.555547363740624,-1.4065666227814801,0.08714596949891068,0.3677502646182925,1.0,3/17,3.07%,SLC47A1;ABCG2;SLC7A5
prerank,regulation of secretion by cell (GO:1903530),-0.4299830065625349,-1.4060084373062407,0.04833836858006042,0.36774613843995696,1.0,11/54,9.50%,MEF2C;SYT1;RIMS2;MCTP1;RIMS1;STXBP5L;RAB3C;ANXA1;DNAJC1;DISP1;NSF
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5808947405127909,1.4058152949796956,0.09090909090909091,0.8432659805618636,1.0,3/22,1.85%,NOTCH2;STXBP4;FGFR2
prerank,positive regulation of metabolic process (GO:0009893),0.44811313867156144,1.4057216907105552,0.04032258064516129,0.8400341620341316,1.0,7/103,2.00%,EPAS1;ACSL1;PPARGC1B;APPL2;LEPR;PPARGC1A;IL18
prerank,regulation of heart contraction (GO:0008016),0.45365780100009245,1.4052013664183038,0.04721030042918455,0.838893462584779,1.0,13/90,6.24%,ATP1A2;CELF2;ATP1B3;ANK2;CORIN;ITPR2;ITPR1;NPR1;SLC8A3;DMPK;TPM1;NPR2;AHCYL1
prerank,transcription by RNA polymerase II (GO:0006366),0.3983124633238093,1.4049159871681791,0.010428736964078795,0.8366119468322155,1.0,71/305,16.38%,NOTCH2;RORA;MAF;THRB;GLIS3;DDX5;PPARGC1A;CCN2;PPARA;POLR2A;SOX5;NCOR2;CTR9;ELOF1;NR6A1;DTX1;PABPN1;ATOH1;RREB1;TTF2;PHAX;AFF4;ESRRA;TEAD3;TBL1X;WWTR1;RORC;TSC22D1;CCNT2;RPRD2;POLR2D;NR1D2;TBL1XR1;TEAD2;TFDP1;NR2C2;HDAC1;ELL;GTF2A1L;MED17;INTS10;GTF2F1;SCAF8;RTF1;RARG;MNT;ZBTB1;NOCT;TEAD1;NELFCD;TAF11;INTS2;DEAF1;NR3C2;INTS5;TBP;TAF4;NCOR1;PMF1;KAT2B;CTDP1;INTS3;NFKB1;TAF7;MED23;RXRA;TAF13;CPSF3;CREBBP;MED26;GTF2I
prerank,fibrinolysis (GO:0042730),0.6433221477041129,1.40397308761992,0.1171003717472119,0.8373652485700555,1.0,5/13,15.66%,KRT1;F2;SERPINE1;HRG;PLAT
prerank,positive regulation of neuron projection development (GO:0010976),-0.3920207788660884,-1.4037545917179757,0.033444816053511704,0.37169809244295293,1.0,33/85,16.18%,BMP5;NTRK3;ITGA6;ROR1;LRRC7;NPTN;TENM3;RIT2;PTK2B;TOX;FUT9;NDNF;SERPINI1;NTRK2;LYN;ROR2;DAB2IP;RAP1A;APOE;STMN2;RELN;PTN;SCARF1;PLPPR5;MARK2;VLDLR;LRP8;PRKD1;RET;FES;COBL;BDNF;PACSIN1
prerank,aspartate family amino acid metabolic process (GO:0009066),0.6014160139877985,1.4034459557633927,0.10575139146567718,0.8361759730669617,1.0,10/18,16.82%,MSRA;ASPA;ASPG;GOT2;MTHFR;ADI1;SLC25A12;FOLH1;GOT1;MTHFD1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.3915302712018629,-1.4026250459589737,0.018518518518518517,0.3731352599731016,1.0,24/79,14.15%,SLIT2;BMPER;BMPR2;THBS1;HTRA3;CASK;VWC2;NOTCH1;VWC2L;EPN2;DAB2IP;SMAD5;SORL1;SMAD1;BMP2;SMAD7;FGF2;ATP2B4;CREB3L1;LEMD3;UBE2D3;SPRY1;BMPR1B;SMURF1
prerank,response to nitric oxide (GO:0071731),-0.5892598585200614,-1.4021423045286017,0.09554140127388536,0.37304755675380297,1.0,9/13,32.65%,KCNC2;GUCY1B1;FOXO1;TXN;MT3;CCL19;MMP3;AQP1;DPEP1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.6068727113224643,-1.4019328772643704,0.08471074380165289,0.37236927425924,1.0,4/12,10.79%,TMEFF2;AR;TGFB1;EDN1
prerank,extracellular matrix organization (GO:0030198),-0.3273898214374994,-1.401765549554725,0.0,0.37156944344234066,1.0,75/276,10.42%,COL8A1;FLRT2;VWF;ELN;COL25A1;LAMA1;COL12A1;TLL1;PECAM1;ADAMTSL3;ITGA6;SH3PXD2A;BSG;GSN;SPOCK2;COL6A3;COL4A1;ADAMTSL1;MFAP5;DCN;THBS1;COL15A1;FN1;ADAMTS5;TGFB2;LAMC3;COL6A1;VIT;VCAM1;COL4A2;DST;LAMA2;COL6A2;NDNF;F11R;GAS6;CYP1B1;ADAMTS17;BGN;FBN2;ITGB4;COLGALT2;GPM6B;COL14A1;KDR;LUM;COL23A1;ICAM1;ITGB8;APP;ADAMTS3;JAM2;TIMP2;ITGB1;ADAM15;COL8A2;TGFBI;HSPG2;VCAN;LAMA3;ITGA4;PPIB;ADAMTS6;MMP16;DPT;TGFB1;TNR;FGF2;CD47;ITGA8;CD44;CAPN2;PDGFA;ITGB3;AGRN
prerank,heart morphogenesis (GO:0003007),-0.4241007113904146,-1.4010427963499794,0.03724928366762178,0.3721243949762779,1.0,18/50,13.77%,FLRT2;ENG;NOS3;RYR2;TGFB2;TBX3;ACVRL1;NOTCH1;TBX1;SOX17;HES1;HEYL;BMP2;PTK2;HEY2;FKBP1A;ACVR1;VEGFA
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.5789903515120638,1.4009923089810872,0.10398613518197573,0.8441877741395061,1.0,4/23,5.56%,TGFBR3;FGFR2;TPM1;ADAMTS9
prerank,ERBB2 signaling pathway (GO:0038128),-0.47902853123621436,-1.4007105227349548,0.07444168734491315,0.37164614299336934,1.0,9/31,10.34%,ERBB4;PIK3R1;PTPN12;GAB1;NRG2;MYOC;ERBIN;ERBB2;HSP90AA1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.5466422111913101,-1.3999866333990003,0.07256235827664399,0.37206950090093516,1.0,8/17,21.84%,PODXL;TGFB2;PIEZO1;P2RY12;RET;SKAP1;SYK;RAC3
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.5807689578673513,-1.399803679031037,0.09071729957805907,0.3713033900637071,1.0,4/15,6.31%,SCARB1;PLTP;APOE;ABCG1
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.4705388847805192,-1.3997025627863309,0.06598984771573604,0.37036599742934234,1.0,10/33,7.53%,SLIT2;PTPRM;PTPRG;DCN;THBS1;EVL;ACVRL1;DAB2IP;APOE;CORO1C
prerank,cellular response to interleukin-2 (GO:0071352),-0.6135762846681375,-1.3996668968277646,0.0931174089068826,0.3681877578515241,1.0,5/11,20.08%,PTK2B;STAT5B;JAK1;SYK;SHC1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.6135762846681375,-1.3996668968277646,0.0931174089068826,0.3681877578515241,1.0,5/11,20.08%,PTK2B;STAT5B;JAK1;SYK;SHC1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.380415155016412,1.3996369431361588,0.001049317943336831,0.8467522539498884,1.0,116/572,14.62%,PRDM6;AEBP1;DAB2;WWOX;BMP6;THRB;SMAD3;GLIS3;OSR1;FHL2;DDX5;MXI1;CUX1;DLG1;PPARA;FGFR2;PRKN;FOXP4;DNMT3A;GLI2;FNIP1;KANK2;ZHX2;ZNF568;MOSPD1;HDAC8;NR2F2;KCNIP3;NCOR2;CTR9;NR6A1;GLI3;MITF;SUFU;CXXC5;FOXC1;PHF21A;NFIB;NEDD4;PCGF2;IFI27;NACC2;EZR;FOXP2;CUX2;RREB1;NSD1;WWC2;OTP;MAP2K5;GPS2;USP9X;ATRX;LCOR;TP53;TBL1X;BHLHE41;SMURF2;RORC;NIPBL;LDB2;LDB1;BCOR;CBX7;MEF2A;KDM2B;SMARCA4;NR1D2;SPEN;TBL1XR1;CPEB3;NUPR2;IRX1;PARP9;HDAC4;SIRT1;NR2C2;HDAC1;SOX13;LARP7;ZFP90;FOXC2;TCF7L2;ZNF219;ATN1;AURKB;PRDM5;AASS;RTF1;NFATC3;RARG;MNT;WWP2;IMPACT;ZBTB1;SKOR1;CBX5;DICER1;ZNF148;DEAF1;ZMYM5;FRK;KMT5A;BEND3;SIN3A;CBX6;NCOR1;ZBTB32;SNAI1;PER2;FLCN;ACVR2B;GADD45A;ZKSCAN3;MIER3;HOXA7
prerank,microvillus assembly (GO:0030033),-0.5740087405172918,-1.399374519485111,0.11572052401746726,0.36770771287844517,1.0,6/14,9.64%,FXYD5;RAP1B;MINK1;RAP1A;RAPGEF6;RAP2A
prerank,establishment of endothelial barrier (GO:0061028),-0.4787335010627654,-1.3992506919180063,0.06030150753768844,0.3668828662043071,1.0,13/29,12.21%,PDE4D;PECAM1;PPP1R16B;F11R;RAP1B;ICAM1;RAP1A;ROBO4;RDX;RAPGEF6;PDE2A;MSN;SOX18
prerank,regulation of microtubule depolymerization (GO:0031114),-0.4889288494100833,-1.3991873948422697,0.07675438596491228,0.36592179710458916,1.0,8/25,12.35%,MAP1B;NAV3;CLASP2;ARHGEF2;STMN2;FGF13;TRPV4;SPEF1
prerank,neuron projection morphogenesis (GO:0048812),-0.3585140444104349,-1.3988275821176064,0.012195121951219513,0.3655585892502654,1.0,37/137,10.21%,NLGN1;CNTNAP2;CTNND2;CTNNA2;DCLK1;DOCK10;MAP1B;ANK3;SHANK3;KLF7;ACTB;EPHB1;CNTN4;DCC;NYAP2;IQGAP1;PAK3;EPB41L3;NGF;NTNG1;S100A6;TRIO;DSCAML1;NRK;SHTN1;DAB2IP;MINK1;PAK1;APP;NRCAM;EPHB2;SLC9A6;BTBD3;MAP6;S100B;SLITRK1;PLPPR4
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.6365046813212647,-1.3988182238599904,0.11693548387096774,0.3644765163425846,1.0,5/10,20.78%,GALNT13;GALNT16;GALNT2;MGAT5B;POGLUT1
prerank,positive regulation of integrin activation (GO:0033625),-0.6234882407588479,-1.398730771142048,0.07276507276507277,0.3636109026302695,1.0,5/11,16.19%,RASIP1;RAP1B;PIEZO1;P2RY12;SKAP1
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.6064777853876164,1.3984266343492189,0.1079646017699115,0.8487358305826939,1.0,7/18,15.24%,DAB2;EZR;PTPN23;SNX12;MAP2K1;MAP2K2;RAB21
prerank,cellular metal ion homeostasis (GO:0006875),0.4452695858732516,1.3981204592998495,0.052845528455284556,0.846519796163471,1.0,11/102,3.59%,ATP1A2;ATP13A5;SLC24A3;SLC41A1;ATP1B3;ANK2;ATP13A3;SLC8A3;PKHD1;CSRP3;DMPK
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.6850173844155308,1.397393575160529,0.11984282907662082,0.8464865517252433,1.0,8/10,25.26%,IVD;ACAD11;ACADM;GCDH;ETFDH;ACADS;ETFB;ETFA
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.6126560149458831,-1.3967685879401157,0.11498973305954825,0.366946206527926,1.0,7/11,32.88%,GPX1;CAT;PRDX1;GPX3;PRDX2;PRDX4;PRDX3
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.618849108894859,-1.3966741986840912,0.08130081300813008,0.3660499250009846,1.0,3/11,5.42%,MEF2C;LYN;ANXA1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.602586213985933,-1.3964907334352614,0.11538461538461539,0.3653292258232989,1.0,7/11,24.07%,ANK3;LYN;RDX;JAK1;SYK;PRKCQ;PLAUR
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.6494870402829331,1.393965895423137,0.12878787878787878,0.8593260487960794,1.0,3/11,9.73%,COLEC12;TLR3;RIPK1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.6156260381366175,-1.3935453050227593,0.09394572025052192,0.36958523569811846,1.0,6/11,21.42%,CALM1;CALM2;CALM3;FKBP1A;CASQ2;GSTM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.6156260381366175,-1.3935453050227593,0.09394572025052192,0.36958523569811846,1.0,6/11,21.42%,CALM1;CALM2;CALM3;FKBP1A;CASQ2;GSTM2
prerank,metanephric mesenchyme development (GO:0072075),0.674855326092137,1.3935445536900608,0.12859884836852206,0.8576268763097862,1.0,2/10,1.09%,WNT4;OSR1
prerank,neurotransmitter uptake (GO:0001504),0.6533089733263677,1.3933702866890452,0.1180952380952381,0.8549801406053192,1.0,4/12,9.52%,ATP1A2;SLC38A1;SLC1A3;GLUL
prerank,monocarboxylic acid transport (GO:0015718),0.4876371423142239,1.3927216809368717,0.0847457627118644,0.8545555378938177,1.0,8/51,6.89%,SLC16A6;SLC6A13;SLC6A12;SLC16A12;SLC16A11;SLC10A4;SLC16A13;SLC27A1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.4341875658409298,-1.392605059002815,0.04143646408839779,0.37050706071553946,1.0,12/45,10.35%,RPS6KA5;PIK3R1;REPS2;PLCE1;IQGAP1;NCK2;GAB1;PTK2B;TGFB1;PTK2;ERBIN;BCAR1
prerank,embryonic appendage morphogenesis (GO:0035113),-0.5883957773324618,-1.3906308253141104,0.10352422907488987,0.37395613471508904,1.0,3/12,6.89%,MBNL1;TGFB2;PTCH1
prerank,peptide metabolic process (GO:0006518),0.46581554468197983,1.3898456717900995,0.07120743034055728,0.8643269560665108,1.0,11/75,10.04%,AEBP1;ACE;CPQ;BACE2;GSTT1;MGAT3;NAALADL1;TPP1;CTNS;NPEPPS;GSTA3
prerank,peptidyl-lysine acetylation (GO:0018394),0.6752989085008798,1.3897885684739306,0.14258188824662812,0.8610256099338646,1.0,7/10,23.60%,SIRT1;KAT7;KAT2B;CREBBP;EP300;ESCO1;BAG6
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.3742649714330532,-1.3896607417383562,0.012244897959183673,0.37502119751009366,1.0,31/124,14.09%,FRY;NLGN1;CNTNAP2;PTPRM;CNTN4;PLP1;CARMIL1;SH3GL2;TMEM108;GPM6B;LYN;GSK3B;STX3;LIMA1;APOE;APP;STMN2;PLEKHA1;ULK1;LGI1;MYOC;GPRIN3;RASGRF1;UHMK1;ARMC2;NCDN;MAP4;MAPT;ERCC6;GPM6A;CDK5R1
prerank,cellular response to BMP stimulus (GO:0071773),0.4736531241138655,1.3894713122102609,0.0734632683658171,0.8588359141082111,1.0,9/66,5.76%,TGFBR3;BMP6;BMP7;SMAD3;DDX5;BMPR1A;SMAD6;RGMB;USP9X
prerank,acylglycerol homeostasis (GO:0055090),0.5885792351651942,1.389212990169714,0.1,0.8564710218159444,1.0,5/20,12.36%,RORA;IL18;ANGPTL8;PLA2G12B;MLXIPL
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.5883711191749852,-1.388171244784029,0.09710743801652892,0.3773126058980686,1.0,5/12,10.43%,SEMA6A;DCN;DAB2IP;XDH;ATP2B4
prerank,regulation of plasminogen activation (GO:0010755),-0.595798495396327,-1.3878215338895432,0.10986547085201794,0.37703073675421683,1.0,3/12,3.67%,SERPINE2;THBS1;RUNX1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.38018592772591225,-1.3869577277033547,0.02097902097902098,0.3778496811249172,1.0,36/94,29.51%,RPS6KA5;IL1R1;IL1RAP;ST18;NOD1;NFKBIA;PSMB2;MAP3K7;IRAK3;PSMD14;EGR1;PSMC6;IKBKB;UBB;PSMA4;PSMB9;PELI1;NOD2;SKP1;PSMD11;PSMB10;PSMD2;PSMA2;UBC;RPS27A;RELA;PSMB3;TAB1;PSMB5;PSMA7;MAP3K8;IRAK4;MAPK3;PSMF1;TOLLIP;PSMD7
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.4180401116504972,1.3865084311923035,0.04,0.8659023600909074,1.0,20/152,8.65%,RNF220;WNT5B;LRRK1;LGR4;RSPO2;WLS;PTK7;FGFR2;LRRK2;SULF2;DDX3X;CAPRIN2;TBL1X;SMURF2;SMARCA4;TNKS2;ADGRA2;TBL1XR1;TERT;GPRC5B
prerank,cortical actin cytoskeleton organization (GO:0030866),0.5772567877436443,1.3861368748448122,0.12522045855379188,0.8642786284802771,1.0,4/20,2.07%,ROCK2;RHOQ;DLG1;FHOD1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.6166694164909634,1.3860868900478378,0.12365591397849462,0.8609897929021341,1.0,5/15,9.56%,WNT6;GLI2;FOXC1;EDA;HDAC1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.47655585898215325,-1.386063123615292,0.09330143540669857,0.37875596290552094,1.0,6/27,2.27%,PDE4D;PDE4B;CAV1;CTNNA3;RYR2;CAMK2D
prerank,melanosome organization (GO:0032438),0.5563492504968351,1.3857726602096734,0.10362694300518134,0.8590150273768477,1.0,12/26,24.28%,SHROOM2;DTNBP1;PIKFYVE;BLOC1S6;HPS1;BLOC1S2;RAB29;KIF13A;AP1M1;SNAPIN;LYST;HPS4
prerank,fatty acid beta-oxidation (GO:0006635),0.49221426848062483,1.3854597990832187,0.07253086419753087,0.857009772470971,1.0,23/51,20.46%,IVD;ACAD11;AMACR;ACAD10;BDH2;CPT2;ACADM;ACOXL;MECR;CRAT;ACOT8;GCDH;ACOX3;ECHDC1;DECR1;EHHADH;SLC25A17;ECI2;ETFDH;CROT;ACADS;HADHA;HADH
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.5694129130714208,-1.385373677697031,0.09030837004405286,0.379222320540513,1.0,3/14,0.36%,PRKG1;SLIT2;MEF2C
prerank,chromatin assembly or disassembly (GO:0006333),0.6587315772193002,1.3852044388024984,0.1377245508982036,0.8548282031573822,1.0,5/11,15.38%,HDAC8;CHAF1B;TP53;CDAN1;MTA2
prerank,amyloid-beta metabolic process (GO:0050435),0.6110057839407537,1.3847385553154525,0.11481481481481481,0.8536947715321885,1.0,5/16,10.71%,ACE;BACE2;MGAT3;APH1B;DYRK1A
prerank,striated muscle contraction (GO:0006941),0.4809749017872626,1.383881245120778,0.08422664624808576,0.8543145198456933,1.0,11/53,9.18%,ATP1A2;CSRP3;RCSD1;PGAM2;DTNA;TPM1;KLHL41;ARHGEF11;CCDC78;PIK3CA;MYL4
prerank,inorganic cation transmembrane transport (GO:0098662),0.39724258709941984,1.3836857084818521,0.02031063321385902,0.8518539467181836,1.0,31/268,8.66%,TRPM3;ATP1A2;SLC6A13;KCNK2;SLC6A1;CACNA1D;SLC24A3;SLC41A1;SLC6A12;ATP1B3;TRPM6;KCND3;KCNA5;LRRC38;SLC8A3;SLC30A10;ATP6V0E1;SLC30A2;CACNA1C;SLC6A9;KCNS1;P2RX3;ATP4A;CCDC51;TRPM5;ANO6;KCNH4;SLC39A13;SLC1A3;SLC6A4;KCNJ14
prerank,tRNA wobble base modification (GO:0002097),0.6141952955337673,1.3832930785113384,0.12596899224806202,0.8504389016689597,1.0,1/14,0.80%,TRMT9B
prerank,organonitrogen compound catabolic process (GO:1901565),0.4817024435405515,1.3831409189119157,0.08878504672897196,0.8477563503942566,1.0,13/57,9.83%,ACE;CPQ;RENBP;NPL;NAALADL1;GGACT;TPP1;CLPX;CLN6;PLA2G6;NPEPPS;CTH;GNPDA1
prerank,regulation of protein dephosphorylation (GO:0035304),-0.4510433793372335,-1.3826020506448176,0.058355437665782495,0.3845359469041949,1.0,11/37,10.44%,PPP1R16B;PPP2R5A;PPIA;YWHAB;CALM1;CALM2;CAMTA1;TGFB1;PPP1R16A;MFHAS1;CALM3
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.5037227612546704,-1.382520005682423,0.08333333333333333,0.3836590737420179,1.0,11/21,21.92%,TOX;DISC1;PROX1;NAP1L1;CTNNB1;VEGFA;CX3CR1;DLL4;DISP3;DRD2;MDK
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.5877908269518554,1.3823637032830334,0.12099644128113879,0.847863637438279,1.0,4/20,3.91%,DAB2;PICALM;RHOQ;PPFIA1
prerank,synaptic vesicle localization (GO:0097479),-0.5873219493767163,-1.382023613068561,0.11057692307692307,0.38368246781407966,1.0,5/13,13.25%,NLGN1;SYNDIG1;RAB27A;KIF5C;TMEM230
prerank,neuromuscular process controlling balance (GO:0050885),-0.5815452182735998,-1.380365255534528,0.09664694280078895,0.3864321312545091,1.0,2/12,1.81%,NRXN1;PCDH15
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.4740918528559377,-1.3792013608310663,0.07823960880195599,0.388064757134508,1.0,10/28,14.41%,NAV3;PAK1;RPS3;MET;OCLN;CDK5RAP2;MAPT;CLIP1;CDK5R1;FES
prerank,sympathetic nervous system development (GO:0048485),-0.5487652816806229,-1.3780231236297686,0.09034907597535935,0.3898144470859811,1.0,2/15,2.99%,NRP1;NRP2
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.657372118749808,1.3780010307957535,0.14785992217898833,0.8652859121333174,1.0,2/10,2.98%,DNMT3A;PCGF5
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.49393638213722346,-1.3773250422363732,0.08845208845208845,0.3903811231286819,1.0,7/23,10.79%,MAP3K5;TNFRSF11A;DAB2IP;PAK1;RPS3;MAP3K7;EDN1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.4490910887365204,-1.377271119691376,0.0748663101604278,0.38940387010595406,1.0,12/36,14.82%,CAV1;NOS3;NOSTRIN;SCARB1;CALM1;APOE;GCH1;HSP90AA1;ATP2B4;HIF1A;CYGB;NUS1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.6115168977463692,1.3770079851334056,0.1404494382022472,0.8665546100364696,1.0,6/15,12.36%,LPGAT1;PPARGC1A;PPARA;SLC45A3;MLYCD;MLXIPL
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.40001618018634266,-1.3767057394098896,0.05504587155963303,0.38954786824887533,1.0,20/67,10.69%,NRP1;PIK3R1;VEGFC;NRP2;NCK2;PTK2B;DOCK1;KDR;CLEC14A;DAB2IP;CRK;PTK2;ABI1;NCF2;FLT4;HSP90AA1;BCAR1;ITGB3;CYBA;ELMO1
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.5675588530901269,-1.3761951531774368,0.11637931034482758,0.3895333890538406,1.0,7/13,25.47%,RPS15;XPO1;LTV1;ABCE1;RAN;NPM1;RRS1
prerank,cellular response to nitrogen compound (GO:1901699),0.5770169381353043,1.3757895390555632,0.1261101243339254,0.8690278075341075,1.0,3/20,5.95%,ROCK2;CPS1;ATRX
prerank,regulation of T cell chemotaxis (GO:0010819),0.6519256274515578,1.375314519125269,0.13320079522862824,0.8679048903546583,1.0,5/11,17.97%,OXSR1;ADAM17;WNK1;CCR2;WNT5A
prerank,lamellipodium assembly (GO:0030032),-0.48350419771958586,-1.3748765721866254,0.07211538461538461,0.39143830081524716,1.0,14/26,13.12%,CDH13;ABLIM1;PARVB;CARMIL1;SPATA13;CCDC88A;ARHGEF7;ABLIM3;ITGB1;S1PR1;P2RY12;ABLIM2;SPEF1;DMTN
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5910381670616917,1.3748332786342703,0.13523809523809524,0.8667942628939591,1.0,4/17,4.75%,ATP1A2;CACNA1D;ANK2;CACNA1C
prerank,regulation of biomineral tissue development (GO:0070167),-0.48330517689140345,-1.3747480070086995,0.085995085995086,0.39062286075564134,1.0,11/26,13.90%,NOS3;SGMS2;GAS6;NOTCH1;ENPP1;ECM1;TGFB1;S1PR1;HEY2;TWIST1;TXLNG
prerank,regulation of neuroinflammatory response (GO:0150077),0.5781175280903743,1.3747391210905027,0.12454873646209386,0.863823612904292,1.0,5/19,6.61%,IGF1;IL18;SPHK1;NUPR1;DAGLA
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6227314999925007,1.3745064426238944,0.1381957773512476,0.8615703770765661,1.0,5/11,14.02%,DDX5;TP53;RIPK1;MAP2K1;MAP2K2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.5463924779255661,1.374221482014571,0.12202852614896989,0.8597094520133833,1.0,6/26,9.56%,DAB2;KANK2;NCOR2;SMARCA4;SIRT1;HDAC1
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.5268936518770329,-1.3719113331549522,0.11383928571428571,0.39640795923687044,1.0,7/18,10.98%,MDFIC;GSK3B;OTUD7B;APOD;MFHAS1;UFM1;CABP1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.5363552458658063,1.3713574356495544,0.11258278145695365,0.8690591686274486,1.0,4/30,5.60%,ROBO1;LPAR1;AKAP13;ARRB1
prerank,positive regulation of hormone secretion (GO:0046887),0.5995487284689565,1.3711889858054238,0.11711711711711711,0.8666561866180076,1.0,2/17,2.52%,C1QTNF3;SPP1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.6628197234078456,1.3701246380806302,0.15648854961832062,0.8682227966519735,1.0,2/10,3.65%,ATP1A2;ADRA2A
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.612904850104595,-1.369082999117931,0.11814345991561181,0.40189313533518767,1.0,3/10,5.34%,CXCL12;GAS6;LYN
prerank,vesicle transport along actin filament (GO:0030050),-0.51412306092471,-1.3688985608380742,0.0975609756097561,0.4012666624540668,1.0,6/19,8.98%,MYO1D;ACTN4;MYO1B;FNBP1L;MYO5A;MYO6
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.5917349998338417,-1.3685222544123183,0.11652542372881355,0.4010093339027145,1.0,6/12,18.29%,HSPA5;SEC62;SEC61B;SGTB;CHMP4B;CHMP4A
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.511649279664602,-1.3679261455462555,0.10633946830265849,0.4013864827495612,1.0,11/20,26.52%,GSN;THBS1;SFRP4;ITGA4;GPER1;ECSCR;PDCD4;RGCC;CD40;PLCG1;CCL2
prerank,protein modification by small protein conjugation (GO:0032446),0.381569935917049,1.3675837666356299,0.01380897583429229,0.8766429745780888,1.0,91/361,19.26%,RNF220;EPAS1;EYA1;RNF152;PDZRN3;RNF43;ASB2;PRKN;FBXL17;SPSB1;TRIM63;RNF213;CTR9;DTX1;CAND2;NEDD4;RNF151;ATG10;PIAS1;RNF135;KLHL41;ARRB1;USP9X;RNF181;SPSB4;MGRN1;UBR2;SMURF2;RNF8;FBXW11;HUWE1;FBH1;BTRC;CDK5RAP3;KLHL7;EIPR1;RNF34;SIRT1;NUP42;ZSWIM8;ATG7;RTF1;UBE2M;RNF41;NUP98;FBXW8;FBXO4;PRKDC;WWP2;PEX10;DCUN1D5;CUL4A;CUL9;UBA6;FBXO10;NUB1;ASB5;USP7;NSMCE2;TRIM62;NUP43;ASB12;FBXO11;DTX3;SDE2;PEX14;UBE2H;AMFR;PIAS3;ANAPC16;BIRC6;NUP155;UBR1;RNF7;UBE2E1;KCTD13;SYVN1;PEX5;CDC34;RNF25;RNF20;CCDC22;ARIH1;MIB2;ASB1;SUMO1;PIAS4;NUP188;KLHL18;MIB1;UBA5
prerank,positive regulation of protein polymerization (GO:0032273),-0.4015828799444383,-1.3675184750327662,0.052941176470588235,0.4011593346097515,1.0,23/65,16.80%,NAV3;NCK2;EVL;CARMIL1;PTK2B;CDC42EP3;PAK1;RPS3;MET;OCLN;BIN1;CDK5RAP2;HSP90AA1;MAPT;PFN2;CLIP1;PINK1;CDK5R1;FES;CDC42EP2;NCK1;ARF6;TPPP
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6275372781574005,1.3672536892547276,0.15087040618955513,0.8749107739821024,1.0,2/12,1.42%,ROCK2;PICALM
prerank,wound healing (GO:0042060),0.4627846060680884,1.3667307535648021,0.1013215859030837,0.874021386948706,1.0,11/62,8.46%,FGF1;SMAD3;SYT11;IGF1;MYOF;CFLAR;TGFBR1;TPM1;FER1L5;FUT10;NRG1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.5228772997151748,1.366610388250918,0.1226890756302521,0.871321469545758,1.0,10/32,13.34%,FOXN3;BABAM2;ATM;DONSON;CDK5RAP3;BRSK1;CDC14B;UIMC1;FZR1;BABAM1
prerank,histone H3-K9 demethylation (GO:0033169),0.6482991079046724,1.3658595842138586,0.15355086372360843,0.8715055353964505,1.0,3/11,11.87%,KDM7A;HR;KDM3B
prerank,epiboly involved in wound healing (GO:0090505),-0.5406547530239826,-1.3652576461548287,0.11363636363636363,0.405688629477057,1.0,7/16,14.35%,TMEFF2;FLNA;MRTFA;CCN1;CEACAM1;CD44;CD151
prerank,detection of mechanical stimulus (GO:0050982),-0.5159228861147329,-1.3649754619665633,0.1201923076923077,0.4053728193854081,1.0,6/19,12.06%,PIEZO2;CDH2;PIEZO1;PTK2;PKD1;CTNNB1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.4817784481136594,1.364354636689097,0.08717105263157894,0.8752500177587805,1.0,17/46,16.30%,LGR4;LAMA4;ZNF423;ALDH1A1;NPR3;PCTP;TLR4;NOVA1;ACOT11;DOCK7;FOXC2;ADAM17;FLCN;ACVR2B;MAP2K6;NRDC;RB1
prerank,synapse assembly (GO:0007416),-0.38950523654032954,-1.3642631107497984,0.049707602339181284,0.4060166958673388,1.0,22/67,11.40%,NLGN1;ADGRL3;NRXN1;GRID2;DNM3;CDH2;KIRREL3;SHANK3;SPOCK2;GABRB3;LRRTM3;DNER;GABRA2;GABRB2;NRCAM;GABRG2;FGF13;SLITRK1;LGI2;SHANK2;NRXN2;CDH1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.5955450073693105,-1.3641619173477222,0.10240963855421686,0.4051751190496108,1.0,3/12,10.91%,ACSL3;MTTP;MFSD2A
prerank,regulation of macroautophagy (GO:0016241),0.42968840664508207,1.3641372179680626,0.05991440798858773,0.8731052107166093,1.0,18/105,11.08%,PRKAG2;PRKAA2;SNX6;PRKAG3;SESN1;CASP3;ATP6V0E1;LRRK2;NEDD4;SESN2;SNX32;SMG1;ATP6V0B;PIK3CA;LARP1;SIRT1;ATP6V1D;ATP6V1E1
prerank,arachidonic acid secretion (GO:0050482),0.6566591840766465,1.363909327103498,0.15843621399176955,0.8678028685267423,1.0,2/10,4.75%,ACE;BDKRB2
prerank,arachidonate transport (GO:1903963),0.6566591840766465,1.363909327103498,0.15843621399176955,0.8678028685267423,1.0,2/10,4.75%,ACE;BDKRB2
prerank,gene silencing by miRNA (GO:0035195),0.5185165156843101,1.3638523396443807,0.1218274111675127,0.8648818066054274,1.0,16/32,26.19%,TNRC6A;ZC3H7B;SNIP1;TNRC6B;MOV10;AJUBA;DICER1;TNRC6C;WTIP;RBM4;XPO5;AGO1;SPOUT1;AGO4;AGO2;PUM2
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3604717710916627,1.3630918535639607,0.0,0.8650850640670414,1.0,295/1668,12.98%,PRDM6;AEBP1;EPAS1;HLF;ZKSCAN2;DAB2;FGF1;WWOX;RORA;MAF;BMP6;KDM7A;PPARGC1B;THRB;SMAD3;TFDP2;GLIS3;AUTS2;OSR1;ZIC2;TRAK1;KIT;FHL2;DDX5;PPARGC1A;MXI1;IGF1;RHOQ;NFYC;BRD8;CUX1;KMT2A;DLG1;PPARA;PKNOX2;SSBP2;CREBRF;FGFR2;ZFHX2;PRKN;FOXP4;IL18;IKZF2;FHOD1;CREB5;HOXB4;DNMT3A;GLI2;FNIP1;ZBTB20;ZNF160;HOXB6;KANK2;CSRP3;NPAS3;GABPB1;GABPB2;ZHX2;FOXD1;HOXC6;HOXA1;TNRC6A;ZNF568;ARID4A;MOSPD1;NFAT5;SOX5;PCGF5;HDAC8;PHIP;NR2F2;KCNIP3;NCOR2;CTR9;BMPR1A;ZNF697;ELF1;TSHZ3;NR6A1;GLI3;MITF;SUFU;ARNT2;CXXC5;FOXC1;PHF21A;MLLT10;NFIB;VGLL3;PCGF2;RFX8;HOXB3;VEZF1;IFI27;ZBTB38;MAFG;ASCL3;ATOH1;NACC2;ZNF462;NFYB;CREB3L2;TLR3;EZR;NHLH2;PRKCB;SMAD6;FOXP2;SALL4;CUX2;RREB1;CHD4;PPP1R13L;PIAS1;TLR4;MEIS1;FBXL19;NSD1;TEF;TET2;FZD5;ATM;DDX3X;WWC2;OTP;ARRB1;ARID3A;NCOA3;CAPRIN2;MAP2K5;GPS2;USP9X;CAMK1;SOD2;ATRX;ABHD14B;ESRRA;TEAD3;STAT2;LCOR;HMGA1;HOXB9;HOXA3;BAZ1B;HOXB5;TP53;TSHZ1;TBL1X;BCAS3;BCLAF3;CAMTA2;WWTR1;BHLHE41;SMURF2;RORC;MED12;SOX12;SERPINE1;MGA;CCNT2;SMARCD3;ZSCAN29;PLSCR1;NIPBL;ZIC5;LDB2;LDB1;LAGE3;BCOR;TNRC6B;ATAD2B;CBX7;ELF2;MEF2A;PTEN;KDM2B;SMARCA4;NR1D2;HOXC4;SRCAP;SPEN;SSBP3;ZSCAN25;TBL1XR1;CPEB3;KAT6B;ZIC1;KDM2A;SLTM;GDNF;TMF1;JMJD6;NUPR2;IRX1;SMARCC2;NEUROD4;TEAD2;KLF3;CALCOCO1;PARP9;SMARCE1;HDAC4;GLI1;ZBTB26;SIRT1;ZIC4;WASL;TFDP1;TCF7;RIPK2;NR2C2;HDAC1;SOX13;LARP7;RIPK1;MAVS;ZFP90;FOXC2;TCF7L2;TCF4;MOV10;HBP1;ZBTB8B;ZNF219;MYBL1;MED17;ATN1;HIVEP2;FOXL1;ZFP28;RBL1;GTF2F1;KMT2C;ZFP3;AURKB;THRAP3;ABL1;PRDM5;AASS;RTF1;ZBTB6;SAP18;ZKSCAN5;ZNF569;ZNF367;NFATC3;RARG;HR;MNT;ATF2;ZFX;RBBP8;PRKDC;ZMIZ2;WWP2;BAZ1A;IMPACT;MLLT6;TFAP2D;ZNF467;ZBTB1;SKOR1;MYBL2;CBX5;TEAD1;ZMIZ1;DICER1;ZSCAN22;NOP2;KDM3B;CCDC62;ZNF148;HES6;ZNF235;BRWD3;HOXB2;BRD7;FOXA2;DEAF1;MLXIPL;NR3C2;TGFA;BRD9;ZMYM5;IRF1;ZKSCAN7;PHF2;FRK;ZNF483;KMT2D;KAT7;ZXDC;PBX4;ZBTB48;FOXJ2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.5917125430557771,1.3628838066724869,0.14756944444444445,0.8629599719823824,1.0,5/17,12.33%,BMP6;SASH1;LY96;TRIB1;PRKCA
prerank,neuron maturation (GO:0042551),-0.5272653247493859,-1.3627602363708264,0.11572052401746726,0.4070844596389569,1.0,12/18,26.26%,ADGRB3;APP;B4GALT5;SRRM4;SCARF1;CLN5;C1QA;ANKS1A;LGI4;RND1;B4GALT6;C3
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.4956565799624558,1.362066888463306,0.09546925566343042,0.863525874701563,1.0,6/41,13.91%,PRKAG2;GCK;NUP42;NUP98;NUP43;OGT
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.6022959117342623,-1.3619182715356788,0.12629399585921325,0.4077985977944169,1.0,6/11,8.00%,KCNJ3;KCNJ2;ATP1B1;YWHAE;ATP1A1;KCNQ1
prerank,regulation of phospholipase activity (GO:0010517),0.6610176026732877,1.361523674989927,0.15445544554455445,0.8627597371625975,1.0,4/10,9.36%,FGFR2;FGFR1;PDPK1;LRP1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.6659696234813848,1.3613686639450453,0.15182186234817813,0.8603346724764603,1.0,4/10,9.83%,ST6GAL1;RENBP;NPL;GNPDA1
prerank,ribosome assembly (GO:0042255),-0.420956257176434,-1.3612465385784354,0.06233766233766234,0.40840612344823163,1.0,21/47,21.95%,RPL3;RPS19;RPS28;RPLP0;RPS15;RPL5;RPL23A;RPS27;RPS5;RPL6;MDN1;NOP53;RPSA;BRIX1;RPS27L;MRPL20;RPL24;RPL11;RSL24D1;NPM1;MRPS2
prerank,ether lipid biosynthetic process (GO:0008611),-0.6047536647155051,-1.360597710113533,0.11561866125760649,0.40889081947359585,1.0,5/10,24.50%,PLA2G4A;LPCAT2;AGPS;GNPAT;DHRS7B
prerank,calcium ion transport into cytosol (GO:0060402),-0.5042327658932607,-1.360373555734433,0.09492273730684327,0.40833103877359145,1.0,11/21,17.86%,SLC8A1;RYR2;CACNA2D1;GRIN2B;GRIN2A;TRPV4;ATP2B4;JPH2;TRPM2;GRIN1;ITPR3
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6721001836252674,1.3601637627283476,0.1375968992248062,0.8595048218622754,1.0,7/10,18.05%,SIRT3;PLA2G6;SPHK2;NSMAF;SMPD3;SMPD2;TNFRSF1A
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.6721001836252674,1.3601637627283476,0.1375968992248062,0.8595048218622754,1.0,7/10,18.05%,SIRT3;PLA2G6;SPHK2;NSMAF;SMPD3;SMPD2;TNFRSF1A
prerank,nucleosome disassembly (GO:0006337),0.6175764410505826,1.359710003311436,0.13780918727915195,0.8554783948511036,1.0,6/14,9.12%,ARID2;HMGA1;SMARCD3;SMARCA4;SMARCC2;SMARCE1
prerank,chromatin disassembly (GO:0031498),0.6175764410505826,1.359710003311436,0.13780918727915195,0.8554783948511036,1.0,6/14,9.12%,ARID2;HMGA1;SMARCD3;SMARCA4;SMARCC2;SMARCE1
prerank,negative regulation of cell activation (GO:0050866),-0.5533962364835805,-1.3592039726791443,0.11777777777777777,0.4100024723354136,1.0,6/14,11.23%,CD200;NOS3;APOE;LDLR;PDGFA;GPER1
prerank,regulation of wound healing (GO:0061041),-0.42488202339846826,-1.3591504135201622,0.06217616580310881,0.40901350978856593,1.0,12/42,9.38%,CAV1;CASK;ACTG1;ANXA1;AJAP1;OCLN;ITGB1;CD109;CRK;EPHB2;PTK2;FGF2
prerank,respiratory tube development (GO:0030323),0.5453712004689125,1.3581752281532735,0.13821138211382114,0.8592167049065532,1.0,6/28,7.54%,FGF1;FGFR2;GLI2;PDPN;LOXL3;RBP4
prerank,signal peptide processing (GO:0006465),-0.5923732907633217,-1.3580296318515666,0.13043478260869565,0.41062915033099884,1.0,5/11,23.85%,PCSK5;SPPL3;SPCS1;CLN5;PARL
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4625029922076886,1.357993411390179,0.08567208271787297,0.8569880454626548,1.0,15/66,12.29%,APPL2;UBE2E2;DLG1;KANK2;DDX3X;ANKRD17;PLK5;PTEN;RBL2;CCND3;HYAL1;TFDP1;RBL1;ADAM17;BRD7
prerank,regulation of stress fiber assembly (GO:0051492),0.44867108146536744,1.3570562240879573,0.09292649098474341,0.8581660068358653,1.0,16/74,5.18%,ARHGAP28;ROCK2;LPAR1;CGNL1;CCN2;ARHGEF10L;ARHGEF18;FHOD1;PPM1E;TGFBR1;ASAP3;CLASP1;ARHGAP6;PPFIA1;RAPGEF3;TPM1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.445980680469827,-1.3568532196118466,0.0967741935483871,0.4123232662508828,1.0,17/34,19.06%,NRP1;SEMA6A;VEGFC;GAB1;NOTCH1;KDR;RAMP2;ANXA1;DAB2IP;FLT4;MT1G;PRKD1;VEGFA;NUS1;NR4A1;HSPB1;DLL4
prerank,regulation of epithelial cell migration (GO:0010632),-0.41293006302322466,-1.3565854144724676,0.06958762886597938,0.41199430749559846,1.0,20/51,12.88%,BMPER;RHOJ;BMPR2;PTPRG;RTN4;CLASP2;TGFB2;EVL;DOCK1;DAB2IP;PLCG2;CORO1C;PTK2;PTN;CEACAM1;ENPP2;ADIPOR1;EMP2;PFN2;HIF1A
prerank,neuron projection fasciculation (GO:0106030),-0.6069570708619436,-1.356096898821277,0.11801242236024845,0.4120693998374092,1.0,6/10,14.09%,CNTN4;RTN4;SEMA5A;NRCAM;EPHB2;CDK5R1
prerank,type I interferon signaling pathway (GO:0060337),0.5054496324166591,1.3549226371635508,0.11858974358974358,0.8615288309191146,1.0,14/41,16.59%,IFIT1;IFIT2;OAS2;IFIT3;IFI27;STAT2;GBP2;SAMHD1;RSAD2;IRF1;OAS3;IFI35;IFNAR2;SP100
prerank,cellular response to type I interferon (GO:0071357),0.5054496324166591,1.3549226371635508,0.11858974358974358,0.8615288309191146,1.0,14/41,16.59%,IFIT1;IFIT2;OAS2;IFIT3;IFI27;STAT2;GBP2;SAMHD1;RSAD2;IRF1;OAS3;IFI35;IFNAR2;SP100
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.38167182441954084,-1.3546335823304203,0.05128205128205128,0.41461567872118577,1.0,24/73,14.04%,NTRK3;CAV1;BCAR3;GAS6;NGF;TFRC;HSP90AB1;PAK1;APP;TGFB1;FNIP2;CD44;HSP90AA1;ATP2B4;TNKS1BP1;NOS1;PFN2;AXIN1;SNCA;PRKD1;VEGFA;TXN;PINK1;TERF2IP
prerank,negative regulation of angiogenesis (GO:0016525),-0.3766196579196209,-1.3542876587659776,0.03896103896103896,0.41427494698700856,1.0,25/84,13.89%,PTPRM;TEK;SEMA6A;CLDN5;PDE3B;DCN;THBS1;TGFB2;COL4A2;SLC12A2;EPN2;SEMA3E;DAB2IP;SERPINF1;HSPG2;KLF2;STAB1;AMOT;ATP2B4;CREB3L1;CTNNB1;ISM1;ECSCR;ADGRB1;SPRED1
prerank,membrane assembly (GO:0071709),-0.4474845321551517,-1.352625820726652,0.08353808353808354,0.41717626709112565,1.0,8/34,4.66%,NLGN1;NRXN1;SPTBN1;PTPRD;IL1RAPL1;ANK3;RFTN1;UGCG
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.5952719081861262,-1.3525438570007213,0.1513859275053305,0.4162915252777209,1.0,3/10,8.37%,LRCH1;CD200;APOD
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.579576775030973,1.3518325668858986,0.12316176470588236,0.8719807592837178,1.0,4/18,6.93%,GPR137;TLR3;TLR4;FBN1
prerank,neuron projection organization (GO:0106027),-0.5482062133115815,-1.3516087296888637,0.11065573770491803,0.4174463282273258,1.0,5/15,9.30%,GSK3B;PLS1;APP;PSEN1;ABCD2
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.3455343464833811,-1.3513595272745966,0.014084507042253521,0.4169230132526351,1.0,33/151,10.25%,NRP1;TEK;BMPER;ERBB4;NTRK3;PDE8A;GCNT2;ROR1;HTR2C;SEMA7A;PTK2B;GAS6;NOTCH1;NTRK2;KDR;TNFRSF11A;ROR2;PDGFC;ICAM1;PTPRC;RAP1A;APOE;APP;ACKR3;HTR2A;BMP2;TGFB1;MFHAS1;TNFAIP8L3;FGF2;FLT4;CD44;PDGFA
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.6282616191865602,1.3509114590689417,0.17704280155642024,0.8729995586709618,1.0,2/12,2.92%,IL18;NUPR1
prerank,stress fiber assembly (GO:0043149),0.592445815528891,1.3507544895088133,0.14602587800369685,0.8677492747414406,1.0,4/15,5.60%,SORBS1;PHACTR1;FAM171A1;ARRB1
prerank,contractile actin filament bundle assembly (GO:0030038),0.592445815528891,1.3507544895088133,0.14602587800369685,0.8677492747414406,1.0,4/15,5.60%,SORBS1;PHACTR1;FAM171A1;ARRB1
prerank,regulation of metal ion transport (GO:0010959),0.592327201921951,1.3505553606453988,0.13667820069204153,0.8657144863024612,1.0,3/16,2.04%,ANK2;DLG1;SLC30A10
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.5596611198509174,1.3504809289717543,0.11327433628318584,0.8630554503100248,1.0,4/23,6.98%,TGFBR3;SMAD3;DKK3;SMURF2
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.47294363025872804,-1.3503517947118004,0.0951276102088167,0.41815246779671805,1.0,10/25,21.74%,CTNNA3;CD200;VCAM1;ITGB1;ITGA4;ITGB3;ITGA5;ITGB2;ITGA7;PKP2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.4411479621440964,1.3492172325131007,0.06376811594202898,0.8657395645169093,1.0,14/85,8.94%,EYA1;CACNA1D;GSDME;WHRN;ALDH7A1;DCDC2;EML2;HOXA1;COL4A3;TBL1X;CDC14A;NIPBL;LRTOMT;EPS8L2
prerank,sensory perception of chemical stimulus (GO:0007606),-0.5418345280556799,-1.3489106391108407,0.1159090909090909,0.42059030074905324,1.0,6/15,21.60%,GNAS;UBR3;GNAL;SYT10;ADCY3;DRD2
prerank,ceramide biosynthetic process (GO:0046513),-0.4309948424440278,-1.3488126003106131,0.07969151670951156,0.41968906596045774,1.0,10/40,11.77%,ST6GALNAC3;ST8SIA4;SGMS1;SGMS2;SPTLC2;DEGS2;ST6GALNAC5;ST8SIA6;CERS4;ASAH2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.46490670150704166,1.3481003860535998,0.10584518167456557,0.8678492420848858,1.0,10/55,10.40%,WWOX;TPD52L1;GSDME;NUPR1;TGFBR1;BID;TP53;DNM1L;RIPK1;BECN1
prerank,microglial cell activation (GO:0001774),-0.5088418015434978,-1.347433037394623,0.10835214446952596,0.42181641615000426,1.0,11/21,28.49%,APP;MAPT;SNCA;CLU;CX3CR1;ITGB2;C1QA;TYROBP;JAK2;GRN;IFNGR1
prerank,peptide catabolic process (GO:0043171),0.5466472619351604,1.3471296924973475,0.12274368231046931,0.8690696333020788,1.0,6/23,9.72%,ACE;CPQ;CTSH;NAALADL1;TPP1;NPEPPS
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5567185843055948,1.3469815346770098,0.11925042589437819,0.8667798779685396,1.0,2/23,0.80%,ATP1A2;ANK2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.3882866226933497,-1.3466656145797171,0.08262108262108261,0.4226079962973488,1.0,19/63,22.40%,MEF2C;VCAM1;NCK2;TFRC;IL6ST;SLC7A1;ANXA1;CD38;PTPRC;EPHB2;TIRAP;NCK1;CD74;IRS2;CCL19;CD320;CD86;CD276;CD81
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.36356465486674894,-1.3463226687458272,0.05226480836236934,0.4223692382570513,1.0,29/100,12.47%,TEK;PIP5K1B;NTRK3;PIK3R1;ROR1;DCN;FN1;PIP4K2A;TGFB2;PPP1R16B;GAB1;NTRK2;KDR;LYN;ROR2;PDGFC;DAB2IP;SEMA4D;MYOC;PTK2;CEACAM1;FBXL2;FGF2;PIK3AP1;PDGFA;PIK3IP1;GPER1;UNC5B;TWIST1
prerank,positive regulation of transmembrane transport (GO:0034764),0.6134771388302177,1.3460844317770309,0.17333333333333334,0.8679001867838719,1.0,7/13,19.12%,ACSL1;BRAF;ANO6;AZIN1;CLIP3;C2CD5;AZIN2
prerank,negative regulation of cell differentiation (GO:0045596),0.39922732007552336,1.3458096102836412,0.043586550435865505,0.8662420252737677,1.0,18/181,6.91%,RANBP3L;COL5A1;TMEM64;RORA;BMP7;SMAD3;OSR1;PPARA;CTR9;SUFU;TGFBR1;DTX1;SMAD6;MEIS1;GPS2;LDLRAD4;TRIB2;WWTR1
prerank,cilium-dependent cell motility (GO:0060285),0.5596677043831901,1.3454588122485867,0.13027522935779817,0.8649870786325282,1.0,1/22,0.21%,CFAP44
prerank,ceramide metabolic process (GO:0006672),-0.4117644707254663,-1.3454461144029692,0.07449856733524356,0.423309308781173,1.0,11/49,11.77%,ST6GALNAC3;SGMS1;SGMS2;ACER3;ACER2;PLPP1;SPTLC2;DEGS2;PPP2R1A;CERS4;ASAH2
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4696868169952868,1.3449770013119273,0.1043613707165109,0.8644372590967718,1.0,9/56,6.74%,DAB2;BMP6;BMP7;BMPR1A;PMEPA1;TGFBR1;SMAD6;LDLRAD4;TWSG1
prerank,homocysteine metabolic process (GO:0050667),0.6402334492957085,1.34484351132848,0.15560165975103735,0.8621843411478698,1.0,5/11,12.38%,CPS1;MTHFR;CTH;NOX4;MTRR
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.5118641079322148,-1.3447130090813624,0.12155963302752294,0.423929379876044,1.0,10/19,31.45%,THBS1;PTK2;MPP1;CMKLR1;RARRES2;MDK;JAM3;MAPK3;BST1;CSF1R
prerank,platelet degranulation (GO:0002576),-0.3534105626285249,-1.3445783021458906,0.028112449799196786,0.4231758290271256,1.0,44/118,19.27%,PCDH7;ABCC4;VWF;ACTN4;PECAM1;TMSB4X;CD9;VEGFC;THBS1;ACTN1;FN1;TGFB2;GAS6;LYN;OLA1;LHFPL2;CALM1;APP;FLNA;PSAP;TGFB3;CD109;ECM1;TAGLN2;TGFB1;PDGFA;ITGB3;WDR1;FAM3C;RAB27B;PROS1;CDC37L1;VEGFA;CLU;RARRES2;ALDOA;NHLRC2;MAGED2;CLEC3B;BRPF3;MANF;QSOX1;TUBA4A;CHID1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.5735016100966007,-1.3445361844460904,0.10755148741418764,0.42218218975992017,1.0,7/13,26.85%,SYT1;CACNA1G;KCNB1;CACNA1H;SYT10;DOC2B;STX1A
prerank,melanocyte differentiation (GO:0030318),0.6318611643804741,1.3437899007557084,0.16602316602316602,0.8638120261749795,1.0,3/11,3.39%,LRMDA;KIT;MITF
prerank,regulation of ATP metabolic process (GO:1903578),0.46261043706744087,1.3434622086703705,0.09752321981424149,0.8623658029475806,1.0,10/54,16.27%,PRKAG2;GCK;AK4;NUP42;NUP98;NUP43;BEND3;OGT;SPHK2;NUP155
prerank,circulatory system development (GO:0072359),-0.3471389722728543,-1.3431797000750851,0.02681992337164751,0.4242976113620566,1.0,34/118,13.46%,MEF2C;TEK;ZFPM2;ERBB4;NTRK3;FGF12;HEG1;PLCE1;FN1;TGFB2;MICAL2;ECE1;ACVRL1;HDAC9;NOTCH1;RAMP2;TBX1;SOX17;HSPG2;STRA6;PCSK5;BMP2;TGFB1;PDLIM1;HEY2;FLT4;ID2;PKD1;RBM20;SOX18;CDKN1A;CRIP1;PDLIM3;ACVR1
prerank,artery morphogenesis (GO:0048844),-0.4567171481032426,-1.343149355620289,0.10837438423645321,0.4233061576913145,1.0,12/30,11.37%,NRP1;BMPR2;ENG;TGFB2;JAG1;NOTCH1;TBX1;HES1;STRA6;SMAD7;HEY2;BMP4
prerank,cardiac muscle cell contraction (GO:0086003),-0.504700432488256,-1.3428613654897008,0.10375275938189846,0.42285172154953016,1.0,8/19,5.60%,FGF12;GSN;CAMK2D;CACNA2D1;KCNJ2;SCN1A;CACNA1G;ATP1A1
prerank,response to purine-containing compound (GO:0014074),-0.5298466403661075,-1.3423310658965442,0.13004484304932734,0.42307088687163213,1.0,5/17,15.03%,RYR2;ABCC9;TRPC3;P2RY1;TRPM2
prerank,positive regulation of phospholipid transport (GO:2001140),-0.6064527027255008,-1.3421447128153912,0.13389121338912133,0.4224446307700913,1.0,7/10,28.27%,APOE;TMEM30A;ABCB4;TRIAP1;PRELID1;ABCA3;DBI
prerank,negative regulation of protein localization to membrane (GO:1905476),0.5542327954355833,1.3420395720251184,0.1252236135957066,0.8656724877210985,1.0,4/24,3.91%,DAB2;PICALM;RHOQ;PPFIA1
prerank,gene expression (GO:0010467),-0.308085945127346,-1.3410618832516796,0.0,0.4238808332026917,1.0,136/348,25.22%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;ADARB1;AGFG1;ADARB2;RPL18A;ELAVL4;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;PTMA;RPL35A;RPLP0;RPS15;RPL30;RPS3;RPL19;RPS21;TSPAN14;RPL4;RPL32;RPL21;RPS16;RPL18;SYNCRIP;RPL5;RPS7;SORL1;RPL39;TASP1;ABCF1;RPL14;RPS17;RPL28;RPL34;EEF1A1;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;DROSHA;HNRNPK;NUP210;RPS4X;RPS5;CHTOP;RPL36A;RPL6;SMG5;THOC5;TAF1B;APOBEC1;POLR2J;RPL31;HBS1L;GLE1;RPSA;RPS26;GALNT2;RBM15B;RPL36;BCL3;ANGPT2;HHEX;RNPS1;EIF4E;NXT1;TSPAN17;RPL13A;XRN2;RPL35;PAX8;COPS5;NUP107;WDR33;RPL24;RBM3;RPS13;MRPL34;RPL11;EIF4A3;RSL24D1;TSPAN33;POM121;MRPS16;POLR2C;POLR2L;TSPAN15;MRPS21;MLF1;MRPL10;MRPL13;NCBP2;ZC3H11A;RPS27A;STUB1;RBM8A;MRPS33;SRSF6;NUP93;NUP85;NUP50;HOXD3;EIF4EBP2;MRPL35;EEF1A2
prerank,mesenchyme development (GO:0060485),0.6021403206102548,1.3409078457499848,0.1702127659574468,0.8676827019525257,1.0,3/15,3.46%,BMP7;FGFR2;TGFBR1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3864105942611556,1.3405599890057938,0.03288672350791717,0.8663060195710114,1.0,38/248,9.99%,RNF220;DAB2;TMEM64;LRRK1;LGR4;WLS;LRP4;BICC1;PTK7;FGFR2;MCC;PRKN;DKK3;GLI3;LRRK2;LZTS2;DDX3X;CAPRIN2;APC2;TBL1X;WWTR1;SMURF2;UBAC2;PTPRU;TNKS2;BTRC;ADGRA2;TBL1XR1;GPRC5B;INVS;TMEM170B;CSNK1A1;GLI1;TLE1;HDAC1;SOX13;UBR5;TCF7L2
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.6236187469729593,1.3403814318993803,0.1902834008097166,0.864238403848037,1.0,6/10,24.29%,USP7;OGT;GNMT;PDK2;SELENOS;DGKQ
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.5842802403392474,1.3402848656917608,0.14542190305206462,0.861947395151793,1.0,3/16,5.31%,UPB1;DPYD;TET2
prerank,mesonephric tubule development (GO:0072164),0.6017453459055194,1.340156326673664,0.166015625,0.8597934988975376,1.0,5/15,3.64%,BMP7;OSR1;FGFR2;NPNT;FOXC1
prerank,peptide cross-linking (GO:0018149),-0.4748171617769885,-1.3399921569999045,0.11083123425692695,0.4252703688429247,1.0,4/25,5.42%,THBS1;FN1;NDNF;ANXA1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.562483628023819,1.339869025884437,0.13756613756613756,0.8583555318703027,1.0,2/19,0.51%,BMP6;AFDN
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5915768115770111,-1.3397901409661637,0.13184584178498987,0.42462492575015365,1.0,4/10,9.31%,DGKH;PRKD3;PLPP1;GAP43
prerank,cellular response to interleukin-6 (GO:0071354),-0.48004851428583944,-1.3396519385618906,0.09397590361445783,0.42392241413441795,1.0,9/26,11.87%,PID1;PTPRT;ST18;STAT3;PTGIS;IL6ST;ST3GAL6;JAK1;SBNO2
prerank,lipid biosynthetic process (GO:0008610),0.442438173843618,1.3391310410414476,0.09143686502177069,0.8588015325351201,1.0,10/77,7.40%,ACSL1;PRKAA2;AGPAT4;GPAT2;CYP21A2;FDXR;DHRS11;PDSS2;SCD5;NDUFAB1
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.5110760432545809,-1.338941337668579,0.11910112359550562,0.4244833393447201,1.0,4/18,11.20%,SPTBN1;ACTB;AR;ZDHHC2
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.4954731204024816,1.3384811117385327,0.09747899159663866,0.8588229914587191,1.0,6/41,7.21%,ACSL1;PTGS1;ALOX12;EPHX1;DAGLA;SCD5
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.5097294200989262,-1.338060006550872,0.10204081632653061,0.4256334126123248,1.0,10/20,28.14%,CHRM3;CHRM2;AGRN;CDK5R1;GNB1;LYPD1;CHRNA7;RGS10;LY6H;RGS8
prerank,retinoid metabolic process (GO:0001523),0.45337283381957916,1.3380015040734028,0.0994236311239193,0.8581547357050208,1.0,13/71,7.54%,ALDH1A2;ABCA4;NAPEPLD;ALDH1A1;RBP1;AKR1B10;CYP26B1;APOM;RHO;PNLIP;DHRS3;SCPEP1;RBP4
prerank,regulation of catabolic process (GO:0009894),-0.5205144315190606,-1.3378007884853678,0.13452914798206278,0.42518071687718273,1.0,7/18,18.68%,FAP;NEDD4L;ITGB1;ZDHHC2;RARRES2;CHEK2;HPGD
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.4721388833906465,-1.3376983205817128,0.12962962962962962,0.424405901324316,1.0,6/23,6.44%,GHR;ERBB4;PTK2B;CYP1B1;NOTCH1;HES1
prerank,positive regulation of neuron differentiation (GO:0045666),-0.43214753594126165,-1.3374184257179782,0.08516483516483517,0.42406196910164756,1.0,12/40,10.02%,MEF2C;BRINP3;BRINP1;NGF;VWC2;ARHGEF2;BEND6;NRCAM;HEYL;BMP2;PROX1;BRINP2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.48534917849046016,1.3373198843164305,0.10932475884244373,0.8582594924321384,1.0,5/45,3.46%,DAB2;BMP6;BMP7;BMPR1A;TGFBR1
prerank,calcium ion import across plasma membrane (GO:0098703),-0.5519696743929653,-1.336975212662026,0.1134453781512605,0.42411735696264524,1.0,5/14,10.43%,SLC8A1;SLC24A2;CACNA2D1;TRPV4;ATP2B4
prerank,digestive tract development (GO:0048565),0.5187094119835596,1.3363669885781213,0.11774461028192372,0.8596710171551367,1.0,8/32,9.30%,KIT;CLMP;FGFR2;GLI2;GLI3;SMO;NIPBL;GLI1
prerank,mesoderm development (GO:0007498),-0.5034593312616915,-1.3363666580423543,0.13958810068649885,0.4245227792124313,1.0,7/18,18.36%,TBX3;TIE1;TBX1;BMX;IKZF1;VEGFA;BTK
prerank,neuromuscular junction development (GO:0007528),0.5464273168545551,1.336163200879685,0.1433389544688027,0.8578498293108887,1.0,7/24,8.47%,PDZRN3;LRP4;UNC13C;LRRK2;NEDD4;CACNB3;PPFIBP2
prerank,regulation of filopodium assembly (GO:0051489),-0.42532396853536136,-1.33590764355226,0.09234828496042216,0.4245587898407266,1.0,16/38,16.20%,NRP1;NLGN1;TENM2;PIK3R1;MYO10;FNBP1L;PPP1R16B;TGFB3;GAP43;PLPPR5;AGRN;FXR1;DMTN;GPM6A;TRPM2;ARF6
prerank,Wnt signaling pathway (GO:0016055),0.42653614569515014,1.3357145058276212,0.07703081232492998,0.857061473454183,1.0,18/92,11.85%,WNT5B;WLS;NXN;WNT4;WNT6;FZD8;LRRK2;FZD5;DDX3X;PTEN;BTRC;RYK;CSNK1A1;TCF7;TCF7L2;USP34;RARG;PORCN
prerank,fatty acid metabolic process (GO:0006631),0.41897165255618884,1.3355315754394328,0.06060606060606061,0.8552715520134292,1.0,28/115,17.08%,ACSL1;PPARGC1A;PPARA;ECHDC3;ALOX12;CEL;ACADSB;CPT1A;GPAT2;ACSBG2;NAAA;NDUFAB1;PON3;CPT2;ACADM;ACOT11;MECR;MLYCD;AASDH;CRAT;ACOT8;PER2;THEM4;ACBD5;GPAM;NUDT19;SGPL1;ACOT12
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.6004940207916922,1.3352107881506956,0.14971209213051823,0.8540626244984848,1.0,5/15,13.15%,RENBP;LARGE1;MGAT3;GNPDA1;CHST3
prerank,lipid oxidation (GO:0034440),0.615967450890377,1.3341915031857992,0.1654275092936803,0.8557109712824269,1.0,2/12,2.35%,PPARGC1A;ALOX12
prerank,mRNA destabilization (GO:0061157),0.4952114625982767,1.3337725099982127,0.12841091492776885,0.854856242354804,1.0,9/38,17.07%,ROCK2;TUT4;POLR2D;CPEB3;MOV10;YTHDF3;ZFP36L1;TUT7;PLEKHN1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5369802033828157,1.3334572890996172,0.14597315436241612,0.8535008495540019,1.0,10/26,17.97%,UBE2E2;DDX3X;ANKRD17;CCND3;HYAL1;TFDP1;ADAM17;RPTOR;KMT2E;EIF4G1
prerank,sodium ion homeostasis (GO:0055078),0.5546144042285697,1.3334052165270038,0.1672661870503597,0.8511069034842351,1.0,2/21,0.71%,ATP1A2;ATP1B3
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.42164786074135,-1.333361969018221,0.07219251336898395,0.4296980866534055,1.0,18/41,15.39%,ANK3;AKAP6;KCNJ3;KCNMA1;KCNJ2;KCNN2;KCNMB2;GNG2;FLNA;KCNQ1;GABBR2;CTSS;NOS1;ACE2;KCNJ6;GNB1;STAC;KCNJ12
prerank,response to prostaglandin E (GO:0034695),0.6432590006392154,1.333322633043865,0.18128654970760233,0.8488795244915165,1.0,1/10,0.31%,TGFBR3
prerank,protein auto-ADP-ribosylation (GO:0070213),0.6189642249803003,1.332784426608835,0.14922480620155038,0.8486358411009411,1.0,6/12,10.70%,PARP10;TIPARP;PARP12;TNKS2;PARP11;PARP6
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.586182586212366,1.3327128327000233,0.1577981651376147,0.8463364040685106,1.0,4/14,7.35%,IL18;IL12B;TGFBR2;PTPN22
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.4365488558165093,1.332003895156664,0.08941877794336811,0.846756555835369,1.0,17/74,10.58%,EYA1;EYA2;IGF1;EYA4;CFLAR;PHIP;TGFBR1;DDX3X;MAP2K5;SERPINE1;TERT;GDNF;HTT;RNF34;RIPK1;TCF7L2;SH3RF1
prerank,positive regulation of cellular component movement (GO:0051272),-0.47867269322290573,-1.3316982264714743,0.10955710955710955,0.432498357673438,1.0,9/24,15.00%,ACTN4;SPOCK2;CAVIN1;NTN1;LYN;RPS19;TWIST1;VEGFA;TUBB2B
prerank,cardiac muscle cell action potential (GO:0086001),0.5104410182501228,1.3315754326609657,0.1356521739130435,0.8459524607888572,1.0,4/30,1.34%,ATP1A2;CACNA1D;ANK2;KCND3
prerank,neurotransmitter biosynthetic process (GO:0042136),0.5968420482608232,1.331352773505775,0.16729323308270677,0.8443468961745317,1.0,3/14,8.61%,MOXD1;DAGLA;SLC6A4
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.49048620156507483,1.3312083486772146,0.12111292962356793,0.842369075118418,1.0,14/43,18.62%,FOXN3;BABAM2;ATM;DONSON;CDK5RAP3;BRSK1;CDC14B;HUS1;UIMC1;FZR1;BABAM1;INTS3;CLSPN;NBN
prerank,regulation of potassium ion transport (GO:0043266),0.51152206038671,1.3309926460221406,0.14666666666666667,0.8407837322746256,1.0,7/31,3.65%,CACNA1D;ACTN2;ANK2;DLG1;KCNA5;KCNIP3;ADRA2A
prerank,proton transmembrane transport (GO:1902600),0.5017855767292189,1.3305258255418988,0.13989637305699482,0.8402580527782882,1.0,3/36,6.17%,ATP1A2;ATP6V0E1;ATP4A
prerank,ephrin receptor signaling pathway (GO:0048013),-0.3834061814379004,-1.3304477765015919,0.06862745098039216,0.43448412378250945,1.0,31/82,14.09%,ARHGEF28;ACTB;EPHB1;EPHA5;GRIN2B;EFNA5;EPHA6;PAK3;NCK2;CHN1;ACTG1;ARHGEF7;LYN;ACTR2;TIAM1;PAK1;EPHA7;PSEN1;CRK;DNM1;EPHB2;ANKS1B;PTK2;AP2B1;ACTR3;AP2M1;ARPC1B;RASA1;ARPC5;ARPC4;CDK5R1
prerank,positive regulation of ion transport (GO:0043270),0.4749356860860759,1.3302999169697205,0.1050228310502283,0.8386428081364811,1.0,8/48,8.44%,CACNA1D;ACTN2;ANK2;DLG1;ADRA2A;AHCYL1;ANO6;GDNF
prerank,sodium-independent organic anion transport (GO:0043252),-0.5955736538011254,-1.3301068826269231,0.14031620553359683,0.4342005947552795,1.0,7/10,29.32%,SLCO1C1;SLCO2B1;SLCO4A1;SLC16A2;SLCO5A1;SLCO2A1;SLCO1B1
prerank,ketone body metabolic process (GO:1902224),0.6436324711210409,1.33009981738875,0.1746641074856046,0.8370711383504295,1.0,5/10,8.71%,OXCT1;ACSS3;BDH1;BDH2;HMGCS2
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5787877349741337,-1.3299052920654355,0.1160337552742616,0.43365187391539495,1.0,4/11,12.04%,LYN;MFHAS1;CYBA;TIRAP
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.6173102785439225,1.3288633655700344,0.17611336032388664,0.8395878018648113,1.0,1/12,0.35%,ACSL1
prerank,regulation of neuron migration (GO:2001222),-0.4676223674126069,-1.3287058520242045,0.10120481927710843,0.43540785514133884,1.0,7/26,5.82%,CTNNA2;SEMA6A;NEXMIF;NTNG1;SHTN1;ARHGEF2;DAB2IP
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5319153013777669,1.3283387960852533,0.1335559265442404,0.8392889724578417,1.0,8/29,16.40%,SMAD3;ZC3H7B;SNIP1;HNRNPA2B1;TUT4;DICER1;PUS10;TUT7
prerank,sphingolipid biosynthetic process (GO:0030148),-0.3839647614434723,-1.3280026618009901,0.08201892744479496,0.43608168398159336,1.0,15/71,6.90%,ELOVL7;CERT1;SGMS1;SGMS2;ELOVL5;ACER3;PRKD3;ACER2;PPM1L;PLPP1;SPTLC2;DEGS2;SPNS2;ST8SIA1;ST6GALNAC5
prerank,heart looping (GO:0001947),-0.42836401658591844,-1.3275717563435823,0.08740359897172237,0.436089420171236,1.0,9/39,13.22%,MEF2C;ENG;MICAL2;TBX3;NOTCH1;SOX17;VANGL2;SOX18;AHI1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5953136581966809,1.3270512375881311,0.16728624535315986,0.8422147047464562,1.0,3/12,4.07%,PTPN14;NEDD4;IFI27
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.40865982969494197,-1.3270197974139966,0.08064516129032258,0.4364089102171799,1.0,16/51,14.15%,BMPER;GREM2;BMPR2;HTRA3;VWC2;NOTCH1;VWC2L;SMAD5;SORL1;SMAD1;BMP2;SMAD7;LEMD3;UBE2D3;BMPR1B;SMURF1
prerank,negative regulation of metabolic process (GO:0009892),0.45425755926566286,1.3264864736171211,0.11642743221690591,0.842224010517998,1.0,17/54,16.30%,LGR4;LAMA4;ZNF423;ALDH1A1;NPR3;PCTP;TLR4;NOVA1;ACOT11;DOCK7;FOXC2;ADAM17;FLCN;ACVR2B;MAP2K6;NRDC;RB1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.40571179804194496,1.3258392270106416,0.0639686684073107,0.842426177808894,1.0,36/138,16.32%,NOTCH2;RORA;THRB;PPARGC1A;CCN2;PPARA;POLR2A;NCOR2;NR6A1;ESRRA;TEAD3;TBL1X;WWTR1;RORC;POLR2D;NR1D2;TBL1XR1;TEAD2;NR2C2;HDAC1;MED17;GTF2F1;RARG;TEAD1;TAF11;NR3C2;TBP;TAF4;NCOR1;KAT2B;TAF7;MED23;RXRA;TAF13;CREBBP;MED26
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.3721961974618849,-1.3254722740706741,0.05014749262536873,0.43891175860009396,1.0,19/76,16.20%,NRP1;TEK;NTRK3;SEMA5A;NCK2;EVL;CARMIL1;PTK2B;CDC42EP3;BIN1;PROX1;WDR1;EDN1;SYNPO2;PFN2;FES;CDC42EP2;NCK1;ARF6
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.4940108688048106,-1.3249946891523403,0.11956521739130435,0.4390478697678391,1.0,6/22,11.23%,PDE3B;PPP2R5A;APOD;CEACAM1;CCDC3;GPER1
prerank,regulation of Rac protein signal transduction (GO:0035020),0.5774750326239841,1.3247414363485643,0.17013232514177692,0.8443639566873143,1.0,3/16,6.19%,AUTS2;ALS2;ARHGAP17
prerank,diol metabolic process (GO:0034311),-0.5120750797649675,-1.3245423122827693,0.11447084233261338,0.4390809764487647,1.0,8/19,11.77%,NOS3;PLPP1;DEGS2;CALM1;GCH1;HSP90AA1;PRKG2;ASAH2
prerank,regulation of cell growth (GO:0001558),-0.32030878352463266,-1.324470464534339,0.02040816326530612,0.43820232346485544,1.0,52/204,16.25%,NRG3;APBB2;SLIT2;PTPRJ;LTBP4;BMPR2;AKAP6;PLCE1;CAMK2D;RTN4;TGFB2;PAK5;ACVRL1;CCN3;TFRC;NET1;SOX17;SOCS2;ENPP1;ADAM15;LGI1;PPP2R1A;RERG;SH3BP4;TGFB1;SPOCK1;AGTR1;SERTAD2;CEACAM1;BTG1;CXCL16;PPT1;H3-3A;ERBB2;FRZB;KIF26A;RPS6KA3;BCAR1;SLC25A33;MFSD2A;FAM107A;CDKN1A;JADE1;TAF9B;EI24;RPS6KA1;MT3;PTCH2;DCBLD2;RASGRP2;CCDC85B;EGLN2
prerank,metal ion transport (GO:0030001),-0.3669614383473947,-1.323816209971949,0.03389830508474576,0.4386770839896764,1.0,29/86,15.03%,SLC8A1;CALCRL;CAV1;CACNA1E;RYR2;CACNA2D1;TPT1;ATP2C1;RYR3;GRIN3A;TRPC3;ATP2B2;RAMP2;TRPC4;NIPAL2;TRPC1;CACNA1B;PSEN1;NDFIP2;ATP2A3;TRPV4;SELENOK;SLC30A1;RAMP1;MT3;NIPA1;TRPC5;CACNG8;TRPM2
prerank,regulation of supramolecular fiber organization (GO:1902903),0.538477030750948,1.3236631950472317,0.1407942238267148,0.8464072826643027,1.0,6/22,10.68%,AEBP1;AKAP13;MAP2;PIK3CA;ABL1;PRUNE1
prerank,sulfur amino acid metabolic process (GO:0000096),0.5274362145488563,1.3235482175209377,0.15245009074410162,0.8444392587370718,1.0,7/24,12.38%,MSRA;CPS1;MTHFR;ADI1;CTH;NOX4;MTRR
prerank,regulation of Wnt signaling pathway (GO:0030111),0.4157268723219186,1.3235439625330951,0.06512890094979647,0.8420265278532698,1.0,23/108,10.27%,WWOX;RSPO2;RNF43;WLS;NXN;PTK7;FGFR2;PRKN;DCDC2;TRABD2B;APCDD1;CXXC4;LRRK2;SULF2;VGLL4;SMARCA4;BTRC;TERT;LRP1;TLE1;CBY1;GRB10;FOXL1
prerank,regulation of AMPA receptor activity (GO:2000311),-0.45727214826492707,-1.3227476153586943,0.09808612440191387,0.4402949258015226,1.0,7/25,7.93%,NLGN1;MEF2C;SHANK3;SHISA6;SHISA9;MINK1;RELN
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.48365192817467884,-1.3223649421880903,0.10599078341013825,0.44012199774255156,1.0,6/23,21.03%,CADM1;PIK3R6;PVR;ARRB2;LGALS9;RAET1E
prerank,regulation of innate immune response (GO:0045088),0.4532652424684226,1.322173926040178,0.11746987951807229,0.8452109209507387,1.0,18/57,16.01%,APPL2;RNF135;IFNK;TKFC;PTPN22;PLSCR1;SAMHD1;PARP9;DHX58;NMI;PTPN11;IRF1;IFI35;ERAP1;ACOD1;USP18;IFNAR2;BIRC3
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.5988433342099239,-1.3220167932278561,0.1443089430894309,0.4399375405476615,1.0,4/10,8.92%,SEMA6A;DCN;DAB2IP;XDH
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.504825499265289,-1.3210315074004877,0.13501144164759726,0.4412260342591521,1.0,6/18,3.62%,NLGN1;NRXN1;RIMS2;SHANK3;RIMS1;PTK2B
prerank,protein localization to mitochondrion (GO:0070585),0.6264776199755409,1.3207719052231295,0.1903807615230461,0.8486051973033305,1.0,2/11,3.86%,HK2;LRRK2
prerank,negative regulation of ATPase activity (GO:0032780),0.57777179968731,1.320708481002542,0.1650853889943074,0.8464450899892776,1.0,5/16,14.28%,IFIT1;TP53;SIRT1;TNNI3;TSC1
prerank,protein homotetramerization (GO:0051289),0.4758827234863439,1.3199993374230345,0.12832550860719874,0.8469039044554041,1.0,8/49,9.81%,ALDH1A2;APPL2;UPB1;SOD2;SAMHD1;SSBP1;CBY1;CTH
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.5699145331127364,-1.3199002763252403,0.13704496788008566,0.44299236022286803,1.0,6/12,26.87%,PIK3R1;DAB2IP;PTPN1;BCL2L11;ERN1;ATF6
prerank,nucleoside catabolic process (GO:0009164),0.6246654436948911,1.318866966571457,0.166044776119403,0.8489512832166818,1.0,3/11,6.52%,UPB1;DPYD;DERA
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.5610284178366102,-1.3174762217414782,0.15811088295687886,0.44757564811433803,1.0,5/13,8.51%,DCN;BGN;CSPG4;VCAN;HEXB
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.5100123338682843,-1.316837387724669,0.11750599520383694,0.44803568582255354,1.0,9/18,19.62%,RPS6KA5;CD200;EPHA5;RELN;LRP8;PRKD1;VEGFA;CRTC2;ADCY8
prerank,response to fatty acid (GO:0070542),-0.5225109719516408,-1.3164412479462426,0.14831460674157304,0.4479058117463339,1.0,5/17,20.04%,PID1;FOXO1;SCD;NR1H4;IRS1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.3656219711221291,-1.3163492001876764,0.07272727272727272,0.44710007040364524,1.0,40/86,22.96%,NRP1;GHR;PTPRJ;PECAM1;EFNA5;PTK2B;ARHGEF2;PTPRC;APP;PLCG2;EPHA7;CSPG4;SEMA4D;RELN;TGFB1;TEC;CD44;PDGFA;ITGB3;ENPP2;SAMSN1;LRP8;FGF7;DMTN;ACVR1;VEGFA;CD74;PDCL3;ITGA5;ITGB2;VTN;AGT;SFRP1;CNOT7;IL6R;HCLS1;CD81;FYN;THBS4;HGF
prerank,regulation of cellular localization (GO:0060341),0.4791034638648079,1.3163346270689393,0.1104,0.8570267612729536,1.0,7/46,5.21%,PARD6G;ADCY5;STXBP4;PRKN;LRRK2;STXBP2;MAP2
prerank,positive regulation of type 2 immune response (GO:0002830),0.5876804841295648,1.3160390907341573,0.16955684007707128,0.8558290527156306,1.0,3/14,9.33%,PRKCZ;IL18;RSAD2
prerank,engulfment of apoptotic cell (GO:0043652),-0.5227801908135221,-1.3154534206344992,0.10747663551401869,0.44823293939090914,1.0,6/15,13.86%,RHOBTB1;XKR4;THBS1;XKR6;RHOH;ADGRB1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.5841459524082621,1.3151299202321625,0.17890772128060264,0.8571235775097866,1.0,3/15,7.06%,IGF1;PRKN;OPA1
prerank,positive regulation of DNA repair (GO:0045739),0.4773931326045169,1.314620706181314,0.13354037267080746,0.8568429025553731,1.0,10/46,14.73%,EYA1;EYA2;EYA4;BABAM2;RNF8;SIRT1;UIMC1;BABAM1;SMCHD1;MGMT
prerank,regulated exocytosis (GO:0045055),-0.32551766768072615,-1.3146124422976213,0.016304347826086956,0.44915714961746317,1.0,50/173,15.64%,PCDH7;ABCC4;SYT1;VWF;ACTN4;RIMS2;PECAM1;TMSB4X;CD9;SNAP25;RIMS1;VEGFC;THBS1;ACTN1;FN1;TGFB2;PCLO;GAS6;RAB31;MYH9;LYN;OLA1;LHFPL2;CALM1;APP;FLNA;PSAP;TGFB3;CD109;ECM1;TAGLN2;TGFB1;PDGFA;ITGB3;WDR1;FAM3C;RAB27B;PROS1;RAB11FIP1;RAB11FIP5;SNCA;CDC37L1;VEGFA;SDF4;SYT7;CLU;SYNGR2;RARRES2;ALDOA;NHLRC2
prerank,triglyceride metabolic process (GO:0006641),0.46768632388495324,1.3145248104538332,0.1162079510703364,0.8548256025841886,1.0,8/48,9.35%,LPGAT1;MOGAT3;GPAT2;CPS1;GK5;GK;APOBR;SIRT1
prerank,nucleic acid-templated transcription (GO:0097659),0.4744049188053526,1.3142030567121739,0.1388888888888889,0.8537009515132553,1.0,7/42,8.39%,THRB;POLR2A;DTX1;CREBL2;POLR2D;MEF2A;TERT
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.3331520998955243,-1.3141029628149559,0.018018018018018018,0.44923372781749427,1.0,42/163,19.78%,PDE4D;MEF2C;PDE4B;PTPRJ;PIK3R1;RFTN1;PAK3;INPP5D;PSMB2;CD38;PAK1;PTPRC;BMX;PLCG2;PLEKHA1;MAP3K7;MOG;TNFRSF21;PSMD14;TEC;PSMC6;BCAR1;EIF2B3;IKBKB;SH2B2;RBCK1;SPPL3;BTN3A3;NCK1;PSMA4;NFKBIZ;PSMB9;BLNK;SKAP1;SKP1;SYK;PSMD11;BTK;PSMB10;PRKCQ;PSMD2;TXK
prerank,neuromuscular synaptic transmission (GO:0007274),0.5570255281029886,1.3135758054861957,0.18065693430656934,0.8539584314230488,1.0,7/18,20.47%,FCHSD2;DTNA;KIF1B;TSPOAP1;ERC2;CHRNB1;TBC1D24
prerank,axonal fasciculation (GO:0007413),-0.562499968801503,-1.3129079492085112,0.1300639658848614,0.4510893539723331,1.0,5/12,7.96%,CNTN4;RTN4;SEMA5A;NRCAM;EPHB2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.5406051634822936,-1.3128639675954157,0.1425531914893617,0.4501748795148536,1.0,5/13,11.44%,LTBP1;GREM2;FBN2;BMP2;NRROS
prerank,protein localization to membrane (GO:0072657),-0.3228421158129889,-1.3126634659077656,0.019138755980861243,0.44968458771444875,1.0,48/187,11.47%,NLGN1;KCNIP4;DLG2;NRXN1;SPTBN1;DPP10;CACNB2;KCNB2;CAV1;BSG;ANK3;SHANK3;DPP6;EFR3B;LRRC7;CLASP2;MAP7;LIN7A;RFTN1;EPB41L3;ATP1B1;F11R;GAS6;MYO5A;EHD4;RAMP2;RAB3C;RAP1A;NKD2;FLNA;SH3GLB1;TSPAN14;PTCH1;EHD2;ITGA4;FRMPD1;RDX;PTN;RAPGEF6;FGF13;RAP2A;AGRN;ARL5A;KCNB1;ZDHHC2;NRXN2;CDH1;PACS2
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.48548502425286183,-1.3125185539765818,0.1044776119402985,0.4490552318173607,1.0,5/21,6.42%,PRKCH;SLC39A10;PTPRC;FOXP1;RPS3
prerank,positive regulation of reproductive process (GO:2000243),-0.4443784385017995,-1.3120358677856843,0.10199004975124377,0.4491598457863945,1.0,12/31,21.61%,PDE3A;LHFPL2;GLRA1;PGAM4;VEGFA;CFAP69;CACNA1H;SIRT2;INHBA;SYDE1;TACR3;PRDM9
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.513722271218228,-1.3117816687197377,0.13432835820895522,0.4487299950922424,1.0,3/17,1.12%,NRP1;TEK;NTRK3
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.5404816633166056,-1.3117535646879155,0.13655462184873948,0.44779307623619335,1.0,8/13,29.80%,SORL1;GCC2;TMEM30A;CD81;SEC16B;SAR1B;TMEM30B;SAR1A
prerank,ureteric bud development (GO:0001657),0.581064370739079,1.3115870945390513,0.16603053435114504,0.8593564231149359,1.0,5/17,3.64%,BMP7;OSR1;FGFR2;NPNT;FOXC1
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5659957126933791,1.3112913951271503,0.1691449814126394,0.8582285762779309,1.0,9/18,19.69%,KMT2A;SETD7;KMT2D;SETD1B;EHMT2;EHMT1;ASH1L;SETD3;SETD1A
prerank,respiratory system development (GO:0060541),0.5142456485543674,1.311148169610189,0.16286644951140064,0.8564366104003495,1.0,7/32,7.55%,FGF1;FGFR2;GLI2;PDPN;LOXL3;RBP4;CHD7
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.5122077949979758,1.311098645487321,0.15973377703826955,0.8542792897272026,1.0,14/27,20.37%,FBXL17;PPP1CB;TP53;SIK1;FBXL12;PML;PER2;RBM4;PER3;CRY1;CRTC1;FBXL22;MTA1;PDE6B
prerank,glycerol metabolic process (GO:0006071),0.6311344994473098,1.310946913327737,0.21235521235521235,0.8525105978237052,1.0,4/10,16.22%,GK5;TKFC;GK;GOT1
prerank,intracellular cholesterol transport (GO:0032367),-0.5264132519832966,-1.3108203937371867,0.15265486725663716,0.449055560080403,1.0,8/15,21.98%,ABCG1;LDLR;NPC2;STARD4;RELCH;LDLRAP1;OSBP;LRP6
prerank,muscle organ development (GO:0007517),-0.39314374376499245,-1.3107654405644296,0.069164265129683,0.4481623662963599,1.0,11/54,6.46%,UTRN;MEF2C;SGCD;COL6A3;MKX;LAMA2;TEAD4;SGCE;TBX1;SMTN;FKTN
prerank,positive regulation of glycolytic process (GO:0045821),0.5480676598425629,1.3105605380092935,0.15675675675675677,0.8493847463265227,1.0,3/20,2.21%,IGF1;PRKAA2;ZBTB20
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.5480676598425629,1.3105605380092935,0.15675675675675677,0.8493847463265227,1.0,3/20,2.21%,IGF1;PRKAA2;ZBTB20
prerank,Rho protein signal transduction (GO:0007266),0.4597835431935673,1.310483679525671,0.12102874432677761,0.8473745790125013,1.0,16/53,12.27%,CELSR1;ARHGAP29;ROCK2;RHOD;ADRA2A;PDPN;ARHGAP6;ARHGEF11;COL1A2;ARHGEF1;EPS8L2;CTNNAL1;PHACTR4;CDC42;EPS8L1;CDC42EP1
prerank,actomyosin structure organization (GO:0031032),0.4319929366583799,1.3098531665919593,0.10982658959537572,0.8475829750792387,1.0,15/75,6.52%,ROCK2;ACTN2;SORBS1;CSRP3;FRMD6;PHACTR1;TMOD2;EPB41L5;MYO18A;FAM171A1;TMOD3;TPM1;KLHL41;ARRB1;CDC42BPG
prerank,photoperiodism (GO:0009648),0.5100879413971955,1.3097100354543088,0.16166666666666665,0.845864080799714,1.0,14/28,20.37%,FBXL17;PPP1CB;TP53;SIK1;FBXL12;PML;PER2;RBM4;PER3;CRY1;CRTC1;FBXL22;MTA1;PDE6B
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.5682617943598186,-1.3095755115646754,0.14049586776859505,0.4500373665609702,1.0,5/11,11.37%,ZFPM2;TGFB2;JAG1;HEY2;BMP4
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5394764160737947,1.3093804918452867,0.15630550621669628,0.8449218046605086,1.0,3/22,3.65%,TIMP3;SH3D19;ADRA2A
prerank,determination of heart left/right asymmetry (GO:0061371),-0.41547113193857943,-1.3093751608789124,0.09762532981530343,0.44953963590018414,1.0,9/42,13.22%,MEF2C;ENG;MICAL2;TBX3;NOTCH1;SOX17;VANGL2;SOX18;AHI1
prerank,generation of neurons (GO:0048699),-0.32459202390984154,-1.3093011919930218,0.010309278350515464,0.4487477654593961,1.0,42/190,10.30%,NRP1;ADGRL3;MEF2C;PTPRD;IL1RAPL1;MARK1;ASTN2;MAP1B;TGFB2;TAFA1;ASTN1;RUNX1;FUT9;NDNF;DNER;CIT;CDKL5;ACSL3;NTRK2;MYT1L;ATP2B2;MYEF2;FZD4;HES1;MET;DISC1;NRCAM;ACSL4;DCX;LHX6;RELN;HEYL;WNT9A;SIX1;SPOCK1;ATOH8;TUBGCP2;HEY2;FGF13;ERBB2;DDIT4;RUNX2
prerank,negative regulation of chemokine production (GO:0032682),0.5893540648087452,1.3085040002180002,0.1996124031007752,0.8460632851585451,1.0,2/14,5.70%,C1QTNF3;MAP2K5
prerank,brain development (GO:0007420),-0.3375033804655807,-1.3083737044786112,0.03225806451612903,0.44994247031665857,1.0,30/136,10.06%,CNTNAP2;ADGRL3;CTNNA2;ROBO2;ADGRL2;ZFHX3;CDH2;SHANK3;COL4A1;CNTN4;GRIN2B;SHROOM4;PBX3;DSCAML1;PTCH1;EPHA7;GRIN2A;HSPG2;MEIS2;RELN;PCDH18;APOD;PROX1;TUBGCP2;PPT1;RAB18;PBX1;DDIT4;UFM1;CDK5RAP2
prerank,nervous system development (GO:0007399),-0.30252218388895236,-1.308223683376101,0.00847457627118644,0.4492726403074382,1.0,89/429,10.06%,LSAMP;NLGN1;ADGRL3;NRXN1;DNM3;MEF2C;ROBO2;DCLK1;MBNL1;ERBB4;SEMA6A;CDH2;ADGRG6;KIRREL3;FGF12;SLC2A1;GSN;SHANK3;SPOCK2;ST8SIA4;RBFOX1;WWP1;EPHB1;NAV3;CNTN4;CHRM3;MERTK;GRIK1;EFNA5;ADAM23;FN1;TBX3;SEMA5A;MAL;IL1RAPL2;MOBP;EVL;STAT3;NELL1;APAF1;GLRB;DNER;SERPINI1;SH3GL2;NGF;NFASC;SCN2A;JAG1;DSCAML1;APBA2;MYT1L;ZBTB16;GPM6B;MBP;SNTG2;CNTN6;PDGFC;MARCKS;RBFOX3;HES1;FKTN;MET;NRCAM;DCX;PCDH1;SRRM4;MOG;SREBF2;VCAN;LGI1;DACT1;FEZ1;RELN;EPHB2;PTPRZ1;TGFB1;SPOCK1;CHRM2;PROX1;BTBD3;PTN;ADAM22;FGF13;FGF2;PPT1;S100B;ECRG4;SLITRK1;CDK5RAP2
prerank,embryonic heart tube development (GO:0035050),-0.5433409735927811,-1.3082194691937712,0.14977973568281938,0.4482903564268717,1.0,7/14,22.24%,RYR2;SOX17;HES1;SOX18;ACVR1;NDRG4;TBX2
prerank,positive regulation of biosynthetic process (GO:0009891),0.47918255406128324,1.3079466699388347,0.13015873015873017,0.8460280040061978,1.0,8/40,6.42%,SORBS1;WNT4;PPARA;ZBTB20;SLC5A3;TLR4;F2;CREBL2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.35226245799350453,1.3076949495371646,0.004149377593360996,0.8447611102117051,1.0,157/807,14.62%,PRDM6;AEBP1;DAB2;WWOX;BMP6;BMP7;THRB;SMAD3;TFDP2;GLIS3;WNT4;OSR1;ZIC2;FOXN3;FHL2;DDX5;MXI1;CUX1;DLG1;PPARA;FGFR2;PRKN;FOXP4;ZNF423;DNMT3A;JARID2;GLI2;FNIP1;KANK2;ZHX2;SNX6;FOXD1;ZNF568;DKK3;ARID4A;MOSPD1;HDAC8;NR2F2;KCNIP3;NCOR2;CTR9;TSHZ3;NR6A1;GLI3;MITF;SUFU;CXXC5;FOXC1;PHF21A;PCGF2;IFI27;ZBTB38;NACC2;VGLL4;LOXL3;EZR;FOXP2;CUX2;RREB1;NSD1;WWC2;OTP;SFMBT1;MAP2K5;GPS2;USP9X;CBFA2T2;LCOR;HMGA1;LBH;ZNF318;TP53;TBL1X;BHLHE41;SMURF2;RORC;NIPBL;LDB2;LDB1;FBXW11;BCOR;CBX7;MEF2A;KDM2B;SMARCA4;NR1D2;BTRC;RBM15;SPEN;TBL1XR1;CPEB3;KAT6B;KDM2A;NRG1;NUPR2;IRX1;SMARCC2;NIBAN2;PARP9;SMARCE1;HDAC4;SCML4;SIRT1;TLE1;NR2C2;HDAC1;SOX13;CBY1;LARP7;SPINDOC;ZFP90;CHMP1A;FOXC2;TCF7L2;ZNF219;ATN1;AURKB;PRDM5;AASS;RTF1;SAP18;RARG;MNT;BAHD1;WWP2;IMPACT;ZBTB1;SKOR1;CBX5;DICER1;ZNF148;UIMC1;BRD7;DEAF1;MLXIPL;ZMYM5;IRF1;FRK;KAT7;KMT5A;BEND3;SIN3A;PML;CBX6;TLE2;BCL7A;NCOR1;ZBTB32;CRYAB;SNAI1;PER2;FLCN;ACVR2B;GADD45A;ZKSCAN3;MIER3;HOXA7
prerank,receptor internalization (GO:0031623),-0.41113134533426526,-1.307428753113344,0.09289617486338798,0.4491657688997016,1.0,14/44,13.29%,DNM3;CALCRL;CAV1;CD9;RAB31;TFRC;RAMP2;ACKR3;ITGB1;DNM1;CEACAM1;AP2M1;SNCA;RAMP1
prerank,heart development (GO:0007507),-0.331460194867161,-1.3072725041387099,0.03317535545023697,0.4485137065506927,1.0,41/150,13.77%,SGCZ;MEF2C;SGCD;FLRT2;TEK;BMP5;ZFPM2;ERBB4;NTRK3;FGF12;HEG1;BMPR2;PLCE1;FN1;TGFB2;MICAL2;ECE1;ACVRL1;HDAC9;NOTCH1;RAMP2;TBX1;SOX17;STRA6;PCSK5;BMP2;TGFB1;PTK2;PDLIM1;ID2;PKD1;FKBP1A;BMP4;RBM20;SOX18;CDKN1A;CRIP1;PDLIM3;ACVR1;MYOCD;VEGFA
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.5467592162282391,-1.3068948774316564,0.1683366733466934,0.44847029729422766,1.0,6/13,22.09%,TGFB1;MAPT;SYK;ITGB2;TYROBP;SOD1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.517442142787878,-1.3067630057420008,0.14822546972860126,0.4477809332383209,1.0,5/16,10.35%,NRP1;PTPRJ;PDGFC;PDGFA;BCAR1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.4438522368990745,-1.3058129507989993,0.11888111888111888,0.4490611321209318,1.0,17/32,26.21%,AKAP6;CEMIP;CALM1;CALM2;TRPC1;CALM3;JPH2;GPER1;SNCA;APLNR;GSTM2;NPSR1;HAP1;THY1;F2R;CXCL10;PLCG1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.5029359407297006,-1.3057787889811994,0.13793103448275862,0.4481567413379669,1.0,7/18,28.12%,PIK3R1;USP13;NCK1;BCL2L11;ERN1;TMEM259;PMAIP1
prerank,calcium ion import into cytosol (GO:1902656),-0.5300066270236158,-1.3052157054498732,0.14675052410901468,0.44847801380927044,1.0,5/15,10.43%,SLC8A1;SLC24A2;CACNA2D1;TRPV4;ATP2B4
prerank,regulation of platelet aggregation (GO:0090330),-0.5185461523409465,-1.3048191305882906,0.15034168564920272,0.44844204136758486,1.0,6/17,8.90%,PRKG1;CD9;SERPINE2;F11R;LYN;CEACAM1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.2978270733584869,-1.3046682194399282,0.0,0.44786559288236516,1.0,114/390,17.05%,NRP1;FLRT2;ARHGEF28;GHR;PTPRJ;TEK;GRB14;ERBB4;NTRK3;PIK3R1;ACTB;PTPRG;ROR1;EPHB1;MPZL1;VEGFC;EPHA5;MERTK;UBASH3B;ATP6V0A1;GRIN2B;EFNA5;PTPRT;NRP2;EPHA6;TIE1;PAK3;COL4A2;NCK2;STAT3;CHN1;GAB1;PTK2B;BCAR3;ACTG1;CAV2;NGF;NTRK2;ARHGEF7;DOCK1;KDR;LYN;GSK3B;ROR2;PDGFC;ACTR2;TIAM1;PAK1;AP3S1;NAMPT;MET;SOCS2;EPHA7;FOXO1;PSEN1;ATP6V0A4;CRK;DNM1;SORT1;EPHB2;ANKS1B;PTK2;AP2B1;ABI1;NCF2;FGF2;FLT4;ERBB2;DDIT4;PDGFA;HSP90AA1;BCAR1;ITGB3;ACTR3;CYBA;ELMO1;AP2M1;TIAL1;ARPC1B;RASA1;SH2B2;MTSS1;FGF7;ARPC5;COL1A1;PRKD1;AHI1;POLR2J;FGF9;RET;VEGFA;ARPC4;SPRED1;CDK5R1;FES;FGFR3;NUS1;NCK1;RARRES2;STMN1;GRIN1;IL31RA;EIF2AK3;ANGPT2;BDNF;CBL;BLNK;VAV1;GFRA2;PIK3C2A;RBFOX2;APC;TYRO3;WASF2
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.4915149160502605,-1.3044152889840208,0.1261904761904762,0.44749965269903585,1.0,9/20,14.18%,NOTCH1;SMAD5;SMAD1;BMP2;RUNX2;ATF4;HIF1A;VEGFA;MT3
prerank,positive regulation of insulin secretion (GO:0032024),0.4726896589878028,1.3041174292082183,0.14776632302405499,0.8569941367501417,1.0,7/36,9.99%,NNAT;NLGN2;MCU;GCK;RBP4;PLA2G6;TCF7L2
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.6016398299381676,1.304099005684008,0.1875,0.8547839611745817,1.0,3/12,4.95%,THRB;BRD8;CTSH
prerank,cellular potassium ion homeostasis (GO:0030007),0.6086661064493459,1.3033873256169748,0.1851145038167939,0.8553228908751136,1.0,2/13,0.71%,ATP1A2;ATP1B3
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5275466678511054,1.3033191977094245,0.1786339754816112,0.8533400156236649,1.0,5/25,6.76%,ERRFI1;PPARA;SNX6;SLC6A9;CNRIP1
prerank,positive regulation of protein binding (GO:0032092),-0.38725274535188176,-1.302790880814557,0.06432748538011696,0.4502989271886915,1.0,26/56,22.78%,CAV1;CLDN5;EPB41;B2M;GSK3B;TIAM1;APOE;APP;PSEN1;DACT1;BMP2;RALB;ADD2;PKD1;FKBP1A;BMP4;SPPL3;BDNF;HIPK2;MEN1;HIP1R;RAN;VTN;RPL11;TRIB3;FLOT1
prerank,striated muscle tissue development (GO:0014706),-0.45438327249551524,-1.3023423534197827,0.12564102564102564,0.4502775484936731,1.0,8/29,4.11%,SGCZ;MEF2C;SGCD;PGM5;BMP5;CAV1;BMPR2;MYL6
prerank,synaptic vesicle exocytosis (GO:0016079),-0.41061045162425447,-1.3021766019996062,0.07219251336898395,0.44967940029712444,1.0,7/40,5.87%,SYT1;RIMS2;SNAP25;RIMS1;PCLO;UNC13B;STX3
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.5841856222959804,-1.3021575160737633,0.1655773420479303,0.44875748149800443,1.0,4/10,4.47%,PDE3B;ACER2;NEXMIF;CYP1B1
prerank,positive regulation of biomineral tissue development (GO:0070169),0.4833858432683736,1.3016566248806225,0.14169381107491857,0.8576915126139405,1.0,7/40,3.18%,BMP6;BMP7;WNT4;OSR1;KL;WNT6;BMPR1A
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.6349370314424463,1.3009243092740301,0.192,0.8582818113021803,1.0,3/10,9.35%,JARID2;ATRX;SIRT1
prerank,regulation of axon extension (GO:0030516),-0.42523502861427814,-1.300861988698067,0.08719346049046321,0.45083584172417496,1.0,12/37,14.18%,RTN4;SEMA7A;CDKL5;NTN1;SHTN1;GSK3B;APOE;NRCAM;DIP2B;SEMA3G;MAPT;MT3
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.555852466738587,-1.3006568717273248,0.16204690831556504,0.45036444511002843,1.0,2/12,0.36%,PRKG1;MEF2C
prerank,cholesterol transport (GO:0030301),-0.4023947262772913,-1.299595844284231,0.09859154929577464,0.45202745487714713,1.0,15/45,21.36%,CAV1;SCARB1;LIMA1;APOE;ABCG1;LDLR;NPC2;STARD5;STX12;STARD4;CLU;RELCH;LDLRAP1;OSBP;STARD3
prerank,neutrophil activation involved in immune response (GO:0002283),-0.2893214688188434,-1.2993869080298026,0.0,0.45156451664833774,1.0,104/428,19.59%,PTPRB;ATP8A1;PTPRJ;PECAM1;GSN;SNAP25;LRRC7;ATP6V0A1;CST3;ADGRE5;IQGAP1;B2M;FTH1;APAF1;ATP11A;HMOX2;NFASC;RAB31;PTPRN2;HSP90AB1;PRG2;GPI;ACTR2;PPIA;RAP1B;PTPRC;RAP1A;CD93;STK10;CTSD;PSAP;CTSC;RAB27A;TSPAN14;HSPA8;TIMP2;PSEN1;TNFRSF1B;DYNLL1;PGLYRP1;NPC2;SLC44A2;FTL;CKAP4;OSTF1;MME;EEF1A1;HEXB;CTSB;STOM;CEACAM1;PSMD14;CRACR2A;CD47;DOCK2;RAB18;CD44;HSP90AA1;CYBA;IMPDH1;XRCC5;GOLGA7;CTSS;ENPP4;HRNR;SLC2A3;ARPC5;TNFAIP6;LRG1;SRP14;PGAM1;FABP5;TMEM30A;QPCT;SCAMP1;DOK3;RAB6A;TRPM2;ALDOA;CCT8;APEH;PKM;CAT;CCT2;PDXK;STXBP3;SVIP;SYK;RAB37;GCA;CYB5R3;C3AR1;PSMD11;CTSZ;ITGB2;CAND1;SLC27A2;QSOX1;TMEM63A;EEF2;SPTAN1;PSMD2;ATP11B;TYROBP
prerank,membrane depolarization (GO:0051899),-0.43923947336567537,-1.2993522471095633,0.12439024390243902,0.45068874148466,1.0,10/32,12.17%,CAV1;CACNA1E;SCN1A;SCN2A;CACNA1G;SCN7A;CACNA1B;SCN3A;SCN9A;SCN8A
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.38098771759279476,-1.2991901324628938,0.08192090395480225,0.4500874058264451,1.0,18/65,16.10%,HIP1;PTPRJ;CDH13;SH3KBP1;PTPN12;BCAR3;SH3GL2;CCDC88A;ARHGEF7;DAB2IP;CEACAM1;MVB12B;DUSP3;GPER1;PTPN3;SPRY1;ZFYVE28;CBL
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5468448024988678,1.298926928088208,0.16337522441651706,0.8640187114644529,1.0,4/21,6.69%,PPARA;PRKN;SLC30A10;SIRT5
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.5536672611151459,-1.2987510905927016,0.15789473684210525,0.45022316983268773,1.0,3/11,13.88%,ANXA1;SMAD7;SOCS5
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.5149587663125439,1.2986159163923487,0.15202702702702703,0.8630333839293138,1.0,13/27,24.56%,BRD8;CPA4;KAT6B;KAT7;KAT2B;CREBBP;SGF29;TAF6L;RUVBL1;EP300;BAG6;MSL3;PHF20
prerank,negative regulation of hydrolase activity (GO:0051346),0.4556835513789957,1.2981087671719584,0.13622291021671826,0.862879380180906,1.0,7/49,6.81%,CPEB2;SH3RF2;LRRK2;GMIP;MAP2;BCAS3;SH2D4A
prerank,sterol biosynthetic process (GO:0016126),0.49658848054447735,1.297687007659831,0.15586690017513136,0.8622252502880653,1.0,2/33,2.51%,PRKAG2;INSIG2
prerank,sterol metabolic process (GO:0016125),0.44603870549766395,1.2973735299995148,0.11317829457364341,0.8612747421916144,1.0,12/60,13.25%,PRKAG2;CYP27A1;INSIG2;LIPA;CYP21A2;CYP26B1;FDXR;CLN6;SULT2B1;ARV1;TM7SF2;LBR
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.5122321620894856,-1.2964995202229341,0.13452914798206278,0.4546227257721015,1.0,10/18,29.01%,CCT8;CCT2;CCT6A;NHP2;CCT7;DCP2;EXOSC10;RUVBL2;DKC1;NAF1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5364294506092123,1.2963353621817562,0.1597222222222222,0.8632842722989472,1.0,11/20,22.89%,AMPD3;LHPP;AK3;AK4;NT5C2;AMPD2;ADSS1;GART;GMPR2;ADSL;GMPS
prerank,dendrite morphogenesis (GO:0048813),-0.43296743413915384,-1.2963017197298154,0.12239583333333333,0.45412140082930985,1.0,12/35,9.13%,CTNND2;CTNNA2;DOCK10;SHANK3;KLF7;EPHB1;PAK3;MINK1;EPHB2;BTBD3;PTN;MAP6
prerank,response to interleukin-4 (GO:0070670),-0.5917102715500511,-1.2961608290267552,0.18277310924369747,0.4534824089508341,1.0,1/10,0.47%,LEF1
prerank,neuron differentiation (GO:0030182),-0.32275363252972405,-1.295908871642327,0.039301310043668124,0.4531051311582596,1.0,33/165,10.30%,TENM2;MEF2C;PTPRD;IL1RAPL1;EPHA5;TENM3;TGFB2;TENM4;PBX3;RUNX1;FUT9;ATP8A2;ACSL3;UGCG;NTRK2;MYT1L;ATP2B2;MYEF2;RORB;FZD4;MET;ACSL4;VSX1;LHX6;WNT9A;SPOCK1;ATOH8;PPT1;ERBB2;PBX1;DDIT4;ID2;RUNX2
prerank,regulation of blood coagulation (GO:0030193),-0.4460730407911834,-1.2950918384458403,0.13691931540342298,0.4540506181774692,1.0,11/27,13.12%,CAV1;ST3GAL4;SERPINE2;THBS1;FAP;CD34;APOE;EPHB2;EDN1;ENPP4;DMTN
prerank,response to thyroid hormone (GO:0097066),0.5889628570067089,1.2942411206720899,0.19092627599243855,0.8694039209723692,1.0,3/13,4.95%,THRB;BRD8;CTSH
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.40822547163296696,-1.2940690551977991,0.11936339522546419,0.4554727883955623,1.0,15/42,14.56%,GCNT2;VIT;NDNF;NOTCH1;FBLN2;MINK1;FZD4;CORO2B;CORO1C;SPOCK1;PTK2;EMP2;DMTN;PPM1F;LIMS1
prerank,manganese ion transport (GO:0006828),-0.5281007243501323,-1.2939249362489613,0.14221218961625282,0.4549353121766073,1.0,7/14,15.04%,ATP2C1;TRPC3;TRPC4;TRPC1;TRPC6;TRPC5;TRPC7
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.4092698024589999,1.2937233772589187,0.09972677595628415,0.8691016266080336,1.0,14/101,9.35%,FGF1;ROBO1;TPD52L1;KIT;FGFR1;ADRA2A;LRRK2;DDX3X;CAMK1;FLT1;PDGFRB;SLC27A1;CCND3;SIRT1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.46604281539484765,-1.2932406649583639,0.13507109004739337,0.4557261901539831,1.0,6/22,8.56%,GHR;ERBB4;CYP1B1;NOTCH1;HES1;MGAT5
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.6262659509112178,1.2929468945221112,0.2199630314232902,0.8700667797833996,1.0,2/11,2.04%,PPARA;SLC30A10
prerank,neuropeptide signaling pathway (GO:0007218),-0.3826751692539334,-1.2923304040508432,0.08529411764705883,0.4569717068928205,1.0,14/58,16.69%,SORCS1;SORCS3;GLRB;GLRA3;SORL1;SORT1;GLRA1;CYSLTR1;HCRTR2;CYSLTR2;GLRA2;NXPH2;NMU;CPE
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.6007258404886865,1.2922884026265786,0.1893491124260355,0.870442515789542,1.0,5/11,15.63%,RENBP;UAP1L1;PGM3;GNPDA1;GFPT1
prerank,regulation of fat cell differentiation (GO:0045598),0.43096123797564195,1.292034868981868,0.09939759036144578,0.8692715747740377,1.0,12/74,9.62%,TMEM64;RORA;SMAD3;MEDAG;ADIG;GPS2;TRIB2;CREBL2;WWTR1;RORC;SIRT1;LRP3
prerank,epithelial cell-cell adhesion (GO:0090136),0.6095366223894926,1.292015021443133,0.2026266416510319,0.8671202904515005,1.0,2/11,2.63%,KIT;PLEKHA7
prerank,aortic valve development (GO:0003176),-0.42914179819513715,-1.291794291963398,0.1211340206185567,0.45731124036067144,1.0,16/34,12.47%,SLIT2;ROBO2;ELN;BMPR2;NOS3;TIE1;JAG1;NOTCH1;TNFRSF1B;HEYL;NFATC1;BMP2;TGFB1;HEY2;BMP4;TWIST1
prerank,neutrophil degranulation (GO:0043312),-0.28821114191768943,-1.2916099879003533,0.0,0.456761315921388,1.0,103/425,19.59%,PTPRB;ATP8A1;PTPRJ;PECAM1;GSN;SNAP25;LRRC7;ATP6V0A1;CST3;ADGRE5;IQGAP1;B2M;FTH1;APAF1;ATP11A;HMOX2;NFASC;RAB31;PTPRN2;HSP90AB1;PRG2;GPI;ACTR2;PPIA;RAP1B;PTPRC;RAP1A;CD93;STK10;CTSD;PSAP;CTSC;RAB27A;TSPAN14;HSPA8;TIMP2;PSEN1;TNFRSF1B;DYNLL1;PGLYRP1;NPC2;SLC44A2;FTL;CKAP4;OSTF1;MME;EEF1A1;HEXB;CTSB;STOM;CEACAM1;PSMD14;CRACR2A;CD47;DOCK2;RAB18;CD44;HSP90AA1;CYBA;IMPDH1;XRCC5;GOLGA7;CTSS;ENPP4;HRNR;SLC2A3;ARPC5;TNFAIP6;LRG1;SRP14;PGAM1;FABP5;TMEM30A;QPCT;SCAMP1;DOK3;RAB6A;TRPM2;ALDOA;CCT8;APEH;PKM;CAT;CCT2;PDXK;STXBP3;SVIP;RAB37;GCA;CYB5R3;C3AR1;PSMD11;CTSZ;ITGB2;CAND1;SLC27A2;QSOX1;TMEM63A;EEF2;SPTAN1;PSMD2;ATP11B;TYROBP
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.3742884501155213,-1.291407664001571,0.09171597633136094,0.4562615632028481,1.0,21/72,12.16%,TEK;NTRK3;PIK3R1;ROR1;DCN;FN1;TGFB2;GAB1;NTRK2;KDR;LYN;ROR2;PDGFC;SEMA4D;MYOC;PTK2;FGF2;PIK3AP1;PDGFA;GPER1;UNC5B
prerank,synapse organization (GO:0050808),-0.33499929795463385,-1.2912720366400865,0.046511627906976744,0.4556552183907349,1.0,28/125,7.16%,NLGN1;ADGRL3;CTNND2;NRXN1;DNM3;APBB2;LRRC4C;PTPRD;CACNB2;GRM5;PPFIA2;CDH2;KIRREL3;ANK3;SHANK3;SPOCK2;GPC6;LRFN5;PAK3;GPHN;DNER;NTNG1;UNC13B;SEMA3E;APP;NRCAM;PTPRF;PSEN1
prerank,renal system development (GO:0072001),0.4582920226403538,1.2910557199534658,0.1417910447761194,0.8687585591548399,1.0,8/52,3.93%,ACE;LRP4;WNT4;GREB1L;GLI2;TGFBR1;FOXC1;SULF2
prerank,endocrine system development (GO:0035270),0.5568230517408935,1.2901355696580739,0.1486013986013986,0.8700980242456227,1.0,4/21,3.46%,WNT4;GLI2;DKK3;TGFBR1
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.5535667541727499,1.2901257456728938,0.1736745886654479,0.8679342027051443,1.0,4/18,3.53%,ROCK2;PICALM;EPHA4;CASP3
prerank,carboxylic acid transmembrane transport (GO:1905039),0.4743890947530145,1.2898651977801527,0.16229508196721312,0.8667892379084063,1.0,7/40,7.87%,SLC13A3;SLC38A4;SLC38A3;SLC7A11;SLC19A1;SLC27A1;SLC38A1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.41325250474482084,1.289042122448229,0.1111111111111111,0.8678497849474062,1.0,14/95,9.35%,DAB2;TGFBR3;SMAD3;PPARA;SNX6;DKK3;PMEPA1;TGFBR1;SMAD6;LDLRAD4;SMURF2;TGFBR2;PDPK1;SIRT1
prerank,cellular response to organic cyclic compound (GO:0071407),0.3899233178329583,1.2882964391746945,0.07692307692307693,0.8686246841640081,1.0,19/141,7.03%,ATP1A2;RORA;ADCY5;ROCK2;TFPI;SLC5A5;ADCY1;IL18;SPP1;CASP3;LRRK2;RAPGEF3;EZR;SLC26A3;NCOA3;P2RX3;TIPARP;LCOR;RORC
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.5011052512292422,1.2880935566382041,0.15100671140939598,0.8672190341163153,1.0,5/30,6.98%,TGFBR3;SMAD3;DKK3;TWSG1;SMURF2
prerank,clathrin-dependent endocytosis (GO:0072583),0.5157697658784997,1.287449369262193,0.1858108108108108,0.8675227668744491,1.0,3/26,2.14%,DNAJC6;PICALM;FCHSD2
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6165886177475556,1.2872268982498158,0.21484375,0.8662563922832749,1.0,3/10,3.86%,ATP1A2;OSR1;NEDD4
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.5067660093686905,-1.2869920415048852,0.160676532769556,0.46492242952376645,1.0,5/17,12.53%,PRKG1;MEF2C;TGFB3;GPER1;CDKN1A
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.41475330927306997,1.2861920011359265,0.125,0.868108951614119,1.0,16/87,12.28%,FGF1;FGFBP1;FGFR2;KL;POLR2A;FRS2;FGFR1;HNRNPH1;FLRT1;TIA1;POLR2D;HYAL1;FIBP;GTF2F1;KLB;PTPN11
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.45137921714040136,1.2858189988718456,0.14153846153846153,0.8673772227315483,1.0,16/58,13.34%,PAXX;POLM;BABAM2;DNTT;ATM;UVRAG;NHEJ1;RNF8;KDM2A;XRCC4;IFFO1;PRKDC;UIMC1;RAD50;NSMCE2;BABAM1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5373010106041036,1.2849542319578897,0.20292504570383912,0.8685941065806441,1.0,8/18,14.02%,DDX5;NCOR2;TP53;TERT;RIPK1;MAP2K1;NCOR1;MAP2K2
prerank,regulation of superoxide anion generation (GO:0032928),-0.5258305543809279,-1.2841949526842515,0.17540322580645162,0.4705073695149973,1.0,6/14,22.09%,TGFB1;MAPT;SYK;ITGB2;TYROBP;SOD1
prerank,negative regulation of protein metabolic process (GO:0051248),-0.3922612796821377,-1.2832589989248195,0.08870967741935484,0.47171994690879365,1.0,16/48,20.57%,FMN2;HSP90AB1;APOE;FLNA;LDLR;IRAK3;ITGB3;EDN1;CD84;ADGRB1;CLU;IAPP;EDNRB;SIRT2;CYP51A1;MAD2L1
prerank,regulation of protein targeting to membrane (GO:0090313),-0.43993114123226357,-1.2829496708812698,0.11818181818181818,0.47146201505684804,1.0,8/28,18.53%,ANK3;CEMIP;MTCL1;ERBB2;KCNB1;DMTN;GDI1;ITGB2
prerank,cellular response to alkaloid (GO:0071312),-0.49415082796556875,-1.2824354655569739,0.17002237136465326,0.471755750353216,1.0,8/17,22.81%,SLC8A1;RYR2;RYR3;HTR1B;CASP6;CASQ2;GSTM2;BLM
prerank,mRNA splice site selection (GO:0006376),0.49685790414520925,1.2823053296985336,0.1711864406779661,0.8768912976419171,1.0,11/30,20.07%,CELF2;SRSF5;PRPF39;KHDC4;LUC7L3;SFSWAP;PSIP1;SRSF1;SRSF10;SNRPC;SF1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.5222239233596294,-1.2820690164901185,0.16812227074235808,0.47172632048833635,1.0,9/15,30.58%,RYR2;SRPRA;SRP14;SPCS1;SRPRB;ZFAND2B;EDEM1;RAB3GAP2;SEC61A1
prerank,regulation of blood circulation (GO:1903522),0.4854261349821484,1.2819899618110042,0.1507293354943274,0.8760462184366697,1.0,5/34,5.18%,CELF2;ACE;DMPK;BDKRB2;TPM1
prerank,dicarboxylic acid metabolic process (GO:0043648),0.44931167029039476,1.2819877087483074,0.13975155279503104,0.8739055862320932,1.0,18/52,19.92%,ME2;ADHFE1;GPT2;SLC19A1;GOT2;MTHFR;OGDH;IDH1;ALDH1L1;MTRR;ACOT8;D2HGDH;GOT1;MTHFD1;IDH2;PHYH;FOLR2;ACLY
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5552065104238875,1.2818669703723062,0.1712707182320442,0.8722351226554438,1.0,3/16,5.34%,APPL2;PPARA;F2
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3428856742391653,1.2807467542478101,0.01026694045174538,0.8746480564872394,1.0,131/834,11.70%,EPAS1;HLF;DAB2;FGF1;WWOX;RORA;BMP6;PPARGC1B;THRB;SMAD3;TFDP2;GLIS3;AUTS2;OSR1;PPARGC1A;IGF1;RHOQ;BRD8;KMT2A;PPARA;SSBP2;CREBRF;FGFR2;PRKN;IL18;FHOD1;HOXB4;GLI2;CSRP3;GABPB1;GABPB2;HOXA1;MOSPD1;NFAT5;PCGF5;HDAC8;PHIP;NR2F2;BMPR1A;ELF1;GLI3;MITF;ARNT2;FOXC1;MLLT10;NFIB;HOXB3;VEZF1;ZBTB38;ASCL3;ZNF462;NFYB;TLR3;NHLH2;RREB1;TLR4;MEIS1;TET2;FZD5;ATM;DDX3X;ARRB1;NCOA3;CAPRIN2;MAP2K5;GPS2;CAMK1;ATRX;ABHD14B;ESRRA;HMGA1;TP53;TBL1X;BCAS3;BCLAF3;CAMTA2;WWTR1;MED12;SOX12;SERPINE1;CCNT2;SMARCD3;PLSCR1;LDB2;LDB1;LAGE3;ATAD2B;MEF2A;SMARCA4;NR1D2;HOXC4;SSBP3;TBL1XR1;KAT6B;TERT;GDNF;APLN;TMF1;JMJD6;CALCOCO1;HDAC4;GLI1;SIRT1;WASL;TFDP1;RIPK2;NR2C2;HDAC1;LARP7;ELL;RIPK1;MAVS;FOXC2;TCF7L2;TCF4;MYBL1;MED17;RBL1;GTF2F1;KMT2C;THRAP3;ABL1;NFATC3;RARG;ATF2;PRKDC;ZMIZ2;MLLT6;MYBL2;TEAD1;ZMIZ1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.41822502533472056,-1.280695494020744,0.12727272727272726,0.47405334223366097,1.0,8/35,8.92%,MEF2C;PTPRM;CAV1;THBS1;CAV2;APOE;ATOH8;XDH
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.39229208784983166,-1.280659533580142,0.11813186813186813,0.47316854252071744,1.0,25/48,24.98%,PDE4D;AKAP6;CAMK2D;UBASH3B;PTK2B;CEMIP;CALM1;CALM2;TRPC1;CALM3;FKBP1A;JPH2;GPER1;NOS1;SNCA;SELENON;APLNR;CASQ2;GSTM2;JPH3;NPSR1;THY1;DMD;F2R;CXCL10
prerank,negative regulation of secretion by cell (GO:1903531),-0.41193993377915283,-1.2804975232171742,0.11547911547911548,0.47261587139201633,1.0,11/38,16.27%,STXBP6;IL1RAPL1;GRM7;NOTCH1;ANXA1;APOE;TNFRSF1B;SLC30A1;SNCA;HTR1B;ERP29
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.46954132494123274,1.2799380704350318,0.1444991789819376,0.8755080225240978,1.0,6/39,9.99%,NNAT;NLGN2;MCU;GCK;RBP4;TCF7L2
prerank,cellular sodium ion homeostasis (GO:0006883),0.5800704048673095,1.2793019427964174,0.188212927756654,0.8759098238757395,1.0,2/15,0.71%,ATP1A2;ATP1B3
prerank,glucose homeostasis (GO:0042593),0.4183820690529214,1.2787921350655234,0.13043478260869565,0.8758101082347852,1.0,12/83,9.99%,APPL2;LEPR;PPARGC1A;BACE2;PRKAA2;HK2;MCU;ADRA2A;GCK;RBP4;SIRT1;TCF7L2
prerank,regulation of microglial cell activation (GO:1903978),0.5675986399976543,1.278604548039294,0.18484288354898337,0.8744579969254578,1.0,2/15,2.32%,SYT11;SPHK1
prerank,regulation of cholesterol esterification (GO:0010872),-0.5877514683816911,-1.2784792885621659,0.16770186335403728,0.47627691482606227,1.0,5/10,19.80%,APOE;ABCG1;AGTR1;STARD4;AGT
prerank,catecholamine metabolic process (GO:0006584),0.5934562791128999,1.2783194755877507,0.18359375,0.8734051338871518,1.0,3/14,8.51%,SNCAIP;PRKN;LRTOMT
prerank,regulation of viral genome replication (GO:0045069),0.4437158373709275,1.2782210200719013,0.1467304625199362,0.8716759859067897,1.0,15/56,13.47%,PPARA;IFIT1;OAS2;PARP10;DDX3X;CD28;EIF2AK2;PLSCR1;LARP1;RSAD2;ZC3HAV1;MAVS;SRPK2;OAS3;HACD3
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5845113492964327,1.2780317776788062,0.2018348623853211,0.8703296913350758,1.0,3/14,6.47%,IL18;IL17D;IL12B
prerank,ear morphogenesis (GO:0042471),0.5332415290536974,1.2778978962614327,0.20260223048327136,0.868791500640942,1.0,6/20,8.37%,OSR1;FGFR2;HOXA1;NIPBL;CHD7;ZIC1
prerank,dopamine metabolic process (GO:0042417),0.5464892003389561,1.2776764829247835,0.19720767888307156,0.8675551867588709,1.0,3/18,1.98%,MOXD1;SNCAIP;PRKN
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.5581661275350551,1.2769328218299991,0.2100371747211896,0.8682781791049028,1.0,2/16,1.27%,PPARGC1B;DDX5
prerank,positive regulation of cell differentiation (GO:0045597),0.3692264503113027,1.276862007776314,0.07270560190703218,0.8664970948197708,1.0,43/237,12.16%,RANBP3L;DAB2;TMEM64;BMP6;BMP7;SMAD3;WNT4;IGF1;RIN2;CCN2;MEDAG;IL18;HOXB4;NPNT;ADIG;SOX5;FGFR1;BMPR1A;TGFBR1;FOXC1;PDPN;ATOH1;PPP1R13L;CAMK1;CREBL2;WWTR1;TGFBR2;MEF2A;IGFBP3;GDNF;GPRC5B;NEUROD4;NBL1;LRP3;BLOC1S6;TCF4;ABL1;SUCO;CDC42;IMPACT;NOCT;AXIN2;ATRAID
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.5241567963561113,-1.276084382985739,0.17699115044247787,0.4811429066934702,1.0,7/14,31.45%,THBS1;PTK2;CMKLR1;RARRES2;MDK;MAPK3;CSF1R
prerank,transition metal ion transport (GO:0000041),-0.41161841102438534,-1.2751894896849403,0.15027322404371585,0.48238431437854906,1.0,14/35,15.04%,ATP2C1;FTH1;TFRC;TRPC3;TRPC4;TRPC1;TRPC6;ATOX1;SLC30A1;SLC31A1;MT3;TRPC5;TTYH1;TRPC7
prerank,positive regulation of cell migration (GO:0030335),-0.30212543616716286,-1.2746641604365634,0.006211180124223602,0.4826768484753311,1.0,73/253,13.77%,NRP1;LEF1;SEMA3C;ACTN4;SEMA6A;NTRK3;SEMA6D;CDH13;CAV1;PECAM1;ITGA6;BMPR2;GCNT2;PODXL;RTN4;THBS1;CLASP2;FN1;TGFB2;CXCL12;SEMA5A;SEMA7A;STAT3;CARMIL1;GAB1;PTK2B;ACTG1;F3;CEMIP;NOTCH1;ARHGEF7;SEMA3E;DOCK1;SHTN1;ARHGEF2;KDR;ROR2;PDGFC;DAB2IP;TIAM1;PAK1;PTPRC;PLCG2;SEMA4D;ITGB1;VSIR;EPHB2;CCN1;PPP3CA;BMP2;MYOC;HSPA5;TGFB1;PTK2;MGAT5;RDX;DDRGK1;CXCL16;PDGFA;BCAR1;EDN1;ENPP2;TWIST2;GPER1;FAM107A;SEMA3D;SEMA3G;HIF1A;DMTN;COL1A1;ACVR1;RET;VEGFA
prerank,outflow tract septum morphogenesis (GO:0003148),-0.4524405110224368,-1.2745822124043247,0.15671641791044777,0.48192270783003516,1.0,9/24,5.71%,NRP1;ROBO2;SEMA3C;ZFPM2;BMPR2;ENG;TGFB2;NRP2;TBX1
prerank,ribosomal small subunit assembly (GO:0000028),-0.5141989169454029,-1.2744717448123681,0.1759656652360515,0.48123481516685257,1.0,8/16,18.84%,RPS19;RPS28;RPS15;RPS27;XRCC5;RPS5;RPSA;RPS27L
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.5132005062906935,1.2743318188887265,0.18,0.8742486288373301,1.0,4/24,7.27%,SORBS1;IGF1;PPP1R3B;GCK
prerank,modulation by symbiont of host process (GO:0044003),-0.5855223427891245,-1.2735562232072914,0.19723865877712032,0.4824030366030034,1.0,6/10,23.93%,B2M;UBB;MRC1;PGK1;UBC;RPS27A
prerank,regulation of protein localization to cell surface (GO:2000008),0.4744010276870031,1.2724576304259196,0.165,0.879454131318053,1.0,3/33,1.42%,ACTN2;LEPROT;PICALM
prerank,glycolipid metabolic process (GO:0006664),-0.3967009800897601,-1.2724142442821715,0.12112676056338029,0.48418387581859773,1.0,11/47,10.36%,ST6GALNAC3;ST3GAL4;ESYT2;UGCG;PSAP;GLTP;ST3GAL6;HEXB;ST8SIA6;B3GALNT1;ESYT3
prerank,carbohydrate homeostasis (GO:0033500),0.42817267206406695,1.2720398283068013,0.15384615384615385,0.8790507728682332,1.0,8/67,7.54%,APPL2;LEPR;BACE2;PRKAA2;MCU;ADRA2A;GCK;RBP4
prerank,regulation of cellular pH (GO:0030641),-0.4445608416874467,-1.2719869367275827,0.16058394160583941,0.48427506804842857,1.0,6/29,12.97%,SLC4A10;SLC9A2;CA2;SLC9A6;SLC9A7;SLC9B1
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.44301948485261927,-1.2714297772624485,0.14847161572052403,0.4846879467442286,1.0,5/24,10.93%,ANK3;CEMIP;MTCL1;ERBB2;KCNB1
prerank,positive regulation of protein acetylation (GO:1901985),0.5885601466642592,1.2709882696880679,0.2153558052434457,0.8811649220016399,1.0,4/12,5.82%,PRKAA2;RAPGEF3;DDX3X;CAMK1
prerank,amide transport (GO:0042886),-0.45504345988083444,-1.2707752021096272,0.1550925925925926,0.48532459874141587,1.0,8/26,8.48%,ABCG2;CERT1;PLTP;SLC5A6;AQP11;SLC38A5;GLTP;DISP1
prerank,cellular calcium ion homeostasis (GO:0006874),-0.3244106401285949,-1.2706180260927875,0.0635593220338983,0.484686045261681,1.0,39/133,12.96%,SLC8A1;CAV1;SLC24A2;RYR2;CAMK2D;NPTN;HTR2C;STIM2;CXCL12;TPT1;ATP2C1;ATP1B1;SLC35G1;CAV2;TRPC3;YWHAE;ATP2B2;TRPC4;MICU3;SLC10A7;HTR2A;TRPC1;TRPC6;PSEN1;CALR;ATP2A3;TRPV4;ATP2B4;EDN1;PTH1R;GPER1;SELENOK;SMDT1;PACS2;HCRTR2;ATP2B1;EDN3;SLC30A1;MCUB
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.4931380069626958,1.2705859291295643,0.1634304207119741,0.8807096499448803,1.0,9/33,11.58%,UBE2E2;STXBP4;DDX3X;ANKRD17;CCND3;HYAL1;GLI1;TFDP1;ADAM17
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.5327119367631787,-1.270251243933878,0.19675456389452334,0.48464871993419467,1.0,7/13,27.83%,B3GALT1;B3GALNT1;B3GALT5;B3GNT3;B3GNT2;B4GAT1;B3GNT6
prerank,acidic amino acid transport (GO:0015800),0.5520138075412118,1.2701242040627971,0.19011406844106463,0.880477770383716,1.0,2/17,0.37%,SLC6A13;SLC6A1
prerank,negative regulation of wound healing (GO:0061045),-0.4421644784280765,-1.2697243548479467,0.1708542713567839,0.48499537638163104,1.0,11/28,10.79%,SERPINE2;CLASP2;CASK;CD34;SLC12A2;AJAP1;APOE;CD109;CRK;FGF2;EDN1
prerank,RNA metabolic process (GO:0016070),0.3873708214935041,1.2693838751116269,0.1256544502617801,0.8812808365014589,1.0,31/127,16.47%,CELF2;POLR2A;RBMS2;TP53RK;PCBP2;PABPN1;HNRNPR;HNRNPH1;DDX3X;SIDT2;HNRNPA2B1;POLR2D;LAGE3;ATXN2;RBM39;EXOSC7;NOVA1;SND1;TENT2;RBMS1;TBRG4;GTF2F1;HNRNPL;DICER1;WTAP;HNRNPC;SNRNP40;RBM4;TFIP11;HNRNPM;PAPOLG
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.5123808609839328,-1.2691898930466046,0.17025862068965517,0.48533239052724775,1.0,7/15,16.33%,STOX2;TGFB2;CELF4;UBR3;SCEL;USP22;NR5A2
prerank,regulation of integrin activation (GO:0033623),-0.512618863648406,-1.2686410263885128,0.1900647948164147,0.4857734854945488,1.0,9/15,32.42%,RASIP1;RAP1B;PIEZO1;FBLIM1;SKAP1;KIF14;SELP;JAM3;PTGER4
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.5934672330018683,1.2684404631893464,0.2210953346855984,0.8831655257200683,1.0,2/12,0.71%,WNK4;ATP1B3
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.5199226752470568,1.2681481142423003,0.1855123674911661,0.8822031620536231,1.0,3/23,2.21%,IGF1;PRKAA2;ZBTB20
prerank,negative regulation of translation (GO:0017148),0.4128662532377903,1.2672664742812043,0.1510791366906475,0.8834439534200543,1.0,13/87,10.36%,CPEB2;ROCK2;CPEB4;IGF2BP1;DDX3X;EIF2AK2;SAMD4A;LARP1;CPEB3;IGF2BP2;CNOT10;LSM14A;YTHDF3
prerank,response to iron ion (GO:0010039),0.5905818528855691,1.2670520871175428,0.1992619926199262,0.8822801102502024,1.0,1/12,0.40%,BMP6
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.5112818762622202,1.267042480159963,0.19243986254295534,0.880268964048899,1.0,6/23,8.24%,TULP3;GLI3;SUFU;MGRN1;BTRC;IFT122
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.5584867213688727,-1.2667196224651176,0.19665271966527198,0.4893831158369121,1.0,10/11,43.27%,STAT3;IL6ST;JAK1;JAK2;STAT4;IL27RA;IL12A;STAT1;EBI3;CANX
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.5356414349480937,1.2667058781056166,0.19597069597069597,0.8795798400027154,1.0,7/20,15.31%,TNRC6A;MOV10L1;TNRC6B;MOV10;AJUBA;TNRC6C;WTIP
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.31865783531332464,-1.2662747949866862,0.04838709677419355,0.4894790420861958,1.0,25/151,8.20%,ST3GAL4;ELOVL7;CERT1;SGMS1;PLA2G4A;SGMS2;ELOVL5;ACER3;PRKD3;ACER2;GPHN;PPM1L;PLPP1;CEPT1;SPTLC2;DEGS2;SPNS2;APOE;GCH1;B4GALT5;SLC44A5;PAM;PCSK5;SLC44A2;LPCAT2
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.5026557083264424,1.2661507774088512,0.19458544839255498,0.8798290808209925,1.0,2/26,3.65%,ATP1A2;ADRA2A
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.48226383984348103,-1.266097783063154,0.17574257425742573,0.488884248920541,1.0,8/20,21.32%,CAMK2D;PSEN1;SELENOK;PACS2;KCTD17;THADA;BCAP31;ATP2A2
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.44868313744617716,-1.2659900864764124,0.16336633663366337,0.48821179175733015,1.0,10/26,8.85%,NLGN1;NRXN1;RIMS2;SHANK3;RIMS1;PTK2B;TMEM108;APP;RELN;MTMR2
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.37917050967354754,1.2652424600533558,0.09535759096612297,0.8813860839412525,1.0,39/166,16.32%,NOTCH2;RORA;THRB;PPARGC1A;CCN2;PPARA;POLR2A;NCOR2;NR6A1;TAF1D;ESRRA;TEAD3;TBL1X;WWTR1;RORC;POLR2D;NR1D2;TBL1XR1;TEAD2;NR2C2;HDAC1;MED17;GTF2F1;RARG;TEAD1;TAF11;NR3C2;POLR1G;TBP;TAF4;NCOR1;KAT2B;BRF1;TAF7;MED23;RXRA;TAF13;CREBBP;MED26
prerank,muscle cell differentiation (GO:0042692),0.48675913166894347,1.264817732546233,0.19080068143100512,0.8810564988269106,1.0,5/32,3.63%,WNT5B;RORA;NEBL;DUSP29;SPEG
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.4482008081087613,1.264658661648034,0.1704718417047184,0.8796191812729617,1.0,6/47,7.27%,C1QTNF3;ROCK2;WNT4;SIK1;SLC27A1;GCK
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.4361198037408184,1.264006481665256,0.16272189349112426,0.8801493207299269,1.0,6/61,9.69%,PRKAG2;PPARA;NCOR2;SIRT5;SIRT1;AZIN1
prerank,phospholipid translocation (GO:0045332),-0.43925134012532285,-1.2639287162562445,0.14925373134328357,0.4920404515553821,1.0,10/28,14.29%,ATP10A;ATP8A1;ATP8B1;ATP11A;ATP8A2;ATP11C;MFSD2A;TMEM30A;ATP8B2;ABCB4
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.42512600931445044,1.263627681446,0.13343799058084774,0.8795137047299664,1.0,19/63,16.59%,WWOX;IGF1;CFLAR;PHIP;FGFR1;DEPTOR;TGFBR1;BID;HTT;RIPK1;TCF7L2;SH3RF1;TMC8;ITGAV;PML;AGTR2;LGALS3;BIRC6;SP100
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.5374304169561542,-1.2634995875552506,0.2028397565922921,0.492120282317225,1.0,7/12,27.83%,B3GALT1;B3GALNT1;B3GALT5;B3GNT3;B3GNT2;B4GAT1;B3GNT6
prerank,regulation of myelination (GO:0031641),-0.4404188463709979,-1.2627896706177781,0.15294117647058825,0.49290113004301084,1.0,11/25,24.20%,TENM4;JAM2;TNFRSF1B;PTPRZ1;TNFRSF21;PTN;EIF2AK3;TPPP;SIRT2;LGI4;KIF14
prerank,protein-DNA complex disassembly (GO:0032986),0.5620998579282495,1.2626662883103288,0.19064124783362218,0.8812351585001758,1.0,6/16,9.12%,ARID2;HMGA1;SMARCD3;SMARCA4;SMARCC2;SMARCE1
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.4548677574646906,1.2625396354690255,0.17569786535303777,0.8797559499137384,1.0,6/43,3.18%,BMP6;BMP7;WNT4;IGF1;NPNT;BMPR1A
prerank,positive regulation of embryonic development (GO:0040019),0.5325090765420974,1.2624703358050833,0.1956521739130435,0.8780114373404765,1.0,5/19,12.32%,WNT4;OSR1;NIBAN2;NR2C2;FOXA2
prerank,positive regulation of nervous system process (GO:0031646),-0.4782285412742917,-1.262118758118269,0.16702819956616052,0.49359554160108793,1.0,5/18,7.20%,RIMS2;RIMS1;TENM4;UNC13B;TNFRSF1B
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.4964290098602477,1.262075978344428,0.16940789473684212,0.8775101372203639,1.0,5/30,6.50%,ACE;KIT;HOXB4;FLT1;TP53
prerank,granulocyte chemotaxis (GO:0071621),-0.3849932010231808,-1.2619645108998168,0.12285714285714286,0.4929996950882773,1.0,13/55,20.36%,PDE4B;BSG;TGFB2;ANXA1;PPIA;PPIB;EDN1;EDN3;SCG2;CCL13;SYK;ITGB2;CCL19
prerank,macroautophagy (GO:0016236),0.39332683360805537,1.2619190542322063,0.11548913043478261,0.876151123255716,1.0,28/118,18.19%,PRKAG2;PRKAA2;PRKN;MTMR3;PRKAG3;LAMP2;ATG10;UVRAG;ATG5;WIPI1;AMBRA1;LIX1L;TOMM70;BECN1;ATG7;CSNK2A2;CSNK2A1;VIPAS39;MFN2;ACBD5;VPS37A;SNF8;VPS4A;SNX14;CHMP4C;ZFYVE1;SQSTM1;MFN1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.5294332797300682,1.261888452595059,0.20572450805008943,0.8743097615222266,1.0,7/19,15.63%,RENBP;UAP1L1;PGM3;GNPDA1;SLC35D1;GMPPB;GFPT1
prerank,neutral amino acid transport (GO:0015804),-0.4388854212327945,-1.2616689336456677,0.16112531969309463,0.4928074812322111,1.0,10/28,12.51%,SLC6A6;SLC1A5;SLC7A5;SLC38A6;SLC1A1;SLC1A4;SLC38A5;SLC43A2;SLC6A7;SLC43A1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.35382757136373927,1.2615898139475115,0.06336405529953917,0.8734837249616443,1.0,74/327,16.35%,DENND4A;RORA;PPARGC1B;FOXN3;TULP3;PPARGC1A;NFYC;SSBP2;POLR2A;ZNF423;CXXC1;CRABP2;CTR9;MITF;SUFU;TGFBR1;ARNT2;FOXC1;ZBTB38;NFYB;RREB1;BNC2;NSD1;IFNK;WWC2;ASCC2;SBNO1;ATRX;ESRRA;HMGA1;CREBL2;TP53;WWTR1;SOX12;LDB1;CHD7;NR1D2;KAT6B;TEAD2;TCF7;NSD3;NR2C2;SOX13;CCAR1;ZNF219;MYBL1;AJUBA;ABL1;ZKSCAN5;ATF2;MLLT6;SKOR1;MYBL2;ZMIZ1;HES6;MLXIPL;PHF1;KMT2D;KAT7;NFIA;DNM2;PML;ACVR2B;CELSR2;ATXN1L;APBB3;ACVR1B;WTIP;MED23;MZF1;TGIF2;RB1;CREBBP;GPBP1L1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.6145324076886798,1.2615144353789054,0.2178030303030303,0.8717663028606731,1.0,2/10,3.85%,UPB1;DPYD
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.38657039554367867,-1.26142622209496,0.12105263157894737,0.49248450144879674,1.0,15/52,11.23%,SPTBN1;DPP10;PRKCH;PIK3R1;EPB41;EPB41L2;STX3;PLS1;NKD2;GNAI1;ITGB1;EPHB2;EFCAB7;ATP2B4;GPER1
prerank,positive regulation of filopodium assembly (GO:0051491),-0.44445581312589155,-1.2609109681816701,0.15012106537530268,0.49276853034042833,1.0,5/24,1.96%,NRP1;NLGN1;TENM2;PIK3R1;FNBP1L
prerank,sulfur compound transport (GO:0072348),0.5017037420526895,1.2605668431595751,0.19316239316239317,0.8732853881823235,1.0,5/27,7.86%,SLC13A4;SLC6A13;SLC35F3;SLC27A1;SLC26A1
prerank,regulation of interferon-beta production (GO:0032648),0.45450588781113743,1.2605219495083237,0.1671875,0.8715310746649838,1.0,15/46,14.43%,OAS2;TLR3;TLR4;RNF135;DDX3X;TRIM56;RIPK2;MAVS;TOMM70;DHX58;PTPN11;IRF1;POLR3A;OAS3;PPM1B
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.488723479115175,1.2599805762562946,0.17940199335548174,0.8716632393952443,1.0,4/31,3.65%,SYT9;SYT11;SYT12;ADRA2A
prerank,keratinocyte differentiation (GO:0030216),-0.4161894197214531,-1.2591652123832517,0.145,0.496002008622001,1.0,9/29,21.91%,CLIC4;JAG1;UGCG;ANXA1;TXNIP;SCEL;EXPH5;WNT16;ASAH1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.33464971397657095,1.2591337247067265,0.009155645981688708,0.8728973488836614,1.0,188/1082,13.69%,EPAS1;HLF;DAB2;FGF1;WWOX;RORA;BMP6;PPARGC1B;BMP7;THRB;SMAD3;TFDP2;GLIS3;AUTS2;WNT4;OSR1;ZIC2;PPARGC1A;PICALM;IGF1;RHOQ;BRD8;KMT2A;PPARA;SSBP2;CREBRF;FGFR2;PRKN;IL18;FHOD1;ZNF423;CREB5;HOXB4;GLI2;CSRP3;NPAS3;CXXC1;SPP1;GABPB1;GABPB2;HOXA1;MOSPD1;NFAT5;PCGF5;HDAC8;PHIP;NR2F2;BMPR1A;ELOF1;ELF1;GLI3;MITF;TGFBR1;ARNT2;FOXC1;MLLT10;NFIB;CAND2;HOXB3;VEZF1;ZBTB38;ASCL3;ZNF462;NFYB;CREB3L2;TLR3;NHLH2;RREB1;RGMB;TLR4;MEIS1;NSD1;TET2;FZD5;ATM;DDX3X;TRIM56;ARRB1;NCOA3;CAPRIN2;MAP2K5;GPS2;CAMK1;ATRX;ABHD14B;ESRRA;HMGA1;LBH;CREBL2;ZNF318;TP53;TBL1X;BCAS3;BCLAF3;AFAP1L2;CAMTA2;WWTR1;ARHGEF11;RORC;MED12;SOX12;SERPINE1;CCNT2;SMARCD3;PLSCR1;LDB2;LDB1;LAGE3;FBXW11;ATAD2B;ELF2;MEF2A;SMARCA4;NR1D2;HOXC4;BTRC;SSBP3;TBL1XR1;KAT6B;ZIC1;GDNF;TMF1;JMJD6;SMARCC2;TEAD2;NIBAN2;CALCOCO1;PARP9;HDAC4;GLI1;SIRT1;WASL;TFDP1;NSD3;RIPK2;NR2C2;HDAC1;ELL;RIPK1;MAVS;ZFP90;FOXC2;TCF7L2;TCF4;MYBL1;MED17;RBL1;GTF2F1;SCAF8;KMT2C;THRAP3;ABL1;DYRK1A;NFATC3;RARG;ATF2;PRKDC;ZMIZ2;MLLT6;MYBL2;MSANTD1;TEAD1;ZMIZ1;PHF5A;CCDC62;HOXB2;BRD7;FOXA2;DEAF1;MLXIPL;WDR43;IRF1;KMT2D;KAT7;ZXDC;EDRF1;PBX4;ZBTB48;FOXJ2;DHX33;NFIA;SIN3A;DNM2;MAP2K1;MLLT11;ATF6B;PML;PTOV1
prerank,visual system development (GO:0150063),0.4724546502899873,1.258402473936467,0.17781402936378465,0.8737876716590051,1.0,5/37,7.54%,SMOC1;FOXC1;MEIS1;SH3PXD2B;RBP4
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.5640531406581906,1.2583472079820683,0.2178988326848249,0.8720541093939769,1.0,2/14,2.00%,PRKCZ;IL18
prerank,cardiac muscle tissue development (GO:0048738),0.44462997916807745,1.2579952540295027,0.1676829268292683,0.8715399448444401,1.0,11/50,9.63%,NOTCH2;BMP7;GJB6;CSRP3;AKAP13;BMPR1A;ADAMTS9;SIK1;RBP4;NRG1;CBY1
prerank,negative regulation of heart contraction (GO:0045822),0.5994653146547263,1.2579697634774554,0.2193158953722334,0.8697301627936606,1.0,1/11,0.08%,ATP1A2
prerank,cellular response to chemical stress (GO:0062197),0.4053028879815974,1.257566592506226,0.12992700729927006,0.8692887340445142,1.0,17/96,10.63%,CPEB2;MSRA;PPARGC1A;PRKAA2;MGAT3;LRRK2;SESN2;SOD3;ATM;DDX3X;ALDH3B1;NOX1;SOD2;PIK3CA;NOX4;ATG7;ABL1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.49305302459208855,-1.257443448649334,0.17371937639198218,0.4993096656646072,1.0,9/18,25.02%,FLNA;ERBB2;ATF4;EIF2AK3;MAF1;UTP15;PHF8;POLR2L;LYAR
prerank,insulin secretion (GO:0030073),-0.4801393708826874,-1.2574067364182246,0.18930957683741648,0.4984668173623713,1.0,4/19,12.79%,RIMS2;PTPRN2;ANXA1;RAB11FIP5
prerank,cellular response to ketone (GO:1901655),0.4746966132146993,1.2572032486516256,0.17713365539452497,0.8687482184468517,1.0,4/35,2.52%,ADCY5;ROCK2;ADCY1;SPP1
prerank,cellular response to lipid (GO:0071396),0.3728158429928526,1.2570666573105076,0.10137672090112641,0.8673637788111384,1.0,18/191,7.12%,ATP1A2;WNT5B;RORA;ADCY5;ROCK2;TFPI;PTK7;WNT6;ADCY1;SPP1;CTR9;PABPN1;TLR4;ATM;NCOA3;LCOR;RORC;SERPINE1
prerank,receptor metabolic process (GO:0043112),-0.3790247073345055,-1.2570011026378152,0.13897280966767372,0.4984788332562847,1.0,21/53,19.16%,DNM3;CALCRL;CAV1;CD9;RAB31;TFRC;RAMP2;SH3GLB1;ACKR3;ITGB1;DNM1;TGFB1;AP2M1;SNCA;RAMP1;SMURF1;EHD3;SYK;ITGB2;ARRB2;LDLRAP1
prerank,long-term memory (GO:0007616),-0.473904561889972,-1.256794990647096,0.17321016166281755,0.4980387757029299,1.0,5/19,13.89%,APOE;LDLR;RASGRF1;CAMK4;SHANK1
prerank,regulation of muscle cell differentiation (GO:0051147),-0.42318114982880956,-1.2563969188723096,0.1432225063938619,0.49811344194254864,1.0,10/31,14.97%,CTNNA2;MEF2C;CDH2;HDAC9;CDON;ID2;BOC;CTNNB1;MYOCD;MAPK12
prerank,regulation of phosphatase activity (GO:0010921),0.5086503288240338,1.2562693164823928,0.21180555555555555,0.8684935487926837,1.0,4/24,8.60%,SH3RF2;SH2D4A;CDK5RAP3;HTT
prerank,regulation of vasculogenesis (GO:2001212),-0.5139054241512963,-1.2560114136282041,0.19658119658119658,0.4981479749035924,1.0,9/14,15.15%,CD34;KDR;RAP1A;TMEM100;CEACAM1;XDH;HEY2;EMP2;RRAS
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.5242391523888827,-1.2557407208177396,0.19873150105708245,0.4978979760419333,1.0,9/13,29.80%,SORL1;TMEM30A;BCAP31;CD81;SEC16B;SAR1B;EDEM1;TMEM30B;SAR1A
prerank,regulation of protein secretion (GO:0050708),0.3873128144510171,1.2556072435311767,0.12096774193548387,0.869145878937214,1.0,20/119,9.70%,BMP6;CACNA1D;FRMD4A;ITPR2;IGF1;ITPR1;KCNA5;ADRA2A;MYO18A;RAPGEF3;EZR;DPP4;CACNA1C;IL12B;GCK;EIPR1;DNM1L;GOLPH3L;RSAD2;PICK1
prerank,cellular response to fluid shear stress (GO:0071498),-0.5330853744506582,-1.2555464183687022,0.21906693711967545,0.4974643041139283,1.0,4/12,12.92%,MEF2C;SREBF2;KLF2;MTSS1
prerank,positive regulation of macrophage migration (GO:1905523),-0.48026786384271747,-1.2551172937145063,0.17420814479638008,0.4975672268643282,1.0,5/19,15.16%,THBS1;PTK2;P2RY12;CMKLR1;RARRES2
prerank,oligosaccharide metabolic process (GO:0009311),-0.39431300143733355,-1.254974607474976,0.14713896457765668,0.49697560888222836,1.0,15/46,17.10%,ST6GALNAC3;ST3GAL4;ST8SIA4;FUT9;ST6GAL2;ST8SIA1;ST6GALNAC5;B3GALT1;ST3GAL6;ST8SIA6;B3GALT5;MAN1B1;AMY1C;AMY1A;AMY1B
prerank,positive regulation of cell growth (GO:0030307),-0.34458378843488696,-1.2547745382520177,0.10069444444444445,0.4965105616426247,1.0,24/96,14.15%,SYT1;RIMS2;AKAP6;RIMS1;TGFB2;SEMA7A;CDKL5;NGF;NEDD4L;NTN1;SHTN1;SEMA4D;LGI1;CXCL16;H3-3A;ERBB2;RPS6KA3;SLC25A33;EDN1;MFSD2A;MAPT;TAF9B;RPS6KA1;SMURF1
prerank,regulation of hydrolase activity (GO:0051336),-0.3569287138093473,-1.2544644416121473,0.1,0.4963250578655133,1.0,17/71,8.88%,PRKG1;CHN2;CAV1;FGD5;EPHA5;EFNA5;CHN1;RASIP1;NTRK2;DAB2IP;CRK;PLXNC1;ARHGAP15;PTK2;RDX;PLXNA4;RAPGEF6
prerank,chordate embryonic development (GO:0043009),0.44150398663253365,1.254205800947683,0.17533432392273401,0.8725472028071376,1.0,11/55,7.55%,ALDH1A2;BMP7;FGFR2;ZNF568;FGFR1;TGFBR1;ARNT2;SULF2;FUT8;RBP4;CHD7
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.4408893583109171,-1.2541764067883692,0.16985645933014354,0.49608518012252195,1.0,8/27,8.00%,SLC47A1;SLC7A5;SLC1A2;SLC1A1;SLC7A1;SLC25A13;SLC1A4;SLC38A5
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.45435138668907343,-1.2541661880019188,0.15789473684210525,0.49518271817542203,1.0,11/25,26.28%,HIP1;RTN4;BCAR3;CCDC88A;GPER1;CBL;HIP1R;AGT;HAP1;PLAUR;CNOT9
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.4876894619288033,-1.2540727516715269,0.203125,0.4944579830036106,1.0,8/17,16.55%,SFRP4;TMEM100;ATOH8;BTG1;FGF2;BMP4;AHI1;RFX3
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.5525029591303615,1.2540635467529402,0.2137546468401487,0.8712768610775428,1.0,4/16,9.67%,ACE;KLK2;ADM;SPX
prerank,regulation of mitochondrial fission (GO:0090140),0.5104673254953117,1.2536783007962906,0.21453287197231835,0.8707639833921276,1.0,8/24,11.94%,PRKN;MCU;LRRK2;STAT2;MYO19;DNM1L;CYRIB;RALBP1
prerank,necroptotic process (GO:0070266),0.537770544630414,1.2532824349189815,0.22580645161290322,0.8703051365499036,1.0,5/16,10.97%,TLR3;TLR4;DNM1L;RIPK1;LY96
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.47756363684603037,1.252840708637203,0.19298245614035087,0.8701957458563463,1.0,9/34,13.78%,LGR4;CD300A;TLR3;TLR4;GPS2;RAB7B;LY96;LRRC14;ACOD1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.5217822281602886,-1.2525806848585674,0.17180616740088106,0.4971877008895703,1.0,7/14,14.82%,NRP1;VEGFC;GAB1;KDR;FLT4;VEGFA;NUS1
prerank,central nervous system neuron differentiation (GO:0021953),-0.41966863438178637,-1.2520217623215595,0.16136919315403422,0.4976019427943972,1.0,8/33,12.71%,GRID2;MDGA2;TOX;NTRK2;SPOCK1;PROX1;CTNNB1;MAPT
prerank,regulation of response to biotic stimulus (GO:0002831),0.49742335716335445,1.2517062995470145,0.18563922942206654,0.8724520659406065,1.0,10/28,16.01%,APPL2;RNF135;TKFC;PTPN22;SAMHD1;DHX58;IRF1;ERAP1;ZMPSTE24;BIRC3
prerank,regulation of BMP signaling pathway (GO:0030510),-0.3563882939602139,-1.2511963944934117,0.12238805970149254,0.4986790809524741,1.0,21/73,14.15%,BMPER;BMPR2;ENG;HTRA3;ACVRL1;VWC2;NOTCH1;VWC2L;SFRP4;SMAD5;SORL1;SMAD1;CCN1;BMP2;PCSK6;SMAD7;BMP4;LEMD3;UBE2D3;BMPR1B;SMURF1
prerank,T cell receptor signaling pathway (GO:0050852),-0.32153320299606936,-1.251080489259236,0.06201550387596899,0.49802909554674535,1.0,49/138,27.70%,PDE4D;PDE4B;PTPRJ;PIK3R1;RFTN1;PAK3;INPP5D;PSMB2;PAK1;PTPRC;PLCG2;MAP3K7;MOG;TNFRSF21;PSMD14;TEC;PSMC6;BCAR1;EIF2B3;IKBKB;RBCK1;SPPL3;BTN3A3;NCK1;PSMA4;NFKBIZ;PSMB9;SKAP1;SKP1;PSMD11;PSMB10;PRKCQ;PSMD2;TXK;CD276;FYN;PSMA2;THY1;RELA;STOML2;PSMB3;PIK3CD;PLCG1;ICOSLG;PSMB5;LCP2;CARD11;PSMA7;EIF2B2
prerank,regulation of T cell proliferation (GO:0042129),-0.362926060933699,-1.2507235945956607,0.10382513661202186,0.49798718427960625,1.0,9/61,8.57%,VCAM1;NCK2;TFRC;IL6ST;SLC7A1;ANXA1;PTPRC;TNFRSF1B;TNFRSF21
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.5674744663456235,1.250447120413961,0.2333965844402277,0.8753433436251291,1.0,5/13,12.23%,ATG10;ATG7;UBA6;DESI1;DESI2
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.385977262224868,1.2502930682238744,0.12550607287449392,0.8740504322241727,1.0,23/128,11.82%,TGFBR3;BMP6;BMP7;SMAD3;APPL2;PRKCZ;DDX5;ARHGEF18;BMPR1A;TGFBR1;SMAD6;RGMB;USP9X;TWSG1;SMURF2;TGFBR2;COL1A2;CDH5;SIRT1;ZFYVE16;ZMIZ2;ZMIZ1;GDF15
prerank,fatty acid transport (GO:0015908),0.5454501012270901,1.249875079561088,0.19385796545105566,0.8737678814156508,1.0,4/17,7.36%,ACSL1;SLC5A8;SLC27A1;GOT2
prerank,sulfation (GO:0051923),0.5909879717653017,1.2495040595726181,0.23295454545454544,0.8733514741690875,1.0,2/11,9.11%,UST;SULT2B1
prerank,response to muramyl dipeptide (GO:0032495),-0.5234765962363849,-1.248990061855572,0.1891891891891892,0.5012608904059357,1.0,7/12,18.19%,NOD1;ARHGEF2;ERBIN;VIM;NOD2;TRIM41;IRF5
prerank,integrin-mediated signaling pathway (GO:0007229),-0.3590118239977693,-1.2486832087459232,0.10557184750733138,0.5011242410908012,1.0,22/73,10.38%,NRP1;ITGBL1;FN1;SEMA7A;DST;PTK2B;MYH9;DOCK1;ITGB4;ITGB8;ITGB1;ADAM15;LAMA3;PTK2;CUL3;PTN;CEACAM1;TEC;CD47;ERBIN;BCAR1;ITGB3
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.5454072531860426,1.2481820028703898,0.2230347349177331,0.8764572439655831,1.0,6/16,14.03%,KMT5C;KMT5B;PARP9;PRKDC;PNKP;SMCHD1
prerank,DNA methylation (GO:0006306),0.5142926426848223,1.248101405677917,0.20774647887323944,0.8749508229918951,1.0,12/23,24.16%,DNMT3A;ATRX;PICK1;MTRR;BEND3;EHMT2;EHMT1;KMT2E;METTL4;N6AMT1;DMAP1;PPM1D
prerank,cellular response to oxygen levels (GO:0071453),0.5930131530904206,1.247932616198513,0.228515625,0.8737395096699795,1.0,4/10,20.56%,CPEB4;PICK1;ATP6V0D1;CCDC115
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.43833635157625384,-1.2476720173579687,0.15777262180974477,0.5026812709898096,1.0,4/24,5.34%,SLIT2;CXCL12;CCN3;LYN
prerank,response to steroid hormone (GO:0048545),0.480351062735303,1.2476677886354621,0.20065789473684212,0.872874192217451,1.0,4/31,3.37%,ATP1A2;TFPI;PAQR7;CATSPERD
prerank,cell junction organization (GO:0034330),0.418405627056035,1.2476076820300748,0.15657311669128507,0.8712086707390092,1.0,9/71,3.91%,SDK1;SLC6A1;SMAD3;LRP4;SDK2;SLC8A3;PKHD1;NLGN2;PPFIA1
prerank,anterior/posterior pattern specification (GO:0009952),0.44037905397758065,1.2472502109217152,0.17700453857791226,0.8706978201688045,1.0,11/53,8.07%,WLS;HOXB4;HOXB6;HOXC6;TGFBR1;HOXB3;HOXB9;HOXA3;HOXB5;BHLHE41;HOXC4
prerank,positive regulation of binding (GO:0051099),-0.3432435003289971,-1.2467480495134695,0.07216494845360824,0.5039435493403892,1.0,34/84,20.73%,CAV1;CLDN5;EPB41;B2M;NGF;GSK3B;TIAM1;APOE;APP;HES1;MET;PSEN1;DACT1;BMP2;RALB;ADD2;PKD1;FKBP1A;BMP4;TXN;SPPL3;STMN1;HIPK2;DHX9;KDM4D;MEN1;SIRT2;CLN5;HIP1R;RAN;VTN;HMBOX1;RPL11;EDF1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.4472807441870925,-1.2458353493794627,0.15274463007159905,0.5053455004371789,1.0,8/26,11.00%,PDE8A;PTPN12;IQGAP1;DAB2IP;EEF1A1;STAT5B;ERBB2;DUSP3
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5934718545529265,1.2447819521808832,0.23076923076923078,0.8777886026050672,1.0,3/11,7.34%,TGFBR3;TGFBR1;TGFBR2
prerank,mitochondrial membrane organization (GO:0007006),0.47394789699882706,1.2443350360745147,0.18646864686468648,0.8775800110262901,1.0,10/32,18.19%,CHCHD3;SAMM50;OPA1;TMEM11;MICOS10;MFN2;MICOS13;IMMT;MTX2;MFN1
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.2859610939269999,-1.2438310403279003,0.008,0.5093191527601676,1.0,94/348,14.40%,NRP1;LIMCH1;GHR;PTPRJ;RPS6KA5;TEK;BMP5;ERBB4;NTRK3;CAV1;PECAM1;PDE8A;BMPR2;ENG;RASSF2;VEGFC;NPTN;NIBAN1;EFNA5;TGFB2;IQGAP1;PTK2B;BCAR3;GAS6;NGF;ACVRL1;CEMIP;TFRC;NTRK2;HSP90AB1;KRAS;ARHGEF2;KDR;LYN;TBX1;PDGFC;PPIA;PAK1;CALM1;PTPRC;RAP1A;APP;CALM2;CARD14;PLCG2;LIMK2;TGFB3;CSPG4;SEMA4D;RELN;CCN1;BMP2;TGFB1;PTK2;RALB;DDRGK1;TEC;FGF2;FLT4;RAP2A;FNIP2;ERBB2;CAMKK2;CD44;PDGFA;HSP90AA1;ITGB3;ATP2B4;CALM3;ENPP2;GPER1;FXR1;BMP4;XRCC5;ILK;TNKS1BP1;FAS;CDKN1A;NOS1;MMD;PFN2;AXIN1;LRP8;FGF7;SNCA;PRKD1;ACVR1;FGF9;VEGFA;TXN;PINK1;TERF2IP;MT3;P2RY1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.43070643551153215,-1.2436337828368305,0.1761904761904762,0.5088816235820212,1.0,12/27,20.67%,UTRN;FGF12;CAMK2D;FXYD5;NEDD4L;ATP2B4;PTPN3;NOS1;SCN2B;FXYD6;COMMD1;SCN1B
prerank,regulation of vasoconstriction (GO:0019229),-0.4289172058904113,-1.2427066581302255,0.2,0.5101636988609145,1.0,9/27,12.71%,CAV1;BMPR2;CHRM3;ADRA1B;ECE1;KCNMB2;AGTR1;ATP2B1;ACE2
prerank,neutrophil migration (GO:1990266),-0.37886223972026123,-1.2422401819098512,0.13823529411764707,0.510327781018413,1.0,27/58,37.96%,PDE4B;PECAM1;BSG;TGFB2;PPIA;PPIB;EDN1;EDN3;CCL13;SYK;ITGB2;CCL19;PRTN3;CXCL10;PIK3CD;CCL2;IRAK4;JAML;CXCL5;CCL11;CXCL1;PIP5K1C;CCL4;PF4;PPBP;CCL8;PIK3CG
prerank,regulation of protein transport (GO:0051223),-0.4356920687371396,-1.2413482198436863,0.1789709172259508,0.5115854611794027,1.0,10/27,18.41%,STXBP5L;DNAJC1;HSPA8;DISP1;NDFIP2;GAPVD1;PPM1F;DNAJA1;P3H1;PTPN1
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.5065670556741357,-1.2411213889170574,0.20474137931034483,0.511177447050672,1.0,3/14,12.33%,THBS1;IRAK3;CMKLR1
prerank,snRNA metabolic process (GO:0016073),0.5349874931131305,1.2405557652775419,0.22419928825622776,0.8899356963290862,1.0,9/17,21.65%,INTS10;INTS2;INTS5;INTS3;INTS7;INTS1;INTS8;INTS4;TUT1
prerank,actin filament capping (GO:0051693),0.5145931878655323,1.2403900551556115,0.22448979591836735,0.8868771946756792,1.0,4/18,6.82%,ADD3;AVIL;CAPZB;TRIOBP
prerank,barbed-end actin filament capping (GO:0051016),0.5145931878655323,1.2403900551556115,0.22448979591836735,0.8868771946756792,1.0,4/18,6.82%,ADD3;AVIL;CAPZB;TRIOBP
prerank,pore complex assembly (GO:0046931),0.5291142316014175,1.2402943413100582,0.22932330827067668,0.8854203170707103,1.0,4/19,10.91%,AFDN;PLEKHA7;ANO6;NUP98
prerank,regulation of autophagy (GO:0010506),0.3582284078653227,1.240220091697706,0.10506798516687268,0.8838559698339127,1.0,24/216,7.47%,PRKAG2;RNF152;LEPR;ITPR1;PRKAA2;PRKN;SNX6;MTMR3;PRKAG3;NUPR1;GPR137;CASP3;ATP6V0E1;TPCN1;LRRK2;NEDD4;SNX32;FZD5;ATM;WDR41;NPRL2;ATP6V0B;PTPN22;PIP4K2C
prerank,positive regulation of axonogenesis (GO:0050772),-0.39169626366493016,-1.2397626996098632,0.15873015873015872,0.5134870396622087,1.0,14/43,9.95%,SLIT2;ROBO2;SEMA7A;CDKL5;NGF;NTRK2;NTN1;SHTN1;TIAM1;SEMA4D;PLXNC1;PLXNA4;MAP6;SLITRK1
prerank,liver development (GO:0001889),0.47807580051683873,1.2396626000101203,0.19218241042345277,0.8840447946608732,1.0,2/32,1.03%,TGFBR3;WNT4
prerank,atrioventricular valve development (GO:0003171),-0.5010845587908607,-1.2396464693387548,0.2039911308203991,0.5128419741111238,1.0,9/14,21.10%,BMPR2;TGFB2;NOTCH1;HEYL;BMP2;ACVR1;APLNR;ZFPM1;SLIT3
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.48352719171546504,-1.239537461694262,0.210989010989011,0.5121651540017114,1.0,3/17,4.11%,ANK3;AKAP6;KCNAB1
prerank,synaptic vesicle membrane organization (GO:0048499),-0.48150997646885496,-1.2388237627881933,0.19821826280623608,0.5128396473710577,1.0,10/17,35.67%,SNAP25;STX3;SYNGR2;STX1B;SNAP23;AP3D1;STX1A;SYP;SYNGR1;PRRT2
prerank,negative regulation of cell motility (GO:2000146),-0.3320585736298961,-1.2381916195759604,0.08363636363636363,0.5134627002342367,1.0,19/108,4.49%,TMEFF2;FRMD5;SLIT2;LIMCH1;DACH1;PTPRJ;CLIC4;CLDN5;MCTP1;ENG;NAV3;PTPRK;SPOCK3;PTPRT;SRGAP1;ADARB1;ACVRL1;CYP1B1;JAG1
prerank,positive regulation of telomerase activity (GO:0051973),-0.4105832547456581,-1.2374706348225657,0.16097560975609757,0.5142717788016953,1.0,16/33,29.14%,PARM1;HSP90AB1;NEK7;HSP90AA1;XRCC5;CTNNB1;CCT2;PRKCQ;HMBOX1;PTGES3;MAP2K7;KLF4;TNKS;DKC1;NAF1;MAPK3
prerank,regulation of cell-cell adhesion (GO:0022407),-0.40467530202347163,-1.2369860445706573,0.15485564304461943,0.5145443080978291,1.0,15/39,11.40%,PTPRG;PODXL;EFNA5;TENM3;FUT9;JAG1;MINK1;EPHA7;TGFB1;PTK2;CEACAM1;SMAD7;CD47;ZDHHC2;CDH1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5444318357608311,1.2365576965497158,0.22263450834879406,0.8941005282521406,1.0,2/17,1.91%,ANK2;SNTA1
prerank,Golgi localization (GO:0051645),0.5781339417279829,1.2362648603919701,0.25461254612546125,0.8933551888438892,1.0,6/11,20.24%,TBCCD1;UVRAG;CDC42;ARHGAP21;HOOK3;RIPOR1
prerank,sensory organ development (GO:0007423),0.43983463793722966,1.2359021947489266,0.18210361067503925,0.892936795976342,1.0,7/51,7.55%,SMOC1;SHROOM2;FOXC1;MEIS1;SH3PXD2B;RBP4;CHD7
prerank,regulation of axon guidance (GO:1902667),-0.5643015091876434,-1.2356960958337053,0.21548117154811716,0.5167854403470622,1.0,4/10,15.00%,NRP1;MYCBP2;VEGFA;TUBB2B
prerank,regulation of cell communication (GO:0010646),-0.4098930591787608,-1.2355371773425514,0.1687041564792176,0.5162267932264651,1.0,10/35,7.77%,SLC8A1;RYR2;CAMK2D;MGLL;UGCG;ANXA1;TBX18;SOCS2;CRK;YWHAG
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.44834552800480343,-1.2353935648091399,0.19058823529411764,0.5156495630552488,1.0,17/22,47.49%,PSMB2;PSMA4;PSMB9;PSMB10;PSMA2;PSMB3;PSMB5;PSMA7;PSMA5;ENC1;PSME4;PSMB8;PSMB11;NFE2L2;PSMB1;PSMB7;PSMA8
prerank,positive regulation of glucose metabolic process (GO:0010907),0.5493847842133271,1.234781083294424,0.23106796116504855,0.8953837850204611,1.0,3/14,9.53%,PPARGC1A;SIRT1;SLC45A3
prerank,T cell proliferation (GO:0042098),-0.5308040704662019,-1.234695416060821,0.19957537154989385,0.5164028504180134,1.0,3/13,10.85%,CADM1;DOCK8;MSN
prerank,cell-matrix adhesion (GO:0007160),-0.33716151950329376,-1.234673630685762,0.08135593220338982,0.5155386507373058,1.0,25/95,12.49%,ITGBL1;PPFIA2;THSD1;PTPRK;ACTN1;PEAK1;FN1;VCAM1;CD34;ARHGEF7;ITGB4;SGCE;TIAM1;BCAM;ITGB8;MSLN;ITGB1;ADAM15;ITGA4;ITGA8;CD44;ITGB3;PKD1;ILK;EMP2
prerank,retrograde axonal transport (GO:0008090),-0.4960797242953322,-1.2345249166386543,0.20964360587002095,0.515015881120625,1.0,3/16,4.92%,DLG2;DST;TMEM108
prerank,regulation of acute inflammatory response (GO:0002673),-0.4874863495765966,-1.2338948532148006,0.2018348623853211,0.5156029823271827,1.0,3/18,7.80%,OSMR;IL6ST;PTGES
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5293806356039108,1.2336111955594422,0.2153558052434457,0.8981393931728595,1.0,3/20,2.05%,ATP1A2;ATP1B3;LACC1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.3699313099786255,-1.2335776344246685,0.15284974093264247,0.5154302503880439,1.0,14/52,11.23%,SPTBN1;DPP10;PRKCH;PIK3R1;ATP2C1;ACSL3;STX3;PLS1;NKD2;ITGB1;EPHB2;ATP2B4;ZDHHC2;GPER1
prerank,regulation of gene expression (GO:0010468),0.330848029941534,1.233499981485545,0.027835051546391754,0.8967088339176763,1.0,147/903,12.87%,PRDM6;DENND4A;NOTCH2;FGF1;ROBO1;RORA;BMP6;PPARGC1B;BMP7;AFDN;SLC24A3;SMAD3;ROCK2;ANK2;WNT4;OSR1;FOXN3;TULP3;PPARGC1A;PICALM;IGF1;NFYC;PRKAA2;SSBP2;AFF3;WNT6;PRKN;POLR2A;ZNF423;SON;CXXC1;FOXD1;TNRC6A;CRABP2;CTR9;BMPR1A;ZC3H7B;MITF;SUFU;TGFBR1;ARNT2;FOXC1;SNRNP70;PARP10;DTNBP1;PCBP2;ZBTB38;PABPN1;MBNL2;ZNF462;NFYB;TLR3;EZR;PARP14;SMO;CTSH;CUX2;RREB1;BNC2;TLR4;NSD1;IGF2BP1;HNRNPH1;IFNK;ATM;DDX3X;WWC2;ASCC2;SBNO1;TIPARP;ATRX;AFF4;BRAF;ESRRA;CLK4;CD28;HMGA1;CREBL2;IL12B;TP53;WWTR1;SOX12;TOB2;PTPN22;PLSCR1;LDB1;CHD7;TNRC6B;NR1D2;RBL2;LARP1;KAT6B;TERT;GDNF;HRG;APLN;IGF2BP2;NOVA1;CDH5;TEAD2;CALCOCO1;PARP9;HDAC4;SIRT1;C1D;TCF7;TLE1;NSD3;NR2C2;HDAC1;SOX13;LRP3;UBR5;CCAR1;MOV10;DHH;ZNF219;MYBL1;RBL1;CRKL;PIK3R3;AJUBA;SRPK2;ABL1;PRDM5;ZKSCAN5;ATF2;C1QTNF1;HNRNPL;WWP2;MLLT6;SKOR1;NOCT;HMG20B;MYBL2;GLMN;DICER1;ZNF148;HES6;ATRAID;MLXIPL;FLOT2;TDG;PHF1;SNX12;KMT2D;KAT7
prerank,regulation of fibroblast migration (GO:0010762),-0.46015857236912655,-1.233385180392332,0.1822125813449024,0.5149825477665854,1.0,9/20,9.38%,PRR5L;THBS1;ARHGEF7;ITGB1;CORO1C;TGFB1;PTK2;GNA12;FGF2
prerank,positive regulation of viral genome replication (GO:0045070),0.48101000213046863,1.232973110859279,0.2314487632508834,0.8967786839571151,1.0,8/29,13.47%,PPARA;TOP2B;IFIT1;DDX3X;CD28;LARP1;SRPK2;HACD3
prerank,response to calcium ion (GO:0051592),-0.32770089682111464,-1.2328636264007413,0.09016393442622951,0.5152823027842623,1.0,19/102,7.04%,NLGN1;MEF2C;SYT1;CAV1;CLIC4;KCNMA1;RYR2;CAMK2D;THBS1;IQGAP1;KCNMB2;RYR3;TRPC3;SLC25A13;CPNE8;CALM1;CALM2;PLCG2;TRPC1
prerank,anterior/posterior axis specification (GO:0009948),0.5552125486939565,1.232749017192902,0.2349624060150376,0.89582977740223,1.0,2/15,5.39%,WLS;FZD5
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5863943607550988,1.232537367093744,0.2447418738049713,0.894808636173821,1.0,2/11,7.83%,GNAT2;GNAT3
prerank,primary alcohol metabolic process (GO:0034308),0.4955514164528731,1.232386984796172,0.21891418563922943,0.8935930425051442,1.0,5/25,7.54%,IGF1;NAPEPLD;NAAA;DHRS3;RBP4
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.34424955872038693,1.231677360708429,0.08295454545454546,0.8944244474548664,1.0,81/366,16.39%,DENND4A;RORA;PPARGC1B;FOXN3;TULP3;PPARGC1A;NFYC;SSBP2;POLR2A;ZNF423;CXXC1;CCNA2;CRABP2;CTR9;MITF;SUFU;TGFBR1;ARNT2;FOXC1;ZBTB38;NFYB;RREB1;BNC2;NSD1;IFNK;WWC2;ASCC2;SBNO1;ATRX;ESRRA;DSCC1;ANKRD17;HMGA1;CREBL2;TP53;WWTR1;SOX12;LDB1;CHD7;ATXN2;NR1D2;KAT6B;TEAD2;TCF7;NSD3;NR2C2;SOX13;CCAR1;ZNF219;MYBL1;AJUBA;ABL1;ZKSCAN5;ATF2;MLLT6;SKOR1;MYBL2;HES6;MLXIPL;PHF1;KMT2D;KAT7;NFIA;ORC3;DNM2;PML;ACVR2B;TSC1;CELSR2;ATXN1L;APBB3;ACVR1B;WTIP;MED23;MZF1;EHMT2;TGIF2;RB1;CREBBP;GPBP1L1;SMC3
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.5389501164953762,-1.2316376241338984,0.22340425531914893,0.5174664474165616,1.0,3/11,9.15%,PTPRC;CEACAM1;SMAD7
prerank,mitochondrion organization (GO:0007005),0.3697631595284937,1.2311869431825,0.11696658097686376,0.8944516611286408,1.0,51/165,19.97%,TRAK1;PPARGC1A;HK2;PRKN;CHCHD3;GABPB1;IFIT2;PYROXD2;BID;LRRK2;AFG1L;SAMM50;MIGA2;ESRRA;SIRT5;CLUH;NIPSNAP2;OPA1;TIMM44;MEF2A;MTFR2;TWNK;TERT;SIRT3;TMEM11;DNM1L;SSBP1;ADCK1;CXADR;TOMM70;NDUFS1;SIRT4;DNM2;MFN2;ATP5F1D;RAB29;PITRM1;TIMM10;FMC1;SLC25A36;MSTO1;MTX2;MTFP1;TRAK2;MFN1;RHOT1;TIMM17B;RAB5IF;AFG3L2;ATP7A;WDR81
prerank,regulation of phosphate metabolic process (GO:0019220),-0.4961929111675888,-1.2304139657685178,0.2054176072234763,0.5195638688861944,1.0,8/16,18.69%,PSEN1;IKBKB;SMG5;PGAM1;SRPX2;BARD1;SIRT2;TIGAR
prerank,chondrocyte differentiation (GO:0002062),0.46736840673742625,1.2301385544692391,0.18106312292358803,0.8963984594091954,1.0,6/32,4.64%,WNT5B;OSR1;SOX5;NFIB;SULF2;CREB3L2
prerank,negative regulation of cell cycle process (GO:0010948),0.41794382836766114,1.22994764128132,0.1555232558139535,0.8952763451622157,1.0,15/61,16.92%,BMP7;TFDP2;TOM1L2;PCGF2;MGA;TFDP1;NME6;AURKB;RBBP8;CBX5;WAPL;EHMT2;VPS4A;EHMT1;CHMP4C
prerank,primary miRNA processing (GO:0031053),0.6004785755023412,1.2298006989187122,0.2556818181818182,0.8940026074031627,1.0,2/10,7.11%,SMAD3;HNRNPA2B1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.4964939260302809,1.2291975133917583,0.2222222222222222,0.8944786375690652,1.0,4/24,5.65%,ROCK2;ERRFI1;FOXC1;NCOA3
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.4819833666239343,-1.228223111622951,0.21145374449339208,0.5241316159044739,1.0,8/18,28.14%,CHRM3;CHRM2;AGRN;CDK5R1;GNB1;OPRM1;RGS10;RGS8
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3834538844633144,1.2281110905020118,0.14661134163208853,0.8968187401339488,1.0,15/129,8.65%,RNF220;LRRK1;LGR4;WLS;PTK7;FGFR2;LRRK2;DDX3X;CAPRIN2;TBL1X;SMURF2;TNKS2;ADGRA2;TBL1XR1;GPRC5B
prerank,positive regulation of ERAD pathway (GO:1904294),-0.5117268022134871,-1.2273703341070177,0.23736263736263735,0.5252641247270647,1.0,5/13,26.53%,CAV1;USP13;BCAP31;UBQLN2;TMEM259
prerank,"phototransduction, visible light (GO:0007603)",0.550764692472134,1.2273702536530646,0.22851919561243145,0.8978505387938102,1.0,2/14,5.76%,ABCA4;RHO
prerank,positive regulation of T cell activation (GO:0050870),-0.3603017181972079,-1.226970159929202,0.13897280966767372,0.5253494546677472,1.0,21/62,23.71%,VCAM1;NCK2;TFRC;IL6ST;SLC7A1;ANXA1;PTPRC;DOCK8;CD47;RHOH;NCK1;NOD2;PRKCQ;CCL19;LGALS9;PYCARD;MDK;CD86;CD276;CD81;THY1
prerank,positive regulation of B cell activation (GO:0050871),-0.3742140570830844,-1.2266962911036907,0.14049586776859505,0.5251275361252612,1.0,13/50,18.36%,MEF2C;SH3KBP1;TFRC;CD38;PTPRC;EPHB2;HMCES;TIRAP;NOD2;CD74;SYK;IRS2;BTK
prerank,positive regulation of TOR signaling (GO:0032008),0.4414520777459155,1.2266571865382672,0.21826625386996903,0.8987864544624389,1.0,17/40,26.68%,FNIP1;GPR137;RICTOR;PIK3CA;FLCN;WDR24;RPTOR;TELO2;RRAGD;LAMTOR1;RRAGB;SLC38A9;SIK3;HTR6;RRAGC;SEC13;GPR137B
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5811661638720496,1.226578136566285,0.2649402390438247,0.8972703097370598,1.0,2/12,1.76%,PPARGC1A;PPARA
prerank,positive regulation of heart contraction (GO:0045823),0.5265389009316602,1.2263034570207307,0.24593128390596744,0.8964953139861003,1.0,1/19,0.08%,ATP1A2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.46135073397251924,-1.2259960713845193,0.21252796420581654,0.5259788649212032,1.0,10/19,9.43%,CSGALNACT1;HS6ST2;NDST3;HS6ST3;HS3ST5;EXT1;XYLT1;GLCE;NDST4;EXT2
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.5518531141029249,-1.225864787654068,0.24165029469548133,0.5253906451889215,1.0,4/10,26.52%,HSPA5;ATF4;EIF2AK3;CCL2
prerank,positive regulation of bone mineralization (GO:0030501),0.4657963112569206,1.2258376572662162,0.2003257328990228,0.8964266609592045,1.0,6/35,3.18%,BMP6;BMP7;WNT4;OSR1;KL;BMPR1A
prerank,amino sugar biosynthetic process (GO:0046349),0.5694887169518672,1.225837452684143,0.2261904761904762,0.8946585610362081,1.0,5/12,15.63%,RENBP;UAP1L1;PGM3;GNPDA1;GFPT1
prerank,mesenchymal to epithelial transition (GO:0060231),-0.5565063388083514,-1.2254191701093111,0.21205821205821207,0.5256042243432233,1.0,4/10,19.19%,BASP1;BMP4;PAX2;PAX8
prerank,negative regulation of phagocytosis (GO:0050765),0.5338887183095713,1.2254062768750256,0.23826714801444043,0.8944688379925941,1.0,4/17,7.38%,SYT11;CD300A;FER1L5;PLSCR1
prerank,potassium ion transport (GO:0006813),0.3804144197594122,1.2252376041637958,0.14188267394270124,0.8933634274484132,1.0,8/120,1.93%,ATP1A2;KCNK2;SLC24A3;ATP1B3;KCNJ13;KCND3;KCNA5;LRRC38
prerank,epithelium development (GO:0060429),0.3868792241067928,1.225161729493206,0.17349726775956284,0.8918568946309132,1.0,13/107,8.24%,ALDH1A2;WNT4;OSR1;ERRFI1;FGFR2;KANK2;DAG1;CPT1A;LOXL3;SMO;TPP1;BDH2;IFT122
prerank,regulation of neuron projection arborization (GO:0150011),-0.4932549560850227,-1.224966602618064,0.2039045553145336,0.5258116259131893,1.0,4/15,10.91%,GRIP1;NTNG1;FZD4;MFSD2A
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.4669023417322131,-1.2247465377905897,0.21267893660531698,0.5245660587598735,1.0,6/17,20.04%,STAT3;SOCS2;STAT5B;JAK1;IRS2;IRS1
prerank,cellular response to interleukin-7 (GO:0098761),-0.4669023417322131,-1.2247465377905897,0.21267893660531698,0.5245660587598735,1.0,6/17,20.04%,STAT3;SOCS2;STAT5B;JAK1;IRS2;IRS1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.5658419511113533,1.2247190478476115,0.23306772908366533,0.8917151755886723,1.0,5/14,8.39%,ATRX;ACD;TPP1;TNKS2;TERT
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.43789702910145495,-1.2241749351441482,0.19523809523809524,0.5250738411738511,1.0,8/24,14.97%,CTNNA2;MEF2C;CDH2;CDON;BOC;CTNNB1;MYOCD;MAPK12
prerank,protein heterooligomerization (GO:0051291),-0.4724527488988157,-1.2237333056819535,0.1703056768558952,0.5252374803047233,1.0,5/17,15.27%,KCNC2;GRIN2B;MAT2A;PKD1;GRIN1
prerank,pyroptosis (GO:0070269),0.5306998598949773,1.2234397059034985,0.2581888246628131,0.894750521384564,1.0,1/15,1.39%,GSDME
prerank,regulation of neurotransmitter transport (GO:0051588),-0.465925409258916,-1.223199229850279,0.19331742243436753,0.5256902152248973,1.0,3/16,2.23%,MEF2C;MCTP1;RIMS1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.4098325735147679,-1.2230934374807108,0.16666666666666666,0.5250494243850872,1.0,16/32,28.65%,CAV1;AKAP6;CEMIP;TRPC3;TRPC1;GPER1;SNCA;GRIN1;APLNR;NPSR1;THY1;F2R;CXCL10;PLCG1;P2RX7;CASQ1
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.4589890409106152,-1.222842261615664,0.20316027088036118,0.5247676124384453,1.0,9/21,9.18%,NOS3;PTK2B;GAS6;NOTCH1;ASPN;ENPP1;ECM1;TGFB1;HEY2
prerank,positive regulation of phosphorylation (GO:0042327),-0.29054494248818685,-1.2223216614951717,0.05202312138728324,0.5251794629983206,1.0,68/240,14.68%,NRP1;LIMCH1;TEK;ERBB4;NTRK3;PECAM1;ITGA6;PDE8A;ROR1;ENG;EPHB1;VEGFC;THBS1;NPTN;EPHA5;MERTK;NIBAN1;EFNA5;EPHA6;TIE1;GAS6;TFRC;NTRK2;KRAS;KDR;LYN;ROR2;TBX1;AR;PPIA;PAK1;APP;MET;CARD14;LIMK2;EPHA7;SEMA4D;PSEN1;EPHB2;CCN1;BMP2;BTBD10;TGFB1;PTK2;RALB;FGF2;FLT4;RAP2A;ERBB2;CAMKK2;HSP90AA1;ITGB3;GPER1;FXR1;BMP4;ILK;FAS;PFKFB1;HIF1A;AXIN1;FGF7;FGF9;RET;VEGFA;PINK1;MT3;P2RY1;FGFR3
prerank,neuron remodeling (GO:0016322),-0.5569693963191793,-1.222276728914849,0.25311203319502074,0.5243873277376582,1.0,7/10,26.26%,ADGRB3;APP;SCARF1;C1QA;ANKS1A;RND1;C3
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.441531948789126,1.2218821864419531,0.20833333333333334,0.8986570733032566,1.0,6/46,5.16%,DUSP29;FBLN1;TIMP3;DLG1;EZR;TLR4
prerank,presynapse assembly (GO:0099054),-0.4827409454046968,-1.221825142483388,0.19117647058823528,0.5245540358029347,1.0,5/16,3.66%,NLGN1;PTPRD;IL1RAPL1;LRRTM3;PCLO
prerank,smooth muscle tissue development (GO:0048745),-0.5497439524170764,-1.2217939064824632,0.22844827586206898,0.5237531606449851,1.0,5/10,11.37%,ENG;PTCH1;STRA6;PROX1;BMP4
prerank,regulation of interleukin-1 production (GO:0032652),-0.4911625863914687,-1.221450996038913,0.2296137339055794,0.5236821380812271,1.0,4/15,8.90%,GAS6;ANXA1;FOXP1;CEACAM1
prerank,response to amino acid starvation (GO:1990928),0.4020739563456362,1.220987959128989,0.1698389458272328,0.9000653798339899,1.0,22/72,19.47%,RNF152;NPRL3;SESN1;ATP6V0E1;SESN2;NPRL2;ATP6V0B;EIF2AK2;LARP1;ATP6V1D;ATP6V1E1;ATF2;IMPACT;DEPDC5;FLCN;KPTN;WDR24;RPTOR;RRAGD;ATP6V0D1;LAMTOR1;ITFG2
prerank,regulation of transport (GO:0051049),-0.40578164401166655,-1.220384226365728,0.17703349282296652,0.5253702797461693,1.0,14/36,16.82%,NRP1;ICA1;ACTB;EPB41;ACTG1;REEP5;WWC1;MYO6;GAPVD1;SNCA;PINK1;FES;ICA1L;DNAJA1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.42686549858303824,1.2202978799609618,0.17535545023696683,0.9010498886294696,1.0,16/57,14.35%,FOXN3;BABAM2;ATM;TP53;DONSON;CDK5RAP3;BRSK1;EME2;CDC14B;ATF2;PRKDC;HUS1;UIMC1;FZR1;BABAM1;SDE2
prerank,regulation of cartilage development (GO:0061035),-0.4769615825986773,-1.2198560583236613,0.19654427645788336,0.5257734291295623,1.0,7/18,13.95%,BMPR2;TRPS1;ZBTB16;BMP2;BMP4;PTHLH;BMPR1B
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.5300269313960189,1.2197835936367418,0.25,0.9012123210321851,1.0,1/18,0.08%,ATP1A2
prerank,positive regulation of nuclear division (GO:0051785),0.489215321603303,1.2194413499819285,0.22445561139028475,0.9006895295911671,1.0,4/25,6.37%,IGF1;PHIP;CD28;PDGFRB
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5278747753002649,1.2193625706899798,0.23826714801444043,0.8992181147498918,1.0,3/18,6.47%,IGF1;IL18;IL12B
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.4947605968467299,1.2191864290609802,0.23958333333333334,0.8981526494122744,1.0,4/22,3.53%,ROCK2;PICALM;EPHA4;CASP3
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.31016915345223095,-1.219181284980908,0.08403361344537816,0.5264617984008504,1.0,36/149,14.95%,PRKCH;RPS6KA5;CAV1;ROR1;IL1RAP;STAT3;MID2;NOD1;TFRC;NFKBIA;ARHGEF2;TNFRSF11A;AR;PPIA;TRAF5;APP;RPS3;CARD14;MAP3K7;RTKN2;DDRGK1;IRAK3;TRIM14;ERC1;TRIM27;TIRAP;IKBKB;AIM2;PRKD1;RBCK1;CARD16;TERF2IP;TRIM37;CLU;UBB;MTDH
prerank,RNA destabilization (GO:0050779),0.5177410328915408,1.218347913889317,0.26,0.8995382779733294,1.0,3/18,10.36%,ROCK2;ZC3H18;YTHDF3
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.43367629827678256,-1.2183060181637217,0.20554272517321015,0.5275717043334147,1.0,8/24,14.04%,DACH1;BMPR2;ACVRL1;RPS3;XRCC5;CDKN1A;ERCC1;TERF2IP
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.5368507739189894,1.2181907956303273,0.2679245283018868,0.8983876787013197,1.0,3/16,4.75%,ATP1A2;ANK2;CACNA1C
prerank,myelin assembly (GO:0032288),-0.5433541937286138,-1.217822189009701,0.21705426356589147,0.5277875655793458,1.0,3/10,3.60%,CD9;TENM4;EPB41L3
prerank,neutrophil mediated immunity (GO:0002446),-0.2724906955711484,-1.2177039637002467,0.02702702702702703,0.5272335397580146,1.0,103/432,19.59%,PTPRB;ATP8A1;PTPRJ;PECAM1;GSN;SNAP25;LRRC7;ATP6V0A1;CST3;ADGRE5;IQGAP1;B2M;FTH1;APAF1;ATP11A;HMOX2;NFASC;RAB31;PTPRN2;HSP90AB1;PRG2;GPI;ACTR2;PPIA;RAP1B;PTPRC;RAP1A;CD93;STK10;CTSD;PSAP;CTSC;RAB27A;TSPAN14;HSPA8;TIMP2;PSEN1;TNFRSF1B;DYNLL1;PGLYRP1;NPC2;SLC44A2;FTL;CKAP4;OSTF1;MME;EEF1A1;HEXB;CTSB;STOM;CEACAM1;PSMD14;CRACR2A;CD47;DOCK2;RAB18;CD44;HSP90AA1;CYBA;IMPDH1;XRCC5;GOLGA7;CTSS;ENPP4;HRNR;SLC2A3;ARPC5;TNFAIP6;LRG1;SRP14;PGAM1;FABP5;TMEM30A;QPCT;SCAMP1;DOK3;RAB6A;TRPM2;ALDOA;CCT8;APEH;PKM;CAT;CCT2;PDXK;STXBP3;SVIP;RAB37;GCA;CYB5R3;C3AR1;PSMD11;CTSZ;ITGB2;CAND1;SLC27A2;QSOX1;TMEM63A;EEF2;SPTAN1;PSMD2;ATP11B;TYROBP
prerank,nuclear export (GO:0051168),0.39775336409029605,1.2175083573207501,0.17280453257790368,0.8991355724099879,1.0,20/80,21.34%,RANBP3L;SRSF5;PHAX;POLDIP3;NUP42;RANBP3;NXF1;SRSF11;DESI1;SARNP;NUP155;NEMF;CCHCR1;SRSF1;CDC40;NUP188;U2AF1;SRSF7;U2AF2;NUP153
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.4040238830091863,-1.217501020340404,0.1918158567774936,0.5267797597039146,1.0,17/34,21.92%,NRP1;CARMIL1;ARHGEF7;DOCK1;FLNA;CRK;LIMS2;MYOC;CALR;ILK;DMTN;LIMS1;MYADM;CSPG5;S100A10;RAC3;MDK
prerank,glycoprotein catabolic process (GO:0006516),0.526174999459562,1.2174536843766601,0.25448028673835127,0.8976002811118418,1.0,4/17,8.43%,NGLY1;NEU2;ADAMTS9;MANBA
prerank,regulation of Notch signaling pathway (GO:0008593),-0.3445848472806553,-1.2171017313655703,0.09120521172638436,0.5268765709885983,1.0,19/76,12.12%,MAML2;NOS3;NOTCH3;TGFB2;STAT3;CCN3;JAG1;NOTCH1;IL6ST;EPN2;BEND6;TSPAN14;PRAG1;SREBF2;JAG2;GATA2;LFNG;MFNG;TM2D3
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.44741499278440905,-1.2170272624113319,0.22790697674418606,0.5261972122368235,1.0,8/21,19.13%,PPP1R16B;YWHAE;GSK3B;YWHAB;MFHAS1;FKBP1A;CRY2;PPP1R11
prerank,"transcription, DNA-templated (GO:0006351)",0.35416928182059604,1.2165433600207878,0.12830188679245283,0.8991140461646256,1.0,41/207,16.15%,MAF;THRB;GLIS3;DDX5;POLR2A;SOX5;CTR9;DTX1;ATOH1;RREB1;TTF2;AFF4;CREBL2;TP53;TSC22D1;CCNT2;POLR2D;MEF2A;TWNK;TFDP1;ELL;GTF2A1L;GTF2F1;RTF1;MNT;NOCT;NELFCD;TAF11;HIPK3;DEAF1;POLR3A;TBP;TAF4;PMF1;CTDP1;NFKB1;BRF1;TAF7;FUBP3;TTF1;TAF13
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.5132764671879587,-1.2163737792790867,0.23789473684210527,0.5269066257819269,1.0,4/13,8.86%,NRP1;NRP2;PLXNC1;PLXNA4
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.47417036732689255,-1.2161116386501465,0.21710526315789475,0.5266518892701726,1.0,4/17,9.06%,HDAC9;PCSK5;SORT1;PCSK6
prerank,protein sumoylation (GO:0016925),0.4259802724903971,1.2155122102978722,0.21226415094339623,0.9011038515938776,1.0,13/49,21.34%,EYA1;PIAS1;NUP42;NUP98;NSMCE2;NUP43;PIAS3;NUP155;SUMO1;PIAS4;NUP188;UBE2I;NUP153
prerank,calcium ion transmembrane transport (GO:0070588),0.3972483092139328,1.2153689599332838,0.18832116788321168,0.8998953878015007,1.0,12/86,7.30%,TRPM3;CACNA1D;SLC24A3;TRPM6;SLC8A3;MCU;CACNA1C;SLC25A23;MICU1;CACNB3;TRPM5;ANO6
prerank,protein localization to cell periphery (GO:1990778),-0.31342744473120826,-1.2151396940970667,0.09465020576131687,0.5280796815492722,1.0,37/133,12.49%,KCNIP4;SPTBN1;DPP10;CACNB2;KCNB2;CAV1;BSG;ANK3;DPP6;EFR3B;CLASP2;MAP7;LIN7A;EPB41L3;ATP1B1;F11R;GAS6;MYO5A;EHD4;RAMP2;RAB3C;RAP1A;NKD2;FLNA;TSPAN14;PTCH1;EHD2;RDX;RAPGEF6;FGF13;RAP2A;KCNB1;ZDHHC2;CDH1;PACS2;IKBKB;EMP2
prerank,positive regulation of dendritic spine development (GO:0060999),-0.4595056550980129,-1.2151173377984426,0.20657276995305165,0.5272688521213184,1.0,8/20,13.89%,NLGN1;SHANK3;APOE;PSEN1;RELN;LLPH;LRP8;SHANK1
prerank,entry into host (GO:0044409),-0.5086436166328647,-1.2149494895762052,0.23772102161100198,0.5268046058841442,1.0,5/13,16.10%,PPIA;MET;CDH1;CTNNB1;CBL
prerank,cellular response to interleukin-15 (GO:0071350),-0.5028872052609724,-1.2148609020826517,0.2190082644628099,0.5252712781745678,1.0,3/13,9.42%,STAT3;STAT5B;JAK1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.5028872052609724,-1.2148609020826517,0.2190082644628099,0.5252712781745678,1.0,3/13,9.42%,STAT3;STAT5B;JAK1
prerank,negative regulation of developmental growth (GO:0048640),-0.41282481582573927,-1.2147923833317595,0.17884130982367757,0.5245775154685445,1.0,12/30,14.68%,RTN4;DCC;PTCH1;DIP2B;ULK1;ULK2;WWC1;FGF13;SEMA3G;CDKN1A;MT3;FGFR3
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.42176180280471404,-1.2147686342733017,0.19950124688279303,0.5237721305703086,1.0,11/27,14.38%,PDE4D;CACNB2;AHNAK;CAMK2D;YWHAE;CALM1;CALM2;FKBP1A;JPH2;NOS1;SELENON
prerank,positive regulation of stress fiber assembly (GO:0051496),0.44130778305868373,1.2147377868125202,0.21303656597774245,0.9004891487318152,1.0,9/44,5.18%,ROCK2;LPAR1;CCN2;ARHGEF10L;FHOD1;PPM1E;TGFBR1;RAPGEF3;TPM1
prerank,adenine nucleotide transport (GO:0051503),-0.4760929154365608,-1.2142132673991748,0.23464912280701755,0.5242855786690017,1.0,3/17,3.31%,ABCC4;LRRC8C;LRRC8D
prerank,protein localization to vacuole (GO:0072665),-0.49713092703269357,-1.2139603399266963,0.23956043956043957,0.5239752057747761,1.0,9/13,35.78%,RTN4;SH3GLB1;SH3BP4;RNF128;CD81;LMBRD1;SZT2;LAMTOR4;MFSD1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.5254588373088658,-1.2138417000100823,0.2245762711864407,0.5233979622553434,1.0,4/11,8.63%,CD200;THBS1;CD34;PTGS2
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3945242586882487,1.2134987303016525,0.16051136363636365,0.9032027747789406,1.0,16/87,9.36%,NOTCH2;CELSR1;ROCK2;RHOQ;RHOBTB2;RHOD;ARHGAP18;RAPGEF3;EZR;ARHGAP17;PDGFRB;BAIAP2;RICTOR;PIK3CA;HRG;LRP1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.48594376780159204,-1.2130423924118532,0.21052631578947367,0.5245061255064686,1.0,8/15,21.77%,RPL5;RPS7;SMAD7;RPL23;MAD2L1;RPL11;BAG5;BAG2
prerank,myelin maintenance (GO:0043217),-0.5487853747014286,-1.2130187427591594,0.26595744680851063,0.5236954016416936,1.0,6/10,23.09%,EPB41L3;ABCD2;PRX;CLU;SOD1;CXCR4
prerank,potassium ion import across plasma membrane (GO:1990573),0.45027414694955814,1.212929306922934,0.2222222222222222,0.9034753231322742,1.0,3/41,0.87%,ATP1A2;ATP1B3;KCNJ13
prerank,negative regulation of neuron projection development (GO:0010977),0.42713542806915555,1.2127664765723625,0.19230769230769232,0.9023967185056181,1.0,10/56,8.38%,EFNB2;LRP4;LPAR1;EPHA4;PTPN9;NGEF;RUFY3;CBFA2T2;PTEN;DENND5A
prerank,actin filament bundle assembly (GO:0051017),0.46252557209800604,1.2126587115891072,0.2231543624161074,0.9011229371622496,1.0,6/33,6.38%,PAWR;SHROOM2;RHOD;EZR;BAIAP2L1;BAIAP2
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.4393359186517113,1.2121149341076705,0.21543408360128619,0.9014068973647009,1.0,5/45,3.89%,BMP7;SMAD3;TOM1L2;FOXC1;GAS1
prerank,negative regulation of cellular component movement (GO:0051271),0.5321693923412318,1.2115436883504338,0.25285171102661597,0.9017529484823736,1.0,3/15,2.28%,TGFBR3;FBLN1;PKHD1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.3801129965477261,1.2115317308266786,0.16371077762619374,0.9001074987167419,1.0,30/104,16.65%,KSR1;SLC8A3;CCNA2;PPEF2;CCNA1;DDX3X;UVRAG;CAMK1;TRIB2;SLC27A1;CCNT2;CCND3;CDK5RAP3;HTT;CDC25A;SIRT1;GTPBP4;CCNB2;IRGM;ABL1;TRIB1;MAP2K1;MAP2K2;GADD45A;CCNG1;SNF8;RPTOR;RB1;CCNE1;TELO2
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.38334928035024207,1.2114039157667653,0.16083916083916083,0.8988870698113696,1.0,21/112,11.82%,WWOX;TGFBR3;SMAD3;APPL2;WNT4;PRKCZ;ARHGEF18;SOX5;BMPR1A;TGFBR1;SMAD6;USP9X;TWSG1;TGFBR2;COL1A2;CDH5;SIRT1;CRKL;ZMIZ2;ZMIZ1;GDF15
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3205993615765922,1.2113255391618738,0.008032128514056224,0.8974863746515694,1.0,286/1646,14.09%,DENND4A;EPAS1;HLF;ZKSCAN2;RORA;MAF;KDM7A;PPARGC1B;BMP7;SMAD3;TFDP2;GLIS3;WNT4;OSR1;ZIC2;FOXN3;TULP3;TRAK1;KIT;DDX5;PPARGC1A;MXI1;PICALM;IGF1;NFYC;CUX1;KMT2A;PPARA;PKNOX2;SSBP2;CREBRF;ZFHX2;FOXP4;IKZF2;POLR2A;ZNF423;CREB5;HOXB4;JARID2;GLI2;ZBTB20;ZNF160;HOXB6;NPAS3;CXXC1;SPP1;ZHX2;SNX6;FOXD1;HOXC6;HOXA1;ZNF568;DKK3;ARID4A;NFAT5;SOX5;PCGF5;CRABP2;PHIP;NR2F2;NCOR2;CTR9;ZNF697;ELF1;TSHZ3;NR6A1;GLI3;MITF;SUFU;TGFBR1;ARNT2;FOXC1;NFIB;VGLL3;CAND2;RFX8;HOXB3;VEZF1;ZBTB38;MAFG;ASCL3;ATOH1;NACC2;VGLL4;NFYB;LOXL3;CCNA1;CREB3L2;NHLH2;PRKCB;SMAD6;FOXP2;SALL4;CUX2;RREB1;CHD4;PPP1R13L;RGMB;BNC2;PIAS1;MEIS1;FBXL19;NSD1;TEF;IFNK;WWC2;TRIM56;ARRB1;ASCC2;ARID3A;SFMBT1;SBNO1;SOD2;ATRX;ESRRA;TEAD3;CBFA2T2;STAT2;LCOR;HMGA1;LBH;HOXB9;CREBL2;HOXA3;BAZ1B;ZNF318;HOXB5;TP53;TSHZ1;TBL1X;AFAP1L2;CAMTA2;WWTR1;BHLHE41;SMURF2;ARHGEF11;RORC;MED12;SOX12;MGA;CCNT2;SMARCD3;ZSCAN29;NIPBL;ZIC5;LDB1;CHD7;FBXW11;BCOR;ELF2;MEF2A;KDM2B;SMARCA4;NR1D2;HOXC4;SRCAP;BTRC;RBM15;SPEN;ZSCAN25;TBL1XR1;KAT6B;ZIC1;KDM2A;SLTM;NRG1;JMJD6;NUPR2;IRX1;SMARCC2;NEUROD4;TEAD2;NIBAN2;KLF3;CALCOCO1;PARP9;SMARCE1;HDAC4;GLI1;ZBTB26;SCML4;SIRT1;ZIC4;TFDP1;TCF7;TLE1;NSD3;NR2C2;HDAC1;SOX13;CBY1;SPINDOC;CCAR1;ZFP90;CHMP1A;FOXC2;TCF7L2;TCF4;HBP1;ZBTB8B;ZNF219;MYBL1;MED17;HIVEP2;FOXL1;ZFP28;ZFP3;AJUBA;THRAP3;ABL1;PRDM5;DYRK1A;ZBTB6;SAP18;ZKSCAN5;ZNF569;ZNF367;NFATC3;HR;MNT;ATF2;ZFX;RBBP8;BAHD1;ZMIZ2;WWP2;BAZ1A;MLLT6;TFAP2D;ZNF467;ZBTB1;SKOR1;MYBL2;MSANTD1;CBX5;TEAD1;ZMIZ1;PHF5A;ZSCAN22;NOP2;KDM3B;ZNF148;HES6;ZNF235;BRWD3;UIMC1;HOXB2;BRD7;FOXA2;DEAF1;MLXIPL;NR3C2;TGFA;BRD9;IRF1;ZKSCAN7;PHF1;PHF2;ZNF483;KMT2D;KAT7;ZXDC;EDRF1;PBX4;ZBTB48;FOXJ2;KMT5A;PRKAR1A;NFIA;SIN3A;DNM2;MAP2K1;MLLT11;ATF6B;PML;TLE2;PSIP1;BCL7A;NCOR1;ZBTB32;CRYAB;OGT;ILF2;MAP2K2;SNAI1;PER2
prerank,lymphocyte chemotaxis (GO:0048247),-0.40044596127967713,-1.210603242818762,0.2,0.5285572440789917,1.0,11/34,26.52%,CYP7B1;SLC12A2;GAS6;CXCL16;CCL13;CH25H;CCL19;HSD3B7;CXCL10;PIK3CD;CCL2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.4494270009610557,-1.2105719154232402,0.23185011709601874,0.5277852471295864,1.0,9/21,9.43%,HS6ST2;NDST3;HS6ST3;HS3ST4;HS3ST5;EXT1;XYLT1;GLCE;EXT2
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.4518191770720976,-1.210337419270879,0.20785219399538107,0.5274858598659591,1.0,6/21,10.66%,CAV1;PLTP;NFKBIA;APOE;PTCH1;EEPD1
prerank,iron ion transmembrane transport (GO:0034755),-0.531078515118465,-1.2096589632688433,0.25109170305676853,0.5282843161870558,1.0,5/10,28.24%,SCARA5;SLC40A1;SLC25A28;SLC39A14;SLC25A37
prerank,regulation of protein autophosphorylation (GO:0031952),-0.39487879827672717,-1.2095802169959828,0.18932038834951456,0.5276370291284506,1.0,13/36,13.77%,ENG;RASSF2;PPP2R5A;PDGFC;CALM1;CALM2;EPHA7;ENPP1;RAP2A;PDGFA;CALM3;TNKS1BP1;VEGFA
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.36508195885769484,1.2081863586472612,0.14586070959264127,0.9071504964194832,1.0,36/148,16.15%,PRKAG2;PRKAA2;PRKAG3;TP53RK;CHD4;PPP1R13L;ATM;TP53;RICTOR;CDK5RAP3;PDPK1;RNF34;HDAC1;AURKB;RBBP8;HUS1;NOP2;TAF11;CSNK2A2;CSNK2A1;MAPKAP1;BRD7;RAD50;TOP3A;USP7;PPP1R13B;KMT5A;TBP;PML;TAF4;MAP2K6;CCNG1;MTA2;TAF7;EHMT2;TAF13
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.5501615451876236,1.2071580566389006,0.2706333973128599,0.9091577298779743,1.0,5/13,15.63%,RENBP;UAP1L1;PGM3;GNPDA1;GFPT1
prerank,negative regulation of proteolysis (GO:0045861),0.4608052076859546,1.2070729232927235,0.21658206429780033,0.9078010916285479,1.0,7/34,6.96%,TIMP3;EPHA4;LRRK2;GAS1;F2;TM4SF20;KNG1
prerank,negative regulation of cell communication (GO:0010648),-0.4588019289973684,-1.206610794911439,0.21700223713646533,0.5339079456458858,1.0,9/21,25.57%,UBASH3B;HHIP;GLRA1;KIF26A;ACVR1;SOCS5;PTPN1;OPRM1;ERBB3
prerank,hexose biosynthetic process (GO:0019319),0.4385855941502234,1.2063068551361287,0.22749590834697217,0.9089144902114475,1.0,14/42,17.88%,PPARGC1A;SORD;CHST15;PGAM2;GOT2;RBP4;SLC25A12;SLC25A11;PGM1;PER2;SLC25A10;GOT1;SLC37A4;CRY1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.575750874411327,1.2054818919791772,0.25680933852140075,0.9102922184067098,1.0,7/11,16.74%,ENPP3;CTPS2;SLC19A2;THTPA;NT5C3A;TPK1;SLC25A19
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.4797794230649033,-1.2052241587857986,0.2074235807860262,0.5363457582211334,1.0,4/15,20.43%,HECW2;CENPE;CDC23;NEK6
prerank,sulfate transport (GO:0008272),0.5426221550667758,1.2052130283921463,0.27087198515769945,0.9095904652572002,1.0,1/14,0.15%,SLC13A4
prerank,metanephros development (GO:0001656),0.4836479910769639,1.204724155255029,0.23304347826086957,0.9095803084164095,1.0,6/26,8.44%,BMP7;OSR1;FOXD1;CTSH;NIPBL;GDNF
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.49077869681052516,1.2043639121885867,0.2602040816326531,0.90927316793267,1.0,10/23,24.41%,CASP3;DNASE1L1;FBH1;DICER1;DFFB;DFFA;DNASE1L2;CECR2;REXO4;H1-0
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.3142734257112792,-1.2042994897208839,0.10902255639097744,0.5376859104496018,1.0,37/114,27.67%,ACTN4;TMSB4X;ST18;PTK2B;TNFRSF11B;NFKBIA;PSMB2;TNFRSF11A;TRAF5;CARD14;TNFRSF1B;PSMD14;PSMC6;ILK;IKBKB;AIM2;LIMS1;PSMA4;PSMB9;EDAR;MAP3K14;TRAF1;TNFRSF25;PSMD11;PSMB10;PSMD2;PYCARD;TXNDC17;PSMA2;RELA;JAK2;TNFSF8;PSMB3;CD40;PSMB5;CDIP1;PSMA7
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.4715411570936634,-1.2042884689889335,0.24053452115812918,0.5368522923480434,1.0,7/18,8.63%,LTBP1;CD200;FN1;TGFB2;CD34;ITGB8;PTGS2
prerank,purine ribonucleotide transport (GO:0015868),-0.47693873379771423,-1.2038986086659014,0.24,0.5369662338096344,1.0,3/16,3.31%,ABCC4;LRRC8C;LRRC8D
prerank,cholesterol efflux (GO:0033344),-0.4519395619441949,-1.2034685057322234,0.22528735632183908,0.5371319430102115,1.0,5/20,11.28%,SCARB1;APOE;ABCG1;NPC2;STX12
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.4995006252503134,1.203205289590395,0.25268817204301075,0.9118101475612669,1.0,5/21,7.00%,ADCY5;NPR1;ADCY1;NPR2;ADCY9
prerank,positive regulation of protein depolymerization (GO:1901881),-0.5194863726764637,-1.2031153257444396,0.25102880658436216,0.5371611296284017,1.0,4/11,10.63%,SEMA5A;STMN2;TRPV4;WDR1
prerank,oxoacid metabolic process (GO:0043436),0.47443746563614986,1.2030501799024302,0.23958333333333334,0.9106809479248583,1.0,4/27,12.05%,DDO;ABHD14B;SULT2B1;TPST1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.52136502975759,-1.2026067974989723,0.2620545073375262,0.5375724186365126,1.0,5/12,26.85%,SNAP25;STX3;STX1B;SNAP23;STX1A
prerank,cellular response to interleukin-4 (GO:0071353),-0.5500566501958877,-1.2025545641798772,0.2668024439918534,0.5368208996141036,1.0,1/10,0.47%,LEF1
prerank,SNARE complex assembly (GO:0035493),-0.534437267900101,-1.2017290512722876,0.2413793103448276,0.5380335002930521,1.0,2/10,4.59%,STXBP6;VAMP4
prerank,regulation of protein phosphorylation (GO:0001932),-0.2831702778171855,-1.2016790281317915,0.05421686746987952,0.5372919690789837,1.0,71/256,14.40%,SLIT2;LIMCH1;PID1;TEK;BMPER;GRM5;PRR5L;ERBB4;NTRK3;PECAM1;PDE8A;ENG;PLCE1;VEGFC;NPTN;NIBAN1;EFNA5;FN1;SH3GL2;GAS6;CCDC88A;TFRC;NTRK2;KRAS;PPP2R5A;KDR;LYN;TBX1;DAB2IP;PPIA;PAK1;APP;CARD14;OCLN;LIMK2;EPHA7;SEMA4D;CORO1C;EPHB2;CCN1;BMP2;TGFB1;PTK2;RALB;DNAJC10;XDH;FGF2;FLT4;RAP2A;FNIP2;ERBB2;CAMKK2;PDGFA;HSP90AA1;ITGB3;GPER1;FXR1;BMP4;ATF4;ILK;FAS;AXIN1;FGF7;FGF9;VEGFA;PINK1;TERF2IP;NOP53;CCDC88C;MT3;P2RY1
prerank,positive regulation of neurogenesis (GO:0050769),-0.35474880869233133,-1.2014443007464775,0.17073170731707318,0.5369841980610052,1.0,20/68,12.06%,SLIT2;PTPRD;ROBO2;IL1RAPL1;SHANK3;NPTN;CDKL5;NGF;NTRK2;TIAM1;DISC1;SERPINF1;PLXNC1;MME;PLXNA4;MAP6;NAP1L1;SLITRK1;GPER1;CTNNB1
prerank,regulation of synapse maturation (GO:0090128),-0.5368473519987164,-1.201175628712401,0.2515212981744422,0.5367672035248894,1.0,4/10,7.93%,NRXN1;DAB2IP;ARHGEF15;RELN
prerank,regulation of cation transmembrane transport (GO:1904062),-0.40316808776745433,-1.2011595704017752,0.20047732696897375,0.5359730443334166,1.0,7/29,4.11%,KCNIP4;DPP10;FGF12;DPP6;KCNN2;KCNIP1;KCNAB1
prerank,magnesium ion transport (GO:0015693),0.5592719202865604,1.2007231014865123,0.27307692307692305,0.9175420102806151,1.0,4/12,14.32%,SLC41A1;MRS2;NIPA2;MAGT1
prerank,positive regulation of lyase activity (GO:0051349),0.5403924306736005,1.2006886820980507,0.2558983666061706,0.9159922740185529,1.0,3/14,9.72%,CACNA1D;CACNA1C;STIM1
prerank,T cell mediated immunity (GO:0002456),-0.5037043467993941,-1.2006738007191586,0.23717948717948717,0.5362954693993108,1.0,4/13,14.73%,CADM1;JAG1;EMP2;BTN3A3
prerank,positive regulation of response to wounding (GO:1903036),-0.42892072319051033,-1.2005697669189395,0.2181372549019608,0.5356998615448048,1.0,11/24,21.92%,ACTG1;ANXA1;OCLN;ITGB1;PTK2;PTN;SCARF1;DMTN;KANK1;VTN;MDK
prerank,regulation of cellular component movement (GO:0051270),0.4215135087555288,1.2005497092915973,0.21677215189873417,0.9148003113479624,1.0,12/49,11.58%,TGFBR3;ROCK2;PKHD1;ARHGAP18;TGFBR1;PDPN;NRG1;DIAPH1;HBEGF;ZSWIM8;ABL1;ADAM17
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.5344228111553109,1.2005385638725647,0.26591760299625467,0.913189498903773,1.0,9/14,29.19%,SEC31B;MIA3;SEC31A;SCAP;SEC24C;SEC24A;SEC13;SEC24D;SEC23B
prerank,snRNA processing (GO:0016180),0.5242004306423155,1.20041245110419,0.27191413237924866,0.9120278957382163,1.0,9/16,21.65%,INTS10;INTS2;INTS5;INTS3;INTS7;INTS1;INTS8;INTS4;TUT1
prerank,artery development (GO:0060840),-0.43940698847219595,-1.1999325072951963,0.2302325581395349,0.5363092720372975,1.0,10/23,9.51%,NRP1;ROBO2;BMPR2;ENG;ACVRL1;TBX1;HES1;STRA6;SMAD7;PDE2A
prerank,epithelial cell migration (GO:0010631),-0.3924664081921353,-1.1996582247242586,0.18882978723404256,0.536156081115651,1.0,14/37,15.78%,NRP1;CDH13;NOS3;FAP;CYP1B1;ANLN;PLEKHG5;STARD13;LPXN;PKN3;FAT2;SCG2;PTP4A3;PLXND1
prerank,keratan sulfate catabolic process (GO:0042340),0.5543054249873764,1.1995980506044777,0.30278884462151395,0.9134857823204118,1.0,2/11,5.05%,OGN;FMOD
prerank,canonical Wnt signaling pathway (GO:0060070),0.40205340539557366,1.1994539356234002,0.21777777777777776,0.9123365405184868,1.0,13/68,11.85%,WNT5B;WNT4;WNT6;FZD8;LRRK2;FZD5;PTEN;RYK;CSNK1A1;TCF7;TCF7L2;RARG;PORCN
prerank,protein K48-linked ubiquitination (GO:0070936),0.42365131197240663,1.1993837586535545,0.23763955342902712,0.9109206208374567,1.0,16/54,17.39%,RNF152;UBE2E2;PRKN;IFI27;NHLRC4;TTC3;RNF8;RNF34;UBR5;UBE2H;RNF115;AMFR;RNF146;UBE2E1;SYVN1;CDC34
prerank,C4-dicarboxylate transport (GO:0015740),-0.49034001640267383,-1.1993551299150307,0.21991701244813278,0.5360643266938475,1.0,4/14,5.29%,LRRC8D;SLC1A2;SLC1A1;SLC25A13
prerank,cell-substrate junction assembly (GO:0007044),0.44272035598964365,1.199284695060836,0.2273476112026359,0.9096484388467792,1.0,5/33,2.19%,ACTN2;SORBS1;LAMC2;LAMC1;RHOD
prerank,positive regulation of transferase activity (GO:0051347),-0.30564707751037284,-1.1992517586304376,0.1013215859030837,0.5355221386709174,1.0,34/142,14.68%,TEK;ERBB4;NTRK3;ROR1;CD200;EPHB1;EPHA5;MERTK;EPHA6;PARM1;TIE1;NTRK2;HSP90AB1;NEK7;KDR;ROR2;MET;EPHA7;SORL1;EPHB2;TGFB1;FLT4;RPS2;ERBB2;HSP90AA1;SERINC1;XRCC5;CTNNB1;ARRDC4;AXIN1;SERINC5;RET;PINK1;FGFR3
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3397121378106465,1.1991936657003648,0.12082853855005754,0.9083272085012504,1.0,39/308,9.87%,EPAS1;DAB2;ACSL1;PPARGC1B;C1QTNF3;SMAD3;APPL2;LEPR;PPARGC1A;NPR1;IL18;FOXD1;SOX5;BMPR1A;TGFBR1;FOXC1;ADRA2A;PDPN;KMT5C;SMO;RREB1;NCOA3;CD28;KMT5B;IL12B;EIF2AK2;SLC27A1;WWTR1;SMURF2;SERPINE1;TGFBR2;TERT;CPT2;GDNF;NIBAN2;SIRT1;LRP1;NR2C2;GRB10
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.48053114913860984,1.198909517052281,0.2517605633802817,0.9077376707617182,1.0,4/28,4.13%,ARHGAP28;FCHSD2;ARHGAP18;NAA80
prerank,regulation of myoblast differentiation (GO:0045661),0.46395248905603753,1.1985209841757078,0.22673434856175972,0.907488076379711,1.0,1/32,0.01%,RANBP3L
prerank,activation of adenylate cyclase activity (GO:0007190),0.4476505294111462,1.1984895216927571,0.2370617696160267,0.9060229527468336,1.0,3/35,1.98%,ADCY5;LGR4;ADCY1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.4266052685526303,-1.197275987059363,0.2225,0.5395393059633137,1.0,10/24,24.46%,CXCL12;TPT1;ACKR3;CD44;TAF9B;CLU;CD74;TRIAP1;CCAR2;SNAI2
prerank,maturation of LSU-rRNA (GO:0000470),0.4744009609183203,1.1965732211406888,0.26548672566371684,0.9112972548102046,1.0,7/26,18.39%,NSA2;DDX18;NOP2;RSL1D1;MRPL1;ZNHIT6;WDR12
prerank,response to leucine (GO:0043201),0.5710098376325096,1.196497844695377,0.2845528455284553,0.9083280210876903,1.0,6/10,17.13%,SESN1;SESN2;UBR2;RPTOR;UBR1;RRAGD
prerank,cellular response to leucine (GO:0071233),0.5710098376325096,1.196497844695377,0.2845528455284553,0.9083280210876903,1.0,6/10,17.13%,SESN1;SESN2;UBR2;RPTOR;UBR1;RRAGD
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.48307674189900746,1.195930300843767,0.23117338003502627,0.9087868378367476,1.0,9/23,22.63%,NMT2;METAP2;RHO;FNTB;SAG;FNTA;PDE6B;GRK4;CAMKMT
prerank,glucan catabolic process (GO:0009251),0.5217589200483075,1.1956938838140343,0.27256317689530685,0.9079838200024505,1.0,4/15,8.86%,PYGM;PHKB;MGAM;PHKG1
prerank,muscle tissue development (GO:0060537),-0.49408282537051057,-1.1955915084406685,0.2415966386554622,0.5426666762871368,1.0,6/13,11.37%,PGM5;ENG;PTCH1;CSRP2;STRA6;BMP4
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.38029955345027444,1.195495267957851,0.1736111111111111,0.9070678903870958,1.0,10/113,3.46%,NOTCH2;FGF1;BMP6;OSR1;IGF1;STXBP4;FGFR2;LAMC1;PKHD1;TGFBR1
prerank,regulation of B cell proliferation (GO:0030888),-0.3730174066641662,-1.1953495125743656,0.18974358974358974,0.5423656450606922,1.0,13/44,22.40%,MEF2C;TFRC;LYN;CD38;PTPRC;EPHB2;TNFRSF21;TIRAP;CD74;IRS2;TYROBP;CD320;CD81
prerank,regulation of cellular component size (GO:0032535),0.46194338546356006,1.1949426737335755,0.24489795918367346,0.9073684702679862,1.0,10/30,15.84%,PICALM;PEX11A;EZR;RIN3;PTEN;PEX11B;RARG;RAB22A;VAV3;RPTOR
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.41744077093753196,-1.194903280561116,0.23929471032745592,0.5426164653117879,1.0,9/28,14.07%,MAP3K5;DAB2IP;DNAJC10;ATP2A3;AIFM1;TMEM117;SELENOK;ATF4;BBC3
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.5017598758367483,-1.1943647831245146,0.2530612244897959,0.5431390958528827,1.0,9/14,26.52%,THBS1;ITGA4;GPER1;ECSCR;PDCD4;RGCC;CD40;PLCG1;CCL2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.4313549411008878,1.1939627168518632,0.23102866779089376,0.9093150631827825,1.0,10/43,11.69%,SMAD3;DDX5;PPARA;NFIB;TP53;SMARCA4;TERT;APLN;NFATC3;TEAD1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.4822798274193005,1.1937642712794585,0.24957841483979765,0.9084016274858534,1.0,8/26,14.57%,ROCK2;PRKN;FHOD1;ASAP3;CDC42;VIL1;TSC1;ALMS1
prerank,Notch signaling involved in heart development (GO:0061314),0.5514992118440515,1.19364673759976,0.2824427480916031,0.9072243346330299,1.0,1/11,0.19%,NOTCH2
prerank,protein dephosphorylation (GO:0006470),0.3669979511871882,1.1935614807741095,0.17928286852589642,0.9058993122794592,1.0,29/135,12.28%,EYA1;PTPN13;EYA2;DUSP29;PPP2R2B;PTPN14;PTPN9;MTMR3;PPEF2;EYA4;PPP1CB;PPM1E;TNS2;LHPP;DAPP1;PTPRU;PTPN22;FBXW11;PTEN;PP2D1;BTRC;PPP2R1B;PTPN21;DUSP10;CDC14B;PPP2R5E;PTPN4;CTDSP2;PTPN11
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.5066485669983878,-1.1935329792082958,0.25260960334029225,0.5443136352018254,1.0,4/12,14.72%,APOE;LDLR;CLU;IAPP
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.5167051889107654,-1.1932693601573856,0.2574468085106383,0.544129081424667,1.0,9/12,41.00%,GNL3L;CCT8;CCT2;CCT6A;CCT7;DKC1;CCT3;GNL3;CCT5
prerank,negative regulation of viral genome replication (GO:0045071),0.4414559030380667,1.1932144967216567,0.2261904761904762,0.9055558726594937,1.0,12/40,16.95%,IFIT1;OAS2;PARP10;EIF2AK2;PLSCR1;RSAD2;ZC3HAV1;MAVS;SRPK2;OAS3;MPHOSPH8;ILF3
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.3892040632605656,1.19301588572849,0.20253164556962025,0.9047108840728079,1.0,7/86,3.46%,DAB2;BMP6;BMP7;ZNF423;FOXD1;BMPR1A;TGFBR1
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.5742803677963635,1.1925311858112684,0.2846441947565543,0.904775236470351,1.0,1/11,0.51%,AFDN
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.33042017490912023,-1.1924788087540787,0.13071895424836602,0.5451652570575358,1.0,32/84,15.15%,NRP1;TEK;BMPR2;TMSB4X;NOS3;THBS1;NRP2;SEMA5A;PTK2B;SCARB1;AKT3;KDR;GPI;FOXP1;MET;RHOB;GATA2;TGFB1;PROX1;CALR;ATOH8;FGF2;FLT4;BCAR1;ITGB3;EDN1;BMP4;HIF1A;PRKD1;VEGFA;NUS1;RRAS
prerank,electron transport chain (GO:0022900),0.5285942436017199,1.1923808688620359,0.2757281553398058,0.9036865664248024,1.0,2/15,5.35%,PPARGC1A;POR
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.42444682407388856,1.192339853413051,0.21608832807570977,0.902268822771196,1.0,6/48,13.91%,PRKAG2;GCK;NUP42;NUP98;NUP43;OGT
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.44990156339032356,1.192238887452134,0.23720136518771331,0.9010814195498895,1.0,9/35,12.45%,PPARGC1B;DDX5;PMEPA1;NEDD4;TMF1;CALCOCO1;UBR5;ZMIZ1;NR3C2
prerank,alpha-amino acid metabolic process (GO:1901605),0.4274165570103342,1.1920595101990907,0.2448,0.9001998350303864,1.0,13/45,12.51%,ASPA;ASPG;CPS1;KYAT3;GPT2;GOT2;MTHFR;SRR;GLUL;SLC25A12;NOX4;MTRR;FOLH1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.5317780056711213,1.1919418065146015,0.2829076620825147,0.8990583916457298,1.0,5/15,7.38%,FGFR2;HOXA1;TGFBR1;TGFBR2;NIPBL
prerank,presynapse organization (GO:0099172),-0.5274978134972285,-1.1919378360932322,0.23868312757201646,0.5456110056938442,1.0,2/10,3.65%,NLGN1;LRRTM3
prerank,prostanoid metabolic process (GO:0006692),0.543993379001764,1.191657407012155,0.2622641509433962,0.8985105848415945,1.0,2/13,9.98%,PTGS1;PTGR2
prerank,organic anion transport (GO:0015711),-0.3365149541766689,-1.191450483827867,0.12721893491124261,0.5459193295157853,1.0,10/76,6.93%,SLC4A10;ABCC4;ABCG2;SLC26A7;SLCO1C1;LRRC8C;LRRC8D;SLCO2B1;CA4;CA2
prerank,positive regulation of cyclase activity (GO:0031281),0.5300079505603751,1.1913639072903282,0.27060931899641577,0.8979464263288823,1.0,3/14,9.72%,CACNA1D;CACNA1C;STIM1
prerank,histone H2B ubiquitination (GO:0033523),0.5799499930072545,1.1908752684922874,0.28598130841121494,0.8981109265392351,1.0,4/10,18.43%,CTR9;RNF8;UBE2E1;RNF20
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.45381936384944094,-1.1907325105088782,0.24288840262582057,0.546794364299457,1.0,4/18,3.62%,NLGN1;NRXN1;SHANK3;PTK2B
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.5476684011243869,1.1905524754698837,0.27255985267034993,0.8977146480932023,1.0,2/13,5.45%,DDX5;ATM
prerank,regulation of amyloid-beta formation (GO:1902003),0.4440285994967025,1.1902388820323144,0.24429967426710097,0.8972438423300022,1.0,5/34,3.53%,ROCK2;PICALM;IGF1;EPHA4;CASP3
prerank,lytic vacuole organization (GO:0080171),0.456776781880813,1.1899146922242716,0.2706270627062706,0.8968635808342769,1.0,13/32,20.57%,HOOK2;LRRK2;TPP1;CLN6;ARSB;HPS1;MBTPS1;ZKSCAN3;HOOK3;MYO7A;LAMTOR1;TPCN2;SNAPIN
prerank,response to ionizing radiation (GO:0010212),0.3982790170009302,1.1898163761631095,0.22948328267477203,0.8956839562182887,1.0,23/70,20.25%,EYA1;BABAM2;ATM;NHEJ1;TP53;RNF8;XRCC4;SIRT1;BRSK1;HUS1;UIMC1;BABAM1;GADD45A;BRAT1;INTS3;CLK2;INTS7;MAPK14;MTA1;FANCD2;LIG4;TANK;RAD9A
prerank,negative regulation of transposition (GO:0010529),0.5230930564875402,1.1880333144262136,0.272552783109405,0.9003332128318591,1.0,5/16,16.40%,UBR2;TUT4;MOV10;MYBL1;TUT7
prerank,response to estradiol (GO:0032355),-0.39801569784302865,-1.1878204555754601,0.20902612826603326,0.5530229440252176,1.0,8/31,12.06%,ESR1;STAT3;ANXA1;SOCS2;TGFB1;STAT5B;GPER1;CTNNB1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.5285981956601927,1.1877072781583842,0.30129390018484287,0.8999660164746914,1.0,3/16,3.64%,HOXB4;SOX5;FOXC1
prerank,positive regulation of ruffle assembly (GO:1900029),-0.4945268449549003,-1.187267723437519,0.2564102564102564,0.5535152419719099,1.0,3/13,10.24%,NLGN1;P2RY12;EPS8
prerank,regulation of multicellular organism growth (GO:0040014),-0.47889512588503413,-1.1872538750164945,0.2570806100217865,0.552705275704306,1.0,6/15,10.91%,GHR;APP;PTCH1;PPIB;STAT5B;MFSD2A
prerank,cellular response to amino acid starvation (GO:0034198),0.39282029137560315,1.1870467017498034,0.20497803806734993,0.9009217018155327,1.0,21/71,19.47%,RNF152;NPRL3;SESN1;ATP6V0E1;SESN2;NPRL2;ATP6V0B;EIF2AK2;ATP6V1D;ATP6V1E1;ATF2;IMPACT;DEPDC5;FLCN;KPTN;WDR24;RPTOR;RRAGD;ATP6V0D1;LAMTOR1;ITFG2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.43323409328455076,1.1865995523895585,0.23817034700315456,0.9009090939960243,1.0,4/44,0.80%,WNK4;ACTN2;ATP1B3;ANK2
prerank,protein ubiquitination (GO:0016567),0.32549136769474013,1.1863023416986527,0.11653718091009989,0.9003797747311073,1.0,104/471,19.26%,RNF220;EPAS1;RNF152;PDZRN3;SH3RF2;UBE2E2;RNF43;ASB2;SASH1;PRKN;FBXL17;SPSB1;TRIM63;RNF213;CTR9;DTX1;CAND2;NEDD4;RNF151;RNF135;FBXL19;KLHL41;ARRB1;USP9X;RNF181;SPSB4;MGRN1;UBR2;SMURF2;RNF8;FBXW11;RNF141;HUWE1;TRIP12;FBH1;RNF217;TNKS2;BTRC;RNF19A;KLHL7;EIPR1;RNF34;HERC6;SIRT1;NPEPPS;UBR5;FBXO22;ZSWIM8;FBXL12;SH3RF1;RTF1;RNF41;FBXW8;FBXO4;RNF13;PRKDC;WWP2;PEX10;CUL4A;CUL9;UBA6;FBXO10;NUB1;ASB5;USP7;TRIM62;ASB12;DDB2;FBXO11;DTX3;FBXL20;SDE2;DZIP3;LONRF1;PEX14;UBE2H;RNF115;RMND5A;AMFR;RNF31;ANAPC16;RNF146;BIRC6;RNF19B;UBR1;RNF7;UBE2E1;KCTD13;SYVN1;PEX5;CDC34;RNF25;FBXW10;RNF20;CCDC22;TAF1;ARIH1;MIB2;ASB1;NHLRC3;UBE4B;FBXL22;KLHL18;MIB1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.4829811992544905,-1.1861933221876506,0.26180257510729615,0.554546778962075,1.0,7/15,8.00%,KCNJ3;KCNJ2;KCNN2;ATP1B1;YWHAE;ATP1A1;KCNQ1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.46366995560232194,-1.1860520008324502,0.2266355140186916,0.5540506745803501,1.0,5/20,9.63%,FAR2;ACSL3;ACSL4;PPT1;SCD
prerank,lipid transport (GO:0006869),-0.31907502746359684,-1.1857881778227268,0.13286713286713286,0.5538589534195314,1.0,23/97,9.78%,ABCC4;ATP8A1;ATP8B1;SLCO1C1;CERT1;PPARD;PITPNC1;SCARB1;PLTP;SLCO2B1;UGCG;SPNS2;APOE;ABCG1;LDLR;NPC2;GLTP;PITPNB;CEACAM1;STARD5;ABCD2;TNFAIP8L3;MTTP
prerank,signal transduction by p53 class mediator (GO:0072331),0.4725230858215159,1.1856760630943657,0.25510204081632654,0.9010809194692365,1.0,5/30,6.50%,DDX5;FHIT;SESN2;ATRX;TP53
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5187892499565044,1.1854643399294273,0.2862595419847328,0.9003678901338631,1.0,1/16,0.73%,LEPROT
prerank,regulation of angiogenesis (GO:0045765),-0.29119083531830164,-1.185373182128253,0.10454545454545454,0.5540230351824375,1.0,53/192,13.89%,PTPRM;TEK;BMPER;RHOJ;SEMA6A;CLDN5;PDE3B;DCN;NOS3;VEGFC;THBS1;TGFB2;SEMA5A;TIE1;COL4A2;PPP1R16B;GAB1;CD34;RUNX1;PTGIS;F3;CYP1B1;SEMA3E;KDR;RAMP2;DAB2IP;ITGB8;SERPINF1;RHOB;PIK3R6;ITGB1;TSPAN12;HSPG2;ECM1;STAB1;GATA2;CEACAM1;BTG1;AMOT;FGF2;ERBB2;ATP2B4;HIPK1;CTNNB1;TWIST1;EMP2;ISM1;HIF1A;PRKD1;VEGFA;ECSCR;ADGRB1;SPRED1
prerank,neuron projection extension (GO:1990138),-0.4000517458990459,-1.185276759101166,0.20243902439024392,0.5534245280017394,1.0,14/32,12.76%,NRP1;MAP1B;IQGAP1;NRP2;SEMA5A;SH3GL2;TMEM108;HSP90AB1;ULK1;ULK2;SLC9A6;HSP90AA1;CTNNB1;LLPH
prerank,positive regulation of developmental process (GO:0051094),-0.30119933498335266,-1.1852528575405326,0.10294117647058823,0.5526332067014824,1.0,43/164,14.01%,NLGN1;NRXN1;SLC6A6;BMP5;SHANK3;BMPR2;DCN;RTN4;CLASP2;GRIP1;PHLDB1;TFRC;ARHGEF7;ZBTB16;HSP90AB1;KDR;AR;DAB2IP;FZD4;APOE;BASP1;B4GALT5;PSEN1;CORO1C;SORL1;RELN;BMP2;PTN;RPS6KA3;ENPP2;HMCES;BMP4;EDN3;LLPH;VLDLR;LRP8;CFL1;ACVR1;VEGFA;SHANK1;BMPR1B;RPS6KA1;PINK1
prerank,glucose import (GO:0046323),-0.4922876979284,-1.1850591847734129,0.2579908675799087,0.5522631943085053,1.0,3/13,12.80%,SLC2A1;SORT1;SLC2A3
prerank,potassium ion homeostasis (GO:0055075),0.49280233921202127,1.18505042542239,0.2753108348134991,0.9003741420909863,1.0,2/23,0.71%,ATP1A2;ATP1B3
prerank,autonomic nervous system development (GO:0048483),-0.4617386942835008,-1.1848912201594317,0.25473684210526315,0.551865668135614,1.0,5/17,18.48%,NRP1;FN1;KIF26A;EDNRB;SOX8
prerank,protein targeting to peroxisome (GO:0006625),0.45835826476372393,1.1845335940491841,0.2512908777969019,0.9005698149530872,1.0,11/29,17.34%,ZFAND6;PEX11B;PXMP2;PEX10;PEX14;ACBD5;PEX19;RAB8B;SLC25A17;PEX16;PEX5
prerank,regulation of kinase activity (GO:0043549),-0.32187725309178344,-1.1840847786516284,0.1453287197231834,0.5529255959389371,1.0,23/89,12.71%,TEK;ERBB4;NTRK3;ROR1;EPHB1;PLCE1;EPHA5;MERTK;EPHA6;TIE1;NTRK2;KDR;ROR2;MET;EPHA7;EPHB2;EEF1A1;FLT4;ERBB2;CAMKK2;NLRC5;EMP2;MAPT
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.42186475868271445,-1.184063123884462,0.22330097087378642,0.5521334337321198,1.0,4/25,1.39%,SLC8A1;TMTC2;CAV1;ANK3
prerank,negative regulation of cell migration (GO:0030336),-0.3068481525174185,-1.18403892236204,0.13580246913580246,0.5513705630302563,1.0,30/137,9.64%,TMEFF2;SLIT2;LIMCH1;DACH1;PTPRJ;CLIC4;PTPRG;CLDN5;MCTP1;ENG;NAV3;PTPRK;CLASP2;PTPRT;SRGAP1;NEXMIF;EVL;ADARB1;ACVRL1;CYP1B1;JAG1;DAB2IP;RHOB;ADAM15;CORO1C;ARHGDIB;CALR;SMAD7;FGF2;RAP2A
prerank,eye morphogenesis (GO:0048592),0.5065923408933735,1.1837303267448076,0.2773851590106007,0.9018106672440764,1.0,6/19,11.14%,COL5A1;SHROOM2;FBN1;NIPBL;IFT122;RARG
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3531827524146942,1.182912865404098,0.1751269035532995,0.9031199733873876,1.0,43/182,15.24%,NOTCH2;ROBO1;SLC24A3;ROCK2;WNT4;PICALM;IGF1;PRKAA2;PRKN;TNRC6A;BMPR1A;PARP10;PARP14;SMO;TIPARP;RIN3;CD28;PTPN22;TNRC6B;ATXN2;RBL2;TERT;APLN;PARP9;SIRT1;HDAC1;LRP3;MOV10;RBL1;CRKL;WWP2;NOCT;DICER1;ZNF148;FLOT2;SNX12;MAP2K1;MAP2K2;FLCN;TNRC6C;NFKB1;TET1;ANXA7
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.32881456536115367,-1.1828727270682806,0.15593220338983052,0.553294405726525,1.0,32/80,18.81%,MAP3K5;THBS1;NOD1;GAS6;NGF;YWHAE;TNFSF10;CTSD;EPHA7;SIAH2;CD44;GRAMD4;ARL6IP1;RPS6KA3;GPER1;SOX7;DAPK1;SNCA;VEGFA;RPS6KA1;CARD16;MT3;PPM1F;PAX2;GPX1;SYK;SOX2;DHCR24;HTRA2;CYCS;FOXL2;BCAP31
prerank,negative regulation of MAPK cascade (GO:0043409),0.3818286121491038,1.1824380588452266,0.21067415730337077,0.9032746210249522,1.0,10/87,5.16%,BMP7;DUSP29;FBLN1;TIMP3;DLG1;CD300A;PPEF2;DAG1;EZR;TLR4
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.33183810572433564,-1.1819162214726067,0.15460526315789475,0.5547783894819599,1.0,19/72,10.24%,NRP1;ARHGEF28;HEG1;RIT2;ARHGEF3;F11R;RASIP1;NET1;ARHGEF2;STARD8;APOE;MET;PRAG1;KCTD10;MYOC;ARHGDIB;CUL3;STARD13;EPS8
prerank,regulation of extracellular matrix organization (GO:1903053),0.5097735568438612,1.1818661926979797,0.27289048473967686,0.903692517811733,1.0,1/15,0.12%,AEBP1
prerank,negative regulation of glycolytic process (GO:0045820),0.563490678482928,1.1818658345646298,0.3038461538461538,0.9006802094190273,1.0,4/10,13.82%,PPARA;NUPR1;HDAC4;NCOR1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.563490678482928,1.1818658345646298,0.3038461538461538,0.9006802094190273,1.0,4/10,13.82%,PPARA;NUPR1;HDAC4;NCOR1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.5100204196139203,1.181845197754425,0.2864864864864865,0.8992567877145617,1.0,4/16,16.81%,APPL2;SIRT4;NCOR1;ERLIN2
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.5254817858381016,-1.181210347588375,0.29591836734693877,0.5556589810498502,1.0,2/10,5.71%,ACTN4;TBX1
prerank,sterol transport (GO:0015918),-0.4473403236903423,-1.18084270269229,0.2163355408388521,0.5556524342298337,1.0,9/19,32.22%,CAV1;LDLR;NPC2;LDLRAP1;OSBP;STARD3;CD36;MSR1;NPC1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.41825302042021195,1.1802902285447021,0.24261275272161742,0.9030192574234704,1.0,9/51,5.18%,ROCK2;LPAR1;CCN2;ARHGEF10L;FHOD1;PPM1E;TGFBR1;RAPGEF3;TPM1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3895056459363737,1.1802723843862273,0.2134670487106017,0.90157275290289,1.0,22/76,18.65%,DAB2;SH3RF2;PRKN;LRRK2;PIAS1;TRIB2;PTEN;RNF217;CDK5RAP3;RNF19A;CSNK1A1;FBXO22;TRIB1;NUB1;DNAJB2;ZYG11B;HECTD1;RNF19B;CCDC22;TAF1;ARIH1;SUMO1
prerank,negative regulation of kinase activity (GO:0033673),0.40382467616058587,1.1801369336736987,0.2325925925925926,0.9005036491306263,1.0,8/62,8.75%,PRKAG2;PPM1E;DEPTOR;DTNBP1;NPRL2;TRIB2;WWTR1;PDPK1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.4704218636194184,-1.18001995664679,0.24307036247334754,0.556849695566778,1.0,10/16,42.81%,CADM1;PVR;RAET1E;RASGRP1;LAMP1;IL12A;CRTAM;KLRD1;CD160;KLRK1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.4809596307104354,-1.1791646862766543,0.2620545073375262,0.5579853388692051,1.0,3/13,9.18%,TMSB4X;PSEN1;HEY2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.42002668118598496,-1.1791141630617825,0.2494331065759637,0.5572765489890265,1.0,10/24,16.75%,PTK2B;APOE;CTSC;PSMD14;PKD1;PINK1;UBB;GPX1;USP14;UBE3A
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.47165716659959045,1.1789582466919248,0.2747068676716918,0.9030324426152507,1.0,7/27,3.91%,ARHGAP28;CGNL1;PRKN;ARHGEF18;CLASP1;ARHGAP6;PPFIA1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.5263848585228279,-1.1789407217419765,0.2823779193205945,0.5568420893824773,1.0,8/10,45.99%,SMAD7;NFKBIZ;RC3H2;MALT1;IL4;ZC3H12A;FOXP3;TBX21
prerank,macrophage activation (GO:0042116),-0.4003026196844449,-1.177785317496636,0.1969309462915601,0.558685079480836,1.0,13/34,19.14%,FOXP1;CD93;APP;PLCG2;DYSF;SBNO2;MAPT;SNCA;CLU;LBP;SYK;ITGB2;C1QA
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.3756080733442603,-1.1774653563563178,0.21243523316062177,0.5586148438907674,1.0,18/40,20.70%,PTK2B;RPL5;RPS7;XPO1;PTK2;GNA12;RPL23;RAD23B;FOXF2;AXIN1;LAPTM5;SMURF1;CLU;HIPK2;UBE3A;PDCL3;COMMD1;RPL11
prerank,limb morphogenesis (GO:0035108),-0.44521568238229114,-1.1773834324373944,0.2570694087403599,0.5579342290823167,1.0,5/20,7.72%,MBNL1;TGFB2;TBX3;PTCH1;PCSK5
prerank,cellular response to fatty acid (GO:0071398),-0.5005331681631252,-1.1773333383157425,0.2786177105831533,0.5572385104620484,1.0,1/12,0.40%,PID1
prerank,intestinal lipid absorption (GO:0098856),-0.5033183720757808,-1.1773182609965493,0.2572062084257206,0.5564609740672121,1.0,3/11,6.74%,UGCG;LIMA1;LDLR
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.4094762416100862,-1.1770779777480225,0.21951219512195122,0.5562532981089658,1.0,9/25,12.19%,CSGALNACT1;NDST3;FUT9;EXT1;NDST4;B3GALT1;B3GALNT1;EXT2;B3GALT5
prerank,male meiosis I (GO:0007141),0.5264846899722082,1.1766404930932772,0.2962962962962963,0.909579361417874,1.0,4/16,12.98%,CCNA1;MOV10L1;MYBL1;FOXJ2
prerank,regulation of microtubule-based process (GO:0032886),-0.3760768967291852,-1.1763588554020026,0.21534653465346534,0.5571983023619689,1.0,14/36,16.95%,CLASP2;EFNA5;PHLDB1;GSK3B;MAP6;ERBB2;MARK2;FAM107A;TRIM36;MAPT;BICD2;ATF5;TPPP;APC
prerank,steroid catabolic process (GO:0006706),0.5624090111564766,1.1763220899081068,0.2968127490039841,0.9091836794969513,1.0,1/10,2.52%,SPP1
prerank,neurotransmitter transport (GO:0006836),-0.33870152067412684,-1.1761461700693445,0.15384615384615385,0.5568973820525152,1.0,15/73,7.19%,NRXN1;SYT1;PPFIA2;SNAP25;RIMS1;CASK;LIN7A;SLC1A2;PTPRN2;GABRA2;UNC13B;SLC1A1;SYN2;HSPA8;GLS
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.4982126903289701,1.1760267579877288,0.2737030411449016,0.9087228602569173,1.0,6/18,17.62%,PPARA;PTPN22;MIA3;WNK1;GPNMB;LAX1
prerank,negative regulation of gene expression (GO:0010629),0.3356913866225072,1.175847709150457,0.15930232558139534,0.9079082161164744,1.0,64/302,15.76%,NOTCH2;ROBO1;LGR4;SLC24A3;ROCK2;WNT4;SYT11;PICALM;IGF1;PRKAA2;PRKN;DNMT3A;JARID2;TNRC6A;NCOR2;BMPR1A;PARP10;PARP14;SRGN;SMO;IGF2BP1;DDX3X;TIPARP;CD28;EIF2AK2;TWSG1;PTPN22;TNRC6B;SAMD4A;RBL2;LARP1;CPEB3;TERT;APLN;IGF2BP2;CNOT10;PARP9;SIRT1;HDAC1;LRP3;MOV10;LSM14A;RBL1;CRKL;WWP2;NOCT;DICER1;ZNF148;DDX6;FLOT2;PHF1;SNX12;MAP2K1;NCOR1;MAP2K2;FLCN;TSC1;KAT2B;TNRC6C;NFKB1;ANXA7;MPHOSPH8;SETDB2;RBM4
prerank,negative regulation of cell growth (GO:0030308),-0.3044372365393521,-1.1758236869168497,0.14545454545454545,0.556849006301128,1.0,40/121,21.10%,APBB2;SLIT2;PTPRJ;BMPR2;RTN4;DCC;TGFB2;ACVRL1;CCN3;SOX17;ENPP1;DIP2B;ADAM15;ULK1;PPP2R1A;RERG;SH3BP4;TGFB1;ULK2;SERTAD2;BTG1;FGF13;PPT1;FRZB;SEMA3G;CDKN1A;JADE1;EI24;MT3;DCBLD2;CCDC85B;NDRG3;SIPA1;CDKN2AIP;INHBA;DCUN1D3;RTN4R;ESR2;SFRP1;SLIT3
prerank,sarcomere organization (GO:0045214),0.4765873505639635,1.175702970806636,0.29152542372881357,0.9069291135684786,1.0,3/27,5.18%,ACTN2;CSRP3;TPM1
prerank,positive regulation of cellular component organization (GO:0051130),0.37418385871872273,1.1756022250304947,0.19433198380566802,0.9057832118776644,1.0,20/107,9.36%,DAB2;BMP7;LRP4;FNIP1;TRABD2B;FRMPD4;TGFBR1;BID;RAPGEF3;ADGRL1;MPP7;ANAPC2;CAMK1;PTPN23;NOX1;ASAP1;NRG1;CDH5;HYAL1;LRP1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.46426873382594186,1.1755992805444244,0.24958123953098826,0.9043126031873557,1.0,7/27,14.06%,DDX5;ATM;YJU2;SIRT1;DYRK1A;KMT5A;SNAI1
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.38019389406975307,-1.1754018514768814,0.23759791122715404,0.5570381937632838,1.0,9/39,8.98%,MYO1D;ACTN4;PPFIA2;MYO1B;FNBP1L;TANC2;MYO5A;DYNC1I1;MYO6
prerank,positive regulation of cell development (GO:0010720),-0.394216502146018,-1.175316526194795,0.23136246786632392,0.5564694184236977,1.0,9/31,19.59%,PDE3A;SERPINF1;MME;NAP1L1;GPER1;BMP4;CX3CR1;RFX3;TYROBP
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5350874131575741,1.1738346038301557,0.3026315789473684,0.9089093154964449,1.0,2/13,2.62%,ERRFI1;SNX6
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5139451118802658,1.173415658842541,0.28014842300556586,0.9089139738728127,1.0,3/16,6.37%,PIGN;PIGW;PIGQ
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.36405058257079664,-1.1733587698910457,0.22043010752688172,0.5601803623919055,1.0,13/47,8.69%,NRP1;ACTN4;EFNA5;CARMIL1;ARHGEF7;DOCK1;FLNA;CRK;CORO1C;LIMS2;MYOC;PTK2;CALR
prerank,cardiac muscle cell differentiation (GO:0055007),-0.43130390703994914,-1.1733479774186226,0.2545871559633027,0.5593953113417823,1.0,7/21,13.77%,SLC8A1;MEF2C;BMP2;MYH11;ACVR1;MYOCD;VEGFA
prerank,bicellular tight junction assembly (GO:0070830),0.4218546202741701,1.1731189205938857,0.2267080745341615,0.9084416356664722,1.0,9/46,13.42%,PARD6G;AFDN;DLG1;MPP7;CDH5;RAB13;PATJ;PRKCI;PARD3
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.33551912695286223,-1.1729769680856492,0.17994100294985252,0.559467814016212,1.0,21/72,15.24%,SLIT2;SHANK3;NAV3;CLASP2;KANK3;KANK4;ARHGEF2;LIMA1;APOE;STMN2;LDLR;HSPA8;FGF13;TUBB4A;SPEF1;PFN2;SNCA;SHANK1;CLU;IAPP;STMN1
prerank,positive regulation of MAPK cascade (GO:0043410),0.3378308097696859,1.1728448914694665,0.15140845070422534,0.9078818349423226,1.0,24/245,6.57%,NOTCH2;FGF1;ROBO1;ROCK2;LPAR1;TPD52L1;KSR1;PRKCZ;KIT;GSDME;IGF1;CCN2;FGFR2;SLC30A10;NPNT;FGFR1;ADRA2A;LRRK2;ARRB1;BRAF;EPHA8;FLT1;PDGFRB;EIF2AK2
prerank,regulation of astrocyte differentiation (GO:0048710),-0.49753131457176025,-1.172542353808805,0.27331887201735355,0.5597497890602572,1.0,6/12,10.04%,SERPINE2;NOTCH1;HES1;BIN1;BMP2;ID2
prerank,actin nucleation (GO:0045010),-0.43682602989211977,-1.172351674082105,0.25229357798165136,0.5593783577144746,1.0,6/21,13.79%,ACTR2;ACTR3;TRIM27;ARPC1B;ARPC5;ARPC4
prerank,focal adhesion assembly (GO:0048041),0.4800277221097068,1.1721466280835255,0.2872340425531915,0.9089450052483765,1.0,3/21,2.19%,ACTN2;SORBS1;RHOD
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.5213991938902109,-1.1720297432323314,0.3004115226337449,0.5593208515719257,1.0,6/11,27.81%,TERF1;CCT8;CCT2;CCT6A;CCT7;DKC1
prerank,skeletal system development (GO:0001501),0.3573479235633164,1.1717740852727836,0.21011673151750973,0.9088219606045006,1.0,25/148,9.22%,WWOX;BMP6;BMP7;DYM;IGF1;FGFR2;GLI2;SOX5;NPR3;AKAP13;FGFR1;SUFU;TGFBR1;SULF2;CREB3L2;COL9A2;SH3PXD2B;COL13A1;FBN1;COMP;RBP4;CHD7;COL1A2;EXTL1;HYAL1
prerank,response to cholesterol (GO:0070723),0.5037688482525005,1.1717596900238096,0.2891791044776119,0.9074096862908464,1.0,4/17,7.34%,GRAMD1B;TGFBR1;SMO;TGFBR2
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.48039163727458134,-1.1714099512380656,0.274468085106383,0.5599340290165707,1.0,3/14,8.63%,OSMR;IL6ST;PTGS2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.33336469908926303,-1.1714001335638438,0.18322981366459629,0.5591409030198962,1.0,21/75,13.89%,PTPRM;TEK;SEMA6A;CLDN5;PDE3B;DCN;THBS1;TGFB2;COL4A2;SEMA3E;DAB2IP;SERPINF1;HSPG2;STAB1;AMOT;ATP2B4;CTNNB1;ISM1;ECSCR;ADGRB1;SPRED1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.5013676621376953,1.171215454623827,0.30360205831903947,0.9078153925918752,1.0,5/19,9.79%,TLR3;TLR4;DDX3X;RIPK2;MAVS
prerank,glycerophospholipid catabolic process (GO:0046475),-0.4177744434468562,-1.1711798220452683,0.2517985611510791,0.5588651761232909,1.0,7/27,19.38%,PLA2G4A;GPCPD1;ENPP6;GDPD1;ENPP2;PLA2G4E;PLA2G15
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.36719905047336476,-1.1707945918955551,0.21008403361344538,0.5589528846441002,1.0,14/47,20.60%,GRM5;NFKBIA;APOE;APP;TGFB1;AGTR1;EDN1;EDNRB;EIF4E;PUM3;INHBA;RBM4B;AGT;RBM3
prerank,regulation of monooxygenase activity (GO:0032768),-0.42214760855631406,-1.1706689627490674,0.26540284360189575,0.5584433691637597,1.0,7/23,13.76%,CAV1;NOS3;NOSTRIN;CALM1;HSP90AA1;SNCA;CYGB
prerank,cellular response to hypoxia (GO:0071456),0.3649512525132395,1.1706214056799646,0.20463847203274216,0.9084087414372567,1.0,5/126,1.99%,EPAS1;CPEB2;RORA;BMP7;SLC8A3
prerank,programmed necrotic cell death (GO:0097300),0.4951907157456558,1.1700431978845547,0.29423076923076924,0.9089584330189239,1.0,5/18,10.97%,TLR3;TLR4;DNM1L;RIPK1;LY96
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.4044684497496911,-1.1696864735625245,0.24815724815724816,0.5599415350063869,1.0,4/29,7.62%,RPS8;RPS19;RPS21;RPS16
prerank,regulation of cellular response to heat (GO:1900034),-0.3266258038490009,-1.1693243152402717,0.16716417910447762,0.5600046648958377,1.0,32/77,29.92%,CAMK2D;CD34;YWHAE;HSP90AB1;GSK3B;HSPA8;HSP90AA1;NUP210;MAPT;DNAJC2;HSPB8;RPA1;FKBP4;CAMK2B;HSPH1;NUP107;DNAJB1;PTGES3;AKT1S1;BAG5;BAG2;POM121;CCAR2;NUP93;NUP85;NUP50;MLST8;NUP54;HSF1;MAPK3;RPA3;CAMK2A
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5233761028297128,1.1693182672213118,0.2875457875457875,0.9099154647435405,1.0,2/15,1.44%,ROCK2;IGF1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3897468048030276,1.1692895806685277,0.24707602339181287,0.9085728657096722,1.0,5/75,1.99%,ATP1A2;SLC6A1;ATP1B3;KCNJ13;SLC8A3
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.46446368481103184,-1.1691794968192373,0.25862068965517243,0.5595290211324562,1.0,5/15,13.29%,RTN4;REEP1;RAB18;ARL6IP1;ATL2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.5369340679589678,1.1691557354989828,0.2873134328358209,0.9076131204803278,1.0,7/12,22.34%,PTEN;BTRC;CDC14B;FZR1;GOLGA2;UBE2S;GORASP1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.3119149826963327,-1.168702271255566,0.15547703180212014,0.5598712641843543,1.0,26/110,14.77%,ADGRL3;ADGRB3;ADGRL4;ADGRL2;CALCRL;ADGRG6;GNAS;ADCY2;ADRA1B;ADGRE5;ADCY7;GNG2;RAMP2;ADCY4;S1PR1;LGR5;PTH1R;GPER1;PTHLH;RAMP1;ADGRB1;GPR26;ADGRG1;IAPP;GNAL;GNB1
prerank,receptor clustering (GO:0043113),-0.40546613928395464,-1.1680460352546773,0.2458233890214797,0.5606472940931432,1.0,9/27,11.22%,NLGN1;DLG2;NRXN1;LRRC7;FLNA;ITGA4;PTN;AGRN;NRXN2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.3741003773529059,-1.167449887024981,0.22439024390243903,0.5611912755747153,1.0,12/39,16.10%,PTPRJ;SH3KBP1;PTPN12;SH3GL2;ARHGEF7;DAB2IP;ERBB2;DUSP3;PTPN3;SPRY1;ZFYVE28;CBL
prerank,stabilization of membrane potential (GO:0030322),0.5149947220367046,1.167405636378085,0.29944547134935307,0.9123134418308171,1.0,1/16,0.26%,KCNK2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.43574619501038425,1.1666388914773629,0.25157232704402516,0.9134676334409552,1.0,6/37,9.01%,APPL2;PPARA;TLR4;F2;IL17D;IL17RA
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.4802733796863959,-1.1666125309861586,0.2799145299145299,0.5623127474351658,1.0,4/14,10.04%,THBS1;MEOX2;NOTCH1;STARD13
prerank,mRNA metabolic process (GO:0016071),0.3794453208679196,1.1665469060196465,0.2401685393258427,0.9123882847372672,1.0,25/90,21.54%,DDX5;PPARGC1A;SON;PCBP2;HNRNPR;SRSF5;TP53;HNRNPA2B1;CNOT10;TBRG4;PRPF18;SRSF11;HIPK3;SCAF11;PRPF3;CPSF3;USP39;ALKBH5;SRSF1;PCF11;U2AF1;DXO;SRSF7;U2AF2;SF3B2
prerank,negative regulation of biosynthetic process (GO:0009890),0.5156127290545873,1.1665254166758459,0.3046471600688468,0.9110065548737196,1.0,2/16,2.04%,PPARA;SLC30A10
prerank,negative regulation by host of viral process (GO:0044793),0.557502649032271,1.1665183451975274,0.29887218045112784,0.9095986786848246,1.0,1/10,1.98%,PRKN
prerank,actin filament bundle organization (GO:0061572),0.44352796058275124,1.1663953714867956,0.26791808873720135,0.9085580290003021,1.0,6/33,6.38%,PAWR;SHROOM2;RHOD;EZR;BAIAP2L1;BAIAP2
prerank,spliceosomal complex assembly (GO:0000245),0.4178261305378544,1.165366302142675,0.2787682333873582,0.910553634526724,1.0,13/46,22.74%,CELF2;SRSF5;KHDC4;LUC7L3;SRPK2;SCAF11;USP39;PRPF6;SRSF1;SRSF10;SF1;SF3B1;GCFC2
prerank,cellular response to interleukin-1 (GO:0071347),-0.2987209531492608,-1.1649508381710982,0.100418410041841,0.5654727639811566,1.0,48/143,29.51%,RPS6KA5;IL1R1;IL1RAP;ST18;NOD1;PTGIS;NFKBIA;PSMB2;DAB2IP;MAP3K7;IRAK3;PSMD14;EGR1;CD47;PSMC6;IKBKB;HIF1A;UBB;PSMA4;PSMB9;PELI1;NOD2;CCL13;SKP1;PSMD11;PSMB10;PSMD2;CCL19;HAS2;SFRP1;PYCARD;PSMA2;UBC;RPS27A;RELA;HYAL2;PSMB3;TAB1;CD40;CCL2;PSMB5;PSMA7;MAP3K8;IRAK4;MAPK3;PSMF1;TOLLIP;PSMD7
prerank,modulation by symbiont of entry into host (GO:0052372),-0.45541601854258346,-1.1649146012305276,0.26609442060085836,0.5647765200776127,1.0,4/16,11.13%,CAV1;HS3ST5;TRIM14;TRIM27
prerank,cellular response to dsRNA (GO:0071359),0.51606943640159,1.164541250188385,0.3128390596745027,0.9120673616162677,1.0,2/15,2.84%,COLEC12;IFIT1
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.4267900500512245,-1.1644658558784062,0.252212389380531,0.5650845368192011,1.0,6/21,12.35%,NAV3;CLASP2;ARHGEF2;STMN2;FGF13;SPEF1
prerank,B cell activation (GO:0042113),-0.3284183560783453,-1.1636772241698055,0.1935483870967742,0.5661792575479158,1.0,10/68,7.96%,MEF2C;PTPRJ;TPD52;VCAM1;HDAC9;PTPRC;PLCG2;ITGB1;ITGA4;EPHB2
prerank,axon extension (GO:0048675),-0.41659585903325635,-1.1633361933189583,0.24719101123595505,0.5661463073154823,1.0,10/23,10.34%,NRP1;SLIT2;MAP1B;NRP2;SEMA5A;HSP90AB1;ULK1;ULK2;SLC9A6;HSP90AA1
prerank,histone deubiquitination (GO:0016578),0.5060072186854819,1.1633108048240262,0.28166351606805295,0.9149643746532227,1.0,7/18,19.48%,USP3;USP49;UIMC1;USP7;EPOP;USP21;USP16
prerank,regulation of vacuole organization (GO:0044088),0.5019289087660528,1.162888599326482,0.29845626072041165,0.9150108404483662,1.0,5/20,11.12%,MTMR3;NPRL3;NPRL2;PIKFYVE;IFT88
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.3638009003833172,-1.1627671691949049,0.21311475409836064,0.5666667685993062,1.0,16/44,17.95%,THBS1;GAS6;NGF;YWHAE;SIAH2;CD44;ARL6IP1;RPS6KA3;SNCA;VEGFA;RPS6KA1;CARD16;MT3;PAX2;GPX1;DHCR24
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.32571340675004007,1.16269427056938,0.16027088036117382,0.9141498183937177,1.0,45/348,10.61%,FGF1;ROBO1;BMP6;BMP7;AFDN;SLC24A3;SMAD3;ROCK2;ANK2;OSR1;PPARGC1A;IGF1;WNT6;PRKN;FOXD1;TNRC6A;MAGI2;MITF;TGFBR1;DTNBP1;TLR3;EZR;SMO;CTSH;CUX2;TLR4;ATM;DDX3X;ARRB1;MAP2K5;BRAF;CD28;TP53;PTPN22;PLSCR1;TNRC6B;CDH5;CALCOCO1;TLE1;LRP3;PICK1;UBR5;MOV10;PIK3R3;SRPK2
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.3141116500074044,-1.1625477203740178,0.17857142857142858,0.5663569551479902,1.0,34/92,15.15%,NRP1;TEK;BMPR2;RTN4;THBS1;CLASP2;TGFB2;NRP2;PTK2B;SCARB1;DOCK1;EPB41L4B;KDR;GPI;IQSEC1;FOXP1;PLCG2;RHOB;PROX1;CALR;ATOH8;FGF2;FLT4;BCAR1;ITGB3;EDN1;ENPP2;BMP4;HIF1A;FGF7;PRKD1;VEGFA;PPM1F;RRAS
prerank,regulation of epidermal cell differentiation (GO:0045604),0.4789820845171806,1.1624191483426256,0.29285714285714287,0.9136780244336012,1.0,3/21,4.12%,ROCK2;ERRFI1;MAFG
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.3865793341527655,1.1622817573188562,0.24012158054711247,0.9127162658643577,1.0,7/66,3.80%,ROBO1;TGFBR3;FGFR2;MCC;NUPR1;NR2F2;NFIB
prerank,establishment of protein localization to membrane (GO:0090150),0.3920486705908561,1.1620365155685985,0.22962962962962963,0.9121021937566269,1.0,26/66,24.34%,AFDN;SYNE3;BID;RAB3IP;BRAF;PIKFYVE;RAB11B;ZDHHC18;ZDHHC1;MYO1C;PRKCI;PARD3;MICALL1;VPS37A;ARL6;RABGEF1;ZDHHC23;GORASP2;NECTIN3;ZDHHC12;GORASP1;SDCBP;ICMT;ZDHHC19;RAB10;RAB3GAP1
prerank,cellular response to hormone stimulus (GO:0032870),0.3958048957569969,1.1610515027036594,0.24345146379044685,0.9140312496227317,1.0,10/69,7.27%,ATP1A2;THRB;TFPI;SLC5A5;BRD8;ADRA2A;CTSH;NCOA3;BCAS3;GCK
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.49378909361201506,1.161020987846245,0.2920353982300885,0.9127088342164577,1.0,6/19,16.03%,POLD2;AMPD3;TERT;AMPD2;POLL;APRT
prerank,monocyte differentiation (GO:0030224),-0.529396178094141,-1.1610014172709837,0.2817204301075269,0.5692488389638891,1.0,6/10,15.37%,MYH9;MT1G;BMP4;THOC5;VEGFA;IL31RA
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.3209896607693406,-1.160796802829604,0.16216216216216217,0.5689303485076714,1.0,17/80,10.46%,NRP1;NLGN1;TENM2;PIK3R1;FNBP1L;PLCE1;CCDC88A;ACTR2;CDC42EP3;OCLN;TGFB3;ANLN;PLPPR5;P2RY12;EPS8;AGRN;ACTR3
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.45965427997636443,-1.160329336315302,0.2553191489361702,0.5692886911101981,1.0,5/16,8.77%,ST6GALNAC3;ST8SIA4;ST8SIA1;ST6GALNAC5;ST8SIA6
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.3797802528919763,-1.1600310568137384,0.24119241192411925,0.5691630476642483,1.0,8/35,6.44%,GHR;ERBB4;CAV1;CYP1B1;NOTCH1;NLK;PTPRC;HES1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.35243694981870116,-1.1600138656551513,0.2316715542521994,0.5684005761391335,1.0,11/51,15.16%,VEGFC;THBS1;CXCL12;GAS6;PTK2;CALR;PTN;EDN3;CMKLR1;VEGFA;RARRES2
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4237722738359965,1.1596296625365101,0.24960753532182103,0.9160870919206142,1.0,7/40,6.37%,LPAR1;KIT;LPAR2;FGFR1;ARHGAP6;FLT1;PDGFRB
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.48939368617312673,1.159621371261024,0.30671506352087113,0.9146788376634791,1.0,3/20,4.75%,ATP1A2;ANK2;CACNA1C
prerank,regulation of neuron death (GO:1901214),-0.32601078121023974,-1.1591461339257234,0.18849840255591055,0.5696168556874543,1.0,38/82,23.30%,GRID2;MEF2C;MAP3K5;CD200;EPHB1;DCC;GRIN2B;TRIM2;CD34;GSK3B;TNFRSF1B;SORL1;BTBD10;EGR1;DDIT4;NENF;MAPT;SNCA;CLU;UBB;EGLN2;FAIM2;CHRNA7;DHCR24;HTRA2;CHMP4B;CHMP4A;CTSZ;ITGB2;C1QA;TYROBP;EGLN3;AKT1S1;GRM4;SNCG;FYN;LANCL1;CHGA
prerank,organophosphate biosynthetic process (GO:0090407),0.4412329604634,1.1588709751662265,0.2515923566878981,0.9158153164651975,1.0,14/37,20.17%,AGPAT4;GPAT2;CPS1;GK5;MOCOS;GK;ITPKB;PPIP5K2;GPAM;TPK1;NFS1;IP6K3;PCYT2;MOCS1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.3916982165159288,1.1588358902532587,0.2470059880239521,0.9145192119830624,1.0,17/59,15.04%,ROCK2;OXSR1;TGFBR1;LRRK2;CDC42BPG;TGFBR2;PDPK1;DYRK1A;PRKDC;CSNK2A2;CSNK2A1;PRKCA;HIPK3;WNK1;MAP2K1;CAD;ACVR1B
prerank,positive regulation of signal transduction (GO:0009967),0.33065201160018826,1.1584505518736752,0.18562874251497005,0.9144643354360346,1.0,28/238,6.25%,FGF1;ROBO1;BMP6;RSPO2;WLS;TSPAN5;SORBS1;TPD52L1;PRKCZ;IGF1;SMOC2;SASH1;FGFR2;DCDC2;NLGN2;PHIP;TTC23;TGFBR1;AAK1;LRRK2;SULF2;LOXL3;PRKCB;SMO;CUX2;GPS2;RAB34;GKAP1
prerank,protein localization to organelle (GO:0033365),0.3567555819755014,1.1583493446584987,0.19919786096256684,0.9133943313569028,1.0,24/133,15.83%,BMP7;ANK2;TULP3;ZNF423;CSRP3;OBSL1;CEP250;LRRK2;LAMP2;DDX3X;TRAM2;TIA1;UBAC2;GBP2;IFT122;PIKFYVE;ATP6V1D;DCP1A;ROPN1;STX5;WDR35;MICALL1;ARL6;BBS2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.37669153991611826,1.158252415038667,0.25889046941678523,0.9123187243684339,1.0,18/87,11.82%,TGFBR3;SMAD3;APPL2;PRKCZ;ARHGEF18;BMPR1A;TGFBR1;SMAD6;FMOD;USP9X;TWSG1;TGFBR2;COL1A2;CDH5;SIRT1;ZMIZ2;ZMIZ1;GDF15
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.3915977424730481,-1.1579248036088405,0.2371967654986523,0.5717063696854051,1.0,12/33,11.29%,BMPER;RHOJ;SEMA6A;THBS1;PPP1R16B;EPN2;KLF2;SMAD1;CEACAM1;FGF2;JAK1;CREB3L1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.3539758415164895,-1.1577106736495493,0.2132132132132132,0.5714179637666554,1.0,22/55,34.29%,FBXL7;PSMB2;PSMD14;PSMC6;ATF5;PSMA4;PSMB9;SKP1;PSMD11;PSMB10;PSMD2;PSMA2;PSMB3;FHL1;PSMB5;PSMA7;PSMF1;PSMD7;AURKA;PSMA5;PSMD4;PSME4
prerank,protein tetramerization (GO:0051262),0.39433771966653375,1.1571916510995575,0.23858615611192932,0.9145319038645856,1.0,9/67,9.81%,ALDH1A2;APPL2;UPB1;KRT1;SOD2;SAMHD1;SSBP1;CBY1;CTH
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.4770752159732502,-1.1569939166553407,0.2803532008830022,0.5723228326629249,1.0,8/15,29.01%,CCT8;CCT2;CCT6A;NHP2;CCT7;RUVBL2;DKC1;NAF1
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.5248264683338919,-1.1569278818627378,0.28964059196617337,0.5717092032511424,1.0,6/10,16.82%,CORO2B;NDFIP2;MAPT;PPM1F;TERF1;DNAJA1
prerank,amino acid import (GO:0043090),0.4791233613280461,1.1567848778874834,0.31282952548330406,0.9145750033818703,1.0,3/21,4.62%,SLC6A13;SLC6A1;SFXN2
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.4799294457600458,1.156766269874995,0.2994652406417112,0.9132247897709725,1.0,7/19,9.30%,TGFBR3;FGFR2;BMPR1A;TGFBR1;VGLL4;RBP4;GLI1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.4744532486977741,1.1566484739715144,0.3053016453382084,0.9122017705414277,1.0,2/22,1.52%,MAN1A2;MAN1C1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.5410950099215488,1.156106467472201,0.31299212598425197,0.9113136679244671,1.0,6/11,26.19%,TNRC6A;TNRC6C;RBM4;AGO1;AGO4;AGO2
prerank,miRNA mediated inhibition of translation (GO:0035278),0.5410950099215488,1.156106467472201,0.31299212598425197,0.9113136679244671,1.0,6/11,26.19%,TNRC6A;TNRC6C;RBM4;AGO1;AGO4;AGO2
prerank,neural tube development (GO:0021915),0.5092916419776665,1.1554599044557021,0.3314393939393939,0.9121058152759429,1.0,1/15,0.34%,ALDH1A2
prerank,mitochondrion morphogenesis (GO:0070584),-0.501675577408044,-1.1549709301708724,0.3231441048034934,0.5756506408862145,1.0,3/11,16.33%,PID1;PNPT1;WASF1
prerank,cellular component assembly (GO:0022607),-0.2736772967618857,-1.1549073990444239,0.06832298136645963,0.5749888253438563,1.0,51/253,13.12%,NLGN1;SPTBN1;RHOJ;SLC2A1;GSN;ANK3;ACTB;MYO1B;REPS2;RIMS1;RTN4;PARVB;IL1RAP;LIN7A;PTK2B;LRRTM3;PCLO;ACTG1;SKAP2;GAS6;VMP1;GPM6B;LIMA1;PLS1;FLNA;HES1;OCLN;DCX;CD2AP;PPP2R1A;ELOB;LIMS2;TGFB1;TUBGCP2;RP1;RHOH;ADD2;SHROOM1;ARL6IP1;EPS8;PDGFA;CALD1;CAPZA2;CLDN14;FAM107A;ILK;SPEF1;FAS;LPXN;MDN1;DMTN
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.4971152989344638,1.154904162303263,0.2956989247311828,0.912536345337437,1.0,2/17,0.55%,ROBO1;EFNB2
prerank,atrial septum morphogenesis (GO:0060413),0.5576588425319333,1.154753381674638,0.3005893909626719,0.9116626938934652,1.0,1/10,0.19%,NOTCH2
prerank,regulation of establishment of protein localization (GO:0070201),-0.48842364787425735,-1.154615716687661,0.2648305084745763,0.57485249468935,1.0,5/13,16.82%,CTSD;CORO2B;GAPVD1;PTP4A3;DNAJA1
prerank,regulation of synapse organization (GO:0050807),-0.4038389772429598,-1.154448563275578,0.2935560859188544,0.5745067837094888,1.0,4/26,4.04%,CTNNA2;MEF2C;IL1RAPL1;CDKL5
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.36726096747963344,1.154313607568681,0.2196765498652291,0.9117242466572255,1.0,10/107,3.59%,ATP13A5;SLC24A3;SLC41A1;ANK2;ATP13A3;SLC8A3;SLC30A10;PKHD1;CSRP3;DMPK
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4753376240190545,1.1541437683479292,0.3080895008605852,0.9108968032350704,1.0,6/24,3.91%,ARHGAP28;CGNL1;ARHGEF18;CLASP1;ARHGAP6;PPFIA1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.34593923567501156,-1.1536154660777949,0.23893805309734514,0.5756326614322094,1.0,11/53,15.27%,CALCRL;CHRM3;HTR2C;ANXA1;HTR2A;CHRM2;HTR1F;HTR7;HTR4;HTR1B;HRH1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5144629608217899,1.1535606886422716,0.32234432234432236,0.9114096188710771,1.0,3/14,7.06%,PRKN;LRRK2;OPA1
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.31235694103883754,-1.1532860212540357,0.1875,0.5756107658688706,1.0,33/107,22.78%,PIK3R1;MAP3K5;THBS1;NIBAN1;RASGRF2;GSK3B;DAB2IP;HSPA5;DDRGK1;DNAJC10;RASGRF1;PDIA3;ATP2A3;AIFM1;UFM1;TMEM117;SELENOK;CREB3L1;ATF4;BBC3;NCK1;EIF2AK3;RHBDD1;TMX1;BCL2L11;BCAP31;CASP4;RCN3;CFTR;ATP2A2;TRIB3;THBS4;FLOT1
prerank,embryonic skeletal system development (GO:0048706),0.4348631046849537,1.1526577978755554,0.2761904761904762,0.9130892809568097,1.0,11/35,13.29%,OSR1;HOXB4;SULF2;HOXB3;HOXB9;HOXA3;RBP4;HOXC4;DYNC2I1;DEAF1;SULF1
prerank,membrane depolarization during action potential (GO:0086010),0.46058431789073295,1.152623992999565,0.3048128342245989,0.9118320308461844,1.0,2/26,0.55%,ATP1A2;CACNA1D
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.4943724576365834,1.1524755324812443,0.29084380610412924,0.9109673480645885,1.0,2/17,1.91%,ANK2;SNTA1
prerank,negative regulation of cell projection organization (GO:0031345),0.4167217588099628,1.1521628553941763,0.2546875,0.9106354087521166,1.0,7/48,8.38%,EFNB2;LPAR1;EPHA4;PTPN9;CBFA2T2;PTEN;DENND5A
prerank,membrane raft organization (GO:0031579),-0.47252770540015476,-1.1520901675831259,0.2899786780383795,0.5777750435683684,1.0,7/15,24.45%,RFTN1;PPT1;EMP2;MYADM;S100A10;FLOT1;NAXE
prerank,DNA catabolic process (GO:0006308),0.5614807617966364,1.1516132872684428,0.3191489361702128,0.9110088105328332,1.0,5/11,22.81%,DNASE1L1;FBH1;DFFB;DNASE1L2;REXO4
prerank,cell part morphogenesis (GO:0032990),-0.47865705811535986,-1.1513231741071992,0.3032967032967033,0.5787049290944574,1.0,6/13,28.96%,PID1;PNPT1;WASF1;CSPG5;NUBPL;FIS1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.496312840113181,1.150877709268024,0.2836624775583483,0.9120915967819553,1.0,1/17,0.83%,LPGAT1
prerank,positive regulation of TORC1 signaling (GO:1904263),0.4959740044883371,1.1507786439428815,0.3071297989031079,0.9110471404458418,1.0,7/16,26.68%,GPR137;FLCN;TELO2;RRAGD;RRAGB;SIK3;GPR137B
prerank,extracellular structure organization (GO:0043062),0.33637457895570094,1.1505547555171556,0.20075282308657466,0.9104550268790821,1.0,32/204,8.64%,SMOC1;COL5A1;ADAM12;ADAMTS10;LAMA4;COL22A1;LAMC2;COL4A5;SMOC2;ITGA9;LAMC1;NPNT;SPP1;COL18A1;COL4A3;LOXL1;ADAMTS2;TGFBR1;ADAMTS15;DAG1;ITGA10;ADAMTSL5;ADAMTS9;COL9A2;COL13A1;FBN1;SERPINE1;COMP;COL4A4;COL1A2;MMP19;COL27A1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.505497900709521,1.1504938602822379,0.32304900181488205,0.9092881891732798,1.0,2/14,1.44%,SYT11;IGF1
prerank,membrane repolarization during action potential (GO:0086011),-0.48810192813794345,-1.1498987138907057,0.2857142857142857,0.5813176314079936,1.0,5/13,8.00%,KCNJ2;ATP1B1;YWHAE;ATP1A1;KCNQ1
prerank,central nervous system neuron development (GO:0021954),-0.4683148787373368,-1.1496015360337752,0.2923076923076923,0.5812418487366013,1.0,6/15,12.71%,NTRK2;HSP90AB1;B4GALT5;LHX6;HSP90AA1;MAPT
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.4916268046180109,-1.148769634375754,0.2909090909090909,0.5823925784079349,1.0,4/12,4.54%,SYT1;RIMS2;RIMS1;UNC13B
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.44209740985658286,-1.1484719239551053,0.29175946547884185,0.5824005398955889,1.0,8/19,15.27%,PLCE1;PPP3R1;NFATC1;PPP3CA;EDN1;EDN3;PPP3CC;HRH1
prerank,aminoglycan metabolic process (GO:0006022),-0.5067167336648913,-1.1482883332317337,0.29577464788732394,0.5820746824964653,1.0,6/10,25.17%,XYLT1;B3GAT2;CHST9;B3GALT6;B3GAT3;B3GAT1
prerank,regulation of developmental growth (GO:0048638),-0.39729043204265335,-1.1481519248392569,0.24427480916030533,0.5816203976708841,1.0,10/29,14.68%,GHR;GSK3B;APOE;APP;NRCAM;SIX1;STAT5B;MFSD2A;SPAAR;FGFR3
prerank,purine ribonucleotide metabolic process (GO:0009150),0.3855908886159455,1.1480065441386966,0.25705794947994054,0.9161176755850201,1.0,22/68,20.59%,RHOQ;AMPD3;LRRK2;ABHD14B;OPA1;SULT2B1;ACOT11;AK3;AK4;NT5C2;MLYCD;TPST1;ACOT8;THEM4;AMPD2;ACOT12;MFN1;ADSS1;ACLY;CROT;ACSF2;GMPR2
prerank,regulation of ion transport (GO:0043269),0.3825671086895076,1.147890683129899,0.24475524475524477,0.9151594467908278,1.0,16/76,11.44%,SYT9;KCNJ13;SYT11;SYT12;KCNA5;PRKN;SNX6;NEDD4;DTNBP1;SIK1;GDNF;KCNJ14;HTR1A;RAB11B;SCN10A;WWP2
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.4114049621509666,1.1476111166881402,0.2621951219512195,0.9147250352452277,1.0,9/48,9.41%,ADCY5;NPR1;ADCY1;AMPD3;NPR2;ADCY9;PANK1;SLC26A1;DCAKD
prerank,gland development (GO:0048732),0.3985556524860809,1.1475747025423757,0.2595419847328244,0.9134716130314529,1.0,9/59,8.46%,TGFBR3;WNT4;FGFR2;GLI2;DKK3;TGFBR1;EZR;CDK5RAP3;NRG1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.48293307163776666,1.1472940744735962,0.3045977011494253,0.9130481296283224,1.0,1/17,0.26%,FGF1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.4187594548536911,1.1472021081609534,0.28733766233766234,0.9119989614600013,1.0,7/40,8.88%,IGF1;PRKN;BID;FAM162A;TP53;OPA1;DNM1L
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.44146985141436546,1.1470441037918322,0.2984822934232715,0.911149237499873,1.0,5/33,9.30%,APPL2;STXBP4;PLK5;PTEN;GLI1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.3758624675308503,1.1467723211247667,0.2546230440967283,0.9106472425367542,1.0,17/85,14.24%,DENND4A;NOTCH2;IGF1;ARHGEF18;KANK2;AKAP13;ARHGAP17;SYNGAP1;EPS8L2;OPHN1;CRKL;EPS8L1;MAPKAP1;DENND4C;OGT;MFN2;FLCN
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.3145084300258635,-1.146665515394212,0.20394736842105263,0.5844388538215459,1.0,32/91,22.55%,ABCG2;SCARA5;SLC39A10;FTH1;HMOX2;TFRC;SLC40A1;APP;FBXL5;FTL;MT1E;MT1F;MT1M;MT1G;MT1X;MT1H;MT1A;MT1B;ATOX1;SLC30A1;SLC31A1;SLC39A12;MT3;SLC22A17;ISCU;SKP1;CAND1;GLRX3;IREB2;MT2A;SOD1;CYBRD1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.3929798701132788,-1.1455077111884384,0.2569444444444444,0.5863598154841628,1.0,7/27,14.29%,CAV1;PLTP;NFKBIA;APOE;PTCH1;EEPD1;ABCB4
prerank,cellular respiration (GO:0045333),0.40985864956341805,1.1449654733410792,0.2744479495268139,0.9156379658934292,1.0,14/41,19.65%,PPARGC1A;MTFR2;SIRT3;COQ10A;UQCRC2;NDUFS1;COX10;LYRM7;SDHAF4;ATP5F1D;SDHB;NDUFS4;ETFDH;UQCRC1
prerank,protein oxidation (GO:0018158),0.5418080706073475,1.1449445852107107,0.3031496062992126,0.9143758609603351,1.0,2/11,4.57%,LOXL1;LOXL3
prerank,aortic valve morphogenesis (GO:0003180),-0.3888462978467699,-1.1448872950876645,0.2628992628992629,0.5870764077568629,1.0,13/30,12.47%,SLIT2;ROBO2;ELN;NOS3;TIE1;JAG1;NOTCH1;HEYL;NFATC1;TGFB1;HEY2;BMP4;TWIST1
prerank,lysosome organization (GO:0007040),0.43109350177333833,1.1448614818896836,0.2861788617886179,0.9132843656060236,1.0,13/36,20.57%,HOOK2;LRRK2;TPP1;CLN6;ARSB;HPS1;MBTPS1;ZKSCAN3;HOOK3;MYO7A;LAMTOR1;TPCN2;SNAPIN
prerank,regulation of steroid metabolic process (GO:0019218),0.47126231437654126,1.1447917250545672,0.29473684210526313,0.9121650050263712,1.0,11/23,24.29%,RORA;RORC;ARV1;TTC39B;EPHX2;LAMTOR1;NR5A1;GNB3;ABCA2;STAR;DGKQ
prerank,hemopoiesis (GO:0030097),0.36685107894290997,1.1447644135077018,0.23887240356083086,0.910926236333423,1.0,13/87,7.34%,NOTCH2;TGFBR3;KIT;KMT2A;FGFR2;ZNF160;MEIS1;TET2;PGM3;FLT1;TP53;FUT10;TGFBR2
prerank,glucose transmembrane transport (GO:1904659),-0.43295721526654746,-1.1446991421902597,0.2687224669603524,0.5867564311100292,1.0,5/18,18.25%,SLC2A1;PPARD;SORT1;SLC2A3;SLC45A1
prerank,regulation of sister chromatid cohesion (GO:0007063),0.5184087604769042,1.144244184954448,0.3087378640776699,0.9113485148260391,1.0,5/12,18.70%,HDAC8;WAPL;AXIN2;RB1;FEN1
prerank,regulation of DNA recombination at telomere (GO:0072695),0.4824784316169163,1.1439548170506686,0.3217550274223035,0.9096325767448205,1.0,4/19,7.53%,POLR2A;ATRX;ACD;POLR2D
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.4824784316169163,1.1439548170506686,0.3217550274223035,0.9096325767448205,1.0,4/19,7.53%,POLR2A;ATRX;ACD;POLR2D
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.32604227510854267,-1.1439197353218724,0.21428571428571427,0.587851590441902,1.0,13/67,11.28%,ATP8B1;CAV1;MYO10;PODXL;TBC1D1;PPP1R16B;CDKL5;TBC1D8;TBC1D5;RDX;GAP43;TBC1D2B;FXR1
prerank,positive regulation of ossification (GO:0045778),0.428749399359704,1.1438585042095923,0.3008,0.9086416633007554,1.0,6/39,3.18%,BMP6;BMP7;WNT4;OSR1;KL;BMPR1A
prerank,icosanoid biosynthetic process (GO:0046456),-0.5105419581783176,-1.143391524263541,0.32172131147540983,0.5882568526440156,1.0,5/10,29.00%,PLA2G4A;LTA4H;FADS1;ALOX5AP;MGST2
prerank,cellular response to exogenous dsRNA (GO:0071360),0.5415386057740255,1.1432651245044092,0.30694980694980695,0.9093056040982432,1.0,2/12,2.84%,COLEC12;IFIT1
prerank,regulation of peptide hormone secretion (GO:0090276),0.3886821595734893,1.1427896241672193,0.2747093023255814,0.9094895195964651,1.0,12/67,9.70%,CACNA1D;ITPR2;ITPR1;KCNA5;ADRA2A;RAPGEF3;DPP4;CACNA1C;GCK;CHD7;EIPR1;PICK1
prerank,muscle contraction (GO:0006936),0.34646822555216206,1.1421754400750075,0.23148148148148148,0.910232661285045,1.0,18/126,9.20%,ROCK2;ACTN2;SORBS1;SNTA1;MYOF;TMOD2;PABPN1;PGAM2;TLN1;BDKRB2;DTNA;TMOD3;TPM1;KLHL41;ARHGEF11;CHRNG;MYL4;NMUR1
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.4787586390658749,-1.1421654414501288,0.3024193548387097,0.5904643037380812,1.0,5/13,10.70%,NFKBIA;YWHAB;FLNA;GOPC;PKD1
prerank,long-chain fatty acid import into cell (GO:0044539),0.5455760075339039,1.1419545968467646,0.32023575638506874,0.9096801215283093,1.0,3/10,9.67%,ACSL1;SLC27A1;SPX
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.43714528685748905,1.1414570191713058,0.2980132450331126,0.9099420331530994,1.0,5/30,4.75%,CACNA1D;ANK2;KCNA5;SNTA1;CACNA1C
prerank,regulation of cholesterol efflux (GO:0010874),-0.39144102199436437,-1.141417347891055,0.26329113924050634,0.5914420279282953,1.0,7/30,10.66%,CAV1;PLTP;NFKBIA;APOE;PTCH1;SREBF2;EEPD1
prerank,maturation of SSU-rRNA (GO:0030490),-0.37878414803795524,-1.1413862912253205,0.2777777777777778,0.5907251483063554,1.0,5/34,8.78%,RPS8;RPS19;RPS28;RPS16;WDR3
prerank,positive regulation of response to external stimulus (GO:0032103),0.35333281078452555,1.1412254248293419,0.22493224932249323,0.9093790015864394,1.0,24/128,13.78%,BMP6;SASH1;IL18;NAPEPLD;TLR3;TLR4;F2;IFNK;ANKRD17;PDGFRB;IL12B;SERPINE1;PLSCR1;HRG;GPRC5B;IL17RA;DDX60;RIPK1;LY96;DHX58;NMI;PRKCA;IFI35;ACOD1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.5295559750443928,1.1411688466664454,0.3229357798165138,0.9082735564946618,1.0,2/14,0.89%,ACE;CORIN
prerank,regulation of cell projection organization (GO:0031344),-0.4689210101843161,-1.1410146108606634,0.2883435582822086,0.5908904838315722,1.0,5/13,20.36%,NTNG1;SEMA4D;MFSD2A;ERMN;CCL19
prerank,hyaluronan catabolic process (GO:0030214),-0.44769071656395887,-1.1409903702768487,0.28,0.59014653709558,1.0,5/18,9.92%,CEMIP;TGFB1;HEXB;FGF2;CD44
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.47540791946315497,-1.1405553013179772,0.29273504273504275,0.5904125802158406,1.0,5/13,27.34%,RPS21;ABT1;RRS1;KRI1;NOL9
prerank,defense response to virus (GO:0051607),0.3643057124881541,1.1404754353650008,0.26430517711171664,0.9091793986484207,1.0,24/100,15.46%,IFIT1;IFIT2;OAS2;IFIT3;IFI27;NDUFAF4;TLR3;RNF135;TRIM56;STAT2;EIF2AK2;PLSCR1;SAMHD1;RSAD2;MAVS;MOV10;ATG7;ZDHHC1;IRF1;AKAP1;OAS3;ACOD1;IFNAR2;NT5C3A
prerank,positive regulation of phosphatase activity (GO:0010922),-0.4240164936028433,-1.1400818044748726,0.2727272727272727,0.5907400334766407,1.0,7/21,11.53%,MEF2C;HSP90AB1;CALM1;CALM2;BMP2;CALM3;MTMR9
prerank,regulation of protein polymerization (GO:0032271),0.4285414967487327,1.1400200302711032,0.28619528619528617,0.9093588756322435,1.0,6/35,10.68%,ARHGAP28;FCHSD2;ARHGAP18;MAP2;ABL1;PRUNE1
prerank,ESCRT complex disassembly (GO:1904896),0.5663804922393088,1.1389149108570846,0.33858267716535434,0.910404848930248,1.0,6/10,28.40%,CHMP1A;VPS4A;CHMP2A;IST1;VTA1;CHMP1B
prerank,ESCRT III complex disassembly (GO:1904903),0.5663804922393088,1.1389149108570846,0.33858267716535434,0.910404848930248,1.0,6/10,28.40%,CHMP1A;VPS4A;CHMP2A;IST1;VTA1;CHMP1B
prerank,regulation of regulated secretory pathway (GO:1903305),0.4351353222103435,1.1383745990602623,0.29449838187702265,0.9108380904046705,1.0,5/34,4.05%,SYT9;SYT11;SYT12;LRRK2;DTNBP1
prerank,regulation of actin filament-based process (GO:0032970),0.38057828960400236,1.138118142727592,0.26832844574780057,0.9103605957701535,1.0,14/70,10.63%,CELSR1;ROCK2;RHOQ;RHOBTB2;RHOD;ARHGAP18;EZR;ARHGAP17;PDGFRB;BAIAP2;RICTOR;HRG;LRP1;ABL1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.42832758323444686,1.1379024882614146,0.28833333333333333,0.909742946020044,1.0,6/36,7.35%,SH3RF2;DLG1;PRKN;EZR;GPS2;PTPN22
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5139248390898123,1.1373812422204064,0.32815533980582523,0.9101999738835012,1.0,5/14,17.97%,OXSR1;ADAM17;WNK1;CCR2;WNT5A
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.4984403231624363,-1.1370066364201452,0.29896907216494845,0.5972676470837233,1.0,3/11,19.80%,ABCG1;AGTR1;AGT
prerank,serine family amino acid metabolic process (GO:0009069),0.49419700731268834,1.1368650127673383,0.3148854961832061,0.9106474793122922,1.0,7/16,26.12%,SRR;CTH;SEPSECS;MTHFD1;THNSL2;CBS;CDO1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.4350082138777914,-1.1364496319081565,0.27654867256637167,0.5977442008789174,1.0,6/17,19.71%,MID1;TGFB2;LYN;SEMA4C;NOD2;KLHDC10
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.42474146281202135,1.1363636065258116,0.3160453808752026,0.9110198336009174,1.0,8/37,10.40%,GSDME;NUPR1;BID;NACC2;TP53;FBH1;DNM1L;BECN1
prerank,cation transport (GO:0006812),0.3405527405575321,1.1363101774519777,0.22998729351969505,0.9099143025139869,1.0,16/167,7.65%,TRPM3;ATP1A2;SLC41A1;KCNJ13;TRPM6;SLC5A5;KCND3;KCNA5;SLC8A3;SLC22A18;SLC6A9;KCNS1;SLC5A8;TRPM5;ANO6;KCNH4
prerank,regulation of cellular component organization (GO:0051128),-0.28889271028796054,-1.135690551331287,0.15948275862068967,0.5988663431044916,1.0,34/135,16.25%,NRG3;HIP1;CDH13;LTBP4;PLCE1;CAMK2D;RIT2;STON2;PAK5;TFRC;NET1;DAB2IP;RAP1B;RAP1A;APOE;SOCS2;HSPA8;SEMA4D;SPOCK1;AGTR1;IRAK3;CEACAM1;HJURP;HSP90AA1;BCAR1;FAM107A;SNX17;PINK1;ATF5;ERMN;PTCH2;RASGRP2;PACSIN1;EGLN2
prerank,regulation of endocytic recycling (GO:2001135),0.54269229593018,1.1355480574440795,0.3433395872420263,0.9111215492790885,1.0,3/11,10.14%,ACTN2;EIPR1;RAB11B
prerank,membrane organization (GO:0061024),-0.27459683606211766,-1.135475989731716,0.10982658959537572,0.5985966065735714,1.0,43/227,11.27%,SGCZ;DNM3;SPTBN1;HIP1;SGIP1;SYT1;ANK3;ACTB;FNBP1;SH3KBP1;CERT1;FNBP1L;REPS2;RIMS1;REEP1;ATP2C1;STON2;ACTG1;SH3GL2;AGFG1;CCDC88A;TFRC;VAMP4;EPN2;ACTR2;FZD4;SH3GLB1;LDLR;HSPA8;AMPH;DNM1;CORO1C;BIN1;LPCAT2;GLTP;DYSF;CHRM2;AP2B1;PPT1;TRIP10;ACTR3;PDCD6IP;AP2M1
prerank,import into cell (GO:0098657),0.4161218827516886,1.135382178340151,0.28780487804878047,0.9104113476965728,1.0,8/41,9.52%,ATP1A2;SLC6A13;SLC5A3;SLC19A1;SLC27A1;SLC38A1;SLC1A3;GLUL
prerank,response to exogenous dsRNA (GO:0043330),0.4909243995425017,1.1346941734562417,0.3087971274685817,0.9113872943599438,1.0,4/18,5.44%,COLEC12;IFIT1;TLR3;IFNK
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5333483865275574,1.1345853577314728,0.32706766917293234,0.9105089174649063,1.0,2/12,7.54%,TLR4;RBP4
prerank,protein K11-linked ubiquitination (GO:0070979),0.45797325410339584,1.1342920081566499,0.3053173241852487,0.9102095450883149,1.0,3/27,5.78%,UBE2E2;PRKN;ANAPC2
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.36809415929057804,-1.1341243508853645,0.2625994694960212,0.6011325406795823,1.0,12/39,7.95%,ROBO2;MAML2;NOS3;TGFB2;STAT3;CCN3;JAG1;NOTCH1;IL6ST;EPN2;TSPAN14;JAG2
prerank,female gonad development (GO:0008585),0.4786400192640347,1.1339659094039152,0.3119266055045872,0.9099123706370588,1.0,2/19,3.08%,KIT;NR2F2
prerank,DNA methylation or demethylation (GO:0044728),0.48727048795856015,1.1334164853681619,0.31362007168458783,0.9091503229776969,1.0,7/19,17.67%,DNMT3A;ATRX;MTRR;BEND3;EHMT2;EHMT1;KMT2E
prerank,DNA alkylation (GO:0006305),0.48727048795856015,1.1334164853681619,0.31362007168458783,0.9091503229776969,1.0,7/19,17.67%,DNMT3A;ATRX;MTRR;BEND3;EHMT2;EHMT1;KMT2E
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.35449185032440605,1.1332577949600355,0.268,0.9084512075376969,1.0,38/100,23.65%,DAB2;SH3RF2;FHIT;PRKN;LRRK2;PIAS1;TRIB2;RNF217;RNF19A;CSNK1A1;FBXO22;ARAF;TRIB1;GLMN;DESI1;NUB1;USP7;OGT;DNAJB2;ZYG11B;HECTD1;TLK2;RNF19B;HFE;TAF1;ARIH1;SUMO1;ZER1;USP5;CAMLG;GSK3A;ANKIB1;TRIM39;SDCBP;ARIH2;PRICKLE1;BAG6;PSMD10
prerank,cellular response to peptide (GO:1901653),-0.3459405303763111,-1.1331848821880501,0.2443820224719101,0.6026182884651344,1.0,15/56,12.51%,GRM5;CAV1;CACNA2D1;VCAM1;NOD1;ARHGEF2;GSK3B;ICAM1;APP;GRIN2A;PSEN1;ITGA4;RPL23;GPER1;VIM
prerank,response to cytokine (GO:0034097),0.3458467339054708,1.133033819956762,0.25196850393700787,0.9079278177828073,1.0,24/141,12.44%,ALDH1A2;PTPN13;SMAD3;TIMP3;PTPN14;AFF3;PTPN9;SPHK1;NFAT5;CASP3;IKBKE;TRIM56;PTPN23;EIF2AK2;PLSCR1;MAPKAPK3;HDAC4;RIPK1;CD274;PTPN4;PTPN11;FOXA2;PRKCA;NUB1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.41762716830207147,-1.1327712970933164,0.29605263157894735,0.60281883456572,1.0,8/22,11.03%,AKAP6;RYR2;ATP1B1;VMP1;CALM1;CALM2;CALM3;JPH2
prerank,neutrophil chemotaxis (GO:0030593),-0.351728118652626,-1.1327250631647487,0.2722063037249284,0.6021429864743233,1.0,24/53,37.96%,PDE4B;BSG;TGFB2;PPIA;PPIB;EDN1;EDN3;CCL13;SYK;ITGB2;CCL19;CXCL10;PIK3CD;CCL2;JAML;CXCL5;CCL11;CXCL1;PIP5K1C;CCL4;PF4;PPBP;CCL8;PIK3CG
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.3744788436942968,-1.132692987973209,0.2696335078534031,0.6014159114560684,1.0,8/33,10.22%,PDE3B;TGFB2;ACER2;NEXMIF;CYP1B1;LYN;PTK2;P2RY12
prerank,negative regulation of fat cell differentiation (GO:0045599),0.43388544819609426,1.1325737254899813,0.31216931216931215,0.9081026797441885,1.0,7/34,9.62%,RORA;SMAD3;GPS2;TRIB2;WWTR1;SIRT1;LRP3
prerank,negative regulation of leukocyte activation (GO:0002695),-0.458247669606919,-1.1324305838103421,0.31614349775784756,0.6012675503783965,1.0,6/15,15.37%,CD200;LRFN5;GPER1;HAVCR2;CD84;IL31RA
prerank,negative regulation of growth (GO:0045926),-0.2932490276656471,-1.1322259177751632,0.18840579710144928,0.6009804412062948,1.0,29/121,10.59%,APBB2;SLIT2;PTPRJ;BMPR2;RTN4;TGFB2;ACVRL1;CCN3;NOTCH1;SOX17;ENPP1;ADAM15;PPP2R1A;RERG;SH3BP4;TGFB1;SERTAD2;BTG1;PNPT1;PPT1;FRZB;MT1E;MT1F;MT1M;MT1G;MT1X;MT1H;MT1A;MT1B
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.4171431546154709,-1.1322016531556012,0.2826603325415677,0.6002549867667324,1.0,9/24,14.18%,NOTCH1;KLF2;HSPA5;CREB3L1;ATF4;HIF1A;GCN1;VEGFA;MT3
prerank,regulation of cellular catabolic process (GO:0031329),0.3813710300279588,1.13208522585748,0.2874074074074074,0.9083724255250499,1.0,24/62,24.04%,ITPR1;PRKN;MTMR3;NUPR1;GPR137;LRRK2;ATM;WDR41;PIP4K2C;ABL1;DEPDC5;WDR24;RPTOR;WDR91;RRAGD;TYSND1;USP33;TPCN2;MTMR4;CISD2;EP300;BOK;RRAGB;RMC1
prerank,response to hydroxyurea (GO:0072710),0.5333307114493379,1.1316481357026098,0.3255360623781676,0.9085314242559602,1.0,5/11,21.07%,ATRX;KAT7;DDI1;RTF2;FMR1
prerank,cellular amide metabolic process (GO:0043603),0.36642446609366347,1.131451589516641,0.27221438645980256,0.9079612760047109,1.0,26/102,19.62%,AEBP1;ST6GAL1;PCCA;NAPEPLD;PM20D1;NAAA;SLC19A1;MTHFR;ALDH1L1;ACOT11;MCCC1;MLYCD;MTRR;ACOT8;HLCS;THEM4;CERK;NSMAF;SMPD3;SGPL1;MTHFD1;ACOT12;SMPD2;MCCC2;FOLR2;AASDHPPT
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.3799867030940305,-1.1313870912660045,0.2766497461928934,0.6013882264460256,1.0,8/30,11.60%,SPTBN1;ANK3;RAB31;VAMP4;PREPL;NSF;GCC2;GOLGA7
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5445057638992526,1.1311110213865692,0.32815533980582523,0.9077873253275465,1.0,1/10,1.21%,KIT
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.36707740861127675,-1.130870184814246,0.23785166240409208,0.6018546396974034,1.0,7/38,6.02%,BMP5;NOS3;THBS1;TNFSF10;ARHGEF2;GSK3B;ICAM1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.4844264558801791,1.1305723446872693,0.3302919708029197,0.9082884412197241,1.0,7/16,22.89%,AMPD3;LHPP;AMPD2;ADSS1;GART;ADSL;GMPS
prerank,regulation of cell migration (GO:0030334),0.31360872005996226,1.1303952268927753,0.1959686450167973,0.9075796029697253,1.0,69/382,11.71%,DAB2;FGF1;ROBO1;WNT5B;AFDN;SH3RF2;SYNE2;ROCK2;APPL2;ACE;KIT;LAMC2;IGF1;ZMYND8;SASH1;KIF2A;PLXNA2;EPHA4;RHOD;SPHK1;LMO4;SRGAP2;SRGAP3;PHACTR1;ARID2;MAGI2;MITF;MGAT3;TGFBR1;ADRA2A;PDPN;DAG1;RUFY3;SMO;CTSH;TPM1;SEMA3B;ATM;TBCCD1;SOD2;LDLRAD4;FLT1;PDGFRB;CPNE3;SERPINE1;PTPRU;LDB2;LDB1;PTEN;CDH5;AMOTL2;GTPBP4;CCAR1;HBEGF;FER;CYRIB;TRIP6;SLURP1;ARSB;YTHDF3;PIK3R3;CASS4;RNF41;DUSP10;MMP14;VIL1;MYLK;ADAM17;OSGIN1
prerank,cellular polysaccharide catabolic process (GO:0044247),0.4899732352514818,1.1303724833353794,0.33035714285714285,0.9063878408181121,1.0,4/16,8.86%,PYGM;PHKB;MGAM;PHKG1
prerank,vasculogenesis (GO:0001570),-0.3740625925465448,-1.1296209075696573,0.27638190954773867,0.6040707118284839,1.0,14/32,13.89%,CAV1;ENG;RASIP1;NOTCH1;KDR;RAMP2;ITGB8;SOX17;TGFB1;HEY2;RASA1;SOX18;VEGFA;SPRED1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3391818465051593,1.1291846581204672,0.24415584415584415,0.9088895329453733,1.0,24/166,9.53%,SMAD3;LPGAT1;SORBS1;PPARGC1A;IGF1;SMOC2;GLI2;LARP4B;DUOXA1;SLC6A9;TLR4;DDX3X;CD28;PDGFRB;POLDIP3;SLC27A1;GCK;LDB1;SAMD4A;PAOX;CPEB3;GLI1;SIRT1;SLC45A3
prerank,synaptic vesicle endocytosis (GO:0048488),0.43027581327656855,1.1291131168886215,0.3264659270998415,0.9078453807939741,1.0,6/33,4.58%,DNAJC6;PICALM;NLGN2;STON1;CEL;SYNJ2
prerank,positive regulation of phagocytosis (GO:0050766),-0.36197651763698535,-1.1287385986654823,0.28415300546448086,0.6054225841301797,1.0,12/47,10.68%,PTPRJ;MERTK;GAS6;RAB31;PTPRC;RAB27A;GATA2;CALR;CD47;DOCK2;C4B;CYBA
prerank,negative regulation of multicellular organismal process (GO:0051241),0.33112447327780964,1.1286760806398208,0.22531645569620254,0.9079051838966211,1.0,31/199,9.93%,ROBO1;LGR4;ROCK2;LRP4;LAMA4;SYT11;MCC;ZNF423;ALDH1A1;NPR3;NFIB;PCTP;SMAD6;SRGN;APOM;TLR4;IL17D;WWC2;SFMBT1;PTPN23;LDLRAD4;TWSG1;PTEN;SLC6A4;NOVA1;ADM;ACOT11;CHSY1;SPX;DOCK7;FOXC2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.5312110606142999,1.1284035305208093,0.30918727915194344,0.9074892302107045,1.0,3/12,10.49%,FYCO1;UVRAG;IRGM
prerank,cellular response to increased oxygen levels (GO:0036295),-0.4988680154763906,-1.1283603951629193,0.32335329341317365,0.605557482436286,1.0,3/11,12.36%,CAV1;FOXO1;FAS
prerank,cortical cytoskeleton organization (GO:0030865),0.40949272883944304,1.128112626363429,0.29606299212598425,0.907225236747812,1.0,7/41,4.66%,ROCK2;RHOQ;DLG1;RHOBTB2;FHOD1;RHOD;EZR
prerank,response to peptide hormone (GO:0043434),0.40185203792373714,1.127699055573939,0.2922297297297297,0.9073358481741682,1.0,10/43,15.99%,TGFBR3;ROCK2;STAT2;SLC27A1;SIRT1;OGT;TSC1;EIF2B1;ZFP36L1;STAT6
prerank,granulocyte differentiation (GO:0030851),-0.4354772327463853,-1.1273549718793454,0.3036529680365297,0.6071727257695119,1.0,4/18,14.28%,LEF1;CBFA2T3;CDKN1A;TAL1
prerank,cellular response to oxidative stress (GO:0034599),0.35019621849078025,1.1272846531066787,0.2348901098901099,0.9073986607208188,1.0,12/118,6.50%,CPEB2;MSRA;PPARGC1A;PRKAA2;MGAT3;LRRK2;SESN2;SOD3;TPM1;ALDH3B1;SOD2;TP53
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.4192088420618831,-1.1272141022642448,0.2863741339491917,0.6066867723947625,1.0,7/19,13.46%,BMPR2;TGFB2;NOTCH1;HEYL;BMP2;HEY2;ACVR1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3422402662438721,1.1271356522592935,0.25166444740346205,0.906597014676895,1.0,21/161,9.99%,DAB2;TMEM64;LRP4;BICC1;MCC;PRKN;DKK3;GLI3;LZTS2;APC2;WWTR1;UBAC2;PTPRU;INVS;TMEM170B;CSNK1A1;GLI1;TLE1;HDAC1;SOX13;TCF7L2
prerank,plasma membrane tubulation (GO:0097320),-0.4729088904352108,-1.126964373330657,0.3252747252747253,0.6064991028774827,1.0,5/13,18.29%,FNBP1L;CAVIN2;EHD2;PACSIN1;CHMP4A
prerank,positive regulation of programmed cell death (GO:0043068),-0.2688647265482877,-1.1268118678665393,0.13855421686746988,0.6060839541744565,1.0,86/272,21.40%,SLIT2;ITGA6;MAP3K5;RASSF2;KCNMA1;MCF2L;ABR;RASGRF2;ARHGEF3;APAF1;CSRNP3;RPS6;NGF;CYP1B1;UNC13B;TRIO;ARHGEF9;ARHGEF7;NET1;TNFSF10;ARHGEF2;SFRP4;DAB2IP;TIAM1;CTSD;ARHGEF17;TGFB3;RYBP;RHOB;FOXO1;PSEN1;ITGB1;BIN1;BMP2;PLEKHG5;AIFM1;ARHGEF26;FRZB;RPS6KA2;GPER1;BMP4;ATF4;CTNNB1;DAPK1;FAS;SNCA;SUDS3;GADD45G;LAPTM5;CLU;KLF11;IAPP;UBB;PHLDA3;CRADD;VAV1;TOP2A;DNAJA1;APC;RNPS1;SCRIB;CASP2;BARD1;DIABLO;SYK;PHLDA1;HTRA2;IRF5;APH1A;STPG1;RNF122;BCL2L11;FOXL2;HIP1R;CALHM2;PREX1;PNMA2;GADD45B;DCUN1D3;ECT2;DAPK2;TIAM2;SFRP1;MAP3K11;PYCARD;MCF2
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.4549132048002295,1.126790466487169,0.32642487046632124,0.9064462057517704,1.0,11/25,24.41%,IGF1;NSD1;NIBAN2;SIN3A;PER2;DOT1L;RB1;POU4F1;MSX2;MAD2L2;H1-0
prerank,L-glutamate transmembrane transport (GO:0015813),-0.5071938159132596,-1.126520154516406,0.33059548254620125,0.6060168766503257,1.0,3/10,5.29%,SLC1A2;SLC1A1;SLC25A13
prerank,positive regulation of chromosome organization (GO:2001252),0.504833907551999,1.1262014679417283,0.3213572854291417,0.9071327696427864,1.0,8/15,26.39%,ATRX;RAD50;PML;NBN;FEN1;LIG4;PPP1R10;RTEL1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.525395144127261,1.126177830184112,0.34423076923076923,0.9059739349421656,1.0,3/12,3.80%,GLI2;EPHA4;NFIB
prerank,positive regulation of type I interferon production (GO:0032481),0.3725763993237135,1.1260582433548545,0.2824207492795389,0.9051078407637398,1.0,20/73,16.31%,OAS2;TLR3;TLR4;RNF135;DDX3X;TRIM56;PTPN22;RIPK2;MAVS;TOMM70;PRKDC;DHX58;PTPN11;IRF1;POLR3A;DHX33;OAS3;NFKB1;STAT6;CREBBP
prerank,positive regulation of apoptotic process (GO:0043065),-0.26609292087520475,-1.125661201104526,0.125,0.6072512208517564,1.0,94/293,21.40%,SLIT2;ITGA6;MAP3K5;RASSF2;KCNMA1;MCF2L;ABR;TGFB2;RASGRF2;FAP;ARHGEF3;APAF1;CSRNP3;RPS6;PTGIS;NGF;CYP1B1;UNC13B;TRIO;ARHGEF9;ARHGEF7;NET1;TNFSF10;ARHGEF2;SFRP4;DAB2IP;TIAM1;RPS3;CTSD;ARHGEF17;TGFB3;RYBP;RHOB;EPHA7;FOXO1;PSEN1;ITGB1;BIN1;BMP2;BTG1;PLEKHG5;AIFM1;ARHGEF26;FRZB;RPS6KA2;GPER1;BMP4;ATF4;CTNNB1;DAPK1;FAS;SNCA;SUDS3;GADD45G;CDK5R1;CLU;KLF11;IAPP;UBB;PHLDA3;CRADD;VAV1;TOP2A;DNAJA1;MYBBP1A;APC;RNPS1;SCRIB;CASP2;BARD1;DIABLO;PHLDA1;HTRA2;IRF5;APH1A;STPG1;RNF122;SIRT2;BCL2L11;FOXL2;HIP1R;CALHM2;PREX1;PNMA2;GADD45B;DCUN1D3;ECT2;PTRH2;DAPK2;TIAM2;SFRP1;MAP3K11;PYCARD;MCF2
prerank,external encapsulating structure organization (GO:0045229),0.32921271370479205,1.1256456806308563,0.2425,0.9051352239870181,1.0,31/205,8.64%,SMOC1;COL5A1;ADAM12;ADAMTS10;LAMA4;COL22A1;LAMC2;COL4A5;SMOC2;ITGA9;LAMC1;NPNT;SPP1;COL18A1;COL4A3;LOXL1;ADAMTS2;ADAMTS15;DAG1;ITGA10;ADAMTSL5;ADAMTS9;COL9A2;COL13A1;FBN1;SERPINE1;COMP;COL4A4;COL1A2;MMP19;COL27A1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.4570654554452715,1.1250543339178152,0.3233644859813084,0.9058498934726007,1.0,3/22,9.35%,BMP7;TP53;SIRT1
prerank,regulation of cellular respiration (GO:0043457),-0.452430110259866,-1.1249884740914815,0.31919642857142855,0.6081007063803101,1.0,4/17,14.08%,PRDM16;PNPT1;CBFA2T3;NOP53
prerank,positive regulation of cell death (GO:0010942),0.3912481001357917,1.124922870499187,0.2981072555205047,0.9050370829426512,1.0,10/59,11.87%,SLC6A13;EFNB2;PICALM;PRODH;LRRK2;LRP1;RIPK2;RIPK1;RARG;AXIN2
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.45082807757565324,-1.124493894082826,0.30387931034482757,0.6077464541808519,1.0,7/16,13.12%,THBS1;CLASP2;ACVRL1;CORO1C;APOD;FAM107A;DMTN
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.45082807757565324,-1.124493894082826,0.30387931034482757,0.6077464541808519,1.0,7/16,13.12%,THBS1;CLASP2;ACVRL1;CORO1C;APOD;FAM107A;DMTN
prerank,cytoskeleton organization (GO:0007010),-0.2951299092797184,-1.124010889075998,0.20863309352517986,0.6081259809890902,1.0,19/114,6.96%,FMNL2;ARHGAP10;RHOBTB1;SEMA6A;MARK1;FGD5;SH3KBP1;PLCE1;MAST4;MICAL2;RND3;DST;EPB41L3;PCLO;PAK5;ARAP3;STRIP2;APOE;RHOB
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.4619911834217407,1.1236762526951378,0.31099656357388317,0.9066092520084604,1.0,1/23,0.24%,DAB2
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.4619911834217407,1.1236762526951378,0.31099656357388317,0.9066092520084604,1.0,1/23,0.24%,DAB2
prerank,Rap protein signal transduction (GO:0032486),-0.5030251019085026,-1.1235538755419494,0.3151750972762646,0.6085004469089379,1.0,4/10,9.64%,RAP1B;PLK2;RAP1A;RAP2A
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.34741638057318985,-1.1227495298995336,0.25336927223719674,0.6096391545386546,1.0,12/48,8.69%,NRP1;PTPRD;IL1RAPL1;CARMIL1;CDKL5;ARHGEF7;DOCK1;FLNA;CRK;LIMS2;MYOC;CALR
prerank,regulation of B cell activation (GO:0050864),-0.3982778154468324,-1.1224717410541092,0.2847222222222222,0.6095179729081903,1.0,14/25,42.70%,SH3KBP1;SAMSN1;LAPTM5;NOD2;AHR;TNFAIP3;FOXJ1;THEMIS2;BANK1;IL4;CD22;IL4I1;IL6;FCGR2B
prerank,glycoprotein biosynthetic process (GO:0009101),-0.30815196122212174,-1.1222930250340835,0.22551928783382788,0.6091666388635469,1.0,19/79,15.63%,CSGALNACT1;ST3GAL4;ST8SIA4;BMPR2;GCNT2;FUT9;XYLT1;ST8SIA1;B4GALT5;B3GALT1;ST3GAL6;ST8SIA6;B3GALNT1;DAD1;B3GALT5;BMPR1B;CHST12;NUS1;CHST9
prerank,protein deacylation (GO:0035601),0.4594290505300222,1.1220274624607085,0.3163444639718805,0.9105894257900118,1.0,8/23,13.51%,ABHD17C;SIRT5;LYPLA1;SIRT3;HDAC4;SIRT1;HDAC1;SIN3A
prerank,positive regulation of gene expression (GO:0010628),0.3100512486113799,1.1212982631810173,0.20153340635268346,0.9116410613645675,1.0,58/442,11.33%,FGF1;ROBO1;BMP6;BMP7;C1QTNF3;AFDN;SLC24A3;SMAD3;ROCK2;ANK2;OSR1;DDX5;PPARGC1A;IGF1;WNT6;PRKN;POLR2A;FOXD1;TNRC6A;MITF;TGFBR1;LARP4B;ADRA2A;TAF1D;DTNBP1;TLR3;EZR;SMO;CTSH;CUX2;TLR4;ATM;DDX3X;BRAF;CD28;BAZ1B;POLDIP3;TP53;EIF2AK2;PTPN22;PLSCR1;TNRC6B;SAMD4A;CPEB3;CDH5;CALCOCO1;TLE1;LRP3;RIPK1;UBR5;MOV10;YTHDF3;PIK3R3;SRPK2;DYRK1A;ATF2;C1QTNF1;PRKDC
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.2836058812116251,-1.120525414361363,0.1557377049180328,0.6127317707099502,1.0,30/150,10.34%,KITLG;HIP1;PTPRJ;TEK;ERBB4;PIK3R1;ESR1;GCNT2;ENG;RTN4;THBS1;SEMA5A;GAB1;GAS6;F3;NRG2;HSP90AB1;MET;ITGB1;MYOC;TGFB1;PTK2;MFHAS1;TNFAIP8L3;FGF2;PIK3AP1;ERBB2;P2RY12;PDGFA;HSP90AA1
prerank,sensory perception of smell (GO:0007608),-0.4841532717967938,-1.1200909767367404,0.3706896551724138,0.6130587282920128,1.0,4/11,21.60%,UBR3;SYT10;ADCY3;DRD2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.44268451648920537,1.1200432725451255,0.3289036544850498,0.914351593911979,1.0,2/29,1.44%,NOTCH2;IGF1
prerank,positive regulation of cell population proliferation (GO:0008284),-0.2522861159512685,-1.1195718907657597,0.08080808080808081,0.6135712141227679,1.0,81/423,12.53%,MEF2C;PID1;LEF1;KITLG;PRKCH;BMP5;ZFPM2;ERBB4;NTRK3;CDH13;OSMR;CLDN5;GCNT2;LIFR;VEGFC;THBS1;FN1;ACER3;TGFB2;TBX3;ACER2;PTK2B;TOX;RPS6;GAS6;S100A6;NOTCH1;NTRK2;IL6ST;KRAS;RPS15A;KDR;LYN;TNFRSF11A;TBC1D8;TBX1;PDGFC;AR;STX3;TIAM1;PAK1;PTPRC;FOXP1;NAMPT;HES1;TGFB3;MEIS2;AQP11;SSR1;RTKN2;CCN1;BMP2;TGFB1;PTK2;PROX1;CUL3;CALR;DDRGK1;PTN;FGF2;FLT4;S100B;RPS9;CD47;NAP1L1;ERBB2;ID2;PDGFA;RPL23;SLC25A33;EDN1;ESM1;SHANK2;GPER1;BMP4;EDN3;RPS4X;CHTOP;PTHLH;EMP2;CDKN1A
prerank,regulation of proteolysis (GO:0030162),-0.3435472132212004,-1.1194878696797868,0.24661246612466126,0.6129845146509738,1.0,7/48,7.46%,CAV1;LTBP4;SERPINE2;CST3;DNAJC1;GSAP;PERP
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.49817513530342883,-1.11948271587288,0.3249475890985325,0.612221504955776,1.0,4/10,16.20%,EPB41L4B;IQSEC1;FGF7;ARF6
prerank,diol biosynthetic process (GO:0034312),-0.44892252356114426,-1.1193136097626806,0.3384279475982533,0.6118828653376333,1.0,6/15,13.39%,ACER3;ACER2;SPTLC2;GCH1;ASAH2;QDPR
prerank,retina homeostasis (GO:0001895),-0.40253924760174925,-1.1193081454215803,0.29055690072639223,0.6111151371655322,1.0,4/23,3.94%,POTEF;ACTB;B2M;ACTG1
prerank,erythrocyte differentiation (GO:0030218),0.4064870209088674,1.1192510758829466,0.2928,0.9157228330748687,1.0,3/44,3.53%,TGFBR3;KIT;CASP3
prerank,defense response to bacterium (GO:0042742),0.3530911200398769,1.1189664434738655,0.29178470254957506,0.915364607504186,1.0,19/105,14.48%,COLEC12;OAS2;TLR3;TLR4;DEFB1;ANKRD17;IL12B;GBP7;SERPINE1;GBP2;PLA2G6;MAVS;IRGM;ANXA3;ADAM17;CAMP;OAS3;GBP6;CFP
prerank,branched-chain amino acid catabolic process (GO:0009083),0.47286906066023815,1.118918380234277,0.3551236749116608,0.9130704141826128,1.0,6/20,12.68%,IVD;ACADSB;BCAT2;DLD;MCCC1;ALDH6A1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.47286906066023815,1.118918380234277,0.3551236749116608,0.9130704141826128,1.0,6/20,12.68%,IVD;ACADSB;BCAT2;DLD;MCCC1;ALDH6A1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.3582374533024379,1.11874011627994,0.2843273231622746,0.9123772710558635,1.0,14/95,6.99%,HS3ST3A1;UST;HS3ST3B1;OGN;NDST1;CHST15;CHST11;HS2ST1;HS3ST6;ST3GAL3;FMOD;B4GALT1;DSE;PXYLP1
prerank,regulation of smooth muscle cell migration (GO:0014910),0.46574815020820215,1.1187364176854373,0.34115523465703973,0.9111690875920364,1.0,8/20,11.28%,ACE;IGF1;BMPR1A;PDGFRB;SERPINE1;IGFBP3;LRP1;TRIB1
prerank,heart trabecula morphogenesis (GO:0061384),0.48398254985964495,1.118458816229669,0.3500931098696462,0.9108540035349396,1.0,6/18,8.46%,TGFBR3;BMP7;BMPR1A;TGFBR1;RBP4;NRG1
prerank,calcium-ion regulated exocytosis (GO:0017156),0.44485927589498775,1.1180725928016146,0.3120689655172414,0.9108449652645035,1.0,3/27,1.32%,SYT9;SYT11;SYT12
prerank,negative regulation of anoikis (GO:2000811),-0.46221019510019545,-1.1178968954617714,0.3114406779661017,0.6137470185109569,1.0,4/14,8.55%,CAV1;NOTCH1;ITGB1;PTK2
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.4168502357781122,-1.1176111195924394,0.31447963800904977,0.6136610270388966,1.0,8/21,11.00%,LIMCH1;EFNA5;PEAK1;ACTG1;GPM6B;CORO1C;PTK2;DUSP3
prerank,regulation of cellular protein localization (GO:1903827),-0.34872350717921224,-1.116806896701443,0.25384615384615383,0.6147758752621665,1.0,13/45,16.05%,GPC5;GPC6;HSP90AB1;RALB;HSP90AA1;GPC4;CTNNB1;SETD2;MAPT;RAB11FIP5;PPM1F;VCPIP1;BDNF
prerank,response to ATP (GO:0033198),-0.4363758571264316,-1.1165880048403862,0.3276955602536998,0.6145270473723109,1.0,5/18,14.40%,ABCC9;RYR3;TRPC3;P2RY12;P2RY1
prerank,positive regulation of intracellular transport (GO:0032388),0.41700624518368334,1.1162453054271007,0.3179650238473768,0.9154156225309116,1.0,6/38,8.77%,ACTN2;STX18;NEDD4;RUFY3;BCAS3;EIPR1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.36571327176207613,1.1158291874501218,0.2812939521800281,0.9155207650950706,1.0,30/85,23.65%,DAB2;SH3RF2;PRKN;NUPR1;LRRK2;PIAS1;TRIB2;RNF217;RNF19A;CSNK1A1;FBXO22;TRIB1;NUB1;DNAJB2;ZYG11B;HECTD1;RNF19B;TAF1;ARIH1;SUMO1;ZER1;USP5;FMR1;GSK3A;ANKIB1;ARIH2;PRICKLE1;KCNE2;BAG6;PSMD10
prerank,protein maturation (GO:0051604),0.35664548783794137,1.115693741344402,0.30921985815602837,0.9147685820753306,1.0,16/95,15.40%,AEBP1;NNAT;TSPAN5;SRGN;METAP2;NDUFAB1;APH1B;MMP14;ADAM17;NFU1;PCSK7;OGT;SDE2;ISCA1;PITRM1;NAA16
prerank,response to peptide (GO:1901652),-0.37215889079442027,-1.115550450066777,0.2685851318944844,0.6161827033182048,1.0,15/33,28.39%,STAT3;ANXA1;GNAI1;CACNA1B;STAT5B;ERBIN;EIF2B3;CHRNA7;NOD2;IRF5;IRS1;FYN;STAT4;EIF2B2;MMP3
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5387177235262436,1.1152924821902788,0.3651685393258427,0.9148003206417566,1.0,1/10,0.40%,BMP6
prerank,negative regulation of cation channel activity (GO:2001258),-0.3877224763578447,-1.1151126064268524,0.29904306220095694,0.6164354252138201,1.0,9/26,21.60%,KCNAB1;CALM1;CALM2;EPHB2;CALM3;FKBP1A;CASQ2;GSTM2;DRD2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.35949446216345465,-1.1145085185331685,0.2776349614395887,0.6172162082238657,1.0,9/34,11.00%,PTPRB;PTPRJ;PTPN12;UBASH3B;PTPRT;PTPRF;PTPRZ1;DUSP1;DUSP3
prerank,T cell activation (GO:0042110),0.3733521630990604,1.1138469892036074,0.29190751445086704,0.9181988498961717,1.0,9/69,7.55%,LEPR;KIT;KIF13B;DPP4;IFNK;NHEJ1;CD28;PTPN22;CHD7
prerank,regulation of muscle contraction (GO:0006937),0.4453237258577744,1.113494462648164,0.3356164383561644,0.9181330966000398,1.0,2/26,5.18%,ATP1A2;TPM1
prerank,megakaryocyte differentiation (GO:0030219),0.5265923378942526,1.1129560234452862,0.3603082851637765,0.9186367091530238,1.0,1/11,1.21%,KIT
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.46501544974648806,-1.1124861317745516,0.31919642857142855,0.6213840097629555,1.0,5/13,18.41%,HSPA5;DDRGK1;NCK1;BFAR;PTPN1
prerank,plasma membrane organization (GO:0007009),0.3863546101516835,1.1123493339907993,0.3057228915662651,0.9193610402627138,1.0,12/61,11.52%,COL5A1;ANK2;SYT11;MYOF;FER1L5;ANO6;PLSCR1;PLSCR2;TLCD2;ARV1;BIN3;A4GALT
prerank,neuron projection regeneration (GO:0031102),-0.5042947318699532,-1.1123472532409093,0.3545816733067729,0.6209305054975851,1.0,3/10,13.86%,PTN;GAP43;RTN4RL1
prerank,snRNA transcription (GO:0009301),0.37400973296282747,1.1122746842105435,0.3016344725111441,0.9183651798406487,1.0,24/70,23.35%,POLR2A;PHAX;CCNT2;RPRD2;POLR2D;ELL;INTS10;GTF2F1;TAF11;INTS2;INTS5;TBP;INTS3;TAF13;INTS7;INTS1;INTS8;INTS4;POLR2G;GTF2A1;SP1;TAF8;USPL1;POLR2F
prerank,cAMP biosynthetic process (GO:0006171),0.5301817568032513,1.112140176495429,0.353515625,0.9175465795096965,1.0,3/10,7.00%,ADCY5;ADCY1;ADCY9
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3039162559855216,1.1116613256908796,0.21046892039258452,0.9178018668735782,1.0,87/476,14.06%,RORA;BMP7;SMAD3;WNT4;ZIC2;PPARGC1A;PICALM;IGF1;KMT2A;PPARA;ZNF423;CREB5;GLI2;NPAS3;CXXC1;SPP1;PHIP;NR2F2;ELF1;GLI3;MITF;TGFBR1;ARNT2;FOXC1;NFIB;CAND2;CREB3L2;RREB1;RGMB;NSD1;TRIM56;HMGA1;LBH;CREBL2;ZNF318;TP53;TBL1X;AFAP1L2;ARHGEF11;RORC;MED12;SMARCD3;FBXW11;ELF2;SMARCA4;NR1D2;BTRC;TBL1XR1;KAT6B;ZIC1;JMJD6;SMARCC2;TEAD2;NIBAN2;CALCOCO1;PARP9;HDAC4;GLI1;NSD3;HDAC1;ZFP90;FOXC2;TCF4;MYBL1;MED17;THRAP3;DYRK1A;MSANTD1;TEAD1;ZMIZ1;PHF5A;BRD7;FOXA2;DEAF1;MLXIPL;IRF1;ZXDC;EDRF1;PBX4;ZBTB48;DNM2;MAP2K1;MLLT11;PML;ILF2;MAP2K2;SNAI1
prerank,lipid homeostasis (GO:0055088),0.3841695765184091,1.1115578697441089,0.3003048780487805,0.9168687714846117,1.0,11/57,13.59%,PRKAA2;ZBTB20;RBP1;DDX3X;TLCD2;NR1D2;SIRT1;ADCK1;ACOXL;MLXIPL;ACOX3
prerank,vesicle transport along microtubule (GO:0047496),0.45284380689388437,1.1113639906279076,0.3397887323943662,0.9162545142761321,1.0,8/23,17.78%,TRAK1;FYCO1;FBXW11;HTT;KIF1C;KIF5B;TRAK2;KIF13A
prerank,negative regulation of GTPase activity (GO:0034260),0.45606848696971974,1.1111117246074187,0.34804753820033957,0.9158281789068761,1.0,4/22,6.72%,CPEB2;LRRK2;GMIP;BCAS3
prerank,synaptonemal complex assembly (GO:0007130),0.49157885568351883,1.1107200965396038,0.3377609108159393,0.9146762503271495,1.0,7/15,25.31%,TEX12;REC8;STAG3;P3H4;SYCE2;BAG6;TRIP13
prerank,synaptonemal complex organization (GO:0070193),0.49157885568351883,1.1107200965396038,0.3377609108159393,0.9146762503271495,1.0,7/15,25.31%,TEX12;REC8;STAG3;P3H4;SYCE2;BAG6;TRIP13
prerank,diterpenoid metabolic process (GO:0016101),0.3918307245212572,1.1104952628195655,0.31336405529953915,0.9141771490566343,1.0,11/55,9.36%,ABCA4;NAPEPLD;ALDH1A1;RBP1;AKR1B10;APOM;RHO;PNLIP;DHRS3;RBP4;LRP1
prerank,negative regulation of response to stimulus (GO:0048585),-0.32887795223508987,-1.1104556975561333,0.2676056338028169,0.6247647573352457,1.0,16/60,14.58%,SLIT2;KLF7;MCTP1;UBASH3B;CASK;CD34;YBX1;AKT3;LYN;HHIP;AQP11;KIF26A;TWIST1;ACVR1;SOCS5;CLU
prerank,regulation of cell differentiation (GO:0045595),0.33378037482584483,1.1098757255890364,0.2736842105263158,0.9149229019029069,1.0,22/148,8.84%,SMOC1;DDX5;CCN2;FGFR2;ZFHX2;FGFR1;TGFBR1;CLASP1;DAG1;PRKCB;PPP1R13L;KLHL41;GPS2;APC2;CAMK1;SIK1;EIF2AK2;RORC;NR1D2;CDK5RAP3;GDNF;NEUROD4
prerank,positive regulation of defense response to virus by host (GO:0002230),0.45897353496322185,1.1095603277235442,0.339041095890411,0.9147261947410406,1.0,7/24,13.51%,IL12B;PTPN22;PARP9;MAVS;TOMM70;ZDHHC1;SIN3A
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.48034015159219445,-1.109505891630207,0.32505643340857787,0.6261897209841877,1.0,3/11,10.43%,NOTCH1;FOXO1;ATP2B4
prerank,maintenance of protein location in nucleus (GO:0051457),-0.41630650342017494,-1.1092795814527916,0.3094170403587444,0.6259476120053755,1.0,9/20,29.52%,SYNE1;MORC3;BCL3;BARD1;SKP1;SUN2;RANGAP1;CHCHD10;PARK7
prerank,ganglioside metabolic process (GO:0001573),-0.4139272311405747,-1.1082581542146535,0.32450331125827814,0.627638483784453,1.0,5/20,8.77%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;HEXB;ST8SIA6
prerank,protein homooligomerization (GO:0051260),0.34968025849014545,1.1077177981006086,0.29243937232524964,0.9192951923065363,1.0,18/114,9.81%,ALDH1A2;APPL2;UPB1;ALS2;RNF213;CLYBL;ITLN1;NACC2;RNF135;P2RX3;SOD2;ATL1;MICU1;SAMHD1;JMJD6;SSBP1;CBY1;CTH
prerank,response to ketone (GO:1901654),-0.3941005404087592,-1.106736549115877,0.29767441860465116,0.6304696391077365,1.0,7/24,8.45%,SLIT2;ABHD2;CAV1;THBS1;TGFB2;TGFB3;TGFB1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4168127579849001,1.106629646286323,0.32857142857142857,0.921581982787131,1.0,7/40,7.34%,DAB2;SMAD3;TGFBR1;FOXC1;PDPN;WWTR1;TGFBR2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.48224962910375085,-1.1063344739158631,0.3696969696969697,0.630658176750701,1.0,3/11,10.81%,SLIT2;CCN3;DUSP1
prerank,epidermal cell differentiation (GO:0009913),-0.3460154226036628,-1.106303681545047,0.28865979381443296,0.6299337090329805,1.0,11/41,21.91%,CLIC4;JAG1;UGCG;ANXA1;TXNIP;SCEL;CTNNB1;WNT16;GATA6;ERCC2;ASAH1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.4726792421670125,1.106259466121118,0.3046594982078853,0.9215667807292677,1.0,3/18,3.73%,SMAD3;CLASP1;PDPN
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.2462407289982608,-1.1062178057960095,0.08536585365853659,0.6293728091386761,1.0,106/509,14.08%,NLGN1;KITLG;HIP1;PTPRJ;TEK;VWF;ACTN4;ERBB4;NTRK3;PIK3R1;CDH13;CAV1;ESR1;GCNT2;ROR1;ENG;DCN;RTN4;ADRA1B;THBS1;FN1;TGFB2;IQGAP1;RIT2;SEMA5A;ATP2C1;GAB1;MID2;NOD1;BCAR3;CAV2;GAS6;F3;RPS20;TFRC;NRG2;NTRK2;RPL37;HSP90AB1;TNFSF10;ALPK1;KDR;LYN;ROR2;TBX1;PDGFC;DAB2IP;PTPRC;PLK2;TRAF5;APP;RPS15;FLNA;RPS3;MET;PLCG2;MAP3K7;TNFRSF19;SEMA4D;ITGB1;ECM1;SLC44A2;RELN;RTKN2;BMP2;MYOC;TGFB1;PTK2;SHISA5;WWC1;NDFIP2;MFHAS1;TNFAIP8L3;FGF2;FLT4;S100B;PLEKHG5;PIK3AP1;ERBB2;JCAD;P2RY12;TRIM14;PDGFA;RPL23;HSP90AA1;FKBP1A;TRIM27;GPER1;REL;TIRAP;UNC5B;ILK;IKBKB;FGF7;PRKD1;FGF9;RET;VEGFA;RBCK1;TXN;CARD16;PINK1;TERF2IP;PPM1A;BBC3;LAPTM5
prerank,chromosome organization (GO:0051276),0.3524596012773872,1.1061208901800936,0.2763337893296854,0.9208274818324195,1.0,31/99,20.20%,TOP2B;HDAC8;SETD7;MTHFR;LDB1;SMARCA4;SIRT1;HDAC1;TCF7L2;ABL1;BAHD1;MSH3;AXIN2;CUL4A;PHF1;CDAN1;HMGN3;DDB2;DOT1L;LRWD1;NUP155;EHMT1;CENPV;TCF7L1;PADI4;EZH1;COPS8;CENPT;XPA;LIG4;BRWD1
prerank,blood vessel diameter maintenance (GO:0097746),0.41721821123911473,1.1057899765735968,0.3322734499205087,0.9206542394373683,1.0,6/34,7.48%,ROCK2;ACE;NPR1;CPS1;BDKRB2;SCPEP1
prerank,positive regulation of protein sumoylation (GO:0033235),0.5263258229751487,1.1057183264864705,0.36926147704590817,0.9197095363129587,1.0,4/10,18.96%,PIAS1;HDAC4;PIAS3;PIAS4
prerank,B cell proliferation (GO:0042100),-0.42602154753932253,-1.1054961185309542,0.3386363636363636,0.630319905078984,1.0,2/17,6.05%,MEF2C;PTPRC
prerank,regulation of protein localization (GO:0032880),0.38384543830990586,1.105385225400219,0.3223270440251572,0.919562969272296,1.0,6/58,5.82%,AFDN;PICALM;DLG1;AAK1;MAP2;CAMK1
prerank,sphingolipid catabolic process (GO:0030149),-0.4465572247507972,-1.1053551478166557,0.3274725274725275,0.629868805209747,1.0,6/15,11.86%,ACER3;ACER2;PPT1;ENPP2;ASAH2;SMPDL3A
prerank,calcium ion homeostasis (GO:0055074),0.36001582243941144,1.1051803898948642,0.298050139275766,0.9189996358493362,1.0,9/95,3.59%,ATP13A5;SLC24A3;ANK2;ATP13A3;FAM20A;SLC8A3;PKHD1;CSRP3;DMPK
prerank,regulation of protein ubiquitination (GO:0031396),0.3438123244739808,1.1047268639988919,0.28609986504723345,0.9193068160226583,1.0,14/108,9.68%,SH3RF2;NXN;SASH1;PRKN;SPHK1;HDAC8;TGFBR1;LRRK2;ARRB1;FANCI;HUWE1;CDK5RAP3;RIPK2;GTPBP4
prerank,intestinal absorption (GO:0050892),-0.46519360209167715,-1.104701563385318,0.3416149068322981,0.630634741022168,1.0,3/13,8.00%,F11R;UGCG;KCNQ1
prerank,positive regulation of coagulation (GO:0050820),-0.49477456191355357,-1.1046155450718358,0.34243697478991597,0.6292920348539592,1.0,4/10,13.12%,ST3GAL4;THBS1;ENPP4;DMTN
prerank,positive regulation of hemostasis (GO:1900048),-0.49477456191355357,-1.1046155450718358,0.34243697478991597,0.6292920348539592,1.0,4/10,13.12%,ST3GAL4;THBS1;ENPP4;DMTN
prerank,cell projection organization (GO:0030030),-0.37572213062232546,-1.1032492757509882,0.31343283582089554,0.6319121162290299,1.0,7/30,10.25%,RHOJ;GSN;PARVB;ITGB1;RHOH;P2RY12;PDGFA
prerank,regulation of T cell cytokine production (GO:0002724),-0.4526024551549557,-1.1032434692742374,0.32079646017699115,0.6311437118723576,1.0,4/15,9.15%,B2M;MAP3K7;TNFRSF1B;SMAD7
prerank,potassium ion transmembrane transport (GO:0071805),0.3392596053179521,1.1032252964367864,0.29973474801061006,0.9228257330568167,1.0,8/135,1.93%,ATP1A2;KCNK2;SLC24A3;ATP1B3;KCNJ13;KCND3;KCNA5;LRRC38
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.38198708605394627,-1.1031378315356715,0.291866028708134,0.6306337312698076,1.0,6/30,6.02%,BMP5;NOS3;TNFSF10;ARHGEF2;GSK3B;ICAM1
prerank,positive regulation of sodium ion transport (GO:0010765),-0.46326039337780345,-1.1024383102626956,0.34324942791762014,0.6314489900688927,1.0,6/12,24.63%,ANK3;CNKSR3;NOS1;SCN1B;PKP2;GPD1L
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.4510696880919775,1.1024062756740782,0.3487972508591065,0.9241999774438797,1.0,4/20,6.75%,SLC8A3;MCU;SLC25A23;MICU1
prerank,nucleotide metabolic process (GO:0009117),0.4393147088913811,1.102371265067861,0.35478260869565215,0.9231163723012096,1.0,7/23,16.79%,FHIT;NMNAT1;ENPP3;AK4;CTPS2;AK8;NMNAT2
prerank,fatty acid oxidation (GO:0019395),0.3803478658057157,1.1022580530344144,0.31458966565349544,0.9223134960528477,1.0,20/57,22.19%,PPARGC1A;ALOX12;ACAD11;ACAD10;BDH2;CPT2;ACADM;MECR;ECHDC1;DECR1;EHHADH;SLC25A17;PHYH;ECI2;CROT;ACADS;HADHA;HADH;ECHS1;HAO1
prerank,negative regulation of signal transduction (GO:0009968),0.31946331037784587,1.102102818241309,0.26385542168674697,0.9216551568309649,1.0,45/249,12.06%,WWOX;LGR4;LEPROT;RNF43;NXN;PRKCZ;TULP3;KANK2;TRABD2B;DKK3;GLI3;SUFU;APCDD1;CXXC4;LRRK2;NEDD4;SULF2;VGLL4;CYP26B1;PRKCB;TNS2;ARRB1;GPS2;IL12B;MGRN1;PIP4K2C;PTEN;IGFBP3;BTRC;IFT122;HRG;APLN;NIBAN2;LRP1;TLE1;CBY1;GRB10;PHACTR4;CNMD;TRIB1;MMP14;WWP2;GDF15;CSNK2A2;CSNK2A1
prerank,zinc ion homeostasis (GO:0055069),-0.3816171120055778,-1.1020032026382447,0.3121951219512195,0.6317205714629368,1.0,12/28,14.18%,SLC39A10;MT1E;MT1F;MT1M;MT1G;MT1X;MT1H;MT1A;MT1B;SLC30A1;SLC39A12;MT3
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.4808714143067117,1.1016429626144666,0.35424354243542433,0.9219590525176133,1.0,4/16,3.18%,TGFBR3;IGF1;FGFR2;BMPR1A
prerank,positive regulation of endopeptidase activity (GO:0010950),0.43914270712052633,1.100953978829974,0.3384615384615385,0.922947060914934,1.0,3/26,2.17%,ROCK2;PICALM;EPHA4
prerank,cellular macromolecule catabolic process (GO:0044265),0.39486307934329473,1.1004913389859075,0.3359872611464968,0.9232118304406396,1.0,11/49,11.42%,PRKN;NGLY1;NEU2;ADAMTS9;SIDT2;DNASE1L1;EXOSC7;MANBA;SND1;RIPK1;MAGEC2
prerank,cell-cell junction organization (GO:0045216),0.36193862543609273,1.1003671809837248,0.31154381084840055,0.922454262625379,1.0,8/79,2.77%,SDK1;AFDN;SMAD3;PKP4;SDK2;PKHD1;NLGN2;ARVCF
prerank,response to amyloid-beta (GO:1904645),-0.34763749959987644,-1.1002585595214278,0.3053435114503817,0.6352777427051611,1.0,10/44,7.59%,GRM5;CACNA2D1;VCAM1;GSK3B;ICAM1;APP;GRIN2A;CACNA1B;PSEN1;ITGA4
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.4438294617337091,-1.1000900273002259,0.33774834437086093,0.6349362363426965,1.0,4/15,9.33%,PTK2B;KDR;BMX;TEC
prerank,amino acid transport (GO:0006865),0.39081571510934576,1.0999989433323962,0.3525073746312684,0.922405307817196,1.0,7/49,4.27%,SLC6A12;SLC38A4;SLC38A3;SLC7A11;SLC7A2;PDPN;SLC25A48
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3711628228840367,1.099518034993097,0.33084947839046197,0.9226965750028333,1.0,21/69,21.10%,POLR2A;PHAX;CCNT2;RPRD2;POLR2D;ELL;INTS10;GTF2F1;TAF11;INTS2;INTS5;TBP;INTS3;TAF13;INTS7;INTS1;INTS8;INTS4;POLR2G;GTF2A1;SP1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.5220414931883858,1.0992275284112036,0.3720472440944882,0.9224526460676524,1.0,1/12,0.46%,BMP7
prerank,negative regulation of cell population proliferation (GO:0008285),0.3043129376722486,1.0990874192333775,0.26091954022988506,0.9216804144595692,1.0,69/351,14.29%,TGFBR3;ALDH1A2;APPL2;FBLN1;OGN;GSDME;FGFBP1;PTPN14;MCC;KANK2;COL18A1;CD300A;NUPR1;COL4A3;ARID2;MAGI2;IGFBP7;SPEG;PARP10;PDPN;IFIT3;NACC2;VGLL4;SMAD6;TNS2;CLMN;IFNK;SOD2;HMGA1;IL12B;TP53;EIF2AK2;SSTR3;DLG3;PTPRU;RBP4;PTEN;KDM2B;IGFBP3;HRG;NUPR2;NIBAN2;SULT2B1;TFDP1;GTPBP4;SLURP1;NOX4;RNF41;DUSP10;RARG;MNT;TRIB1;GLMN;AXIN2;NMI;ATRAID;BRD7;IRF1;FRK;IFI35;PODN;MAP2K1;PML;DNAJB2;MFN2;PER2;FLCN;TSC1;KAT2B
prerank,visual perception (GO:0007601),0.35568721637113565,1.0979850288194501,0.29814550641940085,0.9239472760742635,1.0,11/84,7.85%,ZIC2;EML2;COL18A1;CEP250;EYA4;RGS16;IMPG2;GNAT2;OPA1;DHRS3;RABGGTA
prerank,apical junction assembly (GO:0043297),0.3867439307115196,1.0977388318016696,0.32819722650231126,0.9235425978714169,1.0,3/53,1.68%,PARD6G;AFDN;DLG1
prerank,negative regulation of viral transcription (GO:0032897),-0.4591297727068896,-1.0975204537437364,0.3394308943089431,0.6404427518547475,1.0,4/13,11.73%,MID2;TRIM14;TRIM27;IFITM3
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.44818762866398426,1.097354919582212,0.3752212389380531,0.9235374608671261,1.0,3/23,8.44%,WNT5B;SMO;GDNF
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.32340358261483104,1.0973429001006716,0.3052362707535121,0.9224144917735995,1.0,38/190,14.43%,UACA;RORA;BMP7;C1QTNF3;CGNL1;ITPR1;PRKAA2;PPARA;FNIP1;PKHD1;PPEF2;NPRL3;DEPTOR;MAGI2;DAG1;VGLL4;DDX3X;WWC2;NPRL2;MGRN1;UBR2;PTEN;RNF34;SIRT1;TLE1;RIPK1;CYRIB;AJUBA;ARHGAP12;PHLPP2;NMI;MAPKBP1;IFI35;DEPDC5;FLCN;TSC1;THEM4;PPM1B
prerank,negative regulation of DNA replication (GO:0008156),0.5095260940678981,1.0973077634708446,0.34296724470134876,0.9213523411291398,1.0,4/13,13.17%,PDS5A;GTPBP4;WAPL;CDAN1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.3876615852907019,-1.0969562255410337,0.32167832167832167,0.6411673361932426,1.0,12/25,38.46%,HSPA8;HSPA5;HSPE1;DNAJB1;PTGES3;HSPA13;ERO1A;HSPA1L;HSPA9;DNAJB4;ST13;SDF2L1
prerank,carbohydrate catabolic process (GO:0016052),0.4102820802307099,1.0966540045436914,0.33881578947368424,0.9223117538223236,1.0,7/38,9.52%,HK2;NEU2;PGAM2;DERA;GCK;MANBA;NEU3
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.43328928251671983,-1.0959394176775898,0.34249471458773784,0.6428610059908388,1.0,8/17,18.67%,CALM1;CALM2;SMAD7;DDIT4;CALM3;DMTN;SPRED1;SIRT2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3365665261942063,1.0959116040965144,0.3082010582010582,0.9233314344989949,1.0,32/140,11.96%,ARHGAP28;ARHGAP29;CGNL1;RHOQ;ARHGEF18;RHOD;ARHGEF16;SRGAP2;SRGAP3;ARHGAP18;FGD4;SYDE2;ARHGAP9;NGEF;AKAP13;ARHGAP6;GMIP;ARHGAP26;ARHGAP17;ARHGEF11;ARHGEF12;ARHGAP23;ARHGEF1;OPHN1;CYRIB;ARHGAP12;FGD1;OCRL;SOS2;CDC42;RALBP1;ITGAV
prerank,regulation of autophagosome maturation (GO:1901096),0.5029421870627556,1.0958634289495068,0.38,0.9223202735899543,1.0,4/13,16.17%,FYCO1;UVRAG;IRGM;TBC1D25
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.5119793526582667,1.095849648702278,0.3679060665362035,0.9212106534485326,1.0,2/11,3.11%,EFNB2;FRS2
prerank,positive regulation of kinase activity (GO:0033674),-0.2953666894438157,-1.0955776106891657,0.27177700348432055,0.6429284029746338,1.0,30/107,12.77%,TEK;ERBB4;NTRK3;ROR1;EPHB1;RASSF2;EPHA5;MERTK;IQGAP1;EPHA6;TIE1;PTK2B;GAS6;NTRK2;KDR;ROR2;PTPRC;RAP1A;MET;EPHA7;RELN;EPHB2;CCN1;PTK2;FLT4;ERBB2;XRCC5;CDKN1A;MAPT;MMD
prerank,negative regulation of protein modification process (GO:0031400),-0.31159583066686447,-1.0955720676665734,0.2822085889570552,0.6421597985601517,1.0,20/79,10.43%,SLIT2;PID1;PRR5L;NTRK3;NIBAN1;PPP1R16B;SH3GL2;LYN;GSK3B;DAB2IP;PPIA;YWHAB;OCLN;CORO1C;EPHB2;TGFB1;DNAJC10;XDH;MFHAS1;ATP2B4
prerank,acylglycerol biosynthetic process (GO:0046463),0.4467236988399723,1.0950686999233177,0.3456140350877193,0.9225196663866261,1.0,4/23,7.28%,LPGAT1;MOGAT3;GPAT2;GK
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.33329132436342096,-1.0950232873935766,0.31896551724137934,0.6427552749219675,1.0,31/50,47.49%,PSMB2;PSMD14;PSMC6;PSMA4;PSMB9;PSMD11;PSMB10;PSMD2;PSMA2;PSMB3;PSMB5;OAZ1;PSMA7;OAZ2;ODC1;PSMF1;PSMD7;PSMA5;PSMD4;PSME4;PSMD3;OAZ3;PSMC2;PSMD1;PSMB8;PSMC3;PSMD8;PSMB11;PSMB1;PSMB7;PSMA8
prerank,ERK1 and ERK2 cascade (GO:0070371),0.4630486580467461,1.0949878820696695,0.34205933682373474,0.9216260276482964,1.0,6/21,15.26%,IGF1;CTSH;ITGAV;MAP2K1;MAP2K2;ZFP36L1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.4878795788528696,-1.094607828303559,0.3496932515337423,0.6429754399177477,1.0,4/10,4.88%,HECW2;HECW1;CAMK2D;NEDD4L
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.36016217535461487,1.0939956366401147,0.31805157593123207,0.9235624700230789,1.0,15/78,14.09%,DAB2;SH3RF2;PRKN;LRRK2;PIAS1;TRIB2;RNF217;RNF19A;CSNK1A1;FBXO22;TRIB1;FZR1;NUB1;DNAJB2;ZYG11B
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.5004358196734969,1.093989812273406,0.36203866432337434,0.9224245267022955,1.0,2/14,3.85%,UPB1;DPYD
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.46212010074848997,1.0939678234246073,0.36395147313691506,0.9213503433574326,1.0,4/20,3.86%,ACTN2;OSR1;ADRA2A;NEDD4
prerank,nitric oxide metabolic process (GO:0046209),-0.4524547618033205,-1.0939566963796474,0.34557235421166305,0.6438110010179992,1.0,5/14,17.93%,NOS3;CYP1B1;GCH1;NOS1;CYB5R3
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.4616225375806301,-1.0939528097182558,0.3516483516483517,0.6430373667832074,1.0,7/13,26.52%,KDR;IL33;NAMPT;EDN1;NOD2;JAK2;CCL2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.4441270841436278,1.0939470563389686,0.34196891191709844,0.9202609263068225,1.0,2/22,3.34%,ROCK2;PPP4R4
prerank,regulation of bone mineralization (GO:0030500),0.3818257903241638,1.0931190998333349,0.33436055469953774,0.9215601918685572,1.0,9/55,7.63%,BMP6;BMP7;WNT4;OSR1;KL;BMPR1A;SRGN;ANO6;BCOR
prerank,response to unfolded protein (GO:0006986),-0.34485296242692803,-1.0930288886801767,0.29736842105263156,0.6445671902488345,1.0,18/48,20.85%,HSP90AB1;DAB2IP;HSPA8;HSPA5;TMBIM6;PACRG;HSP90AA1;TM7SF3;HSPB8;SERPINH1;RHBDD1;DNAJA1;HSPB1;PTPN1;HSPE1;HSPH1;DNAJB1;HSPA4L
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.28489058917340915,-1.092373536520653,0.23703703703703705,0.6453696619189239,1.0,38/117,23.54%,CALCRL;ADCY2;ADCY7;MYH9;GNG2;RAMP2;LYN;PLK2;ADCY4;PLCG2;PTGDR;HTR7;PTH1R;CYSLTR1;PRKAR1B;CYSLTR2;PRKAR2B;HTR4;PTHLH;RAMP1;IAPP;GNB1;VIPR2;SYK;GPR45;ADCY3;ADCY8;PRKAR2A;GPR176;HRH2;ADCYAP1R1;YES1;MC5R;NPSR1;CD81;FYN;LHCGR;RHBDF2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5098056746921175,1.0922492150347125,0.3717693836978131,0.9219437642294597,1.0,1/12,1.22%,FHL2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5098056746921175,1.0922492150347125,0.3717693836978131,0.9219437642294597,1.0,1/12,1.22%,FHL2
prerank,secretory granule organization (GO:0033363),0.5419604106683701,1.0921131117253198,0.3938144329896907,0.921210460498393,1.0,5/10,22.69%,DTNBP1;SRGN;BLOC1S2;VPS33B;LYST
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.3779870660993535,1.0918833931152783,0.3373134328358209,0.9207588426056416,1.0,6/59,7.78%,ALDH1A2;CYP27A1;AMACR;OSBPL9;NDUFAB1;SRR
prerank,endomembrane system organization (GO:0010256),0.32577197153541065,1.0917574716907898,0.3105196451204056,0.9199885326345535,1.0,55/178,19.11%,FAM174B;DYM;HOOK2;MYOF;OBSL1;ALS2;SEC31B;DMPK;CLASP1;LRRK2;MYO18A;SRGN;ATL1;ARFGEF2;BCAS3;FER1L5;HUWE1;TLCD2;LEMD2;HTT;DNM1L;TRAPPC12;GOLPH3L;CSNK1A1;RAB43;FBXW8;RAB22A;CDC42;A4GALT;MIA3;TRAPPC11;PLEKHF1;REEP4;TANGO2;ARHGAP21;SEC23IP;RAB29;VPS51;GOLGA5;GOLGA8B;VPS4A;HOOK3;NUP155;RAB30;WASHC5;PI4K2B;OPTN;COG4;PHETA1;NPLOC4;SQSTM1;SEC31A;GORASP2;GOLGA2;LAMTOR1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.47028524300099434,-1.0916127492115897,0.36909871244635195,0.646406434833802,1.0,4/12,8.07%,CAV1;CTNNA3;RYR2;BIN1
prerank,negative regulation of lipid storage (GO:0010888),0.4671280832803524,1.0915385479756758,0.3607142857142857,0.9195359797072943,1.0,2/19,1.76%,OSBPL8;PPARA
prerank,positive regulation of cell adhesion (GO:0045785),-0.30705579901756874,-1.0915200748651257,0.26198083067092653,0.6458668091079325,1.0,20/74,14.56%,FRMD5;ZFHX3;PTPRJ;TGFB2;CXCL12;VIT;NDNF;EPB41L4B;FBLN2;STX3;PPP3CA;SMAD7;CD47;ERBB2;P2RY12;RET;VEGFA;ADGRG1;PPM1F;LIMS1
prerank,cytosolic calcium ion transport (GO:0060401),-0.38313607550143025,-1.0910640979253612,0.367032967032967,0.6461769043874451,1.0,10/28,12.96%,SLC8A1;RYR2;CACNA2D1;SLC35G1;MICU3;ATP2A3;JPH2;SMDT1;ATP2B1;MCUB
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.46830107511828345,1.0907443178131575,0.36585365853658536,0.9208096026629047,1.0,2/17,3.18%,NOTCH2;BMPR1A
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4435900394341915,1.0900823009003138,0.35906040268456374,0.9216989275721958,1.0,10/26,19.04%,ERRFI1;SNX6;ADRA2A;HBEGF;ADAM17;TGFA;GPRC5A;SOCS4;BTC;ZGPAT
prerank,regulation of cell development (GO:0060284),0.4060272486746739,1.090079675593365,0.3350694444444444,0.9205776451556168,1.0,8/36,14.09%,NOTCH2;BHLHE41;ADGRA2;DOCK7;FBXO22;PRUNE1;HES6;PER2
prerank,lipid droplet organization (GO:0034389),-0.4061175158394225,-1.0900375013413992,0.34140969162995594,0.647902397789728,1.0,8/22,28.62%,PPIA;RAB18;PNPLA3;CDS1;SQLE;AUP1;CDS2;FAF2
prerank,steroid metabolic process (GO:0008202),0.36483417076489194,1.089858037431979,0.32798833819241985,0.9201736753233143,1.0,12/72,12.67%,CYP27A1;LIPA;CYP21A2;CYP26B1;AMACR;FDXR;DHRS11;CYP2R1;SULT2B1;GC;ARV1;SRD5A2
prerank,positive regulation of phospholipase activity (GO:0010518),0.4533677988332477,1.089769176162763,0.3498168498168498,0.9193556453574933,1.0,6/22,8.75%,KIT;FGFR2;FGFR1;FLT1;PDGFRB;PDPK1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4799406272297848,1.089742155530686,0.37265917602996257,0.918315314601789,1.0,2/15,3.65%,SH3D19;ADRA2A
prerank,regulation of adaptive immune response (GO:0002819),-0.42021039122094705,-1.0895735865302705,0.33649289099526064,0.6483414641975435,1.0,6/18,21.18%,ADCY7;IL6ST;TRIM27;SAMSN1;SKAP1;PYCARD
prerank,dephosphorylation (GO:0016311),-0.27559470830518,-1.0894000888671789,0.22566371681415928,0.6480318520357209,1.0,29/147,11.00%,PTPRB;PTPRM;PTPRD;PTPRJ;PTPRG;PTPN12;PPM1H;PTPRK;PTPRT;PPM1L;PLPP1;PTPRN2;PLPPR1;PPP1R12A;PPP2R5A;PTPRC;PTPRF;ALPL;MTMR6;PPP2R1A;PTPRZ1;PPP3CA;PTPRE;MTMR2;PLPPR5;PLPPR4;DUSP1;MTMR7;DUSP3
prerank,nucleosome organization (GO:0034728),0.38050929905789127,1.0892906180072308,0.3359746434231379,0.9185853104964607,1.0,11/55,9.12%,ARID2;CHAF1B;ATRX;HMGA1;SMARCD3;RNF8;SMARCA4;SRCAP;KAT6B;SMARCC2;SMARCE1
prerank,response to organophosphorus (GO:0046683),-0.42784438398831204,-1.0891145794655672,0.34375,0.6479625946855879,1.0,2/16,4.89%,ABCC9;TRPC3
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.359828415385378,-1.088805126314566,0.3197969543147208,0.6479682130727911,1.0,13/37,16.80%,CLASP2;EFNA5;PHLDB1;GSK3B;STMN2;MAP6;MARK2;FAM107A;TRIM36;MAPT;BICD2;STMN1;TPPP
prerank,sensory perception of light stimulus (GO:0050953),0.35376329608075635,1.088796423819461,0.30837004405286345,0.9189179083995246,1.0,11/87,7.85%,ZIC2;WHRN;EML2;COL18A1;EYA4;RGS16;IMPG2;GNAT2;OPA1;DHRS3;RABGGTA
prerank,regulation of activated T cell proliferation (GO:0046006),0.42273169810970435,1.0887150092777405,0.3547297297297297,0.9180539045510466,1.0,7/30,18.04%,IGF1;IL18;IL12B;CD274;PRKAR1A;IGFBP2;AGER
prerank,replicative senescence (GO:0090399),0.509254636148379,1.0882360890560452,0.38721804511278196,0.9183863398904883,1.0,4/12,8.39%,ATM;TP53;SERPINE1;TERT
prerank,positive regulation of natural killer cell activation (GO:0032816),0.49905035192558933,1.0882210136760542,0.3695652173913043,0.917299806436295,1.0,4/13,13.83%,IL18;IL12B;ZBTB1;AXL
prerank,positive regulation of protein transport (GO:0051222),0.36159566877280125,1.0881342491037869,0.32926829268292684,0.9164758796551534,1.0,9/67,9.15%,BMP6;FRMD4A;IGF1;MYO18A;EZR;RUFY3;BCAS3;DNM1L;GOLPH3L
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.3841755217516859,-1.0878855105034095,0.33573141486810554,0.6494320733833655,1.0,14/27,21.28%,CSGALNACT1;DCN;CHSY3;BGN;XYLT1;CSPG4;VCAN;CHST12;B3GAT2;CHST9;CHST7;B3GAT3;CSPG5;BCAN
prerank,organelle fusion (GO:0048284),0.4558608063087282,1.0878178103481555,0.36666666666666664,0.9163490858615847,1.0,8/22,22.36%,CHCHD3;MIGA2;OPA1;MFN2;EEA1;MFN1;AFG3L2;STX4
prerank,negative regulation of interleukin-17 production (GO:0032700),0.5226795391286306,1.0878020325066726,0.37790697674418605,0.9152910538787972,1.0,2/10,6.47%,TLR4;IL12B
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3720320737149278,-1.0877566561630214,0.3276283618581907,0.6489836821079681,1.0,7/29,12.98%,ESR1;RUNX1;PAK1;DDRGK1;CNOT2;UFM1;AXIN1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.48336650452589836,1.0875755861756093,0.36213235294117646,0.9148395953574339,1.0,3/15,8.75%,FGF1;FUT1;PDPK1
prerank,positive regulation of cell motility (GO:2000147),0.3154680447492174,1.0875303296354788,0.3170731707317073,0.9138729496497722,1.0,36/205,12.33%,DAB2;FGF1;WNT5B;SH3RF2;SYNE2;ROCK2;KIT;LAMC2;IGF1;RHOD;SPHK1;TGFBR1;ADRA2A;PDPN;RUFY3;SMO;CTSH;SEMA3B;ATM;SOD2;FLT1;PDGFRB;CPNE3;CDH5;CCAR1;HBEGF;FER;TRIP6;PIK3R3;CASS4;MMP14;VIL1;MYLK;ADAM17;MYO1C;PRKCA
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.2923836521286947,-1.0873729703871104,0.25101214574898784,0.6491154948183514,1.0,45/109,30.01%,PIK3R1;LYN;PSMB2;PAK1;CALM1;PLCG2;MAP3K7;PPP3R1;NFATC1;PPP3CA;PSMD14;TEC;PSMC6;IKBKB;PSMA4;PSMB9;VAV1;SKP1;SYK;PSMD11;BTK;PSMB10;PRKCQ;PSMD2;SHC1;SOS1;PSMA2;MAP2K7;RELA;PSMB3;TAB1;PLCG1;PSMB5;NR4A3;LCP2;CARD11;MAPK8;PSMA7;FOS;MAPK3;PSMF1;PSMD7;JUN;MAP2K4;MALT1
prerank,histone ubiquitination (GO:0016574),0.4597374515601899,1.0865064144769685,0.367003367003367,0.915984018812668,1.0,4/21,7.67%,CTR9;UBR2;RNF8;HUWE1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.3557305228091542,1.0861383557823947,0.33798882681564246,0.9159824193980807,1.0,19/88,16.18%,BMP7;SMAD3;STX18;FNIP1;TRABD2B;BID;MPP7;NRG1;CDH5;HYAL1;AJUBA;VIL1;PRKCA;SDC4;LGALS3;FAF1;SMPD3;SNF8;VPS4A
prerank,regulation of intracellular pH (GO:0051453),-0.3649423986489746,-1.0854380708407776,0.3463541666666667,0.6530894069882277,1.0,10/34,22.43%,SLC4A10;SLC9A2;CA2;SLC9A6;SLC9A7;SLC9B1;GPR89A;GPR89B;CFTR;SLC4A2
prerank,androgen metabolic process (GO:0008209),0.4666902704473166,1.0851293998876514,0.36330935251798563,0.9178812685325717,1.0,3/18,17.33%,SPP1;SRD5A2;MED1
prerank,cardiac muscle cell development (GO:0055013),-0.40245826896814074,-1.0850725694925287,0.35180722891566263,0.6531895787919066,1.0,5/20,9.58%,SORBS2;SLC8A1;FHOD3;HEY2;MYH11
prerank,regulation of interleukin-13 production (GO:0032656),0.4823521463287411,1.0850667895820438,0.3712686567164179,0.9169906621465393,1.0,2/13,2.00%,PRKCZ;IL18
prerank,ethanol metabolic process (GO:0006067),0.4952019459455558,1.0849516209877645,0.38301886792452833,0.9162486499530621,1.0,2/12,7.88%,ALDH1A1;ALDH2
prerank,response to axon injury (GO:0048678),-0.41366616638206033,-1.0847101997490158,0.3670886075949367,0.6532907693118368,1.0,6/18,22.09%,APOD;GAP43;P2RY12;RTN4RL1;TYROBP;SOD1
prerank,regulation of inclusion body assembly (GO:0090083),0.5224206891416273,1.0842242167189393,0.38372093023255816,0.9173870579384338,1.0,1/11,1.24%,SNCAIP
prerank,secondary palate development (GO:0062009),0.488238179084674,1.084019899369375,0.37454545454545457,0.9169523683562611,1.0,3/14,7.55%,TGFBR3;TGFBR2;CHD7
prerank,V(D)J recombination (GO:0033151),0.5109923766903235,1.0838237955825427,0.3850467289719626,0.9164566669921119,1.0,4/11,21.43%,XRCC4;PRKDC;LIG4;LIG1
prerank,regulation of cytoplasmic transport (GO:1903649),0.5154820273857099,1.083163556819708,0.3843283582089552,0.917316448253007,1.0,4/11,14.02%,LRRK2;USP7;MAP2K1;MAP2K2
prerank,tight junction assembly (GO:0120192),0.38545983584777294,1.0828486344644277,0.3281733746130031,0.9171699830297507,1.0,3/49,1.68%,PARD6G;AFDN;DLG1
prerank,positive regulation of cartilage development (GO:0061036),-0.42787619145532585,-1.0827093941623918,0.3407707910750507,0.657405018315004,1.0,7/17,18.23%,BMPR2;ACVRL1;ZBTB16;BMP2;BMP4;BMPR1B;PKDCC
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.40697253709669856,-1.0823175443549562,0.3498964803312629,0.6576401820215202,1.0,5/19,6.59%,PRKCH;CLDN5;RUNX1;F11R;OCLN
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.40322085903207505,1.0819049952768445,0.34471544715447155,0.9188443829062226,1.0,11/41,12.65%,ACE;EPHA4;ADRA2A;DLG3;GPRC5B;HBEGF;NOX4;CASS4;ADAM17;TGFA;SRCIN1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.324146358123784,-1.0814640910501097,0.2833333333333333,0.6589784574304396,1.0,21/53,34.29%,PSMB2;PSMD14;PSMC6;PSMA4;PSMB9;PSMD11;PSMB10;PSMD2;BCKDK;PSMA2;PSMB3;PSMB5;OAZ1;PSMA7;OAZ2;ODC1;PSMF1;PSMD7;PSMA5;PSMD4;PSME4
prerank,heart contraction (GO:0060047),0.3981711302101382,1.0804116327307989,0.33068362480127184,0.9223240035861353,1.0,6/41,9.18%,ATP1A2;ACE;CSRP3;TPM1;PIK3CA;MYL4
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.5052129751374126,1.0803499052152925,0.3835616438356164,0.9213850964158038,1.0,3/11,11.47%,DONSON;FBH1;MSH3
prerank,cellular response to lectin (GO:1990858),-0.2912902652405891,-1.0803089460633228,0.2979591836734694,0.6603244867921261,1.0,32/104,30.01%,RPS6KA5;PAK3;KRAS;LYN;PSMB2;PAK1;PLCG2;MAP3K7;PSMD14;PSMC6;IKBKB;RELB;PSMA4;PSMB9;SKP1;SYK;ICAM2;PSMD11;PSMB10;PSMD2;TYROBP;FYN;PSMA2;RELA;PSMB3;TAB1;PSMB5;CARD11;PSMA7;PSMF1;PSMD7;MALT1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.2912902652405891,-1.0803089460633228,0.2979591836734694,0.6603244867921261,1.0,32/104,30.01%,RPS6KA5;PAK3;KRAS;LYN;PSMB2;PAK1;PLCG2;MAP3K7;PSMD14;PSMC6;IKBKB;RELB;PSMA4;PSMB9;SKP1;SYK;ICAM2;PSMD11;PSMB10;PSMD2;TYROBP;FYN;PSMA2;RELA;PSMB3;TAB1;PSMB5;CARD11;PSMA7;PSMF1;PSMD7;MALT1
prerank,positive regulation of immune effector process (GO:0002699),0.4257512580158435,1.080237141500499,0.3388704318936877,0.9206492159212311,1.0,6/27,11.40%,APPL2;MYO18A;ANKRD17;IL12B;DDX60;DHX58
prerank,glycosphingolipid metabolic process (GO:0006687),-0.34284125565793294,-1.079835143508163,0.33249370277078083,0.6607335951896942,1.0,10/42,10.36%,ST6GALNAC3;ESYT2;UGCG;ST8SIA1;PSAP;ST6GALNAC5;GLTP;HEXB;B3GALNT1;ESYT3
prerank,regulation of histone acetylation (GO:0035065),0.4153589637438342,1.0792782308773814,0.3660436137071651,0.9224198154184474,1.0,5/33,5.82%,PPARGC1A;KMT2A;RAPGEF3;ARRB1;CAMK1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.32730222187569263,-1.07911357941547,0.3183183183183183,0.6618137790977868,1.0,21/50,25.39%,THBS1;GAS6;NGF;YWHAE;SIAH2;CD44;ARL6IP1;RPS6KA3;SNCA;VEGFA;RPS6KA1;CARD16;MT3;PAX2;GPX1;DHCR24;RFFL;TRIAP1;HGF;PLAUR;KLF4
prerank,negative regulation of defense response (GO:0031348),0.3559881186934275,1.0789046231927417,0.35526315789473684,0.9223946913220983,1.0,13/77,14.43%,RORA;C1QTNF3;PPARA;PCBP2;METRNL;GPS2;ENPP3;CDH5;DHX58;NMI;MAPKBP1;ACOD1;PPM1B
prerank,muscle cell development (GO:0055001),0.42355302372862746,1.0786814026604081,0.35343383584589616,0.9219705893105948,1.0,4/30,2.06%,NEBL;ANK2;IGF1;MYOF
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.45207920668891033,-1.0785976983542567,0.37894736842105264,0.6622649993352099,1.0,10/13,40.70%,HSP90AB1;STX3;TYROBP;GPD1L;RANGRF;TMEM35A;TM9SF4;ABCA7;MAP1A;TNF
prerank,muscle cell migration (GO:0014812),-0.4813708622830372,-1.0781677433447647,0.3773987206823028,0.6625360360182557,1.0,5/10,23.02%,CCN3;SIX1;ITGB3;THBS4;AAMP
prerank,response to insulin (GO:0032868),0.3564514125147432,1.0780451187269688,0.3567251461988304,0.9228362996255567,1.0,20/80,17.05%,CPEB2;SORBS1;RHOQ;INSIG2;SLC27A1;GCK;PDPK1;SIRT1;FER;RAB13;PRKDC;PRKCI;DENND4C;OGT;TSC1;KAT2B;ZFP36L1;GOT1;RAB8B;C2CD5
prerank,regulation of protein acetylation (GO:1901983),0.5009937016653458,1.0779271385930986,0.4066147859922179,0.9221098517874367,1.0,4/12,9.35%,RAPGEF3;DDX3X;CAMK1;SIRT1
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.48507376987258344,-1.07791828945854,0.3700623700623701,0.6623541905514455,1.0,3/10,8.32%,DCN;KDR;MYOC
prerank,neural crest cell differentiation (GO:0014033),-0.4062689600048872,-1.0777398880543627,0.3620309050772627,0.662038747720405,1.0,2/18,1.17%,MEF2C;CDH2
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.4227698698093616,-1.077313491239667,0.3811659192825112,0.6622917424174766,1.0,8/18,27.81%,CORO2B;CCT8;PTP4A3;CCT2;CCT6A;CCT7;CEP135;DKC1
prerank,response to glucocorticoid (GO:0051384),-0.37681505932880344,-1.0772943257588043,0.3501199040767386,0.6615574100333778,1.0,5/26,21.10%,SLIT2;ANXA1;FAM107A;BCL2L11;SLIT3
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.37039201975095115,-1.0770912532024937,0.32997481108312343,0.6612823432351449,1.0,7/29,13.89%,BMP5;DAB2IP;IL17RD;SMAD7;ADIPOR1;SPRY1;SPRED1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.41491379079577345,1.0770539438706912,0.3526315789473684,0.9235477092283522,1.0,8/33,12.29%,DLG1;KANK2;NACC2;PLK5;PTEN;RBL2;RBL1;BRD7
prerank,in utero embryonic development (GO:0001701),0.4372385982244726,1.0766910758775954,0.3791390728476821,0.9236040061082522,1.0,6/25,7.55%,FGFR2;ZNF568;TGFBR1;ARNT2;FUT8;CHD7
prerank,mitochondrion localization (GO:0051646),0.4641666785270125,1.0763983019759562,0.3956442831215971,0.9234782118793841,1.0,8/19,18.19%,TRAK1;LRRK2;MEF2A;MFN2;BRAT1;MSTO1;TRAK2;MFN1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.2750347719457278,-1.0762118728776437,0.2675438596491228,0.6626630396880034,1.0,35/152,14.76%,ADGRL3;ADGRB3;ADGRL4;ADGRL2;CALCRL;ADGRG6;GNAS;ADCY2;ADRA1B;ADGRE5;GRM8;ADCY7;RAMP2;ADCY4;PSAP;GNAI1;CHRM2;GNA12;S1PR1;HTR1F;PDE2A;P2RY12;LGR5;PTH1R;GPER1;GNA14;PTHLH;RAMP1;ADGRB1;GPR26;HTR1B;ADGRG1;GNAO1;IAPP;GNAL
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.49474120021244783,-1.0760526888797861,0.39539748953974896,0.6622577832306854,1.0,6/10,34.75%,CCT8;CCT2;CCT6A;CCT7;DKC1;CCT3
prerank,peroxisome organization (GO:0007031),0.4262259448494472,1.0760296647097811,0.3747870528109029,0.9235389735861955,1.0,8/25,17.16%,PEX11A;PEX11B;DNM1L;PEX10;ACOT8;PEX14;PEX19;PEX16
prerank,glycogen catabolic process (GO:0005980),0.4737821941544745,1.0758898987749344,0.3820840950639854,0.9228824843847495,1.0,3/15,8.86%,PYGM;PHKB;PHKG1
prerank,glycolipid biosynthetic process (GO:0009247),0.3978210080663393,1.0758805870929016,0.35702479338842974,0.9218254761207517,1.0,6/38,6.37%,GBGT1;LARGE1;PIGN;ST3GAL5;PIGW;PIGQ
prerank,negative regulation of apoptotic process (GO:0043066),0.29643330375852334,1.0758246201507593,0.29392265193370165,0.9209261754180755,1.0,54/444,9.73%,NOTCH2;DAB2;SH3RF2;OSR1;FHL2;PPARGC1A;IGF1;PRKAA2;PRKN;SLC30A10;RETREG1;FNIP1;PKHD1;GRK5;SPHK1;ALOX12;SON;SNX6;CPEB4;RNF213;NUPR1;CFLAR;PHIP;CASP3;PDPN;IFIT3;BID;TNFAIP8;ZFAND6;BABAM2;MYO18A;SMAD6;CTSH;DDX3X;CD27;MAP2K5;SOD2;AVEN;BRAF;CD28;NUAK2;TP53;OPA1;COMP;ANXA5;KDM2B;PIK3CA;GDNF;NIBAN2;SIRT1;TLE1;RIPK2;HDAC1;RIPK1
prerank,protein homotrimerization (GO:0070207),-0.4338416814117354,-1.0756699014278408,0.36438923395445133,0.6616458086782981,1.0,6/14,12.09%,SCARA5;SLC1A5;SLC1A2;DISP1;PNPT1;MLKL
prerank,protein trimerization (GO:0070206),-0.4338416814117354,-1.0756699014278408,0.36438923395445133,0.6616458086782981,1.0,6/14,12.09%,SCARA5;SLC1A5;SLC1A2;DISP1;PNPT1;MLKL
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.35058262135366125,-1.0755599535456921,0.32273838630806845,0.6611607811244462,1.0,12/36,14.77%,LEF1;GNG2;NLK;CALM1;FZD4;MAP3K7;PPP3R1;NFATC1;PPP3CA;CTNNB1;GNAO1;GNB1
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.2958176773648722,-1.0754326959893663,0.3173431734317343,0.6607075811131111,1.0,11/91,6.05%,NRP1;HIP1;SYT1;RIMS2;CDH13;STXBP5L;RIT2;STON2;SCARB1;RAB3C;PTPRC
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.3706441945209872,-1.0751392745032424,0.340632603406326,0.6606270804900217,1.0,14/29,31.81%,RAD23B;UBB;RPA1;CETN2;GTF2H1;GTF2H4;GTF2H5;ERCC2;UBC;RPS27A;DDB1;RPA3;ERCC3;RPA2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.47901926761124003,1.0751230762015804,0.36981132075471695,0.9218783842479679,1.0,5/15,13.94%,STAT2;SAMHD1;YTHDF3;OAS3;USP18
prerank,regulation of anoikis (GO:2000209),-0.4090396675747484,-1.0747974378052243,0.35095137420718814,0.6607587147752009,1.0,8/19,19.92%,CAV1;NOTCH1;ITGB1;PTK2;ANKRD13C;MYBBP1A;ITGA5;PTRH2
prerank,positive regulation of secretion (GO:0051047),0.5022047715713488,1.074590250361222,0.396584440227704,0.9224310886102088,1.0,1/11,1.93%,NPR1
prerank,regulation of signal transduction (GO:0009966),-0.26521492934251717,-1.0744835970007682,0.24870466321243523,0.6607493168781416,1.0,45/190,13.88%,ESR1;RSPO3;PLCE1;RGS3;LIFR;MDFIC;UBASH3B;RGS5;KCTD8;RGS6;SEMA5A;NCK2;RUNX1;MGLL;UGCG;TMEM108;IGFBP4;PPIA;APP;HHIP;SOCS2;PTCH1;PRAG1;IGFBP6;TSPAN12;CRK;SREBF2;TMEM204;PPP2R1A;YWHAG;FRMPD1;TGFB1;LFNG;KIF26A;MFNG;RGS4;GLRX2;HOMER1;ILK;AXIN1;PRKD1;ACVR1;RGS20;RGS12;SOCS5
prerank,negative regulation of phosphorylation (GO:0042326),0.34645311010921775,1.0740763315912747,0.34553440702781846,0.9229903513255022,1.0,17/85,11.45%,BMP7;PTPN13;FBLN1;PPARA;PRKN;NUPR1;LRRK2;NPRL2;WWTR1;PTEN;IGFBP3;CDK5RAP3;HDAC4;SIRT1;CRKL;PRKDC;IMPACT
prerank,histone deacetylation (GO:0016575),0.39183908115379573,1.0740151069048929,0.3442879499217527,0.9220983608167086,1.0,16/43,23.66%,HDAC8;TBL1X;TBL1XR1;HDAC4;SIRT1;HDAC1;PRDM5;SIN3A;PER2;MIER3;MTA2;MTA1;RCOR1;REST;MIDEAS;MSL3
prerank,cartilage development (GO:0051216),0.3796439573913638,1.0739148857199916,0.35118110236220473,0.9213583037968451,1.0,6/49,4.64%,WNT5B;OSR1;SOX5;NFIB;SULF2;CREB3L2
prerank,cellular response to osmotic stress (GO:0071470),0.43532981626652456,1.0738699403528624,0.3860294117647059,0.9204267157519183,1.0,7/21,15.26%,OXSR1;RCSD1;DDX3X;MYLK;LRRC8E;ZFAND1;ZFP36L1
prerank,cell projection assembly (GO:0030031),-0.39480293521265225,-1.0729903793760027,0.34210526315789475,0.6636184519429209,1.0,5/22,10.25%,RHOJ;GSN;PARVB;RHOH;PDGFA
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.4164546125084477,-1.0729344998851558,0.36619718309859156,0.6630234077226591,1.0,9/16,19.06%,THBS1;PPP1R16B;GATA2;AGTR1;FGF2;JCAD;VEGFA;APLNR;DLL4
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.41131751857289633,1.0722977106896179,0.3569023569023569,0.9240651969011245,1.0,3/30,5.53%,ACSL1;HACD4;HACD1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.28912317622521516,-1.071989323500641,0.3114754098360656,0.6645577214286421,1.0,32/105,30.01%,RPS6KA5;PAK3;KRAS;LYN;PSMB2;PAK1;PLCG2;MAP3K7;PSMD14;PSMC6;IKBKB;RELB;PSMA4;PSMB9;SKP1;SYK;ICAM2;PSMD11;PSMB10;PSMD2;TYROBP;FYN;PSMA2;RELA;PSMB3;TAB1;PSMB5;CARD11;PSMA7;PSMF1;PSMD7;MALT1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.51380297102177,1.0716287758716039,0.38533834586466165,0.9251108043947233,1.0,2/10,12.40%,TLR4;MIA3
prerank,autophagy of peroxisome (GO:0030242),0.48934292530759604,1.071204860096027,0.3968565815324165,0.9252935080891506,1.0,6/12,26.80%,ATM;ACBD5;PEX5;SQSTM1;PIK3C3;TRAPPC8
prerank,cilium organization (GO:0044782),0.3097390242687627,1.0705709947078574,0.33625,0.9261262432286257,1.0,58/209,19.23%,CFAP44;AVIL;CC2D2A;PKHD1;DCDC2;CEP250;CPLANE2;RILPL1;RAB3IP;CYS1;RHO;PTPN23;ASAP1;EXOC2;CCDC28B;SSTR3;CEP162;CDC14A;IFT122;WDR19;CATIP;DYNC2I1;MKKS;TMEM231;CLUAP1;CDC14B;ATP6V1D;IFT88;OCRL;GALNT11;PDE6D;TTC17;ROPN1;UNC119B;WDPCP;CFAP410;WDR35;EXOC4;EXOC3;PARVA;B9D2;ARL6;RP2;BBS2;STK36;RFX2;RAB8B;RILPL2;PIBF1;TMEM237;TRAPPC14;ATP6V0D1;TMEM17;TCTN3;PCM1;CEP164;OFD1;PCNT
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3975300469197074,1.0702930250799576,0.3769968051118211,0.9259053141110222,1.0,7/38,12.06%,LEPROT;PRKN;LRRK2;FZD5;HUWE1;NPEPPS;CSNK2A2
prerank,cellular response to amyloid-beta (GO:1904646),-0.35721579977632933,-1.0698210525515364,0.34278959810874704,0.6692420747266185,1.0,9/35,7.59%,GRM5;CACNA2D1;VCAM1;GSK3B;ICAM1;APP;GRIN2A;PSEN1;ITGA4
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3426281570033538,1.0696175458221828,0.35252808988764045,0.9268208404336328,1.0,24/102,17.05%,CPEB2;ADCY5;SORBS1;RHOQ;ADCY1;SLC30A10;INSIG2;ADCY9;GCK;PDPK1;FER;RAB13;PRKDC;PRKCI;PRKAR1A;ADCY6;DENND4C;KAT2B;NFKB1;ZFP36L1;GOT1;RAB8B;PRKACB;C2CD5
prerank,apical protein localization (GO:0045176),0.5265631493315481,1.0693193337744082,0.37087378640776697,0.9266395097278757,1.0,3/10,2.25%,CELSR1;SHROOM2;SHROOM3
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.4641232778230096,1.0691772460560887,0.4280442804428044,0.9260402376834062,1.0,7/17,17.74%,PRKN;YJU2;RNF34;SIRT1;DYRK1A;SNAI1;KDM1A
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3497792929944945,1.0691355796378619,0.36376811594202896,0.9251294876753062,1.0,8/78,3.91%,DAB2;SORBS1;PICALM;RHOQ;DLG1;PTPN9;ARHGEF16;PPFIA1
prerank,regulation of DNA replication (GO:0006275),0.38363511864020017,1.0689058493520363,0.3409785932721712,0.924724356724707,1.0,16/49,16.63%,GLI2;CCNA2;ZBTB38;DSCC1;ANKRD17;PDS5A;GLI1;GTPBP4;WAPL;KAT7;CDAN1;ORC3;FAF1;EHMT2;SMC3;USP37
prerank,aorta development (GO:0035904),0.47846887647193853,1.0687728070077076,0.3905660377358491,0.9240708857246095,1.0,4/14,9.36%,ROBO1;ADAMTS9;PDGFRB;LRP1
prerank,negative regulation of autophagy (GO:0010507),0.3716340354111938,1.0683915976614384,0.3637795275590551,0.9241901002988039,1.0,16/54,18.90%,LEPR;NUPR1;SNRNP70;LRRK2;SMG1;PTPN22;PIK3CA;TAB2;ATG7;TSC1;ZKSCAN3;TLK2;MCL1;TBC1D14;EIF4G1;GOLGA2
prerank,negative regulation of protein polymerization (GO:0032272),-0.37750746617176767,-1.0682858040345025,0.3586206896551724,0.672426436569845,1.0,13/27,21.68%,SLIT2;KANK3;KANK4;STMN2;TUBB4A;PFN2;SNCA;STMN1;KANK1;HIP1R;MYADM;SSH2;TWF2
prerank,protein kinase A signaling (GO:0010737),0.4822910214326004,1.0682781334060982,0.3916349809885932,0.9234462991965362,1.0,5/12,17.03%,TCP11X2;EZR;RAB13;TCP11;PRKACB
prerank,negative regulation of neuron death (GO:1901215),-0.29240097625210887,-1.0682224157094669,0.30718954248366015,0.6718045513232562,1.0,34/93,19.61%,MEF2C;CD200;PTK2B;CD34;NDNF;NGF;NTRK2;GSK3B;APOE;TGFB3;TNFRSF1B;SORL1;PTPRZ1;SIX1;BTBD10;FOXQ1;TOX3;PPT1;RASA1;ATF4;UNC5B;NENF;SNCA;PINK1;MT3;FBXO7;BDNF;TYRO3;HTRA2;CRLF1;CHMP4B;CHMP4A;VSTM2L;SIX4
prerank,heterochromatin assembly (GO:0031507),0.45059980048079795,1.0682075530921018,0.3843478260869565,0.9225997761398672,1.0,9/20,21.15%,HMGA1;SIRT1;HDAC1;BAHD1;BEND3;SMCHD1;CENPV;EZH1;MBD2
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.4646889477554589,1.0680913077542893,0.37937384898710863,0.9218979160245644,1.0,11/16,31.35%,NAA80;NAA20;KAT2B;NAA16;CREBBP;EP300;AANAT;NAA50;NAA15;NAA60;NAA40
prerank,regulation of RNA export from nucleus (GO:0046831),-0.4518067883227953,-1.0678290786827564,0.391025641025641,0.6720034566741706,1.0,4/11,24.21%,SETD2;DHX9;NCBP2;IWS1
prerank,smoothened signaling pathway (GO:0007224),0.4138328521028485,1.0676842831636733,0.3658119658119658,0.9220541581277403,1.0,12/32,18.83%,CC2D2A;GLI2;GLI3;SMO;GLI1;DHH;TMEM231;STK36;EVC2;TMEM17;TCTN3;IHH
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.38836070941193096,-1.0676188681898369,0.3682983682983683,0.6717714768616075,1.0,8/23,14.77%,PDE4B;RYR2;GNG2;KCNQ1;ATP2B4;ATF4;SNCA;GNB1
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.3365394741248414,-1.0675636611169053,0.336,0.6711658041531943,1.0,12/44,16.20%,GSN;NCK2;EVL;CARMIL1;PTK2B;CDC42EP3;BIN1;PFN2;ARPC4;CDC42EP2;NCK1;ARF6
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.4217081674232275,1.0675272432440353,0.36505190311418684,0.9214607743393372,1.0,3/26,3.65%,ADCY5;STXBP4;ADRA2A
prerank,second-messenger-mediated signaling (GO:0019932),-0.2994392877354654,-1.0675197503490406,0.29354838709677417,0.6704986147803901,1.0,28/82,20.28%,MCTP1;PLCE1;CHRM3;NOS3;RYR2;NDNF;GUCY1B1;KSR2;APOE;GUCY1A1;PLCG2;ACKR3;PPP2R1A;AGTR1;CAMKK2;P2RY12;EDN1;EDN3;NOS1;EDNRB;HRH1;EIF2AK3;CX3CR1;BTK;MCTP2;RCAN3;AGT;PPP1R9A
prerank,isotype switching (GO:0045190),0.5139574332843162,1.0672691861470869,0.40408163265306124,0.9211663570303893,1.0,6/10,31.16%,RNF8;EXOSC3;LIG4;HSPD1;BATF;MSH6
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.2808783568256914,-1.0670493540334727,0.30451127819548873,0.6708998922288685,1.0,37/116,23.54%,CALCRL;ADCY2;ADCY7;MYH9;GNG2;RAMP2;LYN;PLK2;ADCY4;PLCG2;PTGDR;HTR7;PTH1R;CYSLTR1;PRKAR1B;CYSLTR2;PRKAR2B;HTR4;PTHLH;RAMP1;IAPP;GNB1;VIPR2;SYK;GPR45;ADCY3;ADCY8;PRKAR2A;GPR176;HRH2;ADCYAP1R1;YES1;MC5R;NPSR1;FYN;LHCGR;RHBDF2
prerank,acyl-CoA metabolic process (GO:0006637),0.40242866781806524,1.0665825787317633,0.3878887070376432,0.9221458773784356,1.0,9/35,17.08%,SUCLG2;OGDH;HMGCS2;ACOT11;MLYCD;ACOT8;SUCLA2;THEM4;ACOT12
prerank,positive regulation of organelle organization (GO:0010638),0.4127547897412276,1.0665666317679818,0.3772652388797364,0.9211341079733675,1.0,4/32,5.81%,PPARGC1A;STX18;FYCO1;UVRAG
prerank,nucleic acid metabolic process (GO:0090304),0.357572546242902,1.0663167177097226,0.3617339312406577,0.9208236151570908,1.0,21/69,20.42%,POLR2A;PCBP2;DNTT;HNRNPR;POLG;HNRNPH1;DNASE1L1;HNRNPA2B1;POLR2D;ATXN2;GTF2F1;HNRNPL;RAD50;WTAP;HNRNPC;HNRNPM;DNASE1L2;FEN1;MMS19;DXO;POLR2G
prerank,rRNA transcription (GO:0009303),-0.4100081168416718,-1.0652291542063452,0.37447698744769875,0.6746000038044587,1.0,4/17,12.97%,CAVIN1;SPIN1;GTF3C5;TAF1B
prerank,neuromuscular process (GO:0050905),-0.432214750722674,-1.0650823997588321,0.38095238095238093,0.6741964008760463,1.0,4/16,7.68%,NRXN1;GCH1;MYCBP2;STRA6
prerank,negative regulation of endocytosis (GO:0045806),0.4326339426445845,1.0644715152030468,0.3826086956521739,0.9252519374110221,1.0,3/24,2.79%,SYT11;PICALM;CD300A
prerank,embryonic organ development (GO:0048568),0.3653592434802853,1.0642673180479993,0.38073394495412843,0.9247982263030498,1.0,14/61,10.09%,KIT;KMT2A;FGFR2;GLI2;BMPR1A;GLI3;TEAD3;COL13A1;TGFBR2;RBP4;IFT122;GDNF;TEAD2;FLT3LG
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.4750062115913452,1.0642552075923541,0.3916349809885932,0.9237934666605462,1.0,2/15,1.51%,FGF1;SMOC2
prerank,defense response to symbiont (GO:0140546),0.3473872040515125,1.063530322938742,0.35252808988764045,0.9249045078424583,1.0,21/92,15.46%,IFIT1;IFIT2;OAS2;IFIT3;IFI27;NDUFAF4;TLR3;TRIM56;STAT2;EIF2AK2;PLSCR1;SAMHD1;RSAD2;MAVS;MOV10;ATG7;IRF1;OAS3;ACOD1;IFNAR2;NT5C3A
prerank,apoptotic mitochondrial changes (GO:0008637),0.41315383593293864,1.062573606099849,0.37436762225969644,0.9266007394289871,1.0,6/32,10.53%,HK2;IFIT2;BID;SOD2;DNM1L;NDUFS1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.42899499751455805,1.0625458760942077,0.4017241379310345,0.9256504157046216,1.0,8/24,15.63%,LEPR;PPARGC1A;COQ10A;NDUFS1;COX10;LYRM7;SDHAF4;GFPT1
prerank,collagen fibril organization (GO:0030199),0.3408803513842804,1.062543994983813,0.38373751783166904,0.9246135166193962,1.0,16/88,8.64%,COL5A1;COL22A1;COL26A1;LAMC2;COL4A5;COL18A1;COL4A3;LOXL1;ADAMTS2;TGFBR1;LOXL3;COL9A2;COL13A1;COL4A4;COL1A2;COL27A1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.48630782465106515,1.0620043049681793,0.40234375,0.9251567027712178,1.0,4/12,7.77%,CD300A;ELF1;PTPN22;ELF2
prerank,cell differentiation in spinal cord (GO:0021515),-0.47791131207414916,-1.0618505271887397,0.3822937625754527,0.6813451268421495,1.0,1/10,0.35%,MDGA2
prerank,regulation of neuron apoptotic process (GO:0043523),-0.287534922975234,-1.0618466027462752,0.3018292682926829,0.680585946644853,1.0,36/96,22.09%,GRID2;MEF2C;TGFB2;PTK2B;TRIM2;NDNF;NGF;NTRK2;APOE;TGFB3;EPHA7;PTPRZ1;SIX1;FOXQ1;TOX3;PPT1;KCNB1;RASA1;ATF4;CTNNB1;UNC5B;PINK1;CDK5R1;MT3;BDNF;EGLN2;FAIM2;TYRO3;CRLF1;VSTM2L;SIX4;EGLN3;AKT1S1;GRM4;MDK;SOD1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.32550366564916616,1.061667703645284,0.341688654353562,0.9251114535604892,1.0,10/142,5.34%,ATP1A2;ADCY5;SMAD3;LPAR1;CCR9;ACKR2;LPAR2;BDKRB2;CACNA1C;F2
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.31892345560465674,-1.061337496431873,0.3450134770889488,0.6810107102183595,1.0,17/53,16.88%,HSP90AB1;DAB2IP;APOE;XPO1;DDRGK1;PSMD14;GNA12;PSMC6;PKD1;RAD23B;FOXF2;ECSCR;PINK1;UBB;GPX1;USP14;GABARAPL2
prerank,regulation of fibrinolysis (GO:0051917),0.4837452084491317,1.0610394936964835,0.3996316758747698,0.9259396730813815,1.0,4/13,8.46%,F11;F2;SERPINE1;HRG
prerank,organelle fission (GO:0048285),0.43088012755868754,1.0610094683631899,0.3985890652557319,0.9250029497608379,1.0,11/24,17.51%,PRKN;PEX11A;OPA1;PEX11B;MTFR2;DNM1L;ACOT8;DNM2;PEX19;WASHC5;MTFP1
prerank,glycine metabolic process (GO:0006544),0.4852556331240362,1.06095417171407,0.3890977443609023,0.9241016724088847,1.0,2/12,8.99%,GCAT;DLD
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.36026276722384637,-1.060570930573984,0.39568345323741005,0.6821389519503426,1.0,9/30,17.31%,CXCL12;TPT1;RPS3;ACKR3;CD44;TWIST1;THOC5;CLU;CD74
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5219899109022825,1.0603937529731793,0.4188376753507014,0.9247982153623788,1.0,3/10,12.36%,LPGAT1;SLC45A3;MLXIPL
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.3745831435936393,1.0600897383919536,0.38871951219512196,0.9246248086352292,1.0,13/50,13.40%,SASH1;SPHK1;NFAT5;TLR3;TLR4;DDX3X;CD27;IL12B;EIF2AK2;TRIP6;NMI;NR3C2;IFI35
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.40506087573435307,-1.0600780544439645,0.3886255924170616,0.6826185266475092,1.0,6/17,13.51%,CAV1;KLF7;AJAP1;CEACAM1;APOLD1;MAFF
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.4017085621191503,1.059881205952872,0.3902439024390244,0.9242041054947204,1.0,6/34,12.71%,IGF1;PHIP;CD28;PDGFRB;TGFA;NSMCE2
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.4400790333257445,-1.0597342257223714,0.40869565217391307,0.6827162556513366,1.0,7/14,36.66%,ENTPD1;ENTPD2;ENTPD3;NUDT9;NUDT16;NUDT15;ENTPD5
prerank,regulation of GTPase activity (GO:0043087),0.31502310929463834,1.0593154257630406,0.3476005188067445,0.924805028051362,1.0,18/177,4.59%,CPEB2;DOCK11;AFDN;PKP4;PICALM;SIPA1L1;PLXNA2;EPHA4;SRGAP2;FGD4;ARHGAP9;ALS2;NGEF;RGS16;ASAP3;LRRK2;GMIP;RAPGEF3
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.2740811544187377,-1.0592519819981376,0.32644628099173556,0.6831103705283735,1.0,56/145,31.20%,FBXL7;YWHAE;RAD51B;PSMB2;DYNLL1;PPP2R1A;YWHAG;PSMD14;TUBA1A;HAUS2;PSMC6;TUBB4A;CDK5RAP2;HSP90AA1;KCNH5;PRKAR2B;HAUS5;PSMA4;PSMB9;CEP78;SKP1;CETN2;PSMD11;PSMB10;TUBA4A;SSNA1;PSMD2;CEP131;PSMA2;DTL;CCP110;HMMR;TPX2;KIF14;MECP2;NEDD1;HAUS4;CEP135;PSMB3;ACTR1A;NDE1;HAUS6;FHL1;CEP76;PSMB5;CCND1;PSMA7;CENPF;CDC7;PSMF1;PSMD7;AURKA;CDK1;CEP43;BRD4;CSNK1D
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.3908028507945721,1.0591438118839296,0.38449111470113084,0.9242705879672953,1.0,5/38,4.75%,CACNA1D;ANK2;KCND3;KCNA5;CACNA1C
prerank,actin filament network formation (GO:0051639),-0.46412367880401845,-1.0589436813746205,0.3952483801295896,0.6831201130324921,1.0,4/11,6.11%,ACTN1;CARMIL1;FHOD3;PLS1
prerank,regulation of establishment of cell polarity (GO:2000114),0.45935998721319704,1.0587888010087299,0.3770197486535009,0.9242983751648243,1.0,6/16,12.82%,ROCK2;RUFY3;BCAS3;CDH5;CYRIB;KRIT1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.47681299291916235,1.058751535917036,0.40190476190476193,0.9233568462207443,1.0,4/15,13.25%,TLR4;DDX3X;EIF2AK2;DHX33
prerank,lipoprotein transport (GO:0042953),0.5049363503176731,1.0586970451325226,0.40681362725450904,0.9224952431758088,1.0,4/10,13.02%,PRKCB;LRP1;MIA3;UNC119B
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.4101304519482524,1.0584428279234999,0.38605442176870747,0.922219221383097,1.0,5/31,5.18%,TGFBR3;FGFR2;BMPR1A;TGFBR1;TPM1
prerank,cellular response to cytokine stimulus (GO:0071345),-0.2409394394027472,-1.0583601562083524,0.23008849557522124,0.683868482553405,1.0,79/416,13.06%,PID1;LEF1;LRCH1;GHR;IL1RAPL1;PTPRJ;PIK3R1;IL1R1;GREM2;OSMR;AKAP6;PTPN12;LIFR;IL1RAP;FN1;PTPRT;CXCL12;VCAM1;STAT3;INPP5D;SLC12A2;MAOA;GAS6;PTGIS;F3;IL6ST;ARHGEF2;GSK3B;ANXA1;RO60;DAB2IP;STX3;ICAM1;RPS3;AQP4;SOCS2;HSPA8;FOXO1;ITGB1;TNFRSF1B;CRK;SYNCRIP;PTPRZ1;MME;ST3GAL6;TGFB1;TNFRSF21;PTGS2;IRAK3;EGR1;S1PR1;STAT5B;DOCK8;PNPT1;TEC;IFNGR2;FGF2;JAK1;PDE2A;CD47;GBP4;ERBIN;HSP90AA1;MT1X;IL4R;DUSP1;GPER1;ASAH2;SBNO2;DAPK1;YBX3;IKBKB;TWIST1;VIM;CDKN1A;CNTFR;AIM2;HIF1A;LRP8
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.356045237268471,-1.058281027381464,0.3643031784841076,0.6832766059974749,1.0,13/33,20.04%,PIK3R1;NYAP2;PIK3C2B;PLEKHA1;HTR2A;ERBB2;EDN1;MYO16;PIK3C2A;PIK3R5;TYRO3;SIRT2;IRS1
prerank,signal transduction in response to DNA damage (GO:0042770),0.37587942023916227,1.0582308451629707,0.3785488958990536,0.9218150761315079,1.0,25/49,28.43%,BID;SESN2;ATM;ATRX;TP53;DONSON;ABL1;HUS1;GADD45A;DOT1L;CEP63;CLSPN;INTS7;NBN;MAPK14;RAD9A;CASP9;CDC5L;MAD2L2;NDRG1;TIPRL;USP28;E2F7;CHEK1;GRB2
prerank,positive regulation of vacuole organization (GO:0044090),-0.46446281900310094,-1.0582167718749669,0.4068522483940043,0.682682492189388,1.0,7/10,28.79%,PIP4K2A;SH3GLB1;RALB;PIP4K2B;LRSAM1;GRN;RAB3GAP2
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.4641558828116735,1.05800588453174,0.42021276595744683,0.9214575219590343,1.0,5/16,19.02%,TOP2B;FANCM;EME2;MSH4;SLX4
prerank,negative regulation of dephosphorylation (GO:0035305),0.4619736001764313,1.057958014065605,0.40148698884758366,0.9205678490519884,1.0,2/18,6.81%,SH3RF2;SH2D4A
prerank,negative regulation of programmed cell death (GO:0043069),0.29525456483403695,1.0579187317163876,0.338654503990878,0.9196631715474313,1.0,41/355,9.73%,NOTCH2;DAB2;SH3RF2;OSR1;FHL2;IGF1;PRKAA2;PKHD1;KANK2;GRK5;SPHK1;SON;NUPR1;CFLAR;PHIP;CASP3;PDPN;IFIT3;BID;TNFAIP8;ZFAND6;BABAM2;MYO18A;SMAD6;CTSH;DDX3X;CD27;AVEN;BRAF;CD28;NUAK2;TP53;OPA1;COMP;ANXA5;GDNF;NIBAN2;SIRT1;RIPK2;HDAC1;RIPK1
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3623633454338086,-1.0578047539516637,0.36199095022624433,0.6829138755114812,1.0,8/30,8.51%,CSGALNACT1;DCN;CHSY3;NDNF;BGN;CSPG4;VCAN;HEXB
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.4433380680023007,1.057680853004914,0.39497307001795334,0.9193695448578706,1.0,4/21,6.75%,SLC8A3;MCU;SLC25A23;MICU1
prerank,zinc ion transport (GO:0006829),0.44075292910541486,1.056947935955618,0.4080560420315236,0.9205271730608112,1.0,3/21,8.11%,SLC30A10;SLC30A2;SLC39A13
prerank,lipoprotein localization (GO:0044872),0.4961882032331878,1.0568120265355394,0.38779527559055116,0.9199447075819829,1.0,4/11,13.02%,PRKCB;LRP1;MIA3;UNC119B
prerank,receptor-mediated endocytosis (GO:0006898),-0.2780632913590122,-1.056556772560487,0.3038461538461538,0.6852509291780903,1.0,30/132,11.27%,LRP1B;DNM3;SGIP1;CALCRL;CAV1;CD9;FNBP1L;SCARB1;CAV2;RAB31;TFRC;TMEM108;RAMP2;APOE;SNAP91;LDLR;ACKR3;ITGB1;HSPG2;DNM1;SORL1;STAB1;CALR;AP2B1;SCARF1;CXCL16;PPT1;HSP90AA1;CTSL;AP2M1
prerank,regulation of nervous system development (GO:0051960),-0.3429159855944495,-1.0562222723893546,0.35766423357664234,0.6852866790445956,1.0,14/37,24.20%,TENM4;HES1;TNFRSF1B;HEYL;PTPRZ1;PTN;HEY2;CTNNB1;CX3CR1;SIRT2;YTHDF2;LGI4;GBX1;KIF14
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.4189276728502105,1.0559209674493137,0.41206896551724137,0.9215045684512589,1.0,3/29,5.18%,TGFBR3;FGFR2;TPM1
prerank,Golgi to plasma membrane transport (GO:0006893),-0.3269357351848343,-1.0558586608254923,0.3726541554959786,0.6853863526195338,1.0,11/47,11.60%,STXBP6;SPTBN1;ANK3;EXOC6;RAB31;VAMP4;PREPL;GOPC;NSF;GCC2;GOLGA7
prerank,alcohol catabolic process (GO:0046164),0.512534409108072,1.0556464358752615,0.4063745019920319,0.9212650489832593,1.0,2/10,3.74%,CYP27A1;CEL
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.3741217804373701,-1.0553787860532278,0.3859223300970874,0.6857770494079086,1.0,8/26,12.66%,NOS3;ACER3;ACER2;CYP1B1;SPTLC2;GCH1;ASAH2;NOS1
prerank,regulation of protein export from nucleus (GO:0046825),0.4303936391970449,1.0552620157234167,0.3925399644760213,0.9213589383051077,1.0,6/23,9.99%,PTPN14;IFI27;RAPGEF3;CAMK1;TP53;TCF7L2
prerank,regulation of transmembrane transport (GO:0034762),-0.35569533394305175,-1.0551388706143574,0.36895674300254455,0.6856063169398461,1.0,12/31,16.01%,SLC2A1;ACTB;KCNJ3;KCNJ2;NEDD4L;OCLN;ACE2;SNCA;KCNJ8;KCNJ6;KCNJ12;PIM1
prerank,pulmonary valve morphogenesis (GO:0003184),0.4617576929129489,1.0546814557406,0.39233576642335766,0.9220345320002586,1.0,2/17,0.29%,NOTCH2;ROBO1
prerank,muscle tissue morphogenesis (GO:0060415),0.46608028708572835,1.0544675712617835,0.4050632911392405,0.9216575208624195,1.0,1/16,0.31%,TGFBR3
prerank,negative regulation of phosphatase activity (GO:0010923),0.42361448074941543,1.0541756025813682,0.3971631205673759,0.9215217784517022,1.0,3/25,6.81%,SH3RF2;PPP4R4;SH2D4A
prerank,glycoprotein metabolic process (GO:0009100),0.37376324970060676,1.0539434064237816,0.37575757575757573,0.9211629301182044,1.0,14/53,13.89%,MAN1A2;MAN1C1;LARGE1;NGLY1;NEU2;ADAMTS9;FUT8;ST6GALNAC6;MANBA;GAL3ST4;CNMD;MAN2A1;GANC;PRKCSH
prerank,UV protection (GO:0009650),-0.4703711862295833,-1.0537192999503906,0.40083507306889354,0.6883537306159355,1.0,5/10,20.22%,MFAP4;SDF4;GPX1;CAT;ERCC2
prerank,double-strand break repair (GO:0006302),0.32110723758633875,1.0536510387024625,0.3816300129366106,0.9210720253212422,1.0,37/158,20.38%,EYA1;PAXX;POLM;BABAM2;DNTT;ATM;NHEJ1;BAZ1B;RNF8;SAMHD1;FBH1;KDM2A;XRCC4;PARP9;IFFO1;EME2;RBBP8;PRKDC;HUS1;UIMC1;RAD50;NSMCE2;BABAM1;ZFYVE26;TDP2;POLL;NBN;SUMO1;FEN1;RAD51D;PIAS4;SLX4;APTX;MTA1;XRCC3;LIG4;MCM9
prerank,Ras protein signal transduction (GO:0007265),0.3169139949784381,1.053360194884067,0.3769230769230769,0.9209373631311707,1.0,21/137,10.35%,CELSR1;ARHGAP29;ROCK2;KSR1;IGF1;RHOD;CCNA2;ADRA2A;PDPN;ARHGAP6;RAPGEF3;RREB1;TP53;ARHGEF11;COL1A2;ARHGEF1;EPS8L2;RRAS2;CTNNAL1;PHACTR4;CRKL
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.516426511192049,1.0532269336846432,0.4150197628458498,0.9203064213355038,1.0,2/10,7.34%,FGFR2;TGFBR2
prerank,endochondral bone morphogenesis (GO:0060350),-0.46026475842142917,-1.0530880154546307,0.39361702127659576,0.6890477721686096,1.0,7/11,15.48%,MEF2C;BMPR2;TRPV4;BMP4;BMPR1B;FGFR3;TMEM119
prerank,androgen receptor signaling pathway (GO:0030521),0.49691114602842623,1.0528671321746628,0.4031936127744511,0.9203806946428158,1.0,4/11,11.70%,DDX5;PMEPA1;TMF1;ZMIZ1
prerank,negative regulation of macrophage activation (GO:0043031),-0.4179385045611518,-1.0522647218972718,0.3816091954022989,0.6903083710554159,1.0,4/16,6.74%,CD200;LRFN5;PTPRC;LDLR
prerank,postsynaptic membrane organization (GO:0001941),-0.4150712100499034,-1.0520755473346888,0.4031890660592255,0.690042693864207,1.0,5/17,6.19%,NLGN1;NRXN1;SHANK3;GPHN;APOE
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.3196921489624849,-1.0517249947386855,0.36036036036036034,0.6901421743394205,1.0,4/48,3.07%,PDE4D;PDE4B;IL1R1;SLC7A5
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.2745983902093272,-1.0515879656679579,0.3167259786476868,0.689715162938486,1.0,24/121,10.80%,NRP1;GHR;PTPRJ;GRM5;ERBB4;PECAM1;EFNA5;STAT3;PTK2B;GAS6;IL6ST;ARHGEF2;LYN;PTPRC;HES1;PLCG2;CSPG4;SEMA4D;RELN;TGFB1;TEC;CD44;ITGB3;ENPP2
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.3495199055441926,-1.051332173871768,0.3859223300970874,0.6895918391591477,1.0,10/31,11.23%,DLG2;LRRC7;LIN7A;MTCL1;RAP2A;ERBIN;WDR1;PDCD6IP;MSN;MARK2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.33024746497686475,-1.0509841328587994,0.3742857142857143,0.6897172750716102,1.0,18/47,19.80%,PID1;THBS1;PLCG2;RAB27A;TGFB1;AGTR1;XDH;CYBA;CDKN1A;MAPT;ACE2;ADGRB1;GRIN1;SYK;ITGB2;ROMO1;TYROBP;AGT
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.4094623078464826,-1.0507712821835802,0.4025695931477516,0.6894970456592218,1.0,4/16,6.84%,CXCL12;TPT1;RPS3;ACKR3
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.47201312981030646,-1.05037753184935,0.42028985507246375,0.6896644109969033,1.0,6/10,26.52%,KDR;IL33;NAMPT;NOD2;JAK2;CCL2
prerank,serine family amino acid catabolic process (GO:0009071),0.5032136667441229,1.0502347333646784,0.4407114624505929,0.9269661351550946,1.0,4/10,21.92%,DLD;THNSL2;AMT;CBS
prerank,serine family amino acid biosynthetic process (GO:0009070),0.4878166404574116,1.050232248801931,0.42996108949416345,0.9259691322737171,1.0,5/12,21.92%,SRR;CTH;PHGDH;MTHFD1;CBS
prerank,glycosaminoglycan metabolic process (GO:0030203),0.36871774663258083,1.0501697279556486,0.3854166666666667,0.9251408297855539,1.0,7/54,8.06%,HS3ST3A1;HS3ST3B1;NDST1;HS2ST1;HS3ST6;PXYLP1;CLN6
prerank,positive regulation of viral process (GO:0048524),0.35852846786339,1.049897191353725,0.37538461538461537,0.9249672903767723,1.0,15/60,16.18%,PPARA;POLR2A;IFIT1;DDX3X;CD28;POLR2D;LARP1;GTF2F1;KPNA6;SRPK2;NELFCD;HACD3;AXL;CTDP1;VPS4A
prerank,polyol metabolic process (GO:0019751),0.37926741128885727,1.0498625753191917,0.3956723338485317,0.9240847334868373,1.0,10/46,11.18%,ISYNA1;NUDT4;INPPL1;SLC5A3;PLCD3;PTEN;ITPKB;PLCD1;PPIP5K2;OCRL
prerank,cell differentiation in hindbrain (GO:0021533),-0.45665384860457187,-1.049853305994484,0.4364406779661017,0.6902087391086413,1.0,2/11,8.60%,GRID2;PROX1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.3500545435787436,-1.049851933066958,0.36792452830188677,0.6894507452102152,1.0,12/34,14.68%,TEK;PIK3R1;PTK2B;DAB2IP;TGFB1;PTK2;TNFAIP8L3;FGF2;P2RY12;PIK3IP1;PRKD1;FGFR3
prerank,acylglycerol catabolic process (GO:0046464),-0.35769103105074407,-1.0495095230542193,0.39141414141414144,0.6895453380958252,1.0,5/30,13.92%,ABHD2;MGLL;LIPE;FABP5;PNPLA3
prerank,calcium ion transport (GO:0006816),0.32765888843548435,1.0494310512501446,0.38985313751668893,0.9243111159262517,1.0,12/113,7.30%,TRPM3;CACNA1D;SLC24A3;ANK2;TRPM6;ITPR1;SLC8A3;CACNA1C;MICU1;CACNB3;TRPM5;ANO6
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.41910159823739257,1.0492337527959943,0.40635451505016723,0.9238954768481907,1.0,10/25,23.64%,FBXL17;NGLY1;ZYG11B;UFD1;CLPP;ZER1;TOR1A;DERL1;BAG6;RNF5
prerank,regulation of postsynapse organization (GO:0099175),-0.35942673352241206,-1.0491560722106965,0.39650872817955113,0.6897025972859285,1.0,10/28,14.09%,IL1RAPL1;PPFIA2;SHANK3;TANC2;CDKL5;ABI3;HOMER1;ABHD17B;CFL1;CDK5R1
prerank,positive regulation of protein maturation (GO:1903319),-0.4582309689735043,-1.0488254992964547,0.43415637860082307,0.6897257573316687,1.0,4/11,21.77%,CCBE1;NKD2;RHBDD1;BAG2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.4594296499570214,-1.0485634479327839,0.40236686390532544,0.6895780835896669,1.0,2/11,6.61%,CDH13;PLCG2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.3004570420318499,-1.0483446087171637,0.34579439252336447,0.6893402145260591,1.0,24/69,21.18%,PTPRJ;THBS1;STAT3;ARHGEF2;IL33;PTPRC;APP;PLCG2;PSEN1;EPHB2;CYBA;TIRAP;HAVCR2;TWIST1;CLU;LBP;DHX9;NOD2;SYK;HSPB1;TYROBP;CCL19;LGALS9;PYCARD
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.3199232381960838,-1.0481333702069144,0.3651685393258427,0.6891133008142094,1.0,11/51,6.00%,CNTNAP2;DCLK1;NYAP2;EPB41L3;NGF;TRIO;NRK;SHTN1;DAB2IP;MINK1;PAK1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.4365248766694349,-1.0476068129388616,0.39751552795031053,0.6896291411132995,1.0,10/13,32.95%,PDE8A;MET;TXN;HGF;GPR37L1;NR4A3;PYCR1;PARK7;RACK1;GPR37
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.4640548330713723,-1.047492717052861,0.43067226890756305,0.6891745385131218,1.0,3/10,20.09%,SACS;SORL1;DNAJB1
prerank,membrane lipid catabolic process (GO:0046466),-0.47033502013570105,-1.047482976199723,0.4188034188034188,0.6884378497170179,1.0,4/10,19.09%,CYP1B1;PPT1;ENPP2;SMPDL3B
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.4190095765505727,-1.0468120909921355,0.4055793991416309,0.6893197628929724,1.0,9/15,22.93%,SIX1;BMP4;VEGFA;PAX2;SOX8;PAX8;SIX4;AGT;LHX1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.45518041201286125,1.0467506685070935,0.40754039497307004,0.9301376322242649,1.0,5/18,15.34%,NXF2;PABPN1;POLDIP3;NXF1;SARNP
prerank,covalent chromatin modification (GO:0016569),0.47629580189480625,1.045456208634856,0.4266917293233083,0.9329225627050473,1.0,4/14,12.66%,SIRT1;HDAC1;AURKB;HLCS
prerank,monocarboxylic acid catabolic process (GO:0072329),0.4337146092756843,1.0451840307288436,0.3979416809605489,0.9327221550267404,1.0,7/21,15.74%,CEL;CYP26B1;LDHD;FAH;ACOT8;ACBD5;NUDT19
prerank,carbohydrate biosynthetic process (GO:0016051),-0.388050528089841,-1.0449056901442129,0.3881278538812785,0.6932491965730552,1.0,7/21,12.19%,ST3GAL4;FUT9;ST6GALNAC5;B3GALT1;ST3GAL6;ST8SIA6;B3GALT5
prerank,cellular response to growth factor stimulus (GO:0071363),0.3152530998954949,1.0448837716189805,0.3671052631578947,0.9326129894643334,1.0,18/151,7.34%,WWOX;BMP6;BMP7;SMAD3;APPL2;WNT4;SPHK1;SOX5;BMPR1A;MAGI2;TGFBR1;FOXC1;GAS1;MAP2K5;FLT1;PLK5;CPNE3;TGFBR2
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.37969724969222596,1.0447716785944574,0.420545746388443,0.9319381217413926,1.0,7/44,10.36%,ROCK2;TNRC6A;TNRC6B;CPEB3;ZC3HAV1;MOV10;YTHDF3
prerank,mitochondrial fusion (GO:0008053),0.4489326175361212,1.044485816238314,0.4076086956521739,0.9317981072658502,1.0,6/18,19.70%,CHCHD3;MIGA2;OPA1;MFN2;MFN1;AFG3L2
prerank,positive regulation of T cell cytokine production (GO:0002726),0.43887975937424334,1.044442614806429,0.4125,0.9309249690422241,1.0,4/20,9.33%,PRKCZ;IL18;FZD5;RSAD2
prerank,plasma membrane repair (GO:0001778),0.48013257274844007,1.0442691400649688,0.4042145593869732,0.9304308055585736,1.0,3/13,6.80%,SYT11;MYOF;FER1L5
prerank,negative regulation of cell junction assembly (GO:1901889),0.41938686474881676,1.0440792166087225,0.4230088495575221,0.9299664374106134,1.0,6/25,9.70%,ROCK2;ACE;ARHGAP6;BCAS3;PTEN;PHLDB2
prerank,dendritic cell differentiation (GO:0097028),-0.38466417388790153,-1.0436699287138858,0.3881278538812785,0.6955922962605591,1.0,8/22,24.73%,GAS6;LYN;CAMK4;TRPM2;IRF8;CCL19;LGALS9;PRTN3
prerank,negative regulation of signaling (GO:0023057),-0.3795075704951971,-1.0434748834737226,0.39294117647058824,0.6952878272142619,1.0,7/25,18.41%,UBASH3B;HHIP;GLRA1;KIF26A;ACVR1;SOCS5;PTPN1
prerank,skeletal muscle contraction (GO:0003009),0.43992165609822753,1.0427371376041452,0.4040590405904059,0.9328662211458357,1.0,4/19,13.06%,RCSD1;CCDC78;TNNI3;TNNC1
prerank,amino acid import across plasma membrane (GO:0089718),-0.37324061031469274,-1.0420314601154592,0.39260969976905313,0.69817634862017,1.0,8/24,7.84%,SLC6A6;SLC47A1;SLC1A5;SLC7A5;SLC1A2;SLC1A1;SLC7A1;SLC1A4
prerank,neural tube closure (GO:0001843),0.3898742862329865,1.0417777315592982,0.40544871794871795,0.9346853774776813,1.0,14/34,23.33%,CELSR1;LMO4;MTHFR;KDM2B;IFT122;PHACTR4;DEAF1;MTHFD1;VASP;FOLR1;TSC2;FUZ;PRICKLE1;DVL3
prerank,cellular response to unfolded protein (GO:0034620),-0.3706694215052752,-1.0412393072712327,0.4218009478672986,0.699390696261857,1.0,9/26,18.41%,DAB2IP;HSPA8;HSPA5;TMBIM6;PACRG;TM7SF3;HSPB8;RHBDD1;PTPN1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.38672848655447045,-1.0409758707336396,0.4128878281622912,0.6992917851787991,1.0,5/23,18.32%,PLA2G4A;MBOAT1;PLA2G12A;ABHD4;PLA2G4E
prerank,macrophage activation involved in immune response (GO:0002281),-0.43814646878435887,-1.0407483905246209,0.4,0.6991117647560761,1.0,7/13,19.59%,PLCG2;DYSF;SBNO2;LBP;CX3CR1;SYK;TYROBP
prerank,brain morphogenesis (GO:0048854),-0.44649664458036,-1.0405279759441033,0.43070362473347545,0.6989069627571487,1.0,2/12,1.42%,CTNNA2;SHANK3
prerank,negative regulation of binding (GO:0051100),0.343577657349763,1.040375643997899,0.39078751857355126,0.9378348803217711,1.0,24/81,19.18%,DAB2;ARHGAP28;IFIT1;IFIT2;LRRK2;SMO;CAMK1;GTPBP4;GTF2F1;AURKB;TMC8;WAPL;STYX;DNAJB2;EFHB;PEX14;TFIP11;PEX19;SP100;KDM1A;SUMO1;GOLGA2;USP33;ITGB1BP1
prerank,positive regulation of hydrolase activity (GO:0051345),-0.27084842753272753,-1.040347863905933,0.3425196850393701,0.6985860254201844,1.0,29/137,10.44%,DOCK9;DOCK10;ITGA6;RGS7;CD200;RGS6;F11R;BCAR3;CDKL5;CAV2;ARHGEF7;NET1;GSK3B;TBC1D30;CALM1;RAP1A;CALM2;RPS3;PSAP;SEMA4D;ITGB1;BMP2;MTCL1;RASGRF1;RAPGEF6;DOCK8;ERBB2;AGRN;CALM3
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.4282549001307589,-1.0402203277813609,0.41372141372141374,0.698141337555136,1.0,6/14,14.56%,FLNA;LIMS2;EMP2;DMTN;PRKD1;LIMS1
prerank,regulation of lamellipodium organization (GO:1902743),0.4764623467726961,1.0401766582954792,0.4197761194029851,0.9374167441523477,1.0,6/14,14.16%,CAPZB;PDPN;FER;CDC42;VIL1;CARMIL2
prerank,respiratory electron transport chain (GO:0022904),0.46234099137638845,1.0400472469789146,0.43486590038314177,0.9367799806919027,1.0,4/14,18.94%,PPARGC1A;SLC25A12;SDHB;ETFDH
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.45456907629101306,1.0398007329894663,0.39846743295019155,0.9365158177196725,1.0,1/17,0.83%,LPGAT1
prerank,negative regulation of cytokine production (GO:0001818),0.31095486506746894,1.0394168811759041,0.40774193548387094,0.9366281653095018,1.0,19/163,7.35%,C1QTNF3;LGR4;APPL2;SYT11;PPARA;PCBP2;EZR;IKBKE;SSC5D;SRGN;TLR4;RNF135;F2;ARRB1;MAP2K5;TRIB2;IL12B;TWSG1;PTPN22
prerank,MAPK cascade (GO:0000165),-0.24416853735114905,-1.0392030654775326,0.29411764705882354,0.699825707084978,1.0,82/295,20.08%,DLG2;SPTBN1;MEF2C;KITLG;TEK;ERBB4;PIK3R1;SHANK3;RASAL2;MAP3K5;RASGRP3;LRRC7;GRIN2B;RIT2;RASGRF2;NRG2;NRK;YWHAE;KRAS;MBP;KDR;PSMB2;DAB2IP;YWHAB;MINK1;PAK1;CALM1;IL17RD;MET;MAP3K7;ZDHHC9;TGFB1;PTK2;CUL3;RASGEF1A;PEBP1;RASGRF1;PSMD14;FGF13;FGF2;JAK1;ERBB2;PSMC6;CAMKK2;PDGFA;PRKG2;GOLGA7;RASA1;IKBKB;PTPN3;FGF7;ABHD17B;SPTB;FGF9;RET;SPRED1;MT3;FGFR3;UBB;MAPK12;SCG2;GRIN1;IL31RA;PSMA4;PSMB9;GFRA1;GFRA2;SHOC2;SKP1;IRS2;PSMD11;MEN1;SPTBN2;CAMK2B;PSMB10;PRKCQ;SPTAN1;RASA3;PSMD2;PPP1CC;IRS1;SHC1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.355708283587629,-1.0388202693893085,0.3855421686746988,0.6999878503706579,1.0,10/30,22.49%,DACH1;BMPR2;ACVRL1;GNL3L;CDKN1A;TERF1;STN1;MEN1;DCP2;EXOSC10
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.42942977333175775,1.0387598003952363,0.4244604316546763,0.9375717842121863,1.0,3/21,4.75%,ATP1A2;ANK2;CACNA1C
prerank,negative regulation of defense response to virus (GO:0050687),0.5040072778881522,1.0387130450263038,0.4250936329588015,0.936712862337251,1.0,2/10,14.43%,PCBP2;PPM1B
prerank,reverse cholesterol transport (GO:0043691),-0.4452363958386169,-1.0385893610295884,0.42207792207792205,0.6998241758218146,1.0,4/13,14.58%,SCARB1;APOE;ABCG1;CLU
prerank,cellular response to organic substance (GO:0071310),0.3252183864690669,1.0384768866927343,0.3855755894590846,0.9363859026273771,1.0,18/116,7.34%,PTPN13;SMAD3;PTPN14;IL18;PTPN9;SPHK1;NFAT5;BMPR1A;TGFBR1;ADRA2A;LRRK2;NCOA3;MAP2K5;PTPN23;TIPARP;PLK5;CPNE3;TGFBR2
prerank,cellular protein modification process (GO:0006464),0.2776626729157087,1.0383449711520751,0.35794871794871796,0.9357512130863239,1.0,171/982,14.43%,PRKAG2;EPAS1;UST;WNK4;PTPN13;ROCK2;APLP2;UBE2E2;DUSP29;ITIH2;OXSR1;MSRA;PRKCZ;ASB2;SERPIND1;CP;FAM20A;PRKAA2;PTPN14;LAMC1;PTPN9;GRK5;MACROD1;OBSL1;SPP1;LARGE1;SPSB1;MTMR3;PRKAG3;PPEF2;PPP1CB;PPM1E;NGLY1;FGFR1;BMPR1A;LOXL1;TGFBR1;DMPK;IGFBP7;AAK1;PARP10;CEL;LRRK2;TP53RK;NAA80;KRT1;FUT1;DCAF11;PRKCB;PARP14;ST3GAL3;IKBKE;ATG10;LHPP;DAPP1;METAP2;FBXL19;ST3GAL5;ATM;PRRT1;KLHL41;CAMK1;TIPARP;BRAF;ATG5;SPSB4;NUAK2;TRIB2;CDC42BPG;SIK1;EIF2AK2;SIRT5;LGALS1;TRIOBP;FUT10;FBN1;KNG1;PARP4;WIPI1;PTPRU;TGFBR2;PTPN22;FBXW11;RABGGTA;PTEN;IGFBP3;PP2D1;TNKS2;BTRC;RYK;SIRT3;PPP2R1B;MANBA;COQ8B;PDPK1;NUCB1;PTPN21;PARP9;CSNK1A1;RCE1;SIRT1;ASB15;ZC3HAV1;PICK1;CTH;FBXO22;LRRC41;RAB11B;MKNK1;FER;DCAF10;BRSK1;RAB13;FBXL12;ATG7;AURKB;SRPK2;ABL1;PARP6;DYRK1A;MYLK3;UBE2M;ARAF;DUSP10;FBXW8;FBXO4;CDC14B;FNTB;TRIB1;PRKDC;SOCS3;PPP2R5E;PTPN4;WWP2;MAPK6;ASB14;PORCN;CUL4A;CUL9;CSNK2A1;CTDSP2;FBXO10;PRKCA;HIPK3;MIA3;NUB1;MAN2A1;ASB5;SIRT4;HLCS;MAPK10;MAP3K1;FRK;MBTPS1;PRKCI;ART4;WNK1;BMP2K;ASB12;DDB2;MAP2K1;ROS1;COQ8A;GRK3;PRKCSH;FBXO11;SERPINC1;ACVR2B;FBXL20;DUSP2;PPM1B
prerank,regulation of microtubule polymerization (GO:0031113),-0.32819633775411866,-1.0378921783645962,0.41005291005291006,0.7008101345616818,1.0,14/40,15.24%,NAV3;PAK1;RPS3;MET;STMN2;OCLN;TUBB4A;CDK5RAP2;MAPT;CLIP1;SNCA;CDK5R1;FES;STMN1
prerank,actin filament organization (GO:0007015),0.31524015620157897,1.0377219468125274,0.3858267716535433,0.9365681355126833,1.0,28/151,11.40%,NEBL;CGNL1;DLG1;SHROOM2;RHOBTB2;AVIL;FHOD1;RHOD;SHROOM3;INPPL1;TMOD2;MYO5C;MCU;RUFY3;TMOD3;TPM1;BAIAP2L1;ARHGAP17;MPRIP;BAIAP2;TRIOBP;MYO19;WASL;CASS4;ARHGAP12;CDC42;BIN3;VIL1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.453973777439342,-1.0372712866093579,0.42769857433808556,0.7016429442726996,1.0,2/11,1.12%,GHR;PIK3R1
prerank,epidermis development (GO:0008544),0.36007297054703263,1.037183759002615,0.3891402714932127,0.9371201134907272,1.0,7/56,9.56%,LAMC2;CCN2;FGFR2;CRABP2;SVEP1;GLI1;HDAC1
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.3461422668084592,-1.036622233458344,0.3983739837398374,0.7024762335874708,1.0,7/36,12.88%,NRP1;SHANK3;ITGB1;RELN;EPHB2;EDN1;HIF1A
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.2876942351517373,-1.03613060337365,0.3485342019543974,0.7029054781111296,1.0,15/76,12.33%,GRM5;ESR1;PLCE1;ADRA1B;HTR2C;ANO1;HTR2A;AGTR1;CHRM2;GRM1;P2RY12;PTH1R;GNA14;HOMER1;CMKLR1
prerank,negative regulation of transport (GO:0051051),0.3664028651175763,1.036088691192725,0.4031746031746032,0.939255696942976,1.0,13/51,15.10%,SYT11;PRKN;FER1L5;PLSCR1;PTEN;NRG1;WWP2;ITGAV;SNX12;EPHA3;PIP4P2;CRYAB;LGALS3
prerank,regulation of mRNA processing (GO:0050684),0.39339558431521915,1.0360185350351085,0.41050903119868637,0.9384802313863891,1.0,9/32,10.61%,SON;PABPN1;AHCYL1;TIA1;RBM39;SLTM;JMJD6;LARP7;SRPK2
prerank,regulation of coagulation (GO:0050818),-0.4500686431712009,-1.0358519493752631,0.42094017094017094,0.7028165229433863,1.0,3/11,7.96%,CAV1;HS3ST5;EPHB2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.3423268334131564,-1.0353376174427298,0.39951573849878935,0.7033315471742013,1.0,13/35,20.36%,HIP1;SGIP1;B2M;SNAP91;PPT1;HNRNPK;CLU;CBL;ARF6;HIP1R;LDLRAP1;VTN;CCL19
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.45759322270786457,1.0352043077551047,0.43953934740882916,0.9399185933112136,1.0,2/15,2.90%,WNT5B;RNF213
prerank,regulation of transferase activity (GO:0051338),0.4431704110770791,1.0350453017205503,0.39388489208633093,0.9393850082460955,1.0,4/17,7.44%,ATM;PARP4;LDB2;LDB1
prerank,negative regulation of viral process (GO:0048525),0.36054449849494585,1.034789880635322,0.3887147335423197,0.9391576924870225,1.0,13/57,13.66%,IFIT1;OAS2;PARP10;EIF2AK2;PLSCR1;RSAD2;ZC3HAV1;LARP7;MAVS;SRPK2;TRIM62;OAS3;PML
prerank,long-term synaptic potentiation (GO:0060291),-0.3803954409898247,-1.0346649092896805,0.3888888888888889,0.7042362703685469,1.0,6/21,7.11%,SLC24A2;NPTN;GRIN2B;PTK2B;PLK2;GRIN2A
prerank,clathrin coat assembly (GO:0048268),-0.4120404014197397,-1.034522243737531,0.43458980044345896,0.7038246201950747,1.0,3/15,6.80%,HIP1;SGIP1;NSG2
prerank,regulation of intracellular signal transduction (GO:1902531),0.28718303941607926,1.0344653663822534,0.40676117775354415,0.9390898079252467,1.0,88/420,15.50%,PRKAG2;FGF1;ARHGAP28;PTPN13;ARHGAP29;RHOQ;PRKAA2;DLG1;ARHGEF18;RHOD;PKHD1;ARHGEF16;SRGAP2;SRGAP3;ARHGAP18;FGD4;SYDE2;ARHGAP9;PRKAG3;NGEF;AKAP13;ARHGAP6;LRRK2;AKAP12;ZFAND6;GMIP;TP53RK;EZR;ARHGAP26;CHD4;PPP1R13L;ATM;WWC2;ARHGAP17;LBH;TP53;RICTOR;ARHGEF11;ARHGEF12;PTPN22;PIP4K2C;ARHGAP23;PTEN;ARHGEF1;PDPK1;RNF34;OPHN1;HDAC1;AURKB;ARAF;RNF41;ARHGAP12;FGD1;OCRL;SOS2;RBBP8;CDC42;HUS1;NOP2;TAF11;RALBP1;ITGAV;CSNK2A2;CSNK2A1;MAPKAP1;BRD7;RAD50;TOP3A;USP7;PPP1R13B;KMT5A;PRKAR1A;TBP;ROS1;PML;TAF4;ULK4;ARHGAP21;FLCN;MOB3B;MAP2K6;SPHK2;AKAP7;CCNG1;STK4;MTA2;TAF7;VAV3
prerank,positive regulation of cell cycle process (GO:0090068),0.33713436601460467,1.033485185639419,0.40431654676258993,0.9409054298181524,1.0,20/91,20.40%,PKP4;IGF1;PHIP;ATRX;CD28;PDGFRB;CDC14A;PLSCR1;AURKB;CDC14B;CDC42;TGFA;CENPV;DYNC1LI1;PKN2;FEN1;BTC;CEP120;XRCC3;CEP295
prerank,regulation of axonogenesis (GO:0050770),0.36234629117821215,1.0329190181168797,0.40825688073394495,0.9415556933713459,1.0,6/51,2.17%,ROBO1;LRP4;KIF13B;SIPA1L1;PLXNA2;EPHA4
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3530559761214395,1.0328296877091079,0.4098360655737705,0.9408175884596506,1.0,12/65,9.35%,SMAD3;PPARA;SNX6;PMEPA1;TGFBR1;SMAD6;LDLRAD4;FBN1;SMURF2;TGFBR2;PDPK1;SIRT1
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.23897774414890297,-1.032673828589357,0.35570469798657717,0.707572739608984,1.0,56/291,14.77%,SLIT2;MEF2C;PID1;PDE4B;PDE3A;KCNC2;ACTB;ESR1;BRINP3;AKAP6;HCN1;PTPRK;PTK2B;BRINP1;RYR3;GNG2;GUCY1B1;LYN;RORB;TBX1;DAB2IP;RAP1B;FZD4;RAP1A;RPS3;FOXO1;TNFRSF1B;KCNQ1;WNT9A;SH3BP4;GLRA1;EGR1;PDE2A;CAMKK2;BRINP2;CAPN2;P2RY12;ATP2B4;GPER1;SBNO2;TIRAP;DAPK1;VIM;MAPT;SPAAR;DMTN;PRKD1;GLRA2;RET;CARD16;MT3;ABCB4;P2RY1;FES;LBP;GNB1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.4311643984385701,-1.032311928158028,0.4360730593607306,0.7077337292842159,1.0,5/13,21.60%,GRM3;GABBR2;EDNRB;PALM;DRD2
prerank,calcium ion import (GO:0070509),-0.36408495254006157,-1.0318912826830364,0.4268867924528302,0.7080057184069647,1.0,10/28,12.96%,SLC8A1;CACNB2;CACNA1E;CACNA1G;TRPC4;MICU3;CACNA1B;TRPV4;SMDT1;MCUB
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.3838144032323379,-1.031850457272414,0.43707093821510296,0.7073536334653027,1.0,11/21,21.28%,CSGALNACT1;DCN;CHSY3;BGN;CSPG4;VCAN;CHST12;CHST9;CHST7;CSPG5;BCAN
prerank,negative regulation of protein phosphorylation (GO:0001933),0.31250416066370473,1.031220441741755,0.40745672436750996,0.9443960171886716,1.0,25/150,11.45%,PRKAG2;PTPN13;FBLN1;PRKCZ;ERRFI1;PRKN;PPEF2;PPM1E;DEPTOR;PMEPA1;LRRK2;DTNBP1;SMAD6;LDLRAD4;TRIB2;WWTR1;PTEN;IGFBP3;CDK5RAP3;PDPK1;MVP;CRKL;TRIB1;PRKDC;IMPACT
prerank,negative regulation of cyclase activity (GO:0031280),-0.4203027872818778,-1.030998868306625,0.45852534562211983,0.7087106929624659,1.0,5/14,21.60%,GRM3;GABBR2;EDNRB;PALM;DRD2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.42357702867084523,1.0309116450234164,0.4417808219178082,0.9442990153786877,1.0,2/22,1.44%,ROCK2;IGF1
prerank,aminoglycan biosynthetic process (GO:0006023),0.3703769917874107,1.0308164812126457,0.40873634945397813,0.9435643596579142,1.0,5/49,4.34%,HS3ST3A1;HS3ST3B1;NDST1;HS2ST1;HS3ST6
prerank,regulation of osteoclast differentiation (GO:0045670),0.39819942862702445,1.0307225309655008,0.43066884176182707,0.9428532018816962,1.0,5/33,6.93%,GPR137;TLR3;TLR4;IL12B;FBN1
prerank,regulation of protein processing (GO:0070613),-0.38834592059396866,-1.0307135991928549,0.40582959641255606,0.7086276359202439,1.0,5/21,10.91%,SERPINE2;CCBE1;RUNX1;NKD2;TMEM59
prerank,positive regulation of cellular protein localization (GO:1903829),0.3459507702451769,1.0307054571941718,0.4323076923076923,0.9419150463708145,1.0,11/69,9.10%,SYT11;PRKAA2;PRKN;CEP250;SESN2;SLC5A3;F2;WWTR1;CDK5RAP3;TRAPPC12;PARP9
prerank,regulation of peptidase activity (GO:0052547),-0.3957953704732039,-1.0306658075496589,0.4018264840182648,0.7080116828559075,1.0,5/19,14.97%,CAV1;CST3;ECM1;PINK1;MAPK12
prerank,ion homeostasis (GO:0050801),-0.35115276300064613,-1.0302043072573417,0.4098360655737705,0.7084173012128363,1.0,6/30,7.27%,SLC4A10;CAMK2D;UNC80;NEDD4L;KLHL3;WNK2
prerank,embryonic limb morphogenesis (GO:0030326),0.3880586950800713,1.029908251085479,0.43328100470957615,0.9432512326281772,1.0,8/34,11.14%,OSR1;AFF3;GLI3;CYP26B1;CACNA1C;NIPBL;HDAC1;RARG
prerank,ventricular septum morphogenesis (GO:0060412),0.4087978685889228,1.029655387786117,0.41245791245791247,0.9430125467103255,1.0,4/27,3.46%,ROBO1;TGFBR3;BMPR1A;TGFBR1
prerank,regulation of protein modification process (GO:0031399),-0.31424119976875525,-1.0295739267960136,0.4027777777777778,0.7091874932234598,1.0,19/50,18.66%,GRM5;FN1;PPP1R16B;CCDC88A;LYN;FKTN;CORO1C;PPIB;PTK2;PPP1R16A;FNIP2;SPRED1;NOP53;CCDC88C;MT3;HPF1;HSPB1;KDM4D;PUM3
prerank,leukotriene biosynthetic process (GO:0019370),-0.427937303286324,-1.0292097145703643,0.41252699784017277,0.709314156790607,1.0,6/14,33.06%,PLA2G4A;GGT7;LTA4H;ALOX5AP;MGST2;GGT1
prerank,aorta morphogenesis (GO:0035909),-0.402268549333458,-1.028999435144154,0.4418103448275862,0.7090547043002073,1.0,6/17,9.18%,ENG;ACVRL1;JAG1;TBX1;PROX1;HEY2
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.4414060180342896,1.0289908635318372,0.41754385964912283,0.9439698686705091,1.0,7/18,14.46%,ROCK2;RUFY3;BCAS3;CDH5;CYRIB;KRIT1;LLGL2
prerank,positive regulation of translational initiation (GO:0045948),0.4419643954048003,1.028323461734248,0.4444444444444444,0.9449421034964687,1.0,7/18,21.05%,DDX3X;POLR2D;LARP1;YTHDF3;BOLL;POLR2G;RPS6KB2
prerank,regulation of interferon-alpha production (GO:0032647),0.4265263470586229,1.0280341051364081,0.44201680672268906,0.9448244953926161,1.0,5/23,9.79%,TLR3;TLR4;DDX3X;RIPK2;MAVS
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.34650627747235563,1.0275683218977747,0.39204545454545453,0.9451969446497913,1.0,11/74,7.94%,DAB2;SMAD3;TGFBR1;CLASP1;FOXC1;PDPN;DAG1;LDLRAD4;WWTR1;TGFBR2;PTEN
prerank,protein lipidation (GO:0006497),0.35388824845580663,1.0273871913301533,0.416289592760181,0.9447405629627815,1.0,11/59,11.85%,PIGN;ATG10;PIGW;ATG5;PIGQ;WIPI1;GLUL;ATG7;ZDHHC18;ZDHHC1;PORCN
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.37813934065098365,-1.026574612363404,0.42727272727272725,0.7142677322461162,1.0,6/21,17.20%,CAV1;GSK3B;CTNNB1;AXIN1;APC;PPP1CA
prerank,establishment of skin barrier (GO:0061436),-0.413264955037924,-1.0259429464517198,0.43737166324435317,0.7142714049047758,1.0,5/15,15.24%,UGCG;LSR;MET;HRNR;STMN1
prerank,regulation of water loss via skin (GO:0033561),-0.413264955037924,-1.0259429464517198,0.43737166324435317,0.7142714049047758,1.0,5/15,15.24%,UGCG;LSR;MET;HRNR;STMN1
prerank,modification-dependent protein catabolic process (GO:0019941),0.3016783661054554,1.025725875354706,0.40625,0.9485290339181712,1.0,49/193,19.26%,RNF43;ASB2;ANAPC15;PRKN;SPSB1;RNF213;NEDD4;ARRB1;ANAPC2;SPSB4;UBR4;SMURF2;TTC3;RNF8;TRIP12;RNF217;BTRC;RNF19A;RNF34;FBXO22;AURKB;RNF13;UBA6;FZR1;FBXO10;NUB1;FBXO11;UBE2H;AMFR;ANAPC16;RNF146;BIRC6;RNF19B;WDR91;RNF7;UFD1;UBE2E1;SYVN1;CDC34;NPLOC4;SQSTM1;NDFIP1;RNF20;TAF1;ARIH1;KCTD21;USP33;UBE4B;MIB1
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.22975038089284375,-1.0252300700142283,0.2676056338028169,0.7152138109131484,1.0,117/532,18.87%,GHR;PTPRJ;RPS6KA5;ACTN4;PIK3R1;ADIPOR2;IL1R1;GREM2;OSMR;TMSB4X;CAMK2D;LIFR;MID1;IL1RAP;FN1;CXCL12;ST18;VCAM1;B2M;STAT3;INPP5D;PTK2B;NOD1;MAOA;F3;TNFRSF11B;NFKBIA;UGCG;IL6ST;ANXA1;PSMB2;TNFRSF11A;IL33;STX3;PPIA;RAP1B;ICAM1;TRAF5;RPLP0;CARD14;SOCS2;HSPA8;ACKR3;MAP3K7;FOXO1;ITGB1;TNFRSF1B;CRK;PTPRZ1;TGFB1;PTGS2;IRAK3;CEACAM1;PSMD14;EGR1;S1PR1;STAT5B;TEC;IFNGR2;FGF2;JAK1;PSMC6;CD44;HSP90AA1;IL4R;MSN;IFITM3;PITPNA;ILK;ADIPOR1;IKBKB;TWIST1;VIM;CDKN1A;CNTFR;AIM2;HIF1A;TALDO1;LRP8;CFL1;VEGFA;SOCS5;MT3;JUNB;LIMS1;LBP;UBB;IL31RA;PSMA4;PSMB9;PIM1;CBL;VAV1;CAPZA1;AIP;EDAR;NDN;PELI1;NOD2;CCL13;SKP1;SYK;MAP3K14;SOX2;TRAF1;IRS2;PDCD4;IL22;CRLF1;IRF5;TNFRSF25;PSMD11;IRF2;ITGB2;CAMK2B;BCL2L11;PSMB10
prerank,peptidyl-methionine modification (GO:0018206),0.46807062467123683,1.0248565950499156,0.4142857142857143,0.9500698425036148,1.0,3/12,15.40%,METAP2;NAA20;NAA16
prerank,negative regulation of protein ubiquitination (GO:0031397),0.35261432483695343,1.0248257175786613,0.4166666666666667,0.9491743953973671,1.0,8/50,14.09%,SH3RF2;NXN;HDAC8;ARRB1;GTPBP4;ABL1;OGT;PER2
prerank,regulation of interferon-gamma production (GO:0032649),-0.2881681523395413,-1.024717513671463,0.3707482993197279,0.7157604312296053,1.0,18/71,21.18%,PDE4D;PDE4B;IL1R1;SLC7A5;GAS6;VSIR;CD47;TRIM27;HAVCR2;LAPTM5;NR1H4;SCRIB;ZFPM1;INHBA;TLR7;TXK;LGALS9;PYCARD
prerank,negative regulation of blood pressure (GO:0045776),-0.42384457725709074,-1.024514611776595,0.43103448275862066,0.7155069295189391,1.0,2/13,2.22%,BMPR2;NOS3
prerank,activation of phospholipase C activity (GO:0007202),0.3966676622601456,1.0243977368807773,0.42528735632183906,0.9494733950768429,1.0,3/29,3.81%,LPAR1;LPAR2;ARHGAP6
prerank,regulation of exosomal secretion (GO:1903541),0.43015130308940774,1.0243541204027327,0.45346869712351945,0.9486237530525322,1.0,8/19,22.43%,PRKN;SDC4;SMPD3;SNF8;VPS4A;CHMP2A;RAB7A;SDCBP
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.44050246409907917,1.0242046704834786,0.4463276836158192,0.9481007102314262,1.0,3/18,5.53%,ACSL1;ACSBG2;HACD1
prerank,potassium ion export across plasma membrane (GO:0097623),0.46924792917995506,1.023885861634501,0.4214417744916821,0.9480901140848967,1.0,2/13,1.81%,KCND3;KCNA5
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.41750544933408223,1.0237741498713482,0.4253968253968254,0.9474301646544994,1.0,5/26,9.57%,PPARA;SLC30A10;SLC5A3;TLR4;PIKFYVE
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.40850398019431644,-1.0232481413933543,0.42567567567567566,0.7178974433640158,1.0,7/15,13.77%,TMSB4X;SEMA5A;KDR;MET;FGF2;PRKD1;VEGFA
prerank,protein localization to plasma membrane (GO:0072659),0.3186800141484813,1.0229665359816804,0.4270557029177719,0.9487412528201178,1.0,16/129,6.76%,AFDN;ROCK2;ACTN2;ATP1B3;ANK2;TSPAN5;TTC7B;DLG1;FYB1;KCNIP3;EZR;TMEM150A;RAB34;FYB2;PIGW;CACNB3
prerank,regulation of organelle assembly (GO:1902115),0.3424513818376482,1.0228059538504333,0.422316384180791,0.9482368898863801,1.0,14/72,11.12%,STX18;DCDC2;MTMR3;NPRL3;TBC1D16;EZR;ATG5;NPRL2;RABEP2;ATXN2;TRAPPC12;PIKFYVE;SDCCAG8;IFT88
prerank,histone H3 deacetylation (GO:0070932),0.4726080490189232,1.022721945919584,0.44528301886792454,0.9474828247874286,1.0,5/15,14.09%,HDAC8;HDAC4;SIRT1;HDAC1;PER2
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.35823775651198747,1.0225565162449515,0.42902208201892744,0.9469797898004512,1.0,10/52,13.14%,TFDP2;LEPROT;BID;FZD5;TP53;HUWE1;TFDP1;NPEPPS;CSNK2A2;PPP1R13B
prerank,release of cytochrome c from mitochondria (GO:0001836),0.43891326809563447,1.0224547055592437,0.43223443223443225,0.9463204124660877,1.0,3/17,8.88%,BID;SOD2;DNM1L
prerank,ion transport (GO:0006811),0.32339264120277134,1.02233436595499,0.42155525238744884,0.9456906904002294,1.0,13/111,8.49%,TRPM3;WNK4;SLC24A3;SLC5A5;SLC8A3;VDAC2;SLC26A3;SLC5A8;SLC20A2;ANO6;SLC26A1;SLC1A3;CTNS
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.27007673308667074,-1.022324485709587,0.3854166666666667,0.7194580035856767,1.0,30/104,16.37%,BMPER;CAV1;BMPR2;HTRA3;CCN3;VWC2;NOTCH1;VWC2L;PRDM16;ASPN;SMAD5;IL17RD;CD109;SORL1;SMAD1;BMP2;TGFB1;SMAD7;FKBP1A;LEMD3;UBE2D3;ACVR1;SPRY1;SPRED1;BMPR1B;PPM1A;SMURF1;UBB;CILP;HIPK2
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.4834727654276825,1.0222191685281263,0.44360902255639095,0.9450876070587487,1.0,3/10,17.64%,HK2;GFPT1;PFKM
prerank,blood vessel endothelial cell migration (GO:0043534),0.41733055135251124,1.0221611627219578,0.4280821917808219,0.9442957280038922,1.0,2/22,0.55%,ROBO1;EFNB2
prerank,superoxide anion generation (GO:0042554),0.47144662513024665,1.021934705535638,0.4543761638733706,0.9439688207120642,1.0,3/13,10.42%,ALOX12;NOX1;NOX4
prerank,organophosphate ester transport (GO:0015748),-0.36393052069038945,-1.0216377221235724,0.4119047619047619,0.7203856366968151,1.0,9/24,11.95%,PITPNC1;SCARB1;PLTP;LDLR;NPC2;PITPNB;TNFAIP8L3;MTTP;PITPNA
prerank,actin filament-based transport (GO:0099515),-0.3779993092004874,-1.0211820024102434,0.41418764302059496,0.7207198463548116,1.0,5/21,4.23%,MYO1D;ACTN4;MYO1B;FNBP1L;MYO5A
prerank,regulation of cytoskeleton organization (GO:0051493),0.32550875195566387,1.0204001337672568,0.4388888888888889,0.9472777029129053,1.0,18/108,10.63%,CELSR1;ROCK2;RHOQ;PRKAA2;RHOBTB2;RHOD;ARHGAP18;CLASP1;EZR;ARHGAP17;PDGFRB;BAIAP2;RICTOR;HRG;DIAPH1;LRP1;PHLDB2;ABL1
prerank,negative regulation of locomotion (GO:0040013),-0.4305505556934133,-1.020029803281173,0.44763860369609854,0.7227675351957927,1.0,4/12,11.00%,FRMD5;SPOCK3;CRK;DUSP3
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.27575541582394514,-1.0200264437487685,0.4092526690391459,0.7220248794266446,1.0,27/98,19.80%,PID1;SLCO1C1;THBS1;PPARD;ECE1;NFKBIA;SFRP4;TBC1D5;APOE;TGFB1;AGTR1;XDH;NSF;STARD4;CDKN1A;ACE2;SNCA;AHI1;VEGFA;MT3;SCRIB;ATAD1;ARRB2;PAX8;INHBA;ROMO1;AGT
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.4700572373319091,1.0197710877012536,0.44861660079051385,0.9480841241788054,1.0,3/13,3.18%,TGFBR3;FGFR2;BMPR1A
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.46762024654140094,1.0195813772828934,0.4538152610441767,0.9476612140929919,1.0,3/13,11.08%,PPARA;NFIB;NFATC3
prerank,amyloid fibril formation (GO:1990000),-0.30812615505200414,-1.0195177233149193,0.45,0.7225312479433512,1.0,17/51,14.92%,GSN;CST3;B2M;APP;TSPAN14;TGFBI;HSPG2;SORL1;SIAH2;H3-3A;FKBP1A;ITM2B;MAPT;SNCA;MFGE8;IAPP;UBB
prerank,homotypic cell-cell adhesion (GO:0034109),-0.3294319749295027,-1.0193148423377556,0.42028985507246375,0.7222925915725608,1.0,17/39,17.82%,ACTB;GNAS;ACTN1;UBASH3B;FN1;ACTG1;MYH9;PPIA;FLNA;MYL12A;P2RY12;ITGB3;ILK;MYL9;TYRO3;STXBP3;HSPB1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.363667425129804,-1.0192597812235589,0.4191343963553531,0.7216756969467154,1.0,11/25,24.04%,SLIT2;EVL;TBC1D30;LIMK2;ABI3;PFN2;KANK1;ODF2L;ARHGAP44;CCP110;PLXNB3
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.39935610400123267,1.01912818606496,0.4129692832764505,0.947898442857816,1.0,9/27,15.31%,DDX5;TP53;TNRC6B;RIPK1;AJUBA;DDX6;MAP2K1;MAP2K2;WTIP
prerank,mitochondrion transport along microtubule (GO:0047497),-0.42997259788947695,-1.0188313498823502,0.44288577154308617,0.7220010014702475,1.0,6/13,23.64%,SYBU;MAPT;HIF1A;UBB;SPAST;NEFL
prerank,homeostasis of number of cells (GO:0048872),-0.427997557487193,-1.0184124244391572,0.4666666666666667,0.7222544233684323,1.0,3/12,4.65%,NOS3;CCN3;NOTCH1
prerank,T-helper cell differentiation (GO:0042093),-0.4146264241349908,-1.0182216967997526,0.45041322314049587,0.7219535697593809,1.0,2/14,6.10%,LEF1;FOXP1
prerank,transition metal ion homeostasis (GO:0055076),0.40028567406057824,1.0173190862382835,0.4170940170940171,0.9520762732901665,1.0,3/28,1.98%,CP;PICALM;PRKN
prerank,peroxisomal membrane transport (GO:0015919),0.4019584046873995,1.0172751767122812,0.45993031358885017,0.9512345606089646,1.0,10/27,17.34%,PEX11B;PXMP2;PEX10;PEX14;ACBD5;PEX19;RAB8B;SLC25A17;PEX16;PEX5
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.3622479293708214,1.0172095861554231,0.42586750788643535,0.9504564031924756,1.0,12/46,13.99%,OGN;IGF1;IL18;NOX1;PDGFRB;IL12B;IGFBP3;TCF7L2;TRIB1;PRKDC;RBPMS2;MFN2
prerank,actin cytoskeleton reorganization (GO:0031532),0.34668402889056227,1.0171561897643688,0.44036697247706424,0.949663392379241,1.0,11/63,6.94%,AUTS2;KIT;SIPA1L1;PTK7;NPHS2;PHACTR1;MCU;DTNBP1;EZR;CDC42BPG;RICTOR
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.40404910782784137,1.0171262524422742,0.4602076124567474,0.9488005863165095,1.0,16/29,22.95%,SMARCA4;TERT;TCF7;TLE1;HDAC1;ASH2L;TCF7L2;AXIN2;KMT2D;TLE2;CREBBP;TCF7L1;PYGO2;RUVBL1;EP300;BCL9
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.4194423008497164,-1.0169413804620255,0.4288840262582057,0.7244334362942298,1.0,3/13,2.22%,PID1;TMSB4X;NOS3
prerank,icosanoid metabolic process (GO:0006690),0.3728709478895059,1.0166087757385749,0.43800322061191627,0.9492048600998823,1.0,6/40,7.73%,PTGS1;ALOX12;EPHX1;DAGLA;PON3;ABCC10
prerank,regulation of protein import into nucleus (GO:0042306),-0.3327224253445268,-1.0164788678106629,0.46078431372549017,0.7248517406632062,1.0,11/36,11.40%,PIK3R1;MDFIC;FLNA;PSEN1;APOD;TGFB1;UFM1;EFCAB7;CABP1;BMP4;CDH1
prerank,amino acid transmembrane transport (GO:0003333),0.36897177100669937,1.0162929540000538,0.44145569620253167,0.9491500579159585,1.0,5/45,4.62%,SLC6A13;SLC38A4;SLC38A3;SLC7A11;SFXN2
prerank,regulation of gastrulation (GO:0010470),0.4653085422076515,1.016233062376611,0.4533333333333333,0.9483894171760625,1.0,5/14,12.32%,OSR1;CLASP1;DAG1;PHLDB2;FOXA2
prerank,regulation of actin filament-based movement (GO:1903115),-0.4519976753169072,-1.016123836200157,0.44668008048289737,0.7249953456638307,1.0,2/10,0.65%,PDE4D;PDE4B
prerank,vasodilation (GO:0042311),-0.4230571084862677,-1.0160845231825324,0.43829787234042555,0.7243463328597431,1.0,5/13,12.66%,KCNMA1;NOS3;KLF2;GPER1;NOS1
prerank,ovarian follicle development (GO:0001541),0.45519687748962123,1.0158659380405761,0.4559386973180077,0.9485142518981962,1.0,1/13,1.21%,KIT
prerank,heart process (GO:0003015),-0.4143166912146502,-1.0156923608037707,0.44170403587443946,0.7245685511556231,1.0,2/14,0.41%,SGCZ;SGCD
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.4170600838726434,-1.0156771579712436,0.4442105263157895,0.7238571459415235,1.0,7/13,19.62%,SHANK3;APP;RELN;EPHB2;ZDHHC2;CHRNA7;ADCY8
prerank,ceramide catabolic process (GO:0046514),-0.42087844465419116,-1.0155960582564743,0.4403292181069959,0.7233036586364973,1.0,4/14,11.77%,ACER3;ACER2;HEXB;ASAH2
prerank,organelle disassembly (GO:1903008),0.38829952196287726,1.0148473338998987,0.43686006825938567,0.9504011450171765,1.0,11/33,19.26%,RETREG1;PLK5;KLC1;KIF5B;ZFAND1;ATG2A;STX5;TEX264;GFM2;GOLGA2;UBA5
prerank,cellular response to virus (GO:0098586),0.39354714056593343,1.0148472210857435,0.4467005076142132,0.949456463264123,1.0,4/30,10.49%,GSDME;DDX3X;TOMM70;IRGM
prerank,cellular response to hydroxyurea (GO:0072711),0.4880087633504333,1.014550986231371,0.463855421686747,0.9493461222735629,1.0,4/10,21.07%,ATRX;DDI1;RTF2;FMR1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.28800836495514825,1.014534193877924,0.4491916859122402,0.948447435134256,1.0,88/336,20.38%,UBE2E2;PAXX;STXBP4;MACROD1;BID;BABAM2;KMT5C;ZBTB38;USP3;SUSD6;IKBKE;ATM;UVRAG;RAD54L;PLK5;BAZ1B;KMT5B;TP53;SETD7;PARP4;NIPBL;RNF8;SAMHD1;TRIP12;FBH1;NUPR2;PDS5A;SIRT1;UBR5;ASH2L;WDR76;BRSK1;ABL1;ATF2;RBBP8;PRKDC;MSH3;ZBTB1;HUS1;DCUN1D5;CBX5;CUL4A;UBA6;IGHMBP2;FANCA;RAD50;SIRT4;PNKP;PHF1;POLE2;MCM7;DDB2;PML;GADD45A;DOT1L;MAP2K6;MGMT;BRAT1;INTS3;CEP63;VAV3;TLK2;MCL1;ZBTB40;MBD4;PIDD1;CRY1;OGG1;TAF1;NBN;SUMO1;FEN1;MAPK14;RAD51D;SLX4;MMS19;YAP1;PDS5B;APTX;USP16;XPA;BCL6;ASF1A;XRCC3;TANK;RAD9A;NCOA6;MCM9
prerank,regulation of macrophage activation (GO:0043030),-0.3446384358008347,-1.0143456487966855,0.4312169312169312,0.7256644427886308,1.0,8/30,17.31%,CD200;LRFN5;THBS1;IL33;MFHAS1;LBP;IL31RA;CD74
prerank,negative regulation of cell cycle (GO:0045786),0.3328189792696339,1.01379848353218,0.4342105263157895,0.9495400662900666,1.0,6/73,3.89%,BMP7;SMAD3;NUPR1;NR2F2;FOXC1;GAS1
prerank,purine-containing compound salvage (GO:0043101),0.47571299582004206,1.0137820631702976,0.4448669201520912,0.9486420163384732,1.0,4/12,20.59%,AMPD3;AMPD2;APRT;GMPR2
prerank,cellular protein-containing complex assembly (GO:0034622),-0.2549769119813037,-1.0137119444193856,0.40654205607476634,0.7264688091246517,1.0,41/159,20.20%,STXBP6;HIP1;SGIP1;RTN4;NCK2;VAMP4;HSP90AB1;RPL38;TIAM1;NSG2;PDE4DIP;BIN1;SMAD1;TGFB1;IMMP2L;ANLN;AIFM1;HSP90AA1;CYBA;FKBP1A;AP2M1;PSMG2;MAPT;AXIN1;SNCA;CLU;NCK1;PIK3C2A;DHX9;DNAAF3;CCT2;CENPE;CHMP4B;CHMP4A;PSMD11;CASQ2;TBCE;HIP1R;POMP;NUP107;PTGES3
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.439496736235578,1.0134346958822549,0.4473229706390328,0.9486960806783078,1.0,3/17,7.00%,AKAP13;ADRA2A;ADCY9
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.3383139705587007,-1.013273582157469,0.41625615763546797,0.726831769073461,1.0,7/35,4.98%,NRP1;TEK;NTRK3;ESAM;PTK2B;F11R;SEMA3E
prerank,cellular glucose homeostasis (GO:0001678),0.37468169971762255,1.0125976671349861,0.4541139240506329,0.9501073995014617,1.0,4/41,2.21%,PPARGC1A;PRKAA2;HK2;ZBTB20
prerank,spinal cord development (GO:0021510),0.46363898041662055,1.0125579999360435,0.435361216730038,0.9492828747818021,1.0,3/12,7.08%,GLI2;LOXL3;SOX12
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.28914513172096246,-1.0124072193258271,0.3924050632911392,0.7282229996582547,1.0,25/73,22.11%,PTPRJ;THBS1;STAT3;ARHGEF2;IL33;PTPRC;APP;PLCG2;PSEN1;EPHB2;CYBA;TIRAP;HAVCR2;TWIST1;CLU;LBP;DHX9;NOD2;SYK;HSPB1;TYROBP;CCL19;LGALS9;PYCARD;CD86
prerank,protein acetylation (GO:0006473),0.3898049598565348,1.012369847303189,0.45254237288135596,0.9488823662458105,1.0,7/30,16.31%,SPHK1;NAA80;DSCC1;SIRT1;KAT2B;NAA16;CREBBP
prerank,icosanoid secretion (GO:0032309),0.4712040923786904,1.0123522381978267,0.46168958742632615,0.9479827505572195,1.0,2/12,4.75%,ACE;BDKRB2
prerank,cGMP biosynthetic process (GO:0006182),0.4852899384141883,1.0122678552177073,0.45368620037807184,0.9473004337814379,1.0,2/10,6.12%,NPR1;NPR2
prerank,regulation of protein catabolic process (GO:0042176),-0.2745488346196969,-1.012209416759336,0.4158730158730159,0.7279705357463964,1.0,25/99,18.67%,HECW2;WWP1;HECW1;FMN2;NEDD4L;GSK3B;DAB2IP;PLK2;FLNA;FOXO1;DACT1;SORL1;EEF1A1;IRAK3;NSF;ZDHHC2;AXIN1;ADGRB1;SMURF1;HACE1;EGLN2;APC;BARD1;CHEK2;SIRT2
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.266428373309848,-1.0118726790244321,0.4139194139194139,0.7280738493373967,1.0,30/112,17.82%,PTPRJ;THBS1;STAT3;CD34;GAS6;ARHGEF2;IL33;PTPRC;FOXP1;APP;PLCG2;PSEN1;VSIR;EPHB2;IRAK3;CD47;CYBA;TRIM27;TIRAP;HAVCR2;TWIST1;CLU;LBP;CX3CR1;DHX9;CHRNA7;NR1H4;NOD2;SYK;HSPB1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.4759477448692047,1.011713140428643,0.44584837545126355,0.9479919469142369,1.0,1/11,0.65%,ACTN2
prerank,regulation of MAPK cascade (GO:0043408),0.304135416917547,1.0114829105280854,0.43178973717146435,0.9476795697705046,1.0,16/157,6.41%,TGFBR3;ROCK2;LPAR1;KSR1;KIT;GSDME;IGF1;FGFR2;PKHD1;PPEF2;FGFR1;ADRA2A;DAG1;EPHA8;FLT1;LBH
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.34785362333064884,-1.0107729639252154,0.4271356783919598,0.7301412979724564,1.0,9/32,10.44%,PPP1R16B;HSP90AB1;PPP2R5A;PPIA;CALM1;CALM2;CAMTA1;TGFB1;CALM3
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.49232532948989527,1.0104215255627784,0.4590818363273453,0.9496387874452389,1.0,3/10,9.87%,APPL2;PRKCB;GRB10
prerank,positive regulation of vasculature development (GO:1904018),0.32505699385509207,1.0104133602410612,0.4528301886792453,0.9487315024060344,1.0,16/94,9.72%,FGF1;ADAM12;SMOC2;SASH1;HK2;SPHK1;RAPGEF3;PRKCB;CTSH;FLT1;SERPINE1;PDPK1;CDH5;HYAL1;SIRT1;STIM1
prerank,regulation of JUN kinase activity (GO:0043506),-0.33333142309462765,-1.0103536772260093,0.4696969696969697,0.7304318463553425,1.0,8/33,10.79%,MAP3K5;TNFRSF11A;DAB2IP;PAK1;RPS3;MAP3K7;AIDA;EDN1
prerank,regulation of apoptotic process (GO:0042981),-0.22359447042523736,-1.0102922966618413,0.42,0.7298315210732358,1.0,180/676,20.22%,GRID2;SLIT2;MEF2C;LEF1;HIP1;TEK;ARHGAP10;ACTN4;PIK3R1;ITGA6;MAP3K5;RASSF2;FMN2;KCNMA1;RTN4;THBS1;ACTN1;MCF2L;ABR;TBX3;TPT1;RASGRF2;ACER2;RNF144B;PTK2B;ARHGEF3;TRIM2;APAF1;CSRNP3;RPS6;GAS6;NGF;CYP1B1;TFRC;UNC13B;TRIO;NFKBIA;ARHGEF9;ARHGEF7;IL6ST;NET1;TNFSF10;ARHGEF2;KDR;GSK3B;ANXA1;SFRP4;DAB2IP;TIAM1;PPIA;CD38;PTMA;PLK2;PHLPP1;FLNA;RPS3;CTSD;CARD14;SOCS2;ARHGEF17;TGFB3;RYBP;RHOB;FOXO1;SEMA4D;PSEN1;ITGB1;PERP;BIN1;BMP2;SIAH2;HSPA5;PTK2;CALR;DDRGK1;CTSB;VDAC1;TMBIM6;TOX3;PPT1;ANP32A;FLT4;PLEKHG5;AIFM1;CD44;UFM1;ARHGEF26;FRZB;ARL6IP1;HSP90AA1;RPS6KA3;BCAR1;RPS6KA2;ERC1;MAGED1;GPER1;HNRNPK;BMP4;RASA1;ATF4;CTNNB1;DAPK1;ANKRD13C;LCMT1;FAS;IKBKB;SERPINB9;LRP8;SNCA;AHI1;CFL1;SUDS3;TAF9B;VEGFA;GADD45G;RPS6KA1;PINK1;NOP53;MT3;ATF5;DNAJA3;CLU;KLF11;IAPP;CASP6;UBB;MTDH;PHLDA3;PAX2;IL31RA;CRADD;BFAR;BCL3;PIM1;CBL;EGLN2;VAV1;FAIM2;CAT;RHBDD1;TOP2A;DNAJA1;ARHGDIA;APC;RNPS1;NR1H4;SCRIB;CASP2;PIM2;CD74;BARD1;DIABLO;PHLDA1;HSPB1;DHCR24;HTRA2;IRF5;TNFRSF25;APH1A;SOX8;STPG1;RNF122;BCL2L11;FOXL2;HIP1R;CALHM2;PAX8;PREX1;PNMA2;GADD45B;GATA6;SIX4;COPS5;DCUN1D3;AGT;ECT2;IER3IP1;SHC1;EGLN3;DAPK2
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.34641726172202375,-1.0096670780853634,0.4593967517401392,0.7306509012149857,1.0,9/28,11.72%,SHANK3;GSK3B;APOE;APP;RELN;EPHB2;PTN;ZDHHC2;FAM107A
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.2916152264163056,-1.0096338565455885,0.4380664652567976,0.7300032297061061,1.0,14/67,9.84%,GHR;TEK;ERBB4;PTK2B;KDR;LYN;BMX;RELN;EPHB2;PTK2;ABI1;TEC;FLT4;ERBB2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.37228083733395034,-1.0093813784668704,0.4258474576271186,0.7298827607577669,1.0,6/21,9.36%,SLIT2;TGFB2;DAB2IP;CD2AP;EPHB2;ARHGAP25
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.35600218273743117,-1.0092789744805606,0.4528301886792453,0.7293905012442256,1.0,8/25,10.44%,CAV1;CTNNA3;RYR2;CAMK2D;TBX18;CALM1;FGF13;CALM3
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.38763453377835944,-1.009256601114065,0.4533029612756264,0.7287010941102444,1.0,5/17,14.08%,PTPRJ;CEACAM1;DUSP3;DGKZ;LAPTM5
prerank,Golgi organization (GO:0007030),0.31660176121866707,1.0091068608695204,0.42935528120713307,0.9514199287531175,1.0,34/112,18.90%,FAM174B;DYM;OBSL1;CLASP1;LRRK2;MYO18A;PLK5;BCAS3;HUWE1;HTT;TRAPPC12;GOLPH3L;CSNK1A1;RAB43;FBXW8;CDC42;TRAPPC11;VTI1A;STX5;TANGO2;ARHGAP21;SEC23IP;RAB29;VPS51;GOLGA5;GOLGA8B;RAB30;PI4K2B;OPTN;COG4;NPLOC4;GORASP2;BET1;GOLGA2
prerank,regulation of aerobic respiration (GO:1903715),-0.4051573388042213,-1.0090486307376896,0.4421052631578947,0.7284849428963915,1.0,4/15,14.08%,CBFA2T3;SLC25A33;PINK1;NOP53
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.3776543396020421,-1.0085787589266693,0.4444444444444444,0.7289575956590122,1.0,2/20,2.36%,PDE4D;ADRA1B
prerank,positive regulation of catabolic process (GO:0009896),-0.2994658754373129,-1.008477911292075,0.4093567251461988,0.7284885509513961,1.0,18/65,17.51%,HECW2;WWP1;HECW1;NEDD4L;GSK3B;DAB2IP;PLK2;FOXO1;DACT1;VSIR;SORL1;NSF;AXIN1;SMURF1;HACE1;EGLN2;APC;BARD1
prerank,positive regulation of lipid localization (GO:1905954),0.4768984717570506,1.0084368535075716,0.43570057581573896,0.9523361929841738,1.0,3/11,14.88%,IKBKE;LRP1;NFKB1
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.3341409449404703,-1.0084319073907,0.4275,0.7278860455032473,1.0,7/33,6.96%,MAP3K5;CYP1B1;NET1;ANXA1;RPS3;PLEKHA1;RHOB
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.4953246306432937,1.008426683627133,0.4830188679245283,0.9514345894577021,1.0,3/10,16.52%,EMC2;EMC1;EMC3
prerank,protein import into peroxisome membrane (GO:0045046),0.41658924839610717,1.0082705309308975,0.45353159851301117,0.9509464061502888,1.0,9/22,17.34%,PEX11B;PXMP2;PEX14;ACBD5;PEX19;RAB8B;SLC25A17;PEX16;PEX5
prerank,fatty acid catabolic process (GO:0009062),0.34201246072416974,1.008111704736892,0.4535928143712575,0.9504516495637526,1.0,23/67,22.19%,PCCA;CEL;ACAD11;ACAD10;BDH2;CPT2;ACADM;MECR;ACOT8;ECHDC1;ACBD5;DECR1;NUDT19;EHHADH;SLC25A17;PHYH;ECI2;CROT;ACADS;HADHA;HADH;ECHS1;HAO1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.4691890430343271,1.007964023898972,0.45579567779960706,0.9498939294593347,1.0,3/12,12.33%,PRKCB;CCNB2;PRKCA
prerank,positive regulation of blood coagulation (GO:0030194),-0.3894525910073218,-1.0079187629568591,0.452914798206278,0.7283759879212627,1.0,5/17,13.12%,ST3GAL4;THBS1;F3;ENPP4;DMTN
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.3978942543516141,-1.0078476798743794,0.42369020501138954,0.7278003606385626,1.0,7/17,16.77%,RTN4;NTRK2;APOE;SORL1;BIN1;CLU;CHRNA7
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.44995670198557286,1.0078413260228214,0.4548802946593002,0.9493448125757052,1.0,5/15,15.45%,TNRC6A;TNRC6B;CPEB3;TNRC6C;TENT4B
prerank,cellular response to retinoic acid (GO:0071300),0.3745740106781647,1.00772484386793,0.4380952380952381,0.9487235778573958,1.0,4/42,5.45%,WNT5B;PTK7;WNT6;ATM
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.42684697149804807,1.007595376413571,0.4635036496350365,0.948135426048852,1.0,4/19,8.46%,ROBO1;SMOC2;IL12B;HRG
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.3477765593637921,-1.0068896617079175,0.45323741007194246,0.7293741825766862,1.0,13/29,21.68%,SLIT2;SHANK3;KANK3;KANK4;LIMA1;PFN2;SHANK1;FKBP4;KANK1;HIP1R;MYADM;SSH2;TWF2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.44545990876759195,1.006793751094477,0.4613935969868173,0.9493521124952583,1.0,2/17,4.75%,ATP1A2;CACNA1C
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.382031381249049,-1.0064614204338573,0.44635193133047213,0.7297177197892744,1.0,11/19,35.38%,SLCO1C1;APP;KLF2;CHRNA7;PAX8;KLF4;MAPK8;HPN;MTPN;TMEM106A;GATA3
prerank,modulation by host of viral genome replication (GO:0044827),0.46590004967363097,1.0062568870898465,0.4643510054844607,0.9499096505936884,1.0,2/13,4.07%,PRKN;IFI27
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.34863979962784886,1.0062104588425966,0.4398148148148148,0.9491285828085525,1.0,14/56,19.15%,UBE2E2;DDX3X;ANKRD17;CCND3;HYAL1;CDC25A;TFDP1;ADAM17;NSMCE2;RPTOR;RB1;KMT2E;EIF4G1;KLHL18
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.4214405625972254,1.0060269835081879,0.4469178082191781,0.9487010626332111,1.0,3/20,8.92%,IGF1;FOXC1;NIBAN2
prerank,camera-type eye morphogenesis (GO:0048593),0.48512868231304623,1.0059601537941496,0.4565619223659889,0.9479590639370061,1.0,3/10,8.24%,SHROOM2;KDM2B;IFT122
prerank,glial cell development (GO:0021782),-0.36907981459295974,-1.0053417847541766,0.4444444444444444,0.7317906030285568,1.0,14/25,34.02%,APP;NRROS;EIF2B3;MT3;TPPP;CSPG5;MDK;SOX10;NF1;EIF2B2;PRDM8;EIF2B5;TLR2;MYRF
prerank,regulation of sodium ion transport (GO:0002028),0.378422755482514,1.0052111065396359,0.4520766773162939,0.9491364759351828,1.0,6/34,6.54%,WNK4;DLG1;SNTA1;NEDD4;AHCYL1;SIK1
prerank,skin development (GO:0043588),0.34444517407275205,1.0045539603630071,0.44525547445255476,0.9500807061151352,1.0,5/65,5.02%,COL5A1;ERRFI1;ALOX12;CASP3;DACT2
prerank,regulation of mitochondrion organization (GO:0010821),0.35691674084949904,1.0043097316399119,0.4585987261146497,0.9498399503540624,1.0,13/47,18.50%,PPARGC1A;PRKN;LRRK2;FZD5;STAT2;MYO19;DNM1L;CYRIB;CSNK2A2;FLCN;VPS35;SQSTM1;RHOT1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.43960096752983235,1.0041977089518777,0.47491039426523296,0.949253975771906,1.0,8/17,28.89%,EMC2;EMC1;EMC3;CAMLG;GET4;BAG6;UBL4A;SGTA
prerank,negative regulation of protein depolymerization (GO:1901880),-0.3574942984790551,-1.0041513619858118,0.45351473922902497,0.7339589926612118,1.0,7/24,12.35%,NAV3;CLASP2;ARHGEF2;LIMA1;STMN2;FGF13;SPEF1
prerank,urogenital system development (GO:0001655),0.4720336662484694,1.003467563251934,0.4740740740740741,0.9504051679158422,1.0,1/11,1.09%,OSR1
prerank,activation of protein kinase A activity (GO:0034199),0.43571954918753175,1.0031862027369016,0.4428822495606327,0.9502705268898217,1.0,5/16,13.48%,ADCY5;ADCY1;ADCY9;PRKAR1A;ADCY6
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.331236875065061,1.003100299850302,0.44314868804664725,0.9495486983350842,1.0,8/75,6.61%,ROCK2;TULP3;NMT2;GRK5;RGS16;METAP2;RHO;MGRN1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.448736721937404,1.0022804759844874,0.4780316344463972,0.9509378855360816,1.0,5/16,12.62%,ANK2;LRRK2;UBAC2;MIA3;TAPT1
prerank,negative regulation of response to wounding (GO:1903035),-0.38149450946819513,-1.0021303517138969,0.4568764568764569,0.7381599567295687,1.0,9/19,22.05%,CASK;AJAP1;CD109;CRK;FGF2;RTN4RL1;RTN4R;MDK;GIT1
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.39531048030727856,-1.001999313946648,0.4722222222222222,0.737691211989477,1.0,4/15,18.79%,ANXA1;GPER1;FAM107A;BCL2L11
prerank,positive regulation of vasculogenesis (GO:2001214),-0.4496857113500091,-1.0019561130890438,0.47216494845360824,0.7370574374635306,1.0,5/10,8.90%,CD34;KDR;RAP1A;TMEM100;CEACAM1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.3846470726628894,-1.0009879497891987,0.4618834080717489,0.7386680130952092,1.0,5/18,18.27%,LYN;BCAR1;CMKLR1;SH2B2;C3AR1
prerank,gluconeogenesis (GO:0006094),0.3682558838015419,1.0009528159428709,0.4524590163934426,0.9537448796007751,1.0,12/39,17.88%,PPARGC1A;PGAM2;GOT2;RBP4;SLC25A12;SLC25A11;PGM1;PER2;SLC25A10;GOT1;SLC37A4;CRY1
prerank,UV-damage excision repair (GO:0070914),-0.42482045480966224,-1.000123400698222,0.4657258064516129,0.7400664787644488,1.0,3/12,12.56%,POLA1;POLD3;ERCC1
prerank,regulation of phospholipase C activity (GO:1900274),0.44270560186263846,1.0000709362857396,0.475,0.9552206810669472,1.0,5/15,10.63%,KIT;FGFR1;FLT1;PDGFRB;ABL1
prerank,regulation of endopeptidase activity (GO:0052548),0.3472623078612703,0.9999765550067636,0.45813586097946285,0.954548561691855,1.0,9/59,9.56%,TIMP3;SERPIND1;PICALM;KNG1;SERPINE1;SERPINA9;HRG;APH1B;HDAC1
prerank,extracellular matrix disassembly (GO:0022617),-0.3086110817362066,-0.9998466071487888,0.4788732394366197,0.7400340408844874,1.0,12/53,13.30%,TLL1;BSG;GSN;ADAMTS5;TIMP2;ADAM15;MMP16;CD44;CAPN2;CTSL;CTSS;MMP15
prerank,epithelial cell differentiation (GO:0030855),0.32639462474012465,0.9994520953763493,0.4682651622002821,0.9550386935846034,1.0,8/88,9.56%,DAB2;MAF;FGFR2;CPT1A;TPP1;BDH2;GLI1;HDAC1
prerank,regulation of phosphorylation (GO:0042325),0.3080663272097227,0.9993809543669911,0.4518413597733711,0.9543109187762499,1.0,22/120,14.24%,PRKAG2;BMP7;FNIP1;PHIP;SESN2;ROPN1L;STAT2;GCK;LDB2;LDB1;CDH5;SIRT1;NUP42;FER;NUP98;GLMN;ROPN1;NUP43;MCM7;PML;OGT;FLCN
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.27101614282299,-0.9990764981163759,0.4477124183006536,0.7411967166076173,1.0,21/98,11.23%,SPTBN1;DPP10;PRKCH;PIK3R1;ANK3;CEMIP;YWHAE;STX3;YWHAB;PLS1;NKD2;ITGB1;PPP3R1;YWHAG;EPHB2;MTCL1;ERBB2;EFCAB7;ATP2B4;KCNB1;GPER1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.4216469340919123,-0.9990638602261608,0.47789473684210526,0.7404879248851313,1.0,6/13,31.51%,ALG6;ALG8;ALG9;ALG13;ALG3;DPAGT1
prerank,cardiac muscle contraction (GO:0060048),0.3815325586702979,0.9990128708430607,0.4533333333333333,0.9543769717705525,1.0,5/34,9.18%,ATP1A2;CSRP3;TPM1;PIK3CA;MYL4
prerank,negative regulation of cell development (GO:0010721),0.40701255994786517,0.9987437574553419,0.45293072824156305,0.9541744085903343,1.0,3/25,6.93%,APPL2;IGF1;FBN1
prerank,regulation of actin filament polymerization (GO:0030833),-0.29188534095794005,-0.998701558986269,0.4591549295774648,0.7406590218585275,1.0,25/69,21.85%,SLIT2;ESAM;KANK3;PAK3;NCK2;EVL;CARMIL1;PTK2B;KANK4;CDC42EP3;BIN1;RASA1;PFN2;CDC42EP2;NCK1;ARF6;KANK1;HIP1R;NCKAP1;MYADM;SSH2;GBA2;PYCARD;TWF2;HCLS1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.47095903704463016,0.9983769417630357,0.45129224652087474,0.9542753728827452,1.0,5/11,20.74%,ARRB1;ADM;GRK3;SAG;ARR3
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.41927545552620665,-0.998236706754121,0.48822269807280516,0.7410512794438013,1.0,4/14,10.70%,TMSB4X;NFKBIA;G3BP2;PKD1
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.4735042079367678,0.9981208856231841,0.4680451127819549,0.9541457939790509,1.0,3/10,11.05%,BMP7;PHACTR4;ARHGAP12
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.3395069835199841,-0.9976418682868877,0.4642857142857143,0.7417563264998333,1.0,15/30,38.46%,HSPA8;HSPA5;CCT2;HSPE1;DNAJB1;PTGES3;HSPA13;ERO1A;ENTPD5;HSPA1L;HSPA9;DNAJB4;ST13;UGGT1;SDF2L1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.31097252756076454,-0.997631613502791,0.46005509641873277,0.7410445538554289,1.0,14/45,21.33%,CAMK2D;MID1;VCAM1;B2M;ICAM1;IFNGR2;JAK1;CD44;IRF5;IRF2;CAMK2B;IRF8;TRIM68;MT2A
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3837069413136991,0.9975286386267723,0.4519867549668874,0.9548663878965796,1.0,9/33,16.22%,PRODH;CPS1;ALDH4A1;GOT2;GLUL;SIRT4;ART4;CAD;GOT1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.42837890281222674,-0.9975096548064633,0.46637744034707157,0.7406251594935707,1.0,4/11,16.57%,STAT3;LIMD1;FXR1;DHX9
prerank,cellular component disassembly (GO:0022411),-0.3084576152905376,-0.9968867557292346,0.475,0.7413745410546977,1.0,12/53,13.30%,TLL1;BSG;GSN;ADAMTS5;TIMP2;ADAM15;MMP16;CD44;CAPN2;CTSL;CTSS;MMP15
prerank,mRNA modification (GO:0016556),-0.3545370845732845,-0.9968862615747419,0.45707656612529,0.7406433220531763,1.0,13/22,37.75%,TRMT61B;METTL3;TRMT6;PUS1;PUS7;TRUB1;DKC1;ZC3H13;CBLL1;TRMT10C;RPUSD2;TRUB2;TRMT61A
prerank,regulation of defense response to virus by host (GO:0050691),0.3914666043228573,0.9967687185159918,0.47342995169082125,0.9560280290822711,1.0,7/30,13.51%,IL12B;PTPN22;PARP9;MAVS;TOMM70;ZDHHC1;SIN3A
prerank,peptidyl-threonine modification (GO:0018210),0.33258667054476465,0.9965672609140614,0.4725111441307578,0.9556345154298853,1.0,17/66,13.77%,ROCK2;OXSR1;TGFBR1;LRRK2;CDC42BPG;TGFBR2;PDPK1;DYRK1A;PRKDC;GALNT11;CSNK2A2;CSNK2A1;PRKCA;HIPK3;WNK1;MAP2K1;CAD
prerank,ventricular septum development (GO:0003281),0.37415844733074505,0.9965240389738153,0.4739413680781759,0.9548440547767093,1.0,4/37,3.46%,ROBO1;TGFBR3;BMPR1A;TGFBR1
prerank,primary neural tube formation (GO:0014020),0.3848592644514079,0.9963958537915804,0.4461028192371476,0.95432636738568,1.0,6/30,12.35%,CELSR1;LMO4;MTHFR;IFT122;PHACTR4;DEAF1
prerank,apoptotic process (GO:0006915),-0.24604562039643202,-0.9963553595775866,0.46320346320346323,0.7412325861785923,1.0,44/203,14.80%,HIP1;MAGI3;SEMA6A;RTN4;DCC;EFNA5;MAL;PPARD;FAP;PTK2B;PAK5;APAF1;CIT;SCN2A;NFKBIA;ZBTB16;PLAGL1;TBX1;PPIA;APP;RHOB;MAP3K7;TNFRSF19;FOXO1;PRUNE2;ADAM15;PPP2R1A;TNFRSF21;VDAC1;AIFM1;DDIT4;ELMO1;FXR1;GLRX2;PAEP;DAPK1;FAS;RFK;JADE1;BBC3;TRPC5;DAP;IAPP;CASP6
prerank,inner mitochondrial membrane organization (GO:0007007),0.35067088157351883,0.9961131086872589,0.44157814871016693,0.9541600649594928,1.0,14/47,20.02%,CHCHD3;SAMM50;OPA1;TMEM11;MICOS10;TOMM70;ATP5F1D;MICOS13;IMMT;ATP5F1C;TIMM10;MTX2;AFG3L2;DMAC2L
prerank,negative regulation of mitochondrion organization (GO:0010823),0.3832995019933366,0.9959907504212807,0.4654300168634064,0.9535984252015058,1.0,5/33,9.44%,IGF1;PRKN;OPA1;HUWE1;ADCK1
prerank,epithelial structure maintenance (GO:0010669),0.47163428342457636,0.9957057043872495,0.48428835489833644,0.9534914169136363,1.0,2/11,10.27%,RBP4;CXADR
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.42883335738516387,0.9948521504368988,0.46616541353383456,0.9548841542639114,1.0,2/16,4.81%,LEPROT;PARP14
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.4345262187096445,0.9946850945726038,0.48312611012433393,0.9544434181779118,1.0,2/16,1.44%,ROCK2;IGF1
prerank,histone H2A monoubiquitination (GO:0035518),0.43606990138316387,0.9946691319194046,0.46223021582733814,0.9535812021419516,1.0,5/17,13.60%,PCGF5;PCGF2;BCOR;KDM2B;DDB2
prerank,error-prone translesion synthesis (GO:0042276),-0.3726003376681918,-0.9943610298484384,0.48394495412844035,0.7453204016798954,1.0,13/21,33.77%,REV3L;PRIMPOL;UBB;RPA1;RFC4;RFC2;POLK;UBC;RPS27A;RFC5;RPA3;RPA2;POLI
prerank,lipoprotein biosynthetic process (GO:0042158),0.46304868707549,0.9943523196004138,0.4653846153846154,0.9535199809936583,1.0,4/11,11.85%,ATG10;WIPI1;ATG7;PORCN
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.3693841184974535,-0.9940310378084831,0.44273127753303965,0.7453425309117346,1.0,10/20,13.57%,ENG;TGFB2;TBX3;ACVRL1;NOTCH1;HEYL;BMP2;HEY2;BMP4;SPRY1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3047288593935311,0.9937805677621364,0.4783783783783784,0.9541296752987538,1.0,17/132,10.49%,RNF152;IGF1;SH3D19;PRKAA2;PPARA;ZBTB20;ADRA2A;TPCN1;LRRK2;VGLL4;EZR;NPRL2;ZC3H18;ZC3HAV1;MOV10;ZSWIM8;IRGM
prerank,positive regulation of RNA metabolic process (GO:0051254),0.35255139397421176,0.9933403204973944,0.4359375,0.9544683427727952,1.0,14/45,19.72%,DDX5;POLR2A;TP53;ZC3H18;RIOK2;RIPK1;DYRK1A;WDR43;MAP2K1;MAP2K2;NFKB1;GRSF1;BUD23;DXO
prerank,embryonic digestive tract development (GO:0048566),0.4305425289827194,0.993313723581962,0.4680073126142596,0.9536410150884503,1.0,4/18,7.38%,FGFR2;GLI2;GLI3;NIPBL
prerank,positive regulation of mitochondrion organization (GO:0010822),0.34395574320454686,0.9929562075050394,0.4787234042553192,0.9536830159762598,1.0,9/57,9.44%,PPARGC1A;PRKN;MCU;BID;FAM162A;TP53;HTT;DNM1L;ADCK1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.435785374418488,0.9928446067318275,0.46880570409982175,0.9531099392080399,1.0,5/15,20.60%,GLI3;IL12B;CCR2;IHH;CD55
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.4191421752115036,0.9927439421501068,0.4720720720720721,0.9524892169546956,1.0,1/19,1.44%,IGF1
prerank,embryonic hemopoiesis (GO:0035162),0.4551591090642318,0.9927061646452217,0.47547169811320755,0.951702901197199,1.0,4/12,10.09%,KIT;KMT2A;TGFBR2;FLT3LG
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.4233340850821129,-0.9918373188718606,0.4860813704496788,0.7498313043754012,1.0,3/13,9.18%,RYR2;NOTCH1;HEY2
prerank,negative regulation of JNK cascade (GO:0046329),0.3844594593642387,0.9917704968760513,0.48013816925734026,0.9533693418766206,1.0,7/31,13.82%,SH3RF2;PRKN;GPS2;PTPN22;DUSP10;HIPK3;NCOR1
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.24382813793442829,-0.9916292202981024,0.48514851485148514,0.7495901310378809,1.0,42/175,21.96%,PID1;ACTN4;TMSB4X;ST18;PTK2B;TNFRSF11B;NFKBIA;ARHGEF2;PSMB2;TNFRSF11A;DAB2IP;TRAF5;RPS3;CARD14;TNFRSF1B;TNFRSF21;PSMD14;ERBIN;PSMC6;GPER1;ILK;YBX3;IKBKB;AIM2;LIMS1;PSMA4;PSMB9;DHX9;EDAR;CCL13;MAP3K14;TRAF1;TNFRSF25;PSMD11;PSMB10;PSMD2;CCL19;HAS2;SFRP1;PYCARD;ASAH1;TXNDC17
prerank,protein deacetylation (GO:0006476),0.3665050339087925,0.9916101221757407,0.4683954619124797,0.9528895728603997,1.0,12/41,15.38%,TBL1X;SIRT5;TBL1XR1;SIRT3;HDAC4;SIRT1;HDAC1;PRDM5;SIRT4;SIN3A;MIER3;MTA2
prerank,regulation of nervous system process (GO:0031644),0.41235442844157283,0.9911219946680174,0.4755244755244755,0.9532457433153539,1.0,3/18,4.87%,ROCK2;SLC8A3;DLGAP4
prerank,positive regulation of cytokinesis (GO:0032467),0.374095805954761,0.990921661659843,0.45234248788368336,0.9528837285728183,1.0,5/32,11.35%,PKP4;CDC14A;AURKB;CDC14B;CDC42
prerank,DNA conformation change (GO:0071103),0.4268828360961823,0.9908588438379079,0.45960502692998206,0.9521671040023968,1.0,3/17,12.54%,TOP2B;ABL1;TOP3A
prerank,response to retinoic acid (GO:0032526),0.34402792746793576,0.9908285969478233,0.4638109305760709,0.951355009504466,1.0,7/59,7.54%,WNT5B;PTK7;WNT6;CTSH;ATM;OVCA2;RBP4
prerank,supramolecular fiber organization (GO:0097435),0.2780931699989796,0.9908204053165768,0.492468134414832,0.9504933829782417,1.0,36/333,6.82%,COL5A1;TSPAN5;COL22A1;COL26A1;SNCAIP;CGNL1;LAMC2;COL4A5;DLG1;SHROOM2;KIF2A;HOOK2;RHOBTB2;AVIL;PRKN;RHOD;SHROOM3;INPPL1;COL18A1;COL4A3;TMOD2;MYO5C;LOXL1;ADAMTS2;TGFBR1;LOXL3;RUFY3;TMOD3;TPM1;KLHL41;COL9A2;USP9X;ARHGAP17;MPRIP;COL13A1;TRIOBP
prerank,tube closure (GO:0060606),0.38060748747836803,0.9906979148342462,0.4666666666666667,0.9499008691415581,1.0,11/31,20.99%,CELSR1;LMO4;MTHFR;IFT122;PHACTR4;DEAF1;MTHFD1;VASP;FOLR1;TSC2;FUZ
prerank,mitotic cytokinesis (GO:0000281),-0.30052089761266093,-0.9906418489180032,0.4756756756756757,0.7512974933652535,1.0,21/47,25.09%,SPTBN1;ANK3;CIT;RHOB;ANLN;PDCD6IP;RASA1;TRIM36;STMN1;USP8;APC;NUSAP1;CHMP4B;EFHC2;SPAST;ECT2;CUL7;RHOC;KIF4A;CENPA;KIF23
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.2425090737113213,-0.9902147110436926,0.4864864864864865,0.751625919290735,1.0,32/198,11.39%,PTPRB;PTPRD;PLCB4;INPP4B;PLA2G4A;PLCE1;PIP4K2A;STAT3;INPP5D;PLPP1;PLPPR1;GPI;PAK1;CALM1;PTPRC;PLCG2;LIMK2;EPHA7;ALPL;ENPP1;EPHB2;PPP3CA;TGFB1;ITPK1;PLCH1;TNFAIP8L3;PLPPR5;PLPPR4;GFPT2;DUSP3;LIMD1;PGM2L1
prerank,regulation of membrane depolarization (GO:0003254),-0.3812998579900906,-0.9899997252176865,0.47465437788018433,0.7514272225439357,1.0,9/18,27.32%,CAMK2D;NEDD4L;SMAD7;PTPN3;SCN2B;SCN1B;GPD1L;FHL1;RANGRF
prerank,pulmonary valve development (GO:0003177),0.4269907303774182,0.9897392097160483,0.4701627486437613,0.9515637454757182,1.0,2/18,0.29%,NOTCH2;ROBO1
prerank,negative regulation of developmental process (GO:0051093),-0.28445952855260404,-0.9890280120738503,0.49508196721311476,0.7531215499987223,1.0,17/69,14.68%,KLF7;NOS3;DCC;CST3;GAS6;TFRC;NOTCH1;GRIN3A;TBX1;ARHGEF15;BMP2;TGFB1;HEY2;BMP4;MAPT;PINK1;FGFR3
prerank,piRNA metabolic process (GO:0034587),0.42647853504195476,0.9883555413441222,0.4963235294117647,0.9544576870799054,1.0,5/19,21.04%,GPAT2;MOV10L1;MYBL1;EXD1;ASZ1
prerank,regulation of cell adhesion (GO:0030155),0.30392412417170867,0.9882100683108012,0.468232044198895,0.9539586091769244,1.0,25/129,12.40%,ROCK2;PKP4;FBLN1;IL18;PLXNA2;EPHA4;RHOD;PKHD1;PPP1CB;C2CD4B;FUT1;DACT2;TPM1;ATM;EPHA8;IL12B;KNG1;TNFRSF18;HRG;HYAL1;ABL1;ITGAV;PTPN11;PRKCA;MIA3
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.3614065428538688,-0.98799160512825,0.4814004376367615,0.754849794881901,1.0,11/22,30.10%,RAD23B;UBB;CETN2;GTF2H1;GTF2H4;GTF2H5;ERCC2;UBC;RPS27A;DDB1;ERCC3
prerank,inorganic anion transport (GO:0015698),0.3408126389343199,0.9873345626658516,0.4477848101265823,0.9554018481072994,1.0,7/53,9.20%,SLC13A4;SLC5A5;CLCN2;ENPP3;ANO6;SLC26A1;NMUR1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.39117590688222015,0.9871600821652989,0.4915254237288136,0.9549598147022864,1.0,6/28,9.87%,APPL2;PRKCZ;PRKCB;TNS2;PIP4K2C;GRB10
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.31158506211277814,0.9870240316459962,0.4993215739484396,0.9544251790143471,1.0,22/119,11.35%,PTPN13;TTC7B;INPPL1;PI4KA;MTMR3;PIGN;SYNJ2;SMG1;PLEKHA2;TMEM150A;PIGW;PIGQ;SLC27A1;PIP4K2C;PTEN;PIK3CA;ITPKB;PIKFYVE;PLEKHA8;PIK3R3;OCRL;SOCS3
prerank,Notch signaling pathway (GO:0007219),-0.29110366783511554,-0.9870143059965524,0.4601226993865031,0.7565581243698754,1.0,14/59,9.92%,SORBS2;MAML2;NOTCH3;YBX1;JAG1;NOTCH1;HES1;PSEN1;JAG2;HEYL;BMP2;WWC1;HEY2;PBX1
prerank,L-amino acid transport (GO:0015807),-0.3415286980265453,-0.986985774268107,0.4666666666666667,0.7558681273102733,1.0,7/28,8.00%,SLC7A5;SLC1A2;SLC1A1;SLC7A1;SLC25A13;SLC1A4;SLC38A5
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.3956147950779605,0.9866502449144366,0.4605263157894737,0.9544933121289332,1.0,5/27,9.09%,NAPEPLD;NAAA;ETNK2;SLC27A1;PLA2G6
prerank,cristae formation (GO:0042407),0.3844146183408381,0.9865820048538819,0.46534653465346537,0.9537815919947844,1.0,10/27,23.87%,CHCHD3;SAMM50;ATP5F1D;MICOS13;IMMT;ATP5F1C;AFG3L2;DMAC2L;LETM1;CHCHD6
prerank,positive regulation of GTPase activity (GO:0043547),0.2915686707100113,0.9863919007100086,0.5019157088122606,0.953395919589606,1.0,16/188,4.59%,DOCK11;AFDN;ARHGAP29;PKP4;PICALM;SIPA1L1;ARHGEF16;SRGAP2;SYDE2;ALS2;NGEF;RGS16;TBC1D16;ASAP3;GMIP;RAPGEF3
prerank,GPI anchor metabolic process (GO:0006505),0.39018317304382266,0.9862898738562726,0.49246231155778897,0.9528274660067385,1.0,3/26,6.37%,PIGN;PIGW;PIGQ
prerank,cellular response to nutrient levels (GO:0031669),0.335102019759138,0.9861838271440406,0.4521354933726068,0.9522210920636821,1.0,17/62,19.05%,PRKAA2;PPARA;FNIP1;LRRK2;LAMP2;WIPI1;NUPR2;SIRT1;ATG7;FLCN;TSC1;RPTOR;EHMT2;RRAGD;ZFYVE1;EIF4G1;USP33
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.43517861803759417,0.9861778095950304,0.4582560296846011,0.9513592405675395,1.0,2/15,1.53%,KIT;WHRN
prerank,regulation of vasculature development (GO:1901342),-0.3507551331445158,-0.9861624566871883,0.4701670644391408,0.757147224495696,1.0,15/26,33.71%,BMPER;TSPAN12;FGF2;ERBB2;CTNNB1;EMP2;PLXND1;SFRP1;HTATIP2;VASH1;NF1;HMOX1;VASH2;PROK2;RNH1
prerank,positive regulation of interleukin-10 production (GO:0032733),0.37920657613313796,0.9855269346598141,0.45454545454545453,0.9521882802053001,1.0,5/30,10.08%,PRKCZ;TLR4;CD28;IL12B;CD274
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.24724678161276784,-0.985399301601927,0.5428571428571428,0.7582940071280325,1.0,53/173,25.59%,SPTBN1;ANK3;GRIA1;GAS6;VAMP4;CTSC;DYNC1I1;LMAN2L;DYNLL1;CUL3;GOPC;KDELR3;DYNC1LI2;NSF;COG5;DCTN4;CAPZA2;TMED1;PROS1;TMED5;CNIH1;ATL2;SPTB;TMED4;LMAN2;CAPZA1;TMED7;KLHL12;COPE;CTSZ;SPAST;SPTBN2;ATL3;BCAP31;TFG;SPTAN1;TMED9;IER3IP1;MCFD2;VAPA;BCAP29;TRAPPC2L;TMED10;COL7A1;SEC16B;TMED2;SAR1B;DCTN6;TRAPPC3;ACTR1A;RAB1B;ARFGAP2;COG1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.46625420738099965,0.985323365379495,0.4856046065259117,0.9518482342657648,1.0,2/10,11.12%,WHRN;IFT88
prerank,regulation of oxidative phosphorylation (GO:0002082),0.4175598936637985,0.9853185241183329,0.5028571428571429,0.9509864498022663,1.0,5/16,22.11%,NUPR1;AK4;MLXIPL;ATP7A;PPIF
prerank,regulation of ERAD pathway (GO:1904292),-0.43571145224800933,-0.9849582767460615,0.4819532908704883,0.7586953972830414,1.0,2/11,8.03%,AQP11;USP13
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.33961356910276186,-0.9848739099895668,0.48009950248756217,0.7581366008107092,1.0,10/31,18.41%,DAB2IP;HSPA8;HSPA5;TMBIM6;PACRG;TM7SF3;HSPB8;UBE2W;RHBDD1;PTPN1
prerank,renal absorption (GO:0070293),0.47810823938344627,0.9847607674080524,0.46028513238289204,0.9515693592776197,1.0,1/10,0.45%,WNK4
prerank,positive regulation of telomere maintenance (GO:0032206),0.3793176644297164,0.9842187703410367,0.49333333333333335,0.952091309951767,1.0,10/31,19.02%,ATM;ATRX;HNRNPA2B1;TNKS2;AURKB;RAD50;PNKP;PML;NBN;SLX4
prerank,receptor catabolic process (GO:0032801),0.4018226428988969,0.9839215622772101,0.4664371772805508,0.9520570588953524,1.0,6/24,14.64%,RNF43;NEDD4;UVRAG;BECN1;CLTC;AP2A1
prerank,phosphatidylserine metabolic process (GO:0006658),0.38712095839996974,0.9835243581253748,0.47603305785123967,0.9522628764424222,1.0,11/32,21.45%,OSBPL8;PLA1A;SLC27A1;PLSCR1;ABHD12;OSBPL10;PLA2G5;MBOAT2;LPCAT4;PLAAT3;PTDSS1
prerank,negative regulation of cellular process (GO:0048523),0.2669222014275266,0.9830962320643101,0.5120087336244541,0.9525183834436375,1.0,89/521,14.31%,TGFBR3;ALDH1A2;BMP7;SMAD3;APPL2;FBLN1;SYT11;GSDME;FGFBP1;CCN2;PTPN14;NPR1;PRKN;PLXNA2;PKHD1;KANK2;SRGAP2;COL18A1;NUPR1;COL4A3;ARID2;MAGI2;IGFBP7;SPEG;PDPN;IFIT3;SESN2;NACC2;VGLL4;SMAD6;TNS2;DACT2;CLMN;IFNK;DDX3X;CAPRIN2;SOD2;ATG5;HMGA1;TP53;EIF2AK2;UBR2;FER1L5;SSTR3;KNG1;DLG3;PTPRU;PLSCR1;PTEN;SMARCA4;IGFBP3;OSGIN2;HRG;NUPR2;NIBAN2;SULT2B1;HYAL1;SIRT1;GTPBP4;CHMP1A;MYBL1;SLURP1;BECN1;NOX4;NME6;RNF41;RARG;MNT;IMPACT;OSGIN1;GLMN;AXIN2;NMI;BRD7;MIA3;IRF1;FRK;PPP1R13B;IFI35;PODN;PIP4P2;MAP2K1;PML;CRYAB;DNAJB2;FLCN;TSC1;KAT2B;AGTR2
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.37481685134423975,-0.983082650283181,0.4786516853932584,0.761982930170248,1.0,6/19,11.23%,DLG2;CLIC4;LRRC7;MTCL1;ERBIN;MARK2
prerank,regulation of tissue remodeling (GO:0034103),0.42132434852560063,0.9828423512556741,0.506108202443281,0.9523258795381483,1.0,3/18,6.47%,LEPR;IL18;IL12B
prerank,regulation of immunoglobulin production (GO:0002637),-0.3585959631075367,-0.982522175162024,0.4894613583138173,0.7625961149569268,1.0,3/23,7.96%,GPI;PTPRC;EPHB2
prerank,sphingosine metabolic process (GO:0006670),-0.38616167403113133,-0.9824070125437319,0.4701834862385321,0.7621007785314613,1.0,4/17,5.65%,ACER3;ACER2;PLPP1;SPTLC2
prerank,B cell differentiation (GO:0030183),-0.29794796211404173,-0.9813848117633246,0.4778761061946903,0.7638926664797275,1.0,8/46,7.59%,PTPRJ;TPD52;VCAM1;HDAC9;PTPRC;PLCG2;ITGB1;ITGA4
prerank,protein catabolic process (GO:0030163),0.33613502256898087,0.9811549063026453,0.5,0.9559045792786635,1.0,13/59,13.10%,PRKN;NGLY1;LAMP2;NEU2;ADAMTS9;TPP1;CLPX;CLN6;MANBA;RIPK1;RNF41;MAGEC2;DDI1
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.45047604657829804,0.9808790699031164,0.4843462246777164,0.9557548909361845,1.0,3/13,4.75%,ANK2;KCNA5;CACNA1C
prerank,regulation of endocytosis (GO:0030100),0.3354921759732878,0.9804382113398044,0.48201438848920863,0.9560911794062592,1.0,5/61,3.71%,DAB2;SYT11;PICALM;SPHK1;STON1
prerank,activation of protein kinase activity (GO:0032147),0.3130456103691775,0.980403492523149,0.49591280653950953,0.9552954507956379,1.0,13/106,8.75%,FGF1;ADCY5;OSBPL8;IGF1;ADCY1;IL18;ADRA2A;TLR3;RICTOR;ADCY9;TGFBR2;NRG1;PDPK1
prerank,O-glycan processing (GO:0016266),0.3498629937034454,0.9801756197746185,0.4809741248097412,0.9550287938716995,1.0,4/54,4.87%,GXYLT2;ST6GAL1;GALNT12;ST3GAL3
prerank,small GTPase mediated signal transduction (GO:0007264),0.3062777296247724,0.9801289512172339,0.476319350473613,0.9543000577548447,1.0,10/103,5.01%,RAPGEF5;KSR1;IGF1;RIN2;ARHGEF18;ARHGAP18;CCNA2;RGL1;ADRA2A;RREB1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.27157596036131815,0.9798928579827481,0.5149501661129569,0.9540251951213015,1.0,76/417,14.09%,BMP7;TFDP2;WNT4;ZIC2;FOXN3;ZNF423;JARID2;ZHX2;SNX6;FOXD1;ZNF568;DKK3;ARID4A;NR2F2;NCOR2;TSHZ3;GLI3;ZBTB38;NACC2;VGLL4;LOXL3;FOXP2;SFMBT1;CBFA2T2;HMGA1;LBH;ZNF318;TP53;BHLHE41;SMURF2;NIPBL;LDB1;FBXW11;BCOR;SMARCA4;NR1D2;BTRC;RBM15;SPEN;KAT6B;NRG1;SMARCC2;NIBAN2;SMARCE1;HDAC4;SCML4;SIRT1;TLE1;HDAC1;SOX13;CBY1;SPINDOC;CHMP1A;TCF7L2;ZNF219;PRDM5;SAP18;EIF4A2;BAHD1;WWP2;CBX5;ZNF148;UIMC1;BRD7;DEAF1;MLXIPL;IRF1;KAT7;KMT5A;SIN3A;PML;TLE2;BCL7A;NCOR1;CRYAB;PER2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4498366465664928,-0.9798404156423395,0.498989898989899,0.7668671085543914,1.0,3/10,14.31%,ESR1;PSMC6;ATF7IP
prerank,regulation of response to external stimulus (GO:0032101),0.3021206449186321,0.9795528924806413,0.510548523206751,0.9540749092238188,1.0,28/121,16.97%,EFNB2;APPL2;NMT2;LACC1;METAP2;RNF135;F2;RHO;TKFC;PTPN22;SAMHD1;NR1D2;ADGRA2;HRG;CYRIB;NLRP6;FNTB;DHX58;FOXA2;IRF1;ERAP1;USP18;ZMPSTE24;BIRC3;PDGFRA;SAG;FNTA;CCR2
prerank,protein O-linked glycosylation (GO:0006493),0.317595155604187,0.9792867703462188,0.5028490028490028,0.9539173802493349,1.0,9/96,5.77%,GXYLT2;TRAK1;ST6GAL1;TMTC4;GALNT12;LARGE1;ST3GAL3;TET2;PGM3
prerank,regulation of cellular metabolic process (GO:0031323),0.3500376256212572,0.9785625610766847,0.4768976897689769,0.9550341062765912,1.0,20/45,25.11%,PPARA;PRKN;NCOR2;TBC1D16;ANGPTL8;RNF34;RNF41;AGPAT1;COQ7;BCO2;VPS35;MKLN1;LAMTOR1;ACLY;GNB3;ABCA2;PDK2;PM20D2;FOXM1;KIF16B
prerank,intermediate filament organization (GO:0045109),-0.3810987281991234,-0.9785474050189303,0.47368421052631576,0.7692510199302348,1.0,6/17,25.86%,VIM;BFSP2;PKP2;NEFL;GFAP;DES
prerank,response to amino acid (GO:0043200),-0.33227752118678155,-0.9781682550423564,0.47549019607843135,0.7694885708908447,1.0,9/31,15.27%,GLRB;GLRA3;SH3BP4;GLRA1;TMBIM6;CAPN2;SPAAR;GLRA2;GRIN1
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.3017630140508539,-0.9781438711613845,0.5204359673024523,0.7688063248469853,1.0,8/46,14.40%,DGKH;DGKB;PLA2G4A;PLA2G12A;DGKG;DGKZ;PNPLA3;ABHD4
prerank,lymphocyte proliferation (GO:0046651),-0.35619116591052563,-0.9780521083828724,0.5095238095238095,0.7683017465461464,1.0,3/22,10.85%,MEF2C;PTPRC;MSN
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.31726489811169534,-0.9780191213927625,0.5190839694656488,0.7676494571834883,1.0,20/37,31.81%,POLD3;ERCC1;UBB;RPA1;GTF2H1;GTF2H4;GTF2H5;RFC4;ERCC2;POLD4;POLD1;RFC2;POLK;UBC;RPS27A;RFC5;DDB1;RPA3;ERCC3;RPA2
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.43206319155603673,0.9779799263906528,0.49429657794676807,0.9557361258778473,1.0,5/16,13.35%,HMGA1;TWNK;SSBP1;MCM7;MCM2
prerank,oligodendrocyte development (GO:0014003),-0.40142219078266816,-0.9773294996711986,0.5084033613445378,0.7686415319545847,1.0,10/15,34.02%,PLP1;B4GALT5;EIF2B3;TPPP;SOX10;B4GALT6;EIF2B2;PRDM8;EIF2B5;MYRF
prerank,myoblast fusion (GO:0007520),-0.4149691786638982,-0.9773176850777632,0.4787234042553192,0.7679251199901822,1.0,5/12,6.96%,ADGRB3;CD9;ADAMTS5;PTGFRN;JAM2
prerank,skeletal muscle organ development (GO:0060538),0.3928327388562081,0.9771875074193277,0.5093696763202725,0.9569368661722798,1.0,4/26,3.02%,IGSF8;CSRP3;LARGE1;CFLAR
prerank,negative regulation of peptidase activity (GO:0010466),-0.30280782029711917,-0.9766151009564876,0.47580645161290325,0.7688683112860579,1.0,9/47,8.46%,SPOCK2;SERPINE2;CST3;SPOCK3;SERPINI1;SERPINF1;TIMP2;ECM1;SPOCK1
prerank,positive regulation of secretion by cell (GO:1903532),0.32935580148621246,0.9765863422664873,0.5031055900621118,0.957628098722849,1.0,7/70,4.66%,BMP6;FRMD4A;IGF1;CLASP1;DTNBP1;MYO18A;EZR
prerank,negative regulation of blood coagulation (GO:0030195),0.36631004389617144,0.9763068121435619,0.474025974025974,0.9575373959052635,1.0,11/38,16.34%,TFPI;F11;KRT1;F2;KNG1;SERPINE1;HRG;C1QTNF1;F8;PLAT;PDGFRA
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.3663469292494095,0.9760912324875614,0.5069984447900466,0.9572269709616628,1.0,6/36,11.68%,TFDP2;PCGF2;MGA;TFDP1;RBBP8;CBX5
prerank,positive regulation of T cell proliferation (GO:0042102),-0.2870240539387004,-0.9759136837695357,0.5159420289855072,0.7698147628544597,1.0,8/55,6.42%,VCAM1;NCK2;TFRC;IL6ST;SLC7A1;ANXA1;PTPRC;RPS3
prerank,cellular response to leucine starvation (GO:1990253),0.46010268630508766,0.9758874163171511,0.4728682170542636,0.9569196990725507,1.0,4/10,17.13%,SESN1;SESN2;IMPACT;RRAGD
prerank,proteolysis (GO:0006508),0.2792395469751419,0.9754710371506351,0.5076560659599529,0.9571720746674379,1.0,41/252,15.78%,AEBP1;ACE;CPQ;BACE2;TRABD2B;SUFU;CASP3;DPP4;CPA4;SRGN;CTSH;DPP8;METAP2;ADAMTS9;TPP1;CLPX;TBL1X;MMP19;APH1B;NPEPPS;BMP1;MMP14;ADAM17;DESI1;DESI2;ATG4D;FOLH1;MBTPS1;ERAP1;PCSK7;OGT;SDE2;CAPN15;ATG4C;PITRM1;TMPRSS5;ADAMTS7;ZMPSTE24;PLAT;CELA3A;ANPEP
prerank,regulation of cell motility (GO:2000145),0.30047012971178516,0.9750965814964476,0.49795918367346936,0.9572988100691159,1.0,17/121,10.63%,FGF1;ROCK2;FBLN1;KIF2A;PLXNA2;LMO4;ARHGAP18;MGAT3;TBCCD1;LDB2;LDB1;NRG1;DIAPH1;AMOTL2;HBEGF;CYRIB;ABL1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3213353854828768,0.9747495938730182,0.4823008849557522,0.957333884136541,1.0,18/77,16.75%,IGF1;PRKN;CFLAR;PHIP;TGFBR1;DDX3X;OPA1;HTT;RIPK1;TCF7L2;SH3RF1;ITGAV;CSNK2A2;CSNK2A1;LGALS3;BIRC6;RB1;MCL1
prerank,negative regulation of cell death (GO:0060548),0.3176276156038793,0.9745018639166737,0.4900568181818182,0.9571241407283239,1.0,9/88,6.03%,BMP7;PPARGC1A;CCN2;PRKN;KANK2;SRGAP2;LRRK2;PM20D1;ATG5
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.27274549431373324,-0.974441063017031,0.506578947368421,0.7727347060593668,1.0,17/88,8.69%,STXBP6;MYO1B;SORCS1;CLINT1;FTH1;SH3GL2;MYO5A;EXOC6;DOP1B;CLVS1;APP;HSPA8;AP1S2;SORL1;SORT1;FTL;GOPC
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.311754831788822,-0.9742358257273354,0.48737373737373735,0.7725213554299335,1.0,13/39,14.49%,PODXL;FXYD5;NEXMIF;JAG1;NOTCH1;MBP;BMP2;TGFB1;PTK2;RDX;CDH1;VEGFA;PPM1F
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.45594551756379353,0.9742289213615727,0.4972170686456401,0.9569664352976396,1.0,3/12,12.68%,DPYD;CTPS2;ALDH6A1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3139406588485948,0.9741291272717322,0.5043103448275862,0.9563719946572822,1.0,16/84,11.39%,CELF2;DDX5;SON;MBNL2;TIA1;RBM15;RBM39;JMJD6;NOVA1;LARP7;THRAP3;SRPK2;SAP18;SFSWAP;NUP98;HNRNPL
prerank,tRNA 5'-leader removal (GO:0001682),0.44387937596959903,0.9740937770772856,0.4934579439252336,0.9556058566550718,1.0,5/13,20.86%,RPP21;RPP25L;PRORP;POP7;POP1
prerank,digestive tract morphogenesis (GO:0048546),0.4382809705458847,0.9737584976215526,0.4866412213740458,0.9556474381122164,1.0,5/14,16.34%,FGFR2;NIPBL;GLI1;RBPMS2;PDGFRA
prerank,calcium import into the mitochondrion (GO:0036444),0.46361325709008416,0.9733297875914825,0.5193482688391039,0.9559017214706231,1.0,3/10,6.75%,MCU;SLC25A23;MICU1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.37446398996048785,-0.9728498491925519,0.5053533190578159,0.7751953965134999,1.0,6/18,10.85%,APOE;CTSC;DACT1;RDX;HSP90AA1;MSN
prerank,mitotic recombination (GO:0006312),0.43060129784170814,0.9727772464722021,0.5045703839122486,0.9565532939468806,1.0,7/15,19.85%,TPRKB;TEP1;MSH3;RAD50;NSMCE2;RAD51D;XRCC3
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.39462769001096437,0.9727574058731954,0.48404255319148937,0.9557563222363552,1.0,2/24,6.89%,LPGAT1;SLC27A1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.44335788149665956,0.9724267320980783,0.48872180451127817,0.9557856423565809,1.0,4/13,14.63%,TNRC6A;TNRC6B;CPEB3;TNRC6C
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.34519393568216544,0.9723395688765474,0.4858490566037736,0.9551942402166269,1.0,13/49,14.63%,KMT2A;TNRC6A;TNRC6B;RBM15;HDAC1;ASH2L;MOV10;KMT2C;RAB7B;KMT2D;SIN3A;KAT2B;TNRC6C
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.2765777003925956,-0.972284868566421,0.5251572327044025,0.7758663858288616,1.0,30/75,24.71%,SLC8A1;PTPRJ;HEG1;RASIP1;LYN;DAB2IP;APOE;SORL1;IRAK3;UCHL1;DUSP1;BMP4;PRKAR1B;PRKAR2B;MYOCD;SPRY1;HHEX;APC;MEN1;SPRY4;PTPN1;PRKAR2A;AGT;PYCARD;LRP6;STK38;PAQR3;TFAP4;HYAL2;PKIG
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.35135350528446757,0.9722329627814448,0.4845201238390093,0.9546670962380003,1.0,8/43,9.87%,SORBS1;PRKCZ;PRKCB;TNS2;GKAP1;PIP4K2C;SIRT1;GRB10
prerank,retinal metabolic process (GO:0042574),0.45549216172276474,0.9719335784879054,0.5352622061482821,0.9545616141313449,1.0,1/12,1.07%,ABCA4
prerank,regulation of autophagosome assembly (GO:2000785),0.37447975177054577,0.9717657114475241,0.5104333868378812,0.9541553357794149,1.0,8/33,11.12%,MTMR3;NUPR1;NPRL3;LRRK2;NPRL2;PIP4K2C;PIKFYVE;IFT88
prerank,cellular lipid catabolic process (GO:0044242),-0.34311213495080023,-0.9716293068111266,0.5061124694376528,0.7767571995351709,1.0,9/27,19.38%,PPARD;CYP1B1;ENPP2;LPIN3;MT3;AOAH;SIRT2;SMPDL3B;PLA2G15
prerank,response to estrogen (GO:0043627),-0.3282039801780775,-0.9715256030913159,0.4763092269326683,0.7762815968882263,1.0,7/31,21.03%,CAV1;ESR1;AR;SERPINB9;NCOA4;ARID5A;SFRP1
prerank,motile cilium assembly (GO:0044458),0.46054439303375067,0.9712159991025715,0.491588785046729,0.9547422273656969,1.0,7/12,25.46%,E2F4;CCDC39;BBOF1;CCDC40;SPATA6;RSPH6A;BBS5
prerank,positive regulation of angiogenesis (GO:0045766),0.30738008973242287,0.9712069315021403,0.5164520743919886,0.953921154511899,1.0,18/108,9.93%,FGF1;ADAM12;SMOC2;SASH1;HK2;SPHK1;FUT1;RAPGEF3;PRKCB;CTSH;FLT1;SERPINE1;PDPK1;CDH5;HYAL1;SIRT1;STIM1;FOXC2
prerank,global genome nucleotide-excision repair (GO:0070911),-0.3393739482257063,-0.9710571388841649,0.49411764705882355,0.776737005156053,1.0,12/26,30.10%,RAD23B;ERCC1;UBB;CETN2;GTF2H1;GTF2H4;GTF2H5;ERCC2;UBC;RPS27A;DDB1;ERCC3
prerank,oogenesis (GO:0048477),-0.389416488753829,-0.9710547404298757,0.5042372881355932,0.7760015841085176,1.0,6/15,26.21%,FMN2;PTN;METTL3;MEI4;MDK;NANOS3
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.2715150681367219,-0.9710060847123642,0.4935064935064935,0.775409378340517,1.0,31/79,25.09%,SH3GL2;CTSD;MFSD6;DYNC1I1;DYNLL1;AP1S2;DYNC1LI2;AP2B1;KIF26A;DCTN4;CTSL;AP2M1;CAPZA2;CTSS;KIF3A;AP1S3;CAPZA1;CENPE;KIF15;CD74;SPTBN2;KIF11;AP1S1;KIF5A;KIF22;KIF4A;KIF3B;SAR1B;DCTN6;ACTR1A;KIF23
prerank,protein glycosylation (GO:0006486),-0.25004071507313974,-0.9710013270947849,0.5533596837944664,0.7746866681602446,1.0,29/125,17.46%,MGAT4C;ST3GAL4;ST8SIA4;GCNT2;EOGT;FUT9;MGAT4A;ST3GAL1;ST8SIA1;FKTN;GALNT7;B4GALT5;AQP11;B3GALT1;ST3GAL6;MGAT5;ST8SIA6;B3GALNT1;GFPT2;DAD1;B3GALT5;GAL3ST1;NUS1;RPN1;GALNT2;MGAT5B;GALNT10;ALG6;TUSC3
prerank,genitalia development (GO:0048806),-0.41557533434924987,-0.9708641525072513,0.5,0.774289580127104,1.0,4/12,12.26%,TBX3;STRA6;PKD1;FOXF2
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.2811668953766427,0.9706784876080766,0.5242130750605327,0.9544366336071168,1.0,17/214,6.37%,NOTCH2;TGFBR3;DUSP29;FBLN1;TIMP3;PRKCZ;CCN2;DLG1;FGFR2;SLC30A10;PKHD1;NPNT;EZR;TLR4;ARRB1;BRAF;PDGFRB
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.3827138394803401,-0.9705352620718741,0.5161290322580645,0.7743606028123127,1.0,1/17,0.39%,CADM1
prerank,regulation of gene silencing by RNA (GO:0060966),0.34389046717939686,0.9704271346611276,0.49921507064364207,0.9533910455714477,1.0,26/50,30.67%,POLR2A;TNRC6A;POLR2D;NUP42;NUP98;NUP43;NUP155;EIF4G1;NUP188;POLR2G;FMR1;NUP153;AGO1;POLR2F;AAAS;NUP88;AGO2;PUM2;SEC13;POLR2K;IPO8;NUP160;RANBP2;NUP37;RAE1;NUP133
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.34389046717939686,0.9704271346611276,0.49921507064364207,0.9533910455714477,1.0,26/50,30.67%,POLR2A;TNRC6A;POLR2D;NUP42;NUP98;NUP43;NUP155;EIF4G1;NUP188;POLR2G;FMR1;NUP153;AGO1;POLR2F;AAAS;NUP88;AGO2;PUM2;SEC13;POLR2K;IPO8;NUP160;RANBP2;NUP37;RAE1;NUP133
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.3878291559275546,0.970390504677021,0.489010989010989,0.952627492782907,1.0,2/26,1.44%,FHL2;IGF1
prerank,negative regulation of neuron differentiation (GO:0045665),0.4079311624483719,0.9703376498242613,0.5134680134680135,0.9519322288949181,1.0,2/22,3.66%,BMP7;DTX1
prerank,post-translational protein modification (GO:0043687),0.27678408471567817,0.9694577886668928,0.5465116279069767,0.9533598671268001,1.0,50/332,14.35%,EPAS1;APLP2;ITIH2;ASB2;SERPIND1;CP;LAMC1;OBSL1;SPP1;SPSB1;IGFBP7;DCAF11;FBXL19;KLHL41;ATG5;SPSB4;DSCC1;LGALS1;FBN1;KNG1;FBXW11;RABGGTA;IGFBP3;BTRC;NUCB1;ASB15;FBXO22;LRRC41;RAB11B;DCAF10;RAB13;FBXL12;UBE2M;FBXW8;FBXO4;SOCS3;ASB14;CUL4A;CUL9;FBXO10;MIA3;NUB1;ASB5;MBTPS1;ASB12;DDB2;PRKCSH;FBXO11;SERPINC1;FBXL20
prerank,pyruvate metabolic process (GO:0006090),0.340582507024242,0.9692925374685333,0.5136363636363637,0.952942635539994,1.0,7/52,8.99%,ME2;HK2;LDHB;PGAM2;GCK;SRR;DLD
prerank,positive regulation of cation channel activity (GO:2001259),0.3539478464801698,0.9692265262098563,0.49333333333333335,0.9522725918202659,1.0,3/40,1.93%,ACTN2;ANK2;LRRC38
prerank,cellular defense response (GO:0006968),0.35752207053381574,0.9691122797626353,0.511864406779661,0.9517270084110906,1.0,6/40,11.92%,CCR9;DCDC2;VEZF1;BECN1;LY96;ZNF148
prerank,antibacterial humoral response (GO:0019731),0.42415274303204265,0.9689407724412862,0.5160714285714286,0.9513106197970973,1.0,4/16,16.62%,DEFB1;PLA2G6;CAMP;DMBT1
prerank,regulation of p38MAPK cascade (GO:1900744),0.361902514172369,0.9685543881224978,0.5057851239669422,0.9515161998809765,1.0,8/35,14.38%,SASH1;DLG1;SPHK1;EZR;PTPN22;DUSP10;ULK4;GADD45A
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.27532163993429265,-0.9685394151991603,0.5269461077844312,0.7784814108187467,1.0,13/69,10.79%,PLCB4;PIK3R1;PLCL1;PLCE1;NYAP2;PIK3C2B;NGF;PLEKHA1;PLCL2;HTR2A;PLCH1;ERBB2;EDN1
prerank,peptidyl-amino acid modification (GO:0018193),0.46201215820481617,0.9681605323806615,0.50920245398773,0.9516700462726572,1.0,4/10,19.95%,METAP2;FKBP10;TTLL4;ATP7A
prerank,motor neuron axon guidance (GO:0008045),-0.3935621817015452,-0.9679934188760204,0.5191011235955056,0.7790918738444108,1.0,5/15,9.70%,SLIT2;TMEFF1;CHN1;NTN1;RHOH
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.446375383077876,0.9679928033650291,0.49423076923076925,0.9512783610974691,1.0,4/12,14.03%,PCGF5;RBM15;LRIF1;SMCHD1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.3231540710228697,-0.9676491014234064,0.5229591836734694,0.7791891490497271,1.0,8/33,8.32%,TEK;SEMA5A;NDNF;GAS6;KDR;RAMP2;ICAM1;GATA2
prerank,AMP metabolic process (GO:0046033),0.45293471255170187,0.9675203830081236,0.5095419847328244,0.9516204674249841,1.0,6/13,20.77%,AMPD3;AK3;AK4;AMPD2;ADSS1;ADSL
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.4662951877881818,0.9674529270621974,0.5009861932938856,0.9509867542003134,1.0,1/10,1.98%,PRKN
prerank,regulation of interleukin-17 production (GO:0032660),0.36969491020726547,0.9671455964914484,0.48403361344537815,0.9509357482314565,1.0,4/31,6.47%,IL18;SPHK1;TLR4;IL12B
prerank,regulation of mRNA polyadenylation (GO:1900363),0.4241645611052681,0.9669701702407735,0.49458483754512633,0.9505603240298812,1.0,7/17,23.34%,CTR9;CPEB3;VIRMA;RNF20;CPSF7;ZC3H3;NUDT21
prerank,mRNA processing (GO:0006397),0.27488307564294445,0.9669112760014756,0.54,0.9498772473770847,1.0,79/287,23.47%,SRRM2;DDX5;PPARGC1A;POLR2A;SON;SNRNP70;PCBP2;PABPN1;HNRNPR;HNRNPH1;SRSF5;POLDIP3;SNIP1;HNRNPA2B1;RPRD2;POLR2D;RBM15;SPEN;NOVA1;GPKOW;CCAR1;CWC27;TBRG4;GTF2F1;PRPF18;HNRNPL;CWC15;IK;USP49;PHF5A;SRSF11;CMTR2;PRCC;RAMAC;HNRNPC;SCAF11;PRPF3;SARNP;SNRNP40;RBM4;TFIP11;HNRNPM;CPSF3;CWF19L1;FRG1;USP39;ALKBH5;ZCRB1;PRPF6;FUS;SRSF1;CSTF1;HNRNPH3;CDC40;PCF11;SRSF10;U2AF1;EFTUD2;SNRPC;SRSF7;SF1;PNN;POLR2G;WBP4;PRPF31;SNRPA1;U2AF2;SF3B2;SF3B1;PPWD1;SF3B5;CPSF7;GCFC2;PQBP1;CDC5L;RNPC3;NUDT21;POLR2F;CMTR1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.43614627060868705,0.9667996137772367,0.5192660550458715,0.9493376599612081,1.0,7/15,24.43%,ZC3H12B;DICER1;ZC3H12C;NYNRIN;POP7;POP1;LACTB2
prerank,muscle filament sliding (GO:0030049),0.36092270396396947,0.9666427565635198,0.5292153589315526,0.9481234229711177,1.0,5/38,13.06%,ACTN2;TPM1;MYL4;TNNI3;TNNC1
prerank,actin-myosin filament sliding (GO:0033275),0.36092270396396947,0.9666427565635198,0.5292153589315526,0.9481234229711177,1.0,5/38,13.06%,ACTN2;TPM1;MYL4;TNNI3;TNNC1
prerank,regulation of telomere maintenance (GO:0032204),0.3960457765230535,0.966396839548374,0.5098039215686274,0.9479182106714458,1.0,13/26,26.90%,HDAC8;SMG1;ATRX;RAD50;USP7;PML;TINF2;NBN;YLPM1;SMG6;PPP1R10;RTEL1;UPF1
prerank,regulation of cholesterol storage (GO:0010885),-0.3952178853634373,-0.965919226835967,0.5239130434782608,0.7827032157714908,1.0,4/15,7.44%,PPARD;SCARB1;ABCG1;SREBF2
prerank,endosome organization (GO:0007032),0.34827180433848626,0.9658028267939207,0.4848966613672496,0.9486659608494281,1.0,18/41,23.24%,HOOK2;ALS2;ARFGEF2;RAB22A;PLEKHF1;HOOK3;EEA1;WASHC5;PI4K2B;PHETA1;SQSTM1;LAMTOR1;DNAJC13;SNX33;PI4K2A;VPS33B;HOOK1;RILP
prerank,organelle organization (GO:0006996),0.2672230138672864,0.9656414552428654,0.5707865168539326,0.9482706112336273,1.0,90/388,17.30%,FAM174B;SYNE3;PPARGC1A;DYM;MICAL3;SH3D19;PRKN;OBSL1;FGD4;GABPB1;CAPZB;PHIP;PYROXD2;SEC31B;CLASP1;LRRK2;PEX11A;MYO18A;AFG1L;TPM1;RAB34;ATL1;ESRRA;SIRT5;BCAS3;CLUH;NIPSNAP2;OPA1;HUWE1;CNTNAP1;PEX11B;MTFR2;TWNK;TERT;SIRT3;HTT;TMEM11;DIAPH1;DNM1L;TRAPPC12;GOLPH3L;CSNK1A1;SSBP1;WASL;CATIP;ADCK1;PIKFYVE;CHMP1A;RAB43;CXADR;YTHDF3;AJUBA;FBXW8;ZFYVE16;FGD1;CDC42;PEX10;BRWD3;MIA3;TTC17;SIRT4;ROPN1;TRAPPC11;PRKCI;ZMYM6;PLEKHF1;WDPCP;TANGO2;CFAP410;ARHGAP21;SEC23IP;RAB29;PEX14;WTIP;ZMYM4;VPS51;PEX19;SLC25A36;MICAL1;GOLGA5;GOLGA8B;VPS4A;RAB30;PI4K2B;CHMP4C;MSTO1;OPTN;PEX16;MTX2;COG4
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.2425941469024247,-0.9648744093412465,0.5270935960591133,0.784539700852618,1.0,34/172,14.40%,DGKH;DGKB;PIP5K1B;PIK3R1;INPP4B;PLA2G4A;PIP4K2A;PIK3C2B;INPP5D;CEPT1;BMX;PLCG2;PLEKHA1;PIK3R6;SLC44A5;MTMR6;SLC44A2;LPCAT2;MTMR2;FGF2;PLA2G12A;MTMR7;MFSD2A;MTMR9;ETNK1;SLC44A1;DGKG;DGKZ;PLEKHA3;PITPNM3;LPIN3;PNPLA3;CDS1;ABHD4
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.4147507948966985,-0.9645981537560449,0.5203426124197003,0.7844660162038289,1.0,3/13,11.86%,ENTPD1;ENPP1;SMPDL3A
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.3717920458909929,0.9644810344435985,0.5,0.9504165501871711,1.0,6/32,13.66%,DDX5;FHIT;TP53;SIRT1;PPP1R13B;PML
prerank,ncRNA transcription (GO:0098781),-0.39424099210556574,-0.9643535462130166,0.49786324786324787,0.7843346858798678,1.0,2/13,7.75%,CAVIN1;SPIN1
prerank,vitamin transport (GO:0051180),0.37541356347448934,0.9641263613934837,0.506108202443281,0.9505012613340049,1.0,8/29,12.25%,PDPN;SLC35F3;SLC19A1;SLC27A1;TCN2;SLC19A2;GC;TCN1
prerank,N-glycan processing (GO:0006491),0.42149818031297315,0.9638949595590512,0.5062166962699822,0.9502707737865597,1.0,6/18,13.89%,MAN1A2;MAN1C1;FUT8;MAN2A1;GANC;PRKCSH
prerank,regulation of leukocyte activation (GO:0002694),-0.40569749625831225,-0.9638868704569918,0.5251641137855579,0.7847062543457993,1.0,5/14,17.31%,CD200;LYN;MFHAS1;GPER1;CD74
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.24236456685892901,-0.9636138516683542,0.5364806866952789,0.7846614589559022,1.0,49/158,21.48%,ROR1;ATP2C1;MID2;NOD1;TFRC;TNFSF10;ALPK1;PLK2;TRAF5;FLNA;MAP3K7;TNFRSF19;ECM1;SLC44A2;SHISA5;NDFIP2;S100B;PLEKHG5;TRIM14;FKBP1A;TRIM27;REL;TIRAP;IKBKB;PRKD1;RBCK1;CARD16;PINK1;TERF2IP;PPM1A;MTDH;TMED4;EDAR;PELI1;PIM2;NOD2;CD74;TMEM101;MAP3K14;GPR89A;TIFA;TFG;ECT2;CCL19;NEK6;TRIM68;LGALS9;EEF1D;VAPA
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.4022930052391373,0.9635343661773761,0.5017064846416383,0.9503679228329004,1.0,5/21,17.12%,IGF1;BMPR1A;FOXJ2;MFN2;MEF2D
prerank,cognition (GO:0050890),-0.30512047278252563,-0.9630553120128753,0.5201072386058981,0.7853121812250562,1.0,11/42,11.72%,GRM5;ST3GAL4;SHROOM4;DOP1B;APP;PTCHD1;STRA6;SLC1A4;GPR155;MFSD2A;FAM107A
prerank,positive regulation of autophagy (GO:0010508),0.3143313546943806,0.9629389147725558,0.5100864553314121,0.9510789843517657,1.0,12/81,10.49%,RNF152;PRKAA2;PRKN;SESN1;TPCN1;LRRK2;SESN2;NPRL2;LARP1;HTT;SIRT1;IRGM
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.37434227656250074,-0.9629217583080075,0.503370786516854,0.7848937045633446,1.0,9/18,30.83%,APOE;ABCG1;PSEN1;TMCC2;APH1A;LDLRAP1;ADAM19;BACE1;ACHE
prerank,glucose metabolic process (GO:0006006),0.33702875623060086,0.9626021958501384,0.5030959752321982,0.9510956733953494,1.0,15/58,17.88%,PPARGC1A;SORD;PGAM2;GALM;GOT2;RBP4;SLC25A12;SLC25A11;PGM1;PER2;BRAT1;SLC25A10;GOT1;SLC37A4;CRY1
prerank,response to alcohol (GO:0097305),0.3815855796535618,0.9624106603111265,0.5255731922398589,0.9507552896385161,1.0,4/27,7.36%,TGFBR3;TGFBR1;TGFBR2;GOT2
prerank,regulation of cellular component biogenesis (GO:0044087),0.35161141722452044,0.9624068892050532,0.494949494949495,0.9499420498827243,1.0,8/39,12.28%,ROCK2;SNCAIP;PARP10;EZR;HRG;IRGM;BBS10;PTPN11
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.35784313210429775,0.9622474886268594,0.5310457516339869,0.9495329497897509,1.0,4/41,7.24%,BMP7;AFDN;PTPN23;PTPRU
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.4601653970782768,0.962058587290447,0.5077821011673151,0.9491939595832966,1.0,4/10,12.26%,EPHA4;CDK5RAP3;ATRAID;RGP1
prerank,polyamine metabolic process (GO:0006595),0.444479903072298,0.9613940340719859,0.5414364640883977,0.9501186644838383,1.0,3/13,8.05%,SMOX;SAT1;PAOX
prerank,positive regulation of potassium ion transport (GO:0043268),0.3621509156310204,0.961352371925411,0.5145161290322581,0.9494019693049847,1.0,4/38,3.65%,ACTN2;ANK2;DLG1;ADRA2A
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.44481839434299697,0.9610073587784912,0.5115384615384615,0.9494010398398633,1.0,2/12,6.47%,IL18;IL12B
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.35159875200177726,0.9609416468590879,0.5228013029315961,0.9487397101235642,1.0,9/38,14.28%,PPARA;PKHD1;MAGI2;DAG1;PTEN;SIRT1;PHLPP2;FLCN;THEM4
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.33187120100338574,0.9608894867433355,0.4976671850699845,0.9480482477592843,1.0,10/62,11.78%,POLR2A;CTR9;ELOF1;AFF4;CCNT2;POLR2D;ELL;GTF2F1;RTF1;NELFCD
prerank,response to lipid (GO:0033993),-0.26016960855441157,-0.9605201214716833,0.5054151624548736,0.7898654172274925,1.0,23/105,13.16%,ESR1;NOS3;ACER2;PPARD;STAT3;ANXA1;TNFRSF11A;FOXP1;ABCG1;GCH1;SOCS2;ALPL;FOXO1;TGFB1;IRAK3;STAT5B;SCD;ERBIN;RPS6KA3;TIRAP;CTNNB1;NOS1;SNCA
prerank,negative regulation of immune system process (GO:0002683),-0.3822987122610983,-0.9602238111205735,0.5247058823529411,0.7898684562441304,1.0,3/16,11.23%,CD200;LYN;GPER1
prerank,positive regulation of JNK cascade (GO:0046330),-0.27763399235202596,-0.960191878186393,0.5046439628482973,0.7892014275401643,1.0,25/70,21.18%,MAP3K5;RASSF2;SH3RF3;PTK2B;DAB2IP;MINK1;TRAF5;APP;TNFRSF19;ANKRD6;MFHAS1;FLT4;TIRAP;AXIN1;GADD45G;MBIP;HIPK2;EDAR;NOD2;TRAF1;WNT16;GADD45B;CCL19;MAP3K11;PYCARD
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.387612820598369,-0.9601376223477758,0.5082644628099173,0.7885939886373647,1.0,9/15,31.26%,TSEN34;FAM98B;TSEN54;RTCB;ERN1;CPSF4;TSEN15;CLP1;CPSF1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.4059403434788708,0.9599349874051472,0.5149384885764499,0.9496613125288724,1.0,9/20,26.19%,ZC3H7B;SNIP1;TERT;DICER1;AGO1;SPOUT1;AGO4;AGO2;PUM2
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.4076164253463861,0.9597141736504133,0.512396694214876,0.9494178712066818,1.0,3/20,5.60%,PPARGC1A;PRKAA2;ARRB1
prerank,inositol phosphate metabolic process (GO:0043647),0.3462371051577126,0.9595791737794837,0.5046583850931677,0.9489253727883021,1.0,9/46,11.18%,ISYNA1;NUDT4;INPPL1;PLCD3;PTEN;ITPKB;PLCD1;PPIP5K2;OCRL
prerank,positive regulation of DNA binding (GO:0043388),0.3749819381746393,0.959534015235354,0.5219594594594594,0.9482147917954523,1.0,3/31,3.64%,IGF1;PRKN;FOXC1
prerank,lipid catabolic process (GO:0016042),0.4127956731995194,0.959419012323341,0.5318761384335154,0.9476930262146586,1.0,3/18,7.25%,CEL;PLA1A;PNLIP
prerank,lymphocyte differentiation (GO:0030098),-0.2718164721387557,-0.9593442775150426,0.5227272727272727,0.7898923576819527,1.0,14/68,10.15%,PTPRJ;TPD52;VCAM1;TOX;HDAC9;PTPRC;PLCG2;ITGB1;ITGA4;IKZF1;JAG2;RHOH;PBX1;LFNG
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3281497199863432,0.9591514795934517,0.516030534351145,0.9475233015784514,1.0,10/64,11.78%,POLR2A;CTR9;ELOF1;AFF4;CCNT2;POLR2D;ELL;GTF2F1;RTF1;NELFCD
prerank,regulation of platelet activation (GO:0010543),-0.35553812751470204,-0.959112290678325,0.5168539325842697,0.7897088215300534,1.0,6/21,10.25%,PLA2G4A;NOS3;LYN;APOE;TEC;PDGFA
prerank,hexose transmembrane transport (GO:0008645),0.39856345394978565,0.9584874233835748,0.5384615384615384,0.9484105175006015,1.0,3/21,9.53%,SLC2A12;SLC5A3;SLC45A3
prerank,telomere capping (GO:0016233),0.4179477258552172,0.9584503867590637,0.5155963302752293,0.9476954345019283,1.0,6/16,18.62%,ACD;PRKDC;RAD50;TFIP11;TINF2;NBN
prerank,RNA biosynthetic process (GO:0032774),0.37866164344876074,0.9583380773466017,0.4841930116472546,0.9471644511523141,1.0,10/31,16.15%,POLR2A;TTF2;TERT;TBP;TAF4;POLA2;BRF1;TAF7;TTF1;TAF13
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3020060588301039,0.9578634089481172,0.5381471389645777,0.947558625765993,1.0,8/108,6.11%,UACA;ROBO1;SMAD3;COL4A3;CFLAR;BID;DDX3X;FAM162A
prerank,positive regulation of protein modification process (GO:0031401),0.28242370554395213,0.9578357722695818,0.5566502463054187,0.9468224456960672,1.0,32/203,11.94%,DAB2;FGF1;ROCK2;ACE;LEPR;FAM20A;FNIP1;TRABD2B;LRRK2;ITLN1;RAPGEF3;ATG10;F2;DDX3X;ARRB1;CAMK1;FBH1;CCND3;CDH5;SIRT1;RIPK1;MAVS;CRKL;PIK3R3;ATG7;IRGM;ABL1;DYRK1A;ADAM17;AXIN2;VEGFD;RALBP1
prerank,cellular response to chemokine (GO:1990869),-0.29417388987197624,-0.9578070818878106,0.5535248041775457,0.7921021906929744,1.0,7/46,10.81%,LRCH1;CXCL12;PTK2B;SLC12A2;ACKR3;DOCK8;DUSP1
prerank,regulation of cytokine production (GO:0001817),0.29329393103475776,0.9577187853391725,0.5232403718459495,0.9462911072170292,1.0,12/126,6.84%,C1QTNF3;LGR4;SYT11;ADRA2A;SRGN;IGF2BP1;TRIM56;CD28;IL12B;EIF2AK2;TWSG1;AFAP1L2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3713273538698877,0.9570537376477866,0.4938704028021016,0.947100816130264,1.0,7/30,12.65%,PRKCZ;CD300A;PARP14;SH3BP5;MVP;SOCS3;SRCIN1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.3942980339028217,-0.9567887964802959,0.4939271255060729,0.7939088795331665,1.0,5/13,17.51%,MDFIC;APOD;UFM1;CABP1;BARD1
prerank,cilium assembly (GO:0060271),0.26719120803932844,0.9566654149245316,0.564042303172738,0.9472384288799035,1.0,71/296,19.23%,CFAP44;AVIL;CC2D2A;PKHD1;DCDC2;CEP250;TNPO1;CLASP1;CPLANE2;RILPL1;NINL;RAB3IP;KIF3C;CYS1;RHO;PTPN23;ASAP1;EXOC2;CCDC28B;SSTR3;CEP162;CDC14A;IFT122;WDR19;DYNC2I1;MKKS;TMEM231;SDCCAG8;CLUAP1;CDC14B;ATP6V1D;IFT88;OCRL;GALNT11;NPHP1;BBS10;PDE6D;UNC119B;GORAB;WDPCP;CFAP410;WDR35;ALMS1;EXOC4;E2F4;EXOC3;PARVA;CCDC39;CEP63;B9D2;ARL6;RP2;BBS2;STK36;RFX2;RAB8B;RILPL2;PIBF1;TMEM237;BBOF1;TRAPPC14;CCDC40;CEP57;ATP6V0D1;AKAP9;TMEM17;TCTN3;PCM1;CEP164;OFD1;PCNT
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.31488103615215735,0.9566148828428673,0.5322812051649928,0.9465513083577386,1.0,26/80,20.47%,SNX6;SNX32;DENND2A;VPS54;DENND5A;PIKFYVE;RAB7B;VPS50;CLTC;RGP1;SNX12;SNX8;VTI1A;STX5;SGSM2;RAB29;VPS51;HEATR5B;RAB9A;PHETA1;VPS35;TBC1D14;EVI5;TMEM87B;STX16;ANKFY1
prerank,proteasome assembly (GO:0043248),-0.41004341320329274,-0.9562443465945168,0.5124481327800829,0.7944750395687639,1.0,5/11,34.08%,PSMG2;PSMD11;POMP;ADRM1;PSMD4
prerank,hexose metabolic process (GO:0019318),0.360818184155312,0.9562004660099562,0.5180327868852459,0.9467914180220259,1.0,10/39,19.58%,SORD;CHST15;GALM;GALK2;GALK1;PGM1;BRAT1;FPGT;SLC37A4;GDPGP1
prerank,pre-replicative complex assembly (GO:0036388),-0.2820889267091087,-0.9561024586018253,0.5139318885448917,0.7940568443172615,1.0,25/64,34.29%,PSMB2;PSMD14;PSMC6;UBB;PSMA4;PSMB9;ORC5;ORC2;PSMD11;PSMB10;PSMD2;PSMA2;UBC;RPS27A;PSMB3;MCM6;PSMB5;PSMA7;PSMF1;PSMD7;MCM4;MCM8;PSMA5;PSMD4;PSME4
prerank,positive regulation of dendrite development (GO:1900006),0.4541775910472731,0.955779789419642,0.5233463035019456,0.947037610349509,1.0,1/10,0.46%,BMP7
prerank,hyaluronan metabolic process (GO:0030212),-0.34344710551572927,-0.9554995639307443,0.5319148936170213,0.7948241849652765,1.0,5/23,9.92%,CEMIP;TGFB1;HEXB;FGF2;CD44
prerank,mesenchymal cell development (GO:0014031),-0.3615830083926648,-0.9554236584900384,0.5221445221445221,0.7942582400772569,1.0,4/18,9.18%,CDH2;NOTCH1;HEYL;HEY2
prerank,glial cell differentiation (GO:0010001),-0.32727101236566014,-0.9551276679645764,0.5251798561151079,0.7942630526681907,1.0,9/28,18.48%,CDH2;ADGRG6;STAT3;RELN;PTPRZ1;PAX2;TPPP;SOX2;SOX8
prerank,regulation of G0 to G1 transition (GO:0070316),0.35703313811930193,0.9545844942712576,0.5376175548589341,0.9492814965323845,1.0,6/38,11.68%,TFDP2;PCGF2;MGA;TFDP1;RBBP8;CBX5
prerank,apoptotic DNA fragmentation (GO:0006309),0.41367082076394446,0.954460217221557,0.5139146567717996,0.9487908883967993,1.0,6/16,24.41%,CASP3;DICER1;DFFB;DFFA;CECR2;H1-0
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.3414919431734164,0.9543907912612614,0.5055821371610846,0.9481603568864592,1.0,14/48,16.41%,ELOF1;TAF1D;HMGA1;BAZ1B;ATAD2B;ZMIZ2;ZMIZ1;MYO1C;POLR1G;PHF2;TBP;KAT2B;SPHK2;ARID1B
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.39427264186917566,0.9541765420745056,0.48961937716262977,0.9478994335795542,1.0,7/21,24.76%,MITF;MED12;MED17;MED1;MED13;MED24;BCLAF1
prerank,cellular response to glucagon stimulus (GO:0071377),0.41339606575109156,0.9541075874382111,0.5324909747292419,0.9472731320142541,1.0,5/17,13.48%,ADCY5;ADCY1;ADCY9;PRKAR1A;ADCY6
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.38449071705786786,0.9539870942423692,0.5258620689655172,0.9467535805126192,1.0,6/25,12.71%,LDB1;RNF8;LARP7;ELL;NELFCD;WDR43
prerank,cardiac atrium morphogenesis (GO:0003209),0.4203638429723233,0.9539557633075633,0.5213523131672598,0.9460535077202669,1.0,1/16,0.19%,NOTCH2
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.32666504036086114,0.9538025082231005,0.5084226646248086,0.9456067330728689,1.0,4/54,5.60%,SH3RF2;NXN;HDAC8;ARRB1
prerank,cellular response to metal ion (GO:0071248),0.2967201897718005,0.9536077587537033,0.5509138381201044,0.9453047722910135,1.0,8/123,1.98%,BMP6;SLC41A1;SYT9;SYT11;SYT12;PRKAA2;PRKN;ADCY1
prerank,iron ion homeostasis (GO:0055072),0.3312708166477022,0.9535926064322792,0.5142428785607196,0.9445393128236118,1.0,3/58,1.42%,BMP6;CP;PICALM
prerank,chromatin remodeling (GO:0006338),0.304025674393449,0.953532322318958,0.5350404312668463,0.9439069053239976,1.0,32/100,21.66%,JARID2;CHD4;ATRX;BAZ1B;SMARCD3;SMARCA4;SRCAP;SMARCC2;SMARCE1;HDAC4;SIRT1;HDAC1;BAHD1;BAZ1A;ZBTB1;HNRNPC;KAT2B;MTA2;RB1;ARID1B;KDM6B;PADI4;SATB2;EZH1;CHD8;MPND;TAF6L;CECR2;KDM6A;SMARCD2;MBD2;RUVBL1
prerank,regulation of cell death (GO:0010941),0.3044737672575708,0.9534053775747294,0.526896551724138,0.9434385267130833,1.0,19/94,15.15%,BMP7;CCN2;PRKN;SRGAP2;PRODH;LRRK2;RILPL1;OLFM4;ATG5;RRAS2;LRP1;RIPK2;BECN1;IMPACT;AXIN2;CRYAB;TSC1;RAB29;FAF1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3901073032891292,0.953396228534029,0.5276292335115864,0.9418941811504096,1.0,4/23,9.42%,TFDP2;BID;TP53;TFDP1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3901073032891292,0.953396228534029,0.5276292335115864,0.9418941811504096,1.0,4/23,9.42%,TFDP2;BID;TP53;TFDP1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.26187960613540007,0.9529922161195056,0.6063249727371864,0.9421662016221372,1.0,92/497,14.62%,BMP7;TFDP2;WNT4;ZIC2;FOXN3;ZNF423;JARID2;ZHX2;SNX6;FOXD1;ZNF568;DKK3;ARID4A;NR2F2;NCOR2;TSHZ3;GLI3;ZBTB38;NACC2;VGLL4;LOXL3;FOXP2;IGF2BP1;DDX3X;SFMBT1;CBFA2T2;HMGA1;LBH;ZNF318;TP53;EIF2AK2;BHLHE41;SMURF2;NIPBL;LDB1;FBXW11;BCOR;SAMD4A;SMARCA4;NR1D2;BTRC;RBM15;SPEN;LARP1;CPEB3;KAT6B;NRG1;IGF2BP2;CNOT10;SMARCC2;PDS5A;NIBAN2;SMARCE1;HDAC4;SCML4;SIRT1;TLE1;HDAC1;SOX13;CBY1;GTPBP4;SPINDOC;CHMP1A;TCF7L2;ZNF219;LSM14A;PRDM5;SAP18;BAHD1;WWP2;CBX5;WAPL;ZNF148;UIMC1;DDX6;BRD7;DEAF1;MLXIPL;IRF1;KAT7;CDAN1;KMT5A;SIN3A;PML;TLE2;BCL7A;NCOR1;CRYAB;PER2;TSC1;ZKSCAN3;HOXA7
prerank,regulation of inflammatory response (GO:0050727),0.2824470147724518,0.952979303230639,0.558408215661104,0.9414167760268577,1.0,21/190,9.73%,RORA;C1QTNF3;PPARA;IL18;LACC1;NAPEPLD;SPHK1;SNX6;METRNL;TLR3;TLR4;GPS2;IL12B;DAGLA;ENPP3;SERPINE1;NR1D2;GPRC5B;CDH5;IL17RA;RIPK1
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.2559111980617875,-0.9525446029907872,0.5703703703703704,0.7997725230152074,1.0,34/110,17.88%,GSN;TFRC;GSK3B;DAB2IP;APOE;RPS3;SH3GLB1;HSPA8;ULK1;SORL1;HSPA5;TGFB1;AIDA;RALB;HJURP;FNIP2;GNL3L;HSP90AA1;TIRAP;LCMT1;VEGFA;PINK1;NOP53;TAL1;ATF7IP;CDC42EP2;CLU;FBLIM1;IAPP;NAPB;TPPP;SVIP;SYK;STX1B
prerank,regulation of RNA splicing (GO:0043484),-0.27105091968449524,-0.9522693012013449,0.5679012345679012,0.7996919590914997,1.0,14/69,13.20%,QKI;MBNL1;AHNAK;PIK3R1;KHDRBS2;AHNAK2;HNRNPLL;SRRM4;TMBIM6;PRX;HNRNPK;RBM20;ZNF326;AFF2
prerank,negative regulation of neurogenesis (GO:0050768),0.3621982092899902,0.9521818493392098,0.5234248788368336,0.9425393947213642,1.0,4/34,7.94%,APPL2;LRP4;RUFY3;PTEN
prerank,catecholamine biosynthetic process (GO:0042423),0.45322618479569354,0.9519282499557584,0.5169660678642715,0.9423852279639412,1.0,1/11,1.04%,MOXD1
prerank,eye photoreceptor cell development (GO:0042462),-0.3812657800973917,-0.9518647479178477,0.5403587443946188,0.7999205412321087,1.0,3/15,13.77%,RORB;RP1;VEGFA
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.3992805115937063,0.9507792796490327,0.5459459459459459,0.9444094944449181,1.0,5/19,12.06%,PRKN;FZD5;HTT;DNM1L;CSNK2A2
prerank,stress granule assembly (GO:0034063),0.40204725023703985,0.950724325289213,0.5379061371841155,0.9437643690984627,1.0,8/20,17.14%,DDX3X;ATXN2;LSM14A;YTHDF3;DDX6;UBAP2L;ATXN2L;OGFOD1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.3743957632095965,0.9507211790983082,0.5107142857142857,0.9429960061563691,1.0,4/29,7.21%,ACSL1;ACSBG2;HACD1;SCD5
prerank,axonal transport (GO:0098930),-0.3145178305370204,-0.9505817243089499,0.5025773195876289,0.802383924618461,1.0,17/36,26.88%,SYBU;DST;TMEM108;AP3S1;MAPT;HIF1A;KIF3A;AP3S2;SPAST;AP3B2;SOD1;KIF4A;NEFL;HAP1;KIF3B;AP3D1;KIF1A
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.376957371351122,-0.950521235261738,0.543859649122807,0.8017750900070995,1.0,6/17,10.44%,HSP90AB1;PPP1R12A;CALM1;PTPRC;CALM2;CALM3
prerank,regulation of neuroblast proliferation (GO:1902692),-0.3813738307246561,-0.9502866492867863,0.5161290322580645,0.8015671828427507,1.0,6/15,16.47%,TAFA1;DISC1;PTN;CTNNB1;VEGFA;CX3CR1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.29418704344951835,0.9501595074342745,0.5252659574468085,0.9436325760005577,1.0,25/122,15.15%,SORBS1;IGF1;SMOC2;GLI2;LARP4B;SLC6A9;TLR4;DDX3X;NOX1;CD28;PDGFRB;POLDIP3;GCK;LDB1;SAMD4A;CPEB3;GLI1;SIRT1;YTHDF3;PRKDC;KAT7;PLD1;ZCCHC4;NFKB1;FAF1
prerank,meiosis I (GO:0007127),0.39097156820975026,0.9501289453107576,0.5300353356890459,0.9429212794566593,1.0,4/23,12.98%,CCNA1;MOV10L1;MYBL1;FOXJ2
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.4213152708464302,-0.9499674251830788,0.5331991951710262,0.8015778867782007,1.0,3/10,19.38%,PLA2G4A;ENPP2;PLA2G15
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.4356607250341983,0.949729788268803,0.51340206185567,0.9431228645792055,1.0,1/13,1.44%,IGF1
prerank,nuclear membrane disassembly (GO:0051081),0.42977967371410786,0.949610164218343,0.524904214559387,0.9426379236727606,1.0,3/14,12.33%,PRKCB;CCNB2;PRKCA
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.2798459846120792,-0.9495200450068264,0.5173410404624278,0.8018912772458647,1.0,20/57,18.81%,MAP3K5;GRIN2B;NOD1;TNFSF10;CTSD;GRIN2A;PERP;GRAMD4;GPER1;SOX7;DAPK1;AIM2;PPM1F;USP50;GRIN1;SYK;HTRA2;CYCS;FOXL2;BCAP31
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.3201397745097474,-0.9493035076715168,0.5298507462686567,0.8016945342178836,1.0,9/32,10.80%,PIK3R1;PLCE1;CARMIL1;ARHGEF7;ACTR2;OCLN;CORO1C;ACTR3;ENPP2
prerank,dermatan sulfate metabolic process (GO:0030205),0.4294246676822615,0.9492198174598437,0.5291970802919708,0.9428227453948186,1.0,2/13,6.71%,UST;DSE
prerank,positive regulation of interleukin-4 production (GO:0032753),0.41515025481588674,0.9490578648241892,0.5357798165137615,0.942435584730453,1.0,2/17,6.18%,PRKCZ;CD28
prerank,positive regulation of protein deacetylation (GO:0090312),0.43048852117187364,0.9489825970403096,0.5245901639344263,0.9418359486955512,1.0,6/14,25.14%,NIPBL;DYRK1A;FNTA;ZBTB7B;AKAP8;ING2
prerank,camera-type eye development (GO:0043010),-0.3355999624577821,-0.9485253161961126,0.5357142857142857,0.8028379084642495,1.0,9/25,19.86%,LAMA1;TENM3;CYP1B1;FBN2;STRA6;VEGFA;PAX2;FOXL2;ALDH1A3
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.37516746909690785,0.9482960477766507,0.5563258232235702,0.9428157308073587,1.0,4/26,6.93%,GPR137;TLR3;TLR4;FBN1
prerank,chemical homeostasis (GO:0048878),0.32542711925274376,0.9481358551036642,0.5297709923664122,0.9424192488662894,1.0,12/61,15.45%,WNK4;ZBTB20;RBP1;DDX3X;TLCD2;NR1D2;ADCK1;ACOXL;WNK1;ACOX3;SLC66A1;TENT4B
prerank,regulation of lymphocyte migration (GO:2000401),-0.4147655174316732,-0.9475941129715288,0.5668789808917197,0.8043227903879463,1.0,3/10,10.85%,STK10;JAM2;MSN
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4536174022550339,0.9473030287692542,0.5291902071563088,0.9437897153711119,1.0,4/11,8.82%,PCBP2;IGF2BP1;IGF2BP2;NOVA1
prerank,purine nucleotide catabolic process (GO:0006195),-0.39930159478059596,-0.9472509286941201,0.5489749430523918,0.8044201324102087,1.0,6/13,16.13%,XDH;HINT1;GDA;NT5E;NT5C1A;GPX1
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.27355143890389877,-0.947133019304092,0.567398119122257,0.8039708547171404,1.0,12/70,14.40%,PLA2G4A;MBOAT1;CEPT1;SLC44A5;SLC44A2;LPCAT2;PLA2G12A;ENPP2;MFSD2A;SLC44A1;LPIN3;ABHD4
prerank,myotube differentiation (GO:0014902),0.4102580028100893,0.9471072304416299,0.5261261261261261,0.9435036344909538,1.0,3/17,3.51%,ADAM12;IGF1;ADAMTS15
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.4428879208622575,0.9470603460799839,0.5078125,0.9428424624032462,1.0,1/10,0.65%,ACTN2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.4179776073779255,-0.9470044420676303,0.5420743639921722,0.8035698316098111,1.0,3/11,10.91%,SCARB1;LDLR;MFSD2A
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.29967283135120004,-0.9465440729300164,0.565989847715736,0.8039480526225595,1.0,7/39,7.12%,UTRN;FGF12;CHRM3;FXYD5;NEDD4L;YWHAE;TRPC6
prerank,negative regulation of ossification (GO:0030279),0.3874075233913612,0.94600583410369,0.5288966725043783,0.9446554159013827,1.0,5/23,9.45%,LRP4;SMAD6;SRGN;BCOR;CHSY1
prerank,protein transport (GO:0015031),-0.219775318844638,-0.9459151326021029,0.6666666666666666,0.804701436438092,1.0,66/332,17.31%,LRP1B;SPTBN1;CALCRL;ANK3;TBC1D4;TBC1D1;ATP6V0A1;RABGAP1L;RAB31;TFRC;VAMP4;MYH9;VMP1;SYNDIG1;ARHGEF2;RAMP2;RAB3C;TBC1D8;TBC1D30;TBC1D5;STX3;APOE;ABCG1;SLC10A7;TXNIP;ATP6V0A4;LMAN2L;SGSM1;PREPL;MYO6;NSF;PPT1;MTTP;RAB18;TBC1D2B;ARL5A;ARL1;STX12;GCC2;TMED1;GOLGA7;TMED5;ARRDC4;TVP23B;VLDLR;ARL5B;SNX17;RAMP1;KIF3A;SCAMP3;LAPTM5;SCAMP1;RAB38;CLU;RAB6A;RAB32;SCG2;TMED4;ARF5;SNX27;ARF6;ERP29;NAPB;TMED7;STXBP3;CD74
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.4360760350183128,0.9458610052610882,0.5176252319109462,0.9442149396273591,1.0,3/12,16.97%,IL12B;ZBTB1;CCR2
prerank,regulation of programmed cell death (GO:0043067),-0.23890516465094117,-0.945817025741494,0.6100917431192661,0.8042091393710417,1.0,46/161,22.69%,MECOM;HIP1;ACTN4;RTN4;ACTN1;ACER3;TPT1;ACER2;APAF1;PHLPP1;RPS3;PERP;CALR;CTSB;TOX3;ANP32A;HSP90AA1;BCAR1;MAGED1;DAPK1;LCMT1;FAS;TM7SF3;LRP8;PINK1;NOP53;DNAJA3;CLU;CASP6;PAX2;CRADD;BCL3;CASP2;TNFRSF25;TIGAR;BCL2L11;PAX8;AGT;DAPK2;USP42;AKT1S1;BNIP3;ASAH1;CHM;TRIAP1;SLK
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.41922457468392943,-0.9453969735494713,0.5507246376811594,0.8045703092286011,1.0,2/11,4.21%,FAP;PTGIS
prerank,regulation of monocyte differentiation (GO:0045655),-0.38696825708111016,-0.9453646937152538,0.504424778761062,0.8039104065969027,1.0,4/14,17.31%,FOXP1;CTNNBIP1;FES;CD74
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.3464319376296694,0.9453602138307416,0.5571895424836601,0.9447188642142749,1.0,9/46,9.99%,SMAD3;NEDD4;RAPGEF3;CAMK1;TP53;ZIC1;UBR5;MAVS;TCF7L2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.3873304034010449,0.9449348214105541,0.5212014134275619,0.944991545919777,1.0,6/23,12.74%,ERRFI1;SNX6;SH3BP5;MVP;SRCIN1;GPRC5A
prerank,connective tissue development (GO:0061448),0.35025729689154533,0.9448460991130163,0.5200642054574639,0.9444127933738945,1.0,9/35,13.29%,SOX5;SULF2;CREB3L2;SH3PXD2B;RORC;SLC39A13;HYAL1;COL11A2;SULF1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.39013622450766955,0.9448330211407323,0.5538194444444444,0.9436763898024311,1.0,5/22,13.78%,APPL2;PTPN22;RAB7B;IFI35;ACOD1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.2801649459419048,0.9444264524491421,0.5872611464968153,0.9438833575777312,1.0,18/170,10.64%,PRDM6;ROCK2;IGF1;AFF3;MTMR3;TBC1D16;PCBP2;ZNF462;IGF2BP1;AFF4;TOB2;GDNF;HRG;IGF2BP2;NOVA1;C1D;DHH;PRDM5
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.4388754215577919,0.9438245729455841,0.53125,0.9445657840987285,1.0,2/12,6.71%,UST;DSE
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.29524306088972185,-0.9438239001271921,0.5662983425414365,0.8069118347922045,1.0,9/47,8.46%,SPOCK2;SERPINE2;SPOCK3;SERPINI1;SERPINF1;TIMP2;SORL1;BIN1;SPOCK1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.3177973524641956,0.9433191472670531,0.5489051094890511,0.945013702509782,1.0,19/70,18.82%,SMAD3;CASP3;BID;IFI27;TLR3;DDX3X;CD27;PDPK1;RIPK1;RNF41;ITGAV;BLOC1S2;MLLT11;DEDD;ACVR1B;MCL1;TNFRSF1A;G0S2;DELE1
prerank,central nervous system myelination (GO:0022010),-0.4179245746292282,-0.9431385076497807,0.5274261603375527,0.8078110543177187,1.0,3/11,6.91%,PLP1;TENM4;B4GALT5
prerank,positive regulation of calcium ion transport (GO:0051928),0.3541732349789681,0.942809159498986,0.5145631067961165,0.9454515011294279,1.0,4/36,6.37%,CACNA1D;ANK2;P2RX3;PDGFRB
prerank,lung epithelium development (GO:0060428),0.45439598537962084,0.9428081494971777,0.5206766917293233,0.9446836233091884,1.0,1/10,1.20%,ERRFI1
prerank,cellular response to inorganic substance (GO:0071241),-0.3476819808656514,-0.9428060596590596,0.5655172413793104,0.8079062584385839,1.0,3/21,7.13%,KCNC2;GUCY1B1;FOXO1
prerank,regulation of osteoblast proliferation (GO:0033688),0.40812045071346364,0.9425894867258846,0.5359116022099447,0.9444896871085636,1.0,4/17,12.16%,FGFR2;NPR3;EIF2AK2;ATRAID
prerank,cell chemotaxis (GO:0060326),0.3252589929800426,0.942279947326948,0.5429864253393665,0.94442721786236,1.0,10/60,10.36%,LPAR1;KIT;CCR9;ACKR2;ARHGEF16;PDGFRB;HOXB9;HBEGF;CCL25;RAB13
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.3915432830206096,0.9419955133960661,0.5291005291005291,0.9443671900477838,1.0,3/20,7.35%,IL18;TLR4;PTPN22
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.317251946929897,0.9418608952343803,0.56797583081571,0.9439354847045461,1.0,6/73,6.11%,ROBO1;SMAD3;COL4A3;CFLAR;BID;FAM162A
prerank,RNA processing (GO:0006396),0.2779431789086443,0.9412095170046374,0.5586734693877551,0.9447902294668421,1.0,45/176,21.65%,CELF2;PPARGC1A;SON;RBMS2;PABPN1;HNRNPR;HNRNPH1;SRSF5;YJU2;TSEN2;HNRNPA2B1;TUT4;RBM39;NOVA1;TENT2;RBMS1;LUC7L3;SRPK2;PRPF18;HNRNPL;DICER1;SRSF11;HNRNPC;SCAF11;PRPF3;TENT4B;SNRNP40;RBM4;TFIP11;TUT7;USP39;ALKBH5;ZCRB1;PRPF6;FUS;SRSF1;HNRNPH3;U2AF1;SRSF7;WBP4;SNRPA1;U2AF2;SF3B2;SF3B1;TUT1
prerank,protein K48-linked deubiquitination (GO:0071108),-0.3346439068409634,-0.9405373866674462,0.5215419501133787,0.8127190209875528,1.0,8/23,23.12%,OTUD7A;OTUD7B;YOD1;USP50;VCPIP1;USP8;MINDY1;BAP1
prerank,glutathione biosynthetic process (GO:0006750),-0.41487834893266984,-0.9403369958699719,0.5348360655737705,0.8124585318664199,1.0,7/11,33.06%,GCLM;CHAC2;OPLAH;GGCT;MGST2;GCLC;GGT1
prerank,placenta development (GO:0001890),-0.41509190020358044,-0.9395988484200377,0.550098231827112,0.8134634938516059,1.0,7/12,33.61%,PTK2;CUL7;SOD1;ADAM19;PLAC1;E2F8;PPARG
prerank,postreplication repair (GO:0006301),-0.2933589940289869,-0.9395695267528844,0.5779569892473119,0.8128112058317823,1.0,24/45,31.81%,UBE2V2;POLD3;RAD18;FAAP20;PRIMPOL;UBB;UBE2B;RPA1;RFC4;WDR33;NSMCE1;POLD4;POLD1;RFC2;POLK;DTL;UBC;RPS27A;RFC5;PCLAF;UBE2A;RPA3;BRCA1;RPA2
prerank,negative regulation of DNA recombination (GO:0045910),0.3355475891739001,0.9395629345697937,0.5434439178515008,0.9480752816678207,1.0,17/43,26.79%,POLR2A;ATRX;ACD;POLR2D;FBH1;MSH3;SMCHD1;TINF2;POLR2G;POLR2F;PARP3;MAD2L2;H1-0;SHLD2;UBQLN4;RTEL1;POLR2K
prerank,response to glucagon (GO:0033762),0.39684461451758535,0.9394166746686888,0.5308641975308642,0.9476385156095228,1.0,7/19,17.88%,ADCY5;ADCY1;ADCY9;PRKAR1A;ADCY6;PRKACB;CRY1
prerank,pharyngeal system development (GO:0060037),0.41731334080643967,0.9393491219241443,0.5362595419847328,0.9470556240986725,1.0,3/15,3.46%,BMP7;BMPR1A;TGFBR1
prerank,monoacylglycerol metabolic process (GO:0046462),-0.39449176286582444,-0.9387227631471278,0.5680345572354212,0.814040737444029,1.0,2/13,4.65%,PLA2G4A;MGLL
prerank,carbohydrate transport (GO:0008643),-0.4080112574989204,-0.9387213551214783,0.5507246376811594,0.8133050047090193,1.0,5/11,30.19%,AQP11;SLC50A1;SLC23A1;SLC23A2;AQP1
prerank,hemidesmosome assembly (GO:0031581),0.43516857471260817,0.9386381007158158,0.5503875968992248,0.9480712100876051,1.0,2/11,2.04%,LAMC2;LAMC1
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.37760509480773363,-0.9385955869836505,0.555793991416309,0.8128637416844617,1.0,3/17,10.91%,PDE3B;SORL1;MFSD2A
prerank,striated muscle cell development (GO:0055002),0.4253302213505642,0.9384621021298867,0.5345454545454545,0.94771694524254,1.0,3/14,5.54%,TMOD2;TMOD3;KLHL41
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.3699461712624049,-0.9384438974474962,0.5444444444444444,0.812524398662999,1.0,7/17,31.51%,NUS1;ALG6;ALG8;ALG9;ALG13;ALG3;DPAGT1
prerank,negative regulation of T cell differentiation (GO:0045581),0.4481750541696955,0.9382102013678156,0.5421686746987951,0.9475663028593658,1.0,4/10,21.03%,GLI3;IRF1;IHH;CTLA4
prerank,protein N-linked glycosylation (GO:0006487),0.3134388668322143,0.9378922687148747,0.5583832335329342,0.9475622612226835,1.0,7/66,6.30%,MAN1C1;ST6GAL1;MGAT3;ASGR1;PGM3;B4GALT1;FUT8
prerank,regulation of cell population proliferation (GO:0042127),0.25214045290823706,0.9375839662084255,0.6878914405010439,0.9475481672241514,1.0,103/691,12.87%,FGF1;ALDH1A2;BMP6;EFNB2;KSR1;KIT;LAMC2;GSDME;IGF1;FGFBP1;IL13RA1;PTPN14;FGFR2;PKHD1;KANK2;GRK5;COL18A1;NUPR1;COL4A3;NPR3;PHIP;FGFR1;BMPR1A;ARID2;MAGI2;TGFBR1;IGFBP7;SPEG;ADRA2A;PDPN;IFIT3;NACC2;CDCA7L;DPP4;TNFSF13;SMAD6;TNS2;CTSH;PIAS1;MEIS1;CLMN;IFNK;KLHL41;NOX1;SOD2;FLT1;STAT2;HMGA1;PDGFRB;TP53;EIF2AK2;CACUL1;GAB2;WWTR1;SSTR3;DLG3;PTPRU;TGFBR2;PTEN;IGFBP3;GDNF;NRG1;HRG;NUPR2;NIBAN2;SULT2B1;HDAC4;GLI1;SIRT1;HDAC1;GTPBP4;ASH2L;CCAR1;HTR1A;TCF7L2;HBEGF;FLT3LG;FER;SLURP1;CRKL;TBRG4;NOX4;SRPK2;RNF41;RARG;MNT;PRKDC;TFAP2D;ADAM17;OSGIN1;GLMN;NOP2;AXIN2;VEGFD;ITGAV;CSNK2A1;NMI;BRD7;MLXIPL;TGFA;IRF1;FRK;KMT2D
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.3433955620027422,-0.9375407978627903,0.5634146341463414,0.8139365633721242,1.0,7/24,9.38%,RYR2;HTR2C;RYR3;PTPRC;PLCG2;HTR2A;FGF2
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.3265494428678915,-0.9373830799606229,0.5397196261682243,0.8135749627883666,1.0,10/28,14.58%,DAB2IP;CTSC;PTK2;DDRGK1;PSMC6;AXIN1;ECSCR;LAPTM5;SMURF1;CLU
prerank,protein localization to chromosome (GO:0034502),0.3517768184978403,0.9371492311508312,0.5316239316239316,0.9478564939490169,1.0,8/34,11.77%,ATRX;ACD;TPP1;TNKS2;LEMD2;XRCC4;IFFO1;WAPL
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3308248472253868,-0.9366647160087657,0.5738498789346247,0.8146173436975109,1.0,7/26,9.38%,RYR2;HTR2C;RYR3;PTPRC;PLCG2;HTR2A;FGF2
prerank,embryonic organ morphogenesis (GO:0048562),0.34226948490557313,0.9366141924921865,0.5409309791332263,0.9483589993644197,1.0,12/42,13.00%,FGFR2;HOXB4;HOXB3;HOXB9;HOXA3;FBN1;NIPBL;RBP4;HOXC4;DYNC2I1;RARG;RBPMS2
prerank,protein phosphorylation (GO:0006468),0.25630656212968633,0.9365469575560367,0.6541436464088398,0.9477615184931616,1.0,78/478,13.88%,PRKAG2;TGFBR3;WNK4;ROCK2;OXSR1;PRKCZ;KIT;FAM20A;PRKAA2;FGFR2;EPHA4;GRK5;CCNA2;PRKAG3;STK32B;FGFR1;BMPR1A;TGFBR1;DMPK;AAK1;LRRK2;TP53RK;TLR3;SMG1;PRKCB;IKBKE;TLR4;ATM;PRRT1;CAMK1;BRAF;EPHA8;FLT1;NUAK2;TRIB2;PDGFRB;BAZ1B;CDC42BPG;SIK1;EIF2AK2;RICTOR;TGFBR2;IGFBP3;MAPKAPK3;RYK;COQ8B;PDPK1;CSNK1A1;RIOK2;PICK1;RIPK1;MKNK1;FER;BRSK1;AURKB;SRPK2;ABL1;DYRK1A;MYLK3;TRIB1;PRKDC;MAPK6;CSNK2A2;CSNK2A1;PRKCA;HIPK3;MAPK10;MAP3K1;FRK;PRKCI;EPHA3;WNK1;BMP2K;MAP2K1;ROS1;COQ8A;CAD;GRK3
prerank,protein localization to lysosome (GO:0061462),-0.3203343030459216,-0.9365417622438507,0.5699481865284974,0.8141673797940617,1.0,12/28,25.72%,RTN4;SORL1;SH3BP4;GCC2;LAPTM5;NCOA4;M6PR;SCARB2;RNF128;CD81;LMBRD1;NAGPA
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.3890898224978391,0.9364049111024394,0.5415224913494809,0.9473670704264414,1.0,3/25,5.39%,KIT;LACC1;FZD5
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.39584869188335275,0.9361908568602387,0.5381944444444444,0.9471589832689514,1.0,7/21,20.93%,OSBPL8;PLA1A;OSBPL10;PLA2G5;MBOAT2;LPCAT4;PLAAT3
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.36118476473720534,-0.9361305920982271,0.5633802816901409,0.8144523424845446,1.0,10/19,32.88%,CYBA;GPX1;CAT;PRDX1;SOD1;GPX3;PARK7;PRDX2;PRDX4;PRDX3
prerank,organelle assembly (GO:0070925),0.2580556741700577,0.9358059805666267,0.6299659477866061,0.9473431806045165,1.0,95/384,19.23%,CFAP44;AVIL;CC2D2A;PKHD1;DCDC2;CEP250;TMOD2;CPLANE2;RILPL1;RAB3IP;TMOD3;CYS1;DDX3X;KLHL41;RHO;PTPN23;ASAP1;ATG5;EXOC2;CCDC28B;SH3PXD2B;SSTR3;CEP162;WIPI1;CDC14A;AMBRA1;ATXN2;IFT122;WDR19;DYNC2I1;CHMP1A;RAB43;LSM14A;MKKS;YTHDF3;BECN1;ATG7;IRGM;TMEM231;HPS1;CLUAP1;CDC14B;ATP6V1D;IFT88;OCRL;GALNT11;MAPRE2;PDE6D;DDX6;UNC119B;ATG2A;NCOR1;WDPCP;CFAP410;WDR35;UBAP2L;EXOC4;E2F4;EXOC3;PARVA;LMOD3;CEP63;B9D2;VPS37A;ARL6;SNF8;RP2;BBS2;STK36;GOLGA8B;VPS4A;RFX2;RAB8B;CENPC;LMOD1;RILPL2;CHMP4C;ATXN2L;PIBF1;TMEM237;OGFOD1;ZFYVE1;TRAPPC14;TMEM41B;ATP6V0D1;CCDC61;GORASP2;TMEM17;TCTN3;PCM1;CENPT;CEP164;GOLGA2;OFD1;PCNT
prerank,estrogen metabolic process (GO:0008210),-0.37369003279830565,-0.9356866722885278,0.5600858369098712,0.8148003657742398,1.0,3/15,27.66%,CYP1B1;HSD17B2;HSD17B7
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.3732142539091259,-0.935451548659321,0.5416666666666666,0.8145865518292157,1.0,2/15,7.53%,NLGN1;CNTNAP4
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.35560218621250106,0.9349830569427099,0.5281803542673108,0.9485704245926511,1.0,4/36,5.93%,AFDN;VAMP5;RILPL1;RAB34
prerank,plasma membrane invagination (GO:0099024),-0.31785177841900136,-0.934949951248581,0.5433673469387755,0.8150493820297496,1.0,5/29,10.69%,GSN;MYH9;DOCK1;ARHGAP25;ELMO1
prerank,telomere maintenance (GO:0000723),0.32710126988246113,0.9349487550412162,0.566412213740458,0.9478836742515185,1.0,16/50,19.85%,POLD2;TPRKB;ATM;ACD;TEP1;TERT;PRKDC;HUS1;RAD50;NSMCE2;ZBTB48;SP100;TINF2;NBN;RAD51D;XRCC3
prerank,actin filament polymerization (GO:0030041),0.37300761482857836,0.9348248009032685,0.5402298850574713,0.9474207979908758,1.0,7/29,12.56%,GAS7;ARHGAP6;DIAPH1;WASL;CATIP;VIL1;TTC17
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.3976402538144295,-0.9346286243309145,0.5632411067193676,0.8143511132462677,1.0,5/12,15.66%,AKAP6;CAMTA1;LMCD1;SPPL3;STIMATE
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.3976402538144295,-0.9346286243309145,0.5632411067193676,0.8143511132462677,1.0,5/12,15.66%,AKAP6;CAMTA1;LMCD1;SPPL3;STIMATE
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.3240188212825758,-0.9345600719176899,0.5631067961165048,0.813780461891067,1.0,12/27,29.14%,MAP3K5;MAP3K7;IKBKB;CCDC88C;UBB;SKP1;MAP2K7;UBC;RPS27A;MAPK8;MAP3K8;MAPK3
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.3746807031563332,0.9345466135622864,0.5043327556325823,0.9473140517599471,1.0,6/23,11.30%,EFNB2;IGF1;NRG1;NIBAN2;MYLK3;MMP14
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.4336262780485747,0.9345459588171768,0.5377358490566038,0.9465639867072227,1.0,1/11,1.93%,LRRC38
prerank,female gamete generation (GO:0007292),0.363924930748381,0.9341947174702708,0.5537190082644629,0.9466389543497258,1.0,4/29,7.13%,SPO11;DIAPH2;USP9X;TOB2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.24767445177716635,-0.9341852223726813,0.6466165413533834,0.8138903362630039,1.0,33/113,20.22%,ESR1;TFRC;RASIP1;UNC13B;GSK3B;DAB2IP;RAP1B;RPS3;SH3GLB1;PIEZO1;TGFB1;FNIP2;GNL3L;PSMC6;HSP90AA1;TIRAP;ERCC1;SNCA;VEGFA;TAL1;CDC42EP2;TERF1;CLU;USP50;RPA1;SKAP1;TPPP;SYK;GTF2H1;BCL2L11;GTF2H4;GTF2H5;ERCC2
prerank,relaxation of muscle (GO:0090075),0.43067211272821976,0.9340134536731136,0.5485714285714286,0.9463378192752152,1.0,1/13,0.08%,ATP1A2
prerank,regulation of ATP biosynthetic process (GO:2001169),0.40221875238708804,0.9340002463914907,0.5492700729927007,0.9456140403616486,1.0,5/16,14.77%,PPARGC1A;PPARA;AK4;FLCN;SPHK2
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.4120916581979043,-0.9337866108381121,0.5651302605210421,0.8141254221801255,1.0,2/11,4.47%,MAP3K5;CYP1B1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3589422286875563,0.9336377249088993,0.5510204081632653,0.9457721538903013,1.0,8/31,17.50%,DLG1;KANK2;PTEN;RBL2;RBL1;BRD7;RB1;GPNMB
prerank,sphingoid biosynthetic process (GO:0046520),-0.4028212230791224,-0.9330993475871387,0.5313807531380753,0.8142884356146878,1.0,4/11,11.77%,ACER3;ACER2;SPTLC2;ASAH2
prerank,sphingosine biosynthetic process (GO:0046512),-0.4028212230791224,-0.9330993475871387,0.5313807531380753,0.8142884356146878,1.0,4/11,11.77%,ACER3;ACER2;SPTLC2;ASAH2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.3933391125756497,-0.9330976128708645,0.5297619047619048,0.8135680365859046,1.0,5/13,17.44%,ELOVL7;ELOVL5;ELOVL6;TECRL;TECR
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.37133290879552794,0.932790939491681,0.5579831932773109,0.9470568063937486,1.0,2/25,5.16%,SMAD3;TLR4
prerank,regulation of protein kinase activity (GO:0045859),0.2922748642257143,0.9326853772441679,0.5764546684709067,0.9465532527587603,1.0,14/106,11.28%,PRKAG2;ALS2;PPM1E;DEPTOR;DTNBP1;UVRAG;TRIB2;CACUL1;WWTR1;PDPK1;TAB2;SIRT1;JTB;TRIB1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.319186061088141,0.9319615543387628,0.5753424657534246,0.9475324508997259,1.0,7/64,8.41%,ACSL1;ALOX12;CPT1A;ACSBG2;EPHX1;DAGLA;CPT2
prerank,renal water homeostasis (GO:0003091),0.37951615115183124,0.9319492784222467,0.5596491228070175,0.9468090687361387,1.0,3/23,7.00%,ADCY5;ADCY1;ADCY9
prerank,microtubule polymerization (GO:0046785),-0.3209908329949738,-0.9319109378370163,0.5741176470588235,0.8156328352068744,1.0,12/28,25.62%,CLASP2;TUBGCP2;FGF13;TRPV4;MAPT;MAP7D3;TPPP;TPX2;TUBG2;NDEL1;NDE1;TPPP3
prerank,phospholipid dephosphorylation (GO:0046839),-0.30468845758186847,-0.9318329532068792,0.5813333333333334,0.8150936957277022,1.0,9/37,11.53%,PLPP1;PLPPR1;MTMR6;MTMR2;PLPPR5;MTMR11;PLPPR4;MTMR7;MTMR9
prerank,regulation of myeloid cell differentiation (GO:0045637),0.319350814792435,0.931363548623719,0.5848765432098766,0.9474522125514236,1.0,19/62,16.31%,KMT2A;TNRC6A;CTR9;PRKCB;MEIS1;TNRC6B;RBM15;HDAC1;ASH2L;MOV10;KMT2C;KMT2D;SIN3A;KAT2B;TNRC6C;PURB;LGALS3;HOXB8;CREBBP
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.33968298583471,0.9312222414075776,0.5469255663430421,0.9470389653482814,1.0,6/43,11.76%,SYT11;IGF1;TLR4;PTPN22;CD274;DICER1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.32851489297420267,-0.9311002759322754,0.57,0.8160889656412792,1.0,11/27,20.04%,PID1;GRB14;PIP4K2A;ENPP1;PTPRE;NCK1;KANK1;PTPN1;PRKCQ;PIP4K2B;IRS1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.3860884802606672,0.9302004239314123,0.5451327433628319,0.9486761461288669,1.0,2/19,1.44%,PICALM;IGF1
prerank,relaxation of cardiac muscle (GO:0055119),0.42695191037177505,0.9301769203398653,0.5393258426966292,0.9479898521157223,1.0,1/13,0.08%,ATP1A2
prerank,neuron apoptotic process (GO:0051402),-0.35345660598490364,-0.9301438832397463,0.566079295154185,0.8176259634252835,1.0,10/19,26.11%,CIT;SCN2A;APP;TNFRSF21;FAS;TRPC5;DIABLO;BNIP3;ERBB3;GAPDH
prerank,regulation of cell division (GO:0051302),0.3095740043501921,0.9301258848446514,0.557632398753894,0.9473585376816598,1.0,8/72,10.54%,FGF1;FGFR2;NCOA3;UVRAG;PLK5;MYO19;BECN1;AURKB
prerank,cytosolic transport (GO:0016482),0.29173650759402187,0.9300202374422091,0.5770804911323328,0.9468556475727659,1.0,35/108,20.47%,HOOK2;SNX6;SNX32;DENND2A;PTPN23;VPS54;DENND5A;PIKFYVE;BECN1;VPS50;CLTC;RGP1;ANKRD27;VTI1A;STX5;AP2A1;RAB29;VPS13A;SNF8;VPS51;CCDC91;HOOK3;EEA1;HEATR5B;WDR91;RAB9A;PHETA1;VPS35;MON2;EVI5;AP4M1;TMEM87B;STX16;WDR81;ANKFY1
prerank,cellular response to amino acid stimulus (GO:0071230),0.3592717408788261,0.9297100371414169,0.554806070826307,0.9468196619986372,1.0,10/33,19.11%,CPEB4;SESN1;SESN2;UBR2;CPEB3;RPTOR;UBR1;NSMF;RRAGD;LAMTOR1
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.3871144072414374,-0.9295703030394497,0.5405405405405406,0.8182464774436469,1.0,2/13,9.29%,PRR5L;PNPT1
prerank,apoptotic nuclear changes (GO:0030262),0.3739580766889788,0.9294330944752315,0.5511669658886894,0.9467155752985374,1.0,8/24,20.69%,CASP3;CDK5RAP3;BLCAP;DICER1;DFFB;DFFA;ACIN1;CECR2
prerank,zymogen activation (GO:0031638),0.3442233745803188,0.9294144045250097,0.5726072607260726,0.9460153625342215,1.0,7/39,15.66%,KLK2;F11;CTSH;RIPK2;MMP14;ASPH;PLAT
prerank,negative regulation of protein kinase activity (GO:0006469),0.3007946134614153,0.9291927850986902,0.577247191011236,0.9457638726539681,1.0,14/88,11.28%,PRKAG2;SLC8A3;PPM1E;DEPTOR;DTNBP1;TRIB2;WWTR1;CDK5RAP3;SH3BP5;PDPK1;MVP;ABL1;DUSP10;TRIB1
prerank,positive regulation of mitochondrial fission (GO:0090141),0.4015774583485492,0.9290590356855642,0.5577981651376147,0.9453193637066705,1.0,4/18,11.94%,PRKN;MCU;DNM1L;RALBP1
prerank,heterochromatin organization (GO:0070828),-0.38056361284128826,-0.9290029245171737,0.5683297180043384,0.8188163160973289,1.0,2/14,5.64%,MECOM;PRDM16
prerank,peptidyl-serine phosphorylation (GO:0018105),0.27780603384370417,0.928999331123815,0.5856209150326798,0.9447185269046298,1.0,41/153,19.07%,ROCK2;PRKCZ;STK32B;TGFBR1;DMPK;LRRK2;SMG1;PRKCB;IKBKE;ATM;CAMK1;RICTOR;TGFBR2;MAPKAPK3;PDPK1;CSNK1A1;PIKFYVE;RIPK1;MKNK1;BRSK1;SRPK2;DYRK1A;PRKDC;CSNK2A2;CSNK2A1;PRKCA;HIPK3;PRKCI;WNK1;MAP2K2;STK4;MAPK9;TLK2;CLSPN;PKN2;PAK2;TAF1;MAPK14;SGK3;SGK2;CAMK1D
prerank,phosphatidic acid metabolic process (GO:0046473),-0.28479917556657325,-0.9287155166401256,0.5972222222222222,0.8187739367366583,1.0,8/48,14.40%,DGKH;DGKB;PLA2G4A;PLA2G12A;DGKG;DGKZ;PNPLA3;ABHD4
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.395177537120224,-0.9285836439073539,0.5638297872340425,0.8183740080964145,1.0,8/12,22.93%,SIX1;VEGFA;PAX2;SOX8;PAX8;SIX4;AGT;LHX1
prerank,presynaptic endocytosis (GO:0140238),-0.3275991389762839,-0.9284752018942287,0.575682382133995,0.8179141462543091,1.0,4/24,7.30%,NLGN1;SYT1;STON2;AMPH
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.33801249335593253,-0.9281931557141083,0.5616740088105727,0.8178922493988009,1.0,8/22,17.51%,MDFIC;APOD;UFM1;CABP1;DMTN;SIAH3;GDI1;BARD1
prerank,regulation of mast cell degranulation (GO:0043304),0.42271599915174535,0.9278667826890984,0.5459770114942529,0.9466848938958271,1.0,5/14,14.77%,CD300A;STXBP2;GAB2;FER;SPHK2
prerank,B cell homeostasis (GO:0001782),0.43935640486581884,0.927460818502865,0.5506692160611855,0.9468934538520823,1.0,1/10,0.43%,DOCK11
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.2593494615031018,-0.9272363883001529,0.6178343949044586,0.8186524836739353,1.0,30/78,25.09%,SH3GL2;CTSD;DYNC1I1;DYNLL1;AP1S2;DYNC1LI2;AP2B1;KIF26A;DCTN4;CTSL;AP2M1;CAPZA2;CTSS;KIF3A;AP1S3;CAPZA1;CENPE;KIF15;CD74;SPTBN2;KIF11;AP1S1;KIF5A;KIF22;KIF4A;KIF3B;SAR1B;DCTN6;ACTR1A;KIF23
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.2593494615031018,-0.9272363883001529,0.6178343949044586,0.8186524836739353,1.0,30/78,25.09%,SH3GL2;CTSD;DYNC1I1;DYNLL1;AP1S2;DYNC1LI2;AP2B1;KIF26A;DCTN4;CTSL;AP2M1;CAPZA2;CTSS;KIF3A;AP1S3;CAPZA1;CENPE;KIF15;CD74;SPTBN2;KIF11;AP1S1;KIF5A;KIF22;KIF4A;KIF3B;SAR1B;DCTN6;ACTR1A;KIF23
prerank,endoplasmic reticulum organization (GO:0007029),-0.26921696645413645,-0.9270846573782395,0.6025236593059937,0.8182888186875825,1.0,24/72,23.55%,RTN4;REEP1;CAV2;DOP1B;SHTN1;APP;REEP5;LMAN2L;RAB18;SEC61B;ATL2;EIF2AK3;VCPIP1;LMAN2;CYB5A;EMD;SPTSSB;ATL3;VAPA;TLE6;RTN3;TRAM1;REEP3;SEC16B
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.3167674843674671,-0.9269374010955008,0.5841121495327103,0.8179174340377715,1.0,10/29,20.20%,HSP90AB1;PPIA;HSP90AA1;TNKS1BP1;TERF2IP;TERF1;RPA1;ANKRD28;NHP2;PTGES3
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.35468002647857266,-0.9268295511475336,0.541019955654102,0.8174474059667518,1.0,6/20,13.87%,ENTPD1;HSP90AB1;APP;TXNIP;NT5E;TXN
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.38765320417692645,0.9267839220694523,0.5459558823529411,0.9477599468962769,1.0,4/22,13.22%,BMP7;MAP2K5;FLOT2;WNK1
prerank,protein destabilization (GO:0031648),0.35335128060058696,0.9266654276140489,0.5698412698412698,0.9473013163590208,1.0,7/32,10.49%,PRKN;CTSH;FBXW11;BTRC;HTT;SIRT1;IRGM
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.3267927242344388,-0.9262831563264117,0.5619047619047619,0.8179702926301435,1.0,10/26,25.00%,NOD1;ALPK1;MAP3K7;UBB;NOD2;TIFA;AAMP;UBC;RPS27A;TAB1
prerank,blood circulation (GO:0008015),0.32948426352752846,0.9262691892096429,0.5540540540540541,0.9475246967410762,1.0,6/49,4.75%,ROCK2;ACE;NPR1;MYOF;COL4A3;BDKRB2
prerank,negative regulation of cellular senescence (GO:2000773),0.41859971874657653,0.9262204123421107,0.5304182509505704,0.9469076714205804,1.0,5/13,14.54%,SLC30A10;TERT;SIRT1;RBL1;ZKSCAN3
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.2609172875108051,-0.9261697078773509,0.6215384615384615,0.817508453786857,1.0,32/82,26.46%,YWHAE;DYNLL1;PPP2R1A;YWHAG;TUBA1A;HAUS2;TUBB4A;CDK5RAP2;HSP90AA1;KCNH5;PRKAR2B;ATAD5;ATF5;HAUS5;CEP78;CETN2;TUBA4A;SSNA1;CEP131;NPM1;NEK10;CCP110;HMMR;TPX2;KIF14;NEDD1;HAUS4;CEP135;ACTR1A;NDE1;HAUS6;CEP76
prerank,response to hydrogen peroxide (GO:0042542),-0.28919972950395273,-0.9261391195345766,0.6267029972752044,0.8168613866883326,1.0,12/45,16.43%,MAP3K5;CYP1B1;NET1;ANXA1;RPS3;PLEKHA1;RHOB;GLRX2;TRPM2;PAX2;GPX1;CAT
prerank,establishment of melanosome localization (GO:0032401),0.40246726211161854,0.9261357552311801,0.5586080586080586,0.9463726964763524,1.0,6/19,15.83%,SHROOM2;BLOC1S6;RAB11B;MKKS;ARL6;BBS2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.3487151755762984,0.9260704452245365,0.5289256198347108,0.9458115482009511,1.0,9/36,14.80%,PRKN;PARP14;PARP9;RIPK1;MAVS;IRGM;ADAM17;AXL;AGPAT1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.3292735049148569,-0.9258450406921114,0.5839243498817966,0.816847057510647,1.0,13/23,26.88%,MYO10;CCDC88A;DYNC1I1;KIF5C;MAP6;TUBA1A;CCDC88C;CCDC186;KIF5A;TUBA1B;TUBA1C;F8A1;KIF1A
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.3487704035663648,0.9255361128974198,0.5769230769230769,0.9463367467474786,1.0,3/38,5.16%,SMAD3;ROCK2;TLR4
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.4406902521016492,0.9247442317116341,0.5454545454545454,0.9474746004756296,1.0,1/11,1.98%,PRKN
prerank,response to chemokine (GO:1990868),-0.38507152150045587,-0.924123877645582,0.563169164882227,0.8202217712250898,1.0,5/13,10.81%,LRCH1;CXCL12;SLC12A2;DOCK8;DUSP1
prerank,"wound healing, spreading of cells (GO:0044319)",0.3764903377186422,0.9240292421602226,0.5502645502645502,0.9484265599335735,1.0,2/24,3.73%,COL5A1;PDPN
prerank,mRNA 3'-end processing (GO:0031124),0.30368540424251644,0.9239286776387107,0.5740223463687151,0.9479328697691954,1.0,23/78,22.14%,PABPN1;SRSF5;AHCYL1;POLDIP3;RPRD2;POLR2D;TENT2;SCAF8;SRSF11;SARNP;TENT4B;CPSF3;PAPOLG;GRSF1;SRSF1;CSTF1;CDC40;PCF11;U2AF1;SRSF7;U2AF2;TUT1;CPSF7
prerank,negative regulation of protein catabolic process (GO:0042177),-0.28965554376908204,-0.9239092581784031,0.5932642487046632,0.8199977476907305,1.0,10/40,13.86%,FMN2;CST3;NELL1;DAB2IP;FLNA;TIMP2;IRAK3;PTPN3;SNCA;ADGRB1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.3906081294116331,0.9238484869100188,0.5956284153005464,0.9474078126617191,1.0,3/21,7.06%,PRKN;LRRK2;OPA1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.40022031607276604,-0.9236489696430918,0.5486111111111112,0.8199069306579085,1.0,5/12,22.63%,RPL26;CD44;TAF9B;CD74;TRIAP1
prerank,organelle transport along microtubule (GO:0072384),0.35452423067685185,0.923449994310413,0.5539823008849557,0.9475899730296556,1.0,9/31,18.50%,TRAK1;FBXW11;HTT;CDC42;KIF5B;ARHGAP21;PEX14;TRAK2;RHOT1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.4248222632749884,0.9229596088299705,0.5633270321361059,0.9479912176926222,1.0,4/14,9.79%,KIT;GPRC5B;SIRT1;MAVS
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.3801540215976481,0.9229049625905174,0.5693430656934306,0.9473853239786122,1.0,3/23,5.53%,ACSL1;ACSBG2;HACD1
prerank,protein localization to cell junction (GO:1902414),0.3876620106184031,0.922733307438319,0.5472027972027972,0.9470344105353172,1.0,3/22,2.47%,CGNL1;ARHGEF18;NLGN2
prerank,regulation of JNK cascade (GO:0046328),0.29039559355347155,0.9224243078646044,0.5940054495912807,0.9470160487201998,1.0,5/101,1.98%,TGFBR3;SH3RF2;TPD52L1;CCN2;PRKN
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.29475836620258716,-0.9223971011050665,0.6025641025641025,0.821993830762404,1.0,20/39,31.81%,POLD3;ERCC1;UBB;RPA1;GTF2H1;GTF2H4;GTF2H5;RFC4;ERCC2;POLD4;POLD1;RFC2;POLK;UBC;RPS27A;RFC5;DDB1;RPA3;ERCC3;RPA2
prerank,chromatin assembly (GO:0031497),0.3389824043280061,0.9222614498016797,0.5488215488215489,0.9466853034441516,1.0,14/38,25.22%,CHAF1B;ATRX;TP53;KAT6B;SIRT1;BAHD1;CDAN1;PADI4;EZH1;ASF1A;NOC2L;NAP1L2;H1-0;M1AP
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.30534499726226116,0.9222112964229945,0.5930735930735931,0.9460637102967835,1.0,19/80,15.31%,ROCK2;PICALM;EPHA4;CASP3;LARP4B;DDX3X;CD28;POLDIP3;SAMD4A;CPEB3;SIRT3;PLA2G6;YTHDF3;PRKDC;PLD1;SPHK2;ZCCHC4;NSMAF;SMPD3
prerank,positive regulation of vascular permeability (GO:0043117),0.4358741093845661,0.9220959070952655,0.550098231827112,0.9456153809832124,1.0,1/12,0.40%,BMP6
prerank,myeloid leukocyte differentiation (GO:0002573),-0.271294448980794,-0.9219635800836338,0.5970149253731343,0.8222605124233228,1.0,14/65,15.37%,LEF1;RUNX1;MYH9;TNFRSF11A;FOXP1;CAMK4;CBFA2T3;MT1G;BMP4;SBNO2;CDKN1A;THOC5;VEGFA;IL31RA
prerank,folic acid-containing compound metabolic process (GO:0006760),0.39439713422408273,0.9217273302769181,0.5435606060606061,0.9457866682147392,1.0,6/19,19.24%,SLC19A1;MTHFR;ALDH1L1;MTRR;MTHFD1;FOLR2
prerank,phosphatidylinositol metabolic process (GO:0046488),0.2891735415901496,0.9217206109216036,0.5900537634408602,0.9450745127198936,1.0,18/109,11.18%,PTPN13;LPGAT1;INPPL1;PI4KA;MTMR3;SYNJ2;PLEKHA2;PIGW;PDGFRB;SLC27A1;PIP4K2C;PTEN;PIK3CA;PLCD1;PIKFYVE;PLEKHA8;PIK3R3;OCRL
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.4385440717023282,0.9216022693808658,0.556390977443609,0.9439000450074594,1.0,3/11,11.18%,SYNJ2;PTEN;OCRL
prerank,inositol phosphate dephosphorylation (GO:0046855),0.4385440717023282,0.9216022693808658,0.556390977443609,0.9439000450074594,1.0,3/11,11.18%,SYNJ2;PTEN;OCRL
prerank,melanosome localization (GO:0032400),0.3856521279428221,0.9213747718108207,0.5526315789473685,0.943727362751013,1.0,6/21,15.83%,SHROOM2;BLOC1S6;RAB11B;MKKS;ARL6;BBS2
prerank,regulation of Golgi organization (GO:1903358),0.3987087983538194,0.9210110587880492,0.5595026642984015,0.9438617404422629,1.0,5/17,14.02%,STX18;ARMH3;MAP2K1;STX5;MAP2K2
prerank,negative regulation of B cell proliferation (GO:0030889),0.43098154670237565,0.9207317941892965,0.5557768924302788,0.9437580515935846,1.0,2/11,5.45%,CD300A;ATM
prerank,microtubule bundle formation (GO:0001578),-0.2952162058489471,-0.9205077270517967,0.5822784810126582,0.8250224655845675,1.0,20/42,33.41%,NCKAP5;DCX;MTCL1;RP1;CDK5RAP2;SPEF1;CLIP1;TPPP;CAPN6;SPAST;LRGUK;TPPP3;MARK4;KIF20A;PSRC1;RSPH9;CFAP206;FOXJ1;CCDC66;TTLL3
prerank,regulation of cell cycle (GO:0051726),0.2617510103663119,0.9204744998124066,0.6635182998819362,0.9436264729926231,1.0,48/271,14.68%,NOTCH2;BMP7;SMAD3;FGFR2;GRK5;SON;FBXL17;NUPR1;MAGI2;TGFBR1;ATM;ANKRD17;IL12B;TP53;SIK1;AFAP1L2;CDC14A;CDK5RAP3;NUPR2;SND1;LIN52;CDC25A;SIRT1;CHMP1A;CCNB2;TCF7L2;HBP1;PHACTR4;TBRG4;FBXL12;SRPK2;ABL1;CDC14B;MYBL2;CSNK2A2;CSNK2A1;MLXIPL;IRF1;PPP1R13B;MAP2K1;PML;PRCC;MFN2;PER2;TSC1;KAT2B;GADD45A;MAP2K6
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.3215967524657533,-0.9201352829082958,0.5775,0.8251684002035341,1.0,7/27,12.84%,DACH1;BMPR2;ACVRL1;FGF2;PDGFA;CDKN1A;SMG5
prerank,folic acid metabolic process (GO:0046655),0.3943852576601041,0.920023722549908,0.5508317929759704,0.9440054898392696,1.0,6/18,19.24%,SLC19A1;MTHFR;ALDH1L1;MTRR;MTHFD1;FOLR2
prerank,regulation of RNA metabolic process (GO:0051252),0.3177107695736243,0.9199156561935659,0.5772727272727273,0.9435614361819119,1.0,20/59,18.37%,SON;OAS2;MITF;SNRNP70;PCBP2;MBNL2;IGF2BP1;HNRNPH1;CLK4;IGF2BP2;NOVA1;HNRNPL;OAS3;CLK1;CLK2;GRSF1;FASTK;MED1;FUS;HNRNPH3
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.3738372645230013,0.9197724612870509,0.5746527777777778,0.9431681400278321,1.0,5/26,8.76%,GBGT1;LARGE1;GK5;GK;GAL3ST4
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.36435822026780756,0.9197623554140476,0.5689948892674617,0.9424693237380468,1.0,2/26,5.16%,SMAD3;TLR4
prerank,negative regulation of ATP metabolic process (GO:1903579),0.39332951168082975,0.9194969558489944,0.5566218809980806,0.9423576160673074,1.0,6/17,14.24%,PPARA;NUPR1;HDAC4;MLXIPL;NCOR1;FLCN
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.372260130838945,0.9191165689729915,0.5828877005347594,0.942509852810344,1.0,3/24,5.87%,RORA;SULF2;NOX1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.36208105408553115,0.9181915539625002,0.5809859154929577,0.9438563759827902,1.0,3/26,5.87%,RORA;SULF2;NOX1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.3007094051811537,-0.9180660947634328,0.6,0.8291847897741398,1.0,8/37,14.22%,PRKG1;MEF2C;TGFB3;FGF2;GPER1;CDKN1A;FGF9;HTR1B
prerank,embryonic digit morphogenesis (GO:0042733),0.39116217827400623,0.9178480615913087,0.5373913043478261,0.9439390101466985,1.0,5/18,16.31%,OSR1;GLI3;HDAC1;WDPCP;CREBBP
prerank,negative regulation of nervous system development (GO:0051961),-0.35783692584745197,-0.9176926580671445,0.5991471215351812,0.8293002464731085,1.0,4/17,7.85%,ROBO2;B2M;NOTCH1;SORL1
prerank,filopodium assembly (GO:0046847),-0.3649305807723634,-0.9175971734109868,0.5842217484008528,0.8288049649989799,1.0,3/16,4.20%,DNM3;FGD5;SPATA13
prerank,regulation of viral life cycle (GO:1903900),-0.3336830537622186,-0.9164181966160181,0.581081081081081,0.8308256815839732,1.0,6/21,20.61%,HS3ST5;PPIA;TRIM14;TRIM27;TYRO3;TRIM68
prerank,sodium ion import across plasma membrane (GO:0098719),0.39434186693600304,0.9161762009469908,0.5951035781544256,0.9471934937478266,1.0,1/17,0.37%,SLC6A1
prerank,intraciliary retrograde transport (GO:0035721),0.42800996561705257,0.9161612941806718,0.5337078651685393,0.9465123852399561,1.0,4/12,14.33%,IFT122;WDR19;DYNC2I1;WDR35
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.26444677985979753,0.9160365058103794,0.655980271270037,0.9460965473590084,1.0,67/241,23.35%,SRRM2;DDX5;POLR2A;SNRNP70;PCBP2;PABPN1;HNRNPR;HNRNPH1;SRSF5;SNIP1;HNRNPA2B1;POLR2D;RBM15;SPEN;NOVA1;GPKOW;CCAR1;CWC27;GTF2F1;HNRNPL;CWC15;IK;USP49;PHF5A;SRSF11;PRCC;HNRNPC;PRPF3;SNRNP40;RBM4;TFIP11;HNRNPM;CPSF3;CWF19L1;FRG1;USP39;ZCRB1;PRPF6;FUS;SRSF1;CSTF1;HNRNPH3;CDC40;PCF11;SRSF10;U2AF1;EFTUD2;SNRPC;SRSF7;SF1;PNN;POLR2G;WBP4;PRPF31;SNRPA1;U2AF2;SF3B2;SF3B1;PPWD1;SF3B5;CPSF7;GCFC2;PQBP1;CDC5L;RNPC3;NUDT21;POLR2F
prerank,peptidyl-lysine methylation (GO:0018022),0.359221308846205,0.9160051341154769,0.5751748251748252,0.9454604611441095,1.0,8/26,22.70%,SMYD3;SETD7;KMT5A;EHMT2;EHMT1;SETD3;N6AMT1;EEF1AKMT1
prerank,regulation of protein kinase B signaling (GO:0051896),0.2686262945747958,0.9157510901140301,0.6641414141414141,0.9453018477175968,1.0,32/193,12.47%,FGF1;OSBPL8;KIT;PPARA;FGFR2;KL;IL18;PKHD1;FRS2;FGFR1;MAGI2;TGFBR1;DAG1;CD28;PDGFRB;GAB2;RICTOR;PTEN;PIK3CA;NRG1;PDPK1;SIRT1;TCF7L2;HBEGF;FLT3LG;CASS4;RNF41;KLB;GDF15;PHLPP2;PTPN11;TGFA
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.33765897469775363,-0.9155600536874484,0.5852534562211982,0.8320943160074087,1.0,9/22,13.77%,RASSF2;PDGFC;CALM1;CALM2;RAP2A;PDGFA;CALM3;TNKS1BP1;VEGFA
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.3575993996996953,0.9154383949905033,0.5654450261780105,0.9453114401687271,1.0,9/29,20.24%,TLR3;IKBKE;TLR4;RIPK1;LY96;BIRC3;CD14;TANK;TRAF3
prerank,establishment of epithelial cell polarity (GO:0090162),0.389461314371569,0.9150499362868195,0.5780141843971631,0.9455085583022858,1.0,6/19,13.42%,CLASP1;MYO18A;EZR;OPHN1;CDC42;PARD3
prerank,Fc receptor signaling pathway (GO:0038093),-0.2450707984506937,-0.9148022642843189,0.6585365853658537,0.8330763932324285,1.0,44/110,30.01%,PIK3R1;LYN;PSMB2;PAK1;CALM1;PLCG2;MAP3K7;PPP3R1;NFATC1;PPP3CA;PSMD14;TEC;PSMC6;IKBKB;PSMA4;PSMB9;VAV1;SKP1;SYK;PSMD11;BTK;PSMB10;PRKCQ;PSMD2;SHC1;SOS1;PSMA2;MAP2K7;RELA;PSMB3;TAB1;PLCG1;PSMB5;LCP2;CARD11;MAPK8;PSMA7;FOS;MAPK3;PSMF1;PSMD7;JUN;MAP2K4;MALT1
prerank,methylguanosine-cap decapping (GO:0110156),-0.41525479744553884,-0.9146398649794083,0.5807127882599581,0.8327723182882593,1.0,4/10,21.06%,DCP1B;PNRC2;LSM1;DCP2
prerank,response to growth factor (GO:0070848),0.33159108027284145,0.9145375740419955,0.5853658536585366,0.9459671514821099,1.0,7/41,7.34%,SPHK1;BMPR1A;TGFBR1;MAP2K5;PLK5;CPNE3;TGFBR2
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4107674031849901,0.9142976544496415,0.5698924731182796,0.945810820714743,1.0,1/14,1.09%,OSR1
prerank,regulation of cell killing (GO:0031341),-0.35869747100842153,-0.9140565580274758,0.5783410138248848,0.8333450201788618,1.0,3/16,10.68%,TGFB2;ICAM1;CYBA
prerank,cellular response to hexose stimulus (GO:0071331),0.37741422242943046,0.9140310118024327,0.5629370629370629,0.9457020512697051,1.0,2/23,2.21%,PRKAA2;ZBTB20
prerank,positive regulation of rRNA processing (GO:2000234),0.43725604821911496,0.9137799228670387,0.5527831094049904,0.9455556153062712,1.0,5/10,28.95%,RIOK2;WDR43;BUD23;RIOK1;WDR75
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.2344656666929546,-0.9133777090693038,0.7162790697674418,0.8342167722129795,1.0,28/136,14.71%,ESR1;TMSB4X;CD200;ID1;GAS6;PTGIS;CYP1B1;NFKBIA;SFRP4;DAB2IP;FLNA;HES1;PTCH1;CTNNBIP1;HEYL;PROX1;IRAK3;SMAD7;ERBIN;ID2;PKD1;HAVCR2;NLRC5;CMKLR1;AIM2;RBCK1;TRIM37;DAP
prerank,macromolecule catabolic process (GO:0009057),0.3651589694240186,0.9130377090672663,0.5580589254766031,0.9465543795633437,1.0,6/26,10.40%,NEDD4;UVRAG;TPP1;CLPX;CLN6;BECN1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.3241353595068291,0.9126343572141782,0.5792778649921507,0.9467932509339806,1.0,8/48,13.94%,ROBO1;PARP14;GPS2;STAT2;SAMHD1;YTHDF3;OAS3;USP18
prerank,regulation of primary metabolic process (GO:0080090),0.28314656241808234,0.9125798981270897,0.6244897959183674,0.9461999108451329,1.0,13/126,8.30%,ROCK2;NFYC;PPARA;CHD9;NCOR2;NFYB;GPS2;C1QTNF2;TBL1X;SMARCD3;ANGPTL8;NR1D2;TBL1XR1
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.3251608594509445,-0.9121970252329725,0.5809312638580931,0.8361786214648226,1.0,8/24,16.80%,NCKAP5;STMN2;FGF13;TRPV4;MAPT;STMN1;MAP7D3;TPPP
prerank,positive regulation of T cell differentiation (GO:0045582),0.34202516356829243,0.9118947774772658,0.5877616747181964,0.9470769761015897,1.0,7/36,11.70%,GLI2;GLI3;IL12B;SOX12;DUSP10;ZBTB1;ZMIZ1
prerank,calcium-mediated signaling (GO:0019722),0.2949790795126699,0.9118211867093148,0.6132596685082873,0.9465459227082718,1.0,11/93,5.51%,ANK2;NUDT4;CCR9;ACKR2;SPHK1;MCU;DMPK;LRRK2;CACNA1C;DEFB1;ADGRL1
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.2850069229382311,-0.9116234072102649,0.6173469387755102,0.836789694612572,1.0,16/40,32.88%,PID1;SLC25A33;MAPT;PINK1;UBB;RNF122;SOD1;STOML2;PRELID1;PYCR1;PMAIP1;PARK7;SPART;PIP5KL1;SLC4A11;PRDX3
prerank,negative regulation of histone modification (GO:0031057),0.42061172129003715,0.9115368701170886,0.5570342205323194,0.9464741089696315,1.0,4/14,15.44%,JARID2;AASS;SPHK2;TAF7
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.3930765942331496,0.9115138219185998,0.5555555555555556,0.9458205576167712,1.0,7/16,20.49%,PRPF39;SFSWAP;CWC15;PSIP1;SRSF1;SNRPC;WBP4
prerank,T cell differentiation in thymus (GO:0033077),0.4061093959244892,0.9112924526882842,0.541970802919708,0.9455874128796158,1.0,4/14,20.03%,GLI3;ADAM17;ZFP36L1;LIG4
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.3798954614931533,0.91129144764078,0.5753676470588235,0.9448777016620011,1.0,6/21,16.40%,TUT4;SAMD4A;CNOT10;PAN3;PNLDC1;TUT7
prerank,histone H4 deacetylation (GO:0070933),0.4496102223463039,0.9112340197328352,0.5747126436781609,0.9442968604729111,1.0,3/10,9.56%,HDAC8;HDAC4;HDAC1
prerank,negative regulation of synaptic transmission (GO:0050805),0.37281198382366154,0.9100441419518231,0.5665529010238908,0.9463865038683081,1.0,5/23,9.70%,SYT11;LRRK2;PRRT1;PTEN;PICK1
prerank,regulation of feeding behavior (GO:0060259),0.4270997348567879,0.9092810361227693,0.5739299610894941,0.9474326457257735,1.0,1/11,0.73%,LEPR
prerank,telomere maintenance via recombination (GO:0000722),0.43178028843954896,0.9092585284826961,0.5684410646387833,0.9467755501882561,1.0,6/11,19.85%,TPRKB;TEP1;RAD50;NSMCE2;RAD51D;XRCC3
prerank,protein autophosphorylation (GO:0046777),0.2728833718960088,0.9091724096977944,0.6572528883183568,0.9462670171875712,1.0,25/157,10.71%,OXSR1;KIT;FGFR2;EPHA4;GRK5;FGFR1;AAK1;LRRK2;SMG1;ATM;EPHA8;FLT1;PDGFRB;SIK1;EIF2AK2;MAPKAPK3;PDPK1;RIOK2;PIKFYVE;RIPK1;MKNK1;FER;AURKB;ABL1;DYRK1A
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.36354113920073167,-0.9089590500324446,0.5753715498938429,0.8421633789672837,1.0,5/15,10.35%,NGF;NTRK2;SORT1;DDIT4;BCAR1
prerank,embryonic axis specification (GO:0000578),0.4056245416915033,0.9089402030725889,0.5769230769230769,0.9460807981172938,1.0,3/15,5.39%,CXXC4;SMAD6;FZD5
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3331184278234376,0.9087350640041236,0.5937007874015748,0.9458258506042664,1.0,18/42,22.68%,CHD4;RNF8;SMARCA4;SRCAP;SMARCC2;SMARCE1;HDAC1;NASP;HNRNPC;MTA2;ARID1B;ACTR6;CHD8;CECR2;SMARCD2;MBD2;DMAP1;SMARCB1
prerank,positive regulation of transporter activity (GO:0032411),0.42267029845090726,0.9086460018543763,0.5810055865921788,0.9453134199491435,1.0,4/13,19.91%,KMT2A;RXRA;SGK2;NR1H3
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.26534448932492677,-0.908632242430868,0.6432584269662921,0.8421838696151469,1.0,22/56,25.09%,SPTBN1;ANK3;CIT;RHOB;ANLN;PDCD6IP;RASA1;TRIM36;STMN1;SEPTIN9;USP8;APC;NUSAP1;CHMP4B;EFHC2;SPAST;ECT2;CUL7;RHOC;KIF4A;CENPA;KIF23
prerank,establishment of spindle localization (GO:0051293),-0.360840890982737,-0.9084431834974853,0.59958071278826,0.8418964951694157,1.0,6/14,24.14%,CLASP2;MAP4;CFL1;NUSAP1;TLE6;KPNB1
prerank,cellular response to interleukin-12 (GO:0071349),-0.2832402639373669,-0.9079211152954314,0.6229508196721312,0.8422991416387868,1.0,16/48,25.99%,PPIA;RAP1B;RPLP0;JAK1;CD47;MSN;PITPNA;TALDO1;CFL1;CAPZA1;AIP;PDCD4;SOD1;MTAP;JAK2;STAT4
prerank,regulation of telomere capping (GO:1904353),0.37140784662970144,0.9078996482473279,0.6038394415357766,0.9463513719106131,1.0,6/23,12.69%,ATM;TNKS2;AURKB;RAD50;USP7;PNKP
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.4153266437411819,-0.907052628870567,0.6018099547511312,0.8434933724367351,1.0,5/10,21.60%,DISC1;CTNNB1;VEGFA;CX3CR1;DRD2
prerank,striated muscle cell differentiation (GO:0051146),-0.3594863689018325,-0.9067364611938297,0.5664488017429193,0.8435054064138202,1.0,4/16,8.22%,MEF2C;MYEF2;SORT1;BMP2
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.3095405078435741,0.9064822818499954,0.5968992248062015,0.9487676930859709,1.0,11/66,9.79%,SMAD3;SESN2;F2;WWTR1;CDK5RAP3;ZIC1;TERT;PARP9;LARP7;UBR5;MAVS
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.3857204574100143,-0.9062750364217608,0.6012396694214877,0.8438070006434276,1.0,4/13,12.20%,BMP5;APOE;BMP2;ERLIN1
prerank,respiratory chain complex IV assembly (GO:0008535),0.37959906611421534,0.9062165513366822,0.5942028985507246,0.9486727559290627,1.0,12/21,30.07%,COX16;COX10;SMIM20;COX19;FASTKD3;COX15;TIMM21;COA5;SCO1;COX14;PET100;SURF1
prerank,gonad development (GO:0008406),0.33371389897083903,0.9059201681770672,0.5924170616113744,0.948647426181752,1.0,3/41,3.08%,WNT4;KIT;NR2F2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.3688695699489966,0.9059043532228378,0.573170731707317,0.9479802303592054,1.0,3/24,7.06%,PRKN;LRRK2;OPA1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.3327231028263876,0.9057796708236214,0.5766192733017378,0.9475585839165435,1.0,14/39,18.64%,TTC7B;PI4KA;SMG1;TMEM150A;PIP4K2C;PIK3CA;ITPKB;PIK3R3;SOCS3;PI4K2B;SOCS4;SOCS7;IP6K3;PI4KB
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.3342908007103865,0.9054499641616626,0.5954323001631321,0.9475984477519861,1.0,4/41,7.35%,SYT11;IGF1;TLR4;PTPN22
prerank,DNA repair (GO:0006281),0.2568738959088641,0.9053236868304442,0.6745005875440658,0.9471712846318032,1.0,65/284,20.25%,EYA1;POLD2;BABAM2;KMT5C;USP3;ATM;ASCC2;UVRAG;RAD54L;BAZ1B;KMT5B;TP53;PARP4;RNF8;FANCI;HUWE1;FBH1;XRCC4;FANCM;PDS5A;PARP9;SIRT1;ABL1;EME2;RBBP8;PRKDC;MSH3;ZBTB1;HUS1;IGHMBP2;UIMC1;FANCA;RAD50;PNKP;TDG;POLE2;BABAM1;DDB2;GADD45A;DOT1L;MGMT;INTS3;TDP2;TEX264;POLL;ALKBH5;MBD4;OGG1;USP1;NBN;SUMO1;FEN1;RAD51D;PIAS4;SLX4;MMS19;PDS5B;APTX;MTA1;XPA;ASF1A;FANCD2;XRCC3;LIG4;RAD9A
prerank,inositol phosphate biosynthetic process (GO:0032958),0.427804419289959,0.9052212607740718,0.580896686159844,0.9467247776122629,1.0,3/11,17.98%,ITPKB;PPIP5K2;IP6K3
prerank,lipid droplet formation (GO:0140042),-0.40701937486914697,-0.9049775058778771,0.6,0.8460149634014937,1.0,4/10,26.56%,CDS1;SQLE;AUP1;CDS2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.25598178324048454,0.9043886724172356,0.6536180308422301,0.9478916467447961,1.0,58/259,17.06%,CFAP44;ACTN2;KIT;AVIL;CC2D2A;RHOD;PKHD1;DCDC2;SRGAP2;FGD4;CEP250;CPLANE2;RILPL1;EZR;RAB3IP;CYS1;RHO;PTPN23;ASAP1;EXOC2;CCDC28B;SSTR3;CEP162;ANO6;CDC14A;IFT122;WDR19;OPHN1;DYNC2I1;MKKS;TMEM231;CLUAP1;CDC14B;ATP6V1D;FGD1;IFT88;OCRL;MYLK;GALNT11;PDE6D;UNC119B;WDPCP;CFAP410;WDR35;EXOC4;EXOC3;PARVA;B9D2;ARFIP2;ARL6;RP2;BBS2;STK36;RFX2;RAB8B;RILPL2;PIBF1;TMEM237
prerank,phagosome-lysosome fusion (GO:0090385),0.43425226098905223,0.9043407934404092,0.5818540433925049,0.9472906700267191,1.0,5/10,21.80%,RAB34;PIKFYVE;RAB7B;PLA2G5;RAB7A
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.23766566610594564,-0.9040049160162207,0.7387755102040816,0.8475533487251168,1.0,28/124,15.89%,LEF1;PRICKLE2;DAAM1;GNG2;SFRP4;PSMB2;NLK;ROR2;TIAM1;CALM1;FZD4;MAP3K7;PPP3R1;NFATC1;PPP3CA;PSMD14;AP2B1;PSMC6;FRZB;VANGL2;AP2M1;CTNNB1;CCDC88C;SMURF1;GNAO1;GNB1;PSMA4;PSMB9
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2602499158460169,0.9039882660422738,0.6890756302521008,0.9473967917026862,1.0,29/234,11.27%,PPARGC1B;SMAD3;ZIC2;PRKCZ;KIT;PPARGC1A;ADCY1;IL18;SPHK1;CFLAR;EDA;NHLH2;PRKCB;IKBKE;SMO;TLR4;EIF2AK2;PTEN;SMARCA4;HDAC4;TAB2;TFDP1;RIPK2;RIPK1;MAVS;FER;RAB7B;ATF2;ANXA3
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.32400480234085793,-0.9036348254286151,0.6124401913875598,0.8476719911204181,1.0,10/24,19.64%,EPN2;DAB2IP;TMEM204;ITGB3;HIF1A;MT3;HHEX;ITGA5;PTPN1;VTN
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.2941649773161307,-0.9036069630129018,0.6124031007751938,0.8470094295887717,1.0,6/33,17.31%,LEF1;RUNX1;CTNNBIP1;ID2;FES;CD74
prerank,oligosaccharide biosynthetic process (GO:0009312),0.378543235239693,0.9035489425017411,0.575812274368231,0.947683446251646,1.0,5/20,6.51%,FUT1;ST3GAL3;B4GALT1;FUT8;ST6GALNAC6
prerank,tRNA 5'-end processing (GO:0099116),0.3999849099106906,0.9034571241204323,0.5693160813308688,0.9471998247700206,1.0,5/15,20.86%,RPP21;RPP25L;PRORP;POP7;POP1
prerank,response to organonitrogen compound (GO:0010243),-0.29146697243908115,-0.9033005080642549,0.6345177664974619,0.8469598317375273,1.0,11/38,21.60%,GLRB;GLRA3;IRAK3;GLRA1;GLRA2;TRPM2;RHBDD1;NR1H4;IRF5;RCN3;DRD2
prerank,regulation of keratinocyte migration (GO:0051547),-0.3810633762566494,-0.9032208085092676,0.6064908722109533,0.8464277515480629,1.0,4/12,16.20%,EPB41L4B;IQSEC1;FGF7;ARF6
prerank,histone H2A acetylation (GO:0043968),0.3928874594860957,0.9029832817058538,0.5869120654396728,0.9475728612174145,1.0,1/16,1.51%,BRD8
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.39093852404070484,0.9026398744581698,0.5831842576028623,0.9476230967736705,1.0,4/18,12.56%,PRKN;ADRA2A;MIDN;SIRT4
prerank,stem cell development (GO:0048864),-0.3571112027694593,-0.9024781654576884,0.5981941309255079,0.8473889221455276,1.0,4/16,18.48%,CDH2;PTPRC;KLHL12;SOX8
prerank,cellular response to insulin stimulus (GO:0032869),0.28176716300571353,0.902476341396057,0.6328767123287671,0.9472874104959726,1.0,19/124,11.33%,CPEB2;SORBS1;RHOQ;INSIG2;PHIP;ATP6V0E1;BAIAP2;ATP6V0B;SLC27A1;GCK;PDPK1;GRB10;FOXC2;FER;RAB13;PIK3R3;ATP6V1D;ATP6V1E1;PRKDC
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.36624531053977977,0.9020998645178927,0.5851063829787234,0.9475078838679689,1.0,2/24,2.15%,DNMT3A;JARID2
prerank,regulation of cell morphogenesis (GO:0022604),0.3575809552161046,0.902029652510963,0.5862676056338029,0.9469780123700151,1.0,11/30,18.47%,SH3D19;CAPZB;PHIP;PDPN;MOV10;VIL1;ZMYM6;WTIP;ZMYM4;MYO9A;LARP4
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.4229011678152055,0.9017862470783207,0.5885509838998211,0.9468325012210347,1.0,3/12,5.16%,SLC5A3;DUOXA1;TLR4
prerank,organic substance transport (GO:0071702),0.28466500021607516,0.9012671393589347,0.6391184573002755,0.9473300423321479,1.0,18/121,10.34%,SLC22A6;ABCA4;SLC35F3;PCTP;SLC22A18;ABCA9;SLC19A1;SLC22A5;TCN2;SLC48A1;HRG;SLC6A4;TOM1;PICK1;MFSD2B;CHMP1A;PLEKHA8;SLC19A2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.351501252027704,0.9008769611218367,0.5826086956521739,0.9475463030395609,1.0,6/29,14.31%,WWOX;BID;PPP2R1B;RIPK1;PML;AGTR2
prerank,cell proliferation in forebrain (GO:0021846),0.44585426064266875,0.9000199287744994,0.5836653386454184,0.948754393055691,1.0,7/10,30.64%,DOCK7;HOOK3;PCM1;CEP120;NUMBL;NUMB;AKNA
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.3978002007482625,0.8996002264223938,0.5915221579961464,0.9489834041464917,1.0,3/15,9.53%,PPARA;ADM;SLC45A3
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.3976462938341041,0.899374796562493,0.5630885122410546,0.9480946291595918,1.0,4/15,15.26%,TNRC6B;CPEB3;TNRC6C;ZFP36L1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.3976462938341041,0.899374796562493,0.5630885122410546,0.9480946291595918,1.0,4/15,15.26%,TNRC6B;CPEB3;TNRC6C;ZFP36L1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.37215080338296463,0.8990426998268679,0.5925266903914591,0.9481708335049115,1.0,6/22,16.18%,NEDD4;PTPN23;RNF115;VPS37A;SNF8;VPS4A
prerank,cardiac ventricle morphogenesis (GO:0003208),0.3292913190144703,0.8989044122397222,0.5993431855500821,0.9477952334585492,1.0,5/41,7.34%,TGFBR3;FGFR2;BMPR1A;TPM1;TGFBR2
prerank,regulation of programmed necrotic cell death (GO:0062098),0.37164544052282333,0.8988929387230157,0.5970961887477314,0.9471227893440394,1.0,6/20,16.01%,NUPR1;CFLAR;RIPK1;FLOT2;OGT;BIRC3
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.3983239421913195,-0.89877341244359,0.5909090909090909,0.8549940282140388,1.0,6/10,28.97%,CSGALNACT1;XYLT1;B3GAT2;B3GAT3;B3GAT1;CSGALNACT2
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.41061209645206054,-0.8986249246725838,0.6123260437375746,0.8546064420230637,1.0,2/10,13.39%,ASRGL1;QDPR
prerank,regulation of mitochondrial fusion (GO:0010635),-0.3953874243742127,-0.8984236550267359,0.6101694915254238,0.8543289791404075,1.0,2/11,4.48%,PID1;TFRC
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.35748630876976806,-0.898399177540761,0.5987525987525988,0.8536611176780892,1.0,3/16,10.91%,SCARB1;LDLR;MFSD2A
prerank,cellular response to alcohol (GO:0097306),0.3284563757556511,0.8980991239606855,0.6048,0.9482667003668127,1.0,4/42,4.94%,ADCY5;ADCY1;GRAMD1B;SMO
prerank,TOR signaling (GO:0031929),0.3542035402633076,0.8980332430955174,0.5931899641577061,0.9477114309036144,1.0,8/26,15.84%,FNIP1;NPRL3;SMG1;RICTOR;LARP1;MAPKAP1;FLCN;RPTOR
prerank,negative regulation of lyase activity (GO:0051350),-0.3525036828209326,-0.8979943951424998,0.6086956521739131,0.8538614554464186,1.0,8/16,32.38%,GRM3;GABBR2;EDNRB;PALM;DRD2;GNAI3;PHPT1;DRD3
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.3410386324692748,0.8979851503765217,0.5881326352530541,0.9471176864103489,1.0,9/31,22.07%,CD300A;ATM;CD274;GLMN;SDC4;GPNMB;CTLA4;DLG5;ARG1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.34702601869737887,0.897934048872582,0.5933333333333334,0.9465395285904925,1.0,7/31,7.94%,SIPA1L1;EPHA4;NGEF;LRRK2;CUX2;CAPRIN2;PTEN
prerank,glucose catabolic process to pyruvate (GO:0061718),0.36694793589023367,0.8979140597126977,0.5911504424778761,0.9452142408251567,1.0,3/24,7.27%,HK2;PGAM2;GCK
prerank,canonical glycolysis (GO:0061621),0.36694793589023367,0.8979140597126977,0.5911504424778761,0.9452142408251567,1.0,3/24,7.27%,HK2;PGAM2;GCK
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3121767632771553,0.8971640865723757,0.6303680981595092,0.9462237458875488,1.0,7/57,7.83%,ADCY5;LPAR1;ADCY1;ADRA2A;AKAP12;ADCY9;GNAT3
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.34883580425082716,0.8971328798460348,0.5898778359511344,0.9456038833373216,1.0,9/30,20.24%,TLR3;IKBKE;TLR4;RIPK1;LY96;BIRC3;CD14;TANK;TRAF3
prerank,regulation of embryonic development (GO:0045995),0.34135449756332686,0.8970739516450446,0.6033898305084746,0.9450289242045911,1.0,10/34,13.86%,CLASP1;DAG1;NIPBL;TRIP12;NIBAN2;NR2C2;PHLDB2;FOXA2;TDG;WDPCP
prerank,male gonad development (GO:0008584),0.33941416388458007,0.8967607736153951,0.6086261980830671,0.9450780735289999,1.0,2/34,1.21%,WNT4;KIT
prerank,homologous chromosome segregation (GO:0045143),-0.3340471354294249,-0.8966692037484433,0.6047516198704104,0.8561010915605687,1.0,4/20,21.61%,FMN2;ZCWPW1;MEI4;PRDM9
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.31545188704204874,0.8964781366720009,0.5977917981072555,0.9450239291120026,1.0,7/49,10.40%,GSDME;NUPR1;BID;DDX3X;TP53;DNM1L;BECN1
prerank,protein localization to kinetochore (GO:0034501),0.39994081310284973,0.8963298204737251,0.5884476534296029,0.9446827223820333,1.0,6/14,24.75%,AURKB;IK;CHAMP1;CENPT;MIS12;SPDL1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.4255165553487768,0.8957795725981063,0.5658914728682171,0.9451930582330776,1.0,4/11,16.41%,ELOF1;ZMIZ2;ZMIZ1;ARID1B
prerank,cardiocyte differentiation (GO:0035051),0.428591525607408,0.895573323490712,0.5608782435129741,0.9449531334918089,1.0,4/10,9.63%,AKAP13;SIK1;NRG1;CBY1
prerank,smooth muscle contraction (GO:0006939),-0.3644935996122439,-0.8952376925683352,0.6043478260869565,0.8585354501261234,1.0,5/14,10.14%,SLC8A1;EDNRA;SMTN;MYH11;ACTA2
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.2614255516573925,-0.8952287917416839,0.643312101910828,0.8578296582909408,1.0,21/68,24.36%,STAT3;MBP;ARHGEF2;IL33;APP;PLCG2;CYBA;TIRAP;TWIST1;LBP;DHX9;NOD2;CD74;SYK;TLR7;TYROBP;LGALS9;PYCARD;IL6R;F2R;HYAL2
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.3024678457253236,-0.8950301679541363,0.61,0.857549092644558,1.0,6/33,12.53%,PRKG1;MEF2C;TGFB3;APOD;GPER1;CDKN1A
prerank,myelination in peripheral nervous system (GO:0022011),-0.38354101702388177,-0.8948512381671453,0.5995623632385121,0.8572484861454326,1.0,8/13,28.47%,ADGRG6;MYOC;PRX;SIRT2;LGI4;SOD1;NF1;NCMAP
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.4154316294269654,0.8945395141579355,0.5962962962962963,0.9466252978415999,1.0,3/12,13.22%,PPARA;MIA3;WNK1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.34344117748781744,0.894539050446115,0.6033057851239669,0.9459420149546007,1.0,6/35,8.71%,ALOX12;ACSS3;BDH1;SCD5;BDH2;HMGCS2
prerank,histone methylation (GO:0016571),0.3527377094452987,0.8938951171208144,0.5901360544217688,0.9467124613101765,1.0,6/26,16.83%,SMYD3;NSD1;NSD3;EHMT2;CREBBP;EHMT1
prerank,rRNA 3'-end processing (GO:0031125),0.4315030048981201,0.8937450108683779,0.6,0.9463895554794035,1.0,3/10,9.99%,ERI3;EXOSC7;ERI2
prerank,positive regulation of interleukin-17 production (GO:0032740),0.3693244337939513,0.8935710496544476,0.6075268817204301,0.9460906917594054,1.0,3/22,6.47%,IL18;SPHK1;IL12B
prerank,negative regulation of cell aging (GO:0090344),0.3921477678299741,0.8935410164445077,0.6065259117082533,0.9454651972848083,1.0,5/16,14.54%,SLC30A10;TERT;SIRT1;RBL1;ZKSCAN3
prerank,nitrogen compound transport (GO:0071705),0.2767490860141731,0.8935297394880791,0.672258064516129,0.9448039047760174,1.0,22/141,12.40%,SLC6A13;SLC6A12;SLC38A4;SLC38A3;SLC7A11;SLC7A2;PDPN;SLC35F3;SLC25A48;SLC22A5;TCN2;SLC38A1;SLC48A1;HRG;SLC6A4;TOM1;PICK1;CHMP1A;SLC19A2;RALBP1;TCN1;MIA3
prerank,tRNA aminoacylation (GO:0043039),-0.29204779814031456,-0.8933517822697461,0.6187050359712231,0.8597609962438678,1.0,4/37,12.09%,LARS2;WARS2;GARS1;DARS2
prerank,histone monoubiquitination (GO:0010390),0.369115958874831,0.8922202282652577,0.5846153846153846,0.9470081525816663,1.0,7/24,19.45%,CTR9;BCOR;KDM2B;DDB2;UBE2E1;RNF20;RNF2
prerank,positive regulation of macrophage activation (GO:0043032),-0.35115964055077487,-0.891986389307863,0.6238738738738738,0.8620991948039161,1.0,3/17,14.58%,THBS1;IL33;LBP
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.320120126894556,0.8912851611424694,0.6178736517719569,0.9484749300573625,1.0,7/49,9.10%,KIT;IGF1;IL18;PARP14;IL12B;TNFRSF18;PARP9
prerank,zinc ion transmembrane transport (GO:0071577),0.3675819706979737,0.891260411985022,0.6042402826855123,0.9478536657788926,1.0,3/22,8.11%,SLC30A10;SLC30A2;SLC39A13
prerank,positive regulation of lipid catabolic process (GO:0050996),0.3779291625626929,0.8911704112766596,0.5953237410071942,0.9473555012736571,1.0,1/19,1.76%,PPARA
prerank,actin polymerization or depolymerization (GO:0008154),0.3133419635820296,0.8910207495705695,0.6273291925465838,0.9469925906169124,1.0,9/50,12.56%,MICAL3;GAS7;AVIL;ARHGAP6;DIAPH1;WASL;CATIP;VIL1;TTC17
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.36325935474450616,0.8909022640768801,0.5879120879120879,0.9465853860361901,1.0,6/21,7.77%,CD300A;ELF1;PRKCB;GPS2;PTPN22;ELF2
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.39002439181414994,0.8907659689671684,0.5982300884955752,0.9462235469672323,1.0,4/16,17.07%,CPEB3;MOV10;ZFP36L1;PLEKHN1
prerank,snRNA 3'-end processing (GO:0034472),0.3820572028198795,0.8907642021112996,0.5843694493783304,0.9455517292942983,1.0,8/19,21.65%,EXOSC7;INTS2;INTS5;INTS7;INTS1;INTS8;EXOSC3;TUT1
prerank,positive regulation of neuron death (GO:1901216),0.31908818545737694,0.8905088788245936,0.6156351791530945,0.9454264330430657,1.0,4/46,5.16%,EFNB2;PICALM;NUPR1;TLR4
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.38226894356848573,0.8902763903914213,0.5553398058252427,0.9452889413038248,1.0,8/16,26.39%,ATM;HNRNPA2B1;TNKS2;TINF2;SLX4;SMG6;PINX1;RTEL1
prerank,negative regulation of coagulation (GO:0050819),-0.36176795378645105,-0.8901566685655669,0.6033755274261603,0.8654557106214504,1.0,5/14,10.79%,SERPINE2;HS3ST5;CD34;APOE;EDN1
prerank,fatty acid elongation (GO:0030497),-0.37442900579355576,-0.8893201788225382,0.6086105675146771,0.8666508869752236,1.0,3/13,10.29%,ELOVL7;ELOVL5;ELOVL6
prerank,inner ear morphogenesis (GO:0042472),0.3620136945308965,0.8892601528730982,0.6083788706739527,0.9468478176511473,1.0,4/22,8.37%,FGFR2;HOXA1;CHD7;ZIC1
prerank,cellular response to reactive oxygen species (GO:0034614),-0.25620513097774555,-0.8889426438847455,0.6508379888268156,0.8667586772076193,1.0,8/59,6.96%,MAP3K5;PTPRK;CYP1B1;NET1;ANXA1;RPS3;PLEKHA1;RHOB
prerank,carboxylic acid metabolic process (GO:0019752),0.3400953612236526,0.8889043241376592,0.6175496688741722,0.9469628250150541,1.0,2/33,1.70%,DDO;ST6GAL1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.38506072080997217,0.888844201370121,0.5954465849387041,0.9464191013089668,1.0,4/17,9.80%,IGF1;DOCK5;PDGFRB;DOCK7
prerank,regulation of protein binding (GO:0043393),-0.23505399686802275,-0.8883163524253476,0.7781954887218046,0.8673747950135663,1.0,35/114,19.64%,CAV1;ACTB;CLDN5;EPB41;B2M;GSK3B;TIAM1;APP;DISC1;CTNNBIP1;PSEN1;CRK;DACT1;SORL1;BMP2;RALB;TMBIM6;GNL3L;ADD2;PKD1;FKBP1A;MARK2;BMP4;CDKN1A;CARD16;SPPL3;HIPK2;PPP1CA;ZFPM1;MEN1;CTSZ;HIP1R;RAN;LDLRAP1;VTN
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.362334780891409,0.8879844758771025,0.5948275862068966,0.9476070865054248,1.0,6/25,12.87%,CCNT2;LDB1;ELL;SCAF8;WDR43;KAT7
prerank,phosphorylation (GO:0016310),0.24634764702238743,0.8878557653390163,0.7419354838709677,0.9472205503475499,1.0,71/384,15.17%,PRKAG2;WNK4;ROCK2;OXSR1;PRKCZ;FAM20A;PRKAA2;GRK5;SPHK1;PI4KA;PRKAG3;FGFR1;BMPR1A;TGFBR1;DMPK;AAK1;LRRK2;TP53RK;PRKCB;GK5;IKBKE;ATM;PRRT1;CAMK1;BRAF;NUAK2;TRIB2;CDC42BPG;SIK1;EIF2AK2;TKFC;GK;TGFBR2;IGFBP3;PIK3CA;RYK;COQ8B;PDPK1;CSNK1A1;PICK1;MKNK1;FER;BRSK1;AURKB;SRPK2;ABL1;DYRK1A;MYLK3;TRIB1;PRKDC;MAPK6;CSNK2A1;PRKCA;HIPK3;PNKP;MAPK10;MAP3K1;FRK;PRKCI;WNK1;BMP2K;MAP2K1;ROS1;COQ8A;GRK3;ACVR2B;STK17B;SPHK2;CERK;ACVR1B;STK4
prerank,regulation of adenylate cyclase activity (GO:0045761),0.36677558617628436,0.8878373137628345,0.5847750865051903,0.9465881291133685,1.0,3/22,9.72%,CACNA1D;CACNA1C;STIM1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.39519653670232036,0.8871524752458612,0.5755813953488372,0.9474170662815745,1.0,1/14,0.45%,WNK4
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.29325918528344286,-0.8869680717848313,0.6304849884526559,0.8696090009185858,1.0,11/32,17.55%,NAV3;CLASP2;ARHGEF2;STMN2;FGF13;TUBB4A;SPEF1;SNCA;STMN1;APC;FKBP4
prerank,retinol metabolic process (GO:0042572),-0.36075825939851225,-0.8868609761619318,0.6289978678038379,0.8691248743041757,1.0,3/14,10.96%,CYP1B1;RDH10;ADH1A
prerank,vesicle organization (GO:0016050),-0.2723229557502929,-0.886603436838994,0.6821917808219178,0.8689664343645479,1.0,8/46,8.22%,CAV1;FNBP1L;CD34;CAV2;LAPTM4B;DNM1;SORT1;ALS2CL
prerank,endodermal cell fate commitment (GO:0001711),0.4278030324743266,0.8863825290667828,0.570902394106814,0.9483712854960497,1.0,2/10,10.74%,CTR9;RTF1
prerank,positive regulation of peptidase activity (GO:0010952),-0.33558875473793637,-0.8861090821111078,0.6037735849056604,0.8693088736678531,1.0,9/20,27.30%,VSIR;DDRGK1;PINK1;MAPK12;APH1A;RCN3;PRELID1;NDUFA13;GRN
prerank,regulation of lysosomal lumen pH (GO:0035751),0.40526927646035615,0.8859463460751495,0.6137566137566137,0.948658825495241,1.0,4/12,21.21%,LRRK2;CLN6;CCDC115;ATP6AP2
prerank,lymphocyte migration (GO:0072676),-0.2969529476118056,-0.8858531970777768,0.6329411764705882,0.869143475032367,1.0,20/32,46.71%,S1PR1;MSN;RET;CCL13;CCL19;CCL2;MYO1G;CCL11;CCL4;GATA3;CRTAM;CCL8;CCL14;CKLF;CCR6;ADAM8;CCL1;CCL3;TBX21;XCL1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.4271705899697811,0.8857908449496805,0.5991902834008097,0.948348000471239,1.0,4/10,16.85%,PRKAA2;SIRT1;FLCN;KLF15
prerank,protein complex oligomerization (GO:0051259),0.2867647292991011,0.8855576222285915,0.6780415430267063,0.9481904101072669,1.0,12/85,8.88%,UPB1;ALS2;RNF213;MCU;NACC2;RNF135;ATL1;MICU1;OPA1;TWNK;JMJD6;DNM1L
prerank,histone mRNA catabolic process (GO:0071044),0.3985873537345237,0.8854440180015177,0.5855018587360595,0.9477835659394629,1.0,7/15,24.21%,ATM;TUT4;TENT2;TENT4B;TUT7;TUT1;XRN1
prerank,pinocytosis (GO:0006907),-0.3944958943997856,-0.8854060483116,0.6266375545851528,0.8693854149264253,1.0,3/10,9.79%,CARMIL1;PPT1;DOCK2
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.3763420103606936,-0.8854021430579594,0.6239316239316239,0.8686732274821529,1.0,3/12,5.51%,PROM1;STAT3;RORB
prerank,cellular response to interferon-gamma (GO:0071346),-0.24660457550997736,-0.8853285777859754,0.7292418772563177,0.8681085619141425,1.0,23/88,21.33%,CAMK2D;MID1;VCAM1;B2M;ICAM1;AQP4;SYNCRIP;IFNGR2;JAK1;CD47;GBP4;CD44;DAPK1;CCL13;RPL13A;IRF5;IRF2;CAMK2B;IRF8;CCL19;TRIM68;LGALS9;MT2A
prerank,receptor signaling pathway via STAT (GO:0097696),-0.30745535360587467,-0.8853137821550989,0.6484018264840182,0.8674206470798432,1.0,5/25,10.70%,GHR;STAT3;SOCS2;STAT5B;PKD1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.2970177958930836,0.8849841332574151,0.6315007429420505,0.9481108953943289,1.0,15/73,15.34%,DNMT3A;JARID2;TAF1D;BAZ1B;HDAC4;GLMN;MYO1C;TDG;POLR1G;PHF1;PHF2;TBP;KAT2B;SPHK2;MPHOSPH8
prerank,N-terminal protein amino acid modification (GO:0031365),0.3961145448656327,0.8849095492323984,0.5864811133200796,0.9475971379993137,1.0,7/14,31.35%,METAP2;NAA16;AANAT;NAA50;NAA15;NAA60;NAA40
prerank,integrated stress response signaling (GO:0140467),-0.36789918975614094,-0.8848727735009451,0.6431718061674009,0.8676922579921511,1.0,3/14,15.44%,HSPA5;ATF4;EIF2AK3
prerank,ruffle organization (GO:0031529),-0.3507144751048618,-0.8848189862222215,0.6274944567627494,0.8670902502339423,1.0,3/16,6.72%,CARMIL1;LIMA1;PLEKHA1
prerank,positive regulation of chemokine production (GO:0032722),0.32442802040063856,0.8846442147316017,0.6273584905660378,0.9474847365102987,1.0,9/44,13.35%,IL18;TLR3;TLR4;DDX3X;EIF2AK2;IL17RA;MAVS;ADAM17;OAS3
prerank,regulation of ion transmembrane transport (GO:0034765),-0.2964174793980344,-0.8836427871537619,0.638961038961039,0.8688078433343861,1.0,7/33,8.00%,AKAP6;KCNJ3;CHRM3;KCNJ2;NEDD4L;YWHAE;KCNQ1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.40435137654227005,0.8834542363661833,0.5941747572815534,0.9494245225617969,1.0,4/13,16.41%,ELOF1;ZMIZ2;ZMIZ1;ARID1B
prerank,synaptic vesicle recycling (GO:0036465),-0.29171278745765317,-0.8833724486756953,0.6623711340206185,0.8686773197606055,1.0,4/31,7.30%,NLGN1;SYT1;STON2;AMPH
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.33043446608155314,-0.8828733812913274,0.6209150326797386,0.8690408375386153,1.0,10/23,27.77%,RAD23B;UBB;COPS4;CETN2;COPS6;COPS5;UBC;RPS27A;DDB1;COPS2
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.4184991635062153,0.8827304355878082,0.596958174904943,0.9503515616110042,1.0,2/11,7.34%,FGFR2;TGFBR2
prerank,protein localization to cell-cell junction (GO:0150105),0.401321876834772,0.8823976532306352,0.6234887737478411,0.9503609859142181,1.0,4/15,8.86%,CGNL1;ARHGEF18;MPP7;CDH5
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.3568890519475159,0.8819695051809764,0.5981818181818181,0.9506796865576722,1.0,4/20,10.01%,FKBP5;NKTR;PPIC;CWC27
prerank,skeletal muscle tissue development (GO:0007519),0.33513654831868966,0.8815626137938902,0.6023102310231023,0.9509308369245006,1.0,5/32,8.50%,IGSF8;CSRP3;CFLAR;KLHL41;LEMD2
prerank,cellular response to calcium ion (GO:0071277),0.3018050828035494,0.8813158230974564,0.6462196861626248,0.9507826971244077,1.0,9/67,9.25%,SYT9;SYT11;SYT12;PRKAA2;ADCY1;BRAF;CPNE3;MEF2A;ITPKB
prerank,cellular response to heat (GO:0034605),0.3407290932467616,0.8807591770529972,0.6306913996627319,0.9513319056574884,1.0,3/35,7.88%,FGF1;POLR2D;HSBP1L1
prerank,regulation of protein metabolic process (GO:0051246),0.3173033990862456,0.8803908775310056,0.657331136738056,0.9514271813393883,1.0,4/44,7.39%,ROCK2;ACE;MAP2K5;ANGPTL8
prerank,protein localization to Golgi apparatus (GO:0034067),-0.30349012858201635,-0.8803720549504055,0.625,0.8738295856226211,1.0,11/27,25.35%,SORL1;ARL5A;ARL1;GCC2;ARL5B;BICD2;RAB6A;TMED10;PAQR3;VPS13C;IFT20
prerank,mammary gland epithelium development (GO:0061180),0.3980906656921853,0.8802444134818895,0.5881294964028777,0.9510647499767901,1.0,1/14,1.03%,WNT4
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.41595745548612245,0.8797819784848347,0.5940959409594095,0.9514626626288483,1.0,4/10,17.39%,EZR;OPHN1;CDC42;MYO9A
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.3744049795868094,-0.8797543264623681,0.6339869281045751,0.8736774509716335,1.0,6/12,18.37%,ACTN4;EFNA5;CORO1C;DMTN;KANK1;SPRY4
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.3744049795868094,-0.8797543264623681,0.6339869281045751,0.8736774509716335,1.0,6/12,18.37%,ACTN4;EFNA5;CORO1C;DMTN;KANK1;SPRY4
prerank,response to tumor necrosis factor (GO:0034612),0.2840677131938028,0.8794320249687727,0.6814285714285714,0.9515562961012837,1.0,12/91,10.18%,GSDME;AFF3;NPNT;SPHK1;CASP3;ZFAND6;GBP3;GBP2;HYAL1;SIRT1;RIPK1;CCL25
prerank,intracellular sterol transport (GO:0032366),-0.3693234543808345,-0.8790856737902533,0.6394849785407726,0.8743966812904911,1.0,5/13,20.99%,ABCG1;NPC2;STARD4;RELCH;OSBP
prerank,negative regulation of myotube differentiation (GO:0010832),-0.37535399963529287,-0.8785062265295345,0.6241299303944315,0.8749583647591674,1.0,4/12,16.05%,CCN3;NOTCH1;TMEM119;BDNF
prerank,high-density lipoprotein particle assembly (GO:0034380),0.4179228601817656,0.8783830504360833,0.6152380952380953,0.9531545220694303,1.0,4/10,17.91%,APOM;BMP1;PRKACB;ZDHHC8
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.39877688729245353,-0.8779704768210191,0.6416184971098265,0.8753655103333039,1.0,4/10,18.23%,ACVRL1;ZBTB16;BMPR1B;PKDCC
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.3486658022047791,0.8779622668172835,0.6048387096774194,0.9533951162743602,1.0,7/26,14.43%,PCBP2;TRIB1;DHX58;NMI;MAPKBP1;ACOD1;PPM1B
prerank,mammary gland development (GO:0030879),0.36767904266780127,0.8778394347863309,0.6115107913669064,0.9530090027294515,1.0,4/21,8.47%,WNT4;GLI2;NRG1;APLN
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.28894351985900335,-0.8776581057471465,0.6596858638743456,0.8753019428889782,1.0,8/33,12.98%,ESR1;RUNX1;AR;CALR;DDRGK1;H3-3A;UFM1;AXIN1
prerank,response to interleukin-1 (GO:0070555),-0.24979542499525798,-0.8776559524193203,0.6993670886075949,0.8745832319303511,1.0,17/73,21.18%,IL1R1;PTGIS;ANXA1;TNFRSF11A;DAB2IP;APP;IRAK3;CD47;HIF1A;SNCA;CCL13;YTHDC2;CCL19;LGALS9;HAS2;SFRP1;PYCARD
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.3466736907199358,0.8775568244007336,0.6423728813559322,0.9529626445893199,1.0,9/29,17.97%,STAT2;SAMHD1;MAVS;YTHDF3;PTPN11;OAS3;USP18;IFNAR2;WNT5A
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.3706724323956529,0.8773252946711971,0.6152450090744102,0.9527939426376832,1.0,6/19,13.83%,CD27;MMP14;PRKDC;ZBTB1;ZMIZ1;AXL
prerank,lipoxygenase pathway (GO:0019372),0.396988719995762,0.8772846889973936,0.5865051903114187,0.9522215413714351,1.0,2/14,7.66%,ALOX12;PON3
prerank,establishment of apical/basal cell polarity (GO:0035089),0.3877958273980482,0.8771200275725177,0.6036697247706422,0.9518997880059386,1.0,4/14,11.35%,EZR;OPHN1;PATJ;CDC42
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.3610152705328765,-0.8769180633061667,0.6186440677966102,0.8754728753729527,1.0,5/13,34.07%,PIK3AP1;TLR7;IRAK4;PIK3R4;MYD88
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.41357410716646087,0.8768853846076724,0.6067864271457086,0.9517274827652542,1.0,1/11,0.73%,LEPROT
prerank,embryonic eye morphogenesis (GO:0048048),-0.3827197085210689,-0.876856601966717,0.6410256410256411,0.87488047404087,1.0,6/11,24.12%,MFAP5;FBN2;ALDH1A3;LRP6;TBX2;MFAP2
prerank,positive regulation of cellular process (GO:0048522),0.23875499550616305,0.8768044179421706,0.8162393162393162,0.9512227511800947,1.0,77/565,12.47%,FGF1;BMP6;COLEC12;EFNB2;LAMC2;IGF1;PRKAA2;CCN2;IL13RA1;FGFR2;ECHDC3;EPHA4;RHOD;PKHD1;GRK5;SPHK1;NUPR1;PHIP;FGFR1;PRODH;TGFBR1;ADRA2A;PDPN;CDCA7L;SLC30A2;DPP4;TNFSF13;CTSH;PPP1R13L;TLR4;TPM1;MEIS1;ATM;DDX3X;P2RX3;NOX1;FLT1;ANKRD17;PDGFRB;IL12B;CACUL1;GAB2;WWTR1;TGFBR2;PTEN;TNFRSF18;GDNF;NRG1;NEUROD4;HDAC4;HYAL1;GLI1;SIRT1;LRP1;RIPK2;HDAC1;ASH2L;CCAR1;HTR1A;HBEGF;FLT3LG;FER;CRKL;TBRG4;SRPK2;MMP14;CDC42;ADAM17;DICER1;NOP2;AXIN2;VEGFD;ITGAV;CSNK2A1;PRKCA;MLXIPL;TGFA
prerank,regulation of phagocytosis (GO:0050764),-0.2652533411071656,-0.8766951604495598,0.7113702623906706,0.8745124295598493,1.0,11/53,10.68%,MERTK;SCARB1;GAS6;PTPRC;RAB27A;GATA2;DYSF;CALR;CD47;DOCK2;CYBA
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.3651427158964965,-0.8762316308404358,0.6354166666666666,0.8747581335667425,1.0,8/14,31.26%,TSEN34;FAM98B;TSEN54;RTCB;CPSF4;TSEN15;CLP1;CPSF1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.3518173929475193,0.8760920753659751,0.6238698010849909,0.9520900167486371,1.0,5/25,11.96%,PICALM;RIN3;ATXN2;NEU3;ITGAV
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.41371419209146276,0.8760079294783003,0.6194174757281553,0.9516044890853168,1.0,2/11,6.05%,STX18;ATL1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.3671471447484346,0.8751485001905557,0.6236933797909407,0.9527701277729588,1.0,7/23,16.92%,PLK5;CDK5RAP3;AURKB;PRCC;INTS3;VPS4A;CHMP4C
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.33168197110485736,0.8751330820166345,0.6359060402684564,0.9521416721166317,1.0,8/37,14.33%,TNPO1;KIF3C;IFT122;WDR19;DYNC2I1;CLUAP1;IFT88;WDR35
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.35898103426726446,0.8750115382940176,0.6384479717813051,0.951717942306674,1.0,1/25,0.73%,LEPROT
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.3519062898670101,-0.8741314515779689,0.6379310344827587,0.8785282793740411,1.0,4/15,8.45%,CLASP2;CST3;FAP;TGFB1
prerank,negative regulation of DNA binding (GO:0043392),-0.2998580333214995,-0.8738194219140425,0.6551724137931034,0.8784876249802569,1.0,3/28,9.18%,LEF1;NFKBIA;HEY2
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.4155814219693419,0.8736639722056786,0.6159844054580896,0.9539637467118985,1.0,1/11,0.55%,EFNB2
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.38310734103906235,-0.8736578173304339,0.6491935483870968,0.8774188354276657,1.0,6/11,27.81%,CCT8;CCT2;CCT6A;CCT7;MEPCE;DKC1
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.38310734103906235,-0.8736578173304339,0.6491935483870968,0.8774188354276657,1.0,6/11,27.81%,CCT8;CCT2;CCT6A;CCT7;MEPCE;DKC1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.30624987479871046,0.8734725802614761,0.6396946564885496,0.9537162123753935,1.0,10/54,14.70%,TFDP2;ATM;ARID3A;TP53;RBL2;CNOT10;TFDP1;PML;GADD45A;E2F4
prerank,intracellular protein transport (GO:0006886),0.2466049900190121,0.8733086936314596,0.7793594306049823,0.953414996144058,1.0,62/304,19.98%,RANBP3L;APPL2;WLS;TRAK1;KIF13B;SNX6;SEC31B;TBC1D16;TNPO1;LAMP2;STXBP2;ACD;FUT10;ARFGAP3;VPS26C;IPO13;PICK1;GRTP1;ARL4A;NUP42;RAB43;COPZ2;RANBP3;RAB22A;VPS45;MYO1C;DESI1;CLTC;SNX8;STX5;SGSM2;VIPAS39;SNX15;AP2A1;SEC23IP;RAB29;RAB21;ARFIP2;ARL6;SNF8;SCFD1;TBC1D25;NUP155;CCHCR1;CLIP3;FAM91A1;SGSM3;C2CD5;VPS35;TRAK2;KIF13A;TBC1D14;SEC31A;EVI5;KATNB1;NUP188;AP4M1;TBC1D22B;STX16;TSC2;LTBP2;EVI5L
prerank,negative regulation of immune effector process (GO:0002698),0.38896086814447994,0.8727966717467958,0.6102003642987249,0.9538826900646157,1.0,4/13,15.10%,CD300A;ENPP3;FER;LGALS3
prerank,regulation of interleukin-12 production (GO:0032655),-0.2667518840630239,-0.8726465031164766,0.6978851963746223,0.878830522483931,1.0,13/47,21.92%,THBS1;FOXP1;PLCG2;IRAK3;CD47;TIRAP;CMKLR1;LAPTM5;SYK;IRF5;CCL19;LGALS9;MDK
prerank,regulation of dephosphorylation (GO:0035303),-0.3584574291171795,-0.8726140302111312,0.6371490280777538,0.8781718433068403,1.0,5/15,12.84%,PPP1R16B;PPP1R16A;MTMR2;MTMR9;SMG5
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.4094347198419412,0.8720244231409966,0.638733705772812,0.9548712566319906,1.0,1/12,0.60%,CELSR1
prerank,establishment of protein localization to organelle (GO:0072594),0.2896550305946425,0.8716143948138888,0.6442748091603053,0.9550823732208836,1.0,4/72,3.98%,APPL2;HK2;TNPO1;LAMP2
prerank,cAMP metabolic process (GO:0046058),0.3939194569864903,0.8711885846556565,0.6111111111111112,0.9553530597737833,1.0,3/13,7.00%,ADCY5;ADCY1;ADCY9
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.2732882530047397,-0.8706867571442535,0.7043010752688172,0.8815208993355906,1.0,15/46,25.99%,PPIA;RAP1B;RPLP0;JAK1;MSN;PITPNA;TALDO1;CFL1;CAPZA1;AIP;PDCD4;SOD1;MTAP;JAK2;STAT4
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.35622307864036457,0.8698452641178429,0.6212389380530974,0.9575442779683231,1.0,2/22,2.32%,SASH1;SPHK1
prerank,myeloid cell differentiation (GO:0030099),-0.26551756224755557,-0.869683447842208,0.7074468085106383,0.8829145586357824,1.0,12/47,19.19%,SNRK;RUNX1;ZBTB16;LYN;RPS19;IKZF1;MFHAS1;TIRAP;TAL1;HIPK2;ZFPM1;INHBA
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.31161287019926837,-0.8695568175108701,0.6697247706422018,0.8824395088724942,1.0,6/24,13.95%,TRPS1;ACVRL1;ZBTB16;WNT9A;PTHLH;BMPR1B
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3675448822228725,0.8694458384828648,0.6374045801526718,0.9577325205099911,1.0,3/18,9.35%,PRKN;SOD2;SIRT1
prerank,regulation of interleukin-10 production (GO:0032653),0.3133536679246608,0.8694095767997503,0.6421725239616614,0.9571485551674972,1.0,5/44,6.47%,PRKCZ;TLR4;CD28;TRIB2;IL12B
prerank,proteoglycan biosynthetic process (GO:0030166),0.33710469051019,0.8693826021669885,0.6197654941373534,0.9565388633707227,1.0,6/31,10.27%,HS3ST3B1;IGF1;CHST11;PXYLP1;GAL3ST4;FOXL1
prerank,negative regulation of hemostasis (GO:1900047),0.4127097595422622,0.8691468447573988,0.62109375,0.956370138346862,1.0,3/12,7.12%,TFPI;KNG1;SERPINE1
prerank,negative regulation of type I interferon production (GO:0032480),0.31988629144405345,0.8689189751831321,0.664,0.9561956842664823,1.0,12/40,21.99%,PCBP2;IKBKE;RNF135;MAVS;DHX58;ACOD1;PPM1B;UFD1;NPLOC4;TAX1BP1;SIRPA;YY1
prerank,protein neddylation (GO:0045116),0.4058164941203033,0.8688495273309682,0.5951940850277264,0.9556918298799998,1.0,3/13,16.61%,UBE2M;DCUN1D5;RNF7
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.3053384565676545,0.868805440782028,0.6574074074074074,0.9551238441659814,1.0,10/49,13.91%,PRKCZ;PMEPA1;SMAD6;DDX3X;LDLRAD4;TMC8;CDC42;IMPACT;ANKRD27;CRYAB
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.37421021056367365,-0.8685420083023878,0.6314699792960663,0.8839309281295218,1.0,3/12,8.45%,ESR1;STAT3;TGFB1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.4100674194329364,0.8683638505203322,0.592079207920792,0.9554318279710677,1.0,3/10,17.02%,PARP14;SOCS3;PIBF1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.34715080199821413,0.8677771343445141,0.6040609137055838,0.95599304557461,1.0,2/24,5.14%,ACE;TAPBPL
prerank,response to reactive oxygen species (GO:0000302),-0.25849192415725725,-0.8677133867796651,0.7142857142857143,0.884968915411122,1.0,25/54,32.88%,PTPRK;APOE;RPS3;APOD;CAMKK2;GLRX2;MAPT;HIF1A;GPX1;CAT;ROMO1;SOD1;FYN;PLK3;HYAL2;HMOX1;MAPK8;FOS;MAPK3;JUN;COA8;HP;STK25;NCF1;PRDX3
prerank,nucleocytoplasmic transport (GO:0006913),-0.2769838214002416,-0.867649851748879,0.7013698630136986,0.8844107944163357,1.0,20/40,40.73%,BACH2;XPO1;ANP32A;RBM15B;SNRPF;NXT1;SNRPD3;NPM1;NCBP2;SNRPB;HTATIP2;MALT1;RITA1;SNRPG;GEMIN2;LSG1;NUP205;NCBP1;GEMIN6;HNRNPA1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.3664796955894051,-0.8675773890982608,0.6731601731601732,0.8838587374032739,1.0,6/13,11.37%,ABHD2;ESR1;PLPP1;AR;GPER1;BMP4
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.2739016605799482,-0.8670395473256454,0.7195767195767195,0.8842606125452606,1.0,18/44,22.48%,PTPRJ;LYN;DAB2IP;APOE;SORL1;AIDA;IRAK3;UCHL1;DUSP1;BMP4;SPRY1;DNAJA1;PDCD4;SPRY4;PTPN1;AGT;STK38;PAQR3
prerank,inositol phosphate catabolic process (GO:0071545),0.4043922546758932,0.8670242673055764,0.611214953271028,0.9569568208379001,1.0,3/12,11.18%,SYNJ2;PTEN;OCRL
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.3853956703032576,0.8668624752579381,0.609942638623327,0.9566362380784166,1.0,2/13,7.34%,GLI3;TGFBR2
prerank,negative regulation of cilium assembly (GO:1902018),-0.37304334757660906,-0.8667825376827306,0.6576763485477178,0.8841042048536473,1.0,5/12,23.56%,TBC1D30;LIMK2;MAP4;ODF2L;CCP110
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3442366052100538,0.8666503234762362,0.637901861252115,0.9564426624159857,1.0,4/25,8.60%,ITPR1;LRRK2;P2RX3;HTT
prerank,transferrin transport (GO:0033572),0.3354097407144637,0.8665700600677068,0.6469622331691297,0.9559608172552564,1.0,11/33,18.72%,ATP6V0E1;ATP6V0B;RAB11B;ATP6V1D;ATP6V1E1;CLTC;DNM2;STEAP3;HFE;ATP6V0D1;ARHGAP1
prerank,establishment of spindle orientation (GO:0051294),0.34711164821425355,0.8663214324534356,0.6511226252158895,0.9558456487631566,1.0,6/28,14.46%,PKHD1;CLASP1;FBXW11;HTT;MISP;LLGL2
prerank,regulation of interleukin-6 production (GO:0032675),0.27479627426859515,0.8662736630844493,0.6976744186046512,0.9553050064209007,1.0,11/96,10.58%,C1QTNF3;SYT11;TLR3;TLR4;IL17D;ARRB1;AFAP1L2;PTPN22;IL17RA;MAVS;RAB7B
prerank,positive regulation of wound healing (GO:0090303),0.3235219281238829,0.8660988001646602,0.6597444089456869,0.9550254351993991,1.0,8/36,11.49%,SMOC2;ADRA2A;RREB1;F2;SERPINE1;FOXC2;HBEGF;MYLK
prerank,protein acylation (GO:0043543),0.32337356485662566,0.8658540087874411,0.6436597110754414,0.954907856855085,1.0,10/38,17.92%,SPHK1;NAA80;GLUL;ZDHHC18;ZDHHC1;PORCN;KAT2B;CREBBP;ZDHHC8;ZDHHC23
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.37325214056859146,-0.8658293170122827,0.6666666666666666,0.8853761393176077,1.0,3/12,20.47%,ANO1;ADCY8;CFTR
prerank,insulin receptor signaling pathway (GO:0008286),0.2908075541545006,0.865784452887314,0.6641104294478528,0.9544044131200737,1.0,13/69,11.08%,SORBS1;RHOQ;PHIP;ATP6V0E1;BAIAP2;ATP6V0B;PIK3CA;GRB10;FOXC2;FER;PIK3R3;ATP6V1D;ATP6V1E1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.33974951408696236,0.865775692519457,0.6317567567567568,0.9537730686820954,1.0,13/31,25.50%,TIMM44;TOMM70;PEX10;PEX14;PEX16;PEX5;TIMM17B;TIMM17A;TIMM21;PEX26;DNAJC15;CHCHD4;GRPEL2
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.24872981988489729,-0.8657340558736457,0.7457627118644068,0.8848764803569769,1.0,28/72,34.29%,PSMB2;CARD14;MAP3K7;PSMD14;PSMC6;REL;TIRAP;RELB;PSMA4;PSMB9;SKP1;MAP3K14;PSMD11;PSMB10;PSMD2;PSMA2;RELA;PSMB3;PSMB5;PSMA7;PSMF1;PSMD7;MALT1;CARD10;TNFSF15;PSMA5;PSMD4;PSME4
prerank,NAD biosynthetic process (GO:0009435),0.3614549584800007,0.8655447216655106,0.618348623853211,0.9536172477798146,1.0,9/20,24.37%,PARP10;NMNAT1;SLC5A8;PARP9;QPRT;NMNAT2;PARP16;NMNAT3;NAPRT
prerank,positive regulation of isotype switching (GO:0045830),0.38290635894987946,0.8653326844757357,0.6338582677165354,0.9533974329966035,1.0,3/15,6.47%,KMT5C;TNFSF13;KMT5B
prerank,positive regulation of inflammatory response (GO:0050729),0.2848754344529738,0.8647712253901767,0.6865021770682148,0.9539066197497393,1.0,11/86,9.73%,IL18;NAPEPLD;NUPR1;C2CD4B;TLR3;TLR4;IL12B;SERPINE1;GPRC5B;IL17RA;RIPK1
prerank,regulation of calcium ion transport (GO:0051924),0.30402528974095056,0.8647275439246251,0.649331352154532,0.9533414507064089,1.0,3/54,3.65%,CACNA1D;ANK2;ADRA2A
prerank,negative regulation of cellular component organization (GO:0051129),0.2871629293600348,0.8645723831452262,0.6686131386861314,0.9530241973822077,1.0,17/74,15.81%,BMP6;PRKCZ;SYT11;RAPGEF3;APOM;DDX3X;WASL;TMC8;CDC42;IMPACT;EPHA3;DNM2;CRYAB;DNAJB2;CARMIL2;LGALS3;TFIP11
prerank,DNA damage checkpoint signaling (GO:0000077),0.34257862466268635,0.8642055684071884,0.654300168634064,0.9531333819138048,1.0,14/28,29.24%,ATM;DONSON;HUS1;DOT1L;CEP63;CLSPN;INTS7;NBN;RAD9A;CDC5L;TIPRL;USP28;CHEK1;E2F1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.3273163135713479,0.8640504669468021,0.6389830508474577,0.952811477074032,1.0,6/33,11.69%,SMAD3;TP53;SMARCA4;TERT;APLN;TEAD1
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.32874024338617647,-0.86397596829035,0.6471861471861472,0.8877974341110805,1.0,6/18,10.85%,NELL1;DAB2IP;DACT1;RDX;HSP90AA1;MSN
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.29010655242903327,-0.8639696930838492,0.6985294117647058,0.8870879760412262,1.0,5/31,11.05%,TFRC;GPI;PTPRC;EPHB2;HMCES
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.3175797710498638,-0.8631072487821926,0.6740088105726872,0.8881320849299955,1.0,12/21,38.60%,RAD51B;ATAD5;NPM1;DTL;MECP2;CCND1;CDC7;CDK1;BRD4;CCNB1;CDC25C;RAB11A
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.33326112861734425,0.8627331581460903,0.6539735099337748,0.9548925071041348,1.0,5/30,12.06%,LEPROT;FZD5;HUWE1;NPEPPS;CSNK2A2
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.34366291749950517,0.8622637460367817,0.6457960644007156,0.9552316827069426,1.0,7/28,15.81%,KMT5C;KMT5B;PARP9;PRKDC;PNKP;SMCHD1;TFIP11
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.2923972326955812,0.8622434034763374,0.6906906906906907,0.9546301197487642,1.0,9/69,8.44%,PPARGC1A;PRKN;SLC30A10;RETREG1;SNX6;CPEB4;SOD2;KDM2B;GDNF
prerank,peptidyl-lysine monomethylation (GO:0018026),0.4111323706007067,0.8615315577648449,0.6304761904761905,0.9555329293742414,1.0,4/10,18.15%,SETD7;KMT5A;EHMT1;SETD3
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.363062868556814,-0.8614254001224446,0.6544276457883369,0.890950266186939,1.0,3/13,9.42%,STAT3;IL6ST;JAK1
prerank,nucleotide catabolic process (GO:0009166),0.3754956082380053,0.8607311203033354,0.6307420494699647,0.9566102150377052,1.0,4/16,10.01%,NT5C1B;DERA;SAMHD1;NT5C2
prerank,glycogen biosynthetic process (GO:0005978),0.3946964531247732,0.8607151880055508,0.6146616541353384,0.9553519407325489,1.0,3/12,14.09%,GYS1;PGM1;PER2
prerank,glucan biosynthetic process (GO:0009250),0.3946964531247732,0.8607151880055508,0.6146616541353384,0.9553519407325489,1.0,3/12,14.09%,GYS1;PGM1;PER2
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.3365189523475888,-0.860545171954993,0.6540178571428571,0.8920271023482775,1.0,8/18,21.18%,PLCG2;DYSF;DOCK2;SBNO2;LBP;SYK;TYROBP;PYCARD
prerank,development of primary male sexual characteristics (GO:0046546),0.32584194367807007,0.8605254428006329,0.6590909090909091,0.9550900228242416,1.0,2/34,1.21%,WNT4;KIT
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.4202584678539941,0.8603167190184785,0.6143410852713178,0.9548648010299459,1.0,2/10,9.28%,ATRX;SSBP1
prerank,mitotic spindle assembly (GO:0090307),0.3108408753459268,0.8597561310812546,0.6624405705229794,0.9553766224334359,1.0,14/42,19.66%,KIF2A;CLASP1;LSM14A;AURKB;MISP;KIFC1;STAG2;SMC3;PIBF1;MAP9;CCDC61;GOLGA2;OFD1;ARHGEF10
prerank,histone H3 acetylation (GO:0043966),-0.27676477055016024,-0.8597035518724425,0.706989247311828,0.8930391261597898,1.0,9/40,19.40%,LEF1;MAP3K7;YEATS2;JADE3;JADE1;MBIP;BRPF3;MEAF6;TAF5
prerank,regulation of interleukin-4 production (GO:0032673),-0.32135356581336116,-0.859681174278956,0.6764705882352942,0.8923623682581865,1.0,8/21,22.11%,LEF1;SLC7A5;HAVCR2;SYK;ZFPM1;PRKCQ;LGALS9;CD86
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.29103838965550444,-0.8593919063102764,0.6954314720812182,0.8922211159955835,1.0,5/32,10.04%,CDK14;CDK17;POLA1;BACH1;ID2
prerank,inner dynein arm assembly (GO:0036159),0.4150448904030113,0.8590703226850926,0.6346153846153846,0.956153475557586,1.0,5/10,27.22%,CCDC39;CCDC40;DNAAF5;CFAP73;DNAH1
prerank,nuclear pore organization (GO:0006999),-0.3497483947588354,-0.858918512455386,0.668724279835391,0.8925103400012666,1.0,8/14,39.60%,RTN4;NUP107;NUP93;NUP54;AHCTF1;TMEM170A;NUP205;NUP35
prerank,kinetochore organization (GO:0051383),-0.35873046396764263,-0.8588514209948128,0.6528066528066528,0.8919426917395717,1.0,8/13,32.22%,CENPE;CENPH;NDC80;CENPA;CENPF;DLGAP5;NUF2;POGZ
prerank,regulation of transposition (GO:0010528),0.3974520069557078,0.8587543285830622,0.6245136186770428,0.9561974211857309,1.0,2/13,10.12%,UBR2;MYBL1
prerank,exit from mitosis (GO:0010458),-0.3698473499475864,-0.8586546112523848,0.6395833333333333,0.8915847921515575,1.0,5/12,18.56%,CLASP2;EPS8;PPP2R2D;CHMP4B;SPAST
prerank,positive regulation by host of viral transcription (GO:0043923),-0.341246009305536,-0.8584076408532847,0.6835164835164835,0.8914072954823623,1.0,1/15,0.47%,LEF1
prerank,sulfur compound biosynthetic process (GO:0044272),0.27668387441813785,0.858385643016691,0.7286713286713287,0.9563131500822515,1.0,13/104,10.04%,UST;OGN;CHST15;CHST11;GSTT1;ST3GAL3;FMOD;B4GALT1;DSE;SLC26A1;CHSY1;CTH;GSTA3
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3468674813572897,0.857793947693964,0.6484098939929329,0.9569047634892066,1.0,10/25,22.89%,AMPD3;PRPSAP1;AMPD2;APRT;PRPSAP2;MTHFD1;GART;GMPR2;ADSL;GMPS
prerank,negative regulation of response to external stimulus (GO:0032102),0.27153384034211486,0.8576880599311814,0.725,0.9564723953743236,1.0,17/105,14.43%,RORA;C1QTNF3;PPARA;EPHA4;PCBP2;METRNL;GPS2;ENPP3;SERPINE1;PTEN;CDH5;TRIB1;DHX58;NMI;MAPKBP1;ACOD1;PPM1B
prerank,heterocycle biosynthetic process (GO:0018130),-0.357360733685253,-0.8570970499018202,0.6585903083700441,0.8932862749848447,1.0,2/14,6.40%,GPHN;GCH1
prerank,DNA-dependent DNA replication (GO:0006261),-0.22137151169172714,-0.8570852755910968,0.8404669260700389,0.892594486386212,1.0,46/128,29.71%,POLA1;REV3L;PSMB2;PRIM2;POLD3;PSMD14;PSMC6;WRNIP1;PRIMPOL;TEFM;UBB;PSMA4;PSMB9;RPA1;ORC5;ORC2;CDC45;PSMD11;DNA2;PSMB10;PSMD2;RFC4;POLD4;POLD1;RFC2;BLM;RECQL5;PSMA2;UBC;RPS27A;PSMB3;RECQL;MCM6;RFC5;PRIM1;PSMB5;TOPBP1;HELB;PSMA7;CDC7;MGME1;PSMF1;RAD51;CDK2AP1;PSMD7;RPA3
prerank,cellular protein catabolic process (GO:0044257),-0.25646630697925904,-0.8570016114451836,0.7159763313609467,0.892073893856578,1.0,20/59,22.23%,FAP;DAB2IP;CTSC;UBE2G1;SIAH2;CTSB;AP2B1;CAPN2;CTSL;AP2M1;CTSS;VLDLR;CTSO;RSPRY1;HTRA2;CHEK2;CTSZ;UBE2G2;BNIP3;MYLIP
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.39717399574038575,0.856998735588448,0.6302367941712204,0.9572620520695335,1.0,1/13,1.45%,ANAPC15
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.40036088864503194,0.8562527117878902,0.6337209302325582,0.9581829745665843,1.0,4/12,14.35%,PLK5;TP53;PRKDC;SDE2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.2411721225300818,0.8557380029318075,0.8218390804597702,0.9586208030499619,1.0,75/341,19.44%,RNF43;ASB2;ANAPC15;PRKN;FBXL17;SPSB1;RNF213;NEDD4;IFI27;PCBP2;DCAF11;FBXL19;ARRB1;USP9X;ANAPC2;PTPN23;SPSB4;UBR4;TBL1X;SMURF2;TTC3;RNF8;FBXW11;HUWE1;TRIP12;RNF217;BTRC;TBL1XR1;RNF19A;RNF34;SIRT1;FBXO22;ZSWIM8;AURKB;RNF13;WWP2;CUL4A;UBA6;FZR1;FBXO10;NUB1;PML;FBXO11;UBE2H;RNF115;RMND5A;FAF1;AMFR;VPS37A;ANAPC16;RNF146;BIRC6;MAEA;VPS4A;RNF19B;WDR91;RNF7;UFD1;UBE2E1;KCTD13;SYVN1;CDC34;NPLOC4;SQSTM1;NDFIP1;RNF20;TAF1;ARIH1;KCTD21;NHLRC3;USP33;UBE4B;FBXL22;MIB1;MTA1
prerank,cellular response to estrogen stimulus (GO:0071391),-0.34737465499254405,-0.8555919829466674,0.6594360086767896,0.894222623296656,1.0,5/14,21.03%,AR;SERPINB9;NCOA4;ARID5A;SFRP1
prerank,JNK cascade (GO:0007254),-0.2723984021767148,-0.855582782597241,0.7142857142857143,0.8935300562075974,1.0,14/40,25.00%,MAP3K5;NOD1;MINK1;MAP3K7;TNFRSF19;MAP4K3;UBB;NOD2;MAP3K11;SH2D3C;MAP2K7;UBC;RPS27A;TAB1
prerank,regulation of lipase activity (GO:0060191),-0.35910532627314073,-0.8554698540925834,0.6581196581196581,0.8930369779034089,1.0,3/13,13.16%,PCSK5;PCSK6;SNCA
prerank,proteoglycan metabolic process (GO:0006029),0.3450362246535446,0.8554300512319724,0.6469565217391304,0.958609384822626,1.0,7/26,13.29%,IGF1;CHST11;SULF2;GAL3ST4;FOXL1;CNMD;SULF1
prerank,negative regulation of hormone secretion (GO:0046888),-0.3889302401189363,-0.8551726862100038,0.6660117878192534,0.892937759476987,1.0,4/10,33.17%,RAB11FIP1;RAB11FIP5;RAB11FIP3;LIF
prerank,protein polyubiquitination (GO:0000209),0.24352351275530498,0.8551631582692553,0.7959667852906287,0.9585129482305625,1.0,62/297,19.14%,RNF152;UBE2E2;SASH1;PRKN;FBXL17;SPSB1;RNF213;NEDD4;IFI27;NHLRC4;RNF135;FBXL19;TRIM56;ANAPC2;UBR2;SMURF2;TTC3;RNF8;FBXW11;HUWE1;TRIP12;RNF217;TNKS2;BTRC;RNF19A;RNF34;HERC6;NPEPPS;UBR5;FBXO22;FBXL12;RNF41;FBXW8;FBXO4;WWP2;FZR1;FBXO10;TRIM62;DDB2;FBXO11;FBXL20;DZIP3;LONRF1;UBE2H;RNF115;RMND5A;AMFR;RNF31;HECTD1;RNF146;RNF19B;UBE2E1;SYVN1;CDC34;FBXW10;RNF20;TAF1;ARIH1;MIB2;NHLRC3;UBE4B;FBXL22
prerank,negative regulation of macroautophagy (GO:0016242),0.3412228938586093,0.8547596358565035,0.6655172413793103,0.9587063341812314,1.0,6/26,15.86%,NUPR1;LRRK2;SMG1;PIK3CA;TSC1;SCFD1
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.38017608167423056,-0.8544262019860313,0.6417910447761194,0.8937464267010148,1.0,5/10,35.64%,NHP2;DKC1;NAF1;RPUSD3;RPUSD2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.24323968421540373,0.8542665946361623,0.7828162291169452,0.959078951216587,1.0,69/264,23.35%,SRRM2;DDX5;POLR2A;SNRNP70;PCBP2;PABPN1;HNRNPR;HNRNPH1;SRSF5;SNIP1;HNRNPA2B1;POLR2D;RBM15;SPEN;NOVA1;GPKOW;CCAR1;CWC27;GTF2F1;SRPK2;HNRNPL;CWC15;IK;USP49;PHF5A;SRSF11;PRCC;HNRNPC;SCAF11;PRPF3;SNRNP40;RBM4;TFIP11;HNRNPM;CPSF3;CWF19L1;FRG1;USP39;ZCRB1;PRPF6;FUS;SRSF1;CSTF1;HNRNPH3;CDC40;PCF11;SRSF10;U2AF1;EFTUD2;SNRPC;SRSF7;SF1;PNN;POLR2G;WBP4;PRPF31;SNRPA1;U2AF2;SF3B2;SF3B1;PPWD1;SF3B5;CPSF7;GCFC2;PQBP1;CDC5L;RNPC3;NUDT21;POLR2F
prerank,negative regulation of immune response (GO:0050777),-0.21511347485266952,-0.8539573472212896,0.8565400843881856,0.8939129224768811,1.0,43/154,23.54%,CALCRL;ADCY2;ADCY7;MYH9;GNG2;RAMP2;LYN;PLK2;ADCY4;PLCG2;PTGDR;IRAK3;HTR7;PTH1R;TRIM27;CYSLTR1;PRKAR1B;CYSLTR2;PRKAR2B;HAVCR2;HTR4;PTHLH;SAMSN1;RAMP1;IAPP;GNB1;VIPR2;TYRO3;SYK;SIRT2;GPR45;ADCY3;ADCY8;PRKAR2A;GPR176;HRH2;ADCYAP1R1;YES1;MC5R;NPSR1;FYN;LHCGR;RHBDF2
prerank,membrane fusion (GO:0061025),-0.28527598291949086,-0.853844800115768,0.7118226600985221,0.8934152202604532,1.0,5/33,9.50%,DNM3;RIMS1;DNM1;DYSF;NSF
prerank,protein localization to cell surface (GO:0034394),0.34514604074773725,0.8537994227380374,0.6522491349480969,0.9593912801624328,1.0,3/26,7.24%,ANK2;PRRT1;PTPRU
prerank,cGMP metabolic process (GO:0046068),0.40132812908805876,0.8536822038298697,0.6609848484848485,0.9589881192717928,1.0,2/12,6.12%,NPR1;NPR2
prerank,positive regulation of growth (GO:0045927),-0.2553335308379527,-0.8529325428675929,0.7507598784194529,0.894522588041811,1.0,13/64,14.49%,AKAP6;TGFB2;RFTN1;LGI1;CXCL16;H3-3A;ERBB2;RPS6KA3;SLC25A33;MFSD2A;TAF9B;RPS6KA1;PPM1F
prerank,histone H2A ubiquitination (GO:0033522),0.3754302352923416,0.8524980140578897,0.6485507246376812,0.9607703731119877,1.0,5/17,13.60%,UBR2;RNF8;BCOR;KDM2B;DDB2
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.292080311379274,0.852471803109429,0.7062314540059347,0.9601801198921323,1.0,12/63,14.70%,TFDP2;ATM;ARID3A;TP53;RBL2;CNOT10;TFDP1;PRKDC;PML;SDE2;GADD45A;E2F4
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.3766802676554039,0.8517732203645042,0.6328413284132841,0.9609801084117716,1.0,1/16,1.27%,DDX5
prerank,response to organic cyclic compound (GO:0014070),0.29714410105274736,0.8512598796928013,0.6550632911392406,0.9613836814644501,1.0,6/52,5.86%,IL18;SPP1;PAQR7;LRRK2;TLR3;TIPARP
prerank,protein monoubiquitination (GO:0006513),0.3212497323636609,0.8512465300271287,0.6688311688311688,0.9607743484856256,1.0,4/36,7.67%,PRKN;CTR9;MGRN1;HUWE1
prerank,tRNA modification (GO:0006400),0.28642303498309774,0.851231398597647,0.6968325791855203,0.960167106145808,1.0,12/62,19.97%,TRMT9B;TPRKB;TRMT44;TYW1;METTL6;PUS10;LCMT2;PUSL1;WDR4;DTWD2;DUS2;ADAT2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.3050176613797808,0.8502256526101774,0.6640378548895899,0.9615756818289428,1.0,12/50,17.51%,CCNA2;CCNA1;CCNT2;CCND3;CDK5RAP3;CDC25A;GTPBP4;CCNB2;GADD45A;CCNG1;CCNE1;CNPPD1
prerank,regulation of telomerase activity (GO:0051972),-0.2644027926140774,-0.8498565255502809,0.6958762886597938,0.9001187816544409,1.0,20/45,31.43%,PARM1;HSP90AB1;NEK7;HSP90AA1;XRCC5;CTNNB1;TERF1;CCT2;MEN1;PRKCQ;HMBOX1;PTGES3;MAP2K7;KLF4;TNKS;DKC1;NAF1;MAPK3;PIF1;PKIB
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.37546158161516957,-0.8493764447092421,0.6624737945492662,0.9003115827894151,1.0,2/10,5.96%,DLGAP1;DLGAP2
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.37776329809701775,0.8491410768428899,0.6329588014981273,0.9632003044161968,1.0,1/14,1.14%,PPP2R2B
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.35451316249454423,0.8486632251239569,0.6474820143884892,0.9635384772562071,1.0,4/19,5.70%,CUX1;OBSL1;CUX2;CAPRIN2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.36545504625002684,0.84826620493452,0.662962962962963,0.9636892058092403,1.0,6/18,11.58%,COL4A3;FGFR1;FLT1;APLN;PDPK1;ADAM17
prerank,negative regulation of viral release from host cell (GO:1902187),-0.3542198054924762,-0.8481716577697234,0.6723044397463002,0.901951868462523,1.0,2/13,14.20%,MID2;TRIM28
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.22247018774454005,-0.847702809877457,0.8453237410071942,0.9021437468801798,1.0,54/125,32.39%,CLASP2;PLK2;DYNC1I1;DYNLL1;XPO1;DYNC1LI2;CEP126;RPS27;SETD2;MAP4;BUB3;CLIP1;STMN1;NUSAP1;CENPE;EFHC2;TBCE;EML1;KIF11;RAN;PPP1CC;NUP107;NEK6;MAD2L1;CENPH;BCCIP;NSL1;NDC80;SUN2;KIF4A;KIF3B;KPNB1;KNTC1;MECP2;TUBG2;DCTN6;CENPA;NUP85;CDCA8;NDEL1;NDE1;RANGAP1;TNKS;CENPF;NUDC;PTPA;STIL;DLGAP5;NUF2;AURKA;CENPI;SPC24;CDC20;BUB1
prerank,DNA metabolic process (GO:0006259),0.24514234057635123,0.8476242571768265,0.8113879003558719,0.9643314679471017,1.0,70/270,21.92%,TOP2B;POLD2;KMT5C;DNTT;USP3;POLG;ATM;UVRAG;RAD54L;ACD;KMT5B;DNASE1L1;PARP4;SAMHD1;TERT;PDS5A;TCF7L2;SRPK2;RBBP8;PRKDC;MSH3;ZBTB1;HUS1;AXIN2;IGHMBP2;FANCA;RAD50;TOP3A;USP7;PNKP;TDG;POLE2;MCM7;MCM2;ORC3;DDB2;DFFB;POLA2;GADD45A;DOT1L;MGMT;INTS3;LRWD1;POLL;DNASE1L2;SP100;MBD4;CDC34;OGG1;TINF2;NBN;SUMO1;FEN1;RAD51D;SLX4;MMS19;PDS5B;RFC1;XPA;ASF1A;XRCC3;LIG4;RAD9A;ZNF445;EID3;MCM5;TOP1MT;LIG1;ORC6;CBS
prerank,hippo signaling (GO:0035329),0.33806949437571465,0.8469814011618598,0.6569965870307167,0.9650219558687958,1.0,8/26,15.17%,CASP3;TEAD3;WWTR1;TEAD2;AMOTL2;TEAD1;SAV1;STK4
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.29338674260113834,0.846961128818525,0.6944024205748865,0.964428091354095,1.0,7/57,9.10%,KIT;IGF1;IL18;PARP14;IL12B;TNFRSF18;PARP9
prerank,regulation of chemotaxis (GO:0050920),0.32554513842151256,0.8458683975171266,0.654054054054054,0.9660749279732624,1.0,5/30,10.37%,EFNB2;PDGFRB;ADGRA2;CYRIB;ZSWIM8
prerank,RNA 3'-end processing (GO:0031123),0.28510988852348607,0.8455894404822458,0.718887262079063,0.9660161121466491,1.0,20/69,22.14%,PABPN1;SRSF5;POLDIP3;RPRD2;TUT4;TENT2;SRSF11;SARNP;TENT4B;CPSF3;TUT7;SRSF1;CSTF1;CDC40;PCF11;U2AF1;SRSF7;U2AF2;TUT1;CPSF7
prerank,protein palmitoylation (GO:0018345),-0.2879867328092119,-0.8455883487267549,0.7150259067357513,0.9055286412161252,1.0,6/30,12.48%,ZDHHC9;HHAT;ZDHHC2;SELENOK;GOLGA7;ZDHHC14
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.27061495099090815,0.8450711368239503,0.7331460674157303,0.9664207840139013,1.0,5/93,2.32%,SH3RF2;TPD52L1;SASH1;CCN2;SPHK1
prerank,phospholipid metabolic process (GO:0006644),-0.23870932762699348,-0.845056888899566,0.7828947368421053,0.9058797241746033,1.0,9/71,10.80%,PLA2G4A;PIP4K2A;PLPP1;MBOAT1;PLPPR1;TNFAIP8L3;PLPPR5;PLPPR4;ENPP2
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.38178979108789035,-0.8450191654273081,0.6707818930041153,0.9052335530129079,1.0,3/10,7.03%,CAV1;ENG;ENPP1
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.32662112068188864,-0.8449233309516002,0.6731601731601732,0.9047112219898908,1.0,7/17,12.51%,RUNX1;TGFB3;VSIR;TGFB1;CREB3L1;BMP4;VIM
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.34883122314922,0.8446472265199265,0.6420168067226891,0.9666337083273836,1.0,4/21,12.55%,HK2;DERA;GCK;PGD
prerank,chemokine-mediated signaling pathway (GO:0070098),0.30852849046634917,0.8446175400416979,0.6780487804878049,0.966053436693746,1.0,7/42,16.97%,OXSR1;FOXC1;RBM15;CCL25;WNK1;CCL15;CCR2
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.3400824224949657,-0.844466474782772,0.6709129511677282,0.9048517403043101,1.0,5/14,24.15%,GAS6;CCDC3;CARD16;RFFL;NLRP2B
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.41300812294731615,0.8442757445017951,0.6551724137931034,0.9661058139051768,1.0,2/10,7.78%,UBAC2;ERLEC1
prerank,membrane protein proteolysis (GO:0033619),0.31196085584642747,0.8442430906589243,0.7,0.9655348973188311,1.0,11/37,19.70%,BACE2;DAG1;CTSH;APH1B;ADAM17;MBTPS1;ERAP1;NFKB1;CLPP;NCSTN;AFG3L2
prerank,tryptophan metabolic process (GO:0006568),0.3982173121586844,0.8439110428291858,0.6442307692307693,0.965576776168576,1.0,11/11,60.21%,ATP7A;KMO;HAAO;KYAT1;KYNU;ACMSD;IDO1;TDO2;IL4I1;IDO2;AADAT
prerank,purine nucleotide metabolic process (GO:0006163),0.3402872272573169,0.843845433856279,0.6564625850340136,0.9650652110216709,1.0,9/24,20.77%,FHIT;NT5C1B;NT5C2;PRPSAP1;PRPSAP2;MTHFD1;NT5C;GART;ADSL
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.36674805407782557,-0.8434979786190104,0.6767676767676768,0.9060197399469793,1.0,7/12,28.99%,MAOA;SMS;DDC;AMD1;SLC22A3;OAZ2;ODC1
prerank,regulation of centrosome duplication (GO:0010824),0.32722820541194486,0.8434056071952428,0.6611295681063123,0.9653300722893404,1.0,9/29,20.41%,PKHD1;SIRT1;CHMP1A;ALMS1;CHMP4C;CEP120;XRCC3;CEP295;CHMP2A
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.3853847932164625,0.8433420467061776,0.6767485822306238,0.964818077339479,1.0,5/13,17.74%,YJU2;SIRT1;DYRK1A;SNAI1;KDM1A
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.34564745611540293,0.8432147326253979,0.6636690647482014,0.9644407222212054,1.0,3/25,7.27%,HK2;PGAM2;GCK
prerank,protein stabilization (GO:0050821),0.2517681755100743,0.8431133413200987,0.7805194805194805,0.9640228148146684,1.0,12/168,6.59%,ATP1B3;ANK2;PPARGC1A;IGF1;STXBP4;PRKN;EPHA4;AAK1;LAMP2;USP9X;CREBL2;TBL1X
prerank,cell-cell junction maintenance (GO:0045217),0.40697269861405977,0.8428071826461947,0.6510721247563352,0.9640061984408796,1.0,1/11,2.47%,NLGN2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.31665384273274216,0.8425443741234144,0.6862745098039216,0.9638647298377518,1.0,9/38,12.65%,ACE;EPHA4;DLG3;SH3BP5;GPRC5B;MVP;NOX4;CASS4;SRCIN1
prerank,copper ion homeostasis (GO:0055070),-0.32679513653656206,-0.8424547005695162,0.7202643171806168,0.9073359288139609,1.0,6/17,24.62%,APP;ATOX1;SLC31A1;COMMD1;MT2A;CUTC
prerank,positive regulation of macroautophagy (GO:0016239),0.3001693893529615,0.8423785802256466,0.6880877742946708,0.9635728136481824,1.0,10/48,10.49%,PRKAA2;SESN1;SESN2;FYCO1;UVRAG;PIP4K2C;LARP1;HTT;SIRT1;IRGM
prerank,axonal transport of mitochondrion (GO:0019896),0.4064387751039875,0.8414989276651775,0.6541666666666667,0.9647715068888064,1.0,2/11,7.06%,TRAK1;OPA1
prerank,coenzyme A metabolic process (GO:0015936),0.38133326011100244,0.8414696889805104,0.6459854014598541,0.9642043146643694,1.0,7/14,27.46%,PANK1;DCAKD;ACLY;CROT;SLC25A16;ACOT7;ACAT1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.3593796375904695,-0.8413925551491099,0.6590909090909091,0.908684188893762,1.0,4/12,14.31%,TASOR;APOBEC1;TRIM28;ATF7IP
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.29075963894085244,-0.8412271557891275,0.7099056603773585,0.9082868593468943,1.0,6/26,14.58%,CAV1;RTN4;MFHAS1;CYBA;TIRAP;LBP
prerank,regulation of lamellipodium assembly (GO:0010591),0.32181607070664126,0.8409009435290942,0.6694214876033058,0.9647147585226135,1.0,7/34,11.35%,AUTS2;AVIL;CAPZB;PIK3CA;HRG;FER;CDC42
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.29586204411972516,0.8403822796994131,0.7103658536585366,0.9651126415145108,1.0,13/52,17.83%,TUT4;POLR2D;SAMD4A;EXOSC7;CNOT10;PAN3;PNLDC1;DDX6;DCP1A;DIS3;TUT7;NT5C3B;EXOSC3
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.35070502559021793,0.840272425331175,0.667262969588551,0.9646939661203968,1.0,3/20,6.89%,WNT4;SIK1;SLC27A1
prerank,negative regulation of complement activation (GO:0045916),-0.36840627340779797,-0.8401605050201391,0.6810344827586207,0.9096380682504084,1.0,4/10,31.88%,SUSD4;A2M;SERPING1;CR1L
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.23616127050973496,-0.839860390181353,0.7866242038216561,0.9095214553337797,1.0,16/73,20.19%,KITLG;RUNX1;LMO2;PSMB2;GATA2;PSMD14;PSMC6;TCF12;TAL1;METTL3;PSMA4;PSMB9;PSMD11;PSMB10;PSMD2;YTHDF2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.29361522766366743,-0.8392418086776231,0.7194570135746606,0.9099853635188542,1.0,8/26,20.43%,HECW2;CUL3;CDK5RAP2;DUSP1;LCMT1;CENPE;CDC23;NEK6
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.3153479153555459,-0.838041876512703,0.711453744493392,0.9115402803948303,1.0,5/20,18.09%,HSP90AB1;PROX1;PKD1;CCNY;RGCC
prerank,negative regulation of interleukin-10 production (GO:0032693),0.3590794573570301,0.8377071856260502,0.6357142857142857,0.9692454640431433,1.0,3/16,10.08%,TRIB2;IL12B;CD274
prerank,response to molecule of bacterial origin (GO:0002237),0.2807260428246235,0.8374814387952142,0.7161764705882353,0.9690617907449278,1.0,14/69,11.59%,CPS1;SMAD6;TLR4;FZD5;PTPN22;SRR;MAPKAPK3;TAB2;FER;CYRIB;LY96;TRIB1;ADAM17;NOCT
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.3072186527988016,0.8373449305684719,0.6952526799387443,0.9687090732115112,1.0,5/43,6.37%,IGF1;IL18;BMPR1A;NOX1;PDGFRB
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.3020988537754039,-0.8364185288935371,0.7030878859857482,0.9139357848170483,1.0,7/25,13.95%,BMPR2;ENG;ACVRL1;NOTCH1;CCN1;BMP4;BMPR1B
prerank,negative regulation of microtubule polymerization (GO:0031115),0.3817442634677821,0.836156243168688,0.6545801526717557,0.9704658439109215,1.0,4/12,10.71%,EML2;MAP2;CDH5;DYRK1A
prerank,myotube cell development (GO:0014904),0.4037755015620362,0.8361505796825346,0.6481113320079522,0.9698440487754044,1.0,1/10,1.44%,IGF1
prerank,protein import (GO:0017038),0.2713404823383249,0.8360731771005565,0.725258493353028,0.9693838812421082,1.0,26/84,24.39%,APPL2;TNPO1;LAMP2;SAMM50;PEX11B;IPO13;PXMP2;HSPA4;PEX14;ACBD5;PEX19;NUP155;RAB8B;SLC25A17;PEX16;PEX5;NUP188;TSC2;TNPO2;NUP153;SNX33;PEX26;HEATR3;PRICKLE1;PPP1R10;HIKESHI
prerank,protein-containing complex subunit organization (GO:0043933),-0.22361252970432652,-0.8360388850791549,0.8724279835390947,0.9139205310828841,1.0,27/109,18.45%,SLC2A1;REPS2;RIMS1;IL1RAP;LIN7A;PTK2B;SKAP2;HES1;OCLN;CD2AP;PPP2R1A;ELOB;TUBGCP2;ADD2;CAPZA2;CLDN14;FAS;LPXN;MDN1;DMTN;SHANK1;WASF1;CAPZA1;APC;CD74;TRAF1;FANCC
prerank,lipoprotein catabolic process (GO:0042159),-0.3642725366244042,-0.8360074570781536,0.691089108910891,0.9132647099486921,1.0,4/11,13.32%,APOE;CTSD;PPT1;ABHD17B
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.37848785972470067,0.8359823958865406,0.6807692307692308,0.9689355683351404,1.0,4/13,11.58%,FGFR1;APLN;PDPK1;ADAM17
prerank,tryptophan catabolic process (GO:0006569),0.3982173121586844,0.8350862907394175,0.6542239685658153,0.9700989326387748,1.0,11/11,60.21%,AFMID;KMO;HAAO;KYAT1;KYNU;ACMSD;IDO1;TDO2;IL4I1;IDO2;AADAT
prerank,negative regulation of potassium ion transport (GO:0043267),0.39092177997394084,0.835035003070265,0.6653771760154739,0.9695776671687848,1.0,1/13,0.65%,ACTN2
prerank,positive regulation of protein kinase activity (GO:0045860),0.25367834717144494,0.8348205541376846,0.7797062750333779,0.9693660219046121,1.0,18/148,11.01%,PRKAG2;ACE;EPHA4;ALS2;ADRA2A;DDX3X;CAMK1;IL12B;CACUL1;SLC27A1;DLG3;TGFBR2;GPRC5B;TAB2;NOX4;IRGM;CASS4;JTB
prerank,miRNA metabolic process (GO:0010586),0.35707489787925845,0.8342596687110616,0.6672661870503597,0.969841371148246,1.0,5/20,16.40%,TUT4;SND1;DICER1;TENT4B;TUT7
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.28224720487879157,0.8337781204663994,0.7521613832853026,0.9701976735201375,1.0,11/80,10.46%,KIF2A;STX18;KIF3C;UVRAG;ARFGAP3;HTT;GOLPH3L;KIF1C;KLC1;PICK1;COPZ2
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.38369376033559655,0.8333351300782949,0.6448598130841121,0.9704058832790822,1.0,3/12,11.78%,RNF8;LARP7;NELFCD
prerank,axoneme assembly (GO:0035082),-0.2838694213529668,-0.8328858868774541,0.729064039408867,0.9183550101860701,1.0,17/30,41.98%,DCX;RP1;SPEF1;DNAAF3;LRGUK;CCDC65;RSPH9;CFAP206;SPAG1;FOXJ1;TTLL3;DNAAF2;RSPH1;TTC12;CFAP74;DNAAF1;RSPH4A
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.35529619920931876,0.8327371394677153,0.6672727272727272,0.9709319275380025,1.0,6/18,17.63%,ANKRD17;DDX60;DHX58;BIRC3;UFD1;NPLOC4
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.37694071642667115,-0.8326443932988277,0.708171206225681,0.9181181800103169,1.0,1/10,3.67%,RUNX1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.379757218110068,0.8322236268696765,0.6797752808988764,0.971310473287266,1.0,4/13,19.09%,NFU1;CISD3;ISCA1;MMS19
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.3467108530521315,0.8316611263911466,0.6488413547237076,0.9717774338833796,1.0,3/17,6.47%,IL18;TLR4;IL12B
prerank,histone H4-K16 acetylation (GO:0043984),0.3470943368630914,0.8315123878924371,0.6544789762340036,0.9714298798485019,1.0,7/19,24.56%,KMT2A;KAT7;OGT;KANSL1;KANSL3;MSL3;PHF20
prerank,protein polymerization (GO:0051258),0.29157378921260907,0.8302781339937388,0.7193500738552437,0.9732913345400528,1.0,9/55,12.56%,GAS7;PRKN;ARHGAP6;RNF135;DIAPH1;WASL;CATIP;VIL1;TTC17
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.28345863364211954,-0.8302151139134198,0.7170263788968825,0.9220027691968739,1.0,9/29,23.18%,SMAD7;RPS2;ARRDC4;AXIN1;PINK1;DCUN1D3;BAG5;TRIB3;ARRDC3
prerank,negative regulation of bone mineralization (GO:0030502),-0.3535094339857046,-0.829750891389441,0.683083511777302,0.9222131120422925,1.0,3/13,7.47%,PTK2B;ENPP1;ECM1
prerank,negative regulation of axonogenesis (GO:0050771),-0.2883544759354685,-0.8296927567664558,0.708433734939759,0.921598719568457,1.0,13/27,21.40%,RTN4;DCC;DIP2B;ULK1;ULK2;FGF13;LINGO1;SEMA3G;MT3;ARHGDIA;GDI1;RTN4R;MCF2
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.33766060112977087,0.8293376210774974,0.6859205776173285,0.9744994779582592,1.0,8/22,21.03%,SOX12;TNFRSF18;DUSP10;FANCA;IRF1;CD46;BCL6;CTLA4
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.25410111241124517,0.8293276877542755,0.7986577181208053,0.9738928776360539,1.0,11/140,6.96%,ADCY5;LPAR1;CCR9;ACKR2;JPH1;LPAR2;BDKRB2;CACNA1C;P2RX3;CACNB3;KNG1
prerank,protein localization to condensed chromosome (GO:1903083),0.3800176861586764,0.8292451588506872,0.6556776556776557,0.9734326897016201,1.0,5/12,24.75%,AURKB;IK;CHAMP1;MIS12;SPDL1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.35360879605269296,0.8291199351401849,0.6934931506849316,0.9730777571268447,1.0,4/18,9.56%,FRS2;BHLHE41;HDAC4;HDAC1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.37644557930666556,0.8286879448706913,0.671559633027523,0.9733131001858593,1.0,2/13,3.86%,NUPR1;LRRK2
prerank,mitochondrion disassembly (GO:0061726),0.31265646162847344,0.8285702789157344,0.6902356902356902,0.9729209719444232,1.0,7/34,13.75%,PRKN;ATG5;WIPI1;AMBRA1;BECN1;ATG7;ATG2A
prerank,positive regulation of exosomal secretion (GO:1903543),0.3654401188112506,0.8283540913372553,0.6642066420664207,0.9727401239077095,1.0,7/15,22.43%,SDC4;SMPD3;SNF8;VPS4A;CHMP2A;RAB7A;SDCBP
prerank,regulation of intracellular transport (GO:0032386),0.30524314920751067,0.8282869932959198,0.7035830618892508,0.972238296380938,1.0,8/38,15.86%,LRRK2;GAS1;MAP2;RAB11B;GRIPAP1;CRYAB;RBM4;SCFD1
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.3569643694896369,0.8281377202189303,0.6591760299625468,0.9719062583197552,1.0,3/18,6.50%,CD300A;PARP10;TP53
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.2483210023100652,-0.8276423720047309,0.7590361445783133,0.9248026072754228,1.0,15/56,19.42%,NOD1;ALPK1;SFTPA1;SFTPA2;PLCG2;MAP3K7;CTSB;RPS6KA3;CTSL;CTSS;LBP;UBB;NOD2;TIFA;TLR7
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.3649005447700214,0.8273967437211059,0.6380255941499086,0.9727079329214602,1.0,1/14,1.76%,PPARA
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.302437710695851,-0.827259334169417,0.7242990654205608,0.9240949351029702,1.0,10/21,31.81%,ERCC1;RPA1;GTF2H1;GTF2H4;GTF2H5;ERCC2;DDB1;RPA3;ERCC3;RPA2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.302437710695851,-0.827259334169417,0.7242990654205608,0.9240949351029702,1.0,10/21,31.81%,ERCC1;RPA1;GTF2H1;GTF2H4;GTF2H5;ERCC2;DDB1;RPA3;ERCC3;RPA2
prerank,cellular response to cAMP (GO:0071320),0.32104940096291623,0.8269359779502127,0.6810344827586207,0.9729722011811937,1.0,4/30,5.60%,SLC5A5;RAPGEF3;EZR;SLC26A3
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.2853886194636088,-0.826933696839423,0.7375,0.9240012158239377,1.0,4/29,8.69%,CXCL12;GAS6;JAM2;CALR
prerank,indolalkylamine catabolic process (GO:0046218),0.39819231734873206,0.826816191245795,0.6483300589390962,0.972600282507661,1.0,10/10,60.21%,KMO;HAAO;KYAT1;KYNU;ACMSD;IDO1;TDO2;IL4I1;IDO2;AADAT
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.3339132752783076,0.82612827878149,0.698019801980198,0.9733494825951238,1.0,2/23,4.33%,ALOX12;ACSBG2
prerank,L-serine metabolic process (GO:0006563),0.3906590088402294,0.8258772532380881,0.6578411405295316,0.9732183978369706,1.0,3/10,21.92%,SRR;PHGDH;CBS
prerank,positive regulation of transport (GO:0051050),-0.22777574723404032,-0.8257085519029584,0.8412162162162162,0.9255697543375209,1.0,17/85,14.35%,ACTB;MERTK;GAS6;ACSL3;NEDD4L;GSK3B;ANXA1;APOE;RAB27A;GATA2;CALR;CD47;DOCK2;CYBA;CAPN10;SNCA;CD151
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.28845349972614404,0.8253846774335646,0.710691823899371,0.9735142561993189,1.0,8/52,11.39%,CELF2;DDX5;MBNL2;RBM15;NOVA1;THRAP3;SAP18;HNRNPL
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.338195527251712,0.8251394145058921,0.6852173913043478,0.9733586513814342,1.0,2/24,1.92%,AUTS2;AVIL
prerank,glutathione derivative biosynthetic process (GO:1901687),0.35291521449113905,0.8246603323243049,0.6751824817518248,0.9730744297897004,1.0,2/20,10.04%,GSTT1;GSTA3
prerank,glutathione derivative metabolic process (GO:1901685),0.35291521449113905,0.8246603323243049,0.6751824817518248,0.9730744297897004,1.0,2/20,10.04%,GSTT1;GSTA3
prerank,positive regulation of lipid kinase activity (GO:0090218),0.325547201970833,0.8245513044716362,0.6827956989247311,0.9726783442464257,1.0,6/29,7.55%,KIT;F2;EPHA8;FLT1;PDGFRB;AMBRA1
prerank,regulation of calcium ion import (GO:0090279),-0.3080552050723061,-0.8245137179961328,0.7222222222222222,0.9271219057598702,1.0,7/21,26.52%,CXCL12;TRIM27;CTNNB1;SLC30A1;PLN;FYN;CCL2
prerank,negative regulation of interleukin-8 production (GO:0032717),0.35787874604411124,0.8244167433494356,0.6903460837887068,0.9723305768582823,1.0,5/17,12.90%,SSC5D;ARRB1;MAP2K5;PTPN22;MAPKBP1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.2970264293838599,-0.8242301916610515,0.7431192660550459,0.9268907667755311,1.0,13/24,31.81%,POLD3;UBB;RPA1;RFC4;POLD4;POLD1;RFC2;POLK;UBC;RPS27A;RFC5;RPA3;RPA2
prerank,positive regulation of myelination (GO:0031643),-0.34798473424355514,-0.8241396245394168,0.6666666666666666,0.9263461982210213,1.0,2/11,7.20%,TENM4;TNFRSF1B
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.2645430962770619,-0.8238622471680419,0.7698209718670077,0.926146309159212,1.0,11/43,16.10%,PTPRJ;SH3KBP1;SH3GL2;ARHGEF7;DAB2IP;DUSP3;PTPN3;SPRY1;SOCS5;ZFYVE28;CBL
prerank,cellular iron ion homeostasis (GO:0006879),0.28930629659917784,0.8236216649791263,0.7424242424242424,0.9732592985974352,1.0,2/55,1.26%,BMP6;CP
prerank,synaptic vesicle transport (GO:0048489),-0.36106016841142846,-0.8236048334916711,0.6930022573363431,0.9258837421370903,1.0,5/11,25.76%,RAB27A;KIF5C;TMEM230;KIF5A;SYNJ1
prerank,cellular senescence (GO:0090398),-0.2904435401385539,-0.8233025520437555,0.7099056603773585,0.9257114942422552,1.0,6/27,12.53%,TBX3;SMC5;CALR;ECRG4;ID2;CDKN1A
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.3677660378061678,0.8227945855185256,0.6691871455576559,0.9742217339864323,1.0,5/14,16.79%,NMNAT1;AK3;AK4;AK8;NMNAT2
prerank,vitamin D metabolic process (GO:0042359),0.3847784632122899,0.822512620961168,0.6878850102669405,0.9741917952716463,1.0,4/13,22.04%,CYP2R1;GC;PIAS4;CUBN
prerank,alanine transport (GO:0032328),-0.3731956226718984,-0.8221861550369303,0.7213822894168467,0.9270913488118512,1.0,2/10,7.84%,SLC6A6;SLC1A4
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.30510325575559916,0.8221715028786267,0.7067545304777595,0.9742199806444225,1.0,6/40,9.70%,DAB2;MAGI2;ARRB1;SERPINE1;WASL;PICK1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.3888712250763083,0.8220625968781714,0.6633663366336634,0.9732057651234141,1.0,3/10,16.87%,ASCC2;MGMT;ALKBH5
prerank,DNA dealkylation (GO:0035510),0.3888712250763083,0.8220625968781714,0.6633663366336634,0.9732057651234141,1.0,3/10,16.87%,ASCC2;MGMT;ALKBH5
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.25799680882395143,-0.8220439814879255,0.7835616438356164,0.9266531934055602,1.0,22/54,22.58%,RPL3;RPL26;RPL7;RPL35A;RPLP0;RPL5;RPL14;RPL7A;RPL23A;RPL10A;RPL6;MDN1;MALSU1;NOP53;BRIX1;MRPL20;NHP2;RPL24;RPL11;RSL24D1;NPM1;RRP15
prerank,nuclear membrane organization (GO:0071763),-0.31169604385945365,-0.8219838658086859,0.6895074946466809,0.926061586244056,1.0,5/19,18.56%,GPER1;TMEM43;EMD;CHMP4B;SPAST
prerank,regulation of sequestering of calcium ion (GO:0051282),0.3823402941838797,0.8219686383131246,0.6767485822306238,0.9727768215608685,1.0,1/12,0.80%,ANK2
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.27640922912233745,0.8219051089485221,0.7428998505231689,0.9722746264046104,1.0,9/72,9.42%,TFDP2;SESN2;ATM;ARID3A;ATRX;TP53;RBL2;CNOT10;TFDP1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.3194495402542877,0.8217536777640989,0.6972176759410802,0.9719620110221792,1.0,4/32,4.05%,SNCAIP;SYT11;LRRK2;DTNBP1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.2765609619804521,-0.8216837386826569,0.764172335600907,0.9259019557306609,1.0,5/29,10.70%,GHR;STAT3;SOCS2;STAT5B;PKD1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.30097937105573774,0.8216827172586899,0.7103559870550162,0.9714902051934202,1.0,6/38,14.43%,RORA;SIRT1;TLE1;RIPK1;MAPKBP1;PPM1B
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.25752984015221436,-0.821288416046532,0.7702349869451697,0.9259094899350556,1.0,17/42,26.40%,POLA1;POLD3;WRNIP1;FAAP20;PRIMPOL;UBB;RPA1;RFC4;POLD4;POLD1;RFC2;POLK;DTL;UBC;RPS27A;RFC5;PCLAF
prerank,regulation of rRNA processing (GO:2000232),0.3588444272993516,0.8210359840768033,0.7010869565217391,0.9721238287113775,1.0,4/16,18.25%,RIOK2;WDR43;KAT2B;BUD23
prerank,GPI anchor biosynthetic process (GO:0006506),0.32105610002039026,0.8207242124670147,0.714765100671141,0.9720966040498349,1.0,3/30,6.37%,PIGN;PIGW;PIGQ
prerank,actin crosslink formation (GO:0051764),-0.3467230898231498,-0.8205489098050454,0.6989690721649484,0.9265825451817145,1.0,4/12,14.11%,FLNA;GAS2;EPS8;GAS2L3
prerank,nuclear pore complex assembly (GO:0051292),-0.3688498150402669,-0.8198506735806596,0.7062374245472837,0.9271033492747687,1.0,6/10,36.86%,RTN4;NUP107;NUP93;AHCTF1;TMEM170A;NUP205
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.30393166767406193,-0.8198111581619898,0.7349397590361446,0.9264608679887649,1.0,6/21,13.74%,PDE4D;XDH;HINT1;PDE2A;NT5E;NT5C1A
prerank,myeloid cell development (GO:0061515),0.35281541683809764,0.819637244580911,0.6494464944649446,0.9735218144124702,1.0,1/18,1.21%,KIT
prerank,mitochondrial fission (GO:0000266),0.3683884626454785,0.8191684859769798,0.6944444444444444,0.9737908424208184,1.0,5/16,13.53%,PRKN;OPA1;MTFR2;DNM1L;DNM2
prerank,morphogenesis of an epithelium (GO:0002009),-0.2900016208004684,-0.8187424255524641,0.7623318385650224,0.9277123368525426,1.0,10/25,23.24%,ACTB;ACTG1;TBX18;LAMA3;AHI1;SOX8;VCL;LRP6;LHX1;SOX10
prerank,positive regulation of protein catabolic process (GO:0045732),0.2672230155181802,0.8184997179772692,0.7833827893175074,0.9745161344345641,1.0,24/84,17.97%,SH3D19;PRKN;ADRA2A;NEDD4;VGLL4;EZR;APC2;TIPARP;SMURF2;HUWE1;ATG7;RNF41;WWP2;CSNK2A1;FZR1;ASB5;STX5;NKD1;FAF1;NRDC;SNF8;VPS35;GPC3;WNT5A
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.2522450410484356,-0.8182412758783643,0.8245125348189415,0.9279131180691044,1.0,14/47,20.71%,EPHB1;MID1;TGFB2;DAB2IP;PPIA;PHLPP1;FOXO1;RAP2A;FAS;SEMA4C;NOD2;KLHDC10;COPS5;LGALS9
prerank,chromatin organization (GO:0006325),0.2546790915674612,0.8177330761612849,0.8028720626631853,0.9753782554598371,1.0,34/132,20.78%,JARID2;HDAC8;ATRX;BAZ1B;SETD7;SMARCD3;SMARCA4;SMARCC2;SMARCE1;HDAC4;SIRT1;HDAC1;BAZ1A;ZBTB1;PHF1;CDAN1;HMGN3;SNAI1;KAT2B;MTA2;LRWD1;SETDB2;RB1;EHMT1;TCF7L1;KDM6B;PADI4;SATB2;EZH1;BRWD1;MPND;TAF6L;KDM6A;SMARCD2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.327795184549822,-0.8171781179225033,0.7117516629711752,0.9290642929813852,1.0,5/16,14.82%,SCARB1;APOE;GCH1;HIF1A;NUS1
prerank,regulation of centriole replication (GO:0046599),-0.31632610713852327,-0.8169355392380574,0.7123595505617978,0.9287591829598593,1.0,7/17,31.17%,PLK2;CDK5RAP2;TRIM37;NPM1;CEP76;STIL;BRCA1
prerank,protein heterotetramerization (GO:0051290),-0.33913155999600303,-0.8166000166873733,0.734020618556701,0.928626909811939,1.0,3/13,15.27%,GRIN2B;PKD1;GRIN1
prerank,neurotrophin signaling pathway (GO:0038179),0.3399042796430236,0.8165097735811788,0.6923076923076923,0.9771325460877606,1.0,3/21,3.53%,FRS2;MAGI2;CASP3
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.3500467191837988,-0.8164443395983487,0.7002053388090349,0.9282045425741072,1.0,4/13,11.37%,TOX;CAMK4;CLPTM1;BMP4
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.3519611025713242,0.8164153019991094,0.6837121212121212,0.9766919805677658,1.0,3/16,10.94%,WNT4;F2;SUCO
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.3623869108962796,0.8163905735199273,0.6728624535315985,0.9761235707765262,1.0,3/16,8.00%,IGF1;PHIP;IGFBP3
prerank,cellular response to mechanical stimulus (GO:0071260),-0.25372437885315935,-0.8158111122765208,0.7648809523809523,0.9286336531109026,1.0,21/46,34.59%,PIEZO2;F11R;PIEZO1;PDE2A;FAS;TMEM150C;CRADD;CASP2;MAP3K14;TLR7;BNIP3;CD40;MAPK8;MAPK3;MAP2K4;AQP1;BCL10;PTGER4;TLR8;MYD88;BAD
prerank,positive regulation of intracellular protein transport (GO:0090316),0.2458283581748483,0.8155649356371618,0.8235294117647058,0.9770975122575375,1.0,17/144,9.99%,SMAD3;TFDP2;LEPROT;BID;RAPGEF3;RUFY3;FZD5;CAMK1;TP53;BCAS3;HUWE1;ZIC1;TFDP1;NPEPPS;UBR5;MAVS;TCF7L2
prerank,sterol homeostasis (GO:0055092),0.2800643968910437,0.8152419838070569,0.753731343283582,0.9771048170532055,1.0,4/65,5.04%,RORA;IL18;GRAMD1B;APOM
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.23886700353761015,-0.8147759612465344,0.8453038674033149,0.9297459662873648,1.0,15/62,18.10%,CXCL12;TPT1;ARHGEF2;PPIA;ACKR3;RTKN2;TMBIM6;CREB3L1;YBX3;ARMC10;PINK1;CLU;DNAJA1;HSPB1;HTRA2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.3138984928374611,0.8147625228556986,0.7157534246575342,0.9774077201538541,1.0,4/31,9.42%,TFDP2;BID;TP53;TFDP1
prerank,non-motile cilium assembly (GO:1905515),0.32290725100590056,0.8146648547836597,0.6916524701873935,0.9769943432579987,1.0,9/30,20.99%,CEP250;IFT122;IFT88;BBS10;GORAB;PIBF1;TMEM17;PCM1;FUZ
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.3378223607475225,-0.8143219963656095,0.7419354838709677,0.9298376262571406,1.0,8/14,36.49%,ELAVL4;TIRAP;YBX3;HNRNPA0;ELAVL1;MYD88;DAZL;ANGEL2
prerank,regulation of pH (GO:0006885),0.385028400572213,0.8143114380601243,0.6772277227722773,0.9770210192313983,1.0,1/11,2.05%,LACC1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.37260418027147607,0.8142878035638922,0.6755218216318786,0.9764515256941798,1.0,5/12,22.89%,LHPP;ADSS1;GART;ADSL;GMPS
prerank,cholesterol homeostasis (GO:0042632),0.2801460680422406,0.8140051611598885,0.7511177347242921,0.9763898677974238,1.0,4/64,5.04%,RORA;IL18;GRAMD1B;APOM
prerank,activation of GTPase activity (GO:0090630),0.26127561875262234,0.8137920814412387,0.7518142235123367,0.9761685927475178,1.0,13/89,11.12%,ARHGAP29;SIPA1L1;ARHGEF16;SYDE2;NGEF;TBC1D16;GMIP;APC2;BCAS3;GRTP1;DOCK7;RALGAPB;MTSS2
prerank,copper ion transport (GO:0006825),-0.3536339444183712,-0.8134768059590803,0.725531914893617,0.9306595242452801,1.0,6/11,31.78%,ATOX1;SLC31A1;COX17;CUTC;STEAP4;ATP7B
prerank,Golgi to lysosome transport (GO:0090160),-0.3578063938235102,-0.813404722795408,0.738562091503268,0.9300753035405092,1.0,3/11,16.53%,SORT1;LAPTM5;EHD3
prerank,keratan sulfate biosynthetic process (GO:0018146),0.3262426024984718,0.813149221475549,0.702276707530648,0.9767804970218588,1.0,4/26,5.98%,OGN;ST3GAL3;FMOD;B4GALT1
prerank,sphingoid metabolic process (GO:0046519),0.3824660873548519,0.8126868656657157,0.6888045540796964,0.9770768594205133,1.0,2/12,5.15%,SPHK1;NAAA
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.3342670045242018,0.8126613650107057,0.7073170731707317,0.9765139236602651,1.0,4/21,13.43%,BACE2;DAG1;ADAM17;ERAP1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.28874424360129675,-0.8126432853414477,0.7629107981220657,0.9306905108928868,1.0,12/25,26.21%,CACNB2;AKAP6;CEMIP;TRPC1;GPER1;SNCA;APLNR;NPSR1;THY1;F2R;CXCL10;PLCG1
prerank,positive regulation of protein export from nucleus (GO:0046827),0.35948712478181444,0.8121266369521783,0.6872586872586872,0.9768641824649795,1.0,4/15,9.99%,RAPGEF3;CAMK1;TP53;TCF7L2
prerank,positive regulation of protein metabolic process (GO:0051247),0.25550971573109904,0.8119538025487789,0.8008356545961003,0.9765946423929395,1.0,19/110,12.53%,ROCK2;PRKN;IL18;NEDD4;SLC6A9;IL17D;MAP2K5;APC2;TIPARP;IL12B;SMURF2;LDB1;HUWE1;ATG7;RNF41;WWP2;CSNK2A1;FZR1;ASB5
prerank,thymus development (GO:0048538),-0.3451536204583795,-0.811779287809353,0.7286324786324786,0.931479317442782,1.0,3/13,8.27%,TBX1;HES1;SIX1
prerank,protein insertion into membrane (GO:0051205),-0.27588829484272126,-0.8114886478840803,0.7858942065491183,0.9312550617603589,1.0,10/32,29.58%,REEP1;APP;SEC61B;CYB5A;EMD;VAPA;TRAM1;STX1A;HMOX1;WDR83OS
prerank,regulation of response to oxidative stress (GO:1902882),0.39519822437034813,0.8111495327117356,0.695049504950495,0.9775063537166468,1.0,1/11,1.98%,PRKN
prerank,nerve growth factor signaling pathway (GO:0038180),-0.3713258035259611,-0.8105889943707132,0.7390396659707724,0.9321121082444767,1.0,3/10,16.05%,NGF;RAP1A;BDNF
prerank,positive regulation of cell cycle (GO:0045787),0.27431697044095676,0.8102475074400395,0.779788838612368,0.978565124796653,1.0,9/62,12.33%,SMOC2;FGFR2;SPHK1;NUPR1;ANKRD17;CCND3;SRPK2;ADAM17;PRKCA
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.25687824470675974,-0.8101287419644688,0.8181818181818182,0.932200680199812,1.0,29/45,41.95%,STAT3;APP;EGR1;AIM2;USP50;NOD2;PANX1;HSPB1;TYROBP;CCL19;LGALS9;PYCARD;JAK2;TRIM16;P2RX7;CD36;MALT1;TLR8;MYD88;TMEM106A;GBP5;ISL1;CASP8;INAVA;TNF;NLRP12;LPL;GSDMD;IL6
prerank,regulation of neurogenesis (GO:0050767),-0.24145624142932062,-0.8098097079934833,0.8497109826589595,0.932052565446642,1.0,11/55,12.06%,B2M;NOTCH1;HES1;SERPINF1;SORL1;HEYL;MME;HEY2;NAP1L1;GPER1;CTNNB1
prerank,purine-containing compound catabolic process (GO:0072523),0.3671295894053538,0.8098026002595559,0.6801470588235294,0.978796906051551,1.0,3/13,10.01%,DPYD;NT5C1B;NT5C2
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.2937693830511834,-0.8097266979412,0.7072599531615925,0.931481608336217,1.0,7/23,20.71%,GAS6;VSIR;HAVCR2;LAPTM5;NR1H4;INHBA;LGALS9
prerank,positive regulation of endocytosis (GO:0045807),0.29246818110932093,0.8094468669109386,0.7504,0.9788348435529607,1.0,2/45,0.68%,DAB2;APPL2
prerank,response to X-ray (GO:0010165),0.3659036215300241,0.8092388883109327,0.685823754789272,0.9786277967399032,1.0,3/14,8.69%,ATM;NIPBL;XRCC4
prerank,"base-excision repair, gap-filling (GO:0006287)",0.3061164695873142,0.809217359314497,0.7431506849315068,0.9780589178431959,1.0,12/35,23.81%,POLD2;POLG;PNKP;TDG;POLL;MBD4;OGG1;FEN1;RFC1;LIG1;ADPRS;SMUG1
prerank,ether lipid metabolic process (GO:0046485),-0.3271009944365807,-0.8090068985397076,0.7214137214137214,0.9320124189622188,1.0,5/14,24.50%,AGPS;NCEH1;LIPE;GNPAT;DHRS7B
prerank,histone H4 acetylation (GO:0043967),0.2835981446505441,0.808308501900172,0.7214170692431562,0.9791176418298452,1.0,7/47,13.91%,BRD8;KMT2A;ZZZ3;ATF2;KAT7;BEND3;OGT
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.36017875160795165,0.8082209639355851,0.6992753623188406,0.9786902349779579,1.0,3/15,9.01%,TLR4;IL17D;IL17RA
prerank,regulation of hemopoiesis (GO:1903706),0.392038027579217,0.8080243342858194,0.683495145631068,0.978442573147277,1.0,5/10,16.31%,PRKCB;IL17D;PURB;LGALS3;CREBBP
prerank,protein alkylation (GO:0008213),-0.29312348439729236,-0.8079491503465772,0.7564402810304449,0.9332296677970123,1.0,11/22,35.22%,LCMT1;FAM98B;METTL22;SNRPD3;SNRPB;PRMT8;PRMT1;PRMT3;ETFBKMT;EEF1AKMT2;FAM98A
prerank,positive regulation of cellular respiration (GO:1901857),0.38278588593063567,0.8077449030026397,0.7075098814229249,0.9783659634846984,1.0,1/11,2.92%,NUPR1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.2276164954425103,-0.8075198133468982,0.8871951219512195,0.9332147297051194,1.0,22/83,24.88%,CDK14;CDK17;USP29;POLA1;PLK2;BACH1;CUL3;E2F3;CDKN1A;ACVR1;KLF11;EIF4E;PIM2;CDC45;NPAT;INHBA;PHF8;CDK18;PLK3;CDKN3;CCNE2;HINFP
prerank,defense response to protozoan (GO:0042832),0.3775510142945725,0.807243658170133,0.7014314928425358,0.9787053063264485,1.0,3/12,13.88%,GBP7;GBP2;GBP6
prerank,vasculature development (GO:0001944),0.35941961951025714,0.8071155807637328,0.6892138939670932,0.9783459971640888,1.0,4/16,8.86%,ERRFI1;PDGFRB;PIK3CA;CDH5
prerank,regulation of organelle organization (GO:0033043),0.26606399491500893,0.8069615222630478,0.7885714285714286,0.978015140531692,1.0,17/80,18.59%,SYT11;STX18;PRKN;CPLANE2;EZR;ARMH3;DIAPH1;DNM1L;MAVS;STX5;TBC1D25;CENPV;VPS35;SQSTM1;PAK2;RHOT1;AKAP9
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.3006195303272828,0.8066271332373512,0.715,0.9780146176895994,1.0,3/36,3.46%,TPD52L1;DEPTOR;TGFBR1
prerank,cellular response to gamma radiation (GO:0071480),0.34760363599357913,0.8065656234643714,0.6962699822380106,0.9775183253203408,1.0,6/17,19.10%,ATM;TP53;CRYAB;TLK2;KDM1A;YAP1
prerank,cellular response to UV-A (GO:0071492),-0.3506142088537839,-0.8063722330078581,0.7202505219206681,0.9345067149405484,1.0,7/11,45.73%,MME;MMP1;MMP3;PPID;MMP2;OPN5;MMP9
prerank,regulation of cytokinesis (GO:0032465),0.26323226780398534,0.8062557169692349,0.7678571428571429,0.9774681476564627,1.0,18/78,18.00%,PKP4;UVRAG;PLK5;CDC14A;MYO19;BECN1;AURKB;CDC14B;CDC42;FLCN;ZFYVE26;BIRC6;VPS4A;CHMP4C;CENPV;KIF13A;MAP9;PKN2
prerank,protein mannosylation (GO:0035268),0.325120819383669,0.8059214094860466,0.706081081081081,0.9774590474521202,1.0,5/22,12.42%,TMTC4;LARGE1;DPY19L3;TMTC1;LARGE2
prerank,regulation of translation (GO:0006417),-0.20148027520546463,-0.8054719611493244,0.9672897196261683,0.9353601123704244,1.0,42/173,21.60%,GRM5;PRR16;THBS1;NIBAN1;YBX1;RPL26;APP;RPS3;SYNCRIP;RPL5;CALR;ERBB2;RPS6KA3;FXR1;EIF4ENIF1;RPS4X;DAPK1;VIM;SHFL;MALSU1;EIF3B;RPS6KA1;MTG2;GLE1;EIF1;METTL3;EIF2AK3;BCL3;DHX9;EIF4E;RPL13A;HSPB1;PUM3;RPS27L;EEF2;RBM4B;BTG2;RBM3;EIF4A3;EIF3D;CNOT7;NPM1
prerank,DNA packaging (GO:0006323),0.35024859819364274,0.8053962681720317,0.7265774378585086,0.9778058000946285,1.0,7/16,27.76%,CHAF1B;TP53;CDAN1;NOC2L;H1-0;M1AP;RBBP4
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.35141431034687853,0.804964855056347,0.7045454545454546,0.9779746105189338,1.0,1/17,0.64%,ROCK2
prerank,pre-miRNA processing (GO:0031054),0.36175198201259495,0.804565483727783,0.7065420560747664,0.9781153263190046,1.0,7/14,28.23%,TUT4;DICER1;TUT7;AGO1;AGO4;AGO2;ADAR
prerank,positive regulation of defense response (GO:0031349),0.2622427067336904,0.804170859992445,0.7727272727272727,0.978200130305468,1.0,11/89,9.73%,IL18;NAPEPLD;TLR3;TLR4;IFNK;IL12B;SERPINE1;PLSCR1;GPRC5B;IL17RA;RIPK1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.2933327485218814,0.8030063949786581,0.7443365695792881,0.9797532810386047,1.0,9/42,17.11%,TLR4;DEFB1;F2;IL12B;SERPINE1;IRGM;CAMP;DMBT1;OPTN
prerank,negative regulation of innate immune response (GO:0045824),0.30564280145046263,0.803006246625576,0.7147707979626485,0.9791499846832853,1.0,9/34,13.94%,STAT2;SAMHD1;FAM3A;YTHDF3;DHX58;NMI;OAS3;ACOD1;USP18
prerank,reticulophagy (GO:0061709),-0.34036876519280446,-0.8029855824496368,0.7473903966597077,0.9388691341057759,1.0,4/12,9.99%,ULK1;ULK2;DDRGK1;UFM1
prerank,regulation of myotube differentiation (GO:0010830),0.32846188348227423,0.8020312236295893,0.7125850340136054,0.9803899096754303,1.0,7/24,11.30%,DMPK;SIK1;BHLHE41;HDAC4;HDAC1;FBXO22;MMP14
prerank,peptidyl-asparagine modification (GO:0018196),0.30665228240371284,0.8019899393723573,0.714759535655058,0.9798520290703577,1.0,6/31,15.71%,ST6GAL1;ASGR1;FUT8;MAGT1;ASGR2;HIF1AN
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.3627563291119247,0.8016671975069681,0.7058823529411765,0.979799543175637,1.0,4/14,15.22%,TGFBR1;PTPN11;RFLNA;ADAMTS7
prerank,response to lipopolysaccharide (GO:0032496),-0.20809744328006896,-0.800964282535847,0.936,0.9415646703955725,1.0,26/138,18.10%,MEF2C;PDE4B;NOS3;SCARB1;TNFRSF11A;DAB2IP;FOXP1;GCH1;TNFRSF1B;IRAK3;ERBIN;RPS6KA3;SBNO2;TIRAP;VIM;NOS1;SNCA;CARD16;LBP;CX3CR1;PELI1;NOD2;CD180;TRIM41;PDCD4;CDC73
prerank,amide biosynthetic process (GO:0043604),-0.24625297544251423,-0.8008866840397431,0.8179419525065963,0.9409541451217329,1.0,20/47,29.48%,SGMS1;SGMS2;SPTLC2;DEGS2;PAM;PCSK5;CERS4;ASAH2;SPTSSB;ASAH1;PCSK1;DMD;CLN8;TLCD3B;NANP;SPTLC3;ASS1;SPTLC1;NMRAL1;CERS2
prerank,P-body assembly (GO:0033962),0.37898966167178316,0.8008191838250578,0.7184466019417476,0.980750258267693,1.0,3/12,12.03%,ATXN2;LSM14A;DDX6
prerank,endocytic recycling (GO:0032456),0.2811132105135915,0.8005780359653324,0.7837837837837838,0.9805762508164708,1.0,15/50,18.46%,PTPN23;VPS26C;EIPR1;RAB11B;RAB13;VPS50;ANKRD27;SNX12;MICALL1;SNF8;VPS51;VPS35;VPS35L;CCDC93;CCDC22
prerank,regulation of mRNA catabolic process (GO:0061013),-0.20974318629465302,-0.800266502524184,0.9409448818897638,0.9413051057689813,1.0,41/121,29.90%,PRR5L;PSMB2;YWHAB;HSPA8;XPO1;PSMD14;PNPT1;ANP32A;PSMC6;FXR1;VIM;UBB;PSMA4;PSMB9;ZC3H14;PABPC1;HSPB1;PSMD11;PSMB10;PSMD2;YTHDF2;DCP2;CNOT7;PSMA2;EXOSC4;UBC;RPS27A;EXOSC1;PSMB3;SET;RBM24;PSMB5;ELAVL1;YWHAZ;YTHDF1;PSMA7;RC3H2;HNRNPD;PSMF1;PSMD7;APEX1
prerank,negative regulation of organelle assembly (GO:1902116),-0.26250903717486906,-0.7995135367596816,0.7924050632911392,0.941847188258059,1.0,11/35,19.43%,TBC1D30;LIMK2;FEZ1;CDK5RAP2;TMEM39A;PINK1;FEZ2;TRIM37;CHMP4B;CHMP4A;ODF2L
prerank,regulation of centrosome cycle (GO:0046605),0.333360141851656,0.7993441031370927,0.7313691507798961,0.9822327933696895,1.0,6/21,20.41%,PKHD1;SIRT1;CHMP1A;CHMP4C;XRCC3;CHMP2A
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.38147583167612453,0.7991026441224783,0.6853281853281853,0.9820852159997677,1.0,3/10,20.37%,RHO;SAG;PDE6B
prerank,peptidyl-serine modification (GO:0018209),0.23731517485478804,0.7990939459957127,0.8631578947368421,0.9814981812815509,1.0,27/166,13.22%,ROCK2;PRKCZ;STK32B;TGFBR1;DMPK;LRRK2;SMG1;PRKCB;IKBKE;ATM;CAMK1;RICTOR;TGFBR2;MAPKAPK3;PDPK1;CSNK1A1;MKNK1;BRSK1;SRPK2;DYRK1A;PRKDC;CSNK2A2;CSNK2A1;PRKCA;HIPK3;PRKCI;WNK1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.36031768249057183,-0.7990370253775687,0.7169421487603306,0.941945845228825,1.0,5/10,32.38%,CALM1;CALM3;DRD2;CRHR1;DRD3
prerank,positive regulation of T cell migration (GO:2000406),0.3274038007305098,0.7990134620165962,0.7103448275862069,0.981060874043334,1.0,5/20,17.97%,OXSR1;ADAM17;WNK1;CCR2;WNT5A
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3547707230385442,0.7988456735270724,0.7099236641221374,0.9807565384191349,1.0,5/15,20.25%,EME2;ATF2;HUS1;FANCD2;RAD9A
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.264333293723922,0.7988120315578382,0.7932551319648093,0.9802213943869688,1.0,16/78,17.75%,CCNA2;NR2F2;CCNA1;CCNT2;PTEN;CCND3;CDK5RAP3;CDC25A;GTPBP4;CCNB2;ADAM17;GADD45A;CCNG1;CCNE1;CNPPD1;HEXIM2
prerank,regulation of sensory perception of pain (GO:0051930),-0.34977711856353144,-0.7987446315343688,0.7128309572301426,0.9417521493206538,1.0,3/11,7.17%,CCN3;MGLL;TMEM100
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.3560272931105384,-0.7985214839301928,0.7046413502109705,0.9400224626433159,1.0,4/10,22.81%,ERCC1;TERF1;DNA2;BLM
prerank,t-circle formation (GO:0090656),-0.3560272931105384,-0.7985214839301928,0.7046413502109705,0.9400224626433159,1.0,4/10,22.81%,ERCC1;TERF1;DNA2;BLM
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.3560272931105384,-0.7985214839301928,0.7046413502109705,0.9400224626433159,1.0,4/10,22.81%,ERCC1;TERF1;DNA2;BLM
prerank,peptidyl-tyrosine modification (GO:0018212),0.27524964894031045,0.7976882618515467,0.7697063369397218,0.9816275177417981,1.0,11/56,13.10%,KIT;FGFR2;EPHA4;FGFR1;FLT1;PDGFRB;FER;ABL1;DYRK1A;TPST1;EPHA3
prerank,telomere maintenance via telomerase (GO:0007004),-0.2744010776123716,-0.797501785253679,0.7494089834515366,0.9410166857179874,1.0,9/28,20.20%,HSP90AB1;HSP90AA1;TNKS1BP1;TERF2IP;TERF1;RPA1;ANKRD28;NHP2;PTGES3
prerank,negative regulation of reproductive process (GO:2000242),0.3472624825274675,0.7974607531655515,0.7419962335216572,0.981446186913107,1.0,1/17,1.44%,IGF1
prerank,regulation of fibroblast proliferation (GO:0048145),0.28513312344170183,0.7973554715350699,0.7532051282051282,0.9810366688880313,1.0,5/45,6.50%,IGF1;SPHK1;CD300A;PARP10;TP53
prerank,selective autophagy (GO:0061912),0.2737368541916727,0.7973073199346482,0.7488653555219364,0.9805196774674995,1.0,16/56,19.97%,PRKN;RETREG1;ATM;ATG5;AMBRA1;BECN1;IFT88;ATG2A;ACBD5;TEX264;PEX5;DYNC1LI1;SQSTM1;PCNT;UBA5;WDR81
prerank,regulation of DNA binding (GO:0051101),0.28882275145553155,0.7972249988393831,0.7620528771384136,0.9800695856660977,1.0,4/44,4.94%,IGF1;PRKN;FOXC1;SMO
prerank,regulation of defense response (GO:0031347),-0.2257586384955098,-0.7970573517004628,0.8862973760932945,0.9410609382377381,1.0,15/76,13.06%,IL1R1;TMSB4X;SEMA7A;MGLL;ANXA1;FOXP1;APOE;PTGES;AGTR1;PTGS2;PIK3AP1;SBNO2;TIRAP;ACE2;LRP8
prerank,translational termination (GO:0006415),0.255824217893935,0.7969550290681383,0.8062234794908062,0.9799763883085463,1.0,29/95,25.77%,MRPS23;MRPS6;MRPL37;MRPL2;MRPL53;MRPS7;ETF1;GSPT2;MRPS26;MTRF1L;MRPL48;MRPL1;GFM2;MTRF1;MRPL45;MRPS17;CHCHD1;N6AMT1;MRPL32;MRPL14;MRPL23;MRPS34;PTCD3;GSPT1;MRPS25;MRPL50;MRPL33;MRPS18B;MRPL19
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.33042651985261307,-0.7969257609463901,0.7727272727272727,0.9405723490740188,1.0,6/14,24.44%,PNPT1;TFAM;SLC25A33;TEFM;TFB1M;FASTKD5
prerank,DNA biosynthetic process (GO:0071897),-0.3117299150949314,-0.7958806512257485,0.7575757575757576,0.9416334391547285,1.0,4/16,12.01%,POLA1;PPIA;POLD3;WRNIP1
prerank,superoxide metabolic process (GO:0006801),0.31457757112587464,0.795864966787619,0.728171334431631,0.9813693224518424,1.0,6/29,10.42%,ALOX12;SOD3;NOX1;SOD2;SH3PXD2B;NOX4
prerank,actin filament depolymerization (GO:0030042),-0.3434760574119704,-0.7954643655590052,0.7096114519427403,0.941602149289926,1.0,4/11,13.37%,GSN;MICAL2;WDR1;CFL1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.325581193498703,0.7953857454074359,0.7052810902896082,0.9816389695408749,1.0,3/22,8.32%,DDX5;ATM;CDK5RAP3
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.29593322564130986,0.7949902475276094,0.7476635514018691,0.9817573519639978,1.0,6/40,11.47%,ATRX;DONSON;FBH1;FANCM;EME2;MSH3
prerank,protein-containing complex assembly (GO:0065003),0.22965594811487103,0.7949718738157614,0.9029940119760479,0.9811886031465548,1.0,74/259,22.95%,AFDN;PPARGC1A;PICALM;KMT2A;LAMC1;PLEKHA7;MCU;MITF;CAND2;LRRK2;SAMM50;TP53;TRAPPC9;SH3PXD2B;OPA1;ANO6;SMARCA4;TERT;WDR19;DNM1L;TEAD2;CSNK1A1;WASL;TCF7;TLE1;HDAC1;RIPK1;ASH2L;TCF7L2;VIL1;TEAD1;AXIN2;FANCA;TGFA;KMT2D;PARD3;PML;TLE2;STX5;SEC23IP;F8;PEX14;DNAJB14;SCFD1;CREBBP;TRAPPC5;PPP6R3;TCF7L1;RANBP9;HFE;ZNHIT6;TNFRSF1A;SEC31A;BET1;GOLGA2;YAP1;ITGB1BP1;FOLR1;AFG3L2;PYGO2;TUBGCP4;GPAA1;SEC24C;DBNL;RUVBL1;CD247;CLDN1;SEC24A;EP300;GORASP1;BOK;SNX9;F5;BCL9
prerank,inorganic ion transmembrane transport (GO:0098660),-0.342023556172215,-0.7948412042635603,0.7250996015936255,0.9419053136814624,1.0,3/12,15.36%,ABCC9;KCNJ8;CACNA1H
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.307929039371203,0.7947637074831692,0.7284991568296796,0.9809734715632863,1.0,3/30,6.30%,ST6GAL1;ASGR1;FUT8
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.19685450556166859,-0.794706056983332,0.966183574879227,0.9414270101627509,1.0,62/184,27.69%,HECW2;YWHAE;PSMB2;DYNLL1;PPP2R1A;YWHAG;CUL3;ANLN;PSMD14;TUBA1A;HAUS2;PSMC6;ID2;TUBB4A;CDK5RAP2;HSP90AA1;KCNH5;PKD1;PRKAR2B;BUB3;UBB;HAUS5;PSMA4;PSMB9;CEP78;CENPE;CDC23;SKP1;CETN2;RGCC;PSMD11;SIRT2;PSMB10;TUBA4A;SSNA1;PSMD2;ERCC2;NEK6;MAD2L1;CEP131;PSMA2;CCP110;HMMR;TFAP4;TPX2;UBC;RPS27A;KIF14;KNTC1;NEDD1;HAUS4;CEP135;PSMB3;ACTR1A;NDE1;HAUS6;CEP76;PSMB5;UBE2D1;DDB1;PSMA7;CENPF
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.2655166444563243,-0.794421666880946,0.7688442211055276,0.9411998515800336,1.0,9/35,19.95%,STAT3;LYN;STAT5B;HIF1A;TAL1;ZFPM1;INHBA;FAM210B;MAFB
prerank,bone morphogenesis (GO:0060349),0.3519666511721845,0.7942877310453629,0.7148362235067437,0.9812386163978494,1.0,2/14,4.67%,FGFR2;CYP26B1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.3127794422406871,-0.7940039196922899,0.74,0.9412169810354909,1.0,4/18,9.42%,ST18;STAT3;IL6ST;JAK1
prerank,spermatid development (GO:0007286),0.30790729544962775,0.7940037373512602,0.7200674536256324,0.9811316826078775,1.0,9/32,25.14%,TOPAZ1;RNF8;MKKS;ACRBP;RFX2;CEP57;NECTIN2;TTC21A;ING2
prerank,phagolysosome assembly (GO:0001845),0.3655330040149154,0.79392563762638,0.7077798861480076,0.9806784269380456,1.0,5/12,21.80%,RAB34;PIKFYVE;RAB7B;PLA2G5;RAB7A
prerank,positive regulation of protein import into nucleus (GO:0042307),0.3134239074146617,0.7937895002415386,0.7401709401709402,0.9803405516388771,1.0,4/28,9.79%,SMAD3;ZIC1;UBR5;MAVS
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.32405792331032146,0.7935330817189832,0.7325383304940375,0.9802291132008225,1.0,4/22,7.35%,CD300A;EZR;GPS2;PTPN22
prerank,protein K63-linked deubiquitination (GO:0070536),-0.26480806055351747,-0.7935138225038387,0.8274231678486997,0.9413599006491111,1.0,8/31,19.26%,OTUD7A;OTUD7B;USP13;PSMD14;YOD1;USP50;USP8;SPATA2
prerank,inositol lipid-mediated signaling (GO:0048017),0.281787664444926,0.7924088054707146,0.7532051282051282,0.9816157913287517,1.0,9/50,9.26%,IGF1;PI4KA;FGFR1;EZR;PLCD3;PDGFRB;GAB2;PIK3CA;PLCD1
prerank,nucleus organization (GO:0006997),-0.24236353238720995,-0.791664631197112,0.848,0.9435982370816217,1.0,6/47,12.31%,SYNE1;RPS19;BIN1;PITPNB;PDCD6IP;LEMD3
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.35081425350807877,0.7915345544630558,0.7035714285714286,0.9825347374988302,1.0,2/15,6.71%,UST;DSE
prerank,7-methylguanosine mRNA capping (GO:0006370),0.30545016829239874,0.7914461625513187,0.7347611202635914,0.9815054536878736,1.0,5/31,13.80%,POLR2A;POLR2D;GTF2F1;CMTR2;RAMAC
prerank,7-methylguanosine RNA capping (GO:0009452),0.30545016829239874,0.7914461625513187,0.7347611202635914,0.9815054536878736,1.0,5/31,13.80%,POLR2A;POLR2D;GTF2F1;CMTR2;RAMAC
prerank,negative regulation of protein binding (GO:0032091),0.263936185922597,0.7909026266626658,0.7972768532526475,0.9818937053429955,1.0,19/71,19.18%,DAB2;IFIT1;IFIT2;LRRK2;MAP2;CAMK1;GTF2F1;AURKB;TMC8;STYX;DNAJB2;EFHB;PEX14;TFIP11;KDM1A;HFE;GOLGA2;USP33;ITGB1BP1
prerank,mitotic DNA replication (GO:1902969),-0.3540809143770967,-0.7908601759663384,0.7346491228070176,0.9442267696544349,1.0,1/10,2.33%,POLA1
prerank,negative regulation of telomere maintenance (GO:0032205),0.3496520632785337,0.790846513496417,0.718336483931947,0.9813980649856435,1.0,8/15,26.39%,ATM;TNKS2;RAD50;NBN;SLX4;SMG6;PINX1;RTEL1
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.2456167815857253,-0.789606661055497,0.8715846994535519,0.9455424583686747,1.0,30/51,41.95%,STAT3;APP;EGR1;AIM2;USP50;NOD2;PANX1;HSPB1;TYROBP;CCL19;LGALS9;PYCARD;TMED10;JAK2;TRIM16;P2RX7;CD36;MALT1;TLR8;MYD88;TMEM106A;GBP5;ISL1;CASP8;INAVA;TNF;NLRP12;LPL;GSDMD;IL6
prerank,RNA transport (GO:0050658),0.26334049625707234,0.7891588723705937,0.7967599410898379,0.9837785077516912,1.0,21/71,21.34%,NXF2;SRSF5;SIDT2;POLDIP3;HNRNPA2B1;SIDT1;TGFBR2;ATXN2;NXF1;SRSF11;ZFP36L1;SARNP;NUP155;SRSF1;CDC40;NUP188;U2AF1;SRSF7;FMR1;U2AF2;NUP153
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.27350198514278895,-0.7891565261351549,0.7958115183246073,0.9455421880997705,1.0,8/28,22.80%,NOTCH3;BEND6;GATA2;LFNG;METTL3;DLL4;YTHDF2;TSPAN15
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.35229682185661004,-0.7890708061725573,0.7574468085106383,0.9449598288498876,1.0,3/10,16.19%,PODXL;PIEZO1;SKAP1
prerank,protein depolymerization (GO:0051261),0.3063221147591584,0.7886466641711556,0.7415329768270945,0.9840887417565495,1.0,2/27,1.81%,MICAL3;KIF2A
prerank,positive regulation of exocytosis (GO:0045921),-0.2565724503387905,-0.7886120378377364,0.8307692307692308,0.9450500186808782,1.0,6/35,13.16%,CADPS;CLASP2;RAB27A;PDCD6IP;RAB27B;SNCA
prerank,regulation of lipid kinase activity (GO:0043550),0.37745887557120705,0.7879389261229186,0.7276190476190476,0.9847566630825486,1.0,7/11,19.97%,F2;RBL2;RBL1;PIK3R3;RB1;WDR91;WDR81
prerank,microtubule anchoring (GO:0034453),0.36107311120920926,0.7879014633944023,0.6946428571428571,0.98423327789597,1.0,5/12,18.75%,CLASP1;DAG1;PEX14;SAXO2;PCM1
prerank,protein deneddylation (GO:0000338),-0.35911799746584905,-0.7874968560013647,0.7429718875502008,0.9460670655129001,1.0,4/10,27.77%,COPS4;COPS6;COPS5;COPS2
prerank,autophagy of nucleus (GO:0044804),0.35112698606248416,0.7870453743991749,0.7217898832684825,0.9852018058197652,1.0,8/16,26.10%,ATG5;WIPI1;ATG7;ATG2A;ATG2B;ATG12;ATG3;ATG9B
prerank,cellular copper ion homeostasis (GO:0006878),-0.3182884474046061,-0.7869564662709262,0.7689075630252101,0.9462039854433946,1.0,3/14,12.87%,APP;ATOX1;SLC31A1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.3729594779322672,0.7868333436821922,0.7559633027522936,0.984994556969828,1.0,5/12,19.92%,IDH1;ACO2;SIRT4;IDH2;ACLY
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.20235826342668367,-0.7865971007314745,0.952755905511811,0.9460579397944837,1.0,39/132,25.52%,CELF4;HSP90AB1;RPL3;RPL38;RPS19;RPS28;RPLP0;RPS15;RPL5;RPL23A;HSP90AA1;RPS27;XRCC5;SART1;RPS5;RPL6;CLNS1A;MDN1;NOP53;RPSA;DHX9;SNRPF;BRIX1;CDC73;COIL;RPS27L;MRPL20;PTGES3;RPL24;RPL11;SNRPD3;LSM4;RSL24D1;PUF60;ABT1;SRSF6;SNRPB;RRS1;WDR77
prerank,regulation of collagen biosynthetic process (GO:0032965),0.3309418648191884,0.7865230838257773,0.7042513863216266,0.9849066240081525,1.0,2/19,5.34%,WNT4;F2
prerank,amino sugar metabolic process (GO:0006040),-0.35181909653195775,-0.7863891350405977,0.7494824016563147,0.9456638995699388,1.0,3/10,10.95%,CSGALNACT1;ST3GAL1;GFPT2
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.36339235355663746,-0.786177813978472,0.764344262295082,0.9452556221522931,1.0,4/10,20.04%,PTH1R;SNCA;IRS2;IRS1
prerank,response to UV-B (GO:0010224),-0.3362492711594676,-0.7860121875878682,0.738045738045738,0.9448066400085566,1.0,6/12,24.36%,MME;MFAP4;CDKN1A;CRIP1;RELA;HYAL2
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3615336594333137,0.785961159281712,0.7084942084942085,0.985298821318572,1.0,3/13,11.78%,RNF8;LARP7;NELFCD
prerank,regulation of intracellular protein transport (GO:0033157),0.29934627084195387,0.7856817824242588,0.7203252032520325,0.985190605777879,1.0,4/32,6.72%,PTPN14;IFI27;RUFY3;BCAS3
prerank,regulation of interleukin-8 production (GO:0032677),0.2585615040969371,0.7854689323239177,0.8057971014492754,0.984989053529954,1.0,11/69,9.79%,TLR3;SSC5D;TLR4;IL17D;ARRB1;MAP2K5;AFAP1L2;SERPINE1;PTPN22;RIPK1;MAVS
prerank,ncRNA catabolic process (GO:0034661),0.3144454355617999,0.7853675751930995,0.7751277683134583,0.9845795874437405,1.0,8/28,20.86%,TUT4;EXOSC7;SND1;DIS3;TENT4B;DIS3L;EXOSC3;POP1
prerank,response to cAMP (GO:0051591),0.2956816520314825,0.7850451078112907,0.7745762711864407,0.9845515215908238,1.0,4/37,5.60%,SLC5A5;RAPGEF3;EZR;SLC26A3
prerank,negative regulation of inflammatory response (GO:0050728),0.2297306505812065,0.7843725402799316,0.8991060025542784,0.9851218676383015,1.0,13/182,9.26%,RORA;C1QTNF3;ADCY5;IGF1;PPARA;ADCY1;METRNL;GPS2;ENPP3;ADCY9;MC2R;CDH5;ADM
prerank,nuclear transport (GO:0051169),-0.3079951305173273,-0.7842663136150156,0.7855530474040632,0.9469213811164909,1.0,6/16,21.60%,XPO1;ANP32A;RBM15B;NXT1;BANF1;NPM1
prerank,telomere organization (GO:0032200),0.28450667732413215,0.7839726682993351,0.7441130298273155,0.9852022941216428,1.0,12/43,18.95%,POLD2;ATM;ACD;TERT;PRKDC;HUS1;RAD50;DOT1L;SP100;TINF2;NBN;RAD51D
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.32513801642981727,0.7839490818982291,0.7211221122112211,0.9846481472449689,1.0,3/22,7.95%,APPL2;LRRK2;KDM2B
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.26989479736337707,-0.7837442252931798,0.7912621359223301,0.9470500619736537,1.0,9/29,33.15%,PLA2G4A;LPCAT2;PLA2G12A;PLA2G4E;PLA2G4F;MBOAT7;DBI;PLBD1;PLB1
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.33176046158593225,-0.782827834009316,0.7627494456762749,0.947765688271378,1.0,2/12,8.55%,LYN;PTK2
prerank,positive regulation of histone acetylation (GO:0035066),0.33073824616669584,0.7826017842848031,0.7463414634146341,0.9863177422665063,1.0,6/23,16.98%,PPARGC1A;ARRB1;BRD7;KAT7;SPHK2;SMAD4
prerank,response to interferon-gamma (GO:0034341),-0.23012189652656836,-0.7825760993688012,0.887905604719764,0.947478592442163,1.0,21/67,26.52%,GCH1;AQP4;SYNCRIP;CXCL16;CD47;GBP4;IFITM3;DAPK1;SHFL;SNCA;CD74;CCL13;RPL13A;IRF8;CCL19;LGALS9;IFITM1;IFITM2;CD40;GAPDH;CCL2
prerank,response to UV-A (GO:0070141),-0.32429991331860986,-0.7824860806150212,0.7693965517241379,0.9469131486452558,1.0,8/14,45.73%,MME;MMP1;CCND1;MMP3;PPID;MMP2;OPN5;MMP9
prerank,regulation of chromosome organization (GO:0033044),0.3203553399300259,0.7820984835160015,0.7336769759450171,0.9866001233345578,1.0,8/22,22.90%,HDAC8;SMG1;WAPL;RB1;CENPV;LIG4;YLPM1;SMG6
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.26542492358296393,0.7817966898053499,0.8128571428571428,0.9865255900563741,1.0,1/74,0.14%,EPAS1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.22845256772793915,0.7816334598316167,0.892059553349876,0.9862107001613509,1.0,20/208,9.79%,RORA;WLS;LPAR1;PRKN;CFLAR;AKAP13;CXXC5;ZFAND6;PRKCB;IKBKE;ANKRD17;LGALS1;GPRC5B;PDPK1;TAB2;SIRT1;TLE1;RIPK2;RIPK1;MAVS
prerank,outer dynein arm assembly (GO:0036158),0.3521560273085981,0.7801431556945928,0.7297794117647058,0.9882171951703276,1.0,1/14,2.99%,ODAD1
prerank,positive regulation of proteolysis (GO:0045862),0.27106926793910663,0.7798585706562691,0.803076923076923,0.9881125996954957,1.0,7/55,8.12%,SH3D19;ADRA2A;CTSH;ANGPTL8;FBXW11;CLN6;BTRC
prerank,protein targeting (GO:0006605),0.24257042756933905,0.7796586043141194,0.8551724137931035,0.987870076687825,1.0,28/118,19.18%,TRAK1;KIF13B;ZFAND6;LAMP2;RAB3IP;FUT10;TIMM44;PIKFYVE;TOMM70;ZDHHC18;ZDHHC1;MYO1C;PRKCI;PARD3;MFN2;MICALL1;PITRM1;VPS37A;TIMM10;ARL6;PEX19;PEX16;RABGEF1;TRAK2;ZDHHC23;KATNB1;TIMM17B;AP4M1
prerank,cell junction maintenance (GO:0034331),0.35713085531653616,0.7795917976103549,0.7595628415300546,0.9873891143075982,1.0,1/14,2.47%,NLGN2
prerank,negative regulation of cellular catabolic process (GO:0031330),0.26138186958273824,0.7793260141005345,0.7951807228915663,0.9872617400080552,1.0,14/63,18.90%,LEPR;TIMP3;NUPR1;PTPN22;CDK5RAP3;TAB2;ATRAID;RGP1;ZKSCAN3;TLK2;MCL1;TBC1D14;EIF4G1;GOLGA2
prerank,protein O-linked mannosylation (GO:0035269),0.32724757742160226,0.7788890711220274,0.7363013698630136,0.9874232805581974,1.0,4/18,12.42%,TMTC4;LARGE1;TMTC1;LARGE2
prerank,autophagy of mitochondrion (GO:0000422),0.28798709163841996,0.7788200147331373,0.7591362126245847,0.9869571562391146,1.0,6/38,10.46%,PRKN;ATG5;WIPI1;AMBRA1;BECN1;ATG7
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.25064568571844154,0.7786739771655625,0.8402203856749312,0.9866269432254267,1.0,14/94,13.66%,DDX5;ITPR1;FHIT;PRODH;IKBKE;ATM;DDX3X;TP53;ABL1;PRKDC;CUL4A;PPP1R13B;MLLT11;PML
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.2727046358634901,-0.7779558729514342,0.8226600985221675,0.9532637845466054,1.0,1/29,0.39%,CADM1
prerank,protein processing (GO:0016485),0.24363731910021189,0.7776350619010208,0.8523035230352304,0.9878251287094093,1.0,14/102,15.27%,AEBP1;KLK2;SRGN;CTSH;METAP2;RCE1;APH1B;MMP14;ADAM17;PCSK7;OGT;SDE2;PITRM1;ZMPSTE24
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.3234491102602659,0.777502786487227,0.7614213197969543,0.9874508677843794,1.0,4/22,11.54%,FZD5;IL12B;CYRIB;ZBTB1
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.31463060620929467,-0.7763514921096948,0.746268656716418,0.9549861663985144,1.0,5/15,13.46%,DACT1;SMAD7;FKBP1A;LEMD3;ACVR1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.3427028125429411,-0.7763099601030146,0.7525773195876289,0.9543536994699228,1.0,2/11,7.83%,RUNX1;VSIR
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3085065661806311,0.7762781284042536,0.7557932263814616,0.9888563761993895,1.0,5/27,7.55%,KIT;EPHA8;FLT1;PDGFRB;AMBRA1
prerank,negative regulation of secretion (GO:0051048),0.38107891919311054,0.775827437213446,0.7436399217221135,0.9890272236114803,1.0,4/10,22.37%,NRG1;SPX;NR1H3;VAMP8
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.2985463285172381,-0.7751738695503909,0.7559912854030502,0.9554123288702668,1.0,10/18,38.60%,RAD51B;DTL;MECP2;CCND1;CDC7;CDK1;BRD4;CCNB1;CDC25C;RAB11A
prerank,dorsal/ventral pattern formation (GO:0009953),-0.2935924955678807,-0.7748687974534076,0.7853982300884956,0.9551982604844247,1.0,6/20,13.95%,ACVRL1;DSCAML1;PTCH1;AIDA;ACVR1;BMPR1B
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.33936322866467,0.7747977799504906,0.7548262548262549,0.9901266234984836,1.0,10/18,30.07%,COX16;SMIM20;COX19;FASTKD3;TIMM21;COA5;SCO1;COX14;PET100;SURF1
prerank,protein prenylation (GO:0018342),0.37551877897197994,0.7739130084855744,0.710727969348659,0.9910596827654485,1.0,4/10,16.78%,RABGGTA;RCE1;FNTB;FNTA
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.2945915955480218,0.7735200954561857,0.771900826446281,0.9911492969654317,1.0,7/35,12.69%,ATM;ACD;HNRNPA2B1;TNKS2;AURKB;FBXO4;PNKP
prerank,positive regulation of protein import (GO:1904591),0.303370269456169,0.7732533016810893,0.7491408934707904,0.991008591405668,1.0,4/30,9.79%,SMAD3;ZIC1;UBR5;MAVS
prerank,regulation of protein kinase C signaling (GO:0090036),-0.3101360279955507,-0.7729153143357413,0.7837837837837838,0.9574476269811822,1.0,6/14,25.58%,FLT4;DGKG;VEGFA;MYADM;GPD1L;CD40
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.2574658736772958,-0.7728846541922659,0.8484107579462102,0.9568067121296137,1.0,3/33,4.40%,HIP1;BCAR3;CCDC88A
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.3655727176239368,0.77263193855609,0.758130081300813,0.9914764801663918,1.0,1/11,1.98%,PRKN
prerank,cell cycle G2/M phase transition (GO:0044839),0.23533094835907137,0.7723676059115365,0.865359477124183,0.9913033853743584,1.0,15/129,10.68%,TPD52L1;FBXL17;CCNA2;CEP250;PPP1CB;CLASP1;NINL;FBXW11;BTRC;CDC25A;CCNB2;BRSK1;FBXL12;AJUBA;SDCCAG8
prerank,cellular response to pH (GO:0071467),0.3251070116284813,0.7723038052866257,0.7441860465116279,0.9908218166317968,1.0,3/17,11.45%,HYAL1;RAB11B;IMPACT
prerank,phagosome maturation (GO:0090382),0.29247692802673664,0.772090473979779,0.7817589576547231,0.9906084815875307,1.0,7/35,11.08%,ATP6V0E1;RAB34;ATP6V0B;PIKFYVE;RAB43;ATP6V1D;ATP6V1E1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.2646628188844814,0.7717344678198693,0.82642089093702,0.990609631136571,1.0,7/59,10.97%,ROCK2;TLR3;TLR4;TAB2;RIPK2;RIPK1;LY96
prerank,regulation of humoral immune response (GO:0002920),-0.24210482877478212,-0.771533829374099,0.8736263736263736,0.9580773786698071,1.0,15/44,26.26%,SUSD4;C1QB;C4B;PROS1;C1QC;CLU;C3AR1;C1QA;GATA6;VTN;C6;C7;CD81;CFH;C3
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.25869490307998716,-0.7710209756415348,0.8142493638676844,0.9581088414062376,1.0,10/33,20.20%,HSP90AB1;HSP90AA1;TNKS1BP1;TERF2IP;TERF1;STN1;RPA1;ANKRD28;NHP2;PTGES3
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.30168173469115844,0.770980674115064,0.7288428324697754,0.9912746243134574,1.0,2/26,2.32%,SMOC2;SPHK1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.22156752194426205,-0.770874096863239,0.8871473354231975,0.9576183923869572,1.0,19/65,30.33%,FBXL7;PSMB2;PSMD14;PSMC6;PSMA4;PSMB9;SKP1;PSMD11;PSMB10;PSMD2;PSMA2;PSMB3;FHL1;PSMB5;PSMA7;ZFYVE19;PSMF1;PSMD7;AURKA
prerank,nucleotide-sugar metabolic process (GO:0009225),0.36320075019244596,0.7706807922564202,0.7288801571709234,0.9912148090944299,1.0,2/12,6.30%,GMDS;FUT8
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.2477011881964567,0.7704151081205507,0.86,0.9910769901589533,1.0,24/87,22.92%,NDUFAF4;SAMM50;NDUFAB1;UQCC1;NDUFS1;COX16;NDUFV2;FOXRED1;LYRM7;SDHAF4;SMIM20;NDUFAF5;COX19;TIMMDC1;DMAC2;NDUFS4;TMEM126B;NDUFA2;FASTKD3;NDUFAF7;NDUFS5;TIMM21;NDUFA9;NDUFB2
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.3028826723278947,0.7700876468912625,0.7724252491694352,0.9910461979608354,1.0,8/31,20.17%,CYP21A2;FDXR;DHRS11;MOCOS;SRD5A2;NFS1;LIAS;MOCS1
prerank,positive regulation of organelle assembly (GO:1902117),-0.23979171525058457,-0.769384777811496,0.8579088471849866,0.9591899503182084,1.0,13/44,23.60%,PIP4K2A;CCDC88A;G3BP2;SH3GLB1;RALB;CNOT2;PDCD6IP;KCTD17;PIP4K2B;LRSAM1;CNOT6L;CCP110;SPAG5
prerank,peptidyl-arginine modification (GO:0018195),0.3423102947726828,0.7688496409631863,0.7567049808429118,0.9924835443234667,1.0,4/15,17.45%,ART5;ART4;NDUFAF5;PADI4
prerank,response to interferon-alpha (GO:0035455),-0.30330136382667716,-0.7676159259413173,0.7635574837310195,0.9610917393542056,1.0,3/16,11.73%,GAS6;RO60;IFITM3
prerank,transport along microtubule (GO:0010970),-0.32114012017560667,-0.7668165340083188,0.7763975155279503,0.9615501097399346,1.0,2/13,7.28%,APP;DYNC1I1
prerank,regulation of type I interferon production (GO:0032479),0.2479411107738341,0.7663455926460291,0.8726752503576538,0.9959173151452769,1.0,27/84,24.20%,PCBP2;IKBKE;RNF135;TRIM56;PTPN22;MAVS;PRKDC;DHX58;IRF1;POLR3A;DHX33;ACOD1;NFKB1;STAT6;CREBBP;UFD1;NPLOC4;TAX1BP1;CD14;TRAF3;EP300;PQBP1;POLR2F;POLR3H;POLR3G;ZBP1;DDX41
prerank,positive regulation of receptor internalization (GO:0002092),0.31839953052248743,0.7662502138046315,0.7393617021276596,0.9954773497326963,1.0,4/22,9.70%,MAGI2;ARRB1;APLN;PICK1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.3544803157408397,0.7661489816655597,0.7074569789674953,0.9950627205952804,1.0,5/11,23.64%,UFD1;TOR1A;DERL1;BAG6;RNF5
prerank,negative regulation of interleukin-1 production (GO:0032692),0.3110870675647711,0.7660483766930992,0.7729636048526863,0.9946254631968143,1.0,1/23,1.44%,IGF1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.33056623584007827,0.7659318739113263,0.75,0.9942383003217571,1.0,5/17,18.07%,ACD;TDG;MBD4;OGG1;TINF2
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.2833450710828743,-0.7653359491720354,0.7981859410430839,0.9629432069659454,1.0,6/22,18.36%,SLC7A5;TNFRSF1B;LAPTM5;TRIL;NOD2;BTK
prerank,B cell activation involved in immune response (GO:0002312),0.3450593052766795,0.7651380470891872,0.7436399217221135,0.9949541491220393,1.0,3/13,20.03%,RNF8;EXOSC3;LIG4
prerank,positive regulation of immune system process (GO:0002684),-0.2993153056820158,-0.7651058719239283,0.7686915887850467,0.9625677687094245,1.0,2/16,5.42%,TGFB2;ANXA1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3095852527596198,-0.7650607183287481,0.788135593220339,0.9619419071513465,1.0,3/15,11.37%,PRKCH;SFRP4;BMP4
prerank,positive regulation of translation (GO:0045727),-0.2063081183071867,-0.7648422420711811,0.9539007092198581,0.9615631397624931,1.0,25/94,21.60%,PRR16;THBS1;NIBAN1;RPL26;RPL5;RPS9;ERBB2;UHMK1;FXR1;EIF5A2;RPS4X;YBX3;VIM;METTL3;BCL3;RCC1L;PKM;DHX9;RPS27L;EEF2;YTHDF2;RBM3;EIF4A3;EIF3D;NPM1
prerank,positive regulation of ATPase activity (GO:0032781),0.28620139272365636,0.7645569299077412,0.792604501607717,0.9952921010265265,1.0,7/41,13.96%,ATP1B3;TPM1;PLSCR1;MYL4;SSBP1;MSH3;DNAJB2
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.3547414561137046,0.764392961184231,0.7101167315175098,0.9949732834738119,1.0,3/11,16.01%,NUPR1;RIPK1;BIRC3
prerank,positive regulation of lipid transport (GO:0032370),0.35514933538365534,0.7643350041630755,0.724907063197026,0.9944901383000044,1.0,2/12,9.36%,SPP1;LRP1
prerank,negative regulation of transmembrane transport (GO:0034763),-0.3416768294138851,-0.7638258299484191,0.7766798418972332,0.9623084283993338,1.0,1/10,2.37%,THBS1
prerank,fluid transport (GO:0042044),-0.32459571844060026,-0.7637295794205154,0.7867494824016563,0.9617469136695103,1.0,2/12,7.57%,AQP4;AQP11
prerank,lymphocyte mediated immunity (GO:0002449),-0.31956411819541464,-0.7636783211237063,0.8032786885245902,0.9611242262900778,1.0,2/12,14.73%,JAG1;BTN3A3
prerank,peptidyl-proline modification (GO:0018208),0.30027076396057395,0.7631198866139492,0.7877697841726619,0.9958738195714881,1.0,4/25,10.01%,FKBP5;NKTR;PPIC;CWC27
prerank,regulation of establishment of planar polarity (GO:0090175),-0.21265514343581476,-0.7629820425893084,0.9028776978417267,0.9614682701169872,1.0,20/88,19.45%,PRICKLE2;DAAM1;PSMB2;ROR2;TIAM1;FZD4;DACT1;PSMD14;AP2B1;PSMC6;VANGL2;AP2M1;SPEF1;SMURF1;PSMA4;PSMB9;PSMD11;ARRB2;PSMB10;PSMD2
prerank,keratan sulfate metabolic process (GO:0042339),0.29812570019820106,0.7629784625676235,0.7903225806451613,0.995537815495034,1.0,4/31,5.98%,OGN;ST3GAL3;FMOD;B4GALT1
prerank,response to nutrient levels (GO:0031667),0.3344884929652887,0.7627320511456844,0.7504798464491362,0.9953301418489687,1.0,1/17,1.62%,PRKAA2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.26015683712501947,-0.7624066435487193,0.8177215189873418,0.9615619366449754,1.0,13/27,29.69%,CD47;CD44;SKAP1;ITGB2;PRKCQ;HAS2;PYCARD;MDK;THY1;RELA;CCL2;NR4A3;RHOA
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.3112956791816525,-0.7621993373003739,0.7914893617021277,0.9611751603815607,1.0,5/15,27.99%,ENTPD1;CMPK1;ENTPD2;CMPK2;ENTPD3
prerank,cholesterol biosynthetic process (GO:0006695),-0.26212934724520875,-0.7618718691363485,0.8474178403755869,0.9609522363708898,1.0,15/31,27.66%,HMGCS1;IDI1;SC5D;PMVK;LSS;SQLE;DHCR7;DHCR24;CYP51A1;MSMO1;ACAT2;EBP;HMGCR;FDPS;HSD17B7
prerank,pseudouridine synthesis (GO:0001522),-0.3202564006832138,-0.7613932798880338,0.7677419354838709,0.9609172097620649,1.0,8/13,38.31%,NHP2;PUS1;PUS7;TRUB1;DKC1;RPUSD2;TRUB2;PUS7L
prerank,water-soluble vitamin metabolic process (GO:0006767),0.25673483436321726,0.7613517058048787,0.8397058823529412,0.9969845862010454,1.0,19/68,19.62%,PCCA;SLC19A1;MTHFR;TCN2;ALDH1L1;MCCC1;SLC19A2;FLAD1;TCN1;MTRR;HLCS;THTPA;TPK1;SLC25A19;MTHFD1;MMACHC;MCCC2;FOLR2;AASDHPPT
prerank,positive regulation of response to stimulus (GO:0048584),-0.2378562067086901,-0.7607715123249593,0.8837837837837837,0.9610894845987435,1.0,12/40,23.12%,TGFB2;B2M;FXR1;ABI3;HOMER1;ILK;SELENON;DHX9;CDKN2AIP;NSMCE1;NSMCE4A;CGAS
prerank,negative regulation of catalytic activity (GO:0043086),0.3053462628642822,0.75981672527699,0.7720848056537103,0.9987985202937496,1.0,4/24,9.35%,IFIT1;TP53;PARP9;SIRT1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.3434634850666594,0.7595928708247919,0.7630597014925373,0.9985461786710159,1.0,3/13,9.10%,PARP10;SLC5A8;PARP9
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.31055748054875,0.7595395853297274,0.779896013864818,0.998057324125073,1.0,5/23,11.35%,PARP14;PIAS1;PARP9;IRGM;SOCS3
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.2796891122731916,-0.759480350144363,0.8111888111888111,0.9622292535908601,1.0,13/23,31.92%,SLIT2;MPP1;TIRAP;CD74;DAPK2;CCL19;MDK;THBS4;MOSPD2;JAM3;BST1;C5AR2;RAC2
prerank,negative regulation of protein processing (GO:0010955),0.35372677621902043,0.7593042765779758,0.7563352826510721,0.9978627763751508,1.0,4/12,12.85%,LRRK2;GAS1;SERPINE1;SNX12
prerank,bile acid biosynthetic process (GO:0006699),0.3120016056012457,0.7591908008505177,0.7602862254025045,0.9974705066394044,1.0,3/24,5.92%,CYP27A1;AMACR;OSBPL9
prerank,adipose tissue development (GO:0060612),-0.3262990439507666,-0.7590991129120864,0.7817460317460317,0.9620716460175415,1.0,5/11,24.99%,SPTLC2;NAMPT;SOX8;PGRMC2;DGAT2
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.37426388077494877,0.7587564409262212,0.7821782178217822,0.9975799819379888,1.0,4/10,17.63%,TKFC;DHX58;UFD1;NPLOC4
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.29587212262956925,0.7583628060290123,0.7711442786069652,0.9975988488320238,1.0,1/27,0.97%,LPAR1
prerank,glycolytic process (GO:0006096),0.3003583004758222,0.7580266760848893,0.782312925170068,0.9975624318171596,1.0,3/28,7.27%,HK2;PGAM2;GCK
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.23217852689924226,0.7578220158870692,0.8919631093544137,0.997335820540094,1.0,15/128,10.68%,TPD52L1;FBXL17;CCNA2;CEP250;PPP1CB;CLASP1;NINL;FBXW11;BTRC;CDC25A;CCNB2;BRSK1;FBXL12;AJUBA;SDCCAG8
prerank,extracellular transport (GO:0006858),0.3522910943696733,0.7575063058951828,0.7570621468926554,0.9972627996033895,1.0,3/12,17.79%,ROPN1L;WWP2;CCDC40
prerank,negative regulation of cellular metabolic process (GO:0031324),0.28265509746199186,0.7573744428559133,0.7953410981697171,0.9968889580612874,1.0,13/37,22.59%,PRKN;RIN3;SIRT5;ATXN2;ITGAV;NCOR1;NFKB1;OPTN;PTX3;ANKRD13D;ANKRD13B;SDCBP;ABCA2
prerank,coenzyme A biosynthetic process (GO:0015937),0.36164477256747035,0.7571172679460922,0.7458256029684601,0.9955825667405792,1.0,2/11,9.41%,PANK1;DCAKD
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.36164477256747035,0.7571172679460922,0.7458256029684601,0.9955825667405792,1.0,2/11,9.41%,PANK1;DCAKD
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.36164477256747035,0.7571172679460922,0.7458256029684601,0.9955825667405792,1.0,2/11,9.41%,PANK1;DCAKD
prerank,innate immune response in mucosa (GO:0002227),0.36684149110588227,0.7570308974550787,0.736328125,0.9951382881513717,1.0,2/10,12.19%,DEFB1;CAMP
prerank,membrane lipid metabolic process (GO:0006643),-0.2775015581521672,-0.7569137200396796,0.8101545253863135,0.9643586496900803,1.0,7/22,19.09%,CYP1B1;ST3GAL6;SERINC1;GAL3ST1;B4GALT4;TECR;SMPDL3B
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.3459777573290199,0.756641315141304,0.7665441176470589,0.9951990279482839,1.0,2/13,10.26%,IL12B;CYRIB
prerank,positive regulation of viral life cycle (GO:1903902),0.30965474376265945,0.7566206633955291,0.788135593220339,0.9946616378684819,1.0,6/22,21.07%,LGALS1;KPNA6;AXL;VPS4A;CHMP2A;FMR1
prerank,negative regulation of cartilage development (GO:0061037),0.3459136473676501,0.7561635040463742,0.7654784240150094,0.9947375671004941,1.0,3/13,15.22%,TGFBR1;PTPN11;ADAMTS7
prerank,response to interferon-beta (GO:0035456),0.3116096862789298,0.7560532850242461,0.8017543859649123,0.9943236430615787,1.0,7/22,17.39%,IKBKE;PLSCR1;IRGM;IRF1;ACOD1;IFNAR2;CDC34
prerank,positive regulation of bone resorption (GO:0045780),0.3542765925351731,0.7557668486061426,0.7337057728119181,0.9941845951346527,1.0,2/11,12.33%,SPP1;PRKCA
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.21074739116522978,-0.7553792475521505,0.9337349397590361,0.9657595225443035,1.0,18/72,19.26%,LIFR;RUNX1;GAS6;HSP90AB1;PTPRC;IRAK3;IFNGR2;JAK1;HIPK1;IKBKB;RBCK1;ABCE1;SIGIRR;CD74;SYK;TRAF1;PTPN1;SPATA2
prerank,DNA replication (GO:0006260),0.23889540296178405,0.7553497705101685,0.875177304964539,0.994276180563446,1.0,29/105,21.76%,POLD2;POLG;ATM;REV1;DONSON;RBMS1;RBBP8;BAZ1A;HUS1;IGHMBP2;RAD50;TOP3A;PNKP;KAT7;POLE2;MCM7;MCM2;ORC3;POLA2;POLL;CLSPN;NBN;FEN1;RFC1;RAD9A;MCM9;MCM5;TOP1MT;ORC6
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.2839956069576437,-0.7543994134357781,0.8106382978723404,0.9663862616002716,1.0,7/19,20.71%,PIK3AP1;TIRAP;LBP;TRIL;NR1H4;ITGB2;LGALS9
prerank,acute-phase response (GO:0006953),-0.32207538886415743,-0.7543897042270001,0.7920997920997921,0.9657132612882252,1.0,4/12,21.72%,LBP;SIGIRR;IL22;IL6R
prerank,microtubule anchoring at centrosome (GO:0034454),0.37111577997705714,0.7542936529822888,0.7445255474452555,0.9953349798053253,1.0,3/10,18.75%,NINL;HOOK3;PCM1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.27553538437598524,-0.7536456157114874,0.8114558472553699,0.9660510469953061,1.0,7/22,25.02%,ERBB2;ATF4;EIF2AK3;NOL11;UTP15;PHF8;LYAR
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.29579705248731836,-0.7535909904822503,0.8237791932059448,0.9654284953611771,1.0,10/16,41.47%,APOE;MYOCD;CLU;CYP51A1;HMGCR;IFNGR1;IL4;ABCA7;TNF;LRPAP1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.3352459270096496,-0.7534662731255964,0.7717842323651453,0.9642034671722493,1.0,3/10,12.90%,AP2B1;AP2M1;VLDLR
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.3352459270096496,-0.7534662731255964,0.7717842323651453,0.9642034671722493,1.0,3/10,12.90%,AP2B1;AP2M1;VLDLR
prerank,acute inflammatory response (GO:0002526),0.3057224623610864,0.7534526596536812,0.7652027027027027,0.9961014803970399,1.0,4/23,10.73%,C2CD4B;ANO6;PLSCR1;MYLK3
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.3365549010245885,0.7533101274089856,0.7475915221579962,0.9957510117242342,1.0,2/14,6.47%,KMT5C;KMT5B
prerank,somite development (GO:0061053),0.36007062150790964,0.7531779333751883,0.734251968503937,0.9953843634366594,1.0,2/11,4.94%,LOXL3;SMO
prerank,regulation of mast cell activation (GO:0033003),0.3626436853018059,0.7531346201625656,0.7359223300970874,0.9948750567330954,1.0,2/10,7.38%,HAVCR1;PLSCR1
prerank,negative regulation of catabolic process (GO:0009895),-0.2343468331727738,-0.7527311255832362,0.8688946015424165,0.964511128356035,1.0,13/47,22.05%,PDE3B;FMN2;CST3;FLNA;IRAK3;CBFA2T3;PFKFB1;ADGRB1;SIRT2;TIGAR;CYP51A1;MAD2L1;GIT1
prerank,positive regulation of cilium assembly (GO:0045724),-0.28816624248416167,-0.7525726104216773,0.8082788671023965,0.96403649850643,1.0,7/18,28.89%,CCDC88A;KCTD17;SEPTIN9;CCP110;HAP1;CEP135;MARK4
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.3365314267033754,0.7525355235779904,0.7829313543599258,0.9952038913978393,1.0,4/14,13.56%,ENPP3;AK3;AK4;AK8
prerank,"DNA-templated transcription, termination (GO:0006353)",0.25072267774204304,0.7524930947596495,0.8686567164179104,0.9946991352169888,1.0,12/68,18.67%,POLR2A;TAF1D;PABPN1;TTF2;SCAF8;POLR1G;MTERF2;TBP;TTF1;CPSF3;CSTF1;PCF11
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2632847336766264,0.7517957194574287,0.8354037267080745,0.9952207118739144,1.0,11/54,19.49%,PRKN;SPHK1;CFLAR;GPS2;RIPK1;ADAM17;RNF31;BIRC3;CLIP3;TNFRSF1A;TAX1BP1
prerank,dendritic cell migration (GO:0036336),-0.3092685732265984,-0.7515636260860952,0.8372591006423983,0.9646601303760736,1.0,4/16,23.09%,EPS8;TRPM2;CCL19;CXCR4
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.2172229415227386,-0.7512311621239975,0.9409937888198758,0.9643837072088589,1.0,30/72,31.81%,POLD3;AQR;ERCC1;ERCC6;POLR2J;UBB;RPA1;COPS4;GTF2H1;COPS6;GTF2H4;GTF2H5;RFC4;COPS5;ERCC2;POLD4;POLD1;RFC2;POLR2C;POLR2L;POLK;UBC;RPS27A;RFC5;DDB1;COPS2;RPA3;ERCC3;XAB2;RPA2
prerank,DNA strand elongation (GO:0022616),0.3203009078002662,0.7509248423307582,0.7531531531531531,0.9959764868567479,1.0,4/18,13.34%,POLD2;TERT;RAD50;MCM7
prerank,ATP transport (GO:0015867),0.3648984229390642,0.7505759436064801,0.7524752475247525,0.9959673686496457,1.0,3/10,16.57%,ABCC6;SLC25A42;SLC25A17
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.25694772873951927,0.7502958435813978,0.8359375,0.995829436014079,1.0,15/59,18.22%,TNRC6A;MITF;TP53;MED12;TNRC6B;PTEN;TCF7L2;MOV10;MED17;TNRC6C;NFKB1;MED23;MED26;MED1;MED8
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.33110121575253365,-0.7500861033491554,0.7876288659793814,0.9651991722217403,1.0,3/11,14.31%,TASOR;TRIM28;ATF7IP
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.3389093229172917,-0.7497474888080063,0.8288100208768268,0.9649875389380494,1.0,5/10,19.64%,ITGB3;HIF1A;MT3;ITGA5;VTN
prerank,mitochondrial translational termination (GO:0070126),0.24389923598331392,0.7492145775528158,0.8764367816091954,0.9969549632620145,1.0,25/88,25.77%,MRPS23;MRPS6;MRPL37;MRPL2;MRPL53;MRPS7;MRPS26;MTRF1L;MRPL48;MRPL1;GFM2;MTRF1;MRPL45;MRPS17;CHCHD1;MRPL32;MRPL14;MRPL23;MRPS34;PTCD3;MRPS25;MRPL50;MRPL33;MRPS18B;MRPL19
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.29323663740756656,0.7490972316828156,0.8177257525083612,0.9965570689659762,1.0,2/27,2.32%,IGF1;SPHK1
prerank,polarized epithelial cell differentiation (GO:0030859),0.3365367078991672,0.7486401695365511,0.7656529516994633,0.9966669008363999,1.0,4/13,17.39%,EZR;OPHN1;CDC42;MYO9A
prerank,regulation of response to cytokine stimulus (GO:0060759),0.32211985613543276,0.7486028599743678,0.7692307692307693,0.9961493340912454,1.0,4/19,9.79%,ELF1;MAP2K5;PARP9;MAVS
prerank,RNA stabilization (GO:0043489),0.28624723420986653,0.7485102486234537,0.7983333333333333,0.9957245838694561,1.0,7/33,11.87%,PHAX;LARP1;GDNF;TENT2;THRAP3;NOCT;AXIN2
prerank,heme biosynthetic process (GO:0006783),-0.27742740277872785,-0.7485068789429572,0.8344827586206897,0.9660385177033194,1.0,1/22,0.78%,ABCG2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.3073613948766099,-0.7484949460528566,0.7944325481798715,0.9653654997456714,1.0,5/14,18.37%,THBS1;FGF2;CREB3L1;SPRY1;SPRY4
prerank,regulation of cell aging (GO:0090342),-0.32600010352025455,-0.7480601010633573,0.7750511247443763,0.9652579273715669,1.0,4/11,26.99%,PNPT1;NUAK1;NEK6;VASH1
prerank,regulation of defense response to virus (GO:0050688),0.3428778657663127,0.747605843707539,0.7953736654804271,0.9965627603006663,1.0,4/14,20.24%,PCBP2;PPM1B;ZMPSTE24;TRAF3
prerank,negative regulation of JUN kinase activity (GO:0043508),0.35448019596026775,0.7470929767308997,0.7648221343873518,0.9967343004799357,1.0,3/10,12.34%,PTPN22;DUSP10;HIPK3
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.3393984466036009,-0.7466742095404661,0.7914110429447853,0.966403364951622,1.0,1/10,0.66%,PRKCH
prerank,protein import into mitochondrial matrix (GO:0030150),0.32707795572157145,0.7458419495488008,0.7889908256880734,0.9980592358295107,1.0,7/18,25.50%,TIMM44;TOMM70;TIMM17B;TIMM17A;TIMM21;DNAJC15;GRPEL2
prerank,RNA polyadenylation (GO:0043631),0.2949713697122635,0.745442282309425,0.7884940778341794,0.9975597675696406,1.0,9/26,21.65%,AHCYL1;TENT2;SCAF8;TENT4B;CPSF3;PAPOLG;GRSF1;PCF11;TUT1
prerank,mRNA polyadenylation (GO:0006378),0.2949713697122635,0.745442282309425,0.7884940778341794,0.9975597675696406,1.0,9/26,21.65%,AHCYL1;TENT2;SCAF8;TENT4B;CPSF3;PAPOLG;GRSF1;PCF11;TUT1
prerank,neurogenesis (GO:0022008),0.2721087939066356,0.745351852381283,0.8284789644012945,0.9971165166024785,1.0,4/43,8.28%,LPAR1;TRAK1;DAGLA;RYK
prerank,regulation of complement activation (GO:0030449),-0.23897726425132113,-0.745266926213322,0.8944591029023746,0.9676274863322996,1.0,17/40,31.88%,SUSD4;C1QB;C4B;PROS1;C1QC;CLU;C3AR1;C1QA;VTN;C6;C7;CD81;CFH;C3;SERPING1;C5AR2;CR1L
prerank,ureteric bud morphogenesis (GO:0060675),-0.30339677106987634,-0.7452148743306504,0.8208955223880597,0.9670077550730042,1.0,6/16,19.19%,BMP2;SIX1;FGF2;BMP4;PAX2;PAX8
prerank,protein-DNA complex assembly (GO:0065004),-0.1976663286169529,-0.7446358027603402,0.9813432835820896,0.9670687127077989,1.0,40/116,32.86%,PSMB2;PSMD14;H3-3A;NAP1L1;PSMC6;RAD23B;UBB;SMARCA5;PSMA4;PSMB9;RPA1;ORC5;ORC2;CETN2;PSMD11;GTF2H1;NAP1L4;PSMB10;GTF2H4;PSMD2;GTF2H5;ERCC2;NPM1;PSMA2;UBC;RPS27A;PSMB3;MCM6;PSMB5;DDB1;PSMA7;PSMF1;RAD51;PSMD7;RPA3;ERCC3;RPA2;MCM4;MCM8;PSMA5
prerank,positive regulation of cytokine production (GO:0001819),0.2126280282660925,0.7441712590273749,0.9693034238488784,0.9983403484969373,1.0,36/292,13.29%,RORA;C1QTNF3;ROCK2;PRKCZ;IL18;LACC1;SPHK1;ADRA2A;SULF2;TLR3;TLR4;FZD5;IL17D;NOX1;CD28;IL12B;EIF2AK2;AFAP1L2;SERPINE1;PTPN22;IL17RA;RIPK2;RIPK1;MAVS;CD274;CYRIB;RAB7B;PRKDC;DHX58;ADAM17;GLMN;PTPN11;IRF1;POLR3A;DHX33;SULF1
prerank,aerobic respiration (GO:0009060),0.31405480475395287,0.7441586302611359,0.800376647834275,0.9977889572107511,1.0,7/20,22.96%,MTFR2;SIRT3;UQCRC2;ATP5F1D;SDHB;UQCRC1;UQCRH
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.2754528636099247,-0.7441488195812822,0.8368298368298368,0.9663161772562882,1.0,4/22,12.48%,ZDHHC9;ZDHHC2;GOLGA7;ZDHHC14
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.2754528636099247,-0.7441488195812822,0.8368298368298368,0.9663161772562882,1.0,4/22,12.48%,ZDHHC9;ZDHHC2;GOLGA7;ZDHHC14
prerank,negative regulation of bone remodeling (GO:0046851),-0.3252448159822591,-0.7438627313983902,0.80083857442348,0.9660102656723151,1.0,7/11,30.81%,UBASH3B;TMEM119;SFRP1;P2RX7;CARTPT;CALCA;TNFAIP3
prerank,calcineurin-mediated signaling (GO:0097720),-0.32801958709090373,-0.7426345785455197,0.7769230769230769,0.9661861880393521,1.0,4/10,15.07%,PPP3R1;NFATC1;PPP3CA;PPP3CC
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.32801958709090373,-0.7426345785455197,0.7769230769230769,0.9661861880393521,1.0,4/10,15.07%,PPP3R1;NFATC1;PPP3CA;PPP3CC
prerank,regulation of leukocyte migration (GO:0002685),-0.28895252156703205,-0.7421496912967492,0.8154897494305239,0.9661355174285522,1.0,8/16,31.92%,ANXA1;RHOH;VEGFA;CD81;RHOG;HMOX1;BST1;RAC2
prerank,mRNA export from nucleus (GO:0006406),0.23373273794960867,0.7419316773437475,0.9062068965517242,1.0,1.0,24/102,21.34%,NXF2;PABPN1;SMG1;SRSF5;POLDIP3;HNRNPA2B1;POLR2D;NUP42;NUP98;NXF1;SRSF11;NUP43;SARNP;CPSF3;NUP155;ALKBH5;SRSF1;CDC40;NUP188;U2AF1;UPF2;SRSF7;U2AF2;NUP153
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.29213292222280335,0.7416880801734084,0.797274275979557,1.0,1.0,5/25,13.62%,BID;FAM162A;TP53;DNM1L;MLLT11
prerank,leukotriene metabolic process (GO:0006691),0.3163877807260709,0.7415901802119601,0.7722419928825622,0.9998869231313837,1.0,2/19,7.73%,ALOX12;ABCC10
prerank,regulation of protein localization to centrosome (GO:1904779),0.3622315812525464,0.7413902492711676,0.7425742574257426,0.9996259667314908,1.0,1/10,2.95%,CEP250
prerank,cellular protein localization (GO:0034613),0.21273375990022517,0.7413601122353543,0.9625603864734299,0.9990988405865467,1.0,57/285,18.14%,CELSR1;ANK2;WLS;CSRP3;SNX6;CEP250;SEC31B;TBC1D16;LRRK2;CPLANE2;DUOXA1;STXBP2;PRRT1;ACD;SH3PXD2B;WIPI1;PTPRU;ARFGAP3;NIPBL;CNTNAP1;VPS26C;PICK1;GRTP1;ARL4A;RAB43;COPZ2;RAB22A;NPHP1;AXIN2;VPS45;CLTC;SNX8;STX5;SGSM2;VIPAS39;MFN2;SNX15;AP2A1;SEC23IP;RAB29;RAB21;ARFIP2;ARL6;BBS2;SCFD1;TBC1D25;FAM91A1;SGSM3;CORO1B;RRAGD;MYO7A;VPS35;KIF13A;TBC1D14;WNT5A;SEC31A;EVI5
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.26631875095820545,-0.7408650926560918,0.8480725623582767,0.9670440285009175,1.0,6/25,19.30%,STAT3;STAT5B;HIF1A;TAL1;INHBA;FAM210B
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.3360631084764157,0.7406182978185624,0.7534246575342466,0.9996206867260148,1.0,2/15,9.35%,PRKN;SIRT1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.34829367352339485,0.7392876118595344,0.7895716945996276,1.0,1.0,6/13,23.81%,TDG;MBD4;OGG1;NT5C;UPP2;SMUG1
prerank,lysosome localization (GO:0032418),0.2787173429038746,0.7386709428753564,0.8272425249169435,1.0,1.0,5/37,14.24%,KIT;RAB34;BLOC1S2;KIF5B;FLCN
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.3348292286550486,-0.7382376583830303,0.803680981595092,0.9690508432413577,1.0,3/10,16.95%,CDC42EP3;CDC42EP2;APC
prerank,regulation of pseudopodium assembly (GO:0031272),-0.3348292286550486,-0.7382376583830303,0.803680981595092,0.9690508432413577,1.0,3/10,16.95%,CDC42EP3;CDC42EP2;APC
prerank,I-kappaB phosphorylation (GO:0007252),0.35747725131878905,0.7376010549897285,0.7640449438202247,1.0,1.0,2/10,5.16%,TLR3;TLR4
prerank,regulation of chemokine production (GO:0032642),0.27840243308331825,0.7372836204779558,0.834920634920635,1.0,1.0,4/36,6.57%,IL18;TLR3;TLR4;EIF2AK2
prerank,nuclear envelope organization (GO:0006998),0.3147718211984414,0.7371681880207587,0.8151408450704225,1.0,1.0,6/20,18.30%,DMPK;LEMD2;REEP4;VPS4A;NUP155;TOR1AIP1
prerank,positive regulation of double-strand break repair (GO:2000781),0.2750027174962812,0.7368852553550471,0.8265993265993266,1.0,1.0,10/39,19.09%,ARID2;KMT5C;KMT5B;PARP9;PRKDC;PNKP;SMCHD1;MGMT;FUS;MMS19
prerank,regulation of mitotic cell cycle (GO:0007346),0.2203631037588794,0.7368574246849255,0.9328263624841572,1.0,1.0,13/171,9.35%,SMAD3;ANAPC15;SMOC2;SPHK1;OBSL1;FOXC1;GAS1;ANAPC2;SIK1;AFAP1L2;BTRC;CDK5RAP3;SIRT1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.3540675137059137,0.7365053770959451,0.7714285714285715,1.0,1.0,1/11,1.03%,WNT4
prerank,regulation of response to stress (GO:0080134),-0.3236704754639867,-0.7364715583459615,0.8063157894736842,0.9706117917335728,1.0,5/10,36.68%,CORO2B;ADCY8;OPRM1;CRHBP;MLC1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.3102975315152914,0.7364241708233235,0.8218181818181818,1.0,1.0,4/22,12.87%,CCNT2;ELL;SCAF8;KAT7
prerank,negative regulation of insulin secretion (GO:0046676),0.3192074303141015,0.7363609452159156,0.7777777777777778,1.0,1.0,4/17,12.56%,PRKN;ADRA2A;MIDN;SIRT4
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.3368382274650666,0.7362983684475555,0.784394250513347,0.9996808930087915,1.0,2/12,12.92%,CLCN2;MBTPS1
prerank,establishment of mitotic spindle localization (GO:0040001),0.29279445304129276,0.7361584172147358,0.825,0.9993279845902634,1.0,5/28,11.97%,PKHD1;CLASP1;FBXW11;HTT;MISP
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.2532140564333588,-0.7359367698849852,0.883054892601432,0.9705485147150281,1.0,9/29,28.16%,NSF;COG5;RAB6A;GABARAPL2;COPE;TRAPPC3;COG1;NAPG;COPG2
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.20885974785158906,-0.7356788489744797,0.9454545454545454,0.9701954847783345,1.0,24/70,29.51%,RUNX1;LMO2;PSMB2;GATA2;PSMD14;PSMC6;N4BP2L2;TCF12;TAL1;METTL3;PSMA4;PSMB9;PSMD11;PSMB10;PSMD2;YTHDF2;PSMA2;PSMB3;PUS7;TCF3;PSMB5;PSMA7;PSMF1;PSMD7
prerank,negative regulation of B cell activation (GO:0050869),-0.27148321316110624,-0.7353399450620648,0.8217391304347826,0.9699387547559805,1.0,8/21,21.03%,LYN;TNFRSF21;ID2;SAMSN1;LAPTM5;INHBA;TYROBP;SFRP1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.2434485095543835,0.7350414155627047,0.886002886002886,1.0,1.0,12/76,15.15%,BMP7;PKHD1;PARP10;ARRB1;MAP2K5;CDK5RAP3;SIRT1;USP7;LRRC14;ACOD1;NWD1;FAF1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.24125756964850673,0.7348160900314185,0.8963503649635036,1.0,1.0,11/84,10.14%,IGF1;SPHK1;IGF2BP1;DDX3X;EIF2AK2;SAMD4A;LARP1;CPEB3;IGF2BP2;CNOT10;LSM14A
prerank,mitochondrial genome maintenance (GO:0000002),0.3549927689746201,0.734446821262853,0.7730769230769231,1.0,1.0,4/11,16.03%,OPA1;MEF2A;TOP3A;SLC25A36
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.32390481424404644,0.7344346612782643,0.767097966728281,0.9989885890552803,1.0,3/15,12.08%,DTNBP1;BLOC1S6;BLOC1S2
prerank,anterograde synaptic vesicle transport (GO:0048490),0.32390481424404644,0.7344346612782643,0.767097966728281,0.9989885890552803,1.0,3/15,12.08%,DTNBP1;BLOC1S6;BLOC1S2
prerank,body fluid secretion (GO:0007589),0.3252429499427189,0.7342972214760564,0.7848101265822784,0.9986410294204453,1.0,2/15,8.47%,NPR1;APLN
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.32659363710718065,0.7340425790583451,0.7665441176470589,0.9984673571799373,1.0,6/14,25.37%,SAP18;SFSWAP;SRSF10;SRSF7;U2AF2;SRSF4
prerank,positive regulation of catalytic activity (GO:0043085),0.2743457497382457,0.7333403661699431,0.8401976935749588,0.998892704642438,1.0,8/37,11.47%,SLC5A3;NHEJ1;BCAS3;XRCC4;SSBP1;PHACTR4;ABL1;MSH3
prerank,protein localization to nucleus (GO:0034504),0.23351339425924583,0.7330855315673439,0.9070100143061517,0.9987067070957513,1.0,3/102,3.53%,BMP7;APPL2;TNPO1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.3059688800643928,0.7330158157799734,0.8102189781021898,0.9982476595601482,1.0,4/23,11.97%,PKHD1;FBXW11;HTT;MISP
prerank,mitochondrial transport (GO:0006839),-0.22076674716327235,-0.7328383345393736,0.9302325581395349,0.9722962027376207,1.0,17/53,28.96%,SLC25A13;HSP90AA1;TOMM7;FBXO7;AIP;GDAP1;BCAP31;TOMM22;TIMM8B;TOMM20;STARD3;BNIP3;TIMM13;SPG7;TOMM5;PMAIP1;FIS1
prerank,iron ion transport (GO:0006826),0.26299114732142903,0.7316742788962767,0.8429003021148036,0.9995997918243563,1.0,12/47,18.72%,CP;ATP6V0E1;ATP6V0B;RAB11B;ATP6V1D;ATP6V1E1;CLTC;DNM2;STEAP3;HFE;ATP6V0D1;ARHGAP1
prerank,positive regulation of viral transcription (GO:0050434),0.2909326137030845,0.731555997245779,0.8075601374570447,0.9992041606653165,1.0,5/25,14.71%,POLR2A;POLR2D;GTF2F1;NELFCD;CTDP1
prerank,sulfur compound catabolic process (GO:0044273),0.26951946353647344,0.7315436679673056,0.8439108061749572,0.9986623679832275,1.0,6/38,10.66%,OGN;FMOD;HYAL1;CTH;ARSB;MLYCD
prerank,cellular response to glucose stimulus (GO:0071333),0.28165249397224434,0.7308276532059499,0.8221476510067114,0.9991318027193774,1.0,2/30,2.21%,PRKAA2;ZBTB20
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.3271652237939431,-0.7303731012797753,0.821501014198783,0.9746533061722595,1.0,3/10,16.59%,PTPRC;IRAK3;SIGIRR
prerank,regulation of lymphocyte differentiation (GO:0045619),0.3091358396461864,0.7303628563460132,0.7898550724637681,0.999249365602062,1.0,5/18,20.39%,ABL1;PRKDC;ZFP36L1;CCR2;IKZF3
prerank,DNA modification (GO:0006304),0.30042413433661075,0.7300613300680813,0.8184991273996509,0.9991341254659805,1.0,8/22,23.98%,ACD;TDG;MBD4;EXOSC3;OGG1;TINF2;SMUG1;PARP3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.32550866558414904,-0.7295271796760892,0.8172484599589322,0.974992054768923,1.0,3/11,11.89%,HSPA5;CREB3L1;ATF4
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.2554481634659986,0.729466995078853,0.8859784283513097,0.9994101563670424,1.0,13/55,14.81%,PRKN;F2;PDGFRB;TP53;SIRT5;TGFBR2;PIKFYVE;RIPK1;RNF41;ACOD1;GADD45A;SPHK2;COQ7
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.2486539835892555,-0.7291977730596113,0.8878504672897196,0.9746823218801847,1.0,6/32,13.67%,CEPT1;SLC44A5;SLC44A2;MFSD2A;SLC44A1;LPIN3
prerank,spliceosomal snRNP assembly (GO:0000387),-0.23424645028531588,-0.7291386859344724,0.8986666666666666,0.9740747790171599,1.0,15/38,35.88%,SART1;CLNS1A;SNRPF;COIL;SRSF12;SNRPD3;LSM4;SNRPB;WDR77;PRMT5;SNRPG;LSM2;USP4;PRPF8;GEMIN2
prerank,innate immune response (GO:0045087),0.21174932230843974,0.7291288597085542,0.9644171779141104,0.9993238727622449,1.0,28/217,13.66%,COLEC12;IFIT1;IFI27;KRT1;TLR3;TLR4;RNF135;DEFB1;DDX3X;TRIM56;ANKRD17;COLEC11;TKFC;RIPK2;MAVS;FER;IRGM;SRPK2;ZDHHC1;ANKHD1;DHX58;CAMP;NUB1;FRK;AKAP1;TRIM62;POLR3A;PML
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.2877997054197004,-0.7287013726437479,0.8085106382978723,0.9739347377393569,1.0,2/15,8.47%,PRKCH;AGTR1
prerank,regulation of stem cell differentiation (GO:2000736),-0.20074518861579832,-0.7285878211536433,0.9498327759197325,0.9733862122031428,1.0,20/89,20.19%,RUNX1;LMO2;JAG1;NOTCH1;PSMB2;HES1;GATA2;PTN;PSMD14;PSMC6;TCF12;TAL1;NELFB;METTL3;PSMA4;PSMB9;PSMD11;PSMB10;PSMD2;YTHDF2
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.2910588529344654,0.7285628213615428,0.7956810631229236,0.9995234902596122,1.0,10/27,24.43%,ZC3H12B;DICER1;ZC3H12C;NYNRIN;CPSF3;POP7;PCF11;POP1;XRN1;LACTB2
prerank,ncRNA export from nucleus (GO:0097064),0.2730068038865801,0.7283516679932622,0.8468013468013468,0.9992666008152246,1.0,19/36,30.67%,PHAX;NUP42;NUP98;NUP43;TSC1;NUP155;NUP188;NUP153;XPOT;AAAS;NUP88;SEC13;NUP160;NOL6;RANBP2;NUP37;SSB;RAE1;NUP133
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.2956970585191794,0.7283172414427003,0.7818499127399651,0.9987597945798444,1.0,6/22,18.08%,PPM1E;DUSP10;DUSP2;PPM1B;DUSP18;DUSP4
prerank,regulation of immune response (GO:0050776),0.22254013815108625,0.7277277868987094,0.9343832020997376,0.9990080161933546,1.0,12/135,11.40%,COLEC12;APPL2;CD300A;RNF135;TKFC;PTPN22;PLSCR1;SAMHD1;COL1A2;RSAD2;CXADR;DHX58
prerank,positive regulation of innate immune response (GO:0045089),0.28680699352914407,0.7275383230646997,0.8333333333333334,0.9987085847064244,1.0,11/30,24.64%,IFNK;PLSCR1;MAVS;NMI;TRIM62;IFI35;WNT5A;PLA2G5;POLR3G;ZBP1;FADD
prerank,bile acid metabolic process (GO:0008206),0.29143128848513333,0.7271334719450454,0.8183391003460208,0.9987158468186877,1.0,3/27,5.92%,CYP27A1;AMACR;OSBPL9
prerank,protein targeting to mitochondrion (GO:0006626),-0.21780234894132974,-0.7258939961707276,0.9329446064139941,0.9759313218786223,1.0,15/52,22.11%,IMMP2L;AIFM1;HSP90AA1;TOMM7;FBXO7;AIP;TIMM29;GDAP1;BCAP31;TOMM22;TIMM8B;ROMO1;DNLZ;TOMM20;TIMM13
prerank,regulation of cell cycle process (GO:0010564),-0.19458835001184244,-0.7252457019180135,0.9704797047970479,0.9759555868194252,1.0,44/104,32.59%,CAV2;CALM1;PLK2;CALM2;SH3GLB1;CALM3;GPER1;PRPF40A;CTNNB1;SETD2;TXLNG;ATF5;E4F1;TIPIN;APC;CETN2;KIF11;RAB11FIP4;DCUN1D3;ECT2;BORA;YTHDF2;CUL7;SFRP1;GIT1;TTL;CCDC8;PLK3;CCP110;SPAG5;PRC1;CDKN2B;KLHL13;HMGA2;RPRD1B;MARK4;KIF20A;NUDT16;AURKA;PRMT5;RAB11FIP3;KNSTRN;BUB1;PIK3R4
prerank,negative regulation of histone acetylation (GO:0035067),0.34278081189686616,0.725016057596601,0.7775665399239544,1.0,1.0,4/11,21.12%,SIRT1;SIN3A;TAF7;NOC2L
prerank,regulation of immune effector process (GO:0002697),-0.23087155898986633,-0.7248548954250178,0.8924731182795699,0.9757386633039874,1.0,17/41,31.88%,SUSD4;C1QB;C4B;PROS1;C1QC;CLU;C3AR1;C1QA;VTN;C6;C7;CD81;CFH;C3;SERPING1;C5AR2;CR1L
prerank,positive regulation of DNA replication (GO:0045740),0.3245026447516593,0.7244810600303447,0.7960992907801419,1.0,1.0,4/16,15.15%,GLI2;GLI1;KAT7;FAF1
prerank,maintenance of protein localization in organelle (GO:0072595),0.30237288715723604,0.7242218652991153,0.7897623400365631,1.0,1.0,8/19,25.41%,HK2;TAPT1;PML;TAF3;TAF8;HK1;SUPT7L;ARL2
prerank,gastrulation (GO:0007369),-0.28829282010252794,-0.7236994406627327,0.8224719101123595,0.9764012371368754,1.0,5/15,27.12%,TASOR;LHX1;UGDH;LMBRD1;NR4A3
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.31698979708113584,-0.7234992381521251,0.8422131147540983,0.9759405413733379,1.0,4/11,10.80%,ARHGEF7;CORO1C;CD44;ENPP2
prerank,negative regulation of hippo signaling (GO:0035331),0.3374816206520237,0.7234620558895858,0.7826923076923077,1.0,1.0,6/12,21.38%,VGLL4;WWC2;AJUBA;WTIP;MAPK14;DLG5
prerank,eosinophil migration (GO:0072677),-0.2956051065869602,-0.723432064819509,0.8284518828451883,0.9746592473863116,1.0,8/14,45.45%,SCG2;CCL13;CCL2;CCL11;CCL4;CCL8;CCL1;CCL3
prerank,eosinophil chemotaxis (GO:0048245),-0.2956051065869602,-0.723432064819509,0.8284518828451883,0.9746592473863116,1.0,8/14,45.45%,SCG2;CCL13;CCL2;CCL11;CCL4;CCL8;CCL1;CCL3
prerank,water transport (GO:0006833),-0.30731225476764923,-0.7233607354813791,0.8477366255144033,0.9740574182558134,1.0,2/12,7.57%,AQP4;AQP11
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.30270083558119515,-0.7231654915988363,0.8179723502304147,0.9735820083307574,1.0,3/14,12.04%,CARD14;MAP3K7;TIRAP
prerank,cholesterol metabolic process (GO:0008203),-0.2103109053974528,-0.7230616664104962,0.9568965517241379,0.9730272653318294,1.0,27/68,27.66%,PPARD;APOE;ABCG1;SCARF1;HMGCS1;IDI1;SNX17;PMVK;MT3;LSS;SQLE;DHCR7;DHCR24;LDLRAP1;CH25H;CYP51A1;MSMO1;GBA2;STARD3;ACAT2;CLN8;EBP;ABCA1;ABCA5;HMGCR;FDPS;HSD17B7
prerank,mitotic spindle organization (GO:0007052),-0.18544481712530544,-0.7227069141665444,0.9916317991631799,0.9727644441339656,1.0,62/153,32.39%,CLASP2;PLK2;FLNA;DYNC1I1;DYNLL1;XPO1;DYNC1LI2;CEP126;RPS27;MAP4;BUB3;CLIP1;MZT1;STMN1;CENPE;EFHC2;CHEK2;STAG1;SPAST;TBCE;EML1;KIF11;RAN;PPP1CC;NUP107;NEK6;MAD2L1;CENPH;BCCIP;NSL1;NDC80;SUN2;KIF4A;KIF3B;TPX2;KPNB1;KNTC1;MECP2;TUBG2;DCTN6;CENPA;PRC1;NUP85;CDCA8;KIF23;NDEL1;NDE1;RANGAP1;TNKS;CENPF;NUDC;PTPA;STIL;RHOA;DLGAP5;NUF2;AURKA;TOGARAM2;CENPI;SPC24;CDC20;BUB1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.23290199422980534,0.7224605868991817,0.8987161198288159,1.0,1.0,20/88,15.76%,IGF2BP1;F2;DDX3X;TM4SF20;EIF2AK2;KNG1;SAMD4A;LARP1;CPEB3;CDK5RAP3;IGF2BP2;CNOT10;LSM14A;DDX6;ATRAID;RGP1;TSC1;NFKB1;PLAT;RBM4
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.30141727073421043,0.7212086024680907,0.8156424581005587,1.0,1.0,3/20,8.47%,SMOC2;SULF2;APLN
prerank,positive regulation of chromatin organization (GO:1905269),0.3329731196537532,0.7210502909871773,0.8106508875739645,1.0,1.0,4/12,18.07%,ATRX;ACD;SIN3A;TINF2
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.2378572417099472,-0.7207640620615872,0.900497512437811,0.9743180388642055,1.0,4/34,7.96%,SLC7A5;GPI;PTPRC;EPHB2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.2963429296419564,0.7204666701131559,0.8214285714285714,1.0,1.0,5/23,13.57%,MTMR3;SYNJ2;PTEN;OCRL;PIP4P2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.29039942360112414,-0.7201695245380416,0.8250497017892644,0.9743080841352919,1.0,3/15,10.91%,SCARB1;LDLR;MFSD2A
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.2492779612601655,0.7201349707111259,0.8947368421052632,1.0,1.0,16/56,22.92%,NDUFAF4;NDUFAB1;NDUFS1;NDUFV2;FOXRED1;NDUFAF5;TIMMDC1;DMAC2;NDUFS4;TMEM126B;NDUFA2;NDUFAF7;NDUFS5;TIMM21;NDUFA9;NDUFB2
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.2492779612601655,0.7201349707111259,0.8947368421052632,1.0,1.0,16/56,22.92%,NDUFAF4;NDUFAB1;NDUFS1;NDUFV2;FOXRED1;NDUFAF5;TIMMDC1;DMAC2;NDUFS4;TMEM126B;NDUFA2;NDUFAF7;NDUFS5;TIMM21;NDUFA9;NDUFB2
prerank,nucleoside salvage (GO:0043174),-0.320799561445001,-0.7200239643871971,0.824945295404814,0.9737865772885159,1.0,4/10,30.34%,HPRT1;UCK2;UPP1;TK2
prerank,pentose-phosphate shunt (GO:0006098),-0.3142804671332891,-0.7186137144515121,0.8355263157894737,0.9746977704343944,1.0,4/11,21.82%,TKT;TALDO1;RPE;RPIA
prerank,protein localization to microtubule organizing center (GO:1905508),-0.2931074303087384,-0.718222114298149,0.8473451327433629,0.9744734371670326,1.0,6/15,31.20%,CEP83;CEP131;SPAG5;NEDD1;STIL;CSNK1D
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.24673491005067794,0.7181686434519,0.8939157566302652,1.0,1.0,9/60,12.69%,SMOC2;ATM;ACD;DSCC1;PDGFRB;TNKS2;AURKB;FBXO4;PNKP
prerank,positive regulation of monooxygenase activity (GO:0032770),0.2868272389487647,0.7163026218467917,0.8303249097472925,1.0,1.0,4/26,8.44%,NPR3;POR;TERT;GDNF
prerank,regulation of protein localization to nucleus (GO:1900180),0.26035773745898405,0.7156050795222139,0.8316831683168316,1.0,1.0,9/43,14.24%,SESN2;F2;WWTR1;CDK5RAP3;PARP9;GLUL;KAT7;SIN3A;FLCN
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.20426789250380967,-0.7155369021294847,0.9651162790697675,0.9767975550425829,1.0,39/66,41.95%,STAT3;FOXP1;APP;EGR1;AIM2;CARD16;USP50;CX3CR1;NOD2;PANX1;HSPB1;TYROBP;CCL19;LGALS9;PYCARD;GIT1;NLRP2B;F2R;JAK2;TRIM16;P2RX7;CD36;MALT1;TNFAIP3;CD33;TLR8;MYD88;TMEM106A;GBP5;CPTP;ISL1;CASP8;INAVA;TNF;NLRP12;ZC3H12A;LPL;GSDMD;IL6
prerank,mRNA catabolic process (GO:0006402),0.2643082862588869,0.7153966406421759,0.865040650406504,1.0,1.0,4/44,10.60%,DDX5;TUT4;CNOT10;THRAP3
prerank,regulation of cilium assembly (GO:1902017),0.2470025682023686,0.715011761837943,0.8904109589041096,1.0,1.0,20/62,21.60%,DCDC2;TBC1D16;ATG5;RABEP2;HTT;SDCCAG8;IFT88;TAPT1;TCHP;SGSM3;TBC1D14;TBC1D7;EVI5;YAP1;TBC1D22B;CEP120;EVI5L;TBC1D24;FUZ;USP6NL
prerank,regulation of cellular senescence (GO:2000772),0.2814739661066659,0.7141079163745779,0.8447098976109215,1.0,1.0,7/28,14.54%,SLC30A10;HMGA1;TERT;SIRT1;RBL1;RSL1D1;ZKSCAN3
prerank,response to laminar fluid shear stress (GO:0034616),0.3408642147680228,0.7137255406176235,0.7867647058823529,1.0,1.0,2/10,5.70%,SMAD6;MAP2K5
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.2913043679527444,0.712757742975801,0.8095238095238095,1.0,1.0,5/20,15.53%,CTR9;MEIS1;LDB1;ZFP36L1;HOXB8
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.293631852071513,-0.712697923255668,0.8461538461538461,0.9792439915004914,1.0,3/14,13.17%,ACTR2;WDR48;ERCC6
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.23473361846549873,0.7125371638810518,0.9041916167664671,1.0,1.0,6/71,6.32%,PRKN;FBXL17;NGLY1;CTSH;USP9X;CLPX
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.29655793185487433,-0.71242222734008,0.8154506437768241,0.9788572607795204,1.0,2/13,7.46%,GRIN2A;PERP
prerank,regulation of isotype switching (GO:0045191),0.3219441093531564,0.7121554794517105,0.8176691729323309,1.0,1.0,2/14,6.47%,KMT5C;KMT5B
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.31690560361245823,-0.7117719419169423,0.8434237995824635,0.9788828491285056,1.0,7/10,41.16%,APC;SIRT2;ECT2;SPAG5;KNSTRN;CCNB1;NEK2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.28263872681426205,-0.7103183659288742,0.8605664488017429,0.9797146533838432,1.0,1/17,0.34%,CTNNA2
prerank,cellular response to acid chemical (GO:0071229),0.281648496323147,0.7101025231198226,0.8327814569536424,1.0,1.0,7/27,19.11%,CPEB4;SESN2;CPEB3;RPTOR;NSMF;RRAGD;LAMTOR1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.344012363483512,0.7100598051522694,0.8003802281368821,1.0,1.0,4/10,21.12%,SIRT1;TAF7;KLF15;NOC2L
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.2530718211104345,-0.7083705194214459,0.8826086956521739,0.981135572260786,1.0,5/24,14.09%,TGFB2;EPHA7;ATF4;CTNNB1;CDK5R1
prerank,steroid hormone biosynthetic process (GO:0120178),0.2768975585417066,0.7078710737710149,0.8402662229617305,1.0,1.0,4/29,12.67%,CYP21A2;FDXR;TSPOAP1;SRD5A2
prerank,protein polyglutamylation (GO:0018095),0.33272802292122594,0.7076158177758415,0.7898832684824902,1.0,1.0,2/11,7.04%,TTLL6;TTLL9
prerank,phasic smooth muscle contraction (GO:0014821),-0.3177210098849209,-0.7073109502886392,0.8675213675213675,0.9815573814222696,1.0,4/10,21.60%,EDN1;EDN3;EDNRB;DRD2
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.2530150750850727,0.7069323748503464,0.8778135048231511,1.0,1.0,12/52,19.51%,CXXC1;TLN1;TPP1;WIPI1;EXTL1;CTDSP2;GFPT1;SYVN1;SEC31A;ATP6V0D1;FKBP14;PARP16
prerank,positive regulation of interleukin-12 production (GO:0032735),0.2738052912874568,0.7067589023120318,0.8713355048859935,1.0,1.0,4/31,9.53%,TLR3;TLR4;IL12B;RIPK2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.2545120299277994,-0.7064110017454643,0.9004524886877828,0.9817765548231728,1.0,1/24,0.78%,ABCG2
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.22696058506053007,-0.706240220878576,0.9101941747572816,0.9812792779548467,1.0,4/42,12.09%,LARS2;WARS2;GARS1;DARS2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.23544689783798106,0.7062028051094107,0.9237410071942446,1.0,1.0,1/86,0.14%,EPAS1
prerank,replication fork processing (GO:0031297),0.26976468020844563,0.7060795773874315,0.8548644338118022,1.0,1.0,5/38,10.85%,ATRX;SAMHD1;FBH1;FANCM;EME2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.2723606590851156,0.7048393125942419,0.8678929765886287,1.0,1.0,8/29,20.28%,ACOT11;MLYCD;ACOT8;THEM4;ACOT12;ACLY;CROT;ACSF2
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.2723606590851156,0.7048393125942419,0.8678929765886287,1.0,1.0,8/29,20.28%,ACOT11;MLYCD;ACOT8;THEM4;ACOT12;ACLY;CROT;ACSF2
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.32281130313735984,0.704642191976968,0.819366852886406,1.0,1.0,3/13,10.95%,NEDD4;NIBAN2;CNMD
prerank,positive regulation of RNA splicing (GO:0033120),-0.24711077141827154,-0.704207690808911,0.9135514018691588,0.9826770697310777,1.0,3/29,4.99%,PIK3R1;CELF4;HNRNPLL
prerank,protein-containing complex disassembly (GO:0032984),-0.2124364908208139,-0.7040449932675695,0.9352941176470588,0.9821559219048572,1.0,10/54,17.20%,CAV1;GSK3B;HSPA8;RPL23;CTNNB1;AXIN1;MAP1LC3A;GABARAPL2;APC;PPP1CA
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.2774543846140873,-0.7036662240462878,0.8629213483146068,0.9818652579376107,1.0,9/16,30.50%,GPER1;GRP;CHGA;NECAB2;MRAP2;C3;SLC39A14;PDE6G;PRMT5
prerank,regulation of hippo signaling (GO:0035330),0.303576432987597,0.7036624149396477,0.8136531365313653,1.0,1.0,7/17,21.38%,VGLL4;WWC2;AJUBA;MOB3B;WTIP;MAPK14;DLG5
prerank,positive regulation of interleukin-8 production (GO:0032757),0.24839843138881104,0.7034352813707753,0.9062003179650239,1.0,1.0,7/49,9.79%,TLR3;TLR4;IL17D;AFAP1L2;SERPINE1;RIPK1;MAVS
prerank,cytoplasmic microtubule organization (GO:0031122),0.24375999926376749,0.7033512189262523,0.9067930489731437,1.0,1.0,4/54,4.66%,DLG1;HOOK2;CLASP1;EZR
prerank,regulation of secretion (GO:0051046),-0.29800946187783284,-0.7031687400557132,0.8636363636363636,0.981733619772488,1.0,3/13,8.98%,ACSL3;KCNQ1;MYO6
prerank,mRNA stabilization (GO:0048255),-0.2260368257838215,-0.7030703685792243,0.9449760765550239,0.9811504932969932,1.0,10/40,17.72%,YBX1;ELAVL4;SYNCRIP;TAF15;EIF4ENIF1;TIRAP;YBX3;TENT5A;DHX9;PABPC1
prerank,regulation of mRNA stability (GO:0043488),0.2152128093069965,0.7030003273847968,0.9477211796246648,1.0,1.0,17/145,12.33%,ROCK2;TNPO1;TNFSF13;IGF2BP1;SAMD4A;LARP1;EXOSC7;GDNF;IGF2BP2;CSDC2;YTHDF3;TBRG4;THRAP3;NOCT;AXIN2;DCP1A;PRKCA
prerank,response to gamma radiation (GO:0010332),0.28721823009175645,0.7029189969648716,0.8393162393162393,1.0,1.0,8/24,20.03%,ATM;TP53;CRYAB;TLK2;KDM1A;YAP1;FANCD2;LIG4
prerank,protein targeting to lysosome (GO:0006622),-0.2590698921684599,-0.7027719801203057,0.8820754716981132,0.980773592017595,1.0,7/20,16.29%,HSPA8;SORL1;GCC2;LAPTM5;CLU;NCOA4;M6PR
prerank,regulation of B cell differentiation (GO:0045577),0.2996419550836074,0.7024168448317036,0.8135283363802559,1.0,1.0,5/17,20.39%,CD27;MMP14;ZFP36L1;INHA;IKZF3
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.28090951588770524,0.7021129407369077,0.8573825503355704,1.0,1.0,2/27,2.00%,PPARA;IL18
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.28852087862854936,0.7020937500452514,0.8396396396396396,1.0,1.0,2/20,7.94%,NR2F2;PTEN
prerank,sensory perception (GO:0007600),-0.22049629262968476,-0.7016175764788989,0.9352112676056338,0.9812559373702214,1.0,17/45,28.82%,GNAS;PCDH15;PTGES;MME;SCN9A;GNAL;TMEM150C;CHRNA7;TRPA1;TTC8;PENK;OPRM1;PNOC;CCL2;OPRL1;P2RX7;CDH23
prerank,cellular response to ATP (GO:0071318),-0.2941181767379698,-0.7009207818334778,0.8458333333333333,0.9812681000220385,1.0,3/14,14.40%,RYR3;P2RY12;P2RY1
prerank,base-excision repair (GO:0006284),0.24905452468614417,0.7008207320306337,0.879746835443038,1.0,1.0,14/48,23.81%,POLD2;POLG;HUWE1;PNKP;TDG;POLL;MBD4;OGG1;FEN1;RFC1;XPA;LIG1;ADPRS;SMUG1
prerank,regulation of actin nucleation (GO:0051125),0.3391714426516083,0.7007062755362305,0.7953667953667953,1.0,1.0,5/12,17.04%,PICK1;VIL1;ARFIP2;WASHC5;CORO1B
prerank,regulation of response to interferon-gamma (GO:0060330),-0.28744700951825786,-0.7002345283876923,0.8423423423423423,0.9812809678959709,1.0,3/14,9.42%,HSP90AB1;IFNGR2;JAK1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.3005621790794045,0.7000241176825925,0.8424908424908425,1.0,1.0,6/17,24.75%,AURKB;IK;CHAMP1;RB1;MIS12;SPDL1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.3024846117489577,0.6998423812781768,0.8138195777351248,1.0,1.0,2/15,5.82%,RAPGEF3;CAMK1
prerank,protein kinase B signaling (GO:0043491),0.2885927900843507,0.6997794179340844,0.824468085106383,1.0,1.0,5/23,15.26%,IGF1;PTEN;PIK3R3;THEM4;ZFP36L1
prerank,cellular response to ionizing radiation (GO:0071479),0.2483577523649685,0.6996128726976002,0.9022801302931596,1.0,1.0,18/47,24.07%,ATM;TP53;NIPBL;SIRT1;HUS1;CRYAB;GADD45A;TLK2;INTS7;KDM1A;MAPK14;YAP1;LIG4;TANK;RAD9A;FIGNL1;TSPYL5;NUCKS1
prerank,vacuolar acidification (GO:0007035),-0.25505422377381093,-0.6994255749717895,0.8891566265060241,0.9814200554997188,1.0,3/21,9.52%,ATP6V0A1;ATP6V0A4;PPT1
prerank,protein import into peroxisome matrix (GO:0016558),-0.2954531538524989,-0.6992462479074464,0.8602794411177644,0.9809260349314723,1.0,1/12,2.23%,PEX5L
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.2695508130718989,-0.6975487120483049,0.84,0.9819569953507044,1.0,6/16,29.69%,ST3GAL4;ITGB2;MDK;RELA;SELP;RHOA
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.2786384403201804,0.697516081925465,0.8667883211678832,1.0,1.0,4/26,9.35%,PRKN;LRRK2;SOD2;SIRT1
prerank,regulation of exit from mitosis (GO:0007096),0.2610932733105349,0.6974018363895144,0.8661290322580645,1.0,1.0,6/38,16.69%,ANAPC15;ANAPC2;CDC14A;CDC14B;ANAPC16;UBE2E1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.23867673846218804,-0.6968498552460155,0.9081885856079405,0.9819729579481997,1.0,7/33,19.30%,STAT3;STAT5B;HIF1A;TAL1;FES;INHBA;FAM210B
prerank,regulation of lymphocyte activation (GO:0051249),0.3214061519146266,0.6963031095216679,0.8049242424242424,1.0,1.0,12/12,67.88%,LAT;IKZF3;PAG1;DCAF15;SIT1;KAT2A;CCL5;CD4;CD19;LCK;CRTAM;THEMIS2
prerank,regulation of multicellular organismal development (GO:2000026),0.2770193889195742,0.6956279456901828,0.8384353741496599,1.0,1.0,5/25,16.83%,OAS2;NIPBL;TRIP12;TDG;EHMT1
prerank,negative regulation of translational initiation (GO:0045947),0.32296142462489896,0.6955917202585069,0.8204667863554758,1.0,1.0,6/13,29.96%,LARP1;RBM4;FMR1;AGO2;EIF4EBP1;EIF2AK1
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.23932255777488967,-0.6953195542136459,0.8891454965357968,0.9828003712855709,1.0,14/30,27.66%,HMGCS1;IDI1;PMVK;LSS;SQLE;DHCR7;DHCR24;CYP51A1;MSMO1;ACAT2;EBP;HMGCR;FDPS;HSD17B7
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.2604278608892645,0.6952570733534664,0.8785357737104825,1.0,1.0,5/35,8.60%,CD300A;PPP4R4;MAGI2;PDGFRB;HTT
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.19484793087037378,-0.6951280329946066,0.9792387543252595,0.9823232909946745,1.0,31/87,30.33%,FBXL7;PSMB2;DACT1;PSMD14;PSMC6;FAM107A;CDKN1A;JADE1;MYO16;PSMA4;PSMB9;APC;SKP1;RGCC;CDC73;PSMD11;PSMB10;PSMD2;DCUN1D3;PSMA2;CDKN2B;PSMB3;KLF4;FHL1;CCL2;PSMB5;PSMA7;PSMF1;PSMD7;WEE1;AURKA
prerank,anterograde axonal transport (GO:0008089),0.2543574669349211,0.6950049682167169,0.8764415156507414,1.0,1.0,8/37,15.24%,TRAK1;DTNBP1;KIF1B;KIF1C;BLOC1S6;BLOC1S2;KIF5B;RAB21
prerank,histone mRNA metabolic process (GO:0008334),0.27390818158390773,0.6945632997882083,0.8677685950413223,1.0,1.0,6/27,16.40%,ATM;TUT4;TENT2;TENT4B;CPSF3;TUT7
prerank,cellular response to light stimulus (GO:0071482),0.2354535820406958,0.6938606175145867,0.9120715350223547,1.0,1.0,20/66,23.79%,NEDD4;RHO;TP53;CDC25A;AURKB;ZBTB1;SDE2;CREBBP;SAG;KDM1A;TAF1;PDE6B;FMR1;NOC2L;OPN1SW;YY1;CASP9;EP300;OPN1MW;OPN1MW3
prerank,regulation of lipid catabolic process (GO:0050994),-0.26773498081058233,-0.6938486417907435,0.8903225806451613,0.9828986145804413,1.0,1/19,2.06%,PDE3B
prerank,regulation of mRNA metabolic process (GO:1903311),0.3204239116409552,0.6928449661059796,0.8327067669172933,1.0,1.0,2/11,10.61%,SLTM;SRPK2
prerank,regulation of actin filament depolymerization (GO:0030834),0.31718428328826526,0.6925484186767993,0.8298676748582231,1.0,1.0,3/12,11.40%,PLEKHH2;PIK3CA;VIL1
prerank,positive regulation of histone modification (GO:0031058),0.2687206013742633,0.6922775948555897,0.8602150537634409,1.0,1.0,3/33,7.38%,PPARGC1A;ARRB1;NIPBL
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.32888835111913767,0.6918803597308916,0.811284046692607,1.0,1.0,6/10,33.22%,ATP5F1D;ATP5F1C;ATP5MC3;VPS9D1;ATP5MG;ATP5MC2
prerank,regulation of neutrophil migration (GO:1902622),-0.3081820772975485,-0.6917641877471935,0.8544303797468354,0.9842025660759525,1.0,6/10,31.92%,MPP1;RHOH;RHOG;JAM3;BST1;RAC2
prerank,mitotic metaphase plate congression (GO:0007080),0.2438969669832302,0.6910449634450815,0.9009433962264151,1.0,1.0,9/51,17.02%,EML4;CHMP1A;BECN1;CHAMP1;KIFC1;VPS4A;CENPC;CHMP4C;PIBF1
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.22292719449674056,-0.6907161254527601,0.9170854271356784,0.9845677749557732,1.0,10/40,19.58%,PGLYRP1;RPL39;GBP4;DROSHA;TIRAP;MPEG1;LBP;RARRES2;PPP1R11;ROMO1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.20443819484325443,-0.6902093297199019,0.9649122807017544,0.9830635838336653,1.0,18/61,25.51%,GRIA1;CTSC;CUL3;NSF;CNIH1;KLHL12;ANKRD28;CTSZ;TFG;MCFD2;TRAPPC2L;TMED10;COL7A1;SEC16B;TMED2;SAR1B;TRAPPC3;RAB1B
prerank,COPII vesicle coating (GO:0048208),-0.20443819484325443,-0.6902093297199019,0.9649122807017544,0.9830635838336653,1.0,18/61,25.51%,GRIA1;CTSC;CUL3;NSF;CNIH1;KLHL12;ANKRD28;CTSZ;TFG;MCFD2;TRAPPC2L;TMED10;COL7A1;SEC16B;TMED2;SAR1B;TRAPPC3;RAB1B
prerank,vesicle coating (GO:0006901),-0.20443819484325443,-0.6902093297199019,0.9649122807017544,0.9830635838336653,1.0,18/61,25.51%,GRIA1;CTSC;CUL3;NSF;CNIH1;KLHL12;ANKRD28;CTSZ;TFG;MCFD2;TRAPPC2L;TMED10;COL7A1;SEC16B;TMED2;SAR1B;TRAPPC3;RAB1B
prerank,RNA modification (GO:0009451),0.2354677695025223,0.6896503582865054,0.9205607476635514,1.0,1.0,9/54,19.97%,TRMT9B;RBM15;JMJD6;NOP2;LCMT2;WDR4;DTWD2;NSUN4;ADAT2
prerank,regulation of melanin biosynthetic process (GO:0048021),0.3369273556001554,0.6896177588356738,0.80859375,1.0,1.0,4/10,30.35%,CTNS;ATP7A;RAPGEF2;CDH3
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.2297563448728667,-0.6894024819537145,0.9261083743842364,0.983155256953366,1.0,6/33,14.08%,PTPRJ;RPS3;CEACAM1;DUSP3;DGKZ;LAPTM5
prerank,chromosome condensation (GO:0030261),-0.22390478285784501,-0.688524657734101,0.9175,0.9833383268278529,1.0,14/36,27.96%,AIFM1;SMC4;GPER1;NCAPG2;TOP2A;NUSAP1;BANF1;MCPH1;PHF8;NCAPH;TTN;SET;NCAPH2;CSNK2B
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.23451819857936435,-0.6879734132588848,0.9063291139240506,0.9831888956977078,1.0,8/28,26.52%,SH3KBP1;CD47;NOD2;PRKCQ;TYROBP;PYCARD;THY1;CCL2
prerank,response to UV (GO:0009411),-0.18734456992423543,-0.6877990498428249,0.9896193771626297,0.9826826466048337,1.0,35/95,30.19%,PTPRK;RPL26;MAP4K3;MFAP4;ATF4;ERCC6;SDF4;PRIMPOL;METTL3;UBE2B;BCL3;GPX1;CAT;RHBDD1;MEN1;DCUN1D3;ERCC2;POLD1;NPM1;TRIAP1;N4BP1;POLK;DTL;MAP2K7;RUVBL2;RELA;CCAR2;PCLAF;UBE2A;CCND1;MAPK8;CIRBP;BMF;ERCC3;AQP1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.3137017739597077,0.6874825578175311,0.8388888888888889,1.0,1.0,3/13,18.50%,VDAC2;BLOC1S2;RHOT1
prerank,negative regulation of centrosome duplication (GO:0010826),-0.2996510466334676,-0.6870650017744109,0.8571428571428571,0.9826608736898617,1.0,3/11,21.60%,CDK5RAP2;TRIM37;NPM1
prerank,negative regulation of cholesterol transport (GO:0032375),-0.30942283195733555,-0.6869006583188059,0.8568376068376068,0.982170639377958,1.0,1/10,7.44%,SREBF2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.3189994633895537,0.6868623099517974,0.8327205882352942,1.0,1.0,2/12,12.62%,INSIG2;TAPT1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.2634898596992094,-0.6865495726526335,0.8755458515283843,0.9818406878504519,1.0,7/19,21.18%,DDIT4;HIPK1;PHLDA3;BCL3;HIPK2;RPS27L;PYCARD
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.29594102282212664,-0.6856286443471851,0.8565737051792829,0.9820182065636373,1.0,3/11,19.59%,CAMK4;ITGB2;TYROBP
prerank,fatty acid biosynthetic process (GO:0006633),0.23145203430622938,0.6851699730912085,0.9320531757754801,1.0,1.0,6/63,7.40%,ALOX12;ACSBG2;HACD4;HACD1;SCD5;NDUFAB1
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.18627060773038653,-0.6845233507525311,0.9964912280701754,0.9823513339386392,1.0,17/101,18.10%,MEF2C;PDE4B;LYN;DAB2IP;TNFRSF1B;TGFB1;SBNO2;VIM;CARD16;LBP;MTDH;CX3CR1;NOD2;CD180;TRIM41;PDCD4;CDC73
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.2822991794978726,-0.684154856331772,0.8919491525423728,0.982054640432616,1.0,6/14,31.26%,NCBP2;ERN1;CPSF4;CPSF4L;CSTF2T;CPSF1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.25681824512124507,-0.6836557153565571,0.8936651583710408,0.9818720544826736,1.0,3/18,18.79%,ANXA1;FAM107A;BCL2L11
prerank,transcription by RNA polymerase III (GO:0006383),-0.23717200700061664,-0.6835852509257737,0.9084668192219679,0.9812813499371645,1.0,3/27,10.80%,IVNS1ABP;RO60;GTF3C5
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3073594074451163,0.6833694003286356,0.8336380255941499,1.0,1.0,1/13,2.89%,NFAT5
prerank,determination of bilateral symmetry (GO:0009855),-0.24175211860819928,-0.6832950082387776,0.9130434782608695,0.9808773863236172,1.0,2/24,5.71%,NOTCH1;TBX1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.3026528220730791,-0.6822550810107736,0.8663594470046083,0.9812059057683404,1.0,4/11,22.63%,CD44;TAF9B;CD74;TRIAP1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.2588435800941114,0.6821529673851405,0.8971807628524047,1.0,1.0,9/36,20.25%,ATM;DONSON;HUS1;DOT1L;CEP63;CLSPN;INTS7;NBN;RAD9A
prerank,positive regulation of mRNA processing (GO:0050685),-0.25166005653085805,-0.6816727051788505,0.8934782608695652,0.9810456426614934,1.0,9/21,33.67%,CELF4;CDC73;TRA2A;RBM3;NCBP2;RBMXL1;CIRBP;SF3B4;CELF3
prerank,B cell mediated immunity (GO:0019724),0.32718264251242357,0.6815213622607925,0.8345588235294118,1.0,1.0,1/10,5.67%,CD27
prerank,regulation of receptor internalization (GO:0002090),0.2569595916860892,0.6806527362121694,0.8916256157635468,1.0,1.0,5/35,9.70%,MAGI2;ARRB1;RIN3;ATXN2;PICK1
prerank,intracellular pH reduction (GO:0051452),-0.22684109534651714,-0.6802695973291466,0.9170854271356784,0.9816158448849576,1.0,9/33,21.62%,ATP6V0A1;ATP6V0A4;RAB38;CLCN3;RAB39A;GPR89A;GPR89B;ATP6V1F;ATP6V1B2
prerank,histone acetylation (GO:0016573),0.22725661988259568,0.6798254793845753,0.9254185692541856,1.0,1.0,21/69,25.13%,BRD8;CPA4;ZZZ3;KAT6B;ATF2;BRD1;KAT14;KAT7;BEND3;KAT2B;CREBBP;SGF29;TAF6L;RUVBL1;EP300;DMAP1;SUPT7L;MSL3;TAF12;PHF20;ING3
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.2932685481976568,-0.6789931412085298,0.8657024793388429,0.9820670770664788,1.0,8/11,38.78%,TIMM29;TIMM8B;ROMO1;TIMM13;NDUFA13;TIMM10B;AGK;TIMM9
prerank,regulation of necroptotic process (GO:0060544),-0.2406204182489338,-0.6787322703450359,0.909706546275395,0.9816222067152891,1.0,9/23,24.31%,ARHGEF2;HSP90AA1;PDCD6IP;MLKL;YBX3;PELI1;SPATA2;FLOT1;STUB1
prerank,microtubule-based transport (GO:0099111),0.31591847913716564,0.6780868667218662,0.8389513108614233,1.0,1.0,2/12,8.60%,ROPN1L;HTT
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.32401794559995145,0.677895523759516,0.8079847908745247,1.0,1.0,2/10,15.81%,ACD;TFIP11
prerank,regulation of gene silencing by miRNA (GO:0060964),0.2331877387880998,0.6774069214455624,0.9357366771159875,1.0,1.0,22/62,26.79%,POLR2A;TNRC6A;POLR2D;NUP42;AJUBA;NUP98;NUP43;WTIP;NUP155;EIF4G1;NUP188;POLR2G;FMR1;NUP153;AGO1;POLR2F;AAAS;NUP88;AGO2;PUM2;SEC13;POLR2K
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.26267377215851323,0.6773722044696981,0.9005059021922428,1.0,1.0,6/32,12.69%,ATM;ACD;TNKS2;AURKB;FBXO4;PNKP
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.2477930525908511,-0.6768834732566437,0.9046563192904656,0.9825810708208432,1.0,10/20,33.06%,GATM;GCLM;GAMT;CHAC2;FPGS;OPLAH;GGCT;MGST2;GCLC;GGT1
prerank,immunoglobulin mediated immune response (GO:0016064),0.32620203408045767,0.6764882405944235,0.8220502901353965,1.0,1.0,1/10,5.67%,CD27
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.23180817252938613,-0.6758854828317764,0.9071925754060325,0.9827941084980154,1.0,6/28,17.55%,MAP1B;CLASP2;STMN2;MAPT;STMN1;FKBP4
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.20668159251668033,-0.674586020135018,0.9703504043126685,0.9832136976760696,1.0,16/51,23.45%,NEK7;GNL3L;XRCC5;CTNNB1;SMG5;TERF1;CCT8;STN1;CCT2;PRKCQ;CCT6A;HMBOX1;CCT7;DCP2;EXOSC10;MAP2K7
prerank,microtubule depolymerization (GO:0007019),0.29376223136813623,0.6743093219779132,0.8522072936660269,1.0,1.0,1/17,1.81%,KIF2A
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.2576110688835563,-0.6742007550921802,0.9086859688195991,0.982889882782435,1.0,2/18,8.42%,POLA1;POLD3
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.320684242980776,0.67408647591186,0.8702290076335878,1.0,1.0,2/11,15.44%,SIRT1;TAF7
prerank,proteasomal protein catabolic process (GO:0010498),0.197858160323315,0.6720517192238415,0.9937027707808564,1.0,1.0,23/201,11.88%,PRKN;FBXL17;SPSB1;NEDD4;IFI27;PCBP2;DCAF11;FBXL19;ARRB1;SPSB4;TBL1X;SMURF2;FBXW11;HUWE1;ERLEC1;BTRC;TBL1XR1;RNF34;SIRT1;ZSWIM8;RNF41;WWP2;CUL4A
prerank,endoderm development (GO:0007492),0.31167145277461367,0.6718056423391647,0.8515769944341373,1.0,1.0,1/13,2.04%,LAMC1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.2131378818089292,0.6717860694579559,0.9650837988826816,1.0,1.0,24/96,22.90%,NXF2;SMG1;SRSF5;POLDIP3;HNRNPA2B1;NUP42;NUP98;NXF1;SRSF11;NUP43;SARNP;CPSF3;NUP155;ALKBH5;SRSF1;CDC40;NUP188;U2AF1;UPF2;SRSF7;U2AF2;NUP153;FYTTD1;SMG6
prerank,mitotic cytokinetic process (GO:1902410),0.2845349883849834,0.6717633187124731,0.8655616942909761,1.0,1.0,6/20,21.80%,KLHDC8B;CHMP1A;VPS4A;CHMP4C;CHMP2A;MITD1
prerank,regulation of axon regeneration (GO:0048679),0.3197144412607873,0.6712224709332716,0.8410852713178295,1.0,1.0,1/12,2.17%,EPHA4
prerank,mRNA transport (GO:0051028),0.2115864289521237,0.6710874586936434,0.9708333333333333,1.0,1.0,26/101,22.90%,NXF2;SMG1;SRSF5;POLDIP3;HNRNPA2B1;NUP42;NUP98;NXF1;SRSF11;NUP43;ZFP36L1;SARNP;CPSF3;NUP155;ALKBH5;SRSF1;CDC40;NUP188;U2AF1;UPF2;SRSF7;FMR1;U2AF2;NUP153;FYTTD1;SMG6
prerank,monocyte chemotaxis (GO:0002548),-0.2274122860259772,-0.6701297794623724,0.9600997506234414,0.9856028640818388,1.0,3/32,5.86%,ANXA1;TNFRSF11A;RPS19
prerank,regulation of histone deacetylation (GO:0031063),-0.2814605425206166,-0.6699940491540558,0.8720173535791758,0.985050329631806,1.0,1/13,2.27%,CAMK2D
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.31020306613574133,0.6699130125100571,0.8709677419354839,1.0,1.0,2/13,7.78%,UBAC2;ERLEC1
prerank,protein localization to centrosome (GO:0071539),-0.2626662470096811,-0.669851522549617,0.9076576576576577,0.9845112046774727,1.0,6/17,31.20%,CEP83;CEP131;SPAG5;NEDD1;STIL;CSNK1D
prerank,triglyceride catabolic process (GO:0019433),0.28951366234893844,0.6694160468519109,0.8707964601769912,1.0,1.0,1/19,4.38%,CPS1
prerank,mitochondrial translational elongation (GO:0070125),0.21809530607177924,0.6693461463715693,0.9543509272467903,1.0,1.0,24/88,26.23%,MRPS23;MRPS6;MRPL37;MRPL2;MRPL53;MRPS7;MRPS26;MRPL48;MRPL1;GFM2;MRPL45;MRPS17;CHCHD1;MRPL32;MRPL14;MRPL23;MRPS34;PTCD3;MRPS25;MRPL50;MRPL33;MRPS18B;MRPL19;TSFM
prerank,cellular response to superoxide (GO:0071451),0.3233802929236227,0.6683851093291623,0.834307992202729,1.0,1.0,2/10,5.89%,SOD3;SOD2
prerank,regulation of cellular response to stress (GO:0080135),0.20973763336329984,0.6680305633347206,0.9612724757952974,1.0,1.0,18/115,16.75%,ROCK2;PRKN;NUPR1;SMG1;ATM;SIRT1;NUP42;AJUBA;ABL1;NUP98;NUP43;CRYAB;RSL1D1;AMFR;RPTOR;NUP155;CREBBP;MCL1
prerank,determination of left/right symmetry (GO:0007368),0.2521097284111682,0.6675237606816042,0.9093799682034976,1.0,1.0,10/36,21.09%,SMO;MKKS;GALNT11;CCDC39;ARL6;ENKUR;CCDC40;OFD1;CITED2;DAND5
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.31075955520871223,0.6668725256727084,0.8415300546448088,1.0,1.0,2/12,7.28%,CYP26B1;DHRS3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.2086306127852189,-0.6653345402553614,0.946927374301676,0.9875012239737392,1.0,13/48,18.84%,TNFRSF1B;FNIP2;DDIT4;HIPK1;CRIP1;PHLDA3;BCL3;HIPK2;CASP2;HTRA2;CHEK2;BCL2L11;RPS27L
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.28856800377772385,0.6647134055473919,0.8838475499092558,1.0,1.0,4/18,10.63%,POR;SIRT3;GDNF;ABL1
prerank,regulation of cell size (GO:0008361),0.2706169487132389,0.6646683610763767,0.8752136752136752,1.0,1.0,6/23,15.84%,DEPTOR;EZR;PTEN;RARG;VAV3;RPTOR
prerank,regulation of acrosome reaction (GO:0060046),-0.2930680427108597,-0.6646424527122955,0.863265306122449,0.9873858611842287,1.0,2/10,15.36%,GLRA1;CACNA1H
prerank,organic cation transport (GO:0015695),0.2858748172739789,0.6643764439550611,0.8886925795053003,1.0,1.0,8/20,19.67%,SLC22A18;SLC22A5;RALBP1;SLC25A42;SLC25A29;SLC25A19;SLC25A26;SLC22A4
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.20735762366339594,-0.6640840253086955,0.959349593495935,0.9871540139587272,1.0,3/45,6.25%,GRM5;GCNT2;APP
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.2952602942266347,0.6637635418639662,0.8440366972477065,1.0,1.0,5/14,22.89%,LHPP;ADSS1;GART;ADSL;GMPS
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.2108540148834409,-0.6636732630127752,0.9605911330049262,0.986806616817558,1.0,13/37,24.23%,HSP90AB1;RYBP;RPL5;RPS7;DDRGK1;RPL23;NOP53;HIPK2;PDCL3;RPL11;BAG5;N4BP1;CCAR2
prerank,cytoplasmic translational initiation (GO:0002183),-0.26043007793459155,-0.6632214215386553,0.9161147902869757,0.9864842409908885,1.0,4/17,20.88%,EIF3M;EIF2B3;EIF4A1;EIF3D
prerank,regulation of microtubule nucleation (GO:0010968),0.31927891008306064,0.663128325409452,0.8171206225680934,1.0,1.0,1/10,2.50%,EML2
prerank,positive regulation of leukocyte migration (GO:0002687),-0.22457385346432093,-0.6629070751456944,0.9257425742574258,0.9860585099805729,1.0,7/27,23.71%,ICAM1;PTN;EDN3;VEGFA;IL6R;MDK;THY1
prerank,regulation of translational initiation (GO:0006446),0.22767800876338348,0.6629052823772118,0.9280359820089955,1.0,1.0,15/63,21.07%,CTIF;MIF4GD;DDX3X;POLR2D;LARP1;YTHDF3;EIF4A2;IMPACT;RBM4;EIF4G1;BOLL;EIF5;POLR2G;RPS6KB2;FMR1
prerank,pigment granule transport (GO:0051904),-0.2561648169810543,-0.6628562508463959,0.9080717488789237,0.9847906576594591,1.0,4/18,16.82%,MYO5A;RAB27A;RAB27B;MREG
prerank,melanosome transport (GO:0032402),-0.2561648169810543,-0.6628562508463959,0.9080717488789237,0.9847906576594591,1.0,4/18,16.82%,MYO5A;RAB27A;RAB27B;MREG
prerank,regulation of B cell apoptotic process (GO:0002902),0.3071280087991142,0.6627155965395228,0.8659217877094972,1.0,1.0,5/12,22.31%,FNIP1;AURKB;BCL6;NOC2L;ORMDL3
prerank,regulation of protein sumoylation (GO:0033233),0.28324037833132115,0.6621964763859624,0.8745519713261649,1.0,1.0,5/17,18.96%,PIAS1;HDAC4;ZMIZ1;PIAS3;PIAS4
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.18427653571831984,-0.6617198818760928,0.9897959183673469,0.9850422452380078,1.0,32/84,34.29%,PSMB2;CUL3;PSMD14;ECRG4;PSMC6;BUB3;UBB;FBXO31;PSMA4;PSMB9;CDC23;PSMD11;PSMB10;PSMD2;MAD2L1;PSMA2;UBC;RPS27A;PSMB3;PSMB5;UBE2D1;PSMA7;PSMF1;PSMD7;AURKA;CDK1;CDC20;PSMA5;UBE2C;PSMD4;ANAPC10;PSME4
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.27157110084324254,0.6614581106240455,0.8869257950530035,1.0,1.0,5/22,18.39%,ERI3;EXOSC7;ERI2;EXOSC3;WDR12
prerank,glutamine family amino acid catabolic process (GO:0009065),0.3050438952447614,0.6613718405959667,0.8512241054613936,1.0,1.0,3/13,9.52%,PRODH;ALDH4A1;GLUL
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.3114485855412991,0.6610871022641994,0.8540856031128404,1.0,1.0,1/12,1.76%,PPARA
prerank,mitotic cell cycle phase transition (GO:0044772),0.19245341549432385,0.6608114892889284,0.9899497487437185,1.0,1.0,44/203,20.83%,TPD52L1;FBXL17;CCNA2;CEP250;PPP1CB;CLASP1;NINL;CCNA1;CACUL1;FBXW11;BTRC;CCND3;CDC25A;CCNB2;BRSK1;FBXL12;AJUBA;SDCCAG8;CUL4A;NASP;DNM2;ALMS1;CTDP1;ACVR1B;CCNG1;CEP63;RB1;CCNE1;USP37;OPTN;CDC34;CEP57;AKAP9;PCM1;CEP164;OFD1;FBXL22;PCNT;TAF2;CHMP2A;UBE2S;DCTN3;CUL5;CCNG2
prerank,toll-like receptor signaling pathway (GO:0002224),0.21699071127375769,0.6594060117986904,0.966275659824047,1.0,1.0,13/84,16.08%,COLEC12;TLR3;TLR4;MAPKAPK3;TAB2;RIPK2;RIPK1;LY96;NMI;MAP3K1;TLR5;BIRC3;SCARA3
prerank,T cell homeostasis (GO:0043029),-0.293555105927969,-0.6590326820389687,0.8712273641851107,0.9863887301803308,1.0,8/10,56.44%,FAS;PMAIP1;FOXP3;RIPK3;NCKAP1L;AKT1;JAK3;PPP2R3C
prerank,protein targeting to membrane (GO:0006612),0.21434082443208724,0.658872969536447,0.9572901325478645,1.0,1.0,21/83,17.92%,RAB3IP;PEX11B;PIKFYVE;PXMP2;ZDHHC18;ZDHHC1;MYO1C;PRKCI;PARD3;MICALL1;PEX14;ACBD5;VPS37A;ARL6;PEX19;RAB8B;SLC25A17;PEX16;RABGEF1;PEX5;ZDHHC23
prerank,protein modification by small protein removal (GO:0070646),0.1887228817586028,0.6584309724974898,1.0,1.0,1.0,62/252,23.65%,SMAD3;PRKN;SENP3;CCNA2;TGFBR1;BABAM2;USP3;CCNA1;USP9X;USP24;TP53;USP11;SMURF2;PTEN;RCE1;CDC25A;RIPK1;BECN1;INO80D;USP34;USP49;UIMC1;DESI1;DESI2;USP12;USP7;BABAM1;DDB2;MBD6;OGT;USP18;KAT2B;BIRC3;USP37;UFD1;CLSPN;SMAD4;ASXL2;USP48;USP1;RHOT1;COPS8;USP33;USP21;USP16;USP35;INO80E;TRAF3;OTUD3;USP5;RUVBL1;YY1;EP300;RNF123;USP20;OTUD4;TOR1A;USPL1;PSMC4;USP9Y;OTUB2;PSMD10
prerank,regulation of T cell mediated immunity (GO:0002709),0.31335425167483555,0.6581183769764871,0.8326612903225806,1.0,1.0,3/10,18.04%,ZBTB1;CCR2;AGER
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.29874570211917456,0.6579148635038029,0.8625235404896422,1.0,1.0,3/13,12.05%,ABHD14B;SULT2B1;TPST1
prerank,sister chromatid segregation (GO:0000819),0.25260998530399087,0.6578935603658509,0.8969072164948454,1.0,1.0,6/31,17.46%,TOP2B;CHAMP1;DSN1;KIFC1;RB1;CENPK
prerank,stress-activated MAPK cascade (GO:0051403),-0.1956613836550585,-0.6578537309209621,0.9700598802395209,0.986655002241515,1.0,17/61,25.00%,MAP3K5;NOD1;MINK1;MAP3K7;TNFRSF19;MAP4K3;IKBKB;UBB;NOD2;SKP1;LGALS9;MAP3K11;SH2D3C;MAP2K7;UBC;RPS27A;TAB1
prerank,RNA export from nucleus (GO:0006405),0.2077717383163255,0.6574273821767035,0.9721448467966574,1.0,1.0,25/100,22.90%,NXF2;SMG1;SRSF5;POLDIP3;HNRNPA2B1;NUP42;NUP98;NXF1;SRSF11;NUP43;SARNP;CPSF3;NUP155;ALKBH5;SRSF1;CDC40;NUP188;U2AF1;UPF2;SRSF7;U2AF2;NUP153;FYTTD1;XPO5;SMG6
prerank,mitochondrial protein processing (GO:0034982),-0.28115264994761446,-0.6567670364785311,0.8862144420131292,0.9867882154778354,1.0,3/11,26.60%,IMMP2L;STOML2;SPG7
prerank,protein localization to chromatin (GO:0071168),0.2738618150738101,0.6565742386767064,0.888695652173913,1.0,1.0,6/18,20.38%,NIPBL;LEMD2;WAPL;LRWD1;SGF29;MCM9
prerank,purine nucleotide biosynthetic process (GO:0006164),0.31102092226567113,0.6558739825044555,0.8627450980392157,1.0,1.0,6/12,20.77%,PRPSAP1;AMPD2;PRPSAP2;MTHFD1;GART;ADSL
prerank,oligodendrocyte differentiation (GO:0048709),0.27413189389151427,0.6545974693562537,0.8607142857142858,1.0,1.0,3/19,15.17%,SLC8A3;SOX13;EIF2B1
prerank,positive regulation of actin nucleation (GO:0051127),0.3084803829396794,0.6540999802968538,0.8682170542635659,1.0,1.0,1/11,2.14%,FCHSD2
prerank,regulation of mitochondrial translation (GO:0070129),-0.2408228355635129,-0.653891986070988,0.9254385964912281,0.9882851333329221,1.0,12/21,37.60%,MALSU1;MTG2;RCC1L;FASTKD2;NSUN3;RPUSD3;COA3;NGRN;TRMT10C;TRUB2;C1QBP;MTG1
prerank,nucleotide-excision repair (GO:0006289),-0.1776358159214626,-0.65386729889217,0.996551724137931,0.987647714774368,1.0,29/101,23.93%,POLA1;POLD3;RAD23B;AQR;ERCC1;ERCC6;POLR2J;UBB;RPA1;COPS4;BRIP1;CETN2;GTF2H1;FANCC;COPS6;GTF2H4;COMMD1;GTF2H5;RFC4;COPS5;ERCC2;POLD4;POLD1;RFC2;POLR2C;POLR2L;POLK;UBC;RPS27A
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.29585245902165325,0.6535489373512852,0.8606870229007634,1.0,1.0,1/13,2.92%,NUPR1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.2688295180013671,0.6518134219320536,0.8969258589511754,1.0,1.0,4/20,13.36%,PTGES3L;MKKS;BBS10;HSPA4
prerank,histone exchange (GO:0043486),0.23977197285572086,0.6517778020745488,0.915282392026578,1.0,1.0,17/37,29.42%,RNF8;SRCAP;NASP;CENPO;CENPC;CENPK;ACTR6;CENPT;ITGB3BP;RUVBL1;DMAP1;RBBP7;RSF1;RBBP4;CENPS;CENPN;CENPQ
prerank,negative regulation of T cell proliferation (GO:0042130),0.2510529877203748,0.6510879498215094,0.8931034482758621,1.0,1.0,7/28,22.07%,CD274;GLMN;PRKAR1A;SDC4;GPNMB;DLG5;ARG1
prerank,negative regulation of protein transport (GO:0051224),-0.2312996330693743,-0.651001034111212,0.9421296296296297,0.9891079326078956,1.0,8/25,23.54%,APOE;NDFIP2;PPM1F;ERP29;PKDCC;CYP51A1;DRD2;RHBDF2
prerank,regulation of hormone secretion (GO:0046883),0.2929098038637097,0.6508776331105763,0.8876190476190476,1.0,1.0,1/15,2.62%,SNX6
prerank,phosphate ion transmembrane transport (GO:0035435),0.30496211564738746,0.6508294196625992,0.8661257606490872,1.0,1.0,5/12,22.63%,SLC20A2;SLC25A11;SLC25A10;SLC37A4;SLC25A3
prerank,cochlea morphogenesis (GO:0090103),-0.2982222864839627,-0.6505281251438606,0.9020408163265307,0.9888037932256589,1.0,7/10,34.32%,TBX1;TBX18;PAX2;MYO3B;MYO3A;HPN;TIFAB
prerank,positive regulation of DNA recombination (GO:0045911),0.25818801711346295,0.6504275072533122,0.9131205673758865,1.0,1.0,3/27,6.47%,ARID2;KMT5C;KMT5B
prerank,cardiolipin metabolic process (GO:0032048),0.29593599907157253,0.6497856620383393,0.8714285714285714,1.0,1.0,5/13,21.29%,SLC27A1;PLA2G6;PLA2G5;HADHA;TAMM41
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.26601751588717854,-0.6494286710476913,0.9072847682119205,0.9889219239985165,1.0,6/14,25.37%,ATP2B4;PRKAR1B;PRKAR2B;PRKAR2A;PKIG;ADRB2
prerank,pancreas development (GO:0031016),-0.27679064823683647,-0.6492254842954072,0.8909090909090909,0.988429774472921,1.0,2/12,8.60%,MET;PROX1
prerank,modulation by host of symbiont process (GO:0051851),0.24958399638296597,0.6490840829371539,0.9112627986348123,1.0,1.0,10/31,24.07%,NAPEPLD;SMARCA4;HDAC1;TAF11;CTDP1;REST;SP1;EP300;SMARCB1;NUCKS1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.24753297014374598,-0.6490277129635189,0.9311163895486936,0.9879042063175664,1.0,4/20,17.18%,DCC;GSK3B;FAS;CASP2
prerank,Golgi ribbon formation (GO:0090161),0.28917543963613024,0.6489691483588961,0.8770949720670391,1.0,1.0,5/13,19.50%,MYO18A;VTI1A;OPTN;GOLGA2;STX16
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.21325433673508828,0.6479076910903491,0.9670958512160229,1.0,1.0,24/76,24.87%,SPHK1;LRRK2;PIAS1;FANCI;HUWE1;CDK5RAP3;HDAC4;RIPK2;FBXO4;DCUN1D5;PIAS3;BIRC3;CRY1;TBC1D7;NDFIP1;PIAS4;TANK;GSK3A;DERL1;PRICKLE1;PSMD10;TSPYL5;RCHY1;PHF23
prerank,establishment of vesicle localization (GO:0051650),0.28214569256288985,0.6474445065367959,0.8791593695271454,1.0,1.0,1/18,1.31%,SYT11
prerank,tetrahydrofolate metabolic process (GO:0046653),0.30881408999960847,0.6473002890419984,0.8313953488372093,1.0,1.0,2/10,16.82%,MTHFR;MTHFD1
prerank,mitotic sister chromatid segregation (GO:0000070),0.20639110008438538,0.6466588721355021,0.981294964028777,1.0,1.0,19/98,19.19%,EML4;NIPBL;PDS5A;CHMP1A;BECN1;CSNK2A2;CSNK2A1;DSN1;KIFC1;KMT5A;REC8;NCAPD3;VPS4A;RB1;CHMP4C;PIBF1;CENPK;NCAPD2;PDS5B
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.24166140725195967,-0.6461877620921831,0.9288990825688074,0.9892552350922441,1.0,8/19,27.94%,SLC26A2;ENPP1;TPST2;BPNT1;SULT4A1;SLC35B3;PAPSS1;BPNT2
prerank,mitotic nuclear division (GO:0140014),0.21552550824617928,0.6459113053958121,0.974124809741248,1.0,1.0,19/71,20.41%,KIF2A;CLASP1;KLHDC8B;LSM14A;MISP;DSN1;KIFC1;STAG2;CTDP1;SMC3;PIBF1;CENPK;MAP9;CCDC61;GOLGA2;OFD1;ARHGEF10;CHMP2A;UBE2S
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.2871132389967545,-0.6454832653578688,0.8993839835728953,0.9891228021189238,1.0,2/10,11.13%,TSNAX;DROSHA
prerank,sensory perception of taste (GO:0050909),0.31386359638353895,0.6454241588608067,0.856353591160221,1.0,1.0,1/10,7.83%,GNAT3
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.17734238357836196,-0.6449506252839754,1.0,0.9888337292754175,1.0,16/95,18.67%,MEF2C;PDE4B;DAB2IP;TNFRSF1B;SBNO2;TIRAP;VIM;CARD16;LBP;CX3CR1;NOD2;CD180;TRIM41;PDCD4;CDC73;SIRT2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.21976497122495237,0.6446095954395893,0.9409937888198758,1.0,1.0,14/60,18.22%,TNRC6A;TP53;MED12;TNRC6B;PTEN;TCF7L2;MOV10;MED17;TNRC6C;NFKB1;MED23;MED26;MED1;MED8
prerank,positive regulation of leukocyte activation (GO:0002696),0.27248734302847033,0.6437238640713961,0.8822495606326889,1.0,1.0,2/18,5.16%,HAVCR1;TLR4
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.24474269506394655,-0.6433336025349392,0.910913140311804,0.9892613298117428,1.0,3/18,9.21%,ESR1;TGFB1;TMBIM6
prerank,cell cycle checkpoint signaling (GO:0000075),-0.27645601792134933,-0.6430363209824207,0.9078947368421053,0.9888207880223258,1.0,6/12,37.88%,PLK2;WEE1;BUB1;ZWILCH;WEE2;ZW10
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.22457834529462395,-0.6429439787733997,0.9683698296836983,0.9882333211073788,1.0,8/30,22.64%,CAVIN1;TAF1B;GTF2H1;GTF2H4;GTF2H5;ERCC2;POLR1F;POLR2L
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.2504515794811838,0.642309159271574,0.9224283305227656,1.0,1.0,6/31,12.24%,PTEN;BTRC;CDC14B;MAGEC2;DCUN1D5;FZR1
prerank,secondary alcohol metabolic process (GO:1902652),0.23627514785969658,0.6421788513212444,0.9370748299319728,1.0,1.0,4/42,9.11%,CYP27A1;IDH1;CLN6;SULT2B1
prerank,regulation of trophoblast cell migration (GO:1901163),0.29844989506382363,0.6417684303999951,0.8953068592057761,1.0,1.0,4/14,16.16%,SMURF2;YTHDF3;ACVR1B;NODAL
prerank,negative regulation of receptor internalization (GO:0002091),0.295874723656578,0.6415408860706963,0.8797709923664122,1.0,1.0,5/12,22.43%,RIN3;ATXN2;ANKRD13D;ANKRD13B;SDCBP
prerank,regulation of phospholipid metabolic process (GO:1903725),0.30910986305547544,0.6412154781186006,0.871939736346516,1.0,1.0,1/10,2.72%,MTMR3
prerank,cellular response to radiation (GO:0071478),0.23227068404431994,0.6411190501649161,0.9474576271186441,1.0,1.0,14/40,23.79%,RHO;TP53;SIRT1;HUS1;GADD45A;INTS7;MAPK14;LIG4;TANK;RAD9A;FIGNL1;OPN1SW;OPN1MW;OPN1MW3
prerank,positive regulation of lipid storage (GO:0010884),0.27095694627819134,0.640598004703419,0.9005328596802842,1.0,1.0,4/21,14.88%,IKBKE;OSBPL11;PLIN3;NFKB1
prerank,mismatch repair (GO:0006298),0.2529445608922347,0.6404089675016572,0.9264214046822743,1.0,1.0,8/27,21.43%,POLD2;ABL1;MSH3;TDG;MSH4;MCM9;MLH1;LIG1
prerank,regulation of myoblast fusion (GO:1901739),0.2935858390523412,0.6403156221172608,0.8621323529411765,1.0,1.0,1/11,3.02%,CFLAR
prerank,cellular response to estradiol stimulus (GO:0071392),-0.2414020554008362,-0.6397703974298554,0.9232456140350878,0.9897054669559925,1.0,6/18,24.16%,ESR1;GPER1;FAM210B;SFRP1;RUVBL2;NRIP1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.29368430928313805,0.639742682092611,0.8723404255319149,1.0,1.0,4/13,20.52%,PRPF3;PRPF6;SRSF10;PRPF31
prerank,mucosal immune response (GO:0002385),-0.256897680276394,-0.6384857050433698,0.936542669584245,0.9898775612122835,1.0,2/15,7.90%,OTUD7B;RPL39
prerank,protein hydroxylation (GO:0018126),0.28981810424899146,0.6380722260163567,0.8853383458646616,1.0,1.0,6/15,22.65%,VIPAS39;ASPH;HIF1AN;OGFOD1;P3H4;VPS33B
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.24446487675058887,0.637000584067938,0.9166666666666666,1.0,1.0,5/32,12.19%,DEFB1;F2;HRG;FAM3A;CAMP
prerank,myeloid dendritic cell activation (GO:0001773),-0.262959215181488,-0.6367148304290978,0.9240246406570842,0.9904102064347435,1.0,2/12,9.79%,CAMK4;DOCK2
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.28860211957870263,0.6366964512690226,0.8808193668528864,1.0,1.0,2/15,9.30%,STXBP4;GLI1
prerank,positive regulation of calcium ion import (GO:0090280),0.2989347136824017,0.6363211469377164,0.8839458413926499,1.0,1.0,3/12,15.10%,PDGFRB;SPHK2;LGALS3
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.20241627298083803,0.6362170138959294,0.9888423988842399,1.0,1.0,20/101,15.57%,LARP4B;VGLL4;EZR;ATG10;DDX3X;CD28;POLDIP3;FBXW11;SAMD4A;CLN6;BTRC;CPEB3;YTHDF3;ATG7;PRKDC;PLD1;OGT;ZCCHC4;FAF1;ASPH
prerank,regulation of protein kinase A signaling (GO:0010738),0.2700533719298633,0.6361770294755648,0.9197207678883071,1.0,1.0,5/20,17.75%,LRRK2;AKAP12;PRKAR1A;AKAP7;ADGRV1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.25487275538586274,0.636083795460107,0.9066427289048474,1.0,1.0,3/24,7.04%,TTLL6;NAA80;TTLL9
prerank,recombinational repair (GO:0000725),-0.17845670876871983,-0.6355141640313271,0.9898648648648649,0.9905305035967876,1.0,26/77,32.76%,REV3L;SMC5;RAD51B;PSMD14;RPA1;KDM4D;EXD2;RFWD3;MMS22L;NSMCE1;BLM;RECQL5;POLQ;AP5S1;RAD54B;RECQL;PALB2;HUS1B;SWI5;RAD51;MEIOB;RPA3;BRCA1;RPA2;SFR1;MCM8
prerank,phagosome acidification (GO:0090383),0.25455570627587465,0.6353065223701851,0.9175257731958762,1.0,1.0,4/26,11.08%,ATP6V0E1;ATP6V0B;ATP6V1D;ATP6V1E1
prerank,natural killer cell activation (GO:0030101),-0.2277740145914789,-0.6351830676586436,0.9530201342281879,0.9900701527349546,1.0,6/23,18.30%,TOX;PTPRC;PBX1;SNX27;PRDX1;NFIL3
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.2874364265105166,0.6349486223541656,0.878095238095238,1.0,1.0,3/12,13.82%,NCOR2;TERT;NCOR1
prerank,axonemal dynein complex assembly (GO:0070286),0.25282533744230123,0.6347940563767033,0.9126712328767124,1.0,1.0,7/27,22.40%,ODAD1;CCDC39;CCDC40;DNAI4;DNAAF5;CFAP73;DNAL1
prerank,cellular component maintenance (GO:0043954),0.2970691277523182,0.6345628343811702,0.8754716981132076,1.0,1.0,6/12,29.31%,PICK1;ITGA3;CLDN1;IGF1R;PRNP;INSR
prerank,neutrophil activation (GO:0042119),-0.2719153202712021,-0.6343770420239335,0.9147121535181236,0.9898980447956712,1.0,3/12,19.59%,SYK;PREX1;TYROBP
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.25781429186204396,0.6343621525202293,0.8962432915921288,1.0,1.0,2/22,7.94%,NR2F2;PTEN
prerank,tRNA export from nucleus (GO:0006409),0.2433577008940319,0.6340241475077675,0.9187817258883249,1.0,1.0,17/32,30.67%,NUP42;NUP98;NUP43;NUP155;NUP188;NUP153;XPOT;AAAS;NUP88;SEC13;NUP160;NOL6;RANBP2;NUP37;SSB;RAE1;NUP133
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.2433577008940319,0.6340241475077675,0.9187817258883249,1.0,1.0,17/32,30.67%,NUP42;NUP98;NUP43;NUP155;NUP188;NUP153;XPOT;AAAS;NUP88;SEC13;NUP160;NOL6;RANBP2;NUP37;SSB;RAE1;NUP133
prerank,aggrephagy (GO:0035973),0.2464290382171332,0.6337774908754167,0.9083333333333333,1.0,1.0,8/27,19.97%,PRKN;ATG5;IFT88;ACBD5;DYNC1LI1;SQSTM1;PCNT;WDR81
prerank,positive regulation of protein ubiquitination (GO:0031398),0.20942954929642393,0.6333949286636261,0.9703389830508474,1.0,1.0,11/80,11.60%,SPHK1;LRRK2;SPSB4;FANCI;HUWE1;CDK5RAP3;FANCM;RIPK2;FBXO4;MAGEC2;DCUN1D5
prerank,regulation of chromatin binding (GO:0035561),0.3143938807264816,0.6326298009687011,0.8718446601941747,1.0,1.0,2/10,11.77%,PARP9;WAPL
prerank,cellular response to interferon-beta (GO:0035458),-0.2637393649832163,-0.6320080079135354,0.9285714285714286,0.9906588353618204,1.0,6/14,25.52%,PNPT1;AIM2;HTRA2;UBE2G2;IFITM2;NDUFA13
prerank,response to glucose (GO:0009749),0.22811036108594207,0.6302943870106819,0.9483037156704361,1.0,1.0,4/46,9.99%,PRKAA2;ZBTB20;GCK;TCF7L2
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.2512828059373044,0.6288807973011215,0.9140893470790378,1.0,1.0,4/28,10.49%,LACC1;TAB2;RIPK2;IRGM
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.1777115813891927,0.6286857429804757,0.9988479262672811,1.0,1.0,51/314,17.63%,ANAPC15;PRKN;FBXL17;SPSB1;NEDD4;IFI27;PCBP2;DCAF11;FBXL19;ARRB1;ANAPC2;SPSB4;TBL1X;UBR2;SMURF2;FBXW11;HUWE1;BTRC;TBL1XR1;FBXO48;RNF34;SIRT1;ECPAS;ZSWIM8;FBXL12;AURKB;FBXO4;WWP2;CUL4A;FZR1;PML;DNAJB2;FBXL20;RMND5A;FAF1;AMFR;ANAPC16;DNAJB14;MAEA;RB1;NEMF;UBR1;UFD1;UBE2E1;KCTD13;ERLIN2;SYVN1;DMAC2;CDC34;DNAJC18;NPLOC4
prerank,regulation of nuclear division (GO:0051783),0.2616491493237186,0.6281979102176648,0.9081272084805654,1.0,1.0,1/20,2.45%,OBSL1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.24701615278723627,-0.6270223568904388,0.9282608695652174,0.9929686313095634,1.0,4/17,18.09%,PROX1;PKD1;CCNY;RGCC
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.2962404760768935,0.6270088371475154,0.878099173553719,1.0,1.0,3/11,19.57%,ATRX;NASP;ASF1A
prerank,negative regulation of protein secretion (GO:0050709),0.23398554532017926,0.6260046590283007,0.9357945425361156,1.0,1.0,5/38,9.33%,PRKN;ADRA2A;IL12B;MIDN;RSAD2
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.2103311263866107,0.6240435711538528,0.9723032069970845,1.0,1.0,15/72,19.72%,SPO11;POLD2;DNASE1L1;FBH1;DICER1;CUL4A;DCP1A;RAD50;DDB2;DNASE1L2;OGG1;FEN1;RFC1;XPA;DXO
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.2672143162203854,-0.6238057348660153,0.9224318658280922,0.9941828632698386,1.0,4/12,21.36%,AKR1B1;STARD3NL;CACNA1H;STARD3
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.20587270279939782,0.6236055676293052,0.9833564493758669,1.0,1.0,6/85,8.28%,CELSR1;MAGI2;VANGL1;FZD5;SMURF2;RYK
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.28537726073389086,-0.6235706014212739,0.9150743099787686,0.9936734732070656,1.0,1/10,1.54%,PDE8A
prerank,regulation of lymphocyte proliferation (GO:0050670),0.2690311211997457,0.6232074276540694,0.9059040590405905,1.0,1.0,4/16,20.39%,IL12B;PTPN22;LGALS3;IKZF3
prerank,receptor recycling (GO:0001881),0.3029091046650849,0.6230302511265094,0.8910505836575876,1.0,1.0,3/10,17.37%,ARFGEF2;RAB11B;PHETA1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.23518239849846506,-0.6222826516060062,0.9425837320574163,0.9937649710027548,1.0,4/20,15.24%,YWHAB;MET;SNCA;STMN1
prerank,nucleosome assembly (GO:0006334),0.24068929934046127,0.6220080726575983,0.9401408450704225,1.0,1.0,6/31,19.57%,CHAF1B;ATRX;KAT6B;NASP;PADI4;ASF1A
prerank,phospholipid biosynthetic process (GO:0008654),0.23496199647416505,0.6214020217262041,0.9591503267973857,1.0,1.0,4/36,8.48%,AGPAT4;GPAT2;CPNE3;SAMD8
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.24707427285799657,0.6213307597011034,0.9179229480737019,1.0,1.0,7/25,18.47%,EPHA4;OPHN1;CSNK2A2;CSNK2A1;PML;HFE;TAF1
prerank,glutamate metabolic process (GO:0006536),0.26370184050319134,0.620958087410621,0.9121265377855887,1.0,1.0,3/19,9.52%,PRODH;GOT2;GLUL
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.24455474653308407,-0.6203431069795241,0.9461697722567288,0.9942500552638958,1.0,5/17,22.09%,PPIA;HSPB1;HTRA2;BAG5;SOD1
prerank,erythrocyte development (GO:0048821),-0.2772141919759227,-0.619518810371943,0.9083665338645418,0.9940760128987646,1.0,7/10,47.95%,DMTN;LYAR;ALAS1;SH2B3;ABCB10;GATA1;NCKAP1L
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.29752810913507355,0.619374884636026,0.8825757575757576,1.0,1.0,3/10,14.02%,RNF13;MAP2K1;MAP2K2
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.19739755291662167,-0.6192684774091263,0.9693877551020408,0.9935659576084718,1.0,15/36,29.52%,HSP90AB1;RYBP;AQP11;DDRGK1;NOP53;GABARAPL2;RPL11;BAG5;N4BP1;PSME3IP1;CCAR2;WAC;F8A1;PSMF1;PARK7
prerank,termination of RNA polymerase II transcription (GO:0006369),0.23617095427670637,0.6186183065627456,0.9389830508474576,1.0,1.0,8/33,23.34%,PABPN1;TTF2;SCAF8;CPSF3;CSTF1;PCF11;CPSF7;NUDT21
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.24202295105929916,0.6181925036537209,0.9463986599664992,1.0,1.0,9/29,27.15%,TEX12;REC8;STAG3;P3H4;FANCD2;SYCE2;BAG6;TRIP13;TERB1
prerank,renal filtration (GO:0097205),-0.27784692057499116,-0.6178229585514478,0.9321663019693655,0.9937491789554758,1.0,2/10,8.44%,CD34;MCAM
prerank,gas transport (GO:0015669),-0.2779830215939092,-0.6176455835337901,0.9054621848739496,0.9931940818561106,1.0,2/10,13.76%,CA2;CYGB
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.2625777729460462,-0.6168665245552677,0.9490022172949002,0.9929698107286563,1.0,5/12,30.34%,DHODH;UCK2;UMPS;UPP1;TK2
prerank,DNA replication initiation (GO:0006270),-0.2015241423442589,-0.6159248382943129,0.9747474747474747,0.9928142726330118,1.0,14/37,32.76%,POLA1;PRIM2;RPA1;ORC5;ORC2;CDC45;MCM6;PRIM1;TOPBP1;CDC7;RPA3;RPA2;MCM4;MCM8
prerank,Golgi inheritance (GO:0048313),0.2880455799849188,0.6154212682918601,0.888235294117647,1.0,1.0,3/11,18.90%,PLK5;STX5;GOLGA2
prerank,negative regulation of T cell activation (GO:0050868),0.22931912531743,0.6151933490834913,0.942339373970346,1.0,1.0,10/35,22.96%,PTPN22;CD274;GLMN;SDC4;LGALS3;GPNMB;LAX1;DLG5;ARG1;RIPOR2
prerank,toxin transport (GO:1901998),0.29978759910383523,0.6151026371654524,0.8949494949494949,1.0,1.0,2/10,14.78%,ANTXR2;RAB29
prerank,positive regulation of histone deacetylation (GO:0031065),-0.26295565572764135,-0.6148874802826438,0.9436008676789588,0.9927245981001818,1.0,3/12,15.93%,PRKD1;VEGFA;APLNR
prerank,positive regulation of cellular senescence (GO:2000774),-0.28109197848435735,-0.614299873852294,0.9225941422594143,0.9924142570758586,1.0,2/10,12.05%,B2M;ABI3
prerank,tRNA processing (GO:0008033),0.20473675308911057,0.614236298212247,0.9803921568627451,1.0,1.0,10/61,21.86%,TRMT9B;TSEN2;RPP21;LCMT2;POP7;WDR4;DTWD2;ADAT2;POP1;KARS1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.2899766771610525,0.614172304107684,0.895870736086176,1.0,1.0,3/12,18.75%,NINL;HOOK3;PCM1
prerank,negative regulation of mRNA processing (GO:0050686),0.27061975659326304,0.6131896242457807,0.9124767225325885,1.0,1.0,6/15,25.37%,SAP18;SFSWAP;SRSF10;SRSF7;U2AF2;SRSF4
prerank,glycerophospholipid metabolic process (GO:0006650),0.20307862240784025,0.6128439435180999,0.9836552748885586,1.0,1.0,9/75,10.53%,PIGN;PIGW;PLA1A;PIGQ;PDGFRB;CPNE3;PLA2G6;PLCD1;ABHD12
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.20914183935068942,-0.610811850684736,0.974937343358396,0.9935900496988792,1.0,8/32,22.64%,CAVIN1;TAF1B;GTF2H1;GTF2H4;GTF2H5;ERCC2;POLR1F;POLR2L
prerank,ncRNA metabolic process (GO:0034660),0.23011660624985023,0.6105306387868726,0.9498381877022654,1.0,1.0,8/37,22.33%,MOV10L1;TUT4;DICER1;TENT4B;TUT7;EXD1;ASZ1;XPO5
prerank,negative regulation of interferon-beta production (GO:0032688),-0.26625717507117197,-0.6092493150543256,0.9194214876033058,0.99376013865017,1.0,3/10,21.18%,REL;RELB;PYCARD
prerank,DNA duplex unwinding (GO:0032508),-0.18851519323267094,-0.6088991634343041,0.989100817438692,0.9933166986317638,1.0,20/50,30.71%,ANXA1;RAD23B;UBB;RPA1;DHX9;CETN2;GTF2H1;GTF2H4;GTF2H5;ERCC2;BLM;RECQL5;UBC;RPS27A;RECQL;MCM6;DDB1;RAD51;ERCC3;PIF1
prerank,dendritic cell chemotaxis (GO:0002407),-0.2581696860249623,-0.6085926118273426,0.93125,0.9928301977376363,1.0,11/14,54.22%,TRPM2;CCL19;CXCR4;CCR1;PIK3CG;CCR6;CXCR2;HMGB1;CCR7;GPR183;CCL5
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.21820540832265445,-0.6077445312572287,0.9462616822429907,0.9926352535319415,1.0,15/23,38.78%,HSP90AA1;TIMM29;BCL2L11;TOMM22;TIMM8B;ROMO1;TIMM13;NDUFA13;PMAIP1;BMF;TIMM10B;BAD;MAIP1;AGK;TIMM9
prerank,positive regulation of stem cell proliferation (GO:2000648),0.2687868612848305,0.6074193320235309,0.896551724137931,1.0,1.0,5/17,19.88%,TERT;KAT7;CCNE1;KDM1A;LTBP3
prerank,regulation of store-operated calcium entry (GO:2001256),-0.2713618470677273,-0.60684221521981,0.9057377049180327,0.992475967148195,1.0,3/10,13.10%,HOMER1;SARAF;CD84
prerank,protein deubiquitination (GO:0016579),0.1748445688457695,0.60647431478856,1.0,1.0,1.0,44/242,19.79%,SMAD3;PRKN;CCNA2;TGFBR1;BABAM2;USP3;CCNA1;USP9X;USP24;TP53;USP11;SMURF2;PTEN;RCE1;CDC25A;RIPK1;BECN1;INO80D;USP34;USP49;UIMC1;DESI2;USP12;USP7;BABAM1;DDB2;MBD6;OGT;USP18;KAT2B;BIRC3;USP37;UFD1;CLSPN;SMAD4;ASXL2;USP48;USP1;RHOT1;USP33;USP21;USP16;USP35;INO80E
prerank,translesion synthesis (GO:0019985),0.22186616408979884,0.6057634213624655,0.9596774193548387,1.0,1.0,9/42,19.36%,POLD2;PARP10;REV1;POLDIP2;ZBTB1;POLE2;UFD1;NPLOC4;RFC1
prerank,sulfur amino acid catabolic process (GO:0000098),0.2979183955286664,0.6055613794646516,0.893223819301848,1.0,1.0,5/10,29.78%,CTH;MTRR;CBS;TST;BLMH
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.28954832204209335,0.6053537591346669,0.8828125,1.0,1.0,2/10,13.24%,CD274;PRKAR1A
prerank,regulation of viral transcription (GO:0046782),0.2222070940275914,0.6053141373660526,0.9621087314662273,1.0,1.0,7/39,14.71%,POLR2A;POLR2D;LARP7;GTF2F1;NELFCD;TRIM62;CTDP1
prerank,protein import into nucleus (GO:0006606),0.20525549788327152,0.6052500540501116,0.9741641337386018,1.0,1.0,2/66,3.53%,APPL2;TNPO1
prerank,rRNA catabolic process (GO:0016075),0.2675398806124525,0.6048000654647644,0.9162011173184358,1.0,1.0,4/16,17.83%,EXOSC7;DIS3;DIS3L;EXOSC3
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.22133789432238965,-0.6045007247027836,0.9566265060240964,0.9929653590917052,1.0,8/24,25.00%,NOD1;MAP3K7;UBB;NOD2;AAMP;UBC;RPS27A;TAB1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.2841145370992431,0.6043151312126153,0.872255489021956,1.0,1.0,3/12,13.35%,TLR4;MAP2K5;OAS3
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.23629493832253898,0.6042150895279762,0.9444444444444444,1.0,1.0,4/27,13.56%,NUDT13;AK4;CTPS2;AK8
prerank,phosphate ion transport (GO:0006817),0.26518065723954337,0.6040120607053219,0.9254302103250478,1.0,1.0,4/16,17.77%,SLC20A2;SLC25A11;SLC25A10;SLC37A4
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2212674058707306,0.6032117111767057,0.9646697388632872,1.0,1.0,17/40,28.60%,SMG1;WDR76;ABL1;KMT5A;MCL1;CRY1;USP1;FMR1;FBXO5;CASP9;BCLAF1;PRKCD;ING2;UBE2V1;FXR2;FEM1B;UBE2N
prerank,cobalamin metabolic process (GO:0009235),0.26058579467987214,0.6030353173645941,0.9108527131782945,1.0,1.0,5/17,22.04%,TCN2;TCN1;MTRR;MMACHC;CUBN
prerank,nucleotide biosynthetic process (GO:0009165),0.25798508086582966,0.6028187072525706,0.9045871559633027,1.0,1.0,8/18,22.77%,NMNAT1;PRPSAP1;PRPSAP2;NMNAT2;MTHFD1;GART;ADSL;NMNAT3
prerank,regulation of lipid storage (GO:0010883),0.2513945559953243,0.601775931801276,0.9393939393939394,1.0,1.0,4/22,14.88%,IKBKE;SIRT1;ITGAV;NFKB1
prerank,protein modification process (GO:0036211),0.20055989317559575,0.6017457965008614,0.9885386819484241,1.0,1.0,19/76,20.99%,MSRA;PARP4;RABGGTA;MANBA;FBXO22;ABL1;UBE2M;ARAF;PRKDC;WWP2;FBXO11;PLAT;PPP4R2;CDC34;PADI4;NTAQ1;GNMT;UBE2S;UBE2I
prerank,DNA double-strand break processing (GO:0000729),0.26046093562446176,0.6017168102019783,0.9357142857142857,1.0,1.0,5/18,19.02%,ATM;RBBP8;RAD50;NBN;SLX4
prerank,early endosome to Golgi transport (GO:0034498),-0.2550836491734349,-0.599666603298166,0.9279475982532751,0.9947080707727358,1.0,3/11,19.87%,RAB6A;EHD3;TMED9
prerank,protein autoprocessing (GO:0016540),-0.2355786853605031,-0.599381378112567,0.9479638009049773,0.9942100074318133,1.0,10/17,47.77%,CTSL;HTRA2;CASP4;FAM111A;MYRF;TMPRSS2;HJV;PCSK9;OMA1;CASP1
prerank,histone H4-K5 acetylation (GO:0043981),-0.24073554324851304,-0.5982487978639893,0.9527720739219713,0.9934275573184945,1.0,4/15,20.11%,JADE3;JADE1;MEAF6;MCRS1
prerank,histone H4-K8 acetylation (GO:0043982),-0.24073554324851304,-0.5982487978639893,0.9527720739219713,0.9934275573184945,1.0,4/15,20.11%,JADE3;JADE1;MEAF6;MCRS1
prerank,tRNA transport (GO:0051031),-0.19835047854120808,-0.5977747507037268,0.9849624060150376,0.993010633565687,1.0,10/35,26.70%,YBX1;NUP210;RAN;NUP107;TOMM20;POM121;NUP93;NUP85;NUP50;NUP54
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.25568687384689975,-0.5973072912734924,0.9483471074380165,0.9925956006845239,1.0,7/12,33.06%,GCLM;CHAC2;OPLAH;GGCT;MGST2;GCLC;GGT1
prerank,regulation of double-strand break repair (GO:2000779),-0.19456592522112942,-0.5972399477600604,0.9722222222222222,0.9919873640842436,1.0,5/39,14.04%,FMN2;ACTR2;SETD2;TWIST1;TERF2IP
prerank,RNA catabolic process (GO:0006401),-0.18503793405505342,-0.5964366755962087,0.9916897506925207,0.9917400526061442,1.0,20/46,34.68%,PNPT1;RNASEH2A;METTL3;RNASEH2B;XRN2;DNA2;YTHDF2;DCP2;MTREX;RNASEH2C;ERN1;HNRNPD;NUDT16;LSM5;LSM2;ZC3H12D;AGO3;RNH1;RNASEH1;PABPC4
prerank,T cell activation involved in immune response (GO:0002286),-0.2564136121771956,-0.5961707356669459,0.9372197309417041,0.9912190628406362,1.0,3/12,21.92%,ICAM1;CD74;MDK
prerank,positive regulation of cell aging (GO:0090343),-0.26844178413288666,-0.595402937999075,0.9349240780911063,0.9909374027906863,1.0,2/11,12.05%,B2M;ABI3
prerank,spindle assembly (GO:0051225),0.20003700813679004,0.5949547896930005,0.9864457831325302,1.0,1.0,18/67,20.06%,KIF2A;CLASP1;LSM14A;MAPRE2;MISP;KIFC1;NCOR1;STAG2;CEP63;GOLGA8B;SMC3;PIBF1;MAP9;CCDC61;GOLGA2;OFD1;ARHGEF10;TUBGCP4
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.228963927551546,-0.5942823152906226,0.9340909090909091,0.9908175872172733,1.0,2/16,8.90%,PTPRC;CEACAM1
prerank,RNA splicing (GO:0008380),0.1877234717524528,0.5939179813111801,0.99302649930265,1.0,1.0,31/95,25.99%,PPARGC1A;YJU2;NOVA1;LUC7L3;SRPK2;PRPF18;SRSF11;HNRNPC;SCAF11;PRPF3;SNRNP40;USP39;ZCRB1;PRPF6;FUS;HNRNPH3;SRSF10;U2AF1;SRSF7;WBP4;SNRPA1;SF3B2;SF3B1;RNPC3;NRDE2;SRSF4;RP9;LSM6;SF3B3;DHX8;RRAGC
prerank,mRNA methylation (GO:0080009),-0.2402659826180686,-0.5932929807192959,0.9417040358744395,0.9906445814109596,1.0,7/15,37.75%,TRMT61B;METTL3;TRMT6;ZC3H13;CBLL1;TRMT10C;TRMT61A
prerank,regulation of cellular amide metabolic process (GO:0034248),0.23151976832340598,0.5927634210952785,0.9474576271186441,1.0,1.0,3/32,8.48%,PICALM;ATXN2;SAMD8
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.25794645567974894,0.5925500256399362,0.9226519337016574,1.0,1.0,2/17,8.88%,MCU;DNM1L
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.286702541868588,0.5910413957438898,0.886,1.0,1.0,2/10,13.22%,MAP2K5;WNK1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.286702541868588,0.5910413957438898,0.886,1.0,1.0,2/10,13.22%,MAP2K5;WNK1
prerank,mitochondrial transcription (GO:0006390),-0.26567746148154,-0.5905677678989375,0.9375,0.9911675176448328,1.0,4/10,22.42%,TFAM;SLC25A33;TEFM;TFB1M
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.24100368955265142,-0.5900136844630899,0.9297872340425531,0.9907719668487072,1.0,8/14,40.25%,RPL7;RPL35;NOL9;RPL7L1;RPF2;PES1;NIFK;URB1
prerank,cilium movement (GO:0003341),0.21100961669015222,0.5897007270423348,0.9780907668231612,1.0,1.0,10/47,22.18%,ODAD1;ROPN1L;CFAP251;CCDC39;CCDC40;DNAI4;GAS8;DNAAF5;CFAP73;RSPH6A
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.22818231436374248,-0.5894852242490457,0.9690721649484536,0.9903553547975259,1.0,6/18,29.49%,MAN1B1;UBB;RNF103;UBC;RPS27A;UGGT2
prerank,regulation of stem cell population maintenance (GO:2000036),0.2537883053308481,0.5889626156589535,0.9353146853146853,1.0,1.0,5/18,20.94%,NCOA3;WDR43;NODAL;TAF6L;REST
prerank,regulation of cholesterol transport (GO:0032374),0.24592294479579235,0.5888874986305322,0.9375,1.0,1.0,10/20,26.86%,LRP1;ARV1;TTC39B;NFKB1;LAMTOR1;NR1H3;ABCA2;NR1H2;YJEFN3;ABCA13
prerank,ncRNA 3'-end processing (GO:0043628),0.2599185385711903,0.5887651081169839,0.9058380414312618,1.0,1.0,4/14,17.43%,INTS2;INTS5;INTS7;INTS8
prerank,osteoclast differentiation (GO:0030316),0.2404673158240164,0.5886962618625093,0.9184027777777778,1.0,1.0,2/22,6.71%,OSTM1;GAB2
prerank,tRNA methylation (GO:0030488),-0.1910714035256996,-0.585914584937604,0.989821882951654,0.9912391503819123,1.0,18/34,44.64%,METTL1;TRMT61B;MTO1;THADA;THUMPD2;METTL2A;METTL2B;TRDMT1;TRMT10C;TRMT5;GTPBP3;TRMT61A;TRMT10A;NSUN6;TRMT13;BCDIN3D;ALKBH8;FTSJ1
prerank,protein secretion (GO:0009306),0.2011413792020023,0.5850726120903544,0.9879336349924586,1.0,1.0,9/56,16.87%,WLS;ARFGAP3;RAB13;PORCN;MIA3;MON1A;TANGO2;RAB8B;STEAP3
prerank,response to light stimulus (GO:0009416),-0.1760375729729586,-0.5847452688378785,0.9835164835164835,0.9910839273433373,1.0,22/55,32.24%,MAP4K3;ERCC6;PRIMPOL;UBE2B;CRY2;MEN1;ERCC2;POLD1;DRD2;DTL;MAP2K7;CCAR2;PCLAF;GPR52;TYR;UBE2A;MAPK8;CIRBP;ERCC3;GPR88;TRIM32;USF1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.24144018169623216,0.5846260361217418,0.9438596491228071,1.0,1.0,7/22,24.29%,TP53;MED12;MED17;MED1;MED13;PSMC4;MED24
prerank,rRNA methylation (GO:0031167),0.2454511630104828,0.583968055652825,0.9407665505226481,1.0,1.0,10/22,29.04%,NOP2;ZCCHC4;BUD23;NSUN4;FDXACB1;MTERF4;METTL5;MRM1;FBLL1;MRM2
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.2478308358161199,0.5829576140540353,0.9398907103825137,1.0,1.0,2/19,8.88%,MCU;DNM1L
prerank,regulation of glycogen metabolic process (GO:0070873),0.2667862526520942,0.5822673236904441,0.922920892494929,1.0,1.0,1/12,5.83%,PPP1R3B
prerank,macrophage differentiation (GO:0030225),-0.24319032287313508,-0.581337038070262,0.9397321428571429,0.9918147860826116,1.0,3/13,15.37%,BMP4;VEGFA;IL31RA
prerank,microtubule nucleation (GO:0007020),-0.22195384755571806,-0.5812036637590257,0.9659863945578231,0.9912385814773257,1.0,9/19,31.53%,CLASP2;TUBGCP2;TPPP;TPX2;TUBG2;NDEL1;NDE1;CSNK1D;TUBGCP6
prerank,autophagosome assembly (GO:0000045),0.2044052225518248,0.5811438405188357,0.9746835443037974,1.0,1.0,20/52,27.02%,ATG5;WIPI1;AMBRA1;RAB43;BECN1;ATG7;IRGM;ATG2A;MFN2;TMEM41B;RAB7A;ATG16L1;UBXN2A;PIK3C3;ATG2B;ATG12;ATG3;ATG9B;TRAPPC8;GABARAPL1
prerank,autophagosome organization (GO:1905037),0.20584473636922387,0.5809704477212772,0.9855072463768116,1.0,1.0,19/50,27.02%,ATG5;WIPI1;AMBRA1;RAB43;BECN1;ATG7;IRGM;ATG2A;TMEM41B;RAB7A;ATG16L1;UBXN2A;PIK3C3;ATG2B;ULK3;ATG12;ATG3;ATG9B;GABARAPL1
prerank,tetrapyrrole metabolic process (GO:0033013),0.25083794903226353,0.5795320687192643,0.9434697855750487,1.0,1.0,5/18,22.04%,TCN2;TCN1;MTRR;MMACHC;CUBN
prerank,positive regulation of neutrophil migration (GO:1902624),0.25046974206823736,0.5794599405489712,0.95,1.0,1.0,2/18,8.88%,MCU;DNM1L
prerank,centromere complex assembly (GO:0034508),-0.18978840101807382,-0.5793440917907027,0.9873417721518988,0.9913705124484854,1.0,14/36,32.22%,HJURP;SMARCA5;CENPE;CENPH;NPM1;CENPA;MIS18BP1;CENPF;MIS18A;CENPX;OIP5;DLGAP5;CENPI;POGZ
prerank,double-strand break repair via homologous recombination (GO:0000724),0.18575358945326784,0.5789450064197557,0.9931600547195623,1.0,1.0,22/95,21.99%,RAD54L;NIPBL;SAMHD1;FBH1;FANCM;RBBP8;HUS1;RAD50;NSMCE2;REC8;MCM7;MCM2;ZFYVE26;POLL;NBN;FEN1;RAD51D;SLX4;XRCC3;MCM9;MCM5;YY1
prerank,protein methylation (GO:0006479),0.2140183298771611,0.5779787914909063,0.9758064516129032,1.0,1.0,12/40,23.75%,NSD1;NSD3;ETF1;EHMT2;EHMT1;SETD3;N6AMT1;CAMKMT;EEF1AKMT1;GSPT1;ICMT;PCMT1
prerank,cellular response to UV (GO:0034644),0.19143334120177422,0.5769296517785168,0.9928876244665719,1.0,1.0,20/76,22.24%,NEDD4;TP53;HYAL1;CDC25A;SIRT1;AURKB;IMPACT;ZBTB1;DDB2;SDE2;CREBBP;KDM1A;TAF1;XPA;FMR1;NOC2L;OPN1SW;YY1;CASP9;EP300
prerank,DNA recombination (GO:0006310),0.2212726763277228,0.57682274755615,0.971900826446281,1.0,1.0,8/37,20.03%,RAD54L;FBH1;MSH3;IGHMBP2;RAD50;RAD51D;XRCC3;LIG4
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.23635043556509,0.5759957713403009,0.9413854351687388,1.0,1.0,9/21,24.19%,PTEN;BTRC;CDC14B;FZR1;GOLGA2;UBE2S;FBXO5;GORASP1;MAD2L2
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.27706406098418973,0.5758259630818462,0.9312977099236641,1.0,1.0,5/11,27.48%,TP53;SP100;MAD2L2;FOXM1;MUC1
prerank,mitotic chromosome condensation (GO:0007076),0.23121685655292623,0.5758054669692283,0.9610169491525423,1.0,1.0,7/26,18.42%,CHMP1A;CSNK2A2;CSNK2A1;KMT5A;NCAPD3;RB1;NCAPD2
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.2291496050277635,0.5757791140194083,0.9646464646464646,1.0,1.0,6/28,18.82%,BID;DDX3X;BLOC1S2;DEDD;TNFRSF1A;DELE1
prerank,import into nucleus (GO:0051170),0.19268034423739988,0.5753921191051001,0.9954682779456193,1.0,1.0,2/73,3.53%,APPL2;TNPO1
prerank,inflammatory response (GO:0006954),0.1707304728577806,0.5750593389461974,1.0,1.0,1.0,17/195,11.08%,KIT;ADCY1;IL18;LOXL3;BDKRB2;TLR4;IL17D;NOX1;AFAP1L2;PARP4;HDAC4;HYAL1;ADM;RIPK2;CCL25;NOX4;NFATC3
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.18177033958730499,0.5745523570032292,0.9942196531791907,1.0,1.0,18/94,19.23%,CC2D2A;CEP250;CLASP1;NINL;RAB3IP;CEP162;SDCCAG8;NPHP1;ALMS1;CEP63;B9D2;CEP57;AKAP9;TCTN3;PCM1;CEP164;OFD1;PCNT
prerank,regulation of T cell differentiation (GO:0045580),0.21720468220959985,0.5743844372859148,0.9834983498349835,1.0,1.0,6/33,12.11%,TNFRSF18;TCF7;ABL1;ZBTB1;ZMIZ1;FANCA
prerank,transcription preinitiation complex assembly (GO:0070897),0.26498990386275656,0.574074618824283,0.9341317365269461,1.0,1.0,6/12,26.04%,TAF11;TBP;TAF7;TAF1;TAF12;BDP1
prerank,regulation of receptor recycling (GO:0001919),-0.22271896733316818,-0.5739957618717635,0.9700214132762313,0.9927523669091323,1.0,4/16,17.17%,ECE1;NSF;SNCA;SCRIB
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.21806326716575322,-0.5737084674657907,0.9713656387665198,0.9922256437503796,1.0,5/20,19.16%,APOE;SREBF2;NR1H4;RAN;LDLRAP1
prerank,autophagosome maturation (GO:0097352),0.21653123884760084,0.5705418775958592,0.9586092715231788,1.0,1.0,5/32,16.37%,LAMP2;UVRAG;LIX1L;VIPAS39;SNX14
prerank,regulation of biosynthetic process (GO:0009889),-0.24763468628468943,-0.5705327467199409,0.9593679458239278,0.992744255905092,1.0,2/11,13.16%,SLC25A33;SNCA
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.25954799116215654,0.5705255293995025,0.9226415094339623,1.0,1.0,2/13,12.26%,KPNA6;RGPD1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.22801595274432485,0.5704417828870605,0.9587073608617595,1.0,1.0,6/24,19.02%,ACD;TNKS2;HNRNPC;TENT4B;TINF2;SLX4
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.2738894117853137,0.5693205386349531,0.9423076923076923,1.0,1.0,3/10,22.54%,TGFBR2;CD55;ZBTB7B
prerank,regulation of microtubule-based movement (GO:0060632),0.27153472402353024,0.5683128180656541,0.9295774647887324,1.0,1.0,1/11,5.21%,MAP2
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.16216832347117416,-0.5679062165211689,1.0,0.9930390692302903,1.0,15/69,24.31%,HSPA5;DNAJC10;PSMC6;SEC61B;ERLIN1;SGTB;YOD1;MAN1B1;RNF103;RNF121;UBE2G2;UBQLN2;FAM8A1;AUP1;STUB1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.20505667935852487,0.5675833013152475,0.9781591263650546,1.0,1.0,12/46,24.06%,HK2;TIMM44;TOMM70;MFN2;PITRM1;TIMM10;TIMM17B;TIMM17A;TIMM21;HK1;DNAJC15;CHCHD4
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.21820311256428046,0.5672812280281088,0.9623287671232876,1.0,1.0,10/30,23.60%,FHIT;STYX;USP7;OGT;TLK2;HFE;CAMLG;TRIM39;SDCBP;BAG6
prerank,response to acidic pH (GO:0010447),0.2527177330750523,0.5668355613468491,0.9335863377609108,1.0,1.0,2/13,11.45%,RAB11B;IMPACT
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.2752931793368651,0.566430971333094,0.9282868525896414,1.0,1.0,3/10,19.91%,PTPN22;IFI35;NR1H3
prerank,tyrosine metabolic process (GO:0006570),0.27079279392379646,0.56576343752041,0.9341085271317829,1.0,1.0,11/11,72.94%,FAH;DCT;GSTZ1;TAT;PAH;TH;HGD;IYD;IL4I1;THAP4;TYR
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.23244826591692141,-0.5651715815497356,0.9425051334702259,0.9933636436905372,1.0,7/14,36.04%,RPS3;CD81;RELA;CARD11;BCL10;TRAT1;LCK
prerank,regulation of cell cycle phase transition (GO:1901987),-0.15336194024786243,-0.5629029035667599,1.0,0.993511126657055,1.0,41/91,39.13%,PSMB2;PSMD14;PSMC6;ATP2B4;CDKN1A;BUB3;PSMA4;PSMB9;CDC23;SKP1;PSMD11;PSMB10;PSMD2;ERCC2;MAD2L1;PSMA2;NEK10;TFAP4;PSMB3;PSMB5;UBE2D1;DDB1;PSMA7;PSMF1;PSMD7;ERCC3;TCIM;CDK1;CDC20;PSMA5;UBE2C;PSMD4;ANAPC10;PSME4;CCNB1;ANAPC1;PSMD3;CDKN1B;GTSE1;FBXW7;PSMC2
prerank,regulation of chromosome segregation (GO:0051983),0.2424268128911341,0.562889903994287,0.9455909943714822,1.0,1.0,3/16,12.06%,AURKB;CSNK2A2;CSNK2A1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.24186298779955895,-0.5623293254774069,0.959830866807611,0.9930798943516668,1.0,4/12,26.23%,WRNIP1;TIPIN;BLM;WDR18
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.23649707249245838,-0.5608808394889161,0.9721627408993576,0.9929526595727766,1.0,3/13,17.31%,GAS6;DHX9;CD74
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.24280848788619308,-0.5608163735926472,0.9445628997867804,0.9923453131865866,1.0,6/11,34.55%,UQCRB;UQCR11;CYCS;UQCC3;UQCR10;CYC1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.2558397495925491,0.5603530717122088,0.9370229007633588,1.0,1.0,2/14,6.89%,ETNK2;SLC27A1
prerank,negative regulation of double-strand break repair (GO:2000780),0.21679121375386337,0.5602321001048991,0.9677966101694915,1.0,1.0,10/30,25.91%,TRIP12;FBH1;UBR5;SMCHD1;TFIP11;OGG1;OTUB2;MAD2L2;SHLD2;UBQLN4
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.26954003618516464,0.5600889547511384,0.9362549800796812,1.0,1.0,1/11,6.47%,IL12B
prerank,mitochondrial translation (GO:0032543),0.1787591290814948,0.5587462904069069,0.9971590909090909,1.0,1.0,27/104,26.77%,MRPS23;MRPS6;MRPL37;MRPL2;MRPL53;MRPS7;MRPS26;MTRF1L;MRPL48;MRPL1;GFM2;MTRF1;MRPL45;MRPS17;CHCHD1;MRPL32;MRPL14;MRPL23;MRPS34;PTCD3;MRPS25;MRPL50;MRPL33;MRPS18B;MRPL19;TSFM;MRRF
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.2546118508482661,0.5585544259844969,0.9377224199288257,1.0,1.0,1/14,6.47%,IL12B
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.26982757963645065,0.557976058423315,0.9326530612244898,1.0,1.0,2/10,16.40%,TUT4;TUT7
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.2464256349346365,0.5567128058424818,0.9498069498069498,1.0,1.0,6/15,27.08%,UFD1;SYVN1;NPLOC4;DERL1;SELENOS;OS9
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.23476425120586294,-0.5566238839360683,0.9560669456066946,0.9931719660433079,1.0,5/13,31.26%,NCBP2;CPSF4;CPSF4L;CSTF2T;CPSF1
prerank,glycine transport (GO:0015816),0.26980963634918,0.5564317460096867,0.9255725190839694,1.0,1.0,1/10,4.88%,SLC6A9
prerank,intracellular protein transmembrane transport (GO:0065002),0.20605876790602515,0.5558178915516145,0.9759229534510433,1.0,1.0,15/42,25.50%,TIMM44;TOMM70;PEX10;PEX14;C2CD5;PEX16;PEX5;TIMM17B;RTN2;TIMM17A;TIMM21;PEX26;DNAJC15;CHCHD4;GRPEL2
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.2651890779579494,0.5526130567937281,0.9321705426356589,1.0,1.0,3/11,17.83%,LARP7;TENT4B;EXOSC3
prerank,error-free translesion synthesis (GO:0070987),-0.2043571861507944,-0.5513412663640013,0.9858823529411764,0.9941563511967797,1.0,10/22,31.81%,UBB;RPA1;RFC4;POLD1;RFC2;UBC;RPS27A;RFC5;RPA3;RPA2
prerank,positive regulation of immune response (GO:0050778),0.18914349566836808,0.5498898645178404,0.9896142433234422,1.0,1.0,9/64,14.77%,IFNK;IL12B;PLSCR1;HRG;RSAD2;SIRT1;NMI;IFI35;SPHK2
prerank,sensory perception of pain (GO:0019233),0.22950596485019703,0.5469885764862943,0.9690189328743546,1.0,1.0,1/21,2.13%,RETREG1
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.23616976519808536,0.5416130428505161,0.9497307001795332,1.0,1.0,2/19,7.64%,CHRNA5;RAPSN
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.2168060408697467,-0.54098354101196,0.96875,0.9964575748889506,1.0,3/16,14.44%,IRAK3;SHFL;GLE1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.21748700484618405,-0.5406722232813371,0.985200845665962,0.9959121809346259,1.0,9/16,39.65%,CELF4;TRA2A;RBM3;RBMXL1;CIRBP;SF3B4;CELF3;NCBP1;RBMX
prerank,positive regulation of telomere capping (GO:1904355),0.23515917193224078,0.5406555901313543,0.9779005524861878,1.0,1.0,3/17,12.69%,TNKS2;AURKB;PNKP
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.23159228635954432,0.5398304006279324,0.9629629629629629,1.0,1.0,3/17,14.57%,AFG1L;COX10;COX8A
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.23375205751336653,0.5391591443251161,0.9543795620437956,1.0,1.0,2/17,7.30%,SERPINE1;ANO6
prerank,response to hexose (GO:0009746),-0.19539503859037324,-0.5389789712125957,0.9913606911447084,0.9957310381902166,1.0,12/25,44.77%,THBS1;EIF2B3;IRS2;EIF2B2;KHK;EIF2B5;ZBED3;SLC2A5;NEUROD1;LPL;SELENOT;HNF4A
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.148544215150168,-0.5385601335413448,0.9966887417218543,0.9951994328713767,1.0,14/88,20.29%,FBXL7;PSMB2;FBXL5;PSMD14;FBXL2;PSMC6;FBXO31;PSMA4;PSMB9;SKP1;PSMD11;PSMB10;PSMD2;AMN1
prerank,C-terminal protein amino acid modification (GO:0018410),0.259717784479587,0.5385414954542662,0.9351145038167938,1.0,1.0,7/11,26.71%,ATG5;ATG7;FOLH1;ICMT;AGTPBP1;ATG12;GPLD1
prerank,protein localization to phagophore assembly site (GO:0034497),0.2573515955478172,0.5378973365926852,0.9368836291913215,1.0,1.0,2/11,13.99%,WIPI1;MFN2
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.2592121900740094,0.537470273554026,0.952,1.0,1.0,2/11,15.26%,AHCYL1;ZFP36L1
prerank,transcription by RNA polymerase I (GO:0006360),-0.18063693961030747,-0.5374258596792074,0.9975124378109452,0.9948493848326933,1.0,8/34,22.64%,CAVIN1;TAF1B;GTF2H1;GTF2H4;GTF2H5;ERCC2;POLR1F;POLR2L
prerank,cell cycle G1/S phase transition (GO:0044843),-0.15955456109212898,-0.5373754582454567,1.0,0.9942352626110547,1.0,15/61,24.88%,USP29;PLK2;CUL3;E2F3;CDKN1A;ACVR1;EIF4E;PIM2;INHBA;PHF8;MAP3K11;PLK3;CDKN3;CCNE2;HINFP
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.23536764829943868,-0.5371775344812836,0.9624217118997912,0.9936564508534874,1.0,2/11,10.04%,TGFB1;ID2
prerank,dopaminergic neuron differentiation (GO:0071542),-0.20376779046920118,-0.5347947577058799,0.9815668202764977,0.9936332822005285,1.0,7/19,30.02%,CTNNB1;VEGFA;MANF;LRP6;LMX1A;WNT2;LMX1B
prerank,neuron fate commitment (GO:0048663),0.24352866263974982,0.5346583680956452,0.946983546617916,1.0,1.0,1/14,3.46%,TGFBR1
prerank,regulation of cilium movement (GO:0003352),0.2623022847100175,0.5345118264926586,0.9676190476190476,1.0,1.0,10/10,73.79%,CCDC39;CCDC40;DNAH11;ODAD2;DRC1;DNAAF1;CFAP298;CFAP206;CCDC65;CFAP43
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.24686565799630683,0.5342825664601387,0.9496981891348089,1.0,1.0,2/13,14.77%,GAB2;SPHK2
prerank,acyl-CoA biosynthetic process (GO:0071616),0.23402258641719026,0.5326251140703019,0.9709090909090909,1.0,1.0,3/16,13.24%,SCD5;MLYCD;GCDH
prerank,negative regulation of lymphocyte activation (GO:0051250),0.21626237842714838,0.5318403821486575,0.9750445632798574,1.0,1.0,5/21,17.62%,PTPN22;LGALS3;PIBF1;GPNMB;LAX1
prerank,regulation of spindle organization (GO:0090224),-0.20305365287562807,-0.5318355466314085,0.981859410430839,0.9937335271627359,1.0,6/18,33.45%,GNAI1;BORA;TPX2;SENP6;PSRC1;DCTN1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.2263781493958893,-0.5303094992508124,0.9549356223175965,0.9934696915745875,1.0,5/12,31.17%,CEACAM1;ERLIN1;TRIB3;ACADVL;BRCA1
prerank,tRNA metabolic process (GO:0006399),0.22953446068399094,0.530171619205995,0.9553072625698324,1.0,1.0,9/17,33.70%,RPP21;POP7;POP1;KARS1;THG1L;SSB;DTD2;AARS1;DTD1
prerank,negative regulation of cell division (GO:0051782),0.2535936388164535,0.5301658893049297,0.9416195856873822,1.0,1.0,4/11,21.76%,AURKB;VPS4A;CHMP4C;ORC6
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.2363133398592292,-0.5295614929432538,0.9653061224489796,0.9930226675263606,1.0,5/10,31.81%,THOC5;RFWD3;CCAR2;ETAA1;RPA2
prerank,metallo-sulfur cluster assembly (GO:0031163),0.22355492132812266,0.5290328457598978,0.9727272727272728,1.0,1.0,7/22,24.36%,NFU1;CIAO3;ISCA1;NFS1;MMS19;ABCB7;IBA57
prerank,negative regulation of RNA splicing (GO:0033119),-0.20441061561958956,-0.5274193855477878,0.9819819819819819,0.9928907062027582,1.0,7/19,28.18%,TMBIM6;RPS26;RNPS1;SRSF12;RPS13;SRSF6;PTBP2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.2312570639206329,0.5273642662672137,0.9707495429616088,1.0,1.0,16/16,76.90%,FBH1;SMCHD1;MAD2L2;SHLD2;UBQLN4;KLHL15;FANCB;SHLD1;RADX;RMI2;PARPBP;RIF1;HELB;SHLD3;POLQ;CGAS
prerank,acetyl-CoA metabolic process (GO:0006084),-0.21005894684547635,-0.5266675463241833,0.9831223628691983,0.9924320329023766,1.0,3/15,13.30%,HMGCS1;DIP2A;PMVK
prerank,C21-steroid hormone metabolic process (GO:0008207),0.2254196314880219,0.5258784808168364,0.978984238178634,1.0,1.0,2/20,10.73%,FDXR;TSPOAP1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.18771398605088013,0.5256882588387477,0.993485342019544,1.0,1.0,14/51,22.04%,LEMD2;CCNB2;NUP98;NUP43;LBR;REEP4;VPS4A;NUP155;CHMP4C;SUMO1;NUP188;CHMP2A;UBE2I;CC2D1B
prerank,mitotic nuclear membrane organization (GO:0101024),0.18771398605088013,0.5256882588387477,0.993485342019544,1.0,1.0,14/51,22.04%,LEMD2;CCNB2;NUP98;NUP43;LBR;REEP4;VPS4A;NUP155;CHMP4C;SUMO1;NUP188;CHMP2A;UBE2I;CC2D1B
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.1820363132533522,-0.5254926744444601,0.9948979591836735,0.9920830453341276,1.0,9/29,23.94%,DCP1B;HBS1L;LSM1;DCP2;CNOT7;LSM4;LSM7;EXOSC4;EXOSC1
prerank,defense response to tumor cell (GO:0002357),0.2520375172456423,0.524958472992704,0.95,1.0,1.0,3/10,17.54%,PLK5;DLEC1;RBMS3
prerank,nuclear body organization (GO:0030575),0.239903628501957,0.5241466965525521,0.963265306122449,1.0,1.0,5/12,24.43%,SRPK2;PML;DYRK3;USPL1;ZPR1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.25164421716181923,0.5239522382257366,0.9435483870967742,1.0,1.0,5/10,29.93%,ZNHIT6;RUVBL1;PIH1D2;PIH1D1;NUFIP1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.20770245649305774,0.5212071584254466,0.9793459552495697,1.0,1.0,25/25,79.26%,SCAF11;PRPF3;SNRNP40;PRPF6;SRSF10;SF3B1;SRSF4;SF3B3;KHSRP;SMNDC1;PRPF4;DBR1;SRRM1;WDR83;TRA2B;TXNL4A;GEMIN2;PRPF8;DDX23;SLU7;SF3B4;MPHOSPH10;BCAS2;SF3A3;LSM1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.23165887616655667,0.5202533146370095,0.9792452830188679,1.0,1.0,3/14,11.58%,APH1B;DYRK1A;ADAM17
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.20390802195596164,0.5191805036914746,0.9898305084745763,1.0,1.0,5/27,13.89%,TLR4;TAB2;LY96;MAP3K1;TLR5
prerank,nuclear membrane reassembly (GO:0031468),0.18259090431321012,0.5188085126165252,0.9968051118210862,1.0,1.0,16/54,23.82%,LEMD2;CCNB2;NUP98;NUP43;LBR;REEP4;VPS4A;NUP155;CHMP4C;SUMO1;NUP188;CHMP2A;UBE2I;CC2D1B;IST1;UBXN2A
prerank,defense response to fungus (GO:0050832),0.22469058875199113,0.5187152811312737,0.9810606060606061,1.0,1.0,2/17,9.00%,HRG;FAM3A
prerank,regulation of oxidoreductase activity (GO:0051341),0.23363954540791823,0.5162167223900043,0.9626865671641791,1.0,1.0,3/13,19.95%,ABL1;SIRT4;ATP7A
prerank,peptidyl-proline hydroxylation (GO:0019511),0.2470256337488713,0.5152046300610805,0.9615384615384616,1.0,1.0,4/11,23.78%,P4HA1;OGFOD1;EGLN1;CRTAP
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.21891484551620202,0.5133994662642657,0.9607142857142857,1.0,1.0,18/18,78.13%,THEM4;PPIF;SLC25A4;SLC25A31;BCL2;MUL1;BCL2L1;SLC25A5;HEBP2;NAIF1;BAK1;TMEM102;BAD;ALKBH7;CAMK2A;PMAIP1;SPG7;BNIP3
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.20097016040181356,-0.51301396396432,0.9757174392935982,0.9941962236370959,1.0,7/16,34.61%,ATP5F1E;ATP5PF;STOML2;ATP5MF;ATP5PD;ATP5MC1;ATP5F1B
prerank,negative regulation by host of viral transcription (GO:0043922),0.23879472693032017,0.5110861351254113,0.9569471624266145,1.0,1.0,12/12,76.14%,HDAC1;REST;TARDBP;POU2F3;CCL5;CCL3;PSMC3;CCL4;INPP5K;JUN;HMGA2;TFAP4
prerank,Golgi to endosome transport (GO:0006895),0.22570140570505923,0.5105823318581235,0.9529190207156308,1.0,1.0,7/16,25.11%,WIPI1;AP2A1;VPS13A;MON2;AP4M1;KLHL20;KIF16B
prerank,chromatin remodeling at centromere (GO:0031055),0.1955966730190108,0.5103850283212086,0.9844559585492227,1.0,1.0,14/31,29.42%,NASP;CENPO;CENPC;CENPV;CENPK;CENPT;ITGB3BP;RUVBL1;RBBP7;RSF1;RBBP4;CENPS;CENPN;CENPQ
prerank,natural killer cell mediated immunity (GO:0002228),0.22286827248416569,0.5073842413419308,0.9736842105263158,1.0,1.0,4/15,22.69%,KIF5B;CEBPG;ULBP1;LYST
prerank,aerobic electron transport chain (GO:0019646),0.167760959427075,0.5029159026581222,1.0,1.0,1.0,16/68,22.96%,AFG1L;NDUFAB1;UQCRC2;NDUFS1;NDUFV2;COX10;COX8A;NDUFS4;NDUFA2;UQCRC1;COX15;NDUFS5;NDUFA9;NDUFB2;SDHD;UQCRH
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.24739151804800308,0.49915975328576256,0.9603174603174603,1.0,1.0,2/10,16.59%,TP53;SP100
prerank,negative regulation of transferase activity (GO:0051348),0.19561924906157047,0.4988938248355401,0.9776247848537005,1.0,1.0,4/28,10.90%,NPRL2;TP53;ABL1;EIF4A2
prerank,establishment of protein localization to extracellular region (GO:0035592),0.18111711409121659,0.49740575471944326,0.9920255183413078,1.0,1.0,10/39,21.45%,ARFGAP3;RAB13;MIA3;MON1A;TANGO2;RAB8B;STEAP3;LTBP2;MIA2;AFM
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.2132287919367808,-0.49490689959987527,0.9728033472803347,0.9968740884317786,1.0,4/12,28.37%,STK33;CHEK2;TOPBP1;HUS1B
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.16523517794370887,0.4947879386978414,1.0,1.0,1.0,16/69,22.96%,AFG1L;NDUFAB1;UQCRC2;NDUFS1;NDUFV2;COX10;COX8A;NDUFS4;NDUFA2;UQCRC1;COX15;NDUFS5;NDUFA9;NDUFB2;SDHD;UQCRH
prerank,mitochondrial gene expression (GO:0140053),0.1775331139726466,0.49442527416798304,0.993431855500821,1.0,1.0,11/42,23.20%,MRPS6;MRPL2;TWNK;MRPS7;FOXO3;GFM2;MRPS17;MRPL23;MRPS34;PTCD3;POLRMT
prerank,phospholipid homeostasis (GO:0055091),-0.21477321443161876,-0.49281965944097655,0.9897330595482546,0.9966074641511762,1.0,3/11,26.80%,ABCG1;RCN3;ABCA1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.20957465061715302,0.49203590433579414,0.9849340866290018,1.0,1.0,1/18,3.85%,BID
prerank,multivesicular body assembly (GO:0036258),0.18972837620248886,0.49158414563694286,0.9882352941176471,1.0,1.0,12/30,28.83%,CHMP1A;VPS37A;SNF8;VPS4A;CHMP4C;CHMP2A;IST1;MVB12A;VTA1;STAM2;CHMP1B;VPS36
prerank,RNA interference (GO:0016246),-0.1897368706855339,-0.49078226396153024,0.9867256637168141,0.9962943393179339,1.0,3/17,16.57%,TSNAX;DROSHA;DHX9
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.18614813299389504,-0.4903080661681145,0.9934497816593887,0.9957528571844703,1.0,5/19,26.06%,AR;MAF1;POLR3F;POLR3C;NAB2
prerank,ERAD pathway (GO:0036503),0.15925398284537748,0.4900475769226729,1.0,1.0,1.0,30/83,28.99%,PRKN;ERLEC1;ECPAS;DNAJB2;AMFR;DNAJB14;UFD1;ERLIN2;SYVN1;DNAJC18;NPLOC4;UBE4B;UBE2J2;GET4;TOR1A;DERL1;SELENOS;BAG6;RNF5;FBXO17;UBXN4;USP19;TMEM67;ANKZF1;TRIM13;OS9;TMUB2;UBE4A;SGTA;UBXN8
prerank,COPII-coated vesicle budding (GO:0090114),0.1667133945957352,0.4900116457728018,0.9985163204747775,1.0,1.0,20/68,23.59%,SEC31B;TRAPPC9;MIA3;TGFA;STX5;SEC23IP;F8;SCFD1;TRAPPC5;PPP6R3;SEC31A;BET1;GOLGA2;SCAP;FOLR1;SEC24C;SEC24A;GORASP1;F5;SEC16A
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.18527107876758164,0.49000069368565213,0.9935064935064936,1.0,1.0,6/37,16.11%,SIDT2;DNASE1L1;EXOSC7;SND1;DFFB;DNASE1L2
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.20004390469772376,0.4866175298743487,0.9836956521739131,1.0,1.0,8/20,25.81%,APH1B;ADAM17;MBTPS1;NFKB1;NCSTN;ADAM9;PSEN2;SPPL2A
prerank,positive regulation of cell killing (GO:0031343),0.22936006597513026,0.4862591548573933,0.9777777777777777,1.0,1.0,1/13,5.87%,NOX1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.18658172496638048,0.48612368178431326,0.9933884297520661,1.0,1.0,10/31,25.86%,EXOSC7;DDX6;DCP1A;DIS3;NT5C3B;EXOSC3;POLR2G;EDC4;LSM6;LSM3
prerank,midbody abscission (GO:0061952),0.21127539976386694,0.4853151119918879,0.9754253308128544,1.0,1.0,5/17,21.80%,CHMP1A;VPS4A;CHMP4C;CHMP2A;MITD1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.18663357609936482,-0.48380783547726125,0.9954853273137697,0.9960796975147704,1.0,7/17,34.61%,ATP5F1E;ATP5PF;STOML2;ATP5MF;ATP5PD;ATP5MC1;ATP5F1B
prerank,regulation of histone modification (GO:0031056),0.21298524999472185,0.48242267323219185,0.9648148148148148,1.0,1.0,2/13,14.24%,MTHFR;FLCN
prerank,translational elongation (GO:0006414),0.15350987784384687,0.4818725424442561,1.0,1.0,1.0,26/101,26.23%,MRPS23;MRPS6;MRPL37;MRPL2;MRPL53;MRPS7;MRPS26;MRPL48;NEMF;MRPL1;GFM2;MRPL45;MRPS17;CHCHD1;MRPL32;MRPL14;MRPL23;MRPS34;PTCD3;MRPS25;MRPL50;LTN1;MRPL33;MRPS18B;MRPL19;TSFM
prerank,regulation of T cell activation (GO:0050863),0.17243521485767235,0.48023435852608626,0.9984126984126984,1.0,1.0,8/42,17.62%,PTPN22;CYRIB;ABL1;LAT;LGALS3;CCR2;GPNMB;LAX1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.23556674294731492,0.4746357932119166,0.9731800766283525,1.0,1.0,1/10,8.32%,CPEB3
prerank,glutathione metabolic process (GO:0006749),0.17462067432120887,0.47305401958701054,0.993485342019544,1.0,1.0,7/38,20.02%,GSTT1;CTNS;GSTA3;MMACHC;GSTT2;ETHE1;CNDP2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.17248311353434972,0.4696447266816893,0.9982788296041308,1.0,1.0,16/38,29.42%,ATRX;NASP;CENPO;CENPC;CENPK;CENPT;ASF1A;ITGB3BP;RUVBL1;RBBP7;RSF1;RBBP4;CENPS;IPO4;CENPN;CENPQ
prerank,DNA replication checkpoint signaling (GO:0000076),-0.18506375121712032,-0.46817439214950135,0.9957983193277311,0.9975484452904846,1.0,5/16,28.37%,TIPIN;CDC45;DNA2;TOPBP1;HUS1B
prerank,positive regulation of mitochondrial translation (GO:0070131),0.2118404512709059,0.46759650146501497,0.9866156787762906,1.0,1.0,3/14,20.23%,MPV17L2;RPUSD4;FASTKD3
prerank,regulation of mitotic spindle assembly (GO:1901673),0.19849287354371722,0.4675572619646514,0.9858156028368794,1.0,1.0,9/19,32.33%,CHMP1A;CHMP4C;CHMP2A;EML3;DRG1;CHMP1B;HSPA1A;CEP97;PLK1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.22241422510991096,0.46754397282497717,0.9741219963031423,1.0,1.0,1/11,7.97%,SMARCA4
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.18605374082436418,0.46686259954558157,0.9931506849315068,1.0,1.0,5/29,11.87%,LARP1;GDNF;THRAP3;NOCT;AXIN2
prerank,double-strand break repair via break-induced replication (GO:0000727),0.21465889875437744,0.4642895928502549,0.975,1.0,1.0,3/12,21.23%,MCM7;MCM2;MCM5
prerank,regulation of macrophage differentiation (GO:0045649),0.2017191705004019,0.4615306731608374,0.9819819819819819,1.0,1.0,5/15,24.64%,RIPK1;PRKCA;INHA;IL34;FADD
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.2028147438489727,-0.4594312769686287,0.9829424307036247,0.997873759596631,1.0,6/11,37.47%,CTNNB1;LRP6;LMX1A;WNT2;FZD1;NR4A2
prerank,cellular response to misfolded protein (GO:0071218),0.19295945147475324,0.4587418938542282,0.9875666074600356,1.0,1.0,7/20,23.64%,DNAJB14;UFD1;DNAJC18;TOR1A;DERL1;BAG6;RNF5
prerank,protein insertion into ER membrane (GO:0045048),0.16983770695223582,0.45663307029145395,0.9983844911147012,1.0,1.0,9/37,23.60%,TRAM2;EMC2;STX5;EMC1;EMC3;UBE2J2;CAMLG;GET4;BAG6
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.21879591985802183,0.45450098011169204,0.9819277108433735,1.0,1.0,3/10,19.76%,IMPACT;HIF1AN;CITED2
prerank,regulation of DNA metabolic process (GO:0051052),0.16772231942651164,0.4543014840364531,0.9984567901234568,1.0,1.0,7/44,18.62%,HDAC8;SMG1;WDR70;KAT7;MPHOSPH8;USP1;NBN
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.1959014562225972,0.4517722071563901,0.9884615384615385,1.0,1.0,4/16,22.69%,KIF5B;CEBPG;ULBP1;LYST
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.1821988785736004,0.44996328668533436,0.9909747292418772,1.0,1.0,8/23,27.08%,UFD1;SYVN1;NPLOC4;DERL1;SELENOS;SEC16A;SEC13;OS9
prerank,DNA geometric change (GO:0032392),-0.16374361612991448,-0.44979092531681514,0.995249406175772,0.9982164233008854,1.0,6/24,25.56%,ANXA1;DHX9;DNA2;BLM;RECQL5;RECQL
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.2080672873890556,0.4496924054814042,0.9905838041431262,1.0,1.0,2/10,17.97%,RYK;WNT5A
prerank,CENP-A containing chromatin organization (GO:0061641),0.17177972206297593,0.44622498203944805,0.9982486865148862,1.0,1.0,13/29,29.42%,NASP;CENPO;CENPC;CENPK;CENPT;ITGB3BP;RUVBL1;RBBP7;RSF1;RBBP4;CENPS;CENPN;CENPQ
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.17177972206297593,0.44622498203944805,0.9982486865148862,1.0,1.0,13/29,29.42%,NASP;CENPO;CENPC;CENPK;CENPT;ITGB3BP;RUVBL1;RBBP7;RSF1;RBBP4;CENPS;CENPN;CENPQ
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.18669473995186936,0.4455264624400656,0.9894551845342706,1.0,1.0,2/20,11.67%,ATM;IK
prerank,spindle assembly checkpoint signaling (GO:0071173),0.18669473995186936,0.4455264624400656,0.9894551845342706,1.0,1.0,2/20,11.67%,ATM;IK
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.18669473995186936,0.4455264624400656,0.9894551845342706,1.0,1.0,2/20,11.67%,ATM;IK
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.1882088538977862,-0.4425350868116785,0.9917184265010351,0.9969361053914195,1.0,2/12,17.47%,CUL3;CDC23
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.1882088538977862,-0.4425350868116785,0.9917184265010351,0.9969361053914195,1.0,2/12,17.47%,CUL3;CDC23
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.1882088538977862,-0.4425350868116785,0.9917184265010351,0.9969361053914195,1.0,2/12,17.47%,CUL3;CDC23
prerank,macrophage migration (GO:1905517),0.20213287946440553,0.44063988020568423,0.9855855855855856,1.0,1.0,4/13,21.81%,LGALS3;CCR2;CXCL17;P2RX4
prerank,iron-sulfur cluster assembly (GO:0016226),0.17941307066388495,0.43806559972078457,1.0,1.0,1.0,7/24,24.36%,NFU1;CIAO3;ISCA1;NFS1;MMS19;ABCB7;IBA57
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.16153169014084523,0.43585333029504164,0.9983606557377049,1.0,1.0,38/38,83.89%,NDUFAB1;NDUFS1;NDUFV2;NDUFS4;NDUFA2;NDUFS5;NDUFA9;NDUFB2;NDUFS2;NDUFA12;NDUFB4;NDUFS8;NDUFV3;NDUFB9;NDUFA1;NDUFAF1;NDUFA10;NDUFV1;NDUFA5;NDUFS3;NDUFB6;NDUFA4;NDUFA3;NDUFC1;NDUFB3;NDUFC2;NDUFB10;NDUFA8;NDUFA13;NDUFA7;NDUFA11;NDUFA6;NDUFB5;NDUFB8;NDUFS7;NDUFS6;NDUFB7;NDUFB11
prerank,regulation of viral release from host cell (GO:1902186),0.1804426903439698,0.4335026221101029,0.9909747292418772,1.0,1.0,7/21,26.35%,TRIM62;PML;VPS4A;CHMP2A;TRIM5;TRIM8;TRIM13
prerank,multivesicular body organization (GO:0036257),-0.14433793857579735,-0.43220260003792926,0.9974874371859297,0.9971217302153389,1.0,5/31,18.29%,RAB27A;PDCD6IP;VPS37C;CHMP4B;CHMP4A
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.15774600302911354,0.43215552132954693,1.0,1.0,1.0,14/42,27.91%,ARID2;FBH1;SMCHD1;PPP4R2;KDM1A;FUS;MMS19;FIGNL1;MAD2L2;SHLD2;UBQLN4;RTEL1;RAD51AP1;CHEK1
prerank,rRNA modification (GO:0000154),0.17969976760253775,0.43176190060837816,0.993103448275862,1.0,1.0,21/21,82.05%,ZCCHC4;BUD23;NSUN4;MTERF4;METTL5;FBLL1;MRM2;TSR3;THUMPD1;NOP10;GAR1;TRMT112;FTSJ3;TFB2M;DIMT1;NAT10;NSUN3;DKC1;TFB1M;NHP2;FBL
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.1823345350905059,0.4268246528494914,0.9942857142857143,1.0,1.0,6/17,27.08%,UFD1;SYVN1;NPLOC4;DERL1;SELENOS;OS9
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.1831493306533445,0.42515081660699483,0.9930434782608696,1.0,1.0,4/18,19.13%,ROPN1L;CCDC39;CCDC40;OFD1
prerank,RNA methylation (GO:0001510),0.14422151373251357,0.42209468913236814,1.0,1.0,1.0,10/60,18.40%,TRMT44;RBM15;NOP2;WTAP;METTL6;ZCCHC4;LCMT2;VIRMA;BUD23;NSUN4
prerank,aromatic amino acid family catabolic process (GO:0009074),0.18775414166879084,0.4205664983797062,0.9963235294117647,1.0,1.0,14/15,60.21%,FAH;KMO;HAAO;KYAT1;GSTZ1;TAT;KYNU;ACMSD;IDO1;HGD;TDO2;IL4I1;IDO2;AADAT
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.17271555770265706,0.4192009482402946,0.9947916666666666,1.0,1.0,2/21,11.67%,ATM;IK
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.1772471443217963,0.41778247523914785,0.9981378026070763,1.0,1.0,4/19,18.07%,ACD;HNRNPC;TENT4B;TINF2
prerank,interstrand cross-link repair (GO:0036297),0.14535121299030948,0.41581723605041776,1.0,1.0,1.0,10/53,20.38%,RNF8;FANCI;FANCM;FANCA;USP1;SLX4;XPA;FANCD2;XRCC3;MCM9
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.19439365105428646,0.4153799595713293,0.9961389961389961,0.999885229777542,1.0,3/12,22.54%,CHAMP1;CENPC;MIS12
prerank,regulation of chromatin organization (GO:1902275),0.1634856855851331,0.3732555377402728,1.0,1.0,1.0,14/14,83.67%,TLK2;SETD1A;METTL4;TLK1;CDK9;MKI67;ALKBH4;PARG;IGF2;HNRNPU;SSRP1;SETD5;MLLT3;HPF1
prerank,regulation of DNA recombination (GO:0000018),0.13913100746195153,0.36465413185668166,1.0,1.0,1.0,11/32,28.30%,MSH3;RAD50;PPP4R2;KDM1A;FIGNL1;H1-0;SHLD2;RTEL1;RAD51AP1;CHEK1;KPNA1
prerank,cranial nerve development (GO:0021545),0.17099683313635905,0.3622123219174776,0.9981412639405205,1.0,1.0,1/11,7.55%,CHD7
prerank,regulation of mitotic spindle organization (GO:0060236),0.13769242009258753,0.3605984595014481,1.0,1.0,1.0,15/35,32.33%,CHMP1A;CLTC;CHMP4C;MAP9;CHMP2A;EML3;PARP3;DRG1;FSD1;CHMP1B;NUMA1;RAE1;HSPA1A;CEP97;PLK1
prerank,organophosphate catabolic process (GO:0046434),0.1628100672652819,0.33705516859301626,1.0,1.0,1.0,2/11,20.67%,ABHD12;PLBD2
prerank,macrophage chemotaxis (GO:0048246),0.15246045694200336,0.3106716983364192,1.0,1.0,1.0,10/10,84.76%,LGALS3;CXCL17;TAFA4;EDN2;SAA1;CCL5;CCL3;CKLF;CCL2;EDNRB
prerank,regulation of spindle assembly (GO:0090169),0.10887426796002538,0.2699573523188715,1.0,0.9999982114695773,1.0,10/25,32.33%,CHMP1A;CHMP4C;CHMP2A;EML3;DRG1;CHMP1B;NUMA1;HSPA1A;CEP97;PLK1
